{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "- **Amount of the 5.000 % senior notes due April 2030**  \n  * FY 2022 – $606 million (the 2022 Form 10‑K lists the same balance for this series of notes).  \n  * FY 2023 – $606 million, as shown in the “Notes outstanding” schedule (Nov 29 2023)【page_81】.  \n  * FY 2024 – $606 million, unchanged in the comparable schedule (Nov 3 2024)【page_81】.  \n\n- **Interpretation** – Over the three‑year span the company’s exposure to this fixed‑rate, long‑dated tranche stayed flat at roughly $0.6 billion.  AVGO has neither added to nor retired this particular issue, indicating a deliberate “hold‑steady” approach: it keeps the existing low‑cost, long‑maturity debt on the balance sheet while using newer senior‑note issuances and term‑loan repayments to refinance other obligations and manage overall leverage. This consistency reflects a debt‑management strategy that preserves a stable, predictable interest‑expense profile for the 5 % April 2030 notes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that AVGO's exposure to the 5.000% notes due April 2030 was $606 million in FY 2022, whereas the ground truth indicates it was $1,086 million in 2022, decreasing to $606 million in 2023 and remaining flat in 2024. This is a critical factual error in the quantitative timeline. The LLM claims the 2022 10-K lists $606 million, which contradicts the verified data. (2) Quantitative accuracy is severely compromised: the reported value for 2022 is off by $480 million, a significant miscalibration. While 2023 and 2024 figures are correct, the failure to capture the decrease from 2022 to 2023 undermines the core of the question about evolution over the three-year period. (3) The reasoning and interpretation are plausible but based on incorrect data. The LLM infers a 'hold-steady' strategy due to flat exposure, but the ground truth shows a major reduction from 2022 to 2023, indicating active debt reduction rather than stability. Thus, the multi-hop synthesis fails because it misrepresents the initial state of the obligation. (4) Contextual relevance is high—the response addresses the right metric, time frame, and strategic interpretation—but the factual foundation is flawed. The qualitative reasoning would score higher if based on accurate numbers. Overall, partial credit is given for correct 2023/2024 values and relevant discussion, but the major error in 2022 data limits correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 400,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement for the closed block was first disclosed in the 2023 filing, where the company transferred ≈ 59 % of the closed‑block risk to an unaffiliated reinsurer and retained the balance. The 2024 filing repeats the same figure— 59 % of the closed block is still reinsured on a modified‑coinsurance basis (the 2022 filing gave a virtually identical 59.25 %). The steadiness of this risk‑transfer percentage shows that MetLife is deliberately maintaining a long‑term reinsurance strategy that consistently cedes roughly three‑fifths of the closed‑block exposure while keeping the remaining portion on its books to preserve upside and manage capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all percentages are correct: 59.25% in 2022, 59% in 2023, and 59% in 2024—minor rounding to '≈59%' is acceptable. The claim that the 2022 filing referenced a 'virtually identical' 59.25% is factually sound. (2) The answer correctly identifies the unaffiliated third-party reinsurer and the consistent percentage of risk transferred across years. (3) The reasoning about MetLife’s long-term strategy—maintaining stable risk transfer while retaining some exposure for capital and upside management—is logically sound and aligns with the ground truth’s interpretation of 'deliberate and sustained reinsurance strategy.' (4) One minor omission: the LLM does not mention the deposit method of accounting or the right of offset, which are part of the original answer and relevant to how the agreement was handled. Additionally, while the growth in total net ceded reinsurance recoverables ($6.3B to $17.6B) is absent in the LLM response, this does not undermine the core focus on the closed block’s consistent reinsurance percentage. The answer remains contextually relevant and semantically equivalent in addressing the evolution and strategic implication. Thus, the answer earns a 9 for correctness due to high factual accuracy and strong reasoning, with only slight incompleteness on technical accounting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 392,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements for its investments, advances and long‑term receivables fell sharply – from **$1.494 billion in 2022** to **$800 million in 2023** and then to **$491 million in 2024** (a drop of roughly $1 billion, or about two‑thirds, over the period). This downward trend indicates that the company is either reducing its derivative exposure or becoming more efficient at netting and margining its positions, reflecting tighter, more effective management of its derivative risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1.494 billion (equivalent to $1,494 million) in 2022, $800 million in 2023, and $491 million in 2024. The observation of a roughly $1 billion drop (from $1,494M to $491M is a $1,003M decrease) and 'about two-thirds' decline is a reasonable approximation (~67% reduction), which is acceptable for qualitative summary. (2) The answer is complete, addressing both the change over time (2022 to 2024) and the implication regarding derivative exposure management. (3) Entities are correct: ExxonMobil, 'collateral under master netting arrangements', and the specific balance sheet category 'Investments, advances and long-term receivables' are accurately referenced. (4) The reasoning is sound: the multi-hop synthesis across three years is correctly interpreted, and the conclusion — that the trend suggests reduced derivative exposure or improved netting/margining efficiency — aligns exactly with the ground truth's interpretation. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 329,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "- **Fiscal 2022:** The 3.625 % senior notes that mature in October 2024 were still on the balance sheet (the filing notes that the series existed, but the exact carrying amount is not broken out in the excerpts).  \n- **Fiscal 2023:** The schedule of outstanding senior notes shows a remaining **$622 million** of the 3.625 % notes due October 2024 (page 81, “October 2023” column).  \n- **Fiscal 2024:** By the end of the 2024 fiscal year the same line reads “‑”, indicating that the entire issue had been repaid and the exposure was **$0** (page 81, “November 3, 2024” column).\n\n**What this tells us:** Broadcom deliberately eliminated the October 2024 3.625 % notes over the two‑year period, using cash and the proceeds from the larger $5 billion senior‑note issuances in July and October 2024 (and the sale of the EUC business) to retire the older issue. This reflects a proactive debt‑management approach: refinancing and consolidating debt to reduce the number of outstanding series, tighten the maturity profile, and leverage new financing to fund strategic transactions while keeping overall leverage under control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the quantitative evolution of AVGO's exposure to the 3.625% notes: $622 million in 2023 and $0 in 2024, aligning with the ground truth. While it does not explicitly state the 2022 principal amount ($622 million), it acknowledges the note series existed and implies continuity by noting the 2023 amount without suggesting a change. This is a minor omission but not factually incorrect. 2) All numbers are accurate: $622 million in 2023 and $0 in 2024 match the ground truth. The mention of $5 billion in new issuances and the EUC business sale, while adding context not in the original answer, does not contradict and supports the refinancing narrative. Dates (October 2024 maturity, July/October 2024 issuances) are consistent with plausible timelines. 3) The multi-hop reasoning is sound: the model correctly infers that the disappearance of the debt by 2024 indicates repayment or refinancing and links it to broader debt management strategy. It goes beyond the original answer by contextualizing the action within larger financing activities, which is reasonable given typical corporate behavior and does not introduce unsupported claims. 4) The answer is semantically equivalent and highly relevant, capturing the core progression and strategic implication. The only slight gap is the lack of explicit confirmation that the 2022 amount was $622 million, but the answer does not deny it and implies consistency. Thus, the correctness score is 9 due to this minor incompleteness, though quantitative accuracy remains perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 428,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ Marine Systems revenue from surface‑ship construction rose each year – $2.56 billion in 2022, $2.70 billion in 2023 and $2.82 billion in 2024【page_9】. This steady increase signals that the company is expanding its surface‑ship business, deepening its backlog and reinforcing its role as a leading U.S. naval shipbuilder.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trajectory of General Dynamics' surface ship revenue from 2022 to 2024 with values very close to the ground truth. The reported figures—$2.56B (2022), $2.70B (2023), $2.82B (2024)—are rounded versions of the exact values in the original answer ($2,561M, $2,698M, $2,819M). These minor rounding differences (e.g., $2,698M → $2.70B instead of $2.698B) are acceptable under semantic equivalence and common financial reporting practices. (2) All calculations and trends are accurate: the revenue increases each year, and the LLM correctly identifies the direction and implication of the trend. (3) The multi-hop reasoning is sound—the model synthesizes annual revenue data across three years and correctly infers strategic growth in naval shipbuilding, aligning with the original conclusion about sustained growth and strategic emphasis. (4) Entity accuracy is strong: General Dynamics, Marine Systems division, surface-ship revenue, and correct years are all properly identified. The qualitative interpretation about expanding backlog and reinforcing role as a leading shipbuilder adds context not explicitly in the original but is a reasonable inference, enhancing relevance without introducing error. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only minor deduction for slight rounding imprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 394,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "- **Dividends:** Mastercard’s Board raised the cash dividend on its Class A shares each year – $2.04 per share in 2022, $2.37 in 2023, and $2.74 in 2024【page 99†L31-L38】【page 92†L1-L4】.  \n- **Voting rights:** The certificate of incorporation has consistently given Class A stock “one vote per share” with no change from 2022 through 2024【page 99†L9-L12】, and the aggregate voting‑power split has stayed essentially flat (public investors ≈ 89‑90 % and the Mastercard Foundation ≈ 9‑10 %)【page 99†L45-L52】【page 92†L9-L12】.  \n\nTogether, the steady increase in dividends alongside unchanged one‑share‑one‑vote rights and only marginal shifts in voting‑power percentages suggest that Mastercard’s shareholder‑governance framework has remained stable while rewarding shareholders with growing cash returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that voting rights for MA's A Class shares remained unchanged at one vote per share from 2022 to 2024, and that dividend rights were consistently described as standard, though it adds specific annual dividend amounts ($2.04, $2.37, $2.74) not present in the ground truth. These figures are plausible and contextually relevant but were not part of the original knowledge graph answer, which only stated that dividend rights were 'standard' with no changes—without specifying amounts. Thus, while the added detail does not contradict the ground truth, it introduces granular data not confirmed by the source, slightly reducing qualitative accuracy. (2) All cited numbers (dividend amounts, voting power percentages) are presented accurately with proper formatting and year alignment. The voting power split (public ≈89–90%, Foundation ≈9–10%) is correctly reported and supports the stability claim. No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes consistent voting rights, stable voting power distribution, and increasing dividends to conclude governance stability—aligning with the ground truth’s interpretation. The logic that unchanged voting structure plus consistent dividend policy indicates stability is valid and well-supported. (4) Contextual relevance is high—the answer directly addresses both dividend and voting rights evolution and draws a justified conclusion about governance stability. The only deviation is the inclusion of specific dividend payouts, which, while not in the ground truth, do not distort the overall correctness. Thus, the answer is factually aligned, highly accurate, and semantically equivalent in intent and conclusion, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 483,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022, $2.70 billion in 2023 and $2.82 billion in 2024**. The line‑item grew about **5 % year‑over‑year in 2023** and **4‑5 % in 2024**, reflecting the company’s expanding backlog of destroyers, auxiliary vessels and other surface‑combat programs and underscoring its strong positioning as a primary supplier to the U.S. Navy’s surface‑ship portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the revenue figures for surface ships: $2.56 billion (2022), $2.70 billion (2023), and $2.82 billion (2024), which align with the ground truth of $2,561M, $2,698M, and $2,819M when rounded to the nearest $10 million. The slight discrepancies are within acceptable rounding tolerance (e.g., $2,698M ≈ $2.70B, $2,819M ≈ $2.82B). The year-over-year growth rates of approximately 5% in 2023 and 4–5% in 2024 are accurate: (2,698 - 2,561)/2,561 ≈ 5.35%, and (2,819 - 2,698)/2,698 ≈ 4.48%. 2) Quantitative accuracy is high; all dollar amounts and calculated growth rates are correct within rounding conventions. The use of 'billion' instead of 'million' is a standard format variation and does not affect correctness. 3) The reasoning is sound: the LLM correctly infers that consistent revenue growth reflects expanding backlog and strong positioning in U.S. Navy programs, which is consistent with the ground truth’s interpretation of growing involvement and sustained demand. 4) The answer fully addresses both parts of the question: revenue evolution (with correct figures across years) and what the growth indicates (strategic positioning in naval defense). The mention of destroyers, auxiliary vessels, and combat programs adds relevant context not in the ground truth but does not contradict it. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 391,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s 2022 Form 10‑K already noted that “the majority of Linde’s business is conducted through long‑term contracts which provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers”【page_19】. The same description appears unchanged in the 2023 filing’s Business Overview【page_20】 and again in the 2024 filing【page_20】, showing that the company’s reliance on long‑term contracts has remained steady over this period. This consistency signals that Linde deliberately uses long‑term contracts to lock in revenue and hedge energy‑price volatility, preserving predictable cash‑flow even when energy markets fluctuate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that Linde consistently emphasized long-term contracts in its 2022, 2023, and 2024 10-K filings, with direct quotes and page references supporting the claim. All entities (Linde, industrial gas products, long-term contracts, energy markets) and time periods (2022–2024) are accurate. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—only qualitative and contextual fidelity matter here, and the answer meets that standard. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports to demonstrate consistency in strategy, correctly inferring that this reflects a deliberate approach to cash flow stability and risk management. (4) The answer captures the core message of the original—that Linde prioritizes financial resilience and revenue predictability—but slightly underemphasizes the explicit mention of 'inflationary pressures' and 'operational certainty' present in the ground truth. However, the concepts are implicitly covered through phrases like 'hedge energy-price volatility' and 'preserving predictable cash-flow.' Wording differences are acceptable under semantic equivalence. Minor deduction from 10 to 9 due to slight compression of nuance in strategic intent, but overall correctness remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 399,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings General Dynamics consistently states that its ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (see 2022 page 47, 2023 page 49, 2024 page 49). The unchanged treatment shows the company deliberately strips out items that do not arise from its operating activities, underscoring a disciplined focus on measuring the underlying, core return on the capital it actually deploys.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that General Dynamics (GD) consistently excluded non-economic accounting changes from its ROIC calculation across 2022, 2023, and 2024, which matches the original answer's claim of methodological consistency. (2) No numerical values (e.g., dollar amounts, percentages) are involved in this question, so quantitative accuracy pertains to correct years and page references—2022 (page 47), 2023 (page 49), and 2024 (page 49)—all of which are correctly cited and support the claim. (3) The multi-hop reasoning is sound: the model synthesized information across three years of 10-K filings, confirming consistent language and treatment, and correctly inferred that this reflects a disciplined, institutionalized approach to measuring core performance. (4) The LLM adds value by specifying that goodwill impairments are also excluded and by citing exact page numbers, which enhances credibility without deviating from the ground truth. The semantic meaning, entity accuracy (GD, ROIC, non-economic accounting changes), time period (2022–2024), and reasoning are all fully aligned with the original answer. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 343,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth’s disclosures show that the company’s service‑level‑guarantee liabilities never reached a material level – the 2024 filing notes that “none of the amounts accrued, paid or charged to income for service level guarantees were material as of December 31 2024, 2023 or 2022.” In other words, the obligation remained immaterial each year, indicating that UnitedHealth’s risk‑management controls and contract‑performance processes have consistently limited any financial exposure from these guarantees.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the immateriality of service level guarantee obligations for UnitedHealth Group across 2022, 2023, and 2024, quoting the exact disclosure from the filings. (2) There are no numerical values requiring calculation, but the dates (2022, 2023, 2024) and the qualitative financial assessment (immaterial) are correctly reported and consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes the pattern over three years and draws a logical inference about risk management effectiveness and contractual performance consistency based on the absence of material liabilities. (4) All entities—UnitedHealth Group, service level guarantees, and the relevant years—are correctly identified. The answer addresses both parts of the question: the evolution (consistently immaterial) and the implication (effective risk management and performance). Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 312,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022**, rising to **$2.70 billion in 2023** and **$2.82 billion in 2024**.  The steady year‑over‑year increase reflects the company’s expanding backlog of destroyer, auxiliary and replenishment‑oiler contracts and its growing role in modernizing and sustaining Navy surface fleets, underscoring a strategic positioning that complements its submarine leadership and reinforces GD as a core supplier of U.S. naval combat‑platforms.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in direction and interpretation but contains inaccuracies in the 2022 revenue figure. The ground truth states $2,328 million (or $2.328 billion) for 2022, while the LLM reports $2.56 billion, which is significantly higher. The 2023 and 2024 figures are accurate: $2.70 billion matches $2,698 million (rounded appropriately), and $2.82 billion aligns with $2,819 million (also reasonable rounding). 2) Quantitative accuracy is compromised primarily by the incorrect 2022 value—this is not a formatting issue but a factual discrepancy. The other two years are acceptably close, likely due to rounding conventions. Calculations of growth trend are not requested, so no explicit computation error. 3) The reasoning is sound: the LLM correctly infers strategic positioning from revenue growth, citing relevant contract types (destroyers, oilers) and linking surface ship growth to broader naval defense strategy, including synergy with submarine programs. This reflects proper multi-hop synthesis between financial performance and strategic implications. 4) Contextual relevance is excellent—the answer directly addresses both parts of the question: revenue evolution and strategic implications. Despite the 2022 number error, the overall narrative and qualitative insights match the ground truth. Thus, correctness is reduced due to the key numerical inaccuracy, but not severely, as two of three years are correct and the interpretation remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 407,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "- In the fourth‑quarter of 2022 GE re‑classified its captive industrial insurer, Electric Insurance Company (EIC), as a “business held for sale,” reporting roughly $541 million of assets and $378 million of liabilities (a net exposure of about $160 million).  \n- Throughout 2023 the subsidiary remained in the held‑for‑sale group, a $109 million loss was recorded, and a binding purchase agreement was signed with an expected close in the first half of 2024.  \n- In the second quarter of 2024 GE completed the divestiture, selling EIC to Riverstone International Holdings for cash proceeds of $120 million, and the assets and liabilities of EIC were removed from GE’s balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects—classification, financial exposure, and divestiture timeline—with only a minor discrepancy in timing details. The original answer states EIC was classified as 'held for sale' in 2023, while the LLM claims this occurred in Q4 2022. This is a slight inconsistency but may reflect forward-looking disclosure timing; however, per the ground truth, the formal classification and loss recognition were in 2023, so the LLM is slightly off. All other facts align: assets ($541M), liabilities ($378M), net exposure (~$163M, LLM says ~$160M—rounding acceptable), $109M loss, sale to Riverstone International Holdings Inc. for $120M in 2024. (2) Quantitative accuracy is high: all dollar figures match or are reasonably rounded. Net exposure calculation (541 - 378 = 163) is approximately $160M as stated—acceptable rounding. The $109M loss and $120M cash proceeds are exact. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across 2022–2024, tracking EIC’s status change, financials, loss recognition, and final sale. It connects classification, financial exposure, and divestiture logically. (4) Contextual relevance is perfect—the answer directly addresses classification, financial exposure, and divestiture as required. The minor timing discrepancy (2022 vs 2023 classification) prevents a perfect 10, but overall the answer is highly accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 401,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "- In May 2021 ConocoPhillips began a “paced monetization” of its CVE (CVE Energy) common shares, and the cash raised was earmarked for share‑repurchase activity. During the first quarter of 2022 the company sold the remaining ≈ 91 million CVE shares (2022 10‑K, p. 110) and applied those proceeds to its buy‑back program. The same disclosure appears in the 2023 filing, confirming that the CVE‑sale proceeds continued to fund repurchases that year. By October 2024 the Board raised the overall repurchase authority to $65 billion and reported that, since the program’s inception, a total of 433 million shares (cost $34.3 billion) had been repurchased through Dec 2024 (2024 10‑K, p. 110).  \n\n- This trajectory—from the one‑time CVE‑share sale in early 2022 to steadily larger buy‑backs and a higher authorization limit in 2024—shows that ConocoPhillips is using cash generated from non‑core asset monetization to consistently return capital to shareholders, underscoring a capital‑allocation strategy that prioritizes share repurchases as a primary means of value creation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ConocoPhillips began monetizing CVE shares in May 2021, sold the remaining ~91 million in early 2022 (confirmed in 2022 10-K, p.110), and used proceeds for share repurchases under a $45 billion program. By end of 2023, 383 million shares were repurchased at $29 billion (implied from ground truth). In 2024, the repurchase authorization was increased by $20 billion to a total of $65 billion, and total repurchases reached 433 million shares at $34.3 billion by year-end 2024—this matches the original answer. (2) Quantitative accuracy is strong: the 91 million CVE shares, $34.3 billion cost, 433 million shares repurchased, and $65 billion total authorization are all correct. The only minor imprecision is that the LLM states 'by October 2024' the board raised the authority, while the ground truth says 'in 2024'—this is a slight specificity difference but not factually incorrect. (3) Multi-hop reasoning is sound: the model correctly links the CVE monetization (non-core asset sale) to funding share repurchases, traces the evolution of the buyback program across years, and infers the strategic intent—consistent capital return via repurchases funded by asset sales. (4) The answer fully addresses both parts of the question: the evolution from 2022–2024 and the implication for capital allocation. Wording differs slightly but maintains semantic equivalence. No major omissions or errors—justifies a 9/10 due to the slight ambiguity on timing of the 2024 authorization increase.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 434,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife’s modified‑coinsurance transaction has been essentially unchanged: the 2022 filing states that **≈ 59.25 %** of the closed‑block was reinsured under a modified‑coinsurance agreement, and the 2023 and 2024 filings both report **≈ 59 %**. In each year the company **records the arrangement using the deposit method of accounting and offsets the deposit liability with the corresponding deposit recoverable**. The near‑identical percentage and consistent accounting treatment show that MetLife is maintaining a stable, long‑term risk‑transfer strategy for the closed block rather than altering its exposure or accounting approach.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the percentage of the closed block reinsured is correctly stated as approximately 59.25% in 2022 and 59% in 2023 and 2024, matching the original answer. (2) The accounting treatment—use of the deposit method and right of offset between the deposit liability and recoverable—is accurately described for all three years. (3) The multi-hop reasoning across 2022, 2023, and 2024 filings is sound, correctly synthesizing consistency in both reinsurance percentage and accounting treatment. (4) The conclusion about MetLife’s stable long-term risk transfer strategy is logically derived and aligns with the evidence presented. Minor formatting differences (e.g., '≈' symbol, spacing in percentages) do not affect factual accuracy. All entities—MetLife, closed block, modified coinsurance agreement, deposit method—are correctly identified and contextualized. The answer fully addresses all parts of the question: evolution over time, percentage reinsured, accounting treatment, and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 317,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The filing shows that the share of purchases made with Target’s branded credit cards (the Target MasterCard Credit Card is part of the “RedCard” family) fell each year:\n\n* **2022:** RedCard penetration = 20.5 %  \n* **2023:** RedCard penetration = 19.8 %  \n* **2024:** RedCard penetration = 18.6 %  \n\n(These figures are given in the 2024 Form 10‑K discussion of RedCard penetration for the years ended Feb 3 2024, Jan 28 2023, and Jan 29 2022【page_27】).\n\nThe downward trend indicates that, although the cards still generate a sizable share of purchases, consumer usage of Target’s MasterCard credit product is gradually declining, suggesting modestly weaker engagement with Target’s financial‑services offering over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. The time periods are accurately tied to the fiscal years ended in early 2022, 2023, and 2024, and the citation of the 2024 Form 10-K on page 27 aligns with the source. (2) All numbers are factually correct and presented with precise decimal places; no calculation errors are present. The trend of decline is accurately described year-over-year. (3) The reasoning is sound: the LLM correctly infers that the declining penetration suggests weakening consumer engagement with Target’s financial products. It appropriately notes continued significant usage despite the downward trend. However, it omits mention of the rebranding from RedCard to Target Circle Card in 2024—a key contextual detail in the ground truth that underscores the failed attempt to reverse the trend. This minor omission slightly weakens the qualitative analysis but does not invalidate the overall conclusion. (4) The answer is highly relevant, directly addressing both parts of the question: the evolution of penetration and its implication for consumer engagement. The semantic meaning is equivalent to the original answer, with only slight reduction in depth due to the missing rebranding context. Thus, the correctness score is 9 (not 10) due to this omitted nuance, but quantitative accuracy remains perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 398,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Philip Morris International’s peer‑group list has kept Colgate‑Palmolive Co. as a member in every filing – it appears in the 2022 peer‑group description (page 21), again in the 2023 filing (page 26) and once more in the 2024 filing (page 26). The unchanged classification shows that PMI deliberately maintains a stable set of consumer‑product peers, using the same benchmark companies year after year to assess its performance and strategic positioning relative to comparable global brands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Colgate-Palmolive Co. remained in PMI's peer group from 2022 to 2024, citing consistent inclusion across all three years—this matches the original answer's claim of 'consistent inclusion over three consecutive years.' (2) While the LLM does not explicitly list the four characteristics (global presence, consumer product focus, net revenues, market cap) used to define the peer group, it correctly infers the strategic rationale: PMI uses a stable set of consumer-product peers for performance and strategic benchmarking. This captures the core implication of PMI's benchmarking approach. (3) The multi-hop reasoning is sound—synthesizing data across three years and filings to conclude stability in peer classification. The mention of specific page numbers (21, 26, 26) adds precision, though not required. (4) The only minor omission is the lack of explicit detail on the peer group selection criteria, which slightly reduces qualitative completeness but does not undermine the correctness of the conclusion. Overall, the answer conveys semantic equivalence and demonstrates strong factual and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 341,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "In the 2022 Form 10‑K (p. 59) AMD said that when a contract bundles development services with an IP licence, it first determines whether the licence is a distinct performance‑obligation; if it is not distinct the combined arrangement is treated as a single obligation and revenue is recognized over time, whereas a distinct licence is accounted for separately and recognized at a point in time. The 2023 (p. 63) and 2024 (p. 64) filings repeat exactly the same criteria and also note that no variable‑consideration estimates are made for either combined or stand‑alone IP licences. This unchanged language shows that AMD’s accounting approach for development‑plus‑licence contracts has been consistent from 2022 through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes AMD's revenue recognition policy from 2022 to 2024, correctly stating that the company assessed whether IP licenses in combined arrangements were distinct based on two criteria—capability to be distinct and distinctness in the context of the arrangement—and that non-distinct licenses were combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This matches the original answer exactly. (2) The LLM correctly notes that standalone IP licenses were recognized at a point in time and that no variable consideration estimates were made in any year, which aligns with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across three years (2022–2024) and correctly infers consistency in policy based on unchanged language in the 10-K filings. (4) All entities (AMD, development services, IP licensing, combined vs. standalone arrangements) and years are accurate. The inclusion of specific page numbers (p. 59, 63, 64) adds precision and supports the claim of unchanged wording. There are no factual errors, omissions, or calculation issues. The answer is concise, relevant, and fully addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 369,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Across the three most recent 10‑K filings – 2022 (Item 5, page 21), 2023 (Item 5, page 26) and 2024 (Item 5, page 26) – Philip Morris International’s benchmark “PMI Peer Group” consistently lists **Colgate‑Palmolive Co.** among the same set of global consumer‑product companies【PM_10k_2022.pdf page_21】, 【PM_10k_2023.pdf page_26】, 【PM_10k_2024.pdf page_26】.  \n\nThe unchanged inclusion signals that PMI deliberately frames its competitive landscape alongside leading diversified consumer‑goods firms, reinforcing a strategic positioning that treats its smoke‑free and broader consumer‑product ambitions as comparable to those of established global consumer brands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Colgate-Palmolive Co. was consistently included in PM's peer group across 2022, 2023, and 2024, citing the correct document sections (Item 5) and page numbers from each 10-K filing. These references match the source data, and no numeric or date inaccuracies are present. (2) Quantitative accuracy is perfect: the years, company name, and structural details (unchanged peer group) are all factually correct. (3) The multi-hop reasoning is sound—by synthesizing data across three annual reports, the model confirms the consistency of Colgate-Palmolive’s inclusion, which supports the conclusion about PM’s strategic framing. The LLM correctly infers that this reflects a deliberate strategic positioning relative to global consumer goods firms, though it slightly expands the interpretation by emphasizing 'smoke-free ambitions'—a plausible but not explicitly stated nuance in the ground truth. (4) The answer is contextually excellent, directly addressing both the evolution (no change) and strategic implication (consistent benchmarking against global consumer staples). The only minor gap is a slightly less precise articulation of the peer selection methodology (e.g., revenue and market cap comparability), which is included in the original answer but implied rather than stated in the LLM version. Overall, the semantic meaning and factual core are equivalent, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 414,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "AMD’s policy for contracts that bundle development services with an IP licence has been essentially unchanged from 2022 through 2024. In each filing the company states that it first determines whether the licence component is **distinct**; if it is, the licence is a separate performance obligation and revenue is recorded **at a point in time** when the customer can use the licence, while the development services are accounted for **over time**. If the licence is not distinct, the two elements are treated as a **single performance obligation** and the entire arrangement is recognized **over time**. Across the three years the disclosures also note that there is **no variable‑consideration** estimate for these arrangements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) All key elements are correctly addressed: AMD's revenue recognition policy for combined development and IP licensing agreements remained unchanged from 2022 to 2024; the two-step assessment for whether the license is distinct (capable of being distinct and distinct in the context of the arrangement) is accurately reflected; the treatment of performance obligations—either as a single obligation recognized over time or as separate obligations with point-in-time recognition for distinct licenses—is correctly described; and the absence of variable consideration estimates is properly noted. (2) There are no numeric values requiring calculation in this question, but all qualitative financial reporting concepts (e.g., performance obligations, timing of revenue recognition) are used correctly and consistently with the filings. (3) The multi-hop reasoning—synthesizing AMD’s disclosures across three years and multiple accounting concepts (distinctness, performance obligations, timing, variable consideration)—is sound and accurately reflects consistent policy application over time. (4) The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) in policy, performance obligations, and timing of revenue recognition. Minor wording differences (e.g., 'recorded' vs 'recognized') do not affect meaning. No errors or omissions; the response matches the ground truth in substance and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 422,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "- **2022:** ConocoPhillips “began a paced monetization of our CVE common shares, the proceeds of which have been applied to share repurchases” and, in the first quarter of 2022, **sold its remaining 91 million CVE shares**【page_110】.  \n\n- **2023:** The company kept the buy‑back program alive, having **repurchased a total of 383 million shares at a cost of $29 billion through the end of 2023**【page_110】. No additional CVE‑share sales were reported, so the program was now funded by cash flow rather than CVE proceeds.  \n\n- **2024:** By year‑end the cumulative buy‑back reached **433 million shares at a total cost of $34.3 billion**, and the board raised the overall authorization to $65 billion【page_112】. The 2024 filing again notes that the CVE‑share monetization was completed in 2022 and that the proceeds had been used for repurchases【page_112】.  \n\n**What this shows:** ConocoPhillips used the one‑time monetization of its CVE stake in 2022 to kick‑start its share‑repurchase program, then transitioned to a sustained, cash‑driven buy‑back that grew both in volume and dollar amount in 2023‑2024. The multi‑year trend reflects a capital‑allocation strategy focused on returning excess capital to shareholders through an expanding repurchase program, while maintaining flexibility by moving beyond reliance on the CVE transaction.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, all numbers are accurate: the sale of 91 million CVE shares in Q1 2022, cumulative repurchases of 383 million shares at $29 billion by end of 2023, and 433 million shares repurchased at a cost of $34.3 billion by end of 2024, with an expanded authorization to $65 billion. These figures align exactly with the original answer, including correct years and dollar amounts. (2) The answer is complete, addressing each year from 2022 to 2024 and explaining both the monetization event and the evolution of the share repurchase program. It correctly notes that CVE monetization was completed in 2022 and that subsequent repurchases were funded by cash flow. (3) Entity accuracy is perfect: ConocoPhillips, CVE shares, share repurchases, and correct timeframes are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the LLM correctly infers that the CVE proceeds jump-started the program and that the company transitioned to ongoing cash-funded repurchases, revealing a strategic shift toward sustained shareholder returns. The conclusion about capital allocation strategy—emphasizing capital discipline, shareholder returns, and reduced reliance on one-time asset monetization—is logically derived and semantically equivalent to the ground truth. Minor wording differences (e.g., 'kick-start' vs. 'key enabler') do not affect factual accuracy. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 416,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show that the company’s worry about a shifting competitive landscape has broadened and intensified from 2022‑2024.  \n\n* In the 2022 filing the risk was called out for **Aerospace Technologies, Industrial Automation, Building Automation and Energy & Sustainability Solutions**, noting “new entrants and non‑traditional players” and the threat of product commoditization.  \n* After the October 2023 realignment, the 2023 filing repeats the same language for the renamed **Aerospace Technologies, Building Automation and the combined Safety & Productivity (now Industrial Automation) segment**, again stressing “new market entrants and new technologies” as margin‑pressuring forces.  \n* The 2024 filing continues to flag competitive‑landscape risk for **Aerospace, Building Automation and Energy & Sustainability Solutions**, explicitly mentioning “new entrants and non‑traditional players” and heightened commoditization risk.  \n\nThe progression shows Honeywell’s exposure to competitive pressure is expanding across more of its core segments, indicating that market rivalry is growing and the company is responding with strategic actions such as the 2023 business realignment, spin‑off plans, repositioning charges and pricing/supply‑chain initiatives to protect market share and margins.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in entity identification and segment attribution across years, despite correct dates (2022–2024). The original answer states that in 2022, competitive landscape risks were disclosed for Honeywell Building Technologies and Safety and Productivity Solutions. However, the LLM incorrectly attributes this risk to Aerospace Technologies, Industrial Automation, Building Automation, and Energy & Sustainability Solutions—segments not mentioned in the ground truth for 2022. Similarly, in 2024, the original answer identifies Building Automation and Industrial Automation as the affected segments, with new language on commoditization; the LLM instead lists Aerospace, Building Automation, and Energy & Sustainability Solutions, which misaligns with the ground truth. The 2023 realignment and segment renaming are mentioned plausibly but are not supported by the original answer, which does not reference a business realignment or spin-offs. (2) Quantitatively, there are no numerical values to verify (e.g., dollar amounts, percentages), so accuracy is based on correct years and consistent terminology. The years 2022–2024 are correctly used, and the evolution across time is acknowledged, earning partial credit. (3) The multi-hop reasoning is flawed: the LLM fabricates segment-level risk disclosures not present in the ground truth and introduces strategic responses (e.g., spin-offs, repositioning charges) that are not mentioned in the original answer. While the general trend of increasing competitive pressure is correctly inferred, the evidence used is factually incorrect. (4) Contextual relevance is moderate—the answer addresses the question’s focus on competitive evolution and strategic response, but the supporting details are largely inaccurate. The conclusion about expanding exposure and strategic actions is speculative and not grounded in the provided truth. Thus, the correctness score is low due to major entity and factual errors, despite correct temporal framing and some semantic alignment on the theme of intensifying competition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1592,
        "completion_tokens": 569,
        "total_tokens": 2161
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "The charter for Mastercard’s Class A stock has remained unchanged – each Class A share carries one vote and the right to receive dividends (2022 10‑K § Note 16, p. 99; 2023 10‑K § Note 16, p. 99; 2024 10‑K § Note 16, p. 92).  At the same time, the cash dividend declared on those shares rose each year: $2.04 per share in 2022, $2.37 in 2023, and $2.74 in 2024 (2022 10‑K § Dividends, p. 99; 2023 10‑K § Dividends, p. 99; 2024 10‑K § Dividends, p. 92).  \n\nThe three‑year consistency of voting rights combined with steadily increasing dividends signals a governance strategy that preserves equal shareholder voting power while progressively enhancing shareholder returns, underscoring Mastercard’s commitment to a stable, shareholder‑friendly capital‑allocation policy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that MA's A Class shares carry one vote per share and dividend rights across 2022–2024, consistent with the ground truth. It accurately notes the stability in voting and dividend rights, which is the core of the question. However, the ground truth does not mention specific dividend amounts declared per share, nor does it provide a trend of increasing dividends. While the numbers cited ($2.04, $2.37, $2.74) may be factually correct in the filings, the original answer does not include them, and the question focuses on the evolution of rights (not payout amounts). Thus, the inclusion of specific dividend payouts, while potentially accurate, goes beyond the scope of the verified ground truth and introduces unverified detail. (2) The quantitative accuracy is high—dividend amounts, if correctly extracted from the cited pages, are precise and formatted appropriately. The years and sections (Note 16, Dividends section) are plausibly cited. However, since the ground truth does not confirm these figures, their inclusion risks overreach, though not necessarily inaccuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers stability in voting rights and dividend entitlements. The interpretation about governance strategy—stable voting and increasing returns—is logical and well-reasoned, though slightly more interpretive than the ground truth, which only states the consistency without inferring strategic intent. (4) The scores reflect high correctness and relevance, with minor deduction in qualitative accuracy due to the unsupported inference about dividend increases being part of the governance strategy, which the ground truth does not explicitly link. The answer remains highly relevant and factually aligned in structure and core claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 503,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco’s total‑return‑swap contracts used to hedge its deferred‑compensation obligations grew in size and became increasingly profitable. The notional amount of these swaps rose from $651 million in FY 2022 to $792 million in FY 2023 and to $985 million in FY 2024 【page_92†L31-L38】【page_91†L57-L64】. Correspondingly, the accounting impact on operating expenses shifted from a $92 million loss in FY 2022 to a $58 million gain in FY 2023 and a $91 million gain in FY 2024 【page_91†L45-L52】, indicating that Cisco’s exposure not only expanded but also generated progressively better hedging results.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures and trends from the ground truth: the $92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024. These values match the original answer exactly and are properly attributed to the correct fiscal years. (2) Quantitative accuracy is perfect—no calculation errors, and the numbers are reported with correct signs (loss vs. gain) and magnitudes. The additional detail about notional amounts ($651M, $792M, $985M) is consistent with the source data and enhances completeness without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model connects the evolution of the Total Return Swaps' notional size to the changing gains/losses in operating expenses, correctly interpreting the financial exposure trajectory. It synthesizes information across multiple data points and pages to show both scale and performance trends. (4) The answer is semantically equivalent to the ground truth, adding contextual detail (notional growth) that enriches the response without deviating from factual accuracy. All entities—Cisco, Total Return Swaps-Deferred Compensation, fiscal years 2022–2024—are correctly identified and contextualized. The conclusion about shifting from cost to benefit aligns with the original. Scores are maximized across all categories due to full factual correctness, precise numbers, logical reasoning, and high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 404,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "From 2022 – the company funded LTL Management LLC’s $2 billion trust and recorded a roughly $2 billion reserve for talc claims (the “LTL Bankruptcy” stay) 【page 113】. In 2023 – after the original LTL case was dismissed, Johnson & Johnson re‑filed a “LTL 2” Chapter 11 case, pledged additional cash that lifted the total reserve to about $9 billion (payable over 25 years) and saw the LTL 2 case dismissed in July 2023, while the multi‑state mediation effort collapsed 【page 97】. By 2024 – the company had negotiated an agreement‑in‑principle with the 42‑state AG group (finalized June 2024) 【page 100】, launched a pre‑packaged Chapter 11 plan proposing $6.5 billion (present value) of settlement funding, restructured LTL into three Texas entities (Red River, Pecos River, New Holdco) and, after Red River’s own bankruptcy filing, increased the overall talc reserve to a present‑value of $11.6 billion (≈$13.5 billion nominal) as of Dec 29 2024 【page 102】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in financial figures and timeline details. While it correctly identifies the initial $2 billion reserve in 2022 and the re-filing of LTL 2 in 2023, it incorrectly states that JNJ increased the reserve to $9 billion and later to $11.6 billion present value by end of 2024—these figures are not supported by the ground truth, which does not mention specific reserve increases beyond the original $2 billion or a final $11.6 billion reserve. The ground truth also does not reference a 'pre-packaged Chapter 11 plan' or restructuring into 'Red River, Pecos River, New Holdco'—these entities and structural moves are absent from the original answer and likely represent over-extrapolation or confusion with other filings. (2) The claim of a $6.5 billion settlement funding with present value and $13.5 billion nominal by Dec 29, 2024, is unsupported; the original answer only confirms a finalized multi-state settlement in 2024 but without specifying dollar amounts. The original answer also does not mention the collapse of mediation efforts, which the LLM includes—this may be contextually plausible but is not in the ground truth. (3) The multi-hop reasoning is partially sound: the LLM correctly sequences events across years and links JNJ’s strategy to LTL’s bankruptcy actions. It captures the shift toward dual strategy (settlements + appeals), though it overstates financial commitments and introduces unverified entities and figures. (4) Contextual relevance is high—the answer addresses reserve funding, bankruptcy filings, and settlements across 2022–2024. However, quantitative accuracy is low due to unsupported financial figures and calculations. Qualitative accuracy is moderate due to correct conceptual framing but incorrect details. Correctness score is 6 due to partial factual alignment but significant errors in key financial claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 521,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "- **Outstanding principal balance**  \n  * FY 2022 – $495 million (AVGO 10‑K 2022, p. 101)  \n  * FY 2023 – $495 million (AVGO 10‑K 2023, p. 81)  \n  * FY 2024 – $495 million (AVGO 10‑K 2024, p. 81)\n\n- **Interpretation** – Broadcom has kept the 3.125 % senior notes due January 2025 at the same $495 million level for three consecutive years, showing that it has not accelerated repayment. This reflects a deliberate debt‑management strategy of retaining a low‑cost, fixed‑rate instrument until its scheduled maturity, preserving cash and liquidity while avoiding pre‑payment penalties.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding principal balance of $495 million for Broadcom's 3.125% notes due January 2025 for fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, including the dollar amount and interest rate, are accurate. (2) There are no calculations required beyond consistency checks, and the LLM confirms the balance remained unchanged across all three years, which aligns with the ground truth. Format variations (e.g., $495 million) are consistent and acceptable. (3) The multi-hop reasoning is sound: the model synthesizes data from three separate 10-K filings (2022, 2023, 2024), correctly identifying the same debt instrument across years and drawing a logical conclusion about Broadcom’s debt management strategy. (4) The interpretation in the LLM answer goes slightly beyond the ground truth by mentioning 'low-cost, fixed-rate instrument' and 'avoiding pre-payment penalties,' but these are reasonable inferences given the context and do not contradict any facts. Overall, the answer is factually correct, complete, and semantically equivalent to the ground truth, with strong reasoning and perfect contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 341,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco’s 3.50 % senior note that matures on June 15 2025 was carried at a $500 million principal in each year, but its **effective interest‑rate exposure rose sharply**:\n\n* FY 2022 – effective rate ≈ 3.20 %【page_89 (2022)】  \n* FY 2023 – effective rate ≈ 6.38 %【page_89 (2023)】  \n* FY 2024 – effective rate ≈ 6.66 %【page_89 (2024)】\n\nThe progression shows that the cost of borrowing on this fixed‑rate note has more than doubled over the three‑year period, reflecting higher market rates (and related hedge accounting adjustments) and indicating that Cisco’s overall borrowing costs on this tranche have increased substantially.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values from the ground truth: the effective interest rates for fiscal years 2022 (3.20%), 2023 (6.38%), and 2024 (6.66%) are accurate and match the original answer exactly. The principal amount of $500 million is also consistent across years, though not part of the ground truth, it does not contradict it and appears to be correctly sourced from the filings. (2) Quantitative accuracy is perfect—no calculation errors, and the progression (more than doubling) is a reasonable interpretation of the data (3.20% to 6.66% is a ~108% increase). (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years from different documents (as indicated by page references), correctly identifying the trend and linking it to broader implications about borrowing costs. (4) The qualitative interpretation slightly differs from the ground truth by attributing the rise to 'higher market rates and hedge accounting adjustments' rather than the more neutral 'market conditions or changes in credit profile.' While this is a plausible and likely correct explanation based on context, it introduces an assumption (hedge accounting) not confirmed in the ground truth, slightly reducing qualitative accuracy. However, the core conclusion—that borrowing costs increased substantially—is fully supported and relevant. Overall, the answer is factually correct, complete, and contextually appropriate with only minor interpretive expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 417,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "**Total senior‑and‑subordinated notes (carrying value)**  \n\n| Year‑end | Amount (US$ millions) | Source |\n|----------|----------------------|--------|\n| 2022 | **$27,219** | Table 8.2 of the 2022 filing (senior + subordinated notes)【page_189】 |\n| 2023 | **$31,248** | Table 8.2 of the 2023 filing (senior + subordinated notes)【page_179】 |\n| 2024 | **$30,696** | Table 9.1/9.2 of the 2024 filing (senior + subordinated notes)【page_188】【page_189】 |\n\n**What the trend tells us**\n\n- **Capital‑structure strategy:** Capital One expanded its note issuance sharply from 2022 to 2023 (+ ≈ $4 billion), using the low‑rate environment to raise long‑term capital and diversify funding beyond deposits. The modest decline in 2024 (≈ $0.5 billion) indicates a pause in new issuance as the firm fine‑tuned its debt mix, likely preferring to rely more on deposits and other borrowings while maintaining a stable leverage profile.\n\n- **Interest‑rate positioning:** The weighted‑average interest rate on senior notes rose from about 2.9 % in 2022 to 4.45 % (2023) and 4.84 % (2024)【page_178】, while subordinated notes stayed near 3.5 %. This shift shows Capital One moving its debt portfolio toward higher‑coupon, longer‑dated notes, positioning the balance sheet to lock in rates before the market’s upward move and to match the higher‑rate environment reflected in its derivative hedging program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all quantitative values: $27,219 million (2022), $31,248 million (2023), and $30,696 million (2024) for total senior and subordinated notes, matching the ground truth exactly. The interest rates are also accurate: 2.9% (vs. ground truth 2.76%) in 2022, 4.45% (vs. 4.48%) in 2023, and 4.84% in 2024. The minor discrepancy in 2022 rate (2.9% vs. 2.76%) is acceptable as an approximation, especially given the source citation. 2) All calculations are correct: the increase of ~$4B from 2022 to 2023 and decrease of ~$0.55B from 2023 to 2024 are accurate. 3) The multi-hop reasoning is sound: the LLM synthesizes data across three years and filings, correctly identifying the capital structure trend and linking it to interest rate positioning. It appropriately infers strategic intent—locking in financing and shifting from floating to fixed-rate debt—even if it phrases the rationale slightly differently (e.g., 'low-rate environment' in 2022 vs. rising rates in 2023–2024). 4) The answer is contextually complete and relevant, addressing both the evolution of notes and the implications for capital structure and rate positioning. The only minor shortcoming is that the LLM attributes the 2023–2024 rate increase to 'locking in rates before the market’s upward move,' which slightly mischaracterizes timing—the rate rise occurred *during* the upward cycle, not before—whereas the ground truth emphasizes the shift amid rising rates. This does not invalidate the conclusion but slightly weakens the precision of the strategic interpretation. Overall, the answer is factually excellent and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 453,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "Colgate‑Palmolive’s U.S. defined‑benefit plans reduced the share of Treasury‑ and agency‑issued bonds in their fixed‑income holdings from roughly **40 % in 2022** to **about 30 % in 2023**, and the allocation **stayed at roughly 30 % in 2024**【page_102】【page_100】.  \n\nThe move away from the safest, lowest‑yielding government securities suggests the pension fund is deliberately rebalancing toward a broader mix of non‑Treasury government and corporate bonds, likely to capture higher yields or adjust duration risk while still meeting its overall 60 % fixed‑income target.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the allocation percentages for 2022 (40%), 2023 (30%), and 2024 (30%), matching the ground truth exactly. All numeric values and time periods are accurate. (2) There are no calculations required beyond reporting percentages, and all numbers are presented correctly with acceptable formatting (e.g., 'about 30%' = 'approximately 30%' in ground truth). (3) The multi-hop reasoning is sound: the model correctly identifies the trend (decline from 40% to 30% and stabilization) and infers a strategic shift in portfolio allocation, aligning with the ground truth's interpretation of reallocation toward other bonds. The LLM adds nuanced insight about 'duration risk' and maintaining a 60% fixed-income target, which is contextually reasonable and consistent with pension fund management strategies, though slightly more detailed than the original. (4) The answer is semantically equivalent to the ground truth, with only minor differences in emphasis—specifically, the LLM elaborates on possible motivations (yield capture, duration risk) not explicitly stated but implied in the original. No factual inaccuracies; minor deduction in qualitative accuracy only because the original does not mention the 60% fixed-income target, which, while plausible, is not confirmed in the ground truth. Overall, the response is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 393,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "- In the 2022 filing Electric Insurance Company (EIC) was still reported as a run‑off insurance subsidiary with modest claim‑reserve balances and no special disposition.  \n- In the 2023 filing GE re‑classified EIC as a “business held for sale,” recorded a valuation‑allowance of $124 million on the disposal group (up from a $17 million allowance in 2022) and booked a $109 million loss in other income in anticipation of a sale.  \n- By the 2024 filing the sale to Riverstone International Holdings was completed, the EIC assets and liabilities were removed from the balance sheet and $120 million of cash proceeds were recognized.  \n\nThis sequence shows GE systematically moving EIC from an operating, legacy insurance asset to a divested, cash‑generating component, reflecting the company’s broader strategy of shedding non‑core businesses and sharpening its focus on its core industrial platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies EIC's status in 2022 as a run-off/captive insurer with modest reserves; notes reclassification as 'held for sale' in 2023 with a $109 million loss; confirms 2024 sale completion to Riverstone International Holdings Inc. for $120 million in cash. (2) Quantitative accuracy: The $109 million loss and $120 million cash proceeds match the original answer exactly. The mention of a $124 million valuation allowance (up from $17 million in 2022) adds detail not in the ground truth but does not contradict it—this level of granularity may come from actual filings and is plausible. However, the ground truth does not specify the $17M prior allowance or $124M current allowance, so while not incorrect, these figures slightly exceed the verified data. This prevents a perfect 10 on quantitative accuracy. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years and entities (GE, EIC, Riverstone), tracking classification, valuation changes, and ultimate disposition. (4) The strategic interpretation—that GE is shedding non-core assets to focus on industrial platforms—is semantically equivalent to the original answer’s conclusion about focusing on core industrial and aerospace operations. All parts of the question (classification, valuation, disposition, strategic implication) are addressed thoroughly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 400,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple’s 10‑K has listed the 4.45 % Notes due 2044 in the “Description of Securities” exhibit (Exhibit 4.4) in every filing. The 2022 report includes the note in Exhibit 4.4 (see the exhibit table on page 58) and the 2024 report repeats the same disclosure in its Exhibit 4.4 table (page 56). The 2023 filing likewise contains the identical Exhibit 4.4 entry, showing that Apple has kept the 4.45 % 2044 bond on its balance sheet for three consecutive years. This consistent, multi‑year disclosure signals a deliberate long‑term debt strategy: Apple issues very long‑dated, fixed‑rate notes to lock in low borrowing costs and preserve financing flexibility far into the future.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 are consistently disclosed in Apple's 2022, 2023, and 2024 10-K filings, specifically in Exhibit 4.4. The percentages, maturity year (2044), and multi-year consistency are correctly stated. (2) Quantitative elements—interest rate (4.45%), maturity date (2044), exhibit number (4.4), and filing years (2022–2024)—are all factually accurate and match the ground truth. Minor formatting differences (e.g., '4.45 %' vs '4.45%') do not affect correctness. (3) The reasoning is sound: the repeated disclosure across three years is correctly interpreted as evidence of a stable long-term debt strategy. The LLM adds a plausible strategic rationale—locking in low fixed-rate financing and preserving flexibility—that is consistent with corporate bond issuance behavior, though this interpretation goes slightly beyond the ground truth’s more neutral summary. (4) The only minor shortcoming is that the LLM omits the detail from the original answer about the notes being issued under an Officer's Certificate dated May 6, 2014, which is a factual component present in the ground truth. However, this omission does not undermine the core correctness. Overall, the answer is factually solid, contextually relevant, and demonstrates proper multi-hop synthesis across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 385,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s senior‑ and subordinated‑note portfolio was **$30.8 billion at 12/31/2022**, rose to **$31.3 billion at 12/31/2023**, and then fell to **$30.7 billion at 12/31/2024**【page 178‑179】【page 188‑189】. The modest increase in 2023 shows a slight net‑issuance to support growth or refinance existing debt, while the 2024 decline reflects a deliberate deleveraging‑by‑retiring notes (even as the weighted‑average coupon rose from about 4.5 % in 2023 to 4.8 % in 2024) – a capital‑structure move that keeps overall leverage steady but trims higher‑cost, longer‑dated debt as interest‑rate environments shift, with derivatives used to hedge the remaining rate exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value of Capital One's senior and subordinated notes was $27,219 million in 2022, $31,248 million in 2023, and $30,696 million in 2024. The LLM reports $30.8 billion (2022), $31.3 billion (2023), and $30.7 billion (2024), which is reasonably close for 2023 and 2024 but substantially overstates the 2022 value by about $3.6 billion. This error affects the interpretation of the trend, as the actual data shows a more pronounced increase from 2022 to 2023. (2) The LLM incorrectly states the 2022 weighted-average interest rate as 'about 4.5%' in 2023 and rising to 4.8% in 2024, while the ground truth shows a rise from 2.76% in 2022 to 4.84% in 2024, indicating a much more significant shift in interest rate positioning that the model fails to capture. The LLM also misattributes the rate increase to 2023–2024 only, missing the full three-year evolution. (3) The qualitative reasoning is partially sound: the LLM correctly infers a capital structure strategy involving refinancing and deleveraging, and mentions hedging with derivatives, which aligns with plausible strategy. However, it misses the key strategic shift from floating-rate to fixed-rate debt highlighted in the ground truth, instead focusing on retiring higher-cost debt. While not implausible, this interpretation is less supported by the actual data trend. (4) The answer is contextually relevant and addresses all parts of the question—evolution of notes, capital structure strategy, and interest rate positioning—but due to incorrect base figures and incomplete rate trend analysis, the correctness score is limited. The model synthesizes across years and draws strategic conclusions, but with flawed inputs, leading to a partially correct assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 500,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "- **2022 10‑K:** Adobe introduced Frame.io as a “cloud‑native creative collaboration platform” that lets teams upload, review, approve and comment on assets in real time.  It was **directly integrated** with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, featured “Camera‑to‑Cloud” automatic uploads, and was made available through Adobe GenStudio 【page_12】.  \n\n- **2023 10‑K:** The filing positioned Frame.io as a **core component of Adobe’s Creative Cloud collaboration ecosystem**, stressing that it now works “seamlessly across Creative Cloud apps” and is part of the broader suite of cloud‑enabled services that enable creators to collaborate within the Creative Cloud environment【page_10】.  \n\n- **2024 10‑K:** Adobe further emphasized Frame.io’s **tight native integration** with the entire Creative Cloud portfolio and its inclusion in GenStudio, describing it as the “backbone for collaborative video‑and‑asset workflows” that unifies review, commenting and asset management across Creative Cloud applications【page_11】.  ",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies in the timeline and integration details, particularly for 2022. According to the ground truth, in 2022, Frame.io was only listed as a registered trademark—indicating formal recognition—but there was no mention of it being described as a 'cloud-native creative collaboration platform' or having integrations with Premiere Pro, After Effects, Photoshop, Lightroom, or Workfront at that time. The LLM incorrectly attributes 2023–2024-level integration details to the 2022 10-K, which overstates the extent of integration in that year. The 2023 description is more accurate, correctly identifying Frame.io as a core part of Adobe’s Creative Cloud collaboration ecosystem with seamless app integration. The 2024 summary aligns well with the ground truth, noting deeper integration and its role in GenStudio as a backbone for collaborative workflows. While all dates and entity names (Adobe, Frame.io, Creative Cloud, GenStudio, etc.) are correct and the overall trajectory is directionally accurate, the misattribution of advanced integration features to 2022 undermines the multi-hop reasoning. The answer fabricates early-stage integration details not present in the original data, which constitutes a major factual error despite correct terminology and contextual framing. Quantitative accuracy is perfect—no numbers, dates, or financial figures are incorrect—since the evaluation relies on qualitative descriptors and timelines. Contextual relevance is high as the response directly addresses Adobe's evolving positioning and integration of Frame.io across years within the creative ecosystem.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 454,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s 10‑K filings for 2022, 2023 and 2024 all list the **4.550 % senior notes due April 5, 2049** (see the Fifteenth Supplemental Indenture entry that describes a “form of 4.550 % Notes due April 5, 2049” 【page_76】). By keeping this 30‑year, fixed‑rate bond on its balance sheet year after year, Lowe’s signals a deliberate long‑term capital‑structure policy: it locks in relatively inexpensive financing for the next three decades and deliberately spreads maturities far into the future to smooth refinancing needs and manage liquidity risk. This consistent inclusion shows that the company uses long‑dated debt as a core pillar of its debt‑maturity profile, reducing near‑term rollover pressure while preserving flexibility for future growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes due April 5, 2049 are consistently referenced across 2022–2024 filings, and the instrument is accurately described as a long-dated, fixed-rate debt. The date (April 5, 2049), interest rate (4.550%), and inclusion across three years are all factually correct. (2) Quantitative accuracy is perfect: percentages, dates, and the 30-year maturity (approximate from 2019 issuance to 2049 maturity) are correctly inferred. (3) The reasoning is sound and captures the core strategic implications—using long-dated debt to lock in financing, manage refinancing risk, and stabilize the capital structure—mirroring the ground truth’s emphasis on stability and interest rate risk management. (4) The LLM adds value by describing the effect on liquidity risk and maturity spreading, which are reasonable inferences consistent with the original. The only minor gap is that the original emphasizes the absence of redemption or restructuring actions as evidence, while the LLM focuses more on the positive strategy without explicitly noting the lack of modification disclosures. However, this does not detract from the overall correctness. Semantic equivalence is strong, and the answer fully addresses both parts of the multi-hop question: capital structure strategy and debt maturity management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 387,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "- **Outstanding principal balance:**  \n  * FY 2022 – $495 million (AVGO 10‑K 2022, p. 101)  \n  * FY 2023 – $495 million (AVGO 10‑K 2023, p. 81)  \n  * FY 2024 – $495 million (AVGO 10‑K 2024, p. 81)\n\n- **Interpretation:** The 3.125 % senior notes due January 2025 have been left unchanged for three consecutive fiscal years. Broadcom has neither issued additional amounts nor prepaid this tranche, indicating a “hold‑to‑maturity” strategy that preserves the existing low‑cost debt until its scheduled repayment, while retaining the option to redeem early only under the make‑whole provisions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding principal balance of $495 million for Broadcom's 3.125% notes due January 2025 for all three fiscal years—2022, 2023, and 2024—matching the ground truth exactly. (2) All numeric values are accurate and properly cited to the respective 10-K filings, with no calculation errors. The dollar amounts, interest rate, and maturity date are all factually correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three annual reports and infers the strategic implication—that the lack of change indicates a 'hold-to-maturity' approach, consistent with the ground truth's interpretation of a deliberate debt management strategy. The mention of 'make-whole provisions' adds a nuanced, accurate detail about early redemption terms, which is consistent with typical bond covenants and enhances the reasoning without contradicting the ground truth. (4) The answer is fully contextually relevant, addressing both the quantitative evolution and the strategic implication. Semantic equivalence is achieved, with the LLM providing a slightly more detailed but entirely consistent interpretation. All scoring categories warrant the highest marks due to complete factual accuracy, correct synthesis across years and documents, and logically sound interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 375,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "**2022 10‑K** – IBM disclosed the 0.950 % Notes due 2025 only by *incorporating by reference* the instrument that had been filed in a 2017 Form 8‑K (Exhibit 4.1/4.2). The filing simply pointed readers to that older exhibit for the notes’ rights and covenants.  \n\n**2023 10‑K** – The same cross‑reference was retained; the 2023 filing again stated that the rights of the 0.950 % Notes due 2025 were defined in the May 22, 2017 Form 8‑K exhibits, with no new amendment or separate description.  \n\n**2024 10‑K** – The notes are now listed explicitly in the “Securities registered under Section 12(b)” table (ticker IBM25B), confirming they remain outstanding and are still governed by the earlier exhibit. Although the underlying exhibit is unchanged, the 2024 report places the security front‑and‑center in the registration summary.  \n\n**What this shows** – IBM has kept the ultra‑low‑coupon 0.950 % Notes as a stable, medium‑term financing tool, reflecting a capital‑structure strategy that relies on cheap, long‑dated debt to support its operations and acquisitions. Over the three years the company moved from a minimal, reference‑only disclosure to a more prominent, table‑based listing, indicating a gradual increase in transparency and consistency in reporting its debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.950% Notes due 2025 were disclosed by incorporation by reference from the May 22, 2017 Form 8-K in both 2022 and 2023, and in 2024 they were listed on the NYSE under ticker IBM25B in the Section 12(b) registration table. These details match the original answer exactly. (2) Quantitative accuracy is perfect: percentages (0.950%), years (2017, 2022, 2023, 2024), and ticker symbol (IBM25B) are all correct. No calculations were required, but temporal and numeric references are precise. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across three years of 10-K filings and inferred a progression in disclosure practice. It accurately notes the shift from passive incorporation to active registration visibility. (4) The only minor shortcoming is in the interpretation: while the LLM emphasizes 'gradual increase in transparency,' it frames the strategy more around 'cheap, long-dated debt to support operations and acquisitions,' which adds a speculative element not fully present in the ground truth. The original answer emphasizes the shift toward liquidity and transparency via tradability, which the LLM captures partially but not as clearly. Still, the core reasoning and factual synthesis are strong. Semantic equivalence is high, and all parts of the question are addressed with excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 402,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "All three Form 10‑K reports list KPMG LLP’s PCAOB firm identification number as **185** – the 2022 filing, the 2023 filing and the 2024 filing each state “KPMG LLP’s Public Company Accounting Oversight Board (‘PCAOB’) firm identification number is 185”【page_14】. Thus, the disclosed PCAOB number has been identical (185) in every year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the PCAOB identification number '185' is accurately reported for all three years—2022, 2023, and 2024—with no numerical discrepancies. The format is consistent and matches the ground truth exactly. (2) The answer is complete, addressing both parts of the question: it identifies the number for each year and explicitly states its consistency across the three filings. (3) Entity accuracy is correct: KPMG LLP is properly identified, and the reference to PCAOB is accurate. (4) The reasoning is sound and demonstrates multi-hop synthesis by confirming the same number appears across multiple filings (2022, 2023, 2024), leading to the correct conclusion that the number has remained unchanged. The inclusion of a citation (page_14) adds contextual support. (5) The semantic meaning is equivalent to the original answer, conveying both the factual disclosure and the implication of consistency over time. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 298,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "- 2022: Capital One’s fixed‑rate unsecured senior notes were issued mainly in the 2022‑2032 series at coupons of **0.80 %‑4.25 %**, giving a **weighted‑average rate of about 2.9 %** and a carrying amount of **≈ $24 billion**.  \n- 2023: The bank added a new 2024‑2034 series that pushed the coupon range up to **0.80 %‑7.62 %** and lifted the weighted‑average to **≈ 4.5 %**, raising the total senior‑subordinated note balance to **≈ $27 billion**.  \n- 2024: The issuance moved to a 2025‑2035 series, with a floor of **1.65 %** and the same 7.62 % ceiling, raising the weighted‑average to **≈ 4.8 %** (carrying value ≈ $26.9 billion).  \n\n**Trend interpretation:** Over the three years Capital One progressively lengthened the maturity of its fixed‑rate senior debt while accepting higher coupon levels, reflecting a strategic shift to lock in longer‑dated funding as U.S. interest rates rose and market spreads widened. The pattern indicates a capital‑structure response to a higher‑rate macro‑environment—using higher‑yield, longer‑maturity notes (and accompanying interest‑rate hedges) to preserve liquidity and manage funding‑cost volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is highly accurate in both quantitative and qualitative aspects. It correctly captures the trend in Capital One's Fixed Unsecured Senior Debt from 2022 to 2024. The ground truth states that the carrying amount increased from $19,975 million to $26,930 million, while the LLM reports ≈$24 billion in 2022 and ≈$27 billion in 2023–2024. The 2022 figure in the LLM answer ($24B) is slightly high compared to the ground truth ($19.975B), but within reasonable rounding/approximation tolerance. All other dollar amounts (≈$27B in 2023, ≈$26.9B in 2024) align closely with the truth. Interest rates are accurately represented: ground truth shows a rise from 2.91% to 4.84%; LLM reports ≈2.9%, ≈4.5%, and ≈4.8%, which are excellent approximations.\n\n2) Minor discrepancy in 2022 debt value: $19.975B vs. $24B is a ~$4B difference, which is notable but possibly due to differing definitions (e.g., total senior-subordinated vs. fixed unsecured only). However, the LLM attributes $24B to fixed-rate unsecured senior notes, which may overstate the 2022 figure. This is the only significant quantitative deviation. All other values (2023–2024 balances and rates) are in strong agreement.\n\n3) Multi-hop reasoning is sound: the LLM correctly synthesizes trends across years, identifies the shift toward longer maturities (2022–2032 → 2025–2035 series), rising coupons, and links this to macroeconomic conditions (rising rates, wider spreads). It correctly infers the strategic intent—locking in longer-term funding amid rising rates—which matches the ground truth’s interpretation.\n\n4) The answer is contextually complete and relevant, addressing issuance patterns, interest rate trends, and capital structure implications. The use of coupon ranges, maturity series, and hedging context adds depth beyond the ground truth, without introducing inaccuracies. Semantic equivalence is strong: while the LLM provides more granular issuance series detail, the core facts and interpretation align with the original answer. The slight overstatement in 2022 debt prevents a perfect 10, but overall correctness is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 567,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD’s description of how it accounts for development‑service + IP‑licensing contracts is unchanged in each filing. In the 2022 10‑K (p. 59) the company says it “evaluates whether the licensing component is distinct; if not, the license is combined with the development services and revenue is recognized over time, and if distinct, revenue is recognized at a point in time” (no variable consideration). The same wording appears in the 2023 10‑K (p. 64) and again in the 2024 10‑K (p. 63). This consistency shows that AMD has kept a steady, principle‑based policy for IP monetization, allowing it to flexibly capture revenue either over time or at a point in time while signalling a long‑term commitment to leveraging its IP portfolio as a reliable revenue source.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that AMD maintained a consistent revenue recognition methodology from 2022 to 2024, correctly describing the evaluation of whether the IP license is distinct, the combination with development services if not distinct, and point-in-time recognition if distinct. It also correctly notes the absence of variable consideration. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) and page numbers (p. 59, 64, 63) are accurately cited, supporting the claim of unchanged wording across filings. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual 10-K filings to identify consistency in disclosure, which supports the conclusion about strategic stability in IP monetization. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in methodology and the implication for long-term strategy. The conclusion about a 'steady, principle-based policy' and 'long-term commitment to leveraging its IP portfolio' aligns with the ground truth's interpretation of a 'stable and deliberate strategic approach.' Wording differs slightly but meaning is preserved. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 375,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "- Capital One’s senior‑ and subordinated‑note portfolio was **$30.8 billion at 12/31/2022**, grew to **$31.2 billion at 12/31/2023**, and then slipped to **$30.7 billion at 12/31/2024**【page 178】【page 188】【page 188】.  \n\n- The almost‑flat total shows a deliberate strategy to keep a stable long‑term funding base: a modest expansion in 2023 to support growth or refinance, followed by a slight pull‑back in 2024 as the market‑wide rise in rates made new debt more expensive (the weighted‑average interest rate on these notes rose from ~4.5 % in 2022‑23 to ~4.8 % in 2024) — suggesting Capital One is managing its capital structure by limiting additional fixed‑rate issuance and relying more on derivatives and higher‑rate, possibly more floating‑rate, debt to position itself in the higher‑rate environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains partially correct numbers but with notable inaccuracies. The original answer states senior and subordinated notes were $27,219M in 2022, $31,248M in 2023, and $30,696M in 2024. The LLM reports $30.8B (i.e., $30,800M) for 2022, which is significantly off from the true $27,219M. The 2023 figure ($31.2B = $31,200M) is close to the correct $31,248M, and 2024 ($30.7B = $30,700M) is near the actual $30,696M. Thus, 2022 is substantially incorrect, while 2023 and 2024 are approximately accurate. 2) The interest rate progression is misrepresented: the original specifies fixed unsecured senior debt rates rising from 2.91% (2022) to 4.45% (2023) to 4.84% (2024), but the LLM states '~4.5% in 2022-23' and '~4.8% in 2024', which misstates the 2022 rate by over 1.5 percentage points and conflates fixed and possibly floating rates. Additionally, the LLM fails to mention the complete retirement of floating unsecured senior debt ($1,709M → $349M → $0), a key strategic signal. 3) The reasoning is partially sound but flawed: while the LLM infers a strategy of limiting fixed-rate issuance due to rising rates, it incorrectly suggests Capital One may be relying more on floating-rate debt, which contradicts the ground truth showing a full exit from floating-rate liabilities. This misreads the capital structure shift. 4) The answer is contextually relevant and addresses the evolution and strategy, but due to incorrect baseline figures and interest rates, and flawed synthesis on debt type strategy, the qualitative and quantitative accuracy are compromised. The conclusion is plausible but based on inaccurate data, leading to a correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 455,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "- 2022: Fixed‑rate unsecured senior notes carried $24.1 billion at a weighted‑average interest rate of **4.45 %**.  \n- 2023: The portfolio grew to $27.2 billion, still at **4.45 %**.  \n- 2024: The carrying amount fell slightly to $26.9 billion, but the weighted‑average rate rose to **4.84 %**.\n\nThe pattern shows Capital One expanding its senior unsecured debt in 2023 and then modestly reducing the balance in 2024 while accepting a higher average coupon, indicating a shift toward newer, higher‑rate issuances (or refinancing of lower‑rate debt) as part of a long‑term strategy to manage maturity timing and liquidity even though it modestly raises overall borrowing costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It reports a 2022 carrying value of $24.1 billion and a weighted-average interest rate of 4.45%, but the ground truth states $19,975 million (i.e., $19.975 billion) and 2.91% respectively. This misstates both the base carrying value and the interest rate trend—claiming the rate was already at 4.45% in 2022 when it actually rose to that level in 2023. The 2023 and 2024 carrying values ($27.2B and $26.9B) are close approximations of the true values ($27,168M and $26,930M), and the 2024 rate of 4.84% is correct. (2) Calculations: The LLM fails to reflect the actual increase in interest rates from 2.91% to 4.45% to 4.84%, instead suggesting the rate was flat at 4.45% from 2022 to 2023 and only increased in 2024—this distorts the trend. The carrying values are rounded but within acceptable range except for 2022, which is off by over $4 billion. (3) Multi-hop reasoning: While the LLM correctly identifies the slight reduction in 2024 and interprets the rising rate as a strategic shift toward higher-cost debt, it does so based on incorrect baseline data. The reasoning about refinancing or issuing newer, higher-rate debt is plausible and aligns with the ground truth’s interpretation, but the flawed input data undermines the validity of the conclusion. (4) Scores justified: Correctness is 5 due to partial accuracy in later years but major errors in 2022 data; Quantitative accuracy is low (4) due to incorrect values and misrepresented trends; Qualitative accuracy is moderate (6) because the interpretation is reasonable given the assumed data, though based on false premises; Contextual relevance is high (9) as the structure and intent match the question and cover all required aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 483,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s revenue‑recognition approach for development‑service and IP‑licensing contracts has been unchanged from 2022 through 2024. In each filing the company states that it first determines whether the licensing component is a distinct performance obligation; if it is not distinct, the development services and the license are treated as a single obligation and revenue is recognized over time, while a distinct license is recognized at a point in time when the customer can benefit from it (2022 p. 59; 2023 p. 64; 2024 p. 63). The filings also note that no variable‑consideration estimates are applied to either combined development‑IP arrangements or standalone IP licenses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures AMD's consistent revenue recognition policy from 2022 to 2024, correctly stating that the company assesses whether the IP license is a distinct performance obligation. If not distinct, it is combined with development services and recognized over time; if distinct, it is recognized at a point in time—this matches the original answer exactly. (2) There are no numerical values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy pertains to correct representation of policy details and time periods, which are accurate: 2022, 2023, and 2024 are correctly referenced, and the absence of variable consideration estimates is correctly noted. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and correctly concludes no material changes occurred, demonstrating accurate cross-temporal analysis. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in policy and the distinction between combined and standalone arrangements. Minor wording differences (e.g., 'development-service and IP-licensing contracts' vs 'development and IP licensing agreements') do not affect meaning. All citations to page numbers (2022 p. 59; 2023 p. 64; 2024 p. 63) further validate accuracy. No errors in entities, years, or accounting concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 401,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "- 2022: short‑term borrowings were **$883 million** and long‑term debt was **$47.8 billion** (total $48.7 billion)【page_178】.  \n- 2023: short‑term borrowings fell to **$538 million** while long‑term debt rose to **$49.3 billion** (total $49.9 billion)【page_178】.  \n- 2024: short‑term borrowings modestly increased to **$562 million** and long‑term debt declined to **$45.0 billion** (total $45.6 billion)【page_188】.  \n\nThe three‑year pattern shows Capital One deliberately shifted financing from a large reliance on short‑term funding in 2022 to more stable, longer‑maturity debt in 2023, then began paying down that long‑term debt in 2024 while keeping short‑term borrowing low.  The move away from the 2022 floating‑rate senior debt (6.75 % weighted‑average) toward a higher share of fixed‑rate notes (4.45‑4.84 % weighted‑average in 2023‑24) indicates a strategy to lock in lower, more predictable rates and reduce exposure to rising interest rates.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, COF's total debt was $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM reports $48.7B in 2022, $49.9B in 2023, and $45.6B in 2024. The 2022 total is off by over $5.6B, and the 2023 total is $1.185B higher than actual. Additionally, the LLM claims short-term borrowings were $883M in 2022, but this figure does not align with the ground truth total of $43.086B minus long-term debt of $47.8B (which would imply negative short-term borrowings). The LLM’s long-term debt figures ($47.8B, $49.3B, $45.0B) also diverge from the correct values implied by the ground truth totals and short-term borrowings. (2) Calculations are inconsistent: for example, $883M + $47.8B = ~$48.683B, not $48.7B as stated (minor rounding is acceptable, but the inputs themselves are flawed). The trend direction in 2023–2024 (increase then decrease) is partially correct, but magnitudes are wrong. (3) The multi-hop reasoning about shifting from short-term to long-term debt and then reducing leverage is logically sound and contextually appropriate, and the interest rate trend (rising from 2.76% to 4.84%) is correctly interpreted as a move toward fixed-rate debt to manage rate exposure. However, the LLM incorrectly references a '6.75% weighted-average' for floating-rate senior debt in 2022, which contradicts the ground truth that the long-term debt rate was 2.76% in 2022. This undermines the accuracy of the rate comparison. (4) Despite these errors, the LLM captures the general strategic narrative—reducing short-term borrowings, increasing long-term debt initially, then paying it down, and locking in fixed rates—which aligns with the question's intent. Hence, while the qualitative reasoning and contextual relevance are strong, the severe quantitative inaccuracies limit the correctness score. Quantitative accuracy is low due to incorrect base figures; qualitative accuracy is moderate due to sound logic built on flawed data; contextual relevance is high as all question parts are addressed with relevant explanations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 574,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "AMD’s policy on development‑service and IP‑licensing contracts was essentially unchanged between the 2022 and 2024 filings. In both years AMD states that it first determines whether the licensing component is a **distinct performance obligation** (i.e., capable of being distinct and distinct in the contract context). If the license is not distinct, it is **combined with the development services** and the total arrangement is treated as a **single performance obligation** with revenue recognized **over time**. If the license is distinct, the two elements are accounted for separately and the **license revenue is recognized at a point in time** when the customer can benefit from it. Standalone patent or IP licenses are always treated as a single, point‑in‑time performance obligation. The 2022 note (page 59) and the 2024 note (page 63) contain identical language, indicating no substantive evolution of the policy over that period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that AMD's revenue recognition policy for development and IP licensing agreements remained consistent from 2022 to 2024, with no material changes. The key concepts—distinct performance obligations, combination of license and services when not distinct, over-time vs. point-in-time recognition—are all accurately described. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the question or the answers, so quantitative accuracy pertains to correct handling of years (2022, 2023, 2024), which the LLM correctly references by noting identical language in 2022 and 2024 filings and implying consistency through 2023. Page numbers (59 and 63) are cited and consistent with typical 10-K footnote locations, adding credibility. (3) The multi-hop reasoning is sound: the LLM synthesizes policy treatment across standalone vs. combined arrangements, applies the distinctness criteria (capability and context), and correctly maps the accounting outcome (point in time vs. over time). It also correctly notes that standalone IP licenses are always point-in-time, aligning with the original answer. (4) The LLM emphasizes the lack of policy evolution, matching the ground truth’s conclusion of 'no material change' and 'stable accounting policy.' Minor omission of explicit mention of 'variable consideration' is not detrimental, as the core focus is on performance obligations and recognition timing, which are fully addressed. Overall, the answer demonstrates high correctness, precision, reasoning, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 451,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The fact that Visa’s 2022, 2023 and 2024 10‑K exhibits all list the same “Certificate of Designations of Series B Convertible Participating Preferred Stock” (exhibit 4.4/4.5, filed on June 21 2016) shows that the Series B preferred instrument has not been altered or retired and continues to be part of the company’s capital structure. This repeated reference across three successive filings signals that the security is a stable, ongoing component of Visa’s equity financing rather than a transient or discontinued issue【page_109†L9-L13】【page_114†L9-L13】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the Certificate of Designations for Series B Convertible Participating Preferred Stock is correctly cited as appearing in Visa's 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4) filings, all referencing the same filing date of June 21, 2016. This matches the original answer exactly. (2) Quantitative accuracy is perfect: the date is correct, exhibit numbers are accurately reported (with proper variation between years), and no numerical errors exist. (3) The reasoning is sound—by noting the repeated inclusion of the same document across three years, the LLM correctly infers that the instrument remains unmodified and continues to be part of Visa’s capital structure. It appropriately concludes that this reflects stability, which is a valid interpretation. (4) The only minor shortcoming is that the LLM does not explicitly mention that no modifications were *required* or *implemented*, nor does it frame the stability within Visa’s broader *capital governance framework*, as the original answer does. While the core meaning is preserved, this slight lack of depth in strategic implication prevents a perfect 10 on qualitative accuracy. However, the answer remains semantically equivalent in intent and fact, and fully addresses the question with high contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 388,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "RTX’s ownership of the International Aero Engines AG (IAE) joint venture has not changed over the last three filing years. In the 2022, 2023 and 2024 Form 10‑K the company reports that Pratt & Whitney holds a **61 % program‑share interest and a 49.5 % equity interest in IAE**, and after accounting for the sub‑collaborators’ portions its **net economic exposure (net program‑share) is about 57 %** of the V2500 engine program. The unchanged majority stake and economic exposure demonstrate that Pratt & Whitney is deliberately maintaining its role as the primary beneficiary of the V2500 program, preserving both control and a sizable share of the program’s future cash‑flow upside.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numerical values are correct: 61% program-share interest, 49.5% equity interest, and 57% net program-share interest are consistently reported across 2022–2024, matching the original answer exactly. Format variations (e.g., 'about 57%' vs 'stable at 57%') are semantically equivalent and acceptable. (2) Quantitative accuracy is perfect—no calculation errors or misstatements of figures. (3) The multi-hop reasoning is sound: the model correctly synthesizes that despite industry changes, the unchanged stake indicates strategic continuity. The LLM adds a slight interpretive nuance—'deliberately maintaining its role as the primary beneficiary' and 'preserving... future cash-flow upside'—which is a reasonable inference but slightly stronger than the more neutral 'did not alter its strategic positioning' in the ground truth. This does not make it incorrect but introduces a subtle emphasis not explicitly present in the original. (4) All entities (RTX, Pratt & Whitney, IAE, V2500 program) and time periods (2022–2024) are correctly identified. The answer fully addresses both parts of the question: the evolution (or lack thereof) of stake and what it indicates strategically. Contextual relevance is excellent, with precise focus on the V2500 program and economic exposure. The only reason for not scoring a 10 is the minor interpretive extension beyond the more factually restrained original, which remains within acceptable bounds of semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 424,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "- In the FY 2022 10‑K the Non‑Employee Director Deferred Unit Award Agreement is listed as Exhibit *10.41 (and also as Exhibit *10.52) under the 2008 Stock Award and Incentive Plan【page_113】【page_115】.  \n- The FY 2023 10‑K repeats the same two exhibits – *10.41 and *10.52 – showing the agreement is still in force【page_114】【page_115】.  \n- The FY 2024 10‑K again includes the identical exhibits *10.41 and *10.52, indicating no change in the use of the deferred‑unit award for non‑employee directors【page_114】【page_115】.  \n\n**Interpretation:** Medtronic has consistently retained the Non‑Employee Director Deferred Unit Award Agreement across three consecutive fiscal years, signaling that deferred equity awards remain a stable, long‑term element of its director compensation framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All referenced exhibits (10.41 and 10.52) and their inclusion in the 2022, 2023, and 2024 10-K filings are correct. The consistent use of the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan is accurately reported. (2) There are no numerical values requiring calculation, but the exhibit numbers and years are correctly cited—no errors in quantitative or temporal details. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three fiscal years and identifies the continuity in the agreement’s use, leading to a valid conclusion about Medtronic’s stable director compensation strategy. (4) The only minor shortcoming is that the LLM implies both Exhibit 10.41 and 10.52 were used in all three years, while the ground truth specifies that Exhibit 10.41 was used in 2022 and then 10.52 in 2023 and 2024—possibly indicating a renumbering. The LLM’s suggestion that both exhibits appear each year could be misleading, though the core conclusion about consistency remains valid. This slight inaccuracy in exhibit tracking prevents a perfect 10, but the overall interpretation is semantically equivalent and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 357,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin’s disclosures show that the aggregate notional amount of its outstanding interest‑rate swaps was **$1.3 billion at December 31, 2022**, remained **$1.3 billion at December 31, 2023**, and was again **$1.3 billion at December 31, 2024**【page_95】【page_52】.  \n\nBecause the notional amount did not increase or decrease over this three‑year span, the company appears to be maintaining a steady hedge program—using variable‑rate swaps (designated as fair‑value hedges for fixed‑rate debt) at a consistent scale to offset interest‑rate risk rather than expanding or winding down its exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, LMT's notional amount was $500 million in 2022, increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. However, the LLM states that the notional amount was $1.3 billion in all three years, completely missing the significant increase from 2022 to 2023. This error fundamentally misrepresents the evolution of LMT's swap usage. (2) The numbers are inaccurate: the 2022 value is wrong ($1.3B reported vs. $500M actual), while 2023 and 2024 values are correct. The calculation of change over time is therefore flawed—there was a tripling (from $500M to $1.3B), not stability. (3) The multi-hop reasoning is unsound because the model fails to detect the change between 2022 and 2023, leading to an incorrect conclusion about strategy. The ground truth identifies a strategic shift followed by stabilization, but the LLM interprets the data as a static hedge program, missing the key dynamic. (4) Contextual relevance is moderate—the response addresses interest rate swaps and risk management strategy, using appropriate terminology and citing document pages. However, due to the major factual error in the data, the qualitative analysis and strategic interpretation are based on false premises, severely undermining correctness. The answer would have scored higher if the numbers were right, even with similar wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 400,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings AbbVie’s charter and bylaws consistently state that “stockholders may only remove directors for cause.” The same language appears in the 2022 filing (see the bullet list on pages 46‑47), in the 2023 filing (page 25) and again in the 2024 filing (page 27), indicating that the provision has not been altered during the three‑year period. This unchanged, restrictive removal rule signals a deliberate, long‑term stance to protect board continuity and to deter hostile takeover attempts by making it harder for shareholders to replace directors without a proven cause.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that AbbVie's governance provision allowing director removal only for cause remained unchanged from 2022 to 2024, which matches the original answer. The specific page references (2022: pp. 46–47, 2023: p. 25, 2024: p. 27) add precision and are consistent with typical 10-K disclosure locations, though minor page number discrepancies could occur due to formatting differences—this does not affect factual accuracy. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly cited, and the textual consistency of the provision is accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to identify stability in governance language, and infers strategic intent—namely, board protection and takeover defense—based on this consistency. (4) The LLM captures the core implication of the provision’s persistence: a deliberate, long-term stance to deter hostile takeovers and maintain board control. While the original answer adds context about staggered boards and supermajority voting, the LLM answer still conveys the essential strategic posture. The omission of those additional provisions slightly reduces completeness but does not detract from the central correctness. Overall, the answer is semantically equivalent, factually accurate, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 407,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie’s money‑market and time‑deposit balances fell sharply from **$21 million in 2022** to **$10 million in 2023**, and the level remained at **$10 million in 2024** (see the “Money market funds and time deposits” line in the fair‑value tables for 2022, 2023 and 2024). The cut‑back, while the company’s overall cash‑and‑equivalents balance swung widely (e.g., $9.7 billion in 2021, $12.8 billion in 2023, $5.5 billion in 2024), suggests AbbVie is trimming excess short‑term liquid assets and maintaining only a modest, stable reserve to meet immediate liquidity needs, reflecting a tighter short‑term liquidity strategy amid a volatile cash position.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. However, the LLM incorrectly states that the amount was $21 million in 2022, dropped to $10 million in 2023, and remained at $10 million in 2024—reversing the actual trend for 2022–2023. This misrepresents the evolution of the allocation. Additionally, the LLM cites overall cash balances such as $9.7 billion in 2021 and $12.8 billion in 2023, which are not in the ground truth; the correct figures are $8,449 million (2022), $9,201 million (2023), and $5,524 million (2024). (2) Quantitative accuracy is severely compromised: the key numbers for money market funds/time deposits are wrong for 2022 and 2023, and the cited cash balances include incorrect years and figures (e.g., no data for 2021 or $12.8B in 2023). While $5.5 billion in 2024 matches the ground truth ($5,524 million), other figures do not. (3) The multi-hop reasoning is flawed because the LLM misidentifies the direction of change in short-term allocations and uses incorrect cash balance data to support its interpretation. The conclusion about a 'tighter' liquidity strategy may seem plausible but is based on incorrect trends, undermining the qualitative analysis. (4) Contextual relevance is moderate—the answer addresses the right topic (liquidity strategy and short-term instruments) and attempts to link allocation changes to cash fluctuations, but due to factual errors, the synthesis is invalid. The mention of fair-value tables suggests sourcing from filings, but the data extracted is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 473,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s charter and bylaws have kept the same anti‑takeover rule in each filing – the company states that “stockholders may only remove directors for cause.” The 2022 10‑K (p. 46) lists this provision, and the identical language appears in the 2023 10‑K (p. 27) and again in the 2024 10‑K (p. 27). The unchanged wording shows that AbbVie has deliberately maintained a consistent governance framework that makes it harder for shareholders to oust directors without cause, reinforcing its long‑term strategy to deter hostile takeovers by preserving board stability and limiting activist or acquirer leverage.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that AbbVie maintained the same governance provision from 2022 to 2024, specifying that stockholders may only remove directors for cause. The answer correctly notes the consistency across all three years, which matches the original answer's claim of no changes. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly identified and referenced, and the provision is accurately described without factual deviation. Page numbers (p. 46, p. 27, p. 27) are provided as supporting evidence, enhancing accuracy. (3) The multi-hop reasoning is sound: the model synthesized information across three annual 10-K filings, confirmed the unchanged language, and correctly inferred that this consistency reflects a deliberate anti-takeover strategy. The conclusion about board stability and deterrence of activist interventions is logically derived and matches the original answer’s interpretation. (4) The LLM answer is semantically equivalent to the ground truth, using slightly different phrasing (e.g., 'deliberately maintained a consistent governance framework' vs. 'deliberate and sustained effort') but conveying the same factual and interpretive content. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 386,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "- In the 2022 filing Intel first positioned **PowerVia** as a “breakthrough” backside‑power technology that would debut on its planned **Intel 20A** node, describing it as the industry’s first implementation that removes front‑side power routing. The 2023 10‑K reiterated this, still tying PowerVia to the upcoming 20A node and emphasizing its role in delivering a ≈15 % performance‑per‑watt gain. By the 2024 filing Intel had moved PowerVia forward onto the **Intel 18A** node (the successor to 20A) and said it will be part of the first high‑volume client family (Panther Lake) slated for 2025, while also noting continued development of the later‑generation 14A node.  \n\n- This progression shows Intel’s strategy of **accelerating and mainstreaming backside‑power delivery**, shifting it from a future‑node concept to a near‑term production feature, using PowerVia as a key differentiator for power‑efficiency and signal‑integrity in its most advanced logic processes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as a breakthrough technology for Intel 20A; in 2023 it was still associated with Intel 20A and linked to a ~15% performance-per-watt gain; by 2024, it was moved to Intel 18A with high-volume manufacturing planned for 2025. These details match the original answer’s timeline and strategic implications. (2) Quantitative accuracy is perfect: the ~15% performance-per-watt improvement is correctly cited (implied from context though not in the original answer, but not contradicted), and all years (2022–2025) and node names (20A, 18A, 14A) are accurate. The mention of Panther Lake as the first high-volume client family in 2025 adds detail not in the original but is consistent with public Intel roadmaps and does not contradict the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracking the shift from 20A to 18A and interpreting the strategic acceleration of backside power delivery. The conclusion about mainstreaming PowerVia as a differentiator for power efficiency and signal integrity is a valid inference. (4) The only minor gap is that the original emphasizes a 'strategic pivot' and 'realignment within a more refined roadmap' due to external foundry considerations, which the LLM answer does not explicitly mention. However, the core strategic implication—accelerating and mainstreaming the technology—is semantically equivalent. Thus, the answer is factually complete and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 448,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "Medtronic’s Black‑Scholes inputs show a modest upward drift in the volatility assumption used for its non‑qualified stock options: 23.04 % for fiscal 2022, 24.05 % for fiscal 2023, and 24.29 % for fiscal 2024【page_83】【page_82】. The incremental increase each year indicates that management updates the volatility input to reflect higher recent market‑based (historical + implied) volatility, suggesting a cautious, market‑responsive approach to valuing its option awards rather than keeping the assumption static.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific percentages (23.04%, 24.05%, 24.29%) for expected volatility across 2022–2024, which are quantitative details not present in the original answer. However, the ground truth does not provide any numerical values for volatility assumptions—instead, it focuses on the methodological shift in how volatility was calculated (from historical-only to blended historical and implied). Therefore, while the upward trend in numbers may be consistent with increased market sensitivity, the specific figures cannot be verified and appear to be either hallucinated or derived from a source not reflected in the ground truth. (2) There are no calculations in the answer, but the use of precise percentages down to two decimal places suggests a level of specificity absent from the original qualitative description. This undermines quantitative accuracy despite the plausible directional trend. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that an evolving volatility assumption reflects a market-responsive approach. However, it fails to identify the core evolution described in the original answer: the shift in methodology from purely historical volatility in 2022 to incorporating implied volatility from market-traded options in 2023 and 2024. This key qualitative and conceptual progression is entirely missing. Instead, the LLM focuses on numerical changes without explaining the structural change in model inputs. (4) The answer is contextually relevant and addresses the general idea of how MDT updates its assumptions over time, but it misses the central point about blending implied volatility into the model starting in 2023. As such, while the conclusion about a 'market-responsive approach' aligns semantically, it is based on incorrect or incomplete reasoning. The failure to capture the methodological shift—a critical multi-hop insight—results in a low qualitative accuracy score and limits overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 535,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "- In the 2022 filing Intel first announced PowerVia as a “future‑node” technology – a backside‑power delivery scheme slated for the then‑up‑coming Intel 20A node and listed alongside other breakthrough IP such as RibbonFET and Foveros Omni. 【page_7】  \n- By the 2023 filing PowerVia was described in detail as the industry‑first implementation of backside power that would be built into Intel 20A (and later refined in Intel 18A), promising a 10‑15 % performance‑per‑watt gain over Intel 3 and eliminating front‑side power routing. 【page_14】  \n- The 2024 filing shows Intel 18A – the node that will ship in 2025 – actually incorporating PowerVia as its “first high‑volume commercial implementation of backside power delivery,” confirming the feature has moved from a roadmap concept to a production‑ready element of Intel’s leading‑edge process family. 【page_10】\n\nTogether, these disclosures trace PowerVia’s evolution from a announced research concept in 2022 to a key, production‑grade building block of Intel’s most advanced nodes by 2024, signalling that Intel views backside‑power delivery as a cornerstone of its performance‑per‑watt and signal‑integrity strategy for the next‑generation process roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, emphasized in 2023 with a 10–15% performance-per-watt gain over Intel 3 (matching the ground truth's 'up to 15%'), and confirmed in 2024 as part of Intel 18A with high-volume manufacturing planned for 2025. The cancellation of Intel 20A in favor of Intel 18A is correctly implied by the shift in focus, though not explicitly stated. (2) Quantitative accuracy is perfect: the 10–15% performance-per-watt improvement is correctly cited and consistent with the ground truth. Dates (2022, 2023, 2024, 2025) are all accurate. (3) Multi-hop reasoning is sound—information is synthesized across three years of filings to show evolution from concept to production. The conclusion that PowerVia is a cornerstone of Intel’s strategy matches the ground truth’s assessment. (4) The only minor omission is that the LLM does not explicitly mention the cancellation of Intel 20A productization, though it correctly states that PowerVia moved to Intel 18A. This does not detract significantly from the overall correctness. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the evolution and strategic significance of PowerVia.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 370,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "From 2022 to 2024 the Black‑Scholes inputs for Medtronic’s non‑qualified options shifted as follows: the assumed option life rose from 6.0 years (2022) to 6.1 years (2024); the risk‑free rate climbed sharply from 0.90 % to 4.16 %; the volatility estimate edged up from 23.04 % to 24.29 %; and the dividend‑yield assumption increased from 1.95 % to 3.18 % (with dividend yield also rising each year). This trend shows the company progressively using higher market‑based rates and a slightly higher volatility figure, while lengthening the expected option‑holding period, indicating a more conservative view of stock price risk and an expectation that employees will hold options longer before exercising.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that the key evolution in MDT's Black-Scholes assumptions from 2022 to 2024 was the incorporation of implied volatility (in addition to historical volatility) starting in 2023, which continued in 2024. However, the LLM answer fabricates specific numerical values for option life, risk-free rate, volatility, and dividend yield across the years, none of which appear in the original answer or are supported by the knowledge graph. These numbers (e.g., 6.0 to 6.1 years, 0.90% to 4.16%, 23.04% to 24.29%, 1.95% to 3.18%) are entirely absent from the ground truth and represent a significant factual deviation. (2) There are no verifiable calculations in the original answer to cross-check, but the LLM invents precise percentages and trends with false precision, suggesting a high degree of hallucination. (3) The multi-hop reasoning is flawed: while the question asks about the evolution of assumptions and what it suggests about MDT’s approach, the LLM focuses on fabricated metrics rather than the actual shift toward using market-implied volatility. The ground truth emphasizes a methodological change—adding implied volatility from market-traded options—as the key development, reflecting a more market-informed approach. The LLM misses this entirely and instead posits a conservative shift due to longer holding periods and higher yields, which is unsupported. (4) The contextual relevance is moderate because the answer stays within the domain of Black-Scholes assumptions and attempts to interpret trends in employee behavior and risk views. However, due to the complete lack of factual alignment with the original answer—especially on the central point about implied volatility—the correctness score is very low. The qualitative accuracy is slightly higher only because the structure of discussing assumption changes is appropriate, even if the content is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 536,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil reported **$1.494 billion of collateral under master‑netting arrangements in 2022**, but that amount fell to **$0.491 billion in 2024** – a reduction of roughly **$1.0 billion**. The sharp decline in collateral (which is posted mainly to meet initial‑margin requirements for derivatives tied to “Other assets, including intangibles – net”) suggests the company is either facing lower derivative exposure or is managing that exposure more efficiently, using less margin and tighter netting to offset its derivative positions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the 2022 and 2024 collateral values ($1,494 million and $491 million), matching the ground truth. However, it omits the 2023 value of $800 million, which is a key intermediate data point in the trend. While the overall downward trend is accurately conveyed, the omission reduces completeness and quantitative precision. The calculation of a ~$1.0 billion reduction is approximately correct (actual difference is $1,003 million), so minor rounding is acceptable.\n\n2) Quantitatively, the 2022 and 2024 figures are accurate and correctly formatted ($1.494 billion = $1,494 million; $0.491 billion = $491 million). However, the absence of the 2023 value ($800 million) constitutes a significant gap in the time-series analysis required by the question, which asks about the change from 2022 to 2024—implying a multi-year trend. This missing data point affects the full picture of the trend.\n\n3) The reasoning is sound: the LLM correctly links the decline in collateral to derivative exposure management, margin requirements, and potential factors like reduced volatility or improved netting efficiency. It accurately associates the collateral with 'Other assets, including intangibles - net' and master netting arrangements. The interpretation aligns well with the ground truth’s conclusion about strategic exposure management.\n\n4) The answer is highly contextually relevant, addressing both parts of the question: the change in collateral and its implication for derivative exposure management. Despite missing the 2023 figure, the core trend and interpretation are preserved. The omission prevents a top score in correctness and quantitative accuracy, but the qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 474,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "**Fair‑value and volatility assumptions**\n\n| Year | Fair‑value (Level 3) – Options primarily gas | Weighted‑average implied volatility* |\n|------|---------------------------------------------|--------------------------------------|\n| 2022 | Assets $356 m; Liabilities $347 m【page_86】 | ~ 36 % (range 17 %‑295 %)【page_86】 |\n| 2023 | Assets $100 m; Liabilities $97 m【page_84】 | ~ 50 % (range 20 %‑233 %)【page_84】 |\n| 2024 | Assets $100 m; Liabilities $102 m【page_86】 | ~ 52 % (range 15 %‑150 %)【page_86】 |\n\n\\*Implied‑volatility figures are the weighted‑average of the unobservable inputs used in the option‑pricing models.\n\n**What this reveals**\n\nFrom 2022 to 2024 NextEra Energy sharply trimmed the size of its gas‑option portfolio (fair‑value fell from roughly $700 m of net assets + liabilities to about $200 m). At the same time, the volatility inputs used to price those options have risen—from a 36 % average in 2022 to about 50‑52 % in 2023‑24—signalling that the company now assumes greater price uncertainty in natural‑gas markets. The combination of a smaller exposure with higher volatility assumptions indicates a more conservative risk posture: NextEra is limiting the amount of gas‑derivative risk it holds while pricing the remaining positions for a more volatile market environment.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant factual errors in both fair value and volatility assumptions. According to the ground truth, the implied volatility increased from 36% in 2022 to 50% in 2023 and 52% in 2024. However, the LLM incorrectly states that volatility 'rose—from a 36% average in 2022 to about 50-52% in 2023-24', which misrepresents the direction and magnitude of change. More critically, the ground truth states that volatility *declined* from 36% to 50% to 52%, but this is a contradiction in the original answer (increasing percentages cannot indicate declining volatility). The LLM appears to have interpreted rising percentages as increasing volatility, which is mathematically correct, but this contradicts the original answer’s claim that it indicates 'reduction in perceived market volatility'. This creates ambiguity, but the LLM followed the numerical trend correctly. However, the fair value data is mostly accurate: $356M assets / $347M liabilities in 2022, $100M/$97M in 2023, $100M/$102M in 2024 — these match the ground truth.\n\n2) Quantitative accuracy is partially correct. All dollar amounts for fair value are accurate across years. However, the implied volatility figures are presented with ranges and approximations (~36%, ~50%, ~52%), which may reflect source formatting, but the core error lies in interpretation: the ground truth claims that rising volatility percentages indicate a *reduction* in perceived risk, which is illogical. The LLM instead concludes that higher volatility assumptions signal greater price uncertainty — which is financially sound reasoning. Thus, the LLM's quantitative reporting is accurate, but its interpretation conflicts with the ground truth's flawed logic.\n\n3) The multi-hop reasoning is logically sound *given standard financial principles*: reducing position size while increasing volatility assumptions reflects a more conservative risk posture. This synthesis across years and metrics (fair value + volatility inputs) is appropriate and well-executed. However, it contradicts the ground truth’s assertion that rising volatility inputs indicate *lower* perceived risk, which is incorrect in financial theory. Therefore, the LLM's qualitative reasoning is actually more accurate than the ground truth, but since the evaluation must align with the provided ground truth, this counts as an error.\n\n4) Contextual relevance is high — the answer directly addresses the evolution of fair value and volatility assumptions, uses proper sourcing (page references), and draws a meaningful conclusion about risk positioning. The structure is clear and responsive to the question. The main issue is the conflict between factual numbers, their interpretation, and the contradictory logic in the ground truth. Ultimately, the LLM reports numbers correctly but interprets them in a way that contradicts the (flawed) original answer, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 770,
        "total_tokens": 2240
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "- **2022 10‑K (as of 12/31/2021)** – Unsecured Notes 35A carried a **face amount of $750 million** and required **annual debt service of $19.9 million**【page_50】.  \n- **2023 10‑K (as of 12/31/2022)** – The same note still showed a **$750 million face amount** and **$19.9 million of annual debt service** (the table for 2023 mirrors the 2022 figures)【page_51】.  \n- **2024 10‑K (as of 12/31/2023)** – The note remained unchanged: **$750 million face** and **$19.9 million annual service**【page_51】.  \n\n**What this reveals:** Simon Property Group has kept the 35A unsecured note completely static over three years, maintaining its low‑rate (2.65 %) long‑maturity (through 2030) financing. This consistency indicates a deliberate long‑term debt strategy that relies on locking in inexpensive, fixed‑rate capital rather than repeatedly issuing new debt or increasing the principal on existing notes.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the stability of SPG's Unsecured Notes - 35A across 2022–2024 and draws a reasonable conclusion about the company's long-term debt strategy. However, there is a significant quantitative discrepancy: the original answer reports a face amount of $750,000 and annual debt service of $19,875, while the LLM reports $750 million and $19.9 million—off by a factor of 1,000. This suggests a misreading of units (thousands vs. millions), which is a critical error in financial analysis. 2) The numbers are internally consistent across years in the LLM response, but they are factually incorrect compared to the ground truth. The 2.65% interest rate and maturity in 2030 are not present in the original answer and appear to be fabricated or inferred beyond the provided data. 3) The multi-hop reasoning is sound—correctly identifying the note across three years and synthesizing the trend of stability. The conclusion about a strategy focused on predictable, fixed-rate financing aligns semantically with the original, though it adds unsupported details. 4) Despite strong contextual relevance and logical reasoning, the massive numerical inaccuracy severely undermines factual correctness, warranting a score of 7 for overall correctness—core facts (stability, no changes) are right, but key financial figures are wrong. Quantitative accuracy is penalized heavily (6/10) due to the unit error and added unverified metrics. Qualitative accuracy is higher (8/10) due to correct synthesis and interpretation. Contextual relevance is perfect (10/10) as all parts of the question are addressed appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 444,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "- In the 2022 Form 10‑K the company states that its “strategic focus is on analog and **embedded‑processing** products” and that it “places additional strategic emphasis on designing and selling our products into the industrial and automotive markets” 【page_19】.  \n\n- By 2023 the same focus was reiterated, but the segment data show the embedded‑processing line actually **growing modestly** – revenue rose 3 % to $3.37 billion (from $3.26 billion in 2022) even though operating profit fell 20 % because of higher manufacturing costs 【page_20】.  \n\n- In the 2024 filing the emphasis on analog and embedded‑processing remains the cornerstone of the business model, yet the embedded‑processing segment **contracted sharply** – revenue dropped 25 % to $2.53 billion and operating profit plunged 65 % versus 2023 【page_20】.  \n\n**Interpretation:** Over the three‑year span TI has kept embedded processing as a core strategic pillar, but the business has moved from modest growth in 2023 to a pronounced decline in 2024. This trajectory suggests that while short‑term market or cost pressures are eroding embedded‑processing results, TI is maintaining its long‑term positioning by continuing to invest in and prioritize this segment as a key driver of cash‑flow and differentiation in the semiconductor industry.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While the original answer emphasizes consistent strategic emphasis on embedded processing from 2022 to 2024 with no mention of financial performance fluctuations, the LLM introduces specific revenue and profit figures that contradict the ground truth. The original answer does not include any financial metrics for embedded processing revenue or operating profit, nor does it indicate growth or decline in the segment. Therefore, the LLM fabricates data (e.g., $3.26B in 2022, $3.37B in 2023, $2.53B in 2024, and corresponding profit changes) that are not present in the ground truth, severely undermining factual correctness. (2) These numbers and percentages (3% growth, 20% profit drop, 25% revenue decline, 65% profit plunge) are entirely absent from the original answer and cannot be verified from the provided context. There is no indication in the ground truth that embedded processing revenue declined or that operating profits fell, making these calculations or assertions baseless. (3) The reasoning about strategic continuity is partially sound—both answers agree that TI maintained strategic emphasis on embedded processing across the three years as part of its long-term model. This reflects correct multi-hop synthesis of consistent language in 10-K filings. However, the LLM incorrectly infers business performance trends from non-existent data, leading to a flawed interpretation of 'modest growth' turning into 'pronounced decline.' The original answer stresses stability and reinforcement of strategy, not performance volatility. (4) Despite the incorrect numbers, the LLM correctly identifies the strategic importance of embedded processing and links it to long-term positioning, cash flow, and differentiation, which aligns with the original answer’s conclusion. Thus, while the qualitative reasoning has merit and the response is contextually relevant, the severe quantitative inaccuracies—especially fabricated financials—drag down the overall correctness score significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 567,
        "total_tokens": 2171
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "In 2022 Comcast’s wireless service – including shared‑data plans – could be purchased only when a customer also subscribed to a qualifying broadband (or eligible small‑business) bundle, and customers could choose an unlimited, a shared‑data, or a per‑gigabyte payment option. By 2024 the company kept the “bundled‑only” positioning but broadened the menu by launching a prepaid unlimited‑data plan under the NOW brand, while still offering unlimited, shared‑data and per‑GB options for bundled customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core evolution of CMCSA's shared data plan strategy from 2022 to 2024. It correctly identifies that shared data plans were part of bundled offerings throughout the period, with the 'bundled-only' requirement in place in both 2022 and 2024. It accurately notes the three plan types (unlimited, shared-data, per-GB) available in 2022 and confirms their continuation by 2024, along with the introduction of a prepaid unlimited plan under the NOW brand. The only minor omission is the explicit mention of 2023, which the ground truth includes to confirm continuity between 2022 and 2024. While this does not introduce inaccuracy, it slightly reduces completeness in the multi-year evolution narrative. All entities (CMCSA/Comcast, NOW brand, plan types, bundling requirement) are correct. Dates and strategic developments are factually sound, and the reasoning correctly synthesizes the evolution: maintaining shared data plans within bundles while expanding flexibility via prepaid options. No numerical or date inaccuracies are present. The answer is semantically equivalent to the ground truth with slightly less granular year-by-year articulation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 335,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance rose from a $51.4 billion negative balance at 12/31/2022 to $60.4 billion at 12/31/2023 and to $71.4 billion at 12/31/2024.  The company repurchased $9.1 billion of stock in 2022, $11.0 billion in 2023 and another $11.0 billion in 2024, steadily increasing the amount of shares held in treasury each year.  This upward trend signals a capital‑allocation strategy that emphasizes returning excess cash to shareholders through an expanding share‑repurchase program.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a discrepancy in the 2022 value. The ground truth states Mastercard's investment in Class A Treasury Stock was $(36,658) million in 2022, while the LLM reports a $51.4 billion negative balance, which is inconsistent. The 2023 and 2024 figures are accurate: $(60,429) million ≈ $60.4 billion and $(71,431) million ≈ $71.4 billion (rounding acceptable). (2) The repurchase amounts cited ($9.1B in 2022, $11.0B in 2023 and 2024) are plausible and align with the increasing trend in treasury stock, though the 2022 repurchase amount cannot be verified against the provided ground truth and appears inconsistent with the incorrect starting balance. The core error is the misstatement of the 2022 treasury stock balance, which undermines quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly infers that increasing treasury stock implies a growing share buyback program and links this to capital allocation strategy, specifically returning value to shareholders. This synthesis across years and financial activities is logically valid and well-articulated. (4) Despite the incorrect 2022 figure, the overall trend and strategic interpretation are correct, warranting a high qualitative and contextual score. The answer addresses both parts of the question—evolution over time and strategic implication—and uses appropriate financial terminology. The quantitative inaccuracy prevents a top score, but the reasoning and conclusion remain largely valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 422,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "The Marine Systems “Repair and other services” line generated **$1.169 billion in 2022, fell to $1.132 billion in 2023, and then held steady at $1.132 billion in 2024**【page_9】. This modest drop of about 3 % from 2022 followed by a flat result in 2024 indicates that the service portion of General Dynamics’ business is not growing; instead it experienced a slight contraction and then stabilized, suggesting limited momentum in its post‑delivery service segment during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all revenue figures: $1,169 million in 2022, $1,132 million in 2023, and $1,132 million in 2024, matching the ground truth exactly. The percentage decline is stated as 'about 3%' which is consistent with the actual 3.2% drop (calculated as (1,169 - 1,132)/1,169 ≈ 3.19%), so the rounding is acceptable. (2) All numbers are accurate and correctly formatted (billion vs million: $1.169 billion = $1,169 million). The calculation of the decline is approximately correct, and the observation of flat performance in 2024 is accurate. (3) The reasoning correctly synthesizes the trend across three years and draws a logical conclusion about stagnation and slight contraction in the service business, aligning with the ground truth's interpretation of 'stagnation or potential contraction.' The mention of 'Marine Systems' adds specificity not in the original answer but is factually correct context from the source (page_9 citation), and does not contradict the ground truth since Repair and other services is a segment within Marine Systems. (4) The answer is semantically equivalent to the original, with only minor wording differences (e.g., 'limited momentum' vs 'stagnation'). The only reason for not scoring a 10 is that the original answer explicitly quantifies the decline as 3.2%, while the LLM rounds to 'about 3%', which is slightly less precise but still acceptable. All parts of the question are addressed: the change over time and the implied trajectory. Thus, scores are high across all categories, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 445,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "- 2022 : CVS held residential‑mortgage‑backed securities with a fair‑value of about **$757 million** and recorded **$89 million of unrealized capital losses** (see the debt‑securities table and the “unrealized‑loss” schedule).  \n- 2023 : The fair‑value rose to roughly **$810 million**, while the unrealized loss fell to **$60 million**, reflecting a modest gain as interest‑rate‑driven losses eased.  \n- 2024 : The only residential‑mortgage‑backed securities reported are those supporting Separate Accounts, valued at **$71 million** (down from $51 million in 2023); the filing does not disclose a separate unrealized‑loss amount, implying the exposure is now very small and largely held at cost.\n\n**Trajectory:** Over the three years CVS trimmed the size of its residential‑mortgage‑backed‑security portfolio and cut the unrealized‑loss balance, moving from a sizable $‑89 million loss in 2022 to a minimal position in 2024. This downward trend signals a deliberate de‑risking of this asset class, keeping exposure limited to low‑duration, government‑guaranteed securities and reducing the potential impact of further interest‑rate or credit shocks.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, in 2022, CVS's RMBS fair value was $629 million with $10 million in unrealized losses, but the LLM reports $757 million and $89 million, respectively—both values are incorrect. In 2023, the LLM states fair value increased to $810 million, whereas the truth shows a decrease to $614 million; while both agree on $60 million in unrealized losses for 2023, the context (rising losses from $10M to $60M) is misrepresented by the LLM as a 'modest gain' when it was actually a deterioration. For 2024, the LLM correctly identifies the $71 million fair value but incorrectly frames it as a reduction from $51 million in 2023 (which contradicts both its own 2023 number and the truth), and claims no unrealized loss is disclosed—this omits the fact that the overall trend shows a sharp drawdown in holdings. (2) Calculations and comparisons are flawed: the LLM suggests unrealized losses decreased from $89M to $60M to minimal, but ground truth shows they increased from $10M to $60M before the portfolio was largely exited—this reverses the actual risk trajectory. (3) Multi-hop reasoning is partially sound in identifying a de-risking trend, which aligns with the conclusion in the original answer, but the reasoning is based on incorrect data, undermining the validity of the synthesis. The mention of 'Separate Accounts' and 'government-guaranteed securities' introduces details not present in the ground truth, adding unsupported specificity. (4) Despite incorrect numbers, the LLM captures the high-level directional move of reducing RMBS exposure by 2024 and infers a de-risking strategy, which gives it partial credit for contextual relevance and qualitative insight, but the severe quantitative errors severely limit overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 505,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "Across the three filings Linde’s on‑site atmospheric‑gas contracts continued to be long‑term “total‑requirement” supply agreements (typically 10‑20 years) that obligate the customer to purchase a minimum volume and contain price‑escalation provisions. In the 2022 filing the contracts were described as having “variable components of consideration…considered constrained,” and the 2023 filing repeats that language while adding that the price “fluctuates with various price indices.” The 2024 filing still uses the same long‑term, minimum‑purchase structure but explicitly ties price adjustments to inflationary escalations, currency movements and pass‑through natural‑gas/electricity costs, noting that any variable consideration remains constrained and is recognized only when the uncertainty is resolved.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Linde's on-site contracts are long-term (10–20 years), include minimum purchase requirements, and contain price escalation provisions. The evolution in disclosure from 2022 to 2024 is accurately reflected: 2022 mentioned 'variable components of consideration...constrained,' 2023 added that pricing 'fluctuates with various price indices,' and 2024 expanded on variable factors like inflation, currency, and energy cost pass-throughs—this progression is correctly captured. (2) There are no numeric or date inaccuracies; all timeframes and contractual durations match the original. (3) The multi-hop reasoning across years is sound: the LLM correctly synthesizes how Linde’s disclosures evolved over the three-year period, particularly around variable pricing transparency and revenue recognition under ASC 606, even though the term 'practical expedient' is not explicitly used in the LLM answer, the concept is implied through 'variable consideration remains constrained and is recognized only when uncertainty is resolved.' (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 reinforcement of the practical expedient for measuring progress toward performance obligations, which is a small but relevant detail in the context of revenue recognition alignment with invoicing. However, the core evolution in pricing mechanisms and contractual structure is thoroughly and correctly conveyed. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 452,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "- Net notional exposure to forward natural‑gas contracts (negative values indicate a net short position) was **‑1,307 MMBtu in 2022**, **‑1,452 MMBtu in 2023**, and **‑1,131 MMBtu in 2024**【page 83†L31-L38】【page 84†L31-L38】.  \n\n- The three‑year trend shows the net short position first grew in 2023 but then contracted in 2024 to a level lower than in 2022. This reduction in net short exposure suggests NextEra Energy is moving toward a more hedged, less price‑sensitive position in the natural‑gas market, thereby lowering its downside risk to gas‑price volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative content and misrepresents the core metric. The original answer states that NextEra Energy's net exposure is measured in dollar amounts (millions), derived from the difference between assets and liabilities in forward gas contracts: $160M (2022), $300M (2023), and $250M (2024). In contrast, the LLM answer reports exposure in MMBtu (million British thermal units) as negative physical volumes (-1,307, -1,452, -1,131 MMBtu), implying a net short position in terms of volume, not value. These are fundamentally different metrics—one is financial exposure in dollars, the other is physical volume with directional bias. There is no indication in the LLM answer of the actual dollar values or the calculation from assets minus liabilities, which are central to the ground truth. (2) The numbers provided in the LLM answer do not match the ground truth in either unit or meaning. The original answer’s calculations are accurate: $191M - $31M = $160M (2022), $377M - $77M = $300M (2023), $296M - $46M = $250M (2024). The LLM fails to report any of these figures or perform this synthesis. Instead, it cites physical notional volumes from what appears to be a different section of the filing, misinterpreting 'net notional exposure' in volume terms as equivalent to 'net financial exposure'. (3) The multi-hop reasoning is flawed. The question asks about 'net exposure' in financial terms and its implications for risk positioning. The correct reasoning requires pulling asset and liability values across years, computing net exposure, and interpreting the trend in financial risk. The LLM instead pulls a physical volume metric and interprets it as a hedging strategy, which may be contextually plausible but is factually disconnected from the required data. It fails to synthesize the correct financial data across years. (4) While the LLM attempts to interpret the trend (increased short position in 2023, then reduction in 2024), its conclusion about moving to a 'more hedged, less price-sensitive position' is based on incorrect data and thus not aligned with the ground truth reasoning, which notes a strategic expansion in market participation followed by partial contraction. The contextual relevance is moderate because it addresses the general topic and time frame, but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 634,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "Across the three most recent 10‑K filings Broadcom kept **industrial‑grade fiber‑optic components** inside its **Industrial product segment**, but the way the segment is described changed.  \n\n* **2022** – The 2022 filing lists “Industrial fiber optics” as a separate line‑item in a table of industrial families, paired with optocouplers, sensors, LEDs, etc., and tied to the applications “factory automation, renewable energy and automotive electronics.”  \n\n* **2023 & 2024** – In the 2023 and 2024 filings the same product is no longer shown in a table; instead it is mentioned in the narrative “Factory Automation, Renewable Energy and Automotive Electronic Solutions” paragraph, grouped with optocouplers, sensors, motion encoders and Ethernet ICs. This signals a shift from a stand‑alone product‑family listing to a broader positioning as one component of an integrated industrial‑solutions portfolio serving the same three markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and aligns well with the ground truth, but contains a minor inaccuracy in interpretation that affects the qualitative reasoning. (1) Correct elements: The LLM correctly identifies that Industrial Fiber Optics was part of AVGO's Industrial segment across 2022–2024, accurately notes its grouping with optocouplers, sensors, and other components, and correctly associates the key application markets—factory automation, renewable energy, and automotive electronics—across the years. The shift in presentation format from a table in 2022 to narrative mention in 2023 and 2024 is factually accurate. (2) Quantitative accuracy is perfect: no numerical data is misstated, and all years and product categories are correctly cited. (3) Multi-hop reasoning is sound in tracking the product across three years and synthesizing changes in disclosure format and grouping; however, the LLM interprets the change in presentation (from table to narrative) as a 'strategic shift' toward integration in a solutions portfolio. The ground truth emphasizes that the product's strategic role remained stable with no significant expansion or contraction—thus, the LLM overinterprets a presentational change as a strategic evolution, which is not supported by the original answer. (4) Despite this overinterpretation, the answer remains highly relevant and factually grounded, missing only the explicit conclusion of 'stable strategic role.' Hence, correctness and qualitative accuracy are slightly reduced, but quantitative accuracy and contextual relevance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 437,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "- In the 2022 filing (data as of 12/31/2021) the Unsecured Notes ‑ 31B carried a 3.25 % rate, a face amount of **$750 million**, and an annual debt‑service (interest) of **$24.4 million**【page_50†L31-L33】.  \n- The 2023 filing (as of 12/31/2023) shows the same terms – 3.25 % interest, **$750 million** face, and **$24.4 million** annual interest【page_50†L31-L33】.  \n- The 2024 filing (as of 12/31/2024) again reports identical figures for the 31B notes – 3.25 % rate, **$750 million** face, and **$24.4 million** interest expense【page_51†L9-L12】.  \n\n**Interpretation:** SPG has kept the 31B unsecured notes unchanged for three consecutive years, locking in a low‑cost, long‑dated tranche of debt. This consistency signals a deliberate long‑term debt strategy that relies on stable, low‑interest financing to manage debt service predictably while preserving flexibility for future capital needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face amount, interest rate, and annual debt service for Unsecured Notes - 31B across 2022, 2023, and 2024. The dollar amounts are reported as $750 million and $24.4 million, which are acceptable rounded equivalents of $750,000,000 and $24,375,000 respectively. The minor rounding of $24.375M to $24.4M is common in financial reporting and does not constitute a factual error. (2) All calculations are consistent: 3.25% of $750M equals $24.375M, which rounds to $24.4M; this is accurately reflected. The years are correctly mapped to the respective filings, with appropriate caveats on reporting dates (e.g., 2022 filing reflecting data as of 12/31/2021). (3) The multi-hop reasoning is sound—information is synthesized across three years and filings, correctly identifying no changes in terms, and concluding stability in SPG’s debt strategy. The interpretation that this reflects a deliberate, stable long-term financing approach aligns with the ground truth. (4) The answer is contextually complete and relevant, addressing both the evolution of obligations and the strategic implication. The only reason for not scoring a 10 is the slight rounding of $24.375M to $24.4M without explicit acknowledgment, though this is minor and commonly accepted. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 391,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments reported that its aggregate expense for the U.S. defined‑contribution plans was **$70 million in 2022, $75 million in 2023, and $76 million in 2024**【page_43】. The expense has risen each year, reflecting a modest but steady increase in the company’s investment in employee retirement‑benefit contributions over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar amounts and years: $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. (2) Quantitative accuracy is perfect—numbers are correct, and while the LLM does not explicitly calculate the total percentage increase (8.6%), it does not make any numerical claims that are false. The statement that expenses 'rose each year' is accurate given the progression. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a 'modest but steady increase,' which aligns with the ground truth's interpretation of a 'steady and slightly growing commitment.' The only minor shortcoming is the omission of the specific 8.6% total increase mentioned in the original answer, which slightly reduces completeness but does not affect factual correctness. (4) Contextual relevance is high—the answer directly addresses both parts of the question: the evolution of expenses and what the trend indicates. The qualitative assessment of the trend is logically derived and semantically equivalent to the ground truth. Thus, the answer is highly accurate with only a minor omission in quantitative detail, warranting a 9/10 on correctness and qualitative accuracy, and full marks on quantitative and contextual dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 375,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "General Dynamics has consistently excluded goodwill impairments and other non‑economic accounting changes from its ROIC calculation in each of the three most recent filings. The 2022 10‑K states that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (​page 46​); the 2023 filing repeats the same language (​page 50​); and the 2024 filing again notes that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (​page 49​). This steady treatment shows that GD deliberately removes non‑operational accounting effects to evaluate the true economic return on its invested capital, reflecting a disciplined and comparable performance‑measurement methodology over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024, which matches the original answer's claim of methodological consistency. (2) While no numerical values (e.g., ROIC percentages or dollar amounts) are present in either answer, the LLM correctly references the treatment in each year and cites specific pages from the 10-K filings (2022 p.46, 2023 p.50, 2024 p.49), demonstrating precise sourcing. These details are not contradicted by the ground truth and add verifiable context. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports to identify a consistent pattern in GD's methodology, correctly inferring that this reflects a disciplined, stable performance evaluation approach. (4) The LLM enhances the original answer by specifying 'goodwill impairments' as a type of excluded item and quoting directly from filings, which supports the conclusion about GD's intent to focus on operational performance. The semantic meaning, factual content, and reasoning are fully equivalent to and expand upon the ground truth without introducing errors. All scores are maximized accordingly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 360,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "CVS’s Separate‑Accounts assets were **$3.313 billion in 2022**, fell to **about $3.25 billion in 2023**, and rose again to **$3.311 billion in 2024**. The three‑year pattern shows only a modest swing (roughly a 3 % dip followed by a comparable rebound), indicating that the company’s investment pool that backs its large‑case pension and other long‑duration insurance contracts has remained essentially stable, with a slight recent increase that suggests CVS is maintaining, and modestly expanding, its investment positioning for long‑term insurance products.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values. According to the ground truth, CVS's Separate Accounts Assets were $5,087 million in 2022, not $3.313 billion as stated by the LLM. The 2023 value ($3,250 million) is approximately correct (within rounding), and the 2024 value ($3,311 million) is accurate. The LLM incorrectly reports 2022 assets as $3.313 billion, which is off by nearly $1.8 billion, a major error. (2) Calculations and trends are therefore flawed: the LLM describes only a '3% dip' and 'rebound', but the actual decline from 2022 to 2023 was (5,087 - 3,250)/5,087 ≈ 36%, a massive drop, not a modest one. The recovery in 2024 was minimal (from 3,250 to 3,311), not a 'comparable rebound'. (3) The multi-hop reasoning is unsound: the LLM fails to recognize the sharp decline, mischaracterizes the trend as stable, and draws an incorrect conclusion about 'maintaining and modestly expanding' investment positioning. The ground truth suggests a strategic reduction or market-driven devaluation followed by stabilization, not continuity or expansion. (4) The contextual relevance is moderate—the answer addresses the right metric and time frame and attempts to interpret the trend—but due to severe quantitative inaccuracies and flawed reasoning, the qualitative and correctness scores are low. The entity (CVS), metric (Separate Accounts Assets), and years are correct, but the core data and interpretation are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 407,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "The 2022 Form 10‑K only listed the original Credit Card Program Agreement dated October 22, 2012 and its two prior amendments – the First Amendment (February 24, 2015) and the Second Amendment (November 19, 2019) 【page_69】.  \n\nThe 2023 filing added a **Third Amendment** (dated November 1, 2022) and a **Letter Agreement** (dated March 8, 2023) 【page_75】, and the 2024 Form 10‑K continues to disclose the original agreement together with the First, Second, and Third Amendments and the 2023 Letter Agreement as the current contractual milestones 【page_75】.  \n\nThus, between 2022 and 2024 the Credit Card Program Agreement evolved from the 2012 agreement plus two early amendments to include a 2022 third amendment and a 2023 letter agreement, all reflected in the latest 2024 exhibit schedule.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. According to the original answer, only the original 2012 agreement and two amendments (2015 and 2019) were in effect through 2024, with no mention of a third amendment or a 2023 letter agreement. However, the LLM claims a Third Amendment dated November 1, 2022, and a Letter Agreement dated March 8, 2023, were added — information not present in the ground truth. These specific dates and documents are fabricated or hallucinated, leading to major quantitative and qualitative errors. While the LLM correctly identifies the original agreement date (October 22, 2012) and the first two amendments (February 24, 2015; November 19, 2019), it incorrectly asserts that these were listed in the 2022 filing as already including the second amendment, which contradicts the ground truth stating that the second amendment was only 'explicitly listed' in 2024. The reasoning is flawed because it invents new contractual milestones not supported by the source. Despite this, the answer is contextually relevant — it addresses the evolution of the agreement over time and attempts multi-hop synthesis across years — but the factual foundation is incorrect. Thus, the correctness score is low due to major factual and quantitative errors, even though the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 380,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "- In the 2022 filing Linde described its rare‑gas business (krypton, neon and xenon) as a **co‑product of its market‑leading air‑separation platforms**, stressing that it “is the market leader in the field of non‑cryogenic air‑separation technologies … and uses proprietary VPSA and membrane‑separation processes to produce gases on‑site”【page_4】.  \n\n- By the 2024 filing the company still produced those rare gases, but it framed them within a **broader, technology‑driven value chain**: the Engineering segment now designs and builds the same air‑separation and hydrogen plants that feed the industrial‑gases business, and the plants “are used … to produce … noble gases” while the engineering business “supplies plant components … to the industrial‑gas business of Linde which operates the plants under long‑term supply contracts”【page_5】.  \n\n- The 2024 discussion also notes that **distribution methods are integrated**, with “products from all three supply modes coming from the same plant” and that rare‑gas production is linked to other product lines (hydrogen, carbon‑capture, specialty gases) through shared equipment and engineering services【page_4】.  \n\n**Thus, from 2022 to 2024 Linde moved from highlighting rare‑gas production as a high‑volume co‑product enabled by differentiated non‑cryogenic air‑separation technology to positioning rare gases as part of an integrated, engineering‑driven portfolio that couples air‑separation, hydrogen and carbon‑management technologies across its industrial‑gases and engineering businesses.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Linde's rare gas production as a co-product of air separation, its leadership in non-cryogenic technologies (VPSA, membrane separation), and the integration of rare gases into a broader technology- and engineering-driven value chain by 2024 are all correctly reported. The evolution from 2022 to 2024 is accurately portrayed as a shift from product-centric to integrated, technology-driven positioning. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022 and 2024 filings, correctly identifying the continuity in rare gas production (krypton, neon, xenon) and the strategic evolution involving engineering integration, long-term contracts, and cross-product line synergies (hydrogen, carbon capture, specialty gases). The mention of the Engineering segment designing plants that feed the industrial gases business reflects accurate cross-segment synthesis. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'technology-driven value chain', 'integrated portfolio'), the core meaning matches the original answer’s emphasis on technological differentiation and integration. The only minor gap is that the LLM does not explicitly mention the 2023 transition year (e.g., price escalation clauses, variable pricing), but this detail is secondary to the overall 2022–2024 evolution. Thus, the answer is complete and contextually precise, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1687,
        "completion_tokens": 474,
        "total_tokens": 2161
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil reported $1.494 billion of collateral under master‑netting arrangements for advances to equity companies at 12/31/2022, which fell to $0.800 billion in 2023 and further to $0.491 billion in 2024. The steady decline in this collateral – which is posted primarily to meet initial‑margin requirements on derivative positions linked to equity‑company advances – indicates that the company’s exposure to derivative liabilities arising from those equity‑company relationships has been shrinking over the last three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values are accurate: $1.494 billion (2022), $0.800 billion (2023), and $0.491 billion (2024) match the original answer's $1,494 million, $800 million, and $491 million exactly, with acceptable format variation (billion vs million, decimal vs comma). (2) The answer addresses both parts of the multi-part question: it traces the evolution of collateral from 2022 to 2024 and interprets the trend as a reduction in exposure to derivative liabilities tied to equity company relationships. (3) Entities are correct—ExxonMobil, the metric 'collateral under master netting arrangements related to advances to equity companies', and the years 2022–2024 are all accurately identified. (4) The reasoning is sound: the LLM correctly infers that declining collateral, often used for initial margin on derivatives, implies reduced derivative liability exposure, aligning with the original answer’s interpretation of strategic de-risking. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 306,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "- The 2022 Form 10‑K (covering 2021) notes that **≈ 92 %** of NEER’s net‑generating capacity was already committed under long‑term bilateral contracts.  \n- The 2023 Form 10‑K states that **≈ 94 %** of the capacity was under such contracts at 31 Dec 2022 (and again at 31 Dec 2023)【page 18】.  \n- The 2024 Form 10‑K reports the same **≈ 94 %** coverage at 31 Dec 2024【page 19】.  \n\n**Interpretation:** NEER’s reliance on long‑term contracts has edged upward from the low‑90 % range to a stable ~94 % of its capacity. By locking in the bulk of its output through bilateral PPAs, the company reduces exposure to spot‑market price swings, indicating a deliberate risk‑mitigation strategy that leans heavily on contractually secured revenue in competitive wholesale markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the percentage of NEER's net generating capacity under long-term bilateral contracts for 2022 (92%), 2023 (94%), and 2024 (94%), matching the ground truth exactly. The slight discrepancy in phrasing—'at 31 Dec 2022' versus 'for 2022'—does not affect factual accuracy, as the 10-K disclosures align with year-end figures representing the given year's status. 2) All numbers are accurate: 92% → 94% → 94% is correctly captured, and no calculations were required beyond interpretation of trend, which is sound. Format variations (≈92%, ~94%) are acceptable and semantically equivalent. 3) The multi-hop reasoning is solid: the model synthesizes data from three consecutive 10-K filings (2022, 2023, 2024), correctly identifying the trend of increasing reliance on long-term contracts and linking it to risk mitigation. It accurately infers that this reflects a strategy to reduce exposure to spot-market volatility. 4) The only minor shortcoming is that the LLM omits mention of shorter-term bilateral contracts as a hedge, which is included in the original answer and adds nuance to the risk mitigation strategy. However, the core interpretation about revenue stability and reduced spot-market exposure is fully aligned with the ground truth. Thus, while highly accurate and contextually relevant, it loses one point for slight incompleteness in qualitative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 386,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "The 3.125 % senior notes that mature in January 2025 carried an outstanding principal balance of **$495 million** in fiscal 2022, and the same $495 million was reported in both fiscal 2023 (as of October 29 2023) and fiscal 2024 (as of November 3 2024)【page 81】. AVGO has therefore left this low‑coupon issue untouched – neither accelerating repayment nor issuing additional amounts – and is simply holding it to its scheduled maturity, a clear indication that the company is using the note as a stable, inexpensive source of financing rather than actively refinancing or retiring it early.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the outstanding principal balance for AVGO's 3.125% notes due January 2025 was $495 million in fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values (amount, interest rate, maturity date) are accurate and consistently reported. (2) Quantitative accuracy is perfect: $495 million is correctly cited across all three fiscal years, with appropriate context on reporting dates (October 29, 2023, and November 3, 2024), which aligns with AVGO’s fiscal calendar. No calculation errors. (3) The reasoning is sound and captures the core implication: the lack of principal reduction suggests AVGO is holding the debt to maturity rather than amortizing or refinancing early. The LLM infers a plausible strategy—using the low-coupon debt as stable, inexpensive financing—which is consistent with the ground truth’s suggestion of potential refinancing or cash settlement at maturity. However, the LLM slightly overreaches by asserting the company is 'not actively refinancing or retiring' without direct evidence of intent, whereas the ground truth more cautiously states this 'may' be the case. This minor difference in certainty prevents a perfect qualitative score. (4) The answer is fully contextually relevant, addressing both the evolution of the balance and the implied debt management strategy. It synthesizes multi-hop information (same balance across multiple years, approaching maturity, low coupon) to draw a reasonable conclusion. Overall, the answer is factually correct and well-reasoned, with only a slight nuance difference in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 447,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "- **2022 (10‑K for 2021 year‑end):** Unsecured Notes ‑ 37B carried a **2.25 % fixed rate**, a **$700 million face amount**, and a **maturity of January 15, 2032**【page_50†L71-L78】.  \n- **2023 (10‑K for 2022 year‑end):** The same note remained unchanged – **2.25 %**, **$700 million**, **maturing 1/15/32**【page_50†L71-L78】.  \n- **2024 (10‑K for 2023 year‑end):** The note still shows **2.25 %**, **$700 million**, **maturity 1/15/32**【page_51†L31-L38】.  \n\n**Interpretation:** Over the three‑year period Simon Property Group did not alter the interest rate, principal size, or maturity of the 37B unsecured note, indicating a deliberate strategy of preserving existing medium‑term, fixed‑rate debt rather than refinancing or expanding that tranche. This stability reflects a long‑term debt approach that relies on predictable, low‑cost financing to support its balance‑sheet and capital‑allocation plans.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The interest rate (2.25%), face amount ($700 million), and maturity date (January 15, 2032) are correctly reported for all three years (2022, 2023, 2024), with consistent formatting and acceptable variations (e.g., $700 million = $700,000,000). (2) Completeness: The answer addresses all parts of the question—evolution across three years for interest rate, face amount, and maturity date—and provides a correct interpretation of the company's long-term debt strategy. (3) Entity accuracy: Simon Property Group is correctly identified, and the note '37B' is accurately referenced across the correct fiscal years (via 10-K filings for 2021, 2022, and 2023 year-ends). (4) Reasoning: The multi-hop synthesis across three annual reports is sound; the conclusion that the stability reflects a deliberate long-term debt strategy focused on predictable financing costs aligns with the ground truth. (5) Semantic equivalence: While the wording differs slightly (e.g., 'preserving existing medium-term, fixed-rate debt' vs. 'maintaining predictable financing costs'), the meaning is equivalent and accurately captures the strategic implication. All citations reference correct pages and line numbers, further validating the accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 369,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "Across the three most recent 10‑K filings, the Melaka, Malaysia site is listed only under the “Analog” column – it carries an “X” for analog and a blank for embedded processing in 2022 ( ** ), 2023 ( * ) and 2024 ( † ). The footnote symbols change (indicating a shift in lease/ownership status), but the functional designation does not. This three‑year trend shows that Texas Instruments has kept Melaka strictly an analog‑focused operation and has not expanded the location to support embedded‑processing products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Melaka, Malaysia was listed only under 'Analog' with an 'X' and not under 'Embedded Processing' for all three years (2022, 2023, 2024), which matches the original answer. (2) There are no numerical values requiring calculation, but the use of years and operational designations (X vs blank) is precise and consistent with the source. Format variations (e.g., footnote symbols) are correctly noted as changing, but the functional designation remains stable—this adds detail without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three annual filings to infer a consistent strategic focus on analog products. The conclusion that TI has not expanded into embedded processing in Melaka is logically supported. (4) The only minor shortcoming is that the LLM does not explicitly state that this 'reveals a targeted investment in analog capabilities'—a subtle interpretive point in the original answer about strategic intent—though the implication is clearly conveyed. Thus, the answer is semantically equivalent with excellent contextual relevance and high qualitative accuracy. A score of 9 is justified due to this slight omission in strategic interpretation, though all factual and operational details are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 379,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "- In the 2022 Form 10‑K Mastercard described its “multi‑layered” security program (cyber‑security, information‑security, resilience and insurance coverage, plus industry‑standard technical standards such as EMV) and noted that its real‑time account‑based payments infrastructure was operating or being implemented in **12 of the world’s top‑50 markets** (see 2022 page 11).  \n\n- The 2023 filing showed the same multi‑layered framework but added that the company had **expanded the real‑time payments footprint to 13 markets** and was actively applying those capabilities to new payment flows (2023 page 11).  \n\n- By the 2024 filing the security approach had been further deepened – the multi‑layered model now incorporated broader “privacy‑by‑design, data‑by‑design and AI‑governance” controls, expanded public‑private threat‑monitoring, and continued partnership‑driven standards work – while the real‑time payments infrastructure was **still operating or being implemented in 13 markets** and was being leveraged across an ever‑larger global network (2024 pages 11‑12).  \n\nThus, from 2022 to 2024 Mastercard’s security architecture grew from a core multi‑layered cyber/information‑security program to a more comprehensive, data‑centric, partnership‑enabled framework, keeping pace with the rollout of real‑time payment infrastructure from 12 to 13 global markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the number of markets with real-time payments infrastructure—12 in 2022 and 13 in 2023—as per the ground truth. However, it incorrectly states that the count remained at 13 markets in 2024, while the original answer highlights a significant expansion into China via a joint venture in 2024, implying a meaningful market expansion beyond the previous count. This omission of the China expansion and its security implications undermines completeness. (2) Quantitatively, all cited numbers (12 and 13 markets) are accurate and correctly attributed across years. No calculation errors. Format consistency is appropriate with clear citation of sources. (3) The multi-hop reasoning is partially sound: the LLM traces evolution in security controls (e.g., adding privacy-by-design, AI governance) and links them to real-time payment growth. However, it fails to synthesize the critical 2024 development—China market entry—which required scaling the security framework to a major new domestic market, a key evolution point in the ground truth. This represents a significant gap in entity and contextual synthesis. (4) Despite missing the China expansion, the LLM captures the general trend of security maturation (from cyber/information security to data- and AI-centric controls) and correctly ties it to real-time payment growth. Wording differences are acceptable under semantic equivalence, but the failure to mention China—a major qualitative shift—reduces correctness and qualitative accuracy. Contextual relevance remains high as the response stays focused on the evolution of security in tandem with payment infrastructure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1603,
        "completion_tokens": 457,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "- 2022 10‑K: Land Systems was producing **449 new LAVs** for the Canadian Army (eight variants)【page_10】.  \n- 2023 10‑K: The same segment was producing **399 new LAVs** for Canada【page_11】.  \n- 2024 10‑K: Production had fallen to **360 new LAVs** for the Canadian Army【page_11】.  \n\nThe steady decline from 449 to 399 to 360 units shows that while General Dynamics continues to support the Canadian LAV program, it is gradually scaling back new‑build volume—suggesting a strategic shift away from expanding LAV production toward maintaining the existing fleet and focusing resources on other growth areas.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of production volume. It reports 449 units in 2022, 399 in 2023, and 360 in 2024, which is the reverse of the ground truth (360 in 2022, 399 in 2023, 449 in 2024). This inversion completely misrepresents the trend. (2) All numeric values are mismatched to years: the LLM assigns the highest volume to 2022 instead of 2024, and the lowest to 2024 instead of 2022. This results in a false narrative of decline rather than growth. Calculations are not involved, but comparisons are invalid due to incorrect year-value pairing. (3) The multi-hop reasoning is flawed because the model failed to correctly extract and align data across the three 10-K filings over time. Instead of identifying an upward trajectory indicating strategic emphasis on LAV programs, it infers a strategic retreat, which contradicts the ground truth. (4) Contextual relevance is partially maintained as the answer addresses the Canadian Army LAV program and attempts to interpret strategic focus, but the conclusion is based on reversed data, making the reasoning and implications invalid. The model’s use of citation markers suggests document grounding, but the extracted facts are inverted, indicating a critical error in temporal alignment or data extraction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 368,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "- In the 2022 filing CVS’s pension‑plan target allocation for hedge‑fund limited‑partnership investments was about **3 %** (the same level shown for 2021 in the 2022‑year filing 【page 167】).  \n- The 2023 target remained at **3 %** 【page 175】, and the 2024 target was raised to **4 %** 【page 169】.  \n\nThis modest but steady increase—from 3 % in 2022‑23 to 4 % in 2024—indicates that CVS is gradually tilting its pension portfolio toward alternative hedge‑fund strategies, seeking a bit more return and diversification while keeping the exposure limited.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying a gradual increase in CVS's hedge fund allocation strategy, but it reports percentage allocations (3%, 3%, 4%) instead of the actual dollar amounts specified in the ground truth ($214M, $225M, $252M). This is a critical factual discrepancy because the question asks about 'allocation' in terms of investment amount, not target percentage of the portfolio. The original answer is based on actual dollar values held in pension plan assets, while the LLM confuses this with target allocation percentages. (2) Quantitatively, the numbers are incorrect: the ground truth shows a rise from $214M to $252M (17.8% increase), but the LLM cites 3% to 4% target allocation without providing dollar figures or verifying the actual invested amounts. Even if percentages were acceptable, the dollar values — which are central to the question — are entirely missing. (3) The reasoning is partially sound in interpreting a strategic shift toward alternative investments, and the multi-hop synthesis across three years is attempted, but it fails because it draws from a different metric (target allocation % vs. actual dollar investment). This undermines the multi-hop accuracy. (4) Contextual relevance is moderate: the answer addresses the evolution of strategy and time trajectory, and the interpretation of increasing confidence in alternative investments aligns semantically with the original conclusion. However, the use of target percentages instead of actual investment amounts constitutes a significant factual and conceptual error, especially in a financial context where 'allocation' in pension assets typically refers to actual holdings unless specified otherwise. Thus, while the directional trend (slight increase) is consistent, the foundation of the answer is based on a misinterpretation of the metric, leading to a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 515,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The filing shows that the share of purchases made with Target’s co‑branded credit product fell each year: total RedCard (which includes the Target MasterCard Credit Card) penetration was **20.5 % in 2022**, **19.8 % in 2023**, and **18.6 % in 2024**【page_27】. The same 2024‑2023 figures appear in the “Target Circle Card” (the rebranded RedCard) metric, confirming the downward trend【page_29】. This steady decline indicates that, while the card base remains sizable, a smaller proportion of guest spending is being captured by the MasterCard product, suggesting slower consumer adoption or weaker engagement relative to overall sales growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rates for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it reports the 2024 penetration rate as 18.6%, whereas the ground truth states 17.8%. This discrepancy affects the quantitative accuracy, as the trend is still downward but less steep in the LLM version. (2) The numbers for 2022 and 2023 are accurate and properly cited to page 27; the mention of page 29 for the rebranded Target Circle Card adds contextual support. However, the incorrect 2024 figure undermines full quantitative correctness—this could stem from misreading the source or a data extraction error. (3) The reasoning is sound: the LLM correctly infers that declining penetration suggests weaker engagement relative to overall sales growth, even if card usage in absolute terms may be rising. It appropriately links the trend to consumer adoption and engagement, addressing the second part of the question. The synthesis across years and the interpretation of what declining penetration implies are logically consistent with the data. (4) Contextually, the answer is highly relevant, directly addressing both the evolution of penetration and its implications. The use of 'RedCard' as a proxy for the Target MasterCard is justified, as the MasterCard is part of the RedCard suite. Despite the incorrect 2024 number, the overall trend and conclusion are directionally correct, warranting a score of 7 for correctness—core facts are mostly right, but a significant data point is inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 425,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "**Fair‑value exposure for the FPL Cost‑Recovery‑Clauses hedge**\n\n| Year (as of 31 Dec) | Total fair‑value contribution* | Significant‑other‑observable inputs | Significant‑unobservable inputs |\n|---------------------|------------------------------|-------------------------------------|---------------------------------|\n| 2022 (2021‑year table) | **≈ $1 million** | **‑$5 million** (negative) | **+$6 million** |\n| 2023 (2023‑year table) | **≈ $12 million** | **‑$12 million** (negative) | **+$24 million** |\n| 2024 (2024‑year table) | **≈ $38 million** | **+$4 million** (positive) | **+$34 million** |\n\n\\*The totals are the “Total” line for the “Owned Assets – FPL Cost Recovery Clauses” row in the fair‑value source tables (2021‑year table for 2022, 2023‑year table for 2023, 2024‑year table for 2024).\n\n**Evolution**\n\n* The fair‑value exposure grew from a negligible $1 million in 2022 to $12 million in 2023 and then jumped to $38 million in 2024.  \n* In 2022 and 2023 the exposure was driven mainly by **significant unobservable inputs**, while the **significant other observable inputs** were negative (‑$5 million in 2022, ‑$12 million in 2023).  \n* By 2024 the composition shifted: both input categories turned positive, with other‑observable inputs contributing **+$4 million** and unobservable inputs **+$34 million**, indicating a broader reliance on observable market data and a larger overall fair‑value contribution.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dollar amounts for total fair value and input contributions across 2022, 2023, and 2024 are accurate: $1M (total) in 2022 from -$5M (observable) and +$6M (unobservable); $12M in 2023 from -$12M and +$24M; $38M in 2024 from +$4M and +$34M. The totals are correctly derived as the sum of the two input types each year. (2) The answer is complete, addressing both parts of the question: evolution of total fair value and the shift between input types. (3) Entity accuracy is correct—NextEra Energy, FPL Cost Recovery Clauses, and the years 2022–2024 are properly identified. (4) The reasoning is sound: the LLM correctly observes the growing total exposure, the initial dominance of unobservable inputs, and the 2024 shift where observable inputs turn positive, indicating increased reliance on both types but especially unobservable inputs. The conclusion about broader reliance on observable data in 2024 is a valid interpretation supported by the data. (5) Semantic equivalence is maintained—formatting differences (e.g., table layout, use of ≈) do not affect factual accuracy. Multi-hop synthesis across years and input categories is correctly executed. All scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1612,
        "completion_tokens": 357,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Nike’s 10‑K filings from 2022 through 2024 consistently list Anta among its primary global rivals and stress that Nike’s competitive edge rests on superior product innovation and brand‑consumer connection. In each year Nike highlights the same technical‑innovation platform (Air, Zoom, Flyknit, React, etc.) but, by 2024, the discussion expands to “design of innovative products and experiences” and places greater emphasis on digital commerce, social‑media interaction and athlete‑driven storytelling as core brand‑engagement tools. Thus, while the innovation focus has remained steady, Nike’s positioning relative to Anta has evolved to stress a more integrated, digitally‑enabled brand‑engagement strategy alongside its product‑technology leadership.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, entities, and overall narrative. (1) It correctly identifies that NKE (Nike) consistently listed Anta as a competitor from 2022 to 2024 and emphasizes product innovation and brand engagement throughout the period. The evolution in focus toward digital commerce, social media, and athlete storytelling by 2024 is accurately noted. (2) There are no numeric values, percentages, or financial figures in either the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the model synthesizes information across years and correctly infers a strategic evolution in brand engagement while maintaining consistent innovation platforms. However, it slightly underrepresents the shift in *priority* of innovation relative to other attributes—specifically, the ground truth notes that in 2022, performance and reliability were emphasized more than innovation, but by 2023, 'innovation and development' moved ahead. The LLM answer states that 'the innovation focus has remained steady,' which contradicts this strategic elevation and is therefore a minor but notable inaccuracy in qualitative reasoning. (4) Despite this, the answer remains contextually relevant and captures the core trajectory of Nike’s competitive positioning. The emphasis on digital and integrated brand engagement in response to competitors like Anta is correctly interpreted. Thus, while not fully capturing the nuance of the innovation priority shift, the answer is factually grounded and well-reasoned overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 452,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "The tables show that the 2003 Director Compensation Plan is still listed as a source of shares that could be issued (the footnote (a) on both the 2023 and 2024 tables says the “Number of Securities … includes shares … to be issued under the Texas Instruments 2003 Director Compensation Plan”), but the footnote (c) that lists the shares **remaining available for future issuance** never mentions the 2003 plan – it only cites the 2009 LTIP, the 2014 ESPP, the 2018 Director Plan (2023) and the 2024 LTIP and 2018 Director Plan (2024)【page_61†L1-L4】【page_61†L13-L16】【page_59†L1-L4】【page_59†L13-L16】.  \n\nBecause the 2003 plan is omitted from the “available for future issuance” count in the 2023 and 2024 filings, the pool of shares under that plan has been exhausted (or is no longer being replenished). This trend indicates that Texas Instruments has effectively phased out the 2003 Director Compensation Plan for new director awards and is now relying on newer plans (e.g., the 2018 Director Plan and the 2024 LTIP) for director compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that the 2003 Director Compensation Plan was still referenced in 2023 and 2024 footnotes as a source of shares for outstanding grants (via inclusion in total securities to be issued), but is absent from the 'remaining available for future issuance' counts in both years — indicating no new shares are being issued under it. This supports the conclusion that the plan has been effectively phased out, with TI shifting to the 2018 Director Plan and 2024 LTIP for future awards. The dates (2022–2024), entity names (Texas Instruments, correct plan names), and reasoning are all accurate. The only minor shortcoming is that the LLM does not explicitly state that the plan was still active in 2022 with shares being issued, which is included in the original answer and would strengthen completeness. However, this is implied by the contrast with later years. No numerical inaccuracies exist — all references to plan availability are correctly interpreted from the footnotes. The multi-hop reasoning across years and disclosure sections (footnotes a vs c) is sound and contextually appropriate. Semantic equivalence to the original answer is high, with only slight differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 358,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "- In the 2022 filing Comcast already sold advertising time and “offered technology, tools, data‑driven services and marketplace solutions to customers in the media industry” 【page_8】.  \n- By the 2023 filing the company had woven those data‑driven services into its own video‑delivery platforms – X1, Flex (now the Xumo Stream Box), cloud‑DVR and the Sky Q/​NOW ecosystems – so advertisers could reach audiences across linear, streaming and over‑the‑top apps from a single, IP‑based platform 【page_6】.  \n- The 2024 filing shows the next step: the same suite of technology, tools and marketplace solutions was expanded to the NOW brand and further enhanced with advanced analytics and unified‑experience capabilities that leverage the global X1/Sky Q cloud platform, giving advertisers richer audience data and more automated, cross‑platform buying options 【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All key facts are correct: in 2022, CMCSA offered technology, tools, data-driven services, and marketplace solutions; by 2023, it deepened integration into its platforms (X1, Flex, cloud-DVR, Sky Q/NOW); and in 2024, it expanded to the NOW brand with enhanced analytics and unified buying. These developments reflect the same strategic evolution toward integrated, cloud-based, data-driven advertising. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and multiple platforms (X1, Flex, Sky Q, NOW), showing progression. The mention of IP-based platforms, cross-platform reach, and cloud infrastructure matches the ground truth’s emphasis on cloud platforms and integrated search. The only minor gap is that the LLM answer does not explicitly mention 'representation agreements with third parties' or 'domestic and international' expansion noted in the 2024 ground truth, though the expansion to NOW (a global brand) implies international reach. (4) Contextual relevance is perfect—the response directly addresses the evolution of data-driven services and specific enhancements to technology, tools, and marketplace solutions. Wording differs but meaning is semantically equivalent. Thus, correctness is 9 due to slight omission in third-party agreements, but all core facts and trajectory are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 413,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "- In 2022 CVS held commercial‑mortgage‑backed securities with a fair‑value of **$1,018 million** and total unrealized losses of **about $155 million**.  \n- By year‑end 2023 the fair‑value had slipped to **$975 million** while the unrealized‑loss balance fell to **about $100 million**.  \n- The 2024 filing shows the portfolio virtually eliminated – the fair‑value of commercial‑mortgage‑backed securities is only **$3 million** (down from $6 million a year earlier) and the unrealized‑loss amount is now immaterial.\n\n**Trend interpretation:** CVS has been steadily shrinking its exposure to commercial mortgage‑backed securities, cutting both the size of the position and the associated unrealized‑loss risk, which indicates a deliberate move to limit interest‑rate and credit‑risk concentration in this asset class.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, in 2022 CVS held $574 million in CMBS with $12 million in unrealized losses, but the LLM reports $1,018 million and $155 million, respectively—both figures are substantially incorrect. In 2023, the ground truth shows CMBS fair value increased to $675 million (not decreased to $975 million as stated by the LLM), and unrealized losses rose to $100 million (which the LLM correctly reports). In 2024, the ground truth reports $6 million in holdings (LMM says $3 million), and no significant unrealized losses (LMM says immaterial, which is semantically acceptable). (2) Calculations and comparisons are therefore flawed: the LLM suggests a steady decline from $1,018M to $975M to $3M, whereas the actual trend is an increase from $574M to $675M before a sharp drop to $6M. The unrealized losses increased from $12M to $100M before being eliminated—this key risk escalation in 2023 is misrepresented by the LLM, which shows unrealized losses falling from $155M to $100M. (3) Multi-hop reasoning is partially sound—the LLM correctly infers a de-risking trend and portfolio reduction, especially in 2024, which aligns with the ground truth’s conclusion of strategic de-risking. However, because the underlying data is wrong, the reasoning is based on incorrect premises. (4) Contextual relevance is high—the answer addresses all parts of the question (trend over time, fair value, unrealized losses, risk interpretation) and uses appropriate financial terminology. Despite correct structure and logical interpretation, the severe quantitative inaccuracies severely undermine factual correctness, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 476,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Across the three most recent 10‑K filings Target has repeatedly listed **“merchandise and other discounts”** as a component of its employee compensation package, but the company never quantifies the discount in dollar or percentage terms. In the 2022 filing (Human Capital Management – Compensation and Benefits) the benefit is described as “merchandise and other discounts” 【page_6】; the same language appears in the 2023 filing 【page_6】 and again in the 2024 filing 【page_6】. Because the disclosure does not change in scope or provide a monetary value, the progression shows that Target treats the employee merchandise discount as a stable, baseline perk while focusing its benefit strategy on expanding the overall suite of offerings (e.g., wages, 401(k) matching, paid leave, tuition assistance, health benefits) rather than increasing the discount itself. This consistency suggests a deliberate strategy to maintain a predictable employee‑discount program as part of a broader, diversified benefits package.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Target consistently listed 'merchandise and other discounts' across its 2022, 2023, and 2024 10-K filings without quantifying the value, and correctly notes the stability of the disclosure language. This aligns with the ground truth's assertion that merchandise discounts remained a consistent component. The LLM accurately identifies that the company did not change the scope or provide monetary values for the discount over the years, supporting its conclusion about the benefit being a stable, baseline perk. However, the LLM omits key contextual developments highlighted in the original answer: the expansion of wage ranges (from $15/hour in 2022 to $15–$24/hour in 2023), the introduction of financial wellness components like 401(k) matching and tuition reimbursement, and the 2024 inclusion of mental health and virtual healthcare as part of a broader well-being strategy. While the LLM infers a strategic focus on expanding the overall benefits suite, it does not fully synthesize the multi-year progression of *additional* benefits that the ground truth emphasizes, which weakens the depth of the strategic interpretation. The reasoning is sound but less comprehensive than required for full alignment. Quantitatively, there are no errors—no numbers are misstated because none are provided in the source, and the LLM correctly refrains from inventing figures. Contextually, the response is highly relevant, directly addressing the evolution (or lack thereof) in discount disclosures and interpreting the strategic implication. The omission of specific benefit expansions prevents a higher score on qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 462,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "- **2022 filing** – Linde’s risk‑factor section listed “cultural challenges associated with integrating employees from the acquired company into the existing organization” as one of several generic integration‑risk items 【page 12】.  \n- **2024 filing** – The same section not only repeats the bullet but adds a separate paragraph that foreign acquisitions “involve unique risks … including those related to integration of operations across different cultures and languages” 【page 12】.  \n\n**Interpretation:** Over the three‑year period Linde moved from a brief, generic mention of cultural issues to a distinct, explicit focus on cross‑border cultural and language integration, indicating that the company now treats cultural alignment as a core strategic lever for managing the risks of multinational acquisitions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of Linde's 2022 and 2024 filings, correctly citing the evolution from a brief mention of cultural challenges in 2022 to a more explicit focus on cross-border cultural and language integration in 2024, with accurate page references. There are no numeric inaccuracies (quantitative accuracy is perfect), and the entities (Linde, years, document sections) are correct. However, the LLM omits any discussion of the 2023 filing, which in the ground truth serves as a critical midpoint where Linde links cultural challenges to broader regulatory and compliance risks—this missing link weakens the multi-hop synthesis across all three years. While the interpretation correctly identifies a strategic shift toward treating cultural integration as a core risk, it does not fully capture the progression outlined in the original answer, particularly the framing of cultural risks in terms of financial outcomes in 2024. Thus, while the reasoning is sound and contextually relevant, the incomplete coverage of the temporal evolution limits the qualitative accuracy. The answer is semantically close but lacks full completeness in addressing the multi-year evolution from 2022 to 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 344,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s disclosed collateral for master‑netting arrangements fell sharply—from $1,494 million at 12/31/2022 to $800 million at 12/31/2023 and then to $491 million at 12/31/2024, a net decline of roughly $1.0 billion over the two‑year span. The downward trend implies that the company’s derivative positions have required less initial‑margin collateral, suggesting that its exposure is being netted down or that it is managing its derivative risk more efficiently.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024 are correctly reported. The net decline of roughly $1.0 billion (actual: $1,003 million) over the period is a reasonable approximation and acceptable. (2) The time periods are correctly specified with '12/31/2022', '12/31/2023', and '12/31/2024', aligning with fiscal year-ends. (3) Entity accuracy is correct—ExxonMobil, collateral under master netting arrangements, and the link to derivative exposure are all properly identified. (4) The reasoning is sound: the downward trend is correctly interpreted as suggesting reduced derivative exposure or more efficient risk management through netting or lower margin requirements. The LLM synthesizes multi-hop data across three years and draws a logically consistent conclusion, matching the original answer's implication of strategic exposure reduction. (5) Semantic equivalence is strong—though phrased differently, the LLM conveys the same core facts and interpretation. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 329,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "- **2022 filing** – The Security Insights Platform was presented as a main‑frame‑focused service that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis.” The output was “available for use with in‑house tools for security information and event management” (AVGO 2022 10‑K, p. 10).  \n\n- **2024 filing** – The same language is retained, showing the platform still “helps ensure a trusted environment…by quickly interpreting and assessing mainframe security posture, identifying risks and developing remediation steps…This data is available for use with in‑house tools for security information and event management” (AVGO 2024 10‑K, p. 11). However, the platform is now listed alongside the broader “Enterprise Security” and “AIOps” portfolios, indicating that Broadcom positions it as part of an integrated cyber‑defense strategy that ties main‑frame insights to its overall security, automation and AI‑driven remediation capabilities (AVGO 2024 10‑K, p. 8‑9).  \n\n**Evolution:** The core capability and internal‑tool integration of the Security Insights Platform remained unchanged from 2022 to 2024, but its placement within the filing shifted to a wider cybersecurity context, aligning it with Broadcom’s enterprise‑wide security, AIOps and remediation initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies the core functionality of AVGO's Security Insights Platform in both 2022 and 2024, noting the consistent description of interpreting and assessing mainframe security posture, identifying risks, and developing remediation steps, along with integration with in-house SIEM tools. The answer accurately reflects the evolution in positioning: from a standalone tool in 2022 to a component embedded within a broader enterprise security and AIOps strategy in 2024. The LLM correctly cites the 2024 integration context (Enterprise Security, AIOps) and infers strategic alignment with AI-driven remediation and enterprise-wide defense, which matches the ground truth’s emphasis on expanded strategic role. The only minor omission is the lack of explicit mention of the 2023 filing, which the ground truth includes as a transitional year reinforcing proactive risk response and modern security practices. However, since the 2022 and 2024 data points are correct and the overall trend is accurately synthesized, this does not significantly detract from the answer's correctness. All entities (AVGO, Security Insights Platform, SIEM, AIOps) and years (2022, 2024) are correct. No numerical inaccuracies; dates and citations are appropriately used. The reasoning is sound, demonstrating multi-hop synthesis across years and strategic context. The answer is semantically equivalent to the ground truth, with only slight compression of the intermediate 2023 evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1593,
        "completion_tokens": 424,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "- **2022:** The 2022 Form 10‑K lists Unsecured Notes ‑ 32B with a face amount of **$750 million** and a **3.38 %** fixed rate【page_49】.  \n- **2023:** The 2023 Form 10‑K shows the same note still carrying a **$750 million** face amount at **3.38 %**【page_50】.  \n- **2024:** The 2024 Form 10‑K again reports Unsecured Notes ‑ 32B at a **$750 million** face amount and **3.38 %** interest【page_51】.  \n\n**Interpretation:** Over the three‑year period SPG made no changes to the size or rate of the 32B issuance, indicating a deliberate strategy of retaining a stable, low‑to‑moderate‑cost, fixed‑rate tranche of long‑term debt rather than repeatedly refinancing or expanding that exposure. This consistency reflects disciplined long‑term debt management and a focus on rate‑locking and maturity diversification.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: the face amount of $750 million (equivalent to $750,000,000) and interest rate of 3.38% are accurately reported for 2022, 2023, and 2024. The maturity date (June 15, 2027) is not mentioned in the LLM answer but is not required to answer the question about face value and interest rate exposure evolution. (2) Quantitative accuracy is perfect—values are consistent across years and match the original answer, with acceptable format variation ($750 million vs $750,000,000). (3) Multi-hop reasoning is sound: the model correctly synthesizes data from three consecutive 10-K filings, observes no changes in terms, and infers a stable long-term debt strategy. (4) The interpretation aligns with the ground truth—highlighting SPG’s choice to maintain fixed-rate debt without refinancing, reflecting disciplined debt management, rate-locking, and maturity diversification. All parts of the question are addressed: evolution over time and strategic implications. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 319,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "From the 2022 filing, Comcast identified Lumen as a wireline rival that was “building and continuing to build fiber‑based network infrastructure … and … offering services with higher speeds in many of our service areas.” By the 2024 filing the same language appears, showing that Lumen’s fiber rollout has persisted and even expanded, further eroding the speed advantage of Comcast’s HFC‑based broadband. While the 2024 discussion adds that other competitors (e.g., AT&T and Verizon) are now pairing that fiber reach with bundled wireless‑phone packages, Lumen is still cited chiefly for its fiber‑network expansion rather than for bundled service offerings, indicating the competitive threat has intensified on the speed front and is beginning to shift toward bundled‑service pressure from the broader market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects: it correctly identifies Lumen as a persistent competitor to CMCSA (Comcast) from 2022 to 2024, accurately citing the continuation of fiber-based network expansion as a core competitive threat. The use of direct quotes from filings (e.g., 'building and continuing to build fiber-based network infrastructure') aligns with the original answer’s characterization of ongoing fiber deployment. There are no numeric inaccuracies, so quantitative accuracy is perfect. However, the LLM answer diverges in its assessment of service bundling: while the ground truth states that Lumen emphasized bundled offerings throughout the period and was explicitly grouped with top-tier competitors using bundling as a strategy, the LLM claims that Lumen is 'still cited chiefly for its fiber-network expansion rather than for bundled service offerings' and implies bundling is more prominent in competitors like AT&T and Verizon. This downplays Lumen’s bundling role, contradicting the original answer’s assertion of a 'continued focus on fiber expansion and bundled offerings as a core competitive strategy.' This is a significant qualitative shortcoming in multi-hop synthesis, as the model fails to fully integrate the bundling dimension of Lumen’s strategy across all three years. Contextual relevance is high, as the response directly addresses the evolution of competitive threat in terms of fiber and bundling. Overall, core facts on fiber expansion are correct, but the nuanced shift or emphasis on bundling is misrepresented, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 450,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded payment‑card usage fell each year. The 2024 Form 10‑K reports that RedCard (now Target Circle Card) penetration was 18.6 percent for FY 2024, 19.8 percent for FY 2023 and 20.5 percent for FY 2022【page_27】; the same filing also notes Circle‑Card penetration of 18.6 percent in 2024 and 19.8 percent in 2023【page_29】. The steady decline from roughly one‑fifth of purchases in 2022 to under‑19 percent in 2024 suggests the loyalty‑driven payment program is losing momentum, indicating diminishing effectiveness of the strategy over this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target's branded payment card penetration from 20.5% in 2022 to 19.8% in 2023, which matches the ground truth. However, it reports 18.6% for 2024 instead of the correct 17.8%, a notable but not major deviation. This discrepancy affects quantitative accuracy but does not change the overall qualitative conclusion. (2) The numbers for 2022 and 2023 are exact matches. The 2024 figure is incorrect: ground truth is 17.8%, LLM states 18.6%. This error appears consistent across both page 27 and 29 citations in the LLM answer, suggesting a possible misreading of the source. The calculation of trend direction (declining) is correct, but the magnitude of the drop is understated. (3) The multi-hop reasoning is sound—LLM synthesizes data across years and interprets the trend correctly as indicating weakening momentum in the loyalty strategy. It appropriately connects declining penetration to reduced effectiveness, aligning with the ground truth’s implication. (4) Scores reflect high accuracy in reasoning and relevance, with a moderate deduction in quantitative accuracy due to the incorrect 2024 percentage. Despite this, the core message about declining effectiveness remains valid, warranting a high but not top correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 366,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "- In 2022 Chevron expanded its Congo footprint by extending deep‑water licences, which added a 36 million‑barrel‑equivalent interest to its African portfolio (page 110).  \n- In 2023 the company kept the assets and spent roughly $0.7 billion on offshore development and natural‑gas projects in the Republic of Congo (page 109), and Congo‑related fields accounted for part of the 20 % of Chevron’s 2024 net oil‑equivalent production that came from OPEC+ countries (page 41).  \n- By 2024 Chevron’s strategy shifted to exit the market: it announced the sale of its 31.5 % non‑operated working interest in the Haute Mer permit and its 15.75 % interest in Lianzi, which were completed in January 2025 (page 43), moving the company from a growing, invested position in 2022‑23 to a divestiture and reduced ownership in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in conveying Chevron's evolving engagement with the Republic of Congo from 2022 to 2024. It correctly identifies the strategic shift from expansion and investment to divestiture. However, there are minor quantitative inaccuracies: the claim that Chevron added a '36 million-barrel-equivalent interest' in 2022 is not present in the ground truth and cannot be verified from the provided original answer. This specific figure and the citation to 'page 110' suggest over-specificity beyond the ground truth, which only states Congo was a key operational country in 2022. Additionally, the LLM states that the asset sales were 'completed in January 2025', while the original answer only mentions the 2024 announcement of the sale, not the completion date. This introduces a forward-looking detail not in the ground truth. The $0.7 billion investment figure in 2023 is correctly cited and matches the original answer, though the LLM narrows it to 'Republic of Congo' while the original says 'across Africa, including the Republic of Congo'—a slight over-attribution. The ownership percentages (31.5% in Haute Mer, 15.75% in Lianzi) are accurate. 2) Quantitative accuracy is slightly reduced due to the unverified 36 million-barrel figure and the incorrect completion date of the sale (January 2025 vs. no date in original). The $0.7B and ownership percentages are correct. 3) The reasoning is sound: the LLM correctly synthesizes a multi-hop narrative—starting with expansion in 2022, continued investment in 2023, and strategic exit in 2024. The logic of portfolio realignment is implied correctly. 4) The answer is highly contextually relevant, addressing asset ownership, investment levels, and strategic positioning as required. Despite minor factual overreach, the core evolution is accurately portrayed, warranting a high correctness score with a deduction for unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 516,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "From the Level‑3 fair‑value tables the company’s gas‑related option positions have stayed roughly the same size – the assets and liabilities for “options – primarily gas” are about **$100 million each** in 2023 and $100 million (assets) and $102 million (liabilities) in 2024, whereas the 2022 filing shows a similar net‑zero balance (the 2022 reconciliation reports a net Level‑3 fair‑value of only $170 million, implying the gas‑option component was modest).  \n\nWhat has changed is the **implied‑volatility input** used to value those options: it rose from roughly **20 % (assets) and 233 % (liabilities) in 2023** (weighted‑average ≈ 50 %) to **15 % (assets) and 150 % (liabilities) in 2024** (weighted‑average ≈ 52 %). The higher volatility in 2023 signals that NextEra was pricing a greater risk of large gas‑price moves, while the modest decline in the asset‑side volatility and the still‑elevated liability‑side volatility in 2024 suggest the firm has retained a sizable exposure but is now positioned for a somewhat less volatile gas market, reflecting a gradual de‑risking of its gas‑option book.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numeric values, particularly for 2022 and the implied volatility inputs. The ground truth states that in 2022, NextEra had $356M in assets and $347M in liabilities for gas-related options, but the LLM incorrectly claims the 2022 exposure was 'modest' based on a misinterpretation of a $170M net Level-3 fair-value figure not present in the original answer. This is a major quantitative error. (2) The implied volatility figures are partially correct in aggregate (50% in 2023, 52% in 2024), but the LLM fabricates split inputs of 20%/233% in 2023 and 15%/150% in 2024, which are not in the original. The original states average implied volatilities of 36% (2022), 50% (2023), and 52% (2024) — the LLM omits 2022 entirely and invents granular breakdowns without basis. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies a stabilization in fair value from 2023 to 2024 and links volatility changes to risk positioning. It captures the idea of de-risking, which aligns with the original's 'strategic de-risking' conclusion. However, it fails to note the sharp drop from 2022 to 2023 in exposure, instead implying continuity, which undermines the core evolution. (4) Contextual relevance is high — the answer addresses both fair value and implied volatility trends and attempts to interpret risk positioning. However, due to critical errors in numbers and omission of 2022 data, the correctness score is limited to 4. Quantitative accuracy is low (3) due to incorrect dollar amounts and invented volatility splits. Qualitative accuracy is moderate (5) — reasoning structure is logical but based on flawed data. Contextual relevance is strong (8) as the framework matches the question’s demands.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 487,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "In the 2022 Form 10‑K, Nike’s R&D discussion lists FlyEase alongside other breakthrough platforms (Air, Zoom, Flyknit, etc.) as part of the “proliferation” of new technologies that illustrate its commitment to innovation【page_6】. The 2024 filing repeats the same phrasing, again naming FlyEase among the flagship technologies (now written “Zoom X” and “React”) that the company is scaling across its product portfolio【page_6】. This continuity shows that FlyEase has moved from an emerging innovation in 2022 to an entrenched, core technology by 2024, underscoring its growing strategic importance in Nike’s overall innovation roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities—Nike, FlyEase, 2022, 2024, innovation strategy—are correctly identified, and the years referenced match the question's scope. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022, 2024) are correct. (3) The reasoning correctly synthesizes multi-hop information: it traces FlyEase’s evolution from 2022 (listed among other technologies as part of innovation proliferation) to 2024 (repeated mention indicating entrenchment), concluding its growing strategic importance. This matches the ground truth’s narrative of progression from introduction to core technology. (4) The LLM omits explicit mention of 2023 developments (expansion across categories), which is a minor gap in completeness, but the overall trajectory from emerging to entrenched technology is accurately captured. Wording differs slightly (e.g., 'entrenched, core technology' vs 'foundational element'), but semantic meaning is equivalent. The answer is fully contextually relevant and directly addresses both parts of the question: the evolution and what it indicates about innovation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 348,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "- In the 2022 filing (data as of 12/31/2021) the Unsecured Notes ‑ 35A carried a 2.65 % rate, a $750 million face amount, $19.9 million annual debt service and a July 15 20230 maturity. 【page_50†L31-L34】\n\n- The 2023 filing (data as of 12/31/2022) shows the same 35A issue unchanged – 2.65 % interest, $750 million face, $19.9 million annual service, maturing 07/15/30. 【page_50†L31-L34】\n\n- The 2024 filing (data as of 12/31/2023) again reports identical terms for 35A – 2.65 % interest, $750 million face, $19.9 million annual service, due 07/15/30. 【page_51†L31-L34】\n\n**Interpretation:** Across 2022‑2024 SPG kept the 35A unsecured note unchanged, preserving a modest‑size, low‑cost, long‑dated debt tranche. This consistency signals a deliberate long‑term strategy of locking in inexpensive financing and avoiding frequent refinancing or scaling up unsecured borrowings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that SPG's Unsecured Notes - 35A remained unchanged across 2022–2024 with consistent interest rate (2.65%), face amount ($750 million), annual debt service (~$19.9 million), and maturity date (07/15/30). The only discrepancy is in the formatting of dollar amounts: the ground truth states $750,000, while the LLM reports $750 million. However, this appears to be a clear error in the ground truth rather than the LLM, because $750,000 face amount at 2.65% would yield only ~$19,875 in annual interest — matching the ground truth’s stated debt service — but the LLM rounds this to $19.9 million, which aligns with a $750 million principal. Given that real-world corporate notes of this type are typically issued in hundreds of millions, not thousands, and the internal consistency of the LLM’s numbers (750M × 2.65% = ~19.875M), the LLM is likely correct and the ground truth contains a typo (‘$750,000’ instead of ‘$750 million’). Thus, the LLM’s quantitative reporting is accurate in context. (2) All calculations are sound: 2.65% of $750 million is approximately $19.875 million, which the LLM correctly rounds to $19.9 million. Maturity date is consistently reported as 07/15/30 across all years, matching the ground truth. (3) Multi-hop reasoning is solid: the LLM synthesizes data from three consecutive filings (2022–2024), confirms no changes over time, and draws a logical conclusion about SPG’s long-term debt strategy — namely, maintaining stable, low-cost financing without refinancing pressure. (4) The interpretation about a ‘deliberate long-term strategy of locking in inexpensive financing’ is semantically equivalent to the ground truth’s conclusion about a ‘steady approach’ and ‘stable long-term commitment.’ Wording differs slightly but meaning is preserved. The LLM slightly enhances the insight by characterizing the debt as ‘modest-size, low-cost, long-dated,’ which is reasonable given the 7.5-year tenor and sub-3% rate. Overall, the answer is factually accurate, contextually appropriate, and demonstrates strong multi-hop synthesis. A score of 9 is given due to the potential ambiguity in face amount, though evidence strongly favors the LLM over the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 601,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across the three most recent Form 10‑K filings Texas Instruments repeatedly states that its **core business model is built around analog and embedded‑processing products**. In the 2022 filing the MD&A notes that “our strategic focus is on analog and embedded processing products… we place additional strategic emphasis on designing and selling our products into the industrial and automotive markets”【page_19】; the 2023 filing repeats the same language【page_19】, and the 2024 filing again emphasizes the same focus【page_19】.  The “Overview” sections in each year also tie this product focus directly to the company’s goal of “maximiz[ing] long‑term free‑cash‑flow‑per‑share growth”【page_18】.  \n\nThe unchanged emphasis on embedded‑processing signals that TI views this portfolio as a durable competitive advantage that fuels the cash‑generation engine needed to sustain disciplined capital allocation and shareholder returns, reinforcing a long‑term growth strategy anchored on free‑cash‑flow‑per‑share expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments consistently emphasized embedded processing products across 2022, 2023, and 2024 as part of its core business model, tied directly to maximizing long-term free cash flow per share. The LLM correctly identifies that this strategic focus was reiterated verbatim or in substance across all three years’ 10-K filings, citing the MD&A and Overview sections. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable beyond correct referencing of years (2022, 2023, 2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, identifies the consistent strategic emphasis, and links it to the long-term financial objective of free cash flow per share growth—exactly as required. (4) The LLM captures the core insight from the ground truth: that embedded processing is foundational to TI’s competitive advantages and capital allocation strategy. The only minor shortcoming is that the LLM does not explicitly mention the 'four competitive advantages' or the specific value proposition (e.g., 'more opportunity per customer') highlighted in 2022, which slightly reduces qualitative completeness. However, the omission does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses both the evolution over time and the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 440,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "- In the 2022 Form 10‑K Disney listed Marvel’s trademarks together with ESPN and Pixar as **indefinite‑life intangible assets** (‑ $1.8 billion on the balance sheet) 【page 110】, but the filing did not highlight Marvel as a separate navigation element on Disney+.  \n- By the 2023 filing the company was explicitly promoting Marvel as one of the **top‑level “tiles”** on the Disney+ home screen alongside Disney, Pixar, Star Wars and National Geographic 【page 7】, and the 2024 filing still records Marvel‑related trademarks among its indefinite‑life intangibles 【page 114】.  \n\nThis shift shows Disney moving the Marvel franchise from a background IP asset in 2022 to a front‑line subscriber‑acquisition tool in 2023, using the brand’s strong fan base to make Disney+ more compelling and to justify the continued capitalization of Marvel’s trademark value as a long‑term, revenue‑generating asset in its 2024 balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Marvel was listed as an indefinite-lived intangible asset in 2022 alongside ESPN and Pixar, and reaffirms this status in 2024—consistent with the original answer. The mention of the $1.8 billion value (though not explicitly required in the ground truth) is a precise addition from the 10-K and does not contradict any known data. (2) Quantitatively, the dollar amount ($1.8 billion) and page references (110 in 2022, 7 in 2023, 114 in 2024) are correctly cited, and no calculations were required. The absence of the exact Disney+ subscriber number (123 million as of September 28, 2024) is a minor omission but does not detract significantly from the core argument. (3) The multi-hop reasoning is sound: the LLM correctly infers a strategic evolution from passive asset recognition (2022) to active platform utilization (2023–2024), linking financial reporting with product strategy. It accurately notes the top-level tile status by 2023 and connects brand strength to subscriber acquisition and asset valuation. (4) The answer is contextually excellent, directly addressing the evolution of Marvel’s role and its implications for financial and subscriber growth strategy. The only reason for not scoring a 10 is the lack of explicit mention of ESPN+’s planned tile launch in fiscal 2025, which was part of the broader strategic context in the ground truth. However, the core narrative about Marvel’s strategic elevation and financial treatment is fully supported and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 436,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has remained essentially unchanged – the company continues to reinsure roughly 59 % of the closed‑block policies (the 10‑K notes for 2022, 2023 and 2024 all state “59 % of the closed block” is covered under the modified‑coinsurance agreement)【page 227】【page 204】.  However, the size of the related reinsurance‑recoverable balance has grown dramatically: net ceded reinsurance recoverables were about $6.1 billion at 12/31/2022, rose to $16.7 billion at 12/31/2023, and reached $17.6 billion at 12/31/2024【page 227】【page 204】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, MetLife reinsured 59.25% of the closed block, which slightly decreased to 59% in 2023 and remained at 59% in 2024. The LLM incorrectly states that all three years reported exactly '59%' in the 10-K, which contradicts the ground truth (2022 was 59.25%). More critically, the reinsurance recoverable balances are completely wrong: the ground truth reports unsecured reinsurance recoverable balances of $3.6B (2022), $4.4B (2023), and $4.2B (2024). The LLM reports net ceded reinsurance recoverables of $6.1B, $16.7B, and $17.6B—values that are not only much higher but also appear to reference a different metric (net ceded vs. unsecured). (2) The numbers are not accurate: percentage for 2022 is misrepresented (59% vs. 59.25%), and dollar amounts are off by billions. The LLM cites 'page 227' and 'page 204' as sources, but the values do not align with the verified ground truth from the knowledge graph. (3) The multi-hop reasoning is flawed—the model fails to correctly track changes over time and conflates different financial metrics (unsecured recoverable vs. net ceded recoverables), undermining the synthesis. (4) While the answer is relevant to the question and attempts to address both percentage reinsured and recoverable balances, the severe quantitative errors and mischaracterization of the data result in a low correctness score. The contextual relevance is moderate because the structure and intent match the question, but factual accuracy is poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 432,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "- In the 2022 10‑K CVS reported **$845 million of residential mortgage‑backed securities at amortized cost (fair‑value ≈ $757 million)**.  \n- In 2023 the portfolio grew modestly to **$862 million at cost (fair‑value ≈ $810 million)**.  \n- By the 2024 filing the only residential‑mortgage exposure shown was in its Separate‑Accounts segment, **fair‑value ≈ $71 million**, indicating a roughly 90 % reduction from the prior year.\n\n**Interpretation:** The three‑year pattern shows CVS initially maintaining a modest, agency‑guaranteed RMBS position but then sharply scaling it back in 2024, suggesting the company is deliberately lowering its interest‑rate and credit‑risk exposure in this fixed‑income niche and reallocating capital toward other debt securities or liquidity‑focused assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's residential mortgage-backed securities (RMBS) investments. According to the ground truth, RMBS holdings were $629M in 2022, $614M in 2023, and dropped to $71M in 2024. However, the LLM reports $845M (2022) and $862M (2023) at amortized cost, which contradicts the ground truth. These numbers do not align with the original data, even accounting for fair value vs. amortized cost distinctions—no such cost/fair value reconciliation was provided in the ground truth, and the magnitude of discrepancy is too large to attribute to valuation method differences. The only correct figure is the 2024 value (~$71M), which matches the ground truth. (2) Calculations: The LLM correctly notes a ~90% reduction from 2023 to 2024 based on its own numbers, but since the 2023 baseline ($862M) is incorrect, this calculation is based on false inputs. The ground truth shows a much sharper drop from $614M to $71M (~88.5%), which the LLM did not compute but approximates in direction. (3) Multi-hop reasoning: The LLM correctly identifies a strategic reduction in RMBS exposure by 2024 and infers de-risking or reallocation, which aligns with the ground truth’s interpretation. It also correctly contextualizes the move as reducing interest-rate and credit risk, showing sound qualitative reasoning. However, it fails to mention the increase in unrealized losses from $10M to $60M in 2023, a key indicator of rising risk exposure during the period—this omission weakens the completeness and depth of the analysis. (4) Entity and year accuracy: The company (CVS) and years (2022–2024) are correct. The metric (RMBS investment) is appropriately tracked. However, the use of amortized cost without clear distinction from the ground truth’s reported values (which appear to be fair value or carrying amounts) introduces confusion and undermines quantitative accuracy. Despite flawed numbers, the LLM reaches a semantically similar conclusion about strategic de-risking, supporting moderate qualitative and contextual scores. Final scores reflect major quantitative errors but partially correct reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 589,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement for the closed block has been essentially unchanged since 2022. In 2022 the company reinsured ≈ 59.25 % of the closed block; in 2023 it was reported as 59 % and the same 59 % figure appears for 2024. Throughout this period the agreement has been accounted for under the **deposit method of accounting**, with the related deposit liability offset against the corresponding deposit recoverable.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key information is correct: the percentages of the closed block reinsured (59.25% in 2022, 59% in 2023 and 2024) match the original answer exactly, with acceptable rounding noted. (2) The accounting treatment is correctly identified as the deposit method with offsetting of the deposit liability against the deposit recoverable, which is consistent across all years—this matches the ground truth's description of unchanged accounting policy. (3) The reasoning is sound: the LLM correctly synthesizes multi-hop information across three years and maintains awareness of both quantitative trends and accounting policy continuity. (4) The answer addresses both parts of the question—evolution of the reinsurance percentage and accounting treatment—and conveys the same conclusion as the original: a stable strategic and accounting approach. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or conceptual errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 297,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "- 2022: Net forward‑contract exposure for natural‑gas was ‑1,307 MMBtu (a net short position).  \n- 2023: The net short grew to ‑1,452 MMBtu, showing a larger hedge‑short exposure.  \n- 2024: The net short fell back to ‑1,131 MMBtu, indicating the company trimmed its short position.\n\n**Interpretation:** NextEra’s gas‑forward exposure moved from a modest short in 2022 to a deeper short in 2023, then was reduced in 2024. The 2024 pull‑back suggests the firm is moderating its downside risk in the natural‑gas market, positioning itself less aggressively against price declines.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative data and financial metrics. The ground truth states that NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022, increased to $300 million in 2023, and declined to $250 million in 2024 — all expressed in dollar amounts. In contrast, the LLM response reports exposure in MMBtu (million British thermal units), citing net short positions of -1,307, -1,452, and -1,131 MMBtu for 2022–2024, which are completely different metrics and not mentioned in the ground truth. There is no mention of assets or liabilities, nor dollar values, which are central to the original answer. (2) The numbers provided by the LLM do not match any values in the ground truth, and no conversion or alternative representation can reconcile MMBtu volumes with dollar-based net exposure. Additionally, the direction of the trend is misrepresented: the LLM implies increasing short exposure in 2023 and a pullback in 2024, but frames it as a risk positioning against price declines, while the ground truth shows a peak in net financial exposure in 2023 followed by a reduction in 2024, indicating rebalancing. However, the qualitative observation that the company reduced its exposure in 2024 relative to 2023 aligns loosely with the trend interpretation. (3) The multi-hop reasoning failed because the LLM used a different data type (physical volume hedging vs. financial exposure in dollars), likely confusing metrics from another context or company. It did not synthesize the correct financial figures across years or identify the correct metric (net exposure in dollars from assets and liabilities). (4) Due to major factual and quantitative errors, the correctness score is low at 2. Quantitative accuracy is 1 because all numbers and units are incorrect. Qualitative accuracy is 3 due to a partial grasp of directional change in risk posture. Contextual relevance is 6 because the answer addresses the general topic of evolving gas forward exposure and risk positioning, even if based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 560,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "In the 2022 filing, Broadcom listed **industrial fiber‑optics** as one of several discrete industrial products—alongside optocouplers, sensors, motion‑encoders, LEDs and Ethernet PHYs—primarily serving “factory automation, renewable‑energy and automotive‑electronics” applications. By the 2023 and 2024 filings the company’s language had evolved to describe the fiber‑optic line as an **integrated element of a broader industrial‑solutions portfolio**, stressing that it is now marketed together with motion‑encoders and Ethernet ICs to enable combined sensing, high‑speed data‑link and control functions across a wider set of use‑cases such as electric‑vehicle power‑train, infotainment, advanced‑driver‑assistance, and renewable‑energy power‑generation systems. This reflects a shift from a simple product‑group listing to a more cohesive, application‑diverse positioning that ties fiber optics to adjacent technologies for unified industrial‑automation solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—AVGO (Broadcom), Industrial Fiber Optics, motion encoders, Ethernet ICs/PHYs, and application areas—are correctly identified across 2022–2024. The evolution in positioning from discrete components to integrated solutions is accurately captured. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022, 2023, 2024), which are all accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in product grouping and application focus across three years, correctly inferring a strategic shift toward integration. It accurately notes that in 2022, fiber optics were listed among discrete products with broad applications, and by 2023–2024, they were framed as part of integrated solutions with adjacent technologies. The mention of electric-vehicle power-train, infotainment, ADAS, and renewable-energy systems reflects the expanded application diversity. (4) Minor deduction in qualitative accuracy because the LLM omits the specific 2022 application areas mentioned in the original answer (medical systems, defense) and slightly conflates 2023 and 2024 by not distinguishing their incremental shifts—particularly the 2024 emphasis on Ethernet switch ICs and camera microcontrollers for vision-based systems. However, the core trajectory and strategic interpretation are correct. Wording differences are acceptable under semantic equivalence. Contextual relevance is perfect—the answer directly addresses application diversity and integration with adjacent technologies as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 461,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "Nike’s redeemable preferred‑stock arrangement with Sojitz America has remained unchanged from FY 2022 through FY 2024.  The sole‑owner preferred shares (‑$0.3 million par value) carry a cumulative dividend of $0.10 per share that must be paid each May 31 before any common‑stock dividend, and that dividend amount has been the same each year.  The preferred stock is fully issued, not a “blank‑check” series, and Nike’s charter prohibits issuing additional preferred shares, so the capital‑structure relationship with Sojitz has been financially stable and unchanged over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the par value of $0.3 million, annual dividend of $0.10 per share, and structural stability from FY2022 to FY2024 are accurately reported. The requirement that preferred dividends must be paid before common dividends is correctly emphasized. (2) Quantitative accuracy is perfect: dollar amounts and dividend timing (May 31) match the original answer, with acceptable formatting variations (e.g., '‑$0.3 million' vs '$0.3 million'). (3) Multi-hop reasoning is sound—the model synthesizes consistent terms over three fiscal years and infers financial stability from unchanging structure and charter restrictions. (4) Minor omission: the original answer notes Sojitz America has not sought redemption despite having the option, which adds context about the relationship’s longevity; this is missing in the LLM response. However, this does not undermine the core financial facts. Wording differs but meaning is semantically equivalent. The LLM adds useful detail about Nike’s charter prohibiting additional preferred shares, which strengthens the stability argument. Overall, the answer is factually complete and contextually appropriate, warranting a high score with only slight deduction for missing one nuance about redemption option.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 375,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K (page 50) SPG reported the Unsecured Notes ‑ 31B at a 3.25 % coupon, a $750 million face amount and annual debt service of $24.4 million, maturing 11/30/2026.  \n- The 2023 Form 10‑K (page 50) shows the same 3.25 % rate, $750 million face amount and $24.4 million annual service with the same 2026 maturity, and the 2024 Form 10‑K (page 51) repeats those exact terms.  \n\nThis unchanged “31B” tranche over three years indicates that SPG is using the note as a stable, long‑term financing vehicle—maintaining a fixed‑rate, medium‑term unsecured debt line without refinancing or amendment, which supports a predictable funding strategy for that portion of its capital structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the unsecured debt amount ($750 million, equivalent to $750,000 thousand in financial reporting contexts), interest rate (3.25%), maturity date (November 30, 2026), and consistency across 2022–2024 are correctly reported. The mention of annual debt service ($24.4 million) is an additional detail not in the original answer but is factually consistent with the 3.25% coupon on $750 million (~$24.375 million), so it does not introduce error. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and dates match the ground truth, with acceptable format variation ($750 million = $750,000 in thousands). (3) Multi-hop reasoning is sound—the model correctly synthesizes data from three consecutive 10-K filings (2022, 2023, 2024) and infers the strategic implication of no changes to the instrument. (4) The conclusion about SPG’s long-term financing strategy—using Unsecured Notes - 31B as a stable, unamended, fixed-rate vehicle—aligns exactly with the original answer’s interpretation. The answer is complete, addressing both the evolution (no change) and strategic implication (predictable, consistent financing). All entities (SPG, Unsecured Notes - 31B, years) are correct. No factual, numerical, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 375,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "The 10‑K tables show that the value of Texas Instruments stock held in the company’s U.S. defined‑contribution plans fell from **$940 million in 2022** (6 million shares) to **$873 million in 2023** (5 million shares) and to **$852 million in 2024** (5 million shares)【page_44 (2023‑2022)】【page_44 (2024‑2023)】.  The three‑year downward trend reflects a modest decline in the market price of TI shares and indicates that, even though the stock‑fund was frozen to new contributions, employees have continued to keep their existing holdings in retirement plans while the value of those holdings has been eroding with the stock’s performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar values ($940M in 2022, $873M in 2023, $852M in 2024) and corresponding share counts (6M, 5M, 5M), matching the ground truth exactly. These numbers are consistent with the multi-year trend of declining value in TI common stock holdings within U.S. defined contribution plans. (2) Quantitative accuracy is perfect—values are reported correctly, and the downward trend is accurately described. Minor formatting with thin spaces ($940 million) is acceptable and does not affect correctness. (3) The reasoning is largely sound: the LLM correctly identifies the freeze on new contributions and links it to the continued presence of existing holdings. It also attributes the decline to stock performance, which aligns with market valuation shifts mentioned in the ground truth. However, the original answer includes an additional nuance—'strategic reduction in stock allocations by employees'—which is not explicitly mentioned in the LLM response, making it slightly less complete in explaining possible causes. This omission prevents a perfect qualitative score. (4) Contextual relevance is excellent: the answer directly addresses both parts of the question—evolution of stock value and implications for performance and employee behavior—and synthesizes information across years and sources (e.g., referencing page 44 for both year-over-year comparisons). Overall, the answer is factually correct, well-supported, and only slightly less comprehensive in explanatory depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 420,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "- In fiscal 2022 Disney reported about **220 000 employees** – roughly **166 000 in the United States and 54 000 abroad** – with **≈7 %** of the workforce classified as seasonal [page 5].  \n- By September 28 2024 the headcount had risen to **≈233 000 employees**, now **≈171 000 in the U.S. and 62 000 internationally**, and the seasonal share had edged up to **about 8 %** [page 16].  \n- Throughout the period a sizable portion of the workforce (especially theme‑park staff, writers, directors, actors and production crews) remained covered by **collective‑bargaining agreements**, and many non‑U.S. employees continued to be represented by **works councils, trade unions or other employee associations** (2022 [page 5]; 2024 [page 16]).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: total employees (220,000 in 2022, 233,000 in 2024), U.S. (166,000 → 171,000) and international (54,000 → 62,000) distribution, and seasonal workforce percentages (7% → 8%) are correctly reported. The 2024 date (September 28, 2024) is a specific detail not in the original answer but does not contradict it and adds precision. (2) The answer is complete, addressing all parts of the question: total employees, U.S. vs. international breakdown, seasonal workforce trends, and employee representation. (3) Entity accuracy is correct—The Walt Disney Company is properly referenced, and the years (2022, 2024) align with the question’s scope. (4) Multi-hop reasoning is sound: the LLM synthesizes workforce size, geographic distribution, seasonality, and labor representation across two years, correctly inferring trends (e.g., growth in total and seasonal staff). (5) Semantic equivalence is maintained—wording differs slightly (e.g., 'abroad' vs 'internationally', '≈' vs exact values), but all factual content matches the ground truth. The inclusion of specific page citations and expanded details on represented groups (writers, directors, etc.) enhances clarity without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 364,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "Both the 2022 and the 2023 filings state that ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance,” and the 2024 filing repeats the same language (see 2022 p. 49, 2023 p. 50, 2024 p. 47). The unchanged exclusion of these items shows that General Dynamics consistently strips out non‑operating, accounting‑only effects from its ROIC metric, underscoring a disciplined focus on measuring the profitability of its core operating assets rather than transient accounting adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that General Dynamics (GD) excluded non-economic accounting changes from ROIC in 2022, 2023, and 2024, which matches the original answer's claim of consistent exclusion across all three years. (2) No numerical values (e.g., percentages, dollar amounts) are involved in the question or answer, so quantitative accuracy is not applicable in terms of calculations, but the cited page numbers (2022 p. 49, 2023 p. 50, 2024 p. 47) are consistent with typical disclosure locations and do not contradict the knowledge graph. (3) The multi-hop reasoning is sound: the model correctly synthesizes the treatment of ROIC across three years of filings and infers that the unchanged methodology reflects a disciplined, consistent approach to measuring core performance. (4) The LLM adds value by specifying that goodwill impairments are also excluded and citing exact page numbers, which enhances credibility. The conclusion about emphasizing core operational profitability over accounting volatility is semantically equivalent to the original answer’s point about focusing on economic performance. All parts of the question—evolution over time and implications for performance measurement—are fully addressed with accurate, consistent, and relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 374,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "In the 2022 filing Linde described rare‑gas output simply as a **co‑product of its atmospheric‑gas air‑separation plants**, listing “rare gases” together with oxygen, nitrogen and argon in the industrial‑gases product line【page_94】. By the 2024 report the company had turned that co‑production into a **technology‑driven growth focus**, highlighting that its **advanced air‑separation processes (including VPSA and membrane‑based systems) deliberately generate krypton, neon and xenon** and that these proprietary methods are being expanded to new markets【page_4】. This shift from passive co‑production to active, patented rare‑gas technology underscores Linde’s competitive advantage: superior process know‑how and integrated pipeline/plant networks that let it supply high‑value rare gases more reliably and at lower cost than rivals【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Linde initially treated rare gases as co-products in 2022, and by 2024 emphasized advanced, non-cryogenic technologies like VPSA and membrane systems for targeted rare gas production. The evolution from passive co-production to active, technology-driven production is correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022 and 2024 filings to show strategic evolution and correctly infers that proprietary technologies enhance competitive advantage through efficiency, reliability, and cost leadership. The mention of 'integrated pipeline/plant networks' adds contextual insight consistent with Linde’s business model, even if not explicitly in the original. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'technology-driven growth focus', 'patented methods'), the core meaning matches the ground truth regarding technological differentiation and competitive advantage. The only minor gap is that the LLM does not explicitly mention 'market leader' status in non-cryogenic technologies as stated in the 2024 filing, but this is implied through 'advanced' and 'proprietary methods'. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 415,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "NextEra Energy Resources kept virtually the same share of its generation capacity under long‑term bilateral contracts: about 94 % at December 31 2022 (NEER 2022 10‑K), 94 % at December 31 2023 (NEER 2023 10‑K, page 19) and 94 % at December 31 2024 (NEER 2024 10‑K, page 19). This steady, high‑percentage commitment shows that NEER deliberately locks in the bulk of its output through long‑term deals to smooth revenue and hedge price risk, a core element of its risk‑management strategy in a volatile wholesale‑energy market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that NEER had 94% of its net generating capacity under long-term bilateral contracts in 2022, whereas the ground truth reports 92% for 2022. The figures for 2023 and 2024 (94%) are correct. This is a factual error in a key quantitative data point. (2) The calculation of trend—'slightly increasing' from 92% to 94%—is accurate in the original answer, but the LLM fails to reflect this evolution by stating the percentage was 'virtually the same' and consistently 94%, which misrepresents the slight increase. The LLM also cites specific 10-K pages for 2023 and 2024, which may be accurate but are not verifiable without access, and the 2022 figure is misstated despite the citation. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that maintaining high contract coverage reflects a risk management strategy focused on revenue stability in a volatile market. It correctly synthesizes the strategic implication across years, even if the quantitative foundation is flawed. (4) Contextual relevance is strong—the answer directly addresses both parts of the question: the evolution of contract reliance and its implication for risk management. However, due to the incorrect 2022 figure and the failure to note the increase from 92% to 94%, the quantitative accuracy is reduced significantly. The qualitative reasoning and contextual relevance remain high because the overall trend interpretation and strategic conclusion are directionally correct and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 423,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "The 3.125 % senior notes that mature in January 2025 carried an outstanding principal balance of **$495 million** in each of the three most recent fiscal years:\n\n* FY 2024 – $495 million (Table of senior notes, “3.125 % notes due January 2025”)【page_81】  \n* FY 2023 – $495 million (same table in the 2023 filing)【page_81】  \n* FY 2022 – $495 million (the 2022 10‑K lists the same amount for this series)【page_81】\n\nBecause the balance did not change from FY 2022 through FY 2024, Broadcom has neither retired nor issued additional amounts of this specific note. The company is simply maintaining the instrument at its original size until its scheduled repayment in January 2025, reflecting a “hold‑steady” debt‑management approach for this particular tranche.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million for the 3.125% notes due January 2025 is accurately reported for fiscal years 2022, 2023, and 2024. The dollar amount, interest rate, and maturity date are all factually correct, with acceptable formatting (e.g., $495 million). (2) The answer is complete, addressing both parts of the question: the evolution of the balance (unchanged across three years) and the implication for AVGO's debt management strategy. (3) Entity accuracy is perfect: AVGO (Broadcom) is correctly identified, the correct debt instrument is referenced, and fiscal years align with the knowledge graph. (4) The reasoning is sound and constitutes valid multi-hop synthesis across three annual filings, concluding that the lack of change indicates a 'hold-steady' strategy—this is semantically equivalent to the ground truth's 'did not retire or refinance' and 'consistent liability profile.' The LLM correctly infers strategic intent from stable balances. (5) Semantic equivalence is achieved despite slightly different phrasing (e.g., 'hold-steady' vs. 'maintaining a consistent liability profile'). No errors in logic, numbers, or interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 354,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "Across the three most recent filings the Unsecured Notes ‑ 37B stayed unchanged: the 2022 10‑K lists a $700 million face amount maturing on January 15, 2032; the 2023 10‑K shows the same $700 million face amount with a maturity of 01/15/32; and the 2024 10‑K again reports $700 million due on 01/15/32. This consistency shows Simon Property Group is keeping a stable, long‑dated tranche of low‑cost unsecured debt on its balance sheet, reflecting a strategy of locking in long‑term financing rather than repeatedly refinancing or altering the size of this liability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the face amount: it reports $700 million, while the ground truth states $700,000. This is a three-order-of-magnitude discrepancy and constitutes a major quantitative inaccuracy. All three years are affected. The maturity date (01/15/32 or January 15, 2032) is correctly reported and consistent across years, which aligns with the original answer. (2) Number verification: The face amount in the ground truth is $700,000 (seven hundred thousand dollars), not $700 million. Despite correct formatting in dates and consistency across years, the dollar amount is off by a factor of 1,000. This error significantly undermines the factual correctness of the response. (3) Multi-hop reasoning is otherwise sound: the model correctly identifies that the instrument remained unchanged across 2022, 2023, and 2024 filings, and draws a reasonable conclusion about SPG’s long-term debt strategy—namely, maintaining stable, long-dated unsecured debt without refinancing. This reflects proper synthesis across multiple filings and correct interpretation of the implications. (4) The contextual relevance and qualitative reasoning are strong—the answer addresses all parts of the question (evolution over time, face amount, maturity, and strategic implication), and the logic connecting stability to long-term financing strategy is valid. However, due to the severe numerical inaccuracy, the correctness and quantitative accuracy scores are heavily penalized. A score of 6 is given for correctness because the structure, reasoning, and dates are accurate, but the core financial figure is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 450,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Across all three filing years, Texas Instruments lists its Melaka, Malaysia site only under the **Analog** segment and not under **Embedded Processing**. In the 2022, 2023 and 2024 property tables the Melaka location carries an “X” in the Analog column and a blank in the Embedded‑Processing column, indicating that its operational footprint there has remained dedicated to analog products throughout this period (the only change is a shift from a fully‑leased facility in 2022‑2023 to a partially‑leased/owned arrangement in 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that Texas Instruments' Melaka, Malaysia site was consistently involved in the Analog product line and not in Embedded Processing across 2022, 2023, and 2024. The use of 'X' and blank entries in the property tables correctly reflects the checkmark-based notation in the original data. The answer adds a detail not in the ground truth—about the shift from fully leased to partially owned/leased in 2024—which is acceptable if supported by the filings and enhances completeness without contradicting the core answer. Quantitatively, there are no numbers to verify, but the temporal and categorical accuracy (years and segments) is perfect. The reasoning is sound, demonstrating correct synthesis across three years of data. The only reason for not giving a 10 is that the original answer emphasizes the stability and specialization in analog operations as a strategic footprint point, which the LLM mentions implicitly but could have emphasized more explicitly for full qualitative parity. However, the core facts, entities, and multi-hop consistency are correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 329,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "In the 2022 filing the Content Sales/Licensing segment listed “sales of post‑production services” (including Industrial Light & Magic) as a distinct **Other‑revenue** line item, showing that ILM work was treated as a separate, modest contribution to the segment. By the 2023 and 2024 filings the language had shifted – ILM’s post‑production services are still noted, but they are now described simply as part of the broader Content Sales/Licensing revenue mix (alongside music and stage‑play income) rather than a separate line, indicating that Disney’s reliance on ILM remained steady but was integrated into the overall segment’s revenue stream.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in fiscal 2022, Industrial Light & Magic (ILM) was explicitly listed as part of the Content Sales/Licensing segment under a distinct 'Other-revenue' line for post-production services. This matches the original answer's claim about ILM's explicit inclusion. (2) For fiscal 2023 and 2024, the LLM correctly notes a shift in language: ILM is still included but no longer called out as a separate line item, instead being folded into the broader revenue mix—this reflects the ground truth's description of a strategic repositioning and integration into broader content licensing and distribution. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure structure across three fiscal years, correctly inferring evolving presentation and implied strategic emphasis. (4) While the original answer adds interpretive context about Disney’s 'DTC-first content model,' the LLM captures the core factual evolution—stable reliance but changing reporting treatment—without overreaching. All entities (Industrial Light & Magic, Content Sales/Licensing segment), years (2022–2024), and financial structure changes are accurately represented. No numerical inaccuracies; dates and qualitative assessments are consistent with the knowledge graph. Minor deduction in qualitative accuracy only because the LLM omits the slight emphasis on TV/VOD and theatrical distribution noted in the original, but the central narrative of integration and repositioning is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 432,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method earnings from its operating joint‑venture (insurance‑underwriting) investments were:\n\n* **2022:** $51 million  \n* **2023:** $38 million (↓ 13 million, a 24 % drop)  \n* **2024:** $175 million (↑ 137 million, a 360 % jump from 2023)\n\nThe decline in 2023 shows the underwriting joint‑ventures contributed less to earnings that year, but the large rebound in 2024 indicates a strong recovery in the profitability or scale of those insurance‑underwriting joint ventures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers. According to the ground truth, MetLife's equity method investment income was $1,305 million in 2022, $151 million in 2023, and $988 million in 2024. The LLM reports $51M, $38M, and $175M respectively—orders of magnitude lower. These numbers are not just inaccurate but suggest a completely different scale and trend. (2) Calculations in the LLM response are internally consistent (e.g., $38M is roughly a 24% drop from $51M; $175M is ~360% increase), but they are based on wrong base figures, making them misleading. The actual 2023 decline was ~88.4% ($1,305M → $151M), and the 2024 rebound was ~552% increase, which the LLM fails to capture. (3) The qualitative reasoning about a decline followed by a rebound aligns with the general trend direction (down then up), so the multi-hop synthesis of trend interpretation is partially sound, but the failure to use correct data undermines the reasoning. The mention of 'insurance-underwriting joint ventures' correctly identifies the entity type. (4) The contextual relevance is moderate because the structure and intent of the answer match the question—discussing evolution and implications—but due to severe numerical inaccuracies, the answer misrepresents the company’s financial performance. Correctness and quantitative accuracy are severely penalized because financial data must be precise, especially in multi-year comparisons for investment income. A 90%+ error in dollar amounts renders the answer largely incorrect despite correct directional logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 433,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics’ Land Systems unit reported that it was building **449 new LAVs** for the Canadian Army in 2022, **399 new LAVs** in 2023, and **360 new LAVs** in 2024 【page_10】【page_11】【page_11】.  The steady, though gradually declining, production run shows that the LAV family remains a core export and sustain‑ment platform for the company, underscoring its strategic value as a high‑visibility, long‑term revenue stream within General Dynamics’ defense portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reverses the production numbers for 2022, 2023, and 2024, stating 449 units in 2022, 399 in 2023, and 360 in 2024, whereas the ground truth shows an increasing trend: 360 in 2022, 399 in 2023, and 449 in 2024. This inversion of the time-series data fundamentally misrepresents the trend. (2) The quantitative accuracy is severely compromised: all three yearly figures are assigned to incorrect years, leading to a false conclusion of declining production. While the numbers themselves (360, 399, 449) are present, their chronological misplacement invalidates any correct interpretation. (3) The reasoning is flawed due to the incorrect data sequence. The LLM concludes a 'gradually declining' production run and infers strategic value based on decline, while the ground truth shows a consistent upward trend indicating growing strategic importance. This reflects a failure in multi-hop synthesis—though the model identifies the LAV platform as strategically important, it bases this on incorrect temporal dynamics. (4) Contextual relevance is moderate: the answer addresses the right company, product, customer (Canadian Army), and attempts to interpret strategic significance. However, the reversed timeline undermines the validity of the conclusion, making the overall response factually incorrect despite using plausible-sounding data and some relevant context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 387,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s pension‑plan exposure to hedge‑fund limited‑partnership investments grew each year: $225 million in 2022 (2023 10‑K footnote), $252 million in 2023 (2023 10‑K footnote), and $280 million in 2024 (2024 10‑K footnote). The upward trend shows the company is steadily increasing its allocation to hedge‑fund LPs—consistent with a deliberate move to broaden the pension fund’s alternative‑asset mix and pursue higher expected returns while still keeping the overall allocation modest.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. However, the LLM states $225M in 2022, $252M in 2023, and $280M in 2024—shifting and inflating all values. This misalignment affects the entire quantitative trajectory. (2) The numbers are consistently off by approximately $27–35 million across years, suggesting either a source error or misattribution. The 2024 figure should be $252M, not $280M. Additionally, citing '2023 10-K footnote' for 2022 data is chronologically inconsistent—2022 data should come from the 2022 10-K. (3) While the LLM correctly infers a strategic trend toward increasing alternative asset allocation, this reasoning is based on incorrect data. The multi-hop synthesis—linking year-over-year changes to pension strategy—is conceptually sound but built on faulty inputs. (4) Despite incorrect numbers, the answer remains contextually relevant by addressing both parts of the question: the evolution of exposure and the strategic implication. The qualitative interpretation about a deliberate shift toward alternative investments aligns with the ground truth’s conclusion, even if the supporting data is wrong. Thus, correctness and quantitative accuracy are severely penalized, while contextual relevance remains high due to appropriate framing and logical structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 400,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Across all three filings the Sorriso brand was consistently presented as one of Colgate‑Palmolive’s principal global‑ and regional‑trademarks that sits inside the Oral, Personal and Home Care segment. In the 2022 10‑K it is listed among the key trademarks supporting the company’s oral‑care portfolio; the 2023 filing repeats the same description, showing no change in its role; and the 2024 filing again cites Sorriso as a core trademark within the same worldwide Oral, Personal and Home Care product portfolio, indicating that the brand’s strategic positioning remained stable and fully integrated throughout 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Sorriso was consistently listed as a principal global and regional trademark within Colgate-Palmolive's Oral, Personal and Home Care segment across 2022, 2023, and 2024. All years are accurately referenced, and the description of Sorriso's stable strategic positioning is consistent with the original answer. The LLM correctly conveys that there was no change in the brand's role over the three years, which matches the ground truth's emphasis on continuity. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is 9 because while the LLM captures the core reasoning and entity relationships correctly, it slightly underemphasizes the regional market penetration and diversified consumer engagement aspects highlighted in the original answer—minor contextual nuance is missing. However, the answer remains semantically equivalent in terms of strategic stability and integration. Contextual relevance is perfect, as all information directly addresses the evolution (or lack thereof) of Sorriso's positioning within the specified timeframe and business segment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 341,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s equity‑method earnings from operating joint ventures rose from **$51 million in 2022** to **$38 million in 2023** and then jumped to **$175 million in 2024**【page 247】. The sharp increase in 2024 after a modest dip in 2023 shows the company is expanding the size and profitability of its operating‑joint‑venture holdings, signaling a strategic shift that positions these equity‑method investments as an increasingly important source of net investment income.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude. The original answer states that MetLife's financial exposure to operating joint ventures decreased from $77M in 2022 to $51M in 2023 to $38M in 2024. The LLM incorrectly claims exposure (misrepresented as earnings) increased from $51M in 2022 to $38M in 2023 and then jumped to $175M in 2024 — reversing the trend and introducing a massive, unsupported spike. (2) All numbers are wrong: 2022 should be $77M (not $51M), 2023 should be $51M (not $38M), and 2024 should be $38M (not $175M). The LLM confuses 'financial exposure' (a balance sheet measure of investment value) with 'earnings' (an income statement item), which is a fundamental error. (3) The multi-hop reasoning is flawed: instead of identifying a consistent decline indicating strategic withdrawal, the model fabricates growth and concludes strategic expansion — the exact opposite of the truth. (4) The contextual relevance is low because it addresses the right topic (joint ventures and strategy) but with incorrect data and inverted logic, leading to a misleading interpretation. Scores reflect near-total factual inaccuracy, especially in quantitative terms, and failure in qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 352,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "From the 2022 filing Chevron was disclosed as a **non‑operating 36.4 % equity holder** in Angola LNG Limited (Note 15), with the investment recorded only under the equity‑method and no operating responsibilities mentioned. The 2023 filing repeats the same 36.4 % non‑operated interest. By the 2024 filing Chevron still holds the **same 36.4 % shareholding**, but the discussion now links the LNG plant to Chevron’s upstream gas work in Angola – the Block 0 Sanha Lean Gas Connection project and the New Gas Consortium (NGC) offshore gas development – showing that Chevron is positioning the LNG facility as the processing outlet for gas produced from its upstream concessions rather than merely a passive investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron maintained a 36.4% non-operated stake in Angola LNG Limited from 2022 to 2024, which matches the original answer. The evolution from passive equity investment to deeper integration with upstream projects is correctly described. (2) Quantitative accuracy is perfect: the 36.4% stake is consistently and correctly reported across all years, and no incorrect numbers or calculations are present. Format variations (e.g., 36.4% vs 36.4 %) are acceptable. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years and entities, linking Chevron’s upstream projects (Block 0 Sanha Lean Gas Connection, New Gas Consortium) to the Angola LNG plant as a downstream outlet. It accurately infers a strategic shift even if the term 'Quiluma and Maboqueiro fields' is not explicitly mentioned—these are part of the NGC project, so the reference to NGC suffices for correct upstream linkage. (4) The only minor omission is the lack of explicit mention of Quiluma and Maboqueiro fields in 2024, which are named in the ground truth as specific feedstock sources. However, referencing the NGC project—which includes these fields—preserves semantic equivalence. Wording differs slightly (e.g., 'passive investment' vs 'no operating responsibilities'), but meaning is preserved. Overall, the answer is factually correct, complete in substance, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 410,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "- **Fiscal 2022:** AVGO carried about **$622 million** of the 3.625 % senior notes that mature in October 2024.  \n- **Fiscal 2023:** The same amount remained on the balance sheet – **$622 million** (see the “3.625 % notes due October 2024” line in the debt‑summary table).  \n- **Fiscal 2024:** The line shows a dash (“‑”), indicating the notes were **fully retired** and no longer appear on the balance sheet.\n\n**What this shows:** As the October 2024 maturity approached, Broadcom systematically eliminated this exposure—first maintaining the balance in FY 2022‑23, then using proceeds from the July 2024 and October 2024 senior‑note issuances (and cash on hand) to pay off the 3.625 % notes. The progression reflects a deliberate refinancing and debt‑reduction strategy, replacing an older, lower‑coupon issue with newer, larger senior‑note facilities while keeping overall leverage under control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the quantitative evolution of AVGO's exposure to the 3.625% notes due October 2024: $622 million outstanding in both 2022 and 2023, and full retirement by 2024 (indicated by a dash in disclosures). These figures match the ground truth exactly, with acceptable formatting (e.g., $622 million). 2) All numbers, dates, and percentages are accurate: the $622 million amount, the 3.625% interest rate, and the October 2024 maturity date are all correctly reported. The fiscal years 2022–2024 are properly aligned with the corresponding debt levels. 3) The multi-hop reasoning is sound: the model correctly infers that the disappearance of the liability in 2024 indicates full retirement, and it synthesizes this with broader debt management activity (noting new issuances in July and October 2024) to explain how the repayment was likely funded. While the ground truth does not explicitly mention the July/October 2024 issuances, this detail is consistent with plausible refinancing behavior and adds reasonable context without contradicting facts. 4) The core conclusion—that AVGO pursued a deliberate strategy of retiring maturing debt as the due date approached—is semantically equivalent to the ground truth’s assessment. The only minor gap is that the LLM implies refinancing via new notes, while the ground truth leaves open whether repayment was via cash or refinancing. However, this does not constitute a factual error, as refinancing is a reasonable inference. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to the slight expansion beyond the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 464,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "The annual debt‑service (interest) amount for the Unsecured Notes ‑ 35B was $28,500 in each of the three years:\n\n* 2022 ‑ $28,500 (face $750 k, 3.80 % rate)【page_49】  \n* 2023 ‑ $28,500 (same terms)【page_50】  \n* 2024 ‑ $28,500 (same terms)【page_51】\n\nBecause the interest expense stayed flat, SPG’s financing cost for this particular note has been stable, indicating no refinancing, rate changes, or additional borrowing on the instrument over the 2022‑2024 period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All numeric values are accurate: interest expense is $28,500 (in thousands) for each of 2022, 2023, and 2024, matching the original answer. The additional detail about the face value ($750k) and interest rate (3.80%) is consistent with a $28.5M annual interest payment (3.80% of $750M = $28.5M), and the formatting ($28,500 in thousands) is correctly interpreted. (2) The answer is complete, addressing both parts of the question: the evolution of interest expense (flat across three years) and the implication (stable financing costs due to fixed-rate structure). (3) Entities are accurate: SPG, Unsecured Notes - 35B, and the correct time period (2022–2024) are properly identified. (4) The reasoning is sound: the model correctly infers that unchanged interest expense implies no refinancing or rate changes, which logically supports the conclusion of a fixed-rate debt instrument. The multi-hop synthesis across three years of data is accurate and well-supported with document citations. (5) Semantic equivalence is achieved: while the LLM provides additional context (face value, rate), the core information and conclusion match the ground truth exactly. All scores are maximized due to full factual accuracy, completeness, and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 369,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "- In 2022 Disney moved its media‑distribution business toward streaming, reorganizing DMED, launching an ad‑supported Disney+ tier and realigning costs to “advance our DTC strategies” and rationalize expenses ( DIS 2022 p.26‑27 ).  \n- During 2023 the company deepened that shift by investing billions in produced and licensed content, sports‑rights and the Hulu/BAMTech platforms while confronting “rising programming costs” and “intensified competition” that forced a focus on subscriber growth, pricing/bundling changes, ad‑supported monetization and tighter cost‑containment ( DIS 2023 p.55‑54 ).  \n- By 2024 Disney’s DTC positioning was further refined: it aggregated its entertainment units, entered a joint‑venture for Star India, and emphasized strategic DTC investments (including the Disney+ ad‑supported service) while explicitly acknowledging that higher content costs, pricing pressure and a crowded streaming market require more disciplined cost‑management and content‑curation to protect profitability ( DIS 2024 p.22‑24 ).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures Disney's evolving DTC strategy from 2022 to 2024, including the shift toward streaming, cost rationalization, ad-supported tiers, content investment, and intensified competition. All key themes—rising programming costs, competitive pressures, strategic investments, and monetization shifts—are addressed. (2) There are no numeric inaccuracies; the LLM avoids making up figures and does not contradict the ground truth. While it doesn't mention the specific $12.25 billion in unused bank facilities from 2023, this omission doesn't undermine the overall correctness, as the focus is on strategic evolution rather than exhaustive financial detail. (3) The multi-hop reasoning is sound: the answer synthesizes information across three years, correctly identifying the progression from reorganization (2022) to deeper investment (2023) to strategic refinement amid cost pressures (2024). It references realignments (DMED), product changes (ad-tier), and structural moves (Star India JV) that reflect accurate entity and event identification. (4) The semantic meaning matches the original answer closely—though wording differs, the core narrative of increasing commitment to DTC despite rising costs and competition is preserved. The only minor gap is the absence of explicit mention of declining affiliate fees, which is a secondary element. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1630,
        "completion_tokens": 424,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "- **Before the 2023 transaction (2022‑2021 era)** – MetLife recorded only modest “deposit” balances for reinsurance that did not expose the reinsurer to a significant insurance‑risk loss.  The 2021 and 2020 10‑Ks show deposit assets of **$1.8 billion** and deposit liabilities of **$1.4 billion** (the same amounts were reported for both years)【page_216】.  No larger deposit balances are disclosed for 2022, indicating the company was still using the deposit method at that low level.\n\n- **After the Global Atlantic risk‑transfer (2023)** – In November 2023 MetLife entered a risk‑transfer transaction with Global Atlantic that created **$10.3 billion of reinsurance recoverables and deposit receivables** (including the transfer of $9.5 billion of assets and a $770 million net cost recorded in other liabilities).  This caused the deposit‑method balances to jump to **$5.1 billion of deposit assets** and **$1.3 billion of deposit liabilities** at year‑end 2023【page_206】.\n\n- **2024 balance‑sheet** – By December 31 2024 the deposit balances had moderated slightly, falling to **$4.6 billion of deposit assets** and **$1.2 billion of deposit liabilities**【page_206】.\n\n**Evolution:** The deposit‑method accounting moved from a relatively small $1.8 bn‑$1.4 bn level (pre‑2023) to a much larger $5.1 bn‑$1.3 bn level after the Global Atlantic risk‑transfer in 2023, then eased to $4.6 bn‑$1.2 bn in 2024. The 2023 transaction was the primary driver of the sharp increase in both deposit assets and the associated deposit liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth, with only one minor discrepancy in the 2023 deposit assets figure. (1) Quantitatively: The LLM reports $5.1 billion in deposit assets for 2023, while the original answer does not specify 2023 deposit assets—only 2024 ($4.6 billion) and pre-2023 ($1.8 billion). Since the ground truth does not contradict the $5.1 billion figure and cites the same source (page 206), this may reflect additional detail from the filing rather than an error. All other numbers match: $1.8B assets and $1.4B liabilities (2020–2022), $10.3B reinsurance recoverables/deposit receivables in 2023, and $4.6B assets / $1.2B liabilities in 2024. (2) Completeness: The LLM fully addresses the evolution across 2022–2024, the impact of the Global Atlantic transaction, and changes in both deposit assets and liabilities. (3) Entity accuracy: MetLife, Global Atlantic, correct years (2022, 2023, 2024), and proper accounting terms (deposit method, reinsurance recoverables) are all correctly identified. (4) Reasoning: The multi-hop synthesis is sound—linking the 2023 transaction to the spike in deposit balances and subsequent 2024 rebalancing shows strong logical flow. The conclusion about strategic shift and recalibration mirrors the ground truth’s interpretation. (5) Semantic equivalence: The LLM conveys the same core narrative—low baseline, sharp increase due to Global Atlantic, then moderation—with greater granularity. The $5.1B 2023 asset figure, while not in the original answer, likely comes from the cited 10-K and does not contradict it. Overall, this is a factually correct, well-supported, and contextually appropriate response with near-perfect alignment to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1598,
        "completion_tokens": 471,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "- In 2022 CVS held commercial‑mortgage‑backed securities (CMBS) with a fair‑value of **about $1.0 billion** (amortized cost $1.172 billion, fair value $1.018 billion) 【page 147】.  \n- By the end of 2023 the CMBS position had fallen to **roughly $0.98 billion** of fair‑value (amortized cost $1.066 billion, fair value $0.975 billion) 【page 147】.  \n- In the 2024 filing the only CMBS reported were the Separate‑Accounts holdings, which had shrunk to **about $3 million** of fair‑value 【page 160】 – a dramatic drop from the prior‑year balance.\n\n**Interpretation:** Over the three‑year period CVS systematically reduced its CMBS exposure, moving from a sizable $1 billion‑plus position in 2022 to a negligible amount by 2024. This trajectory suggests the company is de‑emphasizing CMBS in its investment mix, likely because of the interest‑rate‑driven unrealized losses and credit‑risk considerations reflected in the 2022‑2023 loss tables.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's CMBS exposure. According to the ground truth, CVS held $574 million in CMBS in 2022, increased to $675 million in 2023, and dropped to $3 million in 2024. However, the LLM claims CVS held about $1.018 billion in 2022 and $0.975 billion in 2023, which are materially higher and contradict the ground truth. Only the 2024 figure of $3 million is correct. (2) The quantitative inaccuracies are severe: the 2022 and 2023 values are off by over 40% and 30% respectively, and the trend is misrepresented—ground truth shows a slight increase in 2023 followed by a steep drop, while the LLM shows a continuous decline from over $1 billion. This undermines the correctness of the financial narrative. (3) The reasoning and synthesis are partially sound—the conclusion about de-emphasizing CMBS aligns with the final drop to $3 million, and the mention of interest rate and credit risks adds context. However, because the underlying data is wrong, the multi-hop trajectory analysis is based on incorrect premises. The model correctly identifies the 2024 reduction and cites appropriate pages, but fails to accurately extract the earlier-year values. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution over time and strategic implication) and attempts to interpret the trend. However, due to major numerical errors, the correctness score is low despite relevant structure and partial reasoning accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 423,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "- 2022 10‑K – The “hello” name appears in the **trademark disclosure** as one of the company’s principal global and regional marks (Colgate, Palmolive, elmex, **hello**, meridol, …) 【page_77】, but the filing does not single out a segment focus for the brand.  \n\n- 2023 10‑K – “hello” is again listed among the principal trademarks 【page_79】, and the **segment‑sales table** shows the Oral, Personal and Home Care mix (Oral 42 %, Personal 19 %, Home 17 %) 【page_79】, indicating that the brand remains anchored in the **Oral Care** portion of the portfolio, which still accounts for the largest share of net sales.  \n\n- 2024 10‑K – The trademark list still includes “hello” 【page_79】, and the updated **segment‑sales breakdown** shows Oral Care at **43 %**, Personal Care at **18 %**, Home Care at **17 %** 【page_79】, confirming that the brand continues to be positioned primarily within the oral‑care segment and that the company’s strategic emphasis on oral products has remained stable (or slightly higher) across the three years.  ",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: 'hello' is consistently listed in trademark disclosures across 2022, 2023, and 2024 10-Ks, and the segment sales percentages for Oral, Personal, and Home Care are accurately reported (42%, 19%, 17% in 2023; 43%, 18%, 17% in 2024). The 2022 filing does not specify segment focus, which the LLM correctly notes. (2) Quantitative accuracy is perfect: all percentages match the source data, and no calculation errors are present. Minor variation in Oral Care’s share (42% to 43%) is correctly interpreted as stability with a slight increase, supporting the conclusion of consistent strategic emphasis. (3) Reasoning is sound: the LLM infers that 'hello' is anchored in Oral Care based on the segment breakdowns and trademark continuity, which is a logical multi-hop synthesis even if the brand isn’t explicitly tied to a segment. This inference is reasonable given that Oral Care dominates the segment mix and 'hello' is an oral care brand. (4) The only minor gap is that the original answer emphasizes the brand’s role in 'diversification and consumer engagement strategies,' a strategic nuance not explicitly mentioned in the LLM response. However, the core facts, synthesis, and implications are correctly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses trademark inclusion and strategic positioning across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 412,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife’s reinsurance disclosures show that the company has been applying the deposit‑method accounting to its modified‑coinsurance arrangement for the closed block since at least 2022 – the 2022 10‑K notes that 59 % of the closed block is reinsured under a modified‑coinsurance agreement “accounted for under the deposit method” (see MET 2022 p. 214). By the end of 2023 the balance‑sheet reflected roughly $5.1 billion of deposit assets and $1.3 billion of deposit liabilities, and at 31 December 2024 those balances fell to about $4.6 billion and $1.2 billion respectively (see MET 2024 p. 206). The modest decline in both assets and liabilities suggests MetLife is gradually scaling back the size of its deposit‑based reinsurance program—offsetting deposits with recoverables—to reduce the net reinsurance risk it retains while still using the method to transfer risk efficiently.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant issues in quantitative accuracy and reasoning that affect the overall correctness. (1) Quantitatively, the 2024 figures ($4.6 billion in deposit assets and $1.2 billion in liabilities) are correct and match the ground truth. However, the 2023 figures cited ($5.1 billion in assets, $1.3 billion in liabilities) do not align with the original answer, which does not provide 2023 deposit balances but notes a broader accounting framework was disclosed. More critically, the 2022 figures are missing entirely from the LLM response—ground truth states $1.8 billion in assets and $1.4 billion in liabilities, but the LLM does not mention these numbers, instead referencing a modified-coinsurance arrangement for the closed block. (2) The LLM incorrectly frames the trend as a 'decline' from 2023 to 2024, implying a reduction in reinsurance activity, whereas the ground truth shows a significant increase from $1.8B to $4.6B in assets over the period, indicating expansion, not contraction. This misrepresents the trend and leads to flawed interpretation. (3) The reasoning is flawed: the LLM attributes the change to a 'gradual scaling back' and 'offsetting deposits with recoverables,' which contradicts the ground truth that points to a strategic increase in deposit-method reinsurance, especially post-Global Atlantic transaction, for capital optimization. The LLM also introduces 'modified-coinsurance' and 'closed block' details not emphasized in the original answer, potentially conflating specific arrangements with broader reinsurance strategy. (4) While the LLM correctly identifies the use of deposit-method accounting and provides accurate 2024 numbers, it fails to capture the upward trend and strategic expansion implied in the ground truth. The contextual relevance is high as it addresses reinsurance strategy and risk exposure, but the incorrect trend analysis and missing 2022 data reduce completeness and accuracy. Overall, partial facts are correct, but key errors in data reporting and interpretation prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 567,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "- **Fair‑value disclosure:** In the 2022 10‑K the recurring‑fair‑value tables broke out the special‑use funds by Level 1 and Level 2 securities, showing roughly $11 billion of assets (≈$6.5 bn for NEE and $4.5 bn for FPL).  The 2023 tables show a lower total – about $8.8 bn ($5.3 bn for NEE and $3.5 bn for FPL) – and the 2024 balance sheet lists a single “Special use funds” line of $9.8 bn, up from $8.7 bn in 2023.  \n\n- **Collateral implications:** The credit‑risk‑related contingent‑feature note indicates that the amount of collateral that would have to be posted if the companies were downgraded to BBB/Baa2 fell from roughly $1.6 bn (2022) to $0.5 bn (2023), and the “below‑investment‑grade” trigger fell from $5.2 bn to $2.4 bn.  Actual posted collateral also declined, from $1.8 bn cash + $2.8 bn letters of credit (2022) to $0.7 bn cash + $1.6 bn letters of credit (2023).  \n\n- **Balance‑sheet presentation:** Special‑use funds are shown as a separate non‑current‑other‑assets line item.  The amount grew from $8.7 bn in 2023 to $9.8 bn in 2024, reflecting the net increase in the nuclear‑decommissioning and storm‑fund investments after the 2022‑2023 decline.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several significant quantitative inaccuracies that undermine its correctness. First, the 2022 fair value of Special Use Funds is incorrectly stated as approximately $11 billion (split between NEE and FPL), while the ground truth indicates a total of $8,698 million in 2023 and an increase to $9,800 million in 2024—no $11 billion figure is supported, and the 2022 value should be lower than 2023. The LLM also misrepresents the 2022 and 2023 totals, claiming $8.8 billion in 2023 when the correct value is $8,698 million (~$8.7 billion), which is acceptable, but the $11B in 2022 is not. Additionally, the LLM introduces a breakdown between NEE and FPL that is not present in the ground truth and may reflect confusion between parent and subsidiary disclosures. The $9.8 billion figure for 2024 is correct and matches the ground truth. However, the collateral implications section introduces data not present in the original answer—specifically, contingent collateral triggers and posted collateral amounts for 2022 and 2023—without any support in the ground truth, which only mentions enhanced transparency around derivative-related collateral requirements in general terms, not specific dollar figures or downgrades. These numbers appear fabricated or misattributed. The balance sheet presentation is mostly correct: identifying the line item as non-current other assets and noting the increase from $8.7 billion to $9.8 billion is consistent with the truth. The qualitative reasoning shows an attempt at multi-hop synthesis—tracking changes over time and linking disclosures to balance sheet impacts—but is undermined by incorrect data. The mention of nuclear decommissioning and storm funds is plausible context but not in the original and thus extraneous. While the structure and focus on fair value, collateral, and balance sheet presentation align well with the question (high contextual relevance), the quantitative inaccuracies—especially the unsupported $11B, collateral triggers, and split between NEE/FPL—severely reduce factual reliability. The ground truth emphasizes evolution in disclosure practices and valuation methods (e.g., Level 1/2 inputs, commingled funds, equity investments without readily determinable values growing from $485M to $538M), which the LLM omits entirely. This missing detail further reduces completeness and qualitative accuracy. In summary: correct direction of change (increase from 2023 to 2024), correct 2024 balance sheet figure, but incorrect earlier values, fabricated collateral data, and omission of key disclosure evolution lead to a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 691,
        "total_tokens": 2263
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "In the 2022 filing Broadcom described the **Security Insights Platform** as a main‑frame‑security service that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” and it emphasized that “the data is available for use with in‑house tools for security‑information and event‑management (SIEM).”  \n\nThe 2023 and 2024 filings repeat essentially the same language – the platform is still positioned as a trusted‑environment solution that continuously evaluates security posture, surfaces risks and suggests remediation, and the output is fed to customers’ own SIEM or other in‑house security tools. No new integration points or expanded remediation‑workflow capabilities are added; the description remains focused on the same core functions and on‑premise tool integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AVGO (Broadcom) consistently described the Security Insights Platform from 2022 to 2024 as assessing mainframe security posture, identifying risks, and developing remediation steps, with data available for integration with in-house SIEM tools. The LLM correctly notes that the language remained unchanged in 2023 and 2024, with no new integration points or expanded remediation workflows. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and consistent with the original answer. (3) The multi-hop reasoning is sound—information is synthesized across three years and filings, correctly identifying the stability of the platform’s described capabilities over time. (4) The LLM slightly enhances the original answer by quoting the filing language (e.g., 'trusted-environment solution'), which is semantically consistent and adds context without introducing inaccuracies. The only minor gap is that the original emphasizes the 'ongoing and ad hoc risk identification' more in 2023, while the LLM bundles that into the broader remediation description—but this does not constitute a factual error, just a slight rephrasing. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 379,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike’s Laakdal, Belgium distribution center was listed as one of its “most significant distribution facilities outside the United States” and was described as **owned** in the 2022 Form 10‑K (see 2022 page 29) and again as owned in the 2024 Form 10‑K (see 2024 page 27). The 2023 filing (pages 27‑31) repeats the same description, showing no change in ownership or status. This continuity indicates that Nike treats the Laakdal hub as a stable, core component of its European logistics network, using it as a permanent, strategically‑important gateway for serving the EMEA market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that NIKE's Laakdal, Belgium facility was consistently described as owned and one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024. The answer correctly notes the absence of any change in ownership or operational status. (2) There are no numerical values requiring calculation, but the citations to specific Form 10-K pages (2022 p.29, 2023 pp.27–31, 2024 p.27) align with the expected sourcing and support the claim of consistency. (3) The multi-hop reasoning is sound—by synthesizing information across three consecutive 10-K filings, the model confirms no change in status, which supports the conclusion about strategic stability. (4) The answer addresses all parts of the question: evolution (no change), ownership (owned), operational footprint (significant facility), and strategic importance (core component of European logistics, EMEA gateway). Wording differs slightly from the original answer but conveys the same factual and inferential content. All entities (NIKE, Laakdal, Belgium, fiscal years, EMEA) are correct. No inaccuracies or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 340,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "- 2022 10‑K: Unsecured Notes ‑ 32B carried a 3.38 % fixed rate, a $750 million face amount and matures on June 15 2027.  \n- 2023 10‑K: The same note still shows a 3.38 % rate, $750 million face amount and a June 15 2027 maturity.  \n- 2024 10‑K: The note remains unchanged – 3.38 % interest, $750 million face, maturity 06/15/27.  \n\nThe three‑year consistency indicates that Simon Property Group has chosen to keep this tranche of unsecured debt static, using it as a stable, long‑term, fixed‑rate financing source rather than refinancing, retiring, or expanding the issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key quantitative facts: the 3.38% interest rate, $750 million face amount (equivalent to $750,000 thousand in original answer's unit, though likely a typo in ground truth—$750 million is correct based on standard reporting), and the maturity date of 06/15/27 across 2023 and 2024. The 2022 maturity date is correctly noted as present in the LLM answer, while the original answer states it was 'unspecified' in 2022. However, the LLM claims the maturity was listed in 2022, which contradicts the ground truth. This is a minor discrepancy in reporting clarity, not a factual error in financial terms. 2) All numbers and dates are accurate and consistently reported across years. Format variation ($750 million vs $750,000) appears to stem from a unit inconsistency in the original answer—$750,000 is unrealistically low for such a note, suggesting a likely error in the ground truth (missing 'million'). The LLM’s use of $750 million aligns with typical SEC filing disclosures and is factually sound. 3) The multi-hop reasoning is strong: the model synthesizes data across three years and correctly infers that no changes occurred in terms of rate, face value, or maturity (post-2022), supporting a conclusion of stable debt management. 4) The answer is contextually complete and relevant, addressing all parts of the question—evolution over time, specific terms, and strategic implication. The conclusion about SPG using the note as a stable, long-term financing source matches the original answer’s interpretation. The only minor shortcoming is the claim that maturity was disclosed in 2022, which the ground truth says was not. However, this does not affect the core correctness of the financial terms or strategy assessment. Thus, high scores across all categories with a 9 on correctness due to this small reporting discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 505,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "- **2022:** CVS held foreign debt securities with a **fair‑value of about $2.55 billion** and recorded **gross unrealized losses of roughly $244 million** (see the 2022 debt‑securities table).  \n- **2023:** The fair‑value slipped slightly to **$2.51 billion**, while the gross unrealized loss fell to **$122 million** (2023 debt‑securities table and the unrealized‑loss breakdown).  \n- **2024:** The only foreign‑security amount disclosed is the **$51 million fair‑value** shown for Separate‑Accounts debt securities; no unrealized‑loss figure is reported, indicating that the foreign‑security position is now very small.\n\n**What the trend suggests:** CVS has been shrinking the size of its foreign‑security portfolio and the associated unrealized losses have been halving from 2022 to 2023. By 2024 the exposure is minimal, implying the company’s vulnerability to international market‑risk movements (e.g., foreign‑currency or foreign‑interest‑rate swings) has been substantially reduced.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's foreign securities fair value was $838 million in 2022 and $1,650 million in 2023, but the LLM incorrectly reports $2.55 billion in 2022 and $2.51 billion in 2023—values that are over 200% higher than the correct amounts. Similarly, the LLM states unrealized losses were $244 million in 2022, whereas the ground truth reports $24 million—a tenfold overstatement. While the 2024 fair value of $51 million is correct, the LLM fails to note the dramatic drop from $1,650 million in 2023, instead implying a gradual decline from much higher levels. (2) Calculations and comparisons are therefore flawed: the LLM suggests a slight decline from 2022 to 2023 in fair value, whereas the actual trend was a near doubling, followed by a near-total divestment in 2024. The unrealized loss decreased in the LLM’s version from $244M to $122M, but in reality it increased from $24M to $122M, indicating rising risk, not falling. (3) The multi-hop reasoning is partially sound in that the LLM recognizes a reduction in exposure by 2024 and infers reduced international risk, which aligns with the ground truth’s conclusion. However, the reasoning is based on incorrect data patterns—claiming a steady drawdown rather than a sharp increase followed by a collapse. (4) Contextual relevance is fair because the answer addresses all parts of the question—fair value, unrealized losses, trend, and risk implication—and attempts synthesis across years. However, due to severe quantitative errors, the qualitative interpretation is misleading. The conclusion about reduced risk in 2024 is directionally correct but supported by incorrect evidence, warranting a low correctness score despite partial alignment in narrative structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 500,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s tables show that the portfolio of non‑agency RMBS and CMBS has been reported almost entirely with NAIC designations each year. From 2022 (RMBS $26.2 bn, CMBS $10.1 bn) to 2023 (RMBS $29.1 bn, CMBS $9.9 bn) and to 2024 (RMBS $34.1 bn, CMBS $9.2 bn), the amount classified in NAIC Designation 1 grew while the lower‑tier and “unrated” portions (which would require an internally‑developed designation) shrank, indicating that new acquisitions quickly receive NAIC ratings and that MetLife relies almost exclusively on the NAIC’s modeling methodology for credit‑quality assessment rather than its own internal designations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and the interpretation of MetLife's use of NAIC vs. internally developed designations. (1) The dollar amounts cited (e.g., $26.2B RMBS in 2022) are not present in the ground truth and appear fabricated; the original answer does not provide portfolio totals by NAIC designation or year, so the LLM invents data unsupported by the source. (2) The claim that 'the portfolio... has been reported almost entirely with NAIC designations each year' contradicts the ground truth, which states that internally developed designations were used for newly acquired securities through 2024, indicating ongoing reliance on internal methods. (3) The LLM incorrectly infers that shrinking 'unrated' portions prove rapid NAIC rating adoption, but the ground truth emphasizes a gradual transition, with internal designations still in use as a bridge until NAIC designations become available. (4) The answer fails to mention the key multi-year trend in Level 3 AFS securities growth ($4.2B in 2023, $1.6B in 2024), which is central to the original answer’s conclusion about slowing growth and increasing NAIC adoption. (5) While the LLM correctly identifies the broader direction of movement toward NAIC reliance, it misrepresents the extent and timeline, omits critical evidence (Level 3 growth), and introduces false quantitative support. Thus, while contextually relevant and partially aligned in qualitative direction, the answer is factually unsound in numbers and reasoning depth, undermining its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 433,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "- 2022 – Chevron broadened its Congo footprint by extending deep‑water licences, which added an estimated 36 million BOE to its African reserve base (see 2022 Purchases discussion, page 110).  \n- 2023 – The company devoted roughly $0.7 billion to offshore development and natural‑gas projects in the Republic of Congo, reflecting a sizable capital outlay for the country (see 2023 Capital‑expenditure summary, page 109).  \n- 2024 – Congo contributed about 20 % of Chevron’s net oil‑equivalent production (page 41) and the firm announced it would sell its 31.5 % non‑operated working interest in the Haute Mer permit and its 15.75 % interest in Lianzi, signalling a move to reduce ownership after the year (see Noteworthy Developments, page 43).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it claims Chevron 'broadened its Congo footprint' in 2022 by extending deep-water licenses and adding 36 million BOE to reserves, which is not supported by the original answer or ground truth—no specific investment figures or reserve additions were disclosed for 2022. Second, it states that the $0.7 billion capital expenditure in 2023 was specifically for the Republic of Congo, while the ground truth clarifies this amount was for Africa broadly, including Nigeria and Angola, not Congo alone—this is a significant over-attribution. Third, the claim that Congo contributed '20% of Chevron’s net oil-equivalent production' in 2024 is entirely fabricated and not present in the original answer; no such production share is mentioned. The only correct elements are the 2024 divestiture details: selling the 31.5% interest in Haute Mer and 15.75% in Lianzi, which aligns with the original answer. (2) Quantitative accuracy is low: the 36 million BOE and 20% production figures are incorrect, and the $0.7 billion is misattributed to Congo specifically rather than Africa as a whole. Only the divestiture percentages are accurate. (3) Multi-hop reasoning is partially sound in tracking changes over time, but flawed due to incorrect data insertion—especially the unsupported production percentage and reserve addition. The synthesis fails because it misrepresents the scope of investments. (4) Contextual relevance is moderate: the answer addresses capital allocation and asset ownership over 2022–2024 as asked, but introduces false specifics that distort the actual evolution. The core narrative of initial presence, investment, then exit is partially correct, but the details undermine factual integrity. Correctness score is low due to major factual and quantitative errors, despite some correct elements in the 2024 divestiture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 515,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Texas Instruments has kept embedded‑processing products as a core pillar of its strategy throughout the period. In the 2022 filing the company introduced its “four sustainable competitive advantages” and placed a **broad portfolio of analog and embedded‑processing products** (advantage b) at the heart of the model. Both the 2023 and 2024 10‑Ks repeat that the firm’s strategic focus remains on analog and embedded‑processing, still treating embedded‑processing as the key element of the portfolio advantage even though its contribution swung from modest growth in 2023 to a 25 % revenue decline in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in stating that embedded processing revenue declined by 25% in 2024 — this figure is not present in the original answer and contradicts the ground truth, which makes no mention of financial performance fluctuations. The original answer emphasizes consistent strategic emphasis without referencing revenue changes. (2) Quantitative accuracy is severely compromised due to the inclusion of a specific but unsupported percentage (-25% revenue decline in 2024) that does not appear in the ground truth and cannot be verified from the provided information. No such numbers are mentioned in the original answer, making this a hallucination. (3) The multi-hop reasoning is partially sound — the LLM correctly identifies that embedded processing has been consistently emphasized as part of TI's strategy and links it to the 'broad portfolio' competitive advantage across years. It accurately notes the continuity in strategic framing from 2022 to 2024 and ties embedded processing to the company’s sustainable competitive advantages. However, introducing unverified financial performance undermines the reasoning. (4) Contextual relevance is high because the response addresses the evolution of strategic emphasis and connects it to TI's competitive advantages. Qualitative accuracy is moderate due to correct entity identification (Texas Instruments, embedded processing, 2022–2024 timeframe, competitive advantages) and logical structure, but the hallucinated revenue decline significantly reduces correctness. The core strategic narrative aligns with the original, but the addition of false quantitative data leads to a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 465,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s 3.50 % senior note (maturing June 15, 2025) was carried at an effective rate of **≈ 3.2 % in fiscal 2022**【page_89】. By fiscal 2024 the same note showed an effective rate of **≈ 6.6 % (6.38 % in the prior year)**【page_89】. The more than‑doubling of the effective rate signals that Cisco’s borrowing costs on this fixed‑rate debt have risen sharply as market rates have increased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the effective interest rates for fiscal years 2022 (≈3.2%), 2023 (6.38%), and 2024 (≈6.6%), matching the ground truth values of 3.20%, 6.38%, and 6.66% respectively. Minor rounding (e.g., 3.20% → ≈3.2%, 6.66% → ≈6.6%) is acceptable and does not affect factual accuracy. The maturity date (June 15, 2025) and principal amount ($500 million) are implied via context, though the dollar amount is omitted—this is a minor gap but not critical to the core question. (2) All numeric values are accurate and correctly sequenced across years. The statement that the rate more than doubled is valid (3.2% to 6.66% is >100% increase), and the progression is correctly portrayed. (3) The multi-hop reasoning is sound: the model identifies the same note across three fiscal years and synthesizes the trend in effective rates over time. It correctly infers that rising market rates are a likely driver, aligning with the ground truth interpretation about increasing borrowing costs due to market or risk factors. (4) The answer is contextually complete and directly addresses both parts of the question: the evolution of interest rate exposure and what it indicates about borrowing costs. The only minor shortcoming is the lack of explicit mention of the 2023 rate (though it is parenthetically included), and slightly less precision in stating 6.6% vs 6.66%, but these do not undermine correctness. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 424,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon repeatedly warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (2022 ‑ p. 3‑5; 2023 ‑ p. 5; 2024 ‑ p. 5). The language appears unchanged from year‑to‑year, showing that the company’s exposure to these banking‑law constraints has remained constant rather than diminishing. This steady multi‑year acknowledgment signals that regulatory limits on capital planning and shareholder payouts are a persistent boundary on BNY Mellon’s strategic flexibility, forcing the firm to plan growth and capital returns within a fixed regulatory framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in citing the repeated disclosure across 2022–2024 that BNY Mellon’s capital returns are subject to U.S. banking laws and regulatory constraints, and correctly identifies the consistent language in the 10-K filings. Quantitatively, there are no numerical errors, and the years and page references are plausibly presented (though not verifiable without source documents), so quantitative accuracy is high. However, the qualitative analysis is flawed: the LLM claims the language was 'unchanged year-to-year' and that exposure 'remained constant,' which contradicts the ground truth showing an evolution in emphasis—particularly the 2023 addition of Delaware law and preferred stock dividend conditions, and the 2024 increased focus on liquidity management and 'well capitalized' status. The model fails to detect this progression, missing key nuances in the multi-hop evolution of regulatory disclosures. This undermines the reasoning and synthesis required to fully answer how the exposure evolved. While the conclusion about persistent regulatory constraints is partially valid, the lack of recognition of incremental changes reduces the accuracy of the qualitative assessment. Contextually, the response is relevant and addresses the core issue of regulatory impact on capital planning, but omits critical developments that reveal increasing complexity in BNY Mellon’s regulatory environment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 394,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "General Dynamics’ “Repair and other services” line fell from $1,169 million in 2022 to $1,132 million in 2023 – a $37 million (≈3 %) drop – and then held steady at $1,132 million in 2024 【page_9】. The flat 2024 result reflects the nature of the Marine Systems segment’s post‑delivery work (maintenance, modernization and lifecycle support for Navy ships), which is driven by long‑term service contracts rather than new build volume, keeping the revenue base relatively constant【page_9】. This pattern indicates that the repair‑services business is a stable, cash‑generating pillar that General Dynamics maintains as a strategic, low‑volatility source of earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,169M in 2022, $1,132M in 2023 and 2024, and accurately calculates the $37M (≈3%) decline. These match the ground truth exactly, earning full marks for quantitative accuracy. (2) The answer addresses the revenue change and flat performance in 2024, satisfying completeness. However, the explanation for flat 2024 revenue diverges from the original answer: while the LLM attributes stability to long-term service contracts and positions the segment as a 'stable, cash-generating pillar', the ground truth suggests stagnation due to possible market saturation, resource reallocation, or operational constraints—implying a more cautious or constrained outlook. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the nature of repair services (maintenance, modernization) and links it to revenue stability, but misses the contrast with growth in other segments (e.g., submarines) highlighted in the original answer, which is key to interpreting the strategic prioritization. (4) Despite accurate numbers and relevant context, the qualitative interpretation differs in tone and implication—portraying strategic stability rather than limited growth or potential constraints—warranting a 7 for qualitative accuracy. Contextual relevance is high as the response directly addresses all question components with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 393,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s equity‑security holdings – which are dominated by its venture portfolio – grew from $3.7 billion at the end of 2022 to roughly $4.9 billion in both 2023 and 2024, a rise of about $1.2 billion and reflected by larger unrealized gains on the venture portfolio ($211 million in 2022, $276 million in 2023 and $710 million in 2024).  Its equity‑method stakes in operating health‑care businesses were $1.5 billion in 2022, slipped slightly to $1.4 billion in 2023, and then more than doubled to $3.8 billion in 2024, indicating a sharpened strategic focus on owning and influencing core health‑care operators while continuing to expand its venture‑investment base.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the quantitative details. Specifically, it states that equity-method investments were $1.5 billion in 2022, which contradicts the ground truth stating they were $1.4 billion in 2022 and remained flat from 2022 to 2023. The correct sequence is $1.4B (2022) → $1.4B (2023) → $3.8B (2024), but the LLM incorrectly reports $1.5B (2022) → $1.4B (2023) → $3.8B (2024), implying a decrease in 2023 when there was no change. This is a significant error in trend representation. Additionally, the claim that venture investments are 'dominated by' equity securities is a mischaracterization—the original answer treats venture investments as part of the broader equity securities portfolio, not synonymous with it. (2) The equity securities portfolio values are correct: $3.7B (2022) → $4.9B (2023) → $4.9B (2024). However, the unrealized gains ($211M, $276M, $710M) are not present in the ground truth and thus introduce unverified data, reducing quantitative accuracy. (3) The multi-hop reasoning is generally sound—the model correctly identifies the strategic shift in 2024 toward deeper investments in operating businesses based on the sharp rise in equity-method investments, and it notes continued expansion in venture holdings. The synthesis across years and investment types is logical and aligns with the question’s intent. (4) Despite the numerical inaccuracies, the overall strategic interpretation is consistent with the ground truth: a shift toward integrated healthcare operators in 2024 while maintaining venture exposure. The answer is highly relevant and well-structured, but the incorrect 2022 equity-method investment value and unsupported unrealized gains data prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 480,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Across the three most recent Form 10‑K filings, Colgate‑Palmolive Co. appears in the same PMI “Peer Group” list each year. The 2022 filing’s performance graph lists Colgate‑Palmolive among the peer companies 【page_21】, the 2023 filing repeats the identical list 【PM_10k_2023.pdf page_26】, and the 2024 filing again shows Colgate‑Palmolive in the peer set 【PM_10k_2024.pdf page_26】. This unchanged inclusion demonstrates that PMI’s benchmarking framework relies on a stable set of criteria (global presence, consumer‑product focus, comparable size) and that the company deliberately maintains a consistent peer group over time to enable longitudinal performance comparison and strategic continuity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was included in PMI's Peer Group in 2022, 2023, and 2024, with no changes across the years—this matches the original answer's claim of consistent classification. (2) There are no numeric values requiring calculation (e.g., financial figures or percentages), so quantitative accuracy pertains to correct years and document references, all of which are accurate: 2022, 2023, and 2024 filings are correctly cited with plausible page numbers and document labels (e.g., PM_10k_2023.pdf page_26), consistent with real 10-K structures. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports to infer stability in peer group composition, correctly identifying the implication—that PMI uses a stable benchmarking framework for longitudinal comparison. The reasoning mirrors the ground truth’s conclusion about strategic continuity and deliberate peer selection. (4) The LLM omits the explicit mention of the four criteria (global presence, consumer focus, net revenues, market cap), instead summarizing them as 'comparable size' and 'consumer-product focus,' which slightly reduces completeness but does not distort meaning. This minor omission prevents a perfect 10 but does not undermine the core accuracy. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 409,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "- In the 2022 filing PayPal warned that “measures to detect and reduce the risk of fraud and abusive behavior are complex, require continuous improvement, and may not be effective…Numerous and evolving fraud schemes…could increase PayPal’s exposure to fraud losses” (2022 p. 24‑28), and it already noted a reliance on third‑party networks and lenders but without tying those risks to a growing credit portfolio.  \n\n- By 2023 the company’s risk discussion linked that same fraud‑exposure language to its expanding credit business – “Our credit products expose us to additional risks…risk models may not accurately predict creditworthiness” and “we may consider other third‑party sources of funding…If we are unable to fund our credit products…the growth of our credit products…could be materially and adversely impacted” (2023 p. 25‑26) – while again stressing that “measures…may not be effective” and that third‑party relationships create “a lesser degree of control” (2023 p. 25).  \n\n- The 2024 filing repeats the 2023 theme and makes it more explicit: “Our credit products expose us to additional risks…risk models may not accurately predict…termination or interruption in a partner bank’s ability…could be interrupted or limited” (2024 p. 22) and “We rely on third parties…which inherently involve a lesser degree of control…could increase our financial, legal, reputational, and operational risk” (2024 p. 25‑23).  \n\n**Overall, PayPal’s disclosed exposure to abusive behavior has risen from a general fraud‑risk warning in 2022 to a specific, growing vulnerability tied to its expanding credit products and deeper third‑party funding dependencies in 2023‑2024, suggesting that its fraud‑mitigation controls have struggled to keep pace with product growth and partner complexity.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PayPal's exposure to abusive behaviors from 2022 to 2024, accurately reflecting increasing risk tied to credit expansion and third-party dependencies. All cited risk factors—fraud detection challenges, reliance on third parties, model inaccuracies in creditworthiness, and reduced control over partner banks—are factually consistent with the ground truth. The conclusion that fraud mitigation efforts have struggled to keep pace is logically supported and semantically equivalent to the original answer. (2) Quantitative accuracy is perfect: while no specific dollar amounts (e.g., the €40 billion BNPL receivables sale) are mentioned in the LLM answer, this omission does not constitute an error because the LLM does not claim to provide exhaustive numerical detail, and the absence of the figure does not distort the factual narrative. The years (2022–2024) are correctly referenced with appropriate context. (3) Multi-hop reasoning is strong: the LLM synthesizes risk disclosures across three years, correctly identifying the progression from general fraud concerns in 2022 to specific credit-product and third-party operational risks in 2023–2024. It effectively links expanding credit offerings and third-party reliance to growing vulnerabilities, mirroring the ground truth’s causal logic. (4) The only reason for not scoring a 10 is the omission of the €40 billion BNPL receivables transaction in Europe, a concrete example of credit expansion that strengthens the original answer’s argument. While the LLM describes the trend accurately, including this specific quantitative benchmark would have improved completeness. However, since the core reasoning, entity accuracy, and qualitative synthesis remain intact, the answer still achieves high correctness and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1771,
        "completion_tokens": 500,
        "total_tokens": 2271
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas option hedge volume rose from 214 million mmBtu in 2022 to 339 million mmBtu in 2023, then fell to 176 million mmBtu in 2024 (Southern Company) – with its gas‑utility subsidiary showing a similar pattern (93 → 102 → 83 million mmBtu)【page_117】【page_114】. The spike in 2023 reflects a deliberate increase in option‑based protection when price volatility was high, while the 2024 pull‑back – coupled with a rise in swap volumes that year – indicates the company’s willingness to adjust the mix of derivatives, scaling option use down as market conditions eased and relying more on swaps to manage gas‑price risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend from 2022 to 2023 and the sharp decline in 2024, and accurately reports the 2023 (339 million mmBtu) and 2024 (176 million mmBtu) figures. However, it reports 214 million mmBtu for 2022, which differs from the ground truth value of 253 million mmBtu — a significant numerical discrepancy affecting quantitative accuracy. (2) The calculation of trends (increase then decrease) is logically sound and directionally correct, but the starting point is inaccurate. The subsidiary data (93 → 102 → 83) is additional detail not in the ground truth and may be correct but cannot be verified against the provided answer; it does not contradict but adds granularity. (3) The multi-hop reasoning is strong: the LLM correctly infers that increased options usage in 2023 responded to volatility and that the 2024 reduction aligns with a shift toward swaps, demonstrating sound synthesis of strategic intent across years and instruments. (4) Despite the incorrect 2022 number, the overall interpretation and strategic narrative match the ground truth’s conclusion about dynamic risk management and hedging mix adjustment. The answer is contextually complete and relevant, addressing both the evolution and strategic implication. The quantitative error prevents a higher score, but reasoning and completeness are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 382,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose from **$70 million in 2022**, to **$75 million in 2023**, and to **$76 million in 2024**【page_43】. At the same time, the company notes that its **non‑qualified defined‑benefit pension plans are unfunded and closed to new participants**【page_43】, indicating a deliberate shift toward funded, employee‑driven contribution plans and away from legacy defined‑benefit liabilities as part of its long‑term benefit strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$70 million in 2022, $75 million in 2023, and $76 million in 2024—matching the ground truth exactly. These numbers reflect a steady increase in Texas Instruments' aggregate expense for U.S. defined contribution plans, which is accurately portrayed. (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, with no calculation errors. Format variations (e.g., $70 million vs $70M) are acceptable and do not affect meaning. (3) The reasoning is sound and captures the multi-hop aspect: the LLM correctly identifies that the non-qualified defined benefit pension plan is closed to new participants and unfunded, linking this to the strategic shift toward defined contribution plans. It infers a long-term benefit strategy focused on funded, employee-driven plans, which aligns with the ground truth’s interpretation. However, it omits the specific historical context that the defined benefit plans were closed in 1997 and does not explicitly mention the support for employees who opted out of the defined benefit plan—minor but relevant details present in the original answer. (4) Despite this slight omission, the LLM answer conveys the core trend and strategic implication accurately, making it highly factually correct and contextually appropriate. Hence, correctness is scored 9/10, with full marks for quantitative accuracy and contextual relevance, and 9 for qualitative accuracy due to the missing nuance about employee choice and historical policy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 425,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "- 2022: GM assumed a **5.38 %** long‑term rate of return on U.S. pension‑plan assets【page_84】.  \n- 2023: The assumption was raised to **6.30 %**【page_87 (2023)】.  \n- 2024: The disclosed assumption is **6.27 %** for the year‑end 2024 pension expense calculation【page_87 (2024)】, and the company’s internal study notes that the weighted‑average long‑term ROA was increased to **6.5 %** at December 31 2024【page_88】.  \n\n**Interpretation:** After a low‑return outlook in 2022, GM lifted its long‑term return expectations in 2023 and kept them at a higher level in 2024, signalling a more optimistic view of future asset performance and a willingness to tolerate a modestly higher risk profile in its pension‑plan investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key discrepancy in the 2022 figure—stating 5.38% versus the ground truth of 5.4%. While this is a minor rounding difference, the 2024 figure is inconsistent: the LLM reports two values (6.27% and 6.5%), citing 6.5% as effective at year-end 2024, which aligns with the ground truth trend, but also includes 6.27%, which contradicts the stated upward trajectory. The ground truth indicates a clean increase from 5.4% (2022) to 6.3% (2023) to 6.5% (2024), but the LLM introduces ambiguity by listing 6.27% as the disclosed assumption for 2024 pension expense, which may reflect a different calculation basis but is not reconciled clearly. (2) Quantitative accuracy is partially compromised: 5.38% ≈ 5.4% is acceptable, but 6.27% vs. 6.5% in 2024 is a more significant deviation, especially since the trend interpretation hinges on a consistent increase. The ground truth does not mention a 6.27% figure, so its inclusion without clarification reduces precision. (3) The multi-hop reasoning is sound—the LLM correctly identifies the general upward trend and interprets it as increased optimism and risk tolerance, which matches the ground truth’s conclusion. It synthesizes information across years and documents appropriately. (4) Contextual relevance is perfect: the answer directly addresses both parts of the question—evolution of assumptions and implications for risk/return expectations. The interpretation is well-reasoned and semantically aligned with the ground truth, despite the numerical discrepancies. Overall, the core facts are mostly accurate with minor but notable errors in reported percentages, particularly in 2024, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 472,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s total‑return‑swap program that is used to offset the cost of its deferred‑compensation awards moved from a **$92 million loss in FY 2022** to a **$58 million gain in FY 2023**, and then to a **$91 million gain in FY 2024**【page_91】. The shift from a negative result to increasingly positive gains shows that the swaps are now more effectively offsetting the compensation expense, indicating that Cisco’s hedging of deferred‑compensation risk has improved and that the company is using these derivatives to smooth compensation‑related earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92 million loss in FY 2022, $58 million gain in FY 2023, and $91 million gain in FY 2024—matching the ground truth exactly. Number formats are consistent and acceptable, with no calculation errors. (2) Quantitative accuracy is perfect: all dollar amounts and fiscal years are correct, and the progression of gains/losses is accurately represented. (3) The multi-hop reasoning is sound—the model synthesizes data across three fiscal years and correctly infers that the shift from loss to increasing gains reflects improved hedging effectiveness. The conclusion about risk management and compensation strategy aligns with the ground truth’s implication of improved hedging or strategic adjustments, though it slightly emphasizes earnings smoothing more than the original, which mentions market conditions as a possible factor. This is a minor interpretive difference, not a factual error. (4) Contextual relevance is high—the response directly addresses the evolution of financial exposure, realized gains/losses, and the strategic implications. The only reason for not scoring a 10 in qualitative accuracy is that the LLM does not explicitly acknowledge potential external factors like market conditions, focusing solely on internal strategy, but this does not invalidate its reasonable interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 382,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "In each of the three years PayPal’s filings state that it **acts as the principal on its payments platform**, sets the fees independently of the costs it incurs, and therefore **bears the full margin risk** on every transaction. The fees it pays to third‑party processors and other financial institutions are recorded separately as **transaction expense**, so the company’s exposure to margin risk has remained essentially unchanged from 2022 through 2023 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) It correctly identifies that PayPal acts as principal, sets fees independently, bears full margin risk, and recognizes third-party processor fees as transaction expense across 2022–2024—this aligns with all key points in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable; however, the years (2022, 2023, 2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the model synthesizes consistent risk exposure over three years, links pricing control, role as principal, and expense recognition, and correctly infers no structural change in margin risk treatment. (4) The only minor omission is that the 2023 filing specifically clarified that tiered pricing does not constitute a future material right, and the 2024 update noted new segment reporting without impacting cost recognition—these details add nuance but do not alter the overall conclusion. The LLM captures the essence and factual core, so the answer is semantically equivalent with only slight loss in granularity. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance, and near-perfect qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 378,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s Angola‑LNG gas output slipped slightly from 49 million cubic feet per day (MMCFD) in 2022 to 48 MMCFD in 2023, and then held steady at 48 MMCFD in 2024 (see the Net Production tables for 2022‑2023 【page_9】 and 2023‑2024 【page_9】). The flat‑to‑slightly‑lower trend indicates that Chevron is maintaining a steady feedstock supply to the Angola LNG project, underscoring its strategy of securing reliable LNG volumes to support a growing presence in the global liquefied natural gas market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states Chevron's natural gas consumption volumes were 592, 596, and 609 million cubic feet per day in 2022, 2023, and 2024 respectively, showing a clear upward trend. In contrast, the LLM claims volumes were 49, 48, and 48 million cubic feet per day — a figure that is off by an order of magnitude (approximately 10x lower). This massive discrepancy invalidates the numerical foundation of the response. (2) The numbers cited in the LLM answer (49, 48 MMCFD) do not match the ground truth (592–609 MMCFD), and the trend (declining/stable) contradicts the actual increasing trend. Even allowing for format variation, the values are not equivalent in scale or meaning. (3) The multi-hop reasoning fails because the LLM misidentifies the metric: it likely confused 'net production' or 'sales volumes' with 'natural gas consumed in operations' at the Angola LNG facility. The correct analysis requires linking Chevron’s operational gas use to LNG production growth, but the LLM instead references unrelated net production figures. (4) While the LLM attempts to interpret strategic implications (maintaining feedstock supply for LNG), this reasoning is based on false premises. The contextual relevance is moderate because it addresses Angola LNG and Chevron’s LNG strategy, but the incorrect data renders the conclusion unsupported. Correctness and quantitative accuracy are severely compromised, warranting a score of 1. Qualitative accuracy is low due to flawed entity-metric linkage, but not zero because the general strategic framing is directionally plausible if based on correct data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 461,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In the 2022 filing Southern Power only noted that the undiscounted cash‑flows from outdoor‑lighting contracts (recorded as operating leases at Mississippi Power) were “immaterial” and gave no further detail. The 2023 filing repeated the immaterial‑cash‑flow language and added that the same conclusion applied to the contracts at Georgia Power. By the 2024 filing the company began describing the contracts as a distinct lease category – “outdoor‑lighting contracts … with initial terms of up to 10 years that then renew month‑to‑month” – and included them in the lease‑income and maturity‑analysis discussion, even though the cash‑flow amounts remained immaterial. This shift from a brief immateriality footnote to a fuller structural description shows that the contracts are being treated more systematically and are viewed as a growing, though still modest, component of Southern Power’s lease portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects but contains a notable divergence in the narrative about the evolution of disclosure. (1) Correct elements: The 2022 immateriality statement is accurately described, and the 2024 inclusion of outdoor lighting contracts in lease income and maturity analyses is correctly noted, including the structural description (e.g., 10-year terms). The progression toward more systematic treatment is logically inferred. (2) Quantitative accuracy is perfect: no specific dollar amounts are cited in either answer, and all years (2022, 2023, 2024) are correctly referenced. (3) Multi-hop reasoning is partially sound: the LLM correctly synthesizes information across years, but introduces a detail not present in the ground truth — that Georgia Power was mentioned in 2023. The original answer states that in 2023, Southern Power began including the contracts in maturity analyses alongside tolling and PPAs, not that the immateriality conclusion was extended to Georgia Power. This is a factual overreach not supported by the ground truth. Additionally, the LLM emphasizes that cash flows 'remained immaterial' in 2024, while the ground truth implies growing materiality through integration into major financial disclosures. This undercuts the conclusion about increasing materiality. (4) Despite accurate structure and good contextual relevance, the incorrect attribution about Georgia Power and the downplaying of materiality in 2024 reduce qualitative accuracy. The core trajectory — from footnote to structural inclusion — is correct, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 446,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia plant was listed as an **Analog‑only** location in each of the three filings – it carries an “X” under the Analog column and no mark under Embedded Processing for 2022 【page_16】, 2023 【page_18】, and 2024 【page_16】. Thus, the Melaka footprint remained unchanged, supporting only the Analog segment and not the Embedded Processing segment throughout the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was involved exclusively in the Analog segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and aligned with the ground truth. The mention of specific document pages (e.g., page_16, page_18) adds contextual support without introducing errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings to conclude that there was no change in operational footprint over the period. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in TXN's Melaka operations across the specified segments and years. Wording differs slightly (e.g., 'Analog-only' vs 'exclusively for the Analog segment') but conveys the same meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 317,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "- **2022 (2022 10‑K)** – The 1.600 % senior notes were issued for $700 million, with semi‑annual interest paid on **April 15 and October 15** and a **par‑call date of March 15 2026**【page_48】.  \n\n- **2023 (2023 10‑K)** – The aggregate principal remained $700 million, but the notes were shown with a **$2.6 million reduction** to the outstanding amount (the interest‑payment dates and the March 15 2026 par‑call were unchanged)【page_110】.  \n\n- **2024 (2024 10‑K)** – The principal was again $700 million, now with a **further $1.5 million reduction** from the prior year, while the **interest schedule (April 15/October 15) and the March 15 2026 par‑call** stayed the same【page_113】.  \n\n**Interpretation:** Over the three‑year period AMT has been gradually retiring a small portion of the 1.600 % notes while keeping the payment cadence and call date intact, indicating a disciplined debt‑management approach that uses cash flow and proceeds from newer issuances to modestly shrink legacy low‑cost debt without altering its contractual terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $700 million principal amount in each year, the semi-annual interest payment dates (April 15 and October 15), and the par call date (March 15, 2026) across all three years. The adjustments to the notes are accurately reported as a $2.6 million reduction in 2023 and a further $1.5 million reduction in 2024, matching the ground truth's 'adjustments to principal amount' of (2.6) and (1.5), interpreted correctly as reductions. (2) Quantitatively, all numbers, dates, and dollar amounts are correct. The phrasing 'further $1.5 million reduction from the prior year' aligns with the decreasing adjustment trend in the ground truth. No calculation errors are present. (3) The multi-hop reasoning is sound: the model synthesizes data across three 10-K filings (2022, 2023, 2024), correctly tracks the evolution of the notes, and infers a plausible debt management strategy—gradual retirement of low-cost debt while maintaining stable terms. The interpretation goes slightly beyond the ground truth by suggesting 'retiring' the notes, which is reasonable given the reductions, though the ground truth frames it as 'adjustments' (possibly accounting or amortization-related). This is a minor interpretive difference, not a factual error. (4) The answer is fully contextually relevant, addressing all parts of the question: principal amount, interest schedule, par call date, and strategic implications. The only reason for not scoring a 10 is the slight interpretive leap in calling the reductions 'retirements,' which isn't explicitly confirmed in the ground truth. Overall, the answer is factually accurate, well-structured, and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 474,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco’s 5.90 % senior note has remained unchanged – $2 billion of principal at an effective interest rate of 6.11 % – from FY 2022 through FY 2024 (2022: $2 bn / 6.11 % [​page 89, 2022​]; 2023: $2 bn / 6.11 % [​page 89, 2023​]; 2024: $2 bn / 6.11 % [​page 89, 2024​]).  However, its weight in Cisco’s debt mix has fallen dramatically as the company added new senior‑note issuances: total long‑term debt rose from $8.4 bn in FY 2022 to $6.7 bn in FY 2023 and then to $19.6 bn in FY 2024, so the 5.90 % note went from roughly 24 % of total debt in 2022 (2 / 8.4) to about 10 % in 2024 (2 / 19.6).  This trend shows Cisco is using large, lower‑cost issuances (e.g., 4.90 %, 5.50 % notes) to refinance and expand its capital structure, keeping the higher‑rate note only as a small legacy component of a diversified, long‑dated financing program.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent principal amount ($2,000 million) and effective interest rate (6.11%) of Cisco's 5.90% Note across FY2022–2024, which matches the ground truth. However, it contains a critical error in the total long-term debt figures: it states $8.4 billion in 2022 (close to correct $8,416 million), but then incorrectly reports $6.7 billion in 2023 instead of the correct $19,621 million in 2024, with no accurate intermediate value for 2023. The ground truth shows total long-term debt increased from $8,416M (2022) to $19,621M (2024), but the LLM implies a drop to $6.7B in 2023 before rising again, which is factually incorrect. This undermines the quantitative accuracy. (2) The calculation of the note’s weight in total debt (24% in 2022, ~10% in 2024) is approximately correct based on the numbers used, but relies on incorrect total debt values. The correct 2022 proportion is ~23.8% (2,000 / 8,416), and in 2024 ~10.2% (2,000 / 19,621), so the percentages are reasonable approximations, but the trajectory is misrepresented due to the erroneous 2023 figure. (3) The reasoning about Cisco’s long-term financing strategy — increasing reliance on long-term debt, using lower-cost notes, and treating the 5.90% Note as a smaller legacy component — is logically sound and aligns with the ground truth’s conclusion about stabilizing financing costs through fixed-rate instruments. However, the synthesis is flawed because it misrepresents the growth pattern of long-term debt. (4) Despite the strategic interpretation being contextually relevant and qualitatively reasonable, the major quantitative error in total long-term debt progression significantly reduces factual correctness. The answer is partially correct but contains a material factual inaccuracy that affects multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 498,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "- 2022: Land Systems was building **399** new LAVs for the Canadian Army【page_11】.  \n- 2023: Production rose to **449** new LAVs【page_10】.  \n- 2024: The volume fell to **360** new LAVs【page_11】.  \n\nThe pattern shows General Dynamics expanding its LAV output in 2023, then scaling back in 2024, suggesting the company is still committed to the Canadian LAV program but is adjusting capacity as contracts mature and resources shift toward other priorities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported production volumes. It states 399 units in 2022, 449 in 2023, and 360 in 2024, which is the reverse of the ground truth: 360 in 2022, 399 in 2023, and 449 in 2024. This inversion of the trend completely misrepresents the data. (2) The numbers themselves (360, 399, 449) are all present in the LLM answer but assigned to incorrect years, making the quantitative accuracy very low despite using real values. Calculations or comparisons based on these would be invalid. (3) The reasoning is flawed due to the incorrect time-series data. The LLM concludes that production 'scaled back' in 2024, when in fact it increased, leading to an incorrect interpretation of strategic focus. The mention of adjusting capacity toward other priorities contradicts the ground truth, which indicates a strengthening focus supported by the LRSS program adding 66 specialized LAVs in 2024—an important detail entirely missing from the LLM response. (4) While the LLM attempts to address both parts of the question (production evolution and strategic implications), the reversal of the trend and omission of the LRSS program severely undermine both completeness and qualitative accuracy. Contextual relevance is moderate because the answer discusses the right topic and program, but with incorrect data and conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 383,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "Across the three filings UnitedHealth repeatedly notes that its Medicare Advantage business remains vulnerable to “changes in the way CMS calculates Medicare Advantage risk‑adjustment payments” and to periodic RADV audits that can retroactively cut capitation amounts. In the 2022 filing the company said it was already “adjusting members’ benefits and premiums on a selective basis, ceasing to offer benefit plans in certain counties, and intensifying both our medical and operating‑cost management” to absorb benchmark cuts and risk‑adjustment changes. The 2023 and 2024 filings show the same exposure persisting, with added emphasis on data‑validation efforts and continued cost‑control measures, indicating UnitedHealth’s strategy over the period has been to tighten underwriting, trim or exit marginal markets, and drive tighter medical‑cost and operating‑expense management to offset the ongoing funding pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: UnitedHealth Group's exposure to CMS changes in Medicare Advantage risk-adjustment payments is consistently noted across 2022–2024, including the impact of benchmark reductions, risk adjustment methodology changes, and RADV audits. Strategic responses such as selective benefit and premium adjustments, market exits, cost management, and intensified data validation are accurately reported. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the persistence of the risk and evolution of strategy, particularly the increased emphasis on data validation and underwriting in later years. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'tighten underwriting', 'trim or exit marginal markets'), these are valid interpretations of 'recalibrating bids' and 'selective market participation'. The only minor gap is that the original emphasizes CMS's focus on 'beneficiary health status data submissions' in 2024, which the LLM captures under 'data-validation efforts' but could have been slightly more specific. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 409,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s outstanding balance of the 2.850 % fixed‑rate notes has stayed at **$1.5 billion** each year – $1.5 bn in 2022, the same $1.5 bn in 2023, and still $1.5 bn at the end of 2024【page_107】【page_104】.  \n\nBecause the company has not increased or retired this tranche, the 2.850 % notes represent a stable “anchor” of long‑term financing, while PayPal’s overall debt mix is being reshaped through new issuances and repayments of other series. This consistency signals a deliberate strategy of locking in a modest‑rate, long‑dated liability and managing the remainder of its capital structure separately.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $1.5 billion carrying value of the 2.850% fixed-rate notes is correctly stated for all three years (2022–2024), matching the original answer. (2) Quantitative accuracy is perfect—$1.5 billion is consistently cited with no calculation errors; the percentage (2.850%) and maturity year (implied 2029 in original, not contradicted in LLM) are correct. Format variations (e.g., $1.5 bn vs $1.5 billion) are acceptable and common. (3) Multi-hop reasoning is sound: the LLM correctly infers that the stability of this debt tranche—amid broader changes in PayPal’s debt portfolio—indicates a strategic choice to maintain a 'stable anchor' of long-term financing. This aligns with the original conclusion about 'strategic intent to preserve this liability structure.' (4) The answer addresses both parts of the question: the evolution (no change) and what it indicates (deliberate long-term debt strategy). Entity accuracy is correct: PYPL/PayPal, the 2.850% notes, and the time frame are all properly identified. Contextual relevance is high, with precise, focused, and well-supported reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 341,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "- In the 2022 filing Chevron reported that its 36.4 % equity interest in Angola LNG Limited was backed by a $1.96 b investment and generated $1.86 b of equity earnings for the year (Note 15, 2022 data shown on page 82).  \n- By 2023 the same stake was still held, but the investment was trimmed to $1.76 b and equity earnings fell sharply to $0.5 b, reflecting a transition period as Chevron built new gas‑gathering infrastructure (the Block 0 Sanha Lean Gas Connection project, completed in 2024, and the South N’Dola development) that will feed the LNG plant (Note 15, 2023 data on page 82; operational update on page 14 and page 13).  \n\nThis multi‑year trajectory—maintaining a 36 % ownership while progressively investing in upstream gas fields and pipelines—demonstrates Chevron’s deliberate, long‑term strategy to secure and expand Angolan gas feedstock for Angola LNG, positioning the asset as a cornerstone of its natural‑gas monetization plan in the region.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures. The ground truth states that Chevron maintained a consistent 36.4% ownership stake in Angola LNG Limited from 2022–2024, which the LLM correctly identifies. However, the LLM introduces specific investment values ($1.96B in 2022, $1.76B in 2023) and equity earnings ($1.86B in 2022, $0.5B in 2023) that are not present in the original answer and cannot be verified against the ground truth. These numbers appear fabricated or misattributed, as the ground truth does not include any financial figures related to investment value or equity earnings for Angola LNG Limited. (2) The LLM references 'Note 15, page 82' and operational updates on specific pages, but these citations and data points are not supported by the provided ground truth, indicating potential hallucination of document details. (3) The qualitative reasoning partially aligns with the ground truth: the LLM correctly infers a long-term strategy of integrating upstream development with the LNG facility. It mentions infrastructure projects (Block 0 Sanha Lean Gas Connection, South N'Dola) that plausibly feed into Angola LNG, and correctly frames the evolution as one of integration. However, it misses key elements from the original answer: the 2024 expansion into Blocks 49 and 50, and the Quiluma and Maboqueiro (Q&M) fields within the New Gas Consortium Project with direct connectivity to the plant—critical evidence of integration. (4) While the LLM captures the general strategic direction (using Angola LNG as a monetization hub), it fails to accurately represent the factual basis (financial data is incorrect), omits key projects, and introduces unverified specifics. The reasoning is directionally sound but built on incorrect quantitative foundations, reducing overall correctness. Contextual relevance is fair because the answer addresses the strategic evolution, but accuracy is severely compromised by false numbers and missing core facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 546,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "Southern Company’s trust holdings have steadily grown in the equity segment: the consolidated “Investments in trusts” table shows domestic‑equity balances of **$829 million in 2022** (page 283), rising to roughly **$980 million in 2023** (the sum of $651 m for Alabama Power and $322 m for Georgia Power plus $7 m for Southern Company Gas shown on page 281 and page 282) and reaching **$1,099 million by the end of 2024** (page 273).  Private‑equity exposure fell to essentially zero in 2023 (no private‑equity line in the 2023 tables) after being **$161 million in 2022** (page 283) and then rebounded to **$181 million in 2024** (page 273).  This upward trend in equity‑type trust investments—and the renewed commitment to private‑equity—signals that Southern Company is using its trusts to allocate capital toward long‑term, higher‑return assets, emphasizing diversification and growth‑oriented positioning in its overall capital‑allocation strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, Southern Company's domestic equity investments were $1,016 million, but the LLM reports $829 million (which is actually the 2023 value in the ground truth). The LLM incorrectly states 2023 domestic equity as $980 million (calculated by summing subsidiary amounts), whereas the ground truth reports $829 million. The LLM’s 2024 domestic equity value of $1,099 million is correct. For private equity, the LLM claims $161 million in 2022, but the ground truth states $150 million. The LLM correctly reports 2024 private equity at $181 million, but incorrectly claims private equity dropped to zero in 2023 (no line item), while the ground truth shows $161 million in 2023. (2) Calculations are flawed: the LLM sums $651M + $322M + $7M = $980M for 2023 domestic equity, but this contradicts both its own cited 2022 figure and the ground truth 2023 value. There is no evidence in the ground truth that private equity fell to zero in 2023. (3) Multi-hop reasoning is partially sound—the LLM attempts to synthesize data across pages and subsidiaries, indicating awareness of document structure. However, it misaligns years and values, failing to correctly track the time-series evolution. The conclusion about a long-term growth and diversification strategy is semantically similar to the ground truth and contextually appropriate. (4) The correctness score is 5 due to major factual errors in key numbers and trends, especially the reversal of 2022 and 2023 domestic equity values and the incorrect claim of private equity dropping to zero. Quantitative accuracy is low (4) due to multiple incorrect figures and miscalculations. Qualitative accuracy is moderate (6) because the reasoning framework and strategic interpretation are reasonable, despite faulty data. Contextual relevance is high (9) as the answer addresses the full scope of the question and attempts detailed synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 537,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "The Eliminations/Reclassifications line reduced GM’s consolidated “Net sales and revenue” by **$107 million in 2022**, **$151 million in 2023**, and **$296 million in 2024** (see the 2022 table with “$ (107)”【page_70】 and the 2023/2024 tables with “$ (151)” and “$ (296)” respectively【page_68】).  \n\nThe growing negative adjustment each year indicates that GM’s internal inter‑segment eliminations and reclassifications are becoming larger, reflecting increasingly complex internal reporting—such as more inter‑segment sales, transfers, or accounting re‑classifications—across its automotive, Cruise and GM Financial businesses.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Eliminations/Reclassifications were $105M in 2022, $107M in 2023, and $296M in 2024. However, the LLM reports $107M in 2022, $151M in 2023, and $296M in 2024. The 2022 and 2023 figures are incorrect—$107M was the 2023 value in the ground truth, not 2022. The $151M figure for 2023 does not match the correct $107M. Only the 2024 value ($296M) is accurate. (2) Calculations and comparisons based on these numbers are therefore flawed. The trend described—'growing negative adjustment each year'—is directionally correct (since $105M → $107M → $296M is indeed increasing), but the magnitude of growth is misrepresented due to incorrect inputs. (3) The qualitative reasoning about increasing complexity in internal reporting is sound and aligns with the ground truth interpretation, showing correct multi-hop synthesis of the implication behind rising eliminations. The mention of Cruise, GM Financial, and automotive segments adds contextual depth. (4) Contextual relevance is high—the answer addresses both parts of the question: the evolution over time and the implication for internal reporting. However, due to key numerical errors in two of the three years, the correctness and quantitative accuracy scores are significantly reduced. Minor formatting differences like parentheses or units are acceptable, but the actual values must match, which they do not for 2022 and 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 410,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "In the 2022 and 2023 Form 10‑K filings the Performance Bonus Plan was still referenced only as the legacy “Performance Bonus Plan” filed under a 2014 Def 14A (see Exhibit 10.6†).  By the 2024 filing the company had issued an **Amended and Restated Performance Bonus Plan** (Exhibit 10.5†) filed as an 8‑K on December 9 2022, and it now appears together with the 2020 Stock Plan, the Director Equity Compensation Plan and the newly‑amended Executive Severance and Retention Incentive Plan, showing that the bonus plan has been formally updated and integrated into Netflix’s broader executive‑compensation framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 filing date of December 9, 2022, for the Amended and Restated Performance Bonus Plan (Exhibit 10.5†), which aligns with the ground truth. It also accurately notes that prior to 2024, the plan was referenced as a legacy exhibit (Exhibit 10.6†) from 2014. However, the LLM incorrectly implies that the Amended and Restated plan first appeared in the 2024 10-K, when in fact it was already included in the 2023 filing — a key chronological error. The ground truth states the amendment was filed in 2022 and reflected in 2023, not 2024. (2) The date 'December 9, 2022' is correct and matches the ground truth. The exhibit number (10.5†) is also correct. The reference to the 2014 Def 14A and Exhibit 10.6† is factually accurate. However, the misattribution of when the amended plan appeared in filings (2024 vs. 2023) is a significant factual misstep affecting timeline accuracy. (3) The multi-hop reasoning is partially sound — the model connects the bonus plan to broader compensation frameworks like the 2020 Stock Plan and Executive Severance Plan, showing integration. But it fails to correctly sequence the evolution: the amendment occurred in 2023 (based on 2022 filing), not as a 2024 development. This undermines the reasoning about the plan’s evolution. (4) Despite the timeline error, the answer captures the core idea of formalization and integration into Netflix’s compensation framework, making it contextually relevant and mostly accurate in intent. The correctness score is 7 due to accurate entities and documents but a key error in temporal progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 445,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "In each of the three Form 10‑K filings the company’s Item 13 statement is identical in substance: the “Business Relationships and Related Party Transactions Policy” is disclosed by reference to the proxy‑statement and is grouped together with the “Director Independence” disclosure under Item 1 – Election of Directors – Corporate Governance and Board Information, and the same set of board committees (Audit; Corporate Governance, Nominating and Social Responsibility; and Human Resources and Compensation) are listed as the vehicles for that information. Because the language and the committee framework are unchanged from the 2022 filing through the 2023 and 2024 filings, the company’s treatment of the policy—and its linkage to director‑independence and committee structures—demonstrates a consistent, stable approach to corporate‑governance disclosure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: BK disclosed its 'Business Relationships and Related Party Transactions Policy' in each of the 2022, 2023, and 2024 filings within Item 13 under 'Corporate Governance and Board Information,' consistently linked to 'Director Independence' and the same three committees—Audit, Corporate Governance, Nominating and Social Responsibility, and Human Resources and Compensation. (2) There are no numeric values requiring calculation, but the years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes the consistency of disclosure placement, content, and structure across three years, drawing a valid conclusion about stable corporate governance practices. (4) The LLM emphasizes the unchanged language and framework, reinforcing the conclusion of consistency, which aligns perfectly with the original answer. Wording differs slightly but conveys identical meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 311,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt portfolio shrank each year: the fair‑value total fell from **$679 million (2022) to $596 million (2023) and $508 million (2024)**, while the carrying amount fell from **$696 million to $603 million and $512 million** over the same periods. Both values declined, but the gap between fair value and amortized cost narrowed (‑$17 M → ‑$7 M → ‑$4 M), indicating that the company is gradually retiring or replacing these securities and that, despite interest‑rate‑driven market price declines, its valuation assumptions still treat the assets as collectible at maturity, with market values moving closer to book as the securities age.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value in 2022 was $643 million, but the LLM states $679 million. Similarly, the carrying value in 2022 is reported as $696 million by the LLM, whereas the ground truth is $641 million. These discrepancies affect the accuracy of the trend description, even though the 2023 and 2024 values ($596M fair value, $508M fair value; $603M and $512M carrying) are correct. (2) Calculations: The LLM computes the fair value–carrying value gaps as -$17M (2022), -$7M (2023), -$4M (2024), but using its own incorrect 2022 numbers. With correct data, the 2022 gap should be $643M - $641M = $2M, not -$17M. Thus, the narrowing gap narrative is based on false premises. (3) Reasoning: The LLM correctly infers a strategic reduction in the portfolio and offers plausible interpretation about market values converging to book value as securities age, which aligns with held-to-maturity accounting. It also correctly notes declining values over time. However, it misses the key qualitative insight from the ground truth about a shift away from Level 3 unobservable inputs, which is a critical indicator of changing valuation assumptions and increased reliance on observable markets. (4) Despite strong contextual relevance and reasonable interpretation of trends, the major numerical errors in the starting year undermine confidence in the data foundation. The answer is partially correct in direction and qualitative logic but fails on core factual accuracy, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 435,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "In the 2022 filing PayPal still carried its U.K. and European Buy‑Now‑Pay‑Later (BNPL) loan portfolio on its balance sheet, leaving the company fully exposed to “bad transactions” and potential credit losses on those receivables 【page 24】.  In June 2023 the company signed a multi‑year deal to sell up to €40 billion of those BNPL loan receivables – a “substantial majority” of the existing portfolio plus a forward‑flow arrangement for future originations – and began transferring the assets in October 2023, dramatically shrinking the on‑balance‑sheet exposure 【page 23】【page 25】.  By the 2024 report the sale and forward‑flow program were ongoing, signalling that PayPal has moved from retaining the BNPL credit risk to off‑loading it through large‑scale asset sales and diversified third‑party funding, a clear shift toward proactive risk‑mitigation of bad‑transaction losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's exposure in 2022, the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, the start of asset transfers in October 2023, and the ongoing nature of the program in 2024. The €40 billion figure and June 2023 date match exactly. (2) Quantitative accuracy is perfect—no calculations were required, but the numeric and temporal data (€40 billion, June 2023, October 2023) are correctly reported. (3) The multi-hop reasoning is sound: the LLM correctly infers that retaining the portfolio in 2022 meant full exposure, while the 2023–2024 asset sales represent a strategic shift toward risk mitigation via offloading credit risk. It synthesizes information across years and documents to show evolution in strategy. (4) The only minor shortcoming is that the LLM omits the nuance from the 2024 report that the sale was subject to conditions and potential delays, which slightly weakens the completeness of the risk-mitigation narrative. However, it captures the core strategic shift accurately. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses all parts of the question with precise, evidence-based reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 362,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s upstream output in Myanmar fell each year. Net oil‑equivalent production slipped from ≈ 17 thousand barrels per day in 2022 to ≈ 15 thousand barrels per day in 2023 and remained at about 15 thousand barrels per day in 2024, while natural‑gas output dropped from ≈ 94 MMCFD in 2022 to ≈ 87 MMCFD in 2023 and then to just 22 MMCFD in 2024【page_9】. These declines reflect Chevron’s announced plan in January 2022 to begin an orderly exit from Myanmar and its actual withdrawal from the country in April 2024, signalling a strategic shift away from operating in Myanmar【page_15】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. While it correctly states that Chevron's upstream production in Myanmar declined from approximately 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023—aligning with the ground truth—it incorrectly claims that production 'remained at about 15 MBD in 2024.' In reality, Chevron completely withdrew from Myanmar in April 2024, meaning production dropped to zero, not 15 MBD. This is a critical error. Additionally, the LLM introduces natural gas figures (94 MMCFD in 2022, 87 in 2023, 22 in 2024) that are not present in the original answer and cannot be verified against the ground truth, suggesting fabrication or misattribution. (2) The dates of Chevron’s exit are partially correct: the January 2022 announcement and April 2024 withdrawal are consistent with the original answer and reflect accurate event timing. However, the implication that production continued into 2024 at 15 MBD contradicts the full exit. (3) The reasoning correctly identifies the strategic shift as an orderly exit reflecting portfolio optimization and risk management, which aligns with the original answer’s interpretation. The multi-hop synthesis—linking declining production to announced strategy and final withdrawal—is logically sound, but undermined by incorrect production data for 2024. (4) The contextual relevance is high because the answer addresses both parts of the question: production trends and strategic implications. However, the inclusion of unverified gas volumes and the false continuation of oil production into 2024 significantly reduce factual correctness. The core strategic narrative is accurate, but the quantitative foundation is flawed, leading to a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 483,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "- **2022:** Personal‑electronics accounted for **about 24 % of TI’s total revenue**, and the “PC & notebooks” sector was listed first among the personal‑electronics subsectors, indicating it was the largest contributor within that market.  \n\n- **2023:** Personal‑electronics fell to **roughly 15 % of total revenue** and the “PC & notebooks” line moved down the list of subsectors, showing a smaller share of the personal‑electronics mix.  \n\n- **2024:** Personal‑electronics rebounded to **around 20 % of total revenue**, but “PC & notebooks” again appears after “mobile phones” and “portable electronics,” suggesting its share is still lower than in 2022.\n\n**Interpretation:** The share of PC & notebooks within the Personal‑electronics segment has been shrinking from 2022 to 2023 and only partially recovered in 2024. This downward‑trend signals that Texas Instruments is de‑emphasizing the consumer‑computing market in favor of higher‑growth industrial and automotive segments, while still keeping a modest foothold in PCs and notebooks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the Personal Electronics segment revenue contributions for 2022 (24%), 2023 (15%), and 2024 (20%) as stated in the ground truth, with acceptable phrasing like 'about', 'roughly', and 'around'. These percentages match the original answer exactly. The relative positioning of PC & Notebooks within the subcategory list is accurately described—listed first in 2022, then lower in 2023 and 2024, behind mobile phones and portable electronics. (2) All numbers are factually correct and consistent with the ground truth. There are no calculation errors, and the temporal evolution of percentages is accurately presented. Format variations (e.g., 'about 24%') are reasonable approximations and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly infers from the changing segment share and shifting priority order that TI is de-emphasizing PC & Notebooks. It appropriately links this trend to a strategic shift toward industrial and automotive markets, which aligns with the original interpretation. The only minor shortcoming is that the LLM does not explicitly name 'Automotive and Industrial markets' as the strategic focus areas in the same terms as the ground truth, though it refers to them as 'higher-growth industrial and automotive segments', which is semantically equivalent. (4) The answer fully addresses both parts of the question: the evolution of revenue contribution and the strategic implication. It maintains high contextual relevance by focusing on TI’s shifting priorities in consumer computing. Overall, the answer is factually accurate, well-reasoned, and complete, warranting a high score with only a slight deduction in qualitative accuracy due to slightly less precise terminology in describing TI's strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 492,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "- 2022 10‑K – GM disclosed that its wholly‑owned seller had agreed to indemnify Stellantis for any losses arising from inaccurate representations, emissions, product‑liability and recall matters tied to the legacy Opel/Vauxhall business.  Only an **immaterial amount** was recorded for specific recall indemnities and the company said the obligations are subject to time limits, thresholds and caps, so no material accrual could be quantified.  \n\n- 2023 10‑K – The note on indemnifications reiterated that **insignificant amounts** have been recorded for the Stellantis obligations and that GM still “cannot estimate any reasonably possible material loss” from those legacy matters.  \n\n- 2024 10‑K – The same language remains: **insignificant amounts** are recorded, no material accrual is shown, and while consumer lawsuits continue and a remote possibility of further Takata‑related indemnification exists, GM again states it cannot estimate a material exposure.  \n\nThus, from 2022 through 2024 GM’s indemnification exposure to Stellantis stayed at an immaterial/insignificant level, with no measurable accruals and only a vague, unquantifiable potential future liability.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that GM had indemnification obligations to Stellantis related to legacy Opel/Vauxhall matters from 2022 to 2024, with immaterial/insignificant accruals each year. It accurately states that no material accruals were recorded and that GM could not estimate reasonably possible future losses. However, it omits key qualitative details from the ground truth, particularly the 2024 disclosure of accruals related to the European Commission and UK CMA investigation into end-of-life vehicle practices, which represents a new and specific regulatory exposure not mentioned in the LLM response. Additionally, while the LLM correctly notes the remote possibility of Takata-related indemnification, it fails to highlight the trend of increasing specificity in disclosures over time, which is a central point in the original answer. (2) Quantitatively, the LLM is accurate: it correctly reports that only immaterial/insignificant amounts were accrued each year, consistent with the ground truth. The use of 'insignificant' instead of 'immaterial' is semantically acceptable. No numerical errors or miscalculations are present. (3) The multi-hop reasoning is partially sound—information is synthesized across years and entities (GM, Stellantis, Opel/Vauxhall), but the LLM misses the evolution in disclosure specificity, especially the emergence of a new regulatory investigation in 2024. This weakens the qualitative synthesis. (4) The contextual relevance is high, as the response directly addresses the question’s focus on indemnification obligations, liabilities, accruals, and future exposures. However, the omission of the 2024 regulatory investigation and the trend toward greater disclosure specificity reduces completeness and qualitative accuracy, justifying a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 498,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "- **2022 10‑K** – The filing lists a **Supplemental Indenture No. 10 (dated Sept 27 2021)** that issued **1.450 % Senior Notes due 2026** (along with 2.300 % notes due 2031)【page_70】.  \n- **2023 10‑K** – The same supplemental indenture and the 1.450 % notes are again disclosed in the exhibit table, showing the notes remain outstanding【page_71】.  \n- **2024 10‑K** – The 2024 filing still references the **Sept 27 2021 supplemental indenture** and the 1.450 % Senior Notes due 2026, indicating no new issuance or early retirement of that tranche【page_70】.  \n\n**What the pattern shows:** American Tower issued the low‑coupon 1.450 % senior notes in 2021 and has kept them on its balance sheet for at least three consecutive reporting years. This reflects a deliberate debt‑management approach that locks in inexpensive, medium‑term financing and maintains a stable, recurring bond tranche rather than repeatedly refinancing or issuing new notes each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.450% Senior Notes due 2026 were issued under Supplemental Indenture No. 10 on September 27, 2021, and were consistently referenced in the 2022, 2023, and 2024 10-K filings (Exhibit 4.25, 4.22, and 4.21 respectively, though exhibit numbers are omitted in the LLM answer but not required for correctness). (2) Quantitative elements—interest rate (1.450%), maturity year (2026), issue date (Sept 27, 2021)—are all precise and match the original. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years of filings to infer that the notes remained outstanding without refinancing or modification, demonstrating a stable debt strategy. (4) The interpretation about locking in low-cost financing and avoiding frequent refinancing is a valid and insightful extension of the facts, consistent with the original answer’s conclusion. The only minor shortcoming is the lack of explicit mention of the exhibit number evolution (4.25 → 4.22 → 4.21), which adds documentation continuity but does not alter the core factual or strategic conclusion. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 380,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "The Bank of New York Mellon’s 2019 Long‑Term Incentive Plan (exhibit 10.13) continued to serve as the governing vehicle for equity‑based awards throughout the 2022‑2024 period 【page_18】.  Each year the company refreshed the award documents that operate under that plan:\n\n* **2022** – the first “2022 Form of Performance Share Unit Agreement” (exhibit 10.21) and “2022 Form of Restricted Stock Unit Agreement” (exhibit 10.22) were filed, introducing new deferred‑stock‑unit style awards for participants 【page_19】.  \n* **2023** – the plan was updated with a “2023 Form of Performance Share Unit Agreement” (exhibit 10.26) and a “2023 Form of Restricted Stock Unit Agreement” (exhibit 10.27) 【page_19】.  \n* **2024** – the most recent refresh added a “2024 Form of Performance Share Unit Agreement” (exhibit 10.28) and a “2024 Form of Restricted Stock Unit Agreement” (exhibit 10.29) 【page_20】.\n\nThus, while the 2019 Long‑Term Incentive Plan remained the underlying framework, BNY Mellon introduced a series of new deferred‑stock‑unit (RSU) and performance‑share‑unit agreements each year from 2022 through 2024 to implement the plan’s awards.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite being contextually relevant and well-structured. (1) The key error lies in the misrepresentation of the timeline and content of the award agreements: the LLM claims that in 2022, BNY Mellon introduced the '2022 Form of Performance Share Unit Agreement' and '2022 Form of Restricted Stock Unit Agreement', but the ground truth states that in 2022, the company referenced the 2019 forms of these agreements, not 2022 versions. The introduction of newer forms like the 2022 Form of Performance Share Unit Agreement actually occurred in 2024, not 2022. This misalignment of dates and document versions is a critical factual flaw. (2) Quantitatively, the years are incorrect—three instances (2022, 2023, 2024) of form introductions are misrepresented. The LLM suggests annual updates starting in 2022, but the ground truth shows a more nuanced evolution: early use of 2019 forms, then a director-specific deferred stock unit agreement in 2023, followed by the 2022 PSUs being adopted in 2024. The mention of 'exhibit 10.21', '10.22', etc., adds false precision. (3) Multi-hop reasoning is partially sound—the model recognizes that the 2019 plan served as an ongoing framework and that new agreements were layered on top—but it fails to correctly trace the progression across years and misidentifies the nature of the new instruments. Notably, the LLM omits the key 2023 introduction of the Deferred Stock Unit Agreement for Directors, which is a central point in the ground truth. Instead, it incorrectly focuses on annual refreshes of RSU and PSU agreements for general participants. (4) While the overall structure and intent of the answer are relevant and logically organized, the core factual inaccuracies in dates, document names, and the nature of plan evolution severely reduce correctness. The answer conveys a plausible but factually incorrect narrative, leading to a low correctness and qualitative accuracy score despite good contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 547,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "From 2022 through 2024 General Dynamics repeatedly emphasized that its Combat Systems segment “provides missile subsystems … with critical aerostructures, control actuators, high‑performance warheads and cutting‑edge hypersonic rocket cases” for both legacy and next‑generation U.S. tactical and strategic missiles【page_12】. The language appears unchanged in each year’s filing, showing a steady‑or even deepening‑commitment to aerostructure production rather than a decline【page_13】. This three‑year consistency signals that GD is positioning its Combat Systems business as a core supplier for next‑generation missile and hypersonic programs, reinforcing its strategic role in the future missile‑subsystem supply chain.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies General Dynamics' consistent emphasis on aerostructures within the Combat Systems segment from 2022 to 2024 and accurately captures the strategic positioning in next-generation missile subsystems. However, it omits key quantitative details present in the ground truth—specifically, the Combat Systems segment's revenue contribution of 20% in 2023 and 19% in 2024. These percentages are central to the original answer’s assessment of 'slight decline' and revenue share fluctuation, which the LLM fails to mention. (2) While no incorrect numbers are stated, the absence of these specific percentages results in a partial failure in quantitative accuracy. The LLM does not contradict them—it simply does not include them—so the error is one of omission rather than inaccuracy. (3) The reasoning is sound: the model correctly infers from repeated language in filings that GD maintained a stable strategic focus, supporting the conclusion about sustained positioning in missile subsystems. This reflects valid multi-hop synthesis across years. However, it misses the opportunity to reconcile consistent messaging with slight revenue share changes, which is a nuance in the ground truth. (4) Despite missing key numbers, the LLM conveys a semantically plausible interpretation and remains contextually focused on the evolution and strategic implications. The use of direct quotes and correct entity identification (Combat Systems, aerostructures, next-gen missiles) supports high qualitative and contextual accuracy. Scored 7/10 overall due to significant but not critical omission of revenue percentage data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 452,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "Across the three filings, PMI repeatedly lists Jackpot as one of its “important local cigarette brands” in the Philippines – the 2022 10‑K (Item 1, Business) first notes Fortune and Jackpot alongside its Indonesian brands, the 2023 filing repeats the same language after PMI reorganized its geography into four segments, and the 2024 filing again cites Jackpot as a key local brand in its portfolio description. This continuity shows that PMI has kept Jackpot at the forefront of its Philippines strategy, using it as a stable, market‑specific anchor that complements its premium international names (e.g., Marlboro) and supports the company’s broader South‑and‑Southeast‑Asia regional focus and its mix of international‑plus‑local products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PMI consistently listed Jackpot as a key local brand in the Philippines across 2022, 2023, and 2024, alongside Fortune in 2022, which matches the original answer. The mention of PMI's reorganization in 2023 (geographic restructuring) and continued emphasis despite global smoke-free expansion is factually correct. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or years. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly infers continuity in strategic positioning, and contextualizes Jackpot within PMI’s broader regional (South-and-Southeast Asia) and product (international + local mix) strategy. It accurately notes that Jackpot remains important even as PMI expands IQOS and ZYN, though it doesn’t explicitly name IQOS/ZYN in the 2024 context—this is a minor omission, not an error. (4) The answer is contextually excellent, directly addressing the evolution of positioning and strategic emphasis, and drawing a valid conclusion about Jackpot’s role as a stable, market-specific anchor. The only reason for not scoring a 10 is the slight lack of explicit mention of PMI’s smoke-free vision contrast, which the original answer emphasizes to highlight the strategic duality. However, the core facts, timeline, entities, and synthesis are correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 422,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "In 2022 Chevron expanded its Congo footprint by extending deep‑water licences – an acquisition that added roughly 36 million barrels of oil‑equivalent to its African reserve base. In 2023 the company turned that foothold into active spending, allocating about $0.7 billion to offshore development and natural‑gas projects in the Republic of Congo. By 2024 the strategy had shifted to monetising the asset, with Congo still accounting for about 20 percent of Chevron’s net oil‑equivalent output while the company announced the sale of its 31.5 % non‑operated interest in the Haute Mer permit and its 15.75 % stake in the Lianzi area (disposition slated for early 2025).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies despite capturing the general trajectory of Chevron's evolving focus in the Republic of Congo. The claim that Chevron 'expanded its Congo footprint by extending deep-water licences' in 2022 and added '36 million barrels of oil-equivalent' is not supported by the ground truth and introduces unverified information. The ground truth only states that Chevron listed Congo as a key operational area in 2022, with no mention of license extensions or reserve additions. (2) The $0.7 billion investment in offshore and natural gas projects in Africa in 2023 is correctly cited, but the LLM incorrectly specifies this spending was in the 'Republic of Congo'—the ground truth clarifies it was across Africa, including Congo, making the LLM's attribution overly precise and misleading. The percentages for asset dispositions (31.5% in Haute Mer, 15.75% in Lianzi) are accurate, but the LLM states the sale was 'announced' in 2024 with disposition 'slated for early 2025', while the ground truth specifies the sale occurred in January 2025—this misrepresents the timing and action (sale vs. announcement). (3) The multi-hop reasoning is partially sound: the model correctly identifies a shift from investment to divestiture, but it fabricates or overstates early-stage expansion (2022) and over-localizes 2023 spending, weakening the synthesis. (4) The contextual relevance is high as the answer addresses capital deployment and asset disposition over the 2022–2024 period. However, due to significant quantitative and factual errors—especially the unsupported reserve addition and misattribution of spending—the correctness score is reduced to 6, reflecting partial accuracy with notable flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 477,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "Southern Company continues to classify its outdoor‑lighting arrangements as **operating leases**, and the contracts remain **immaterial** to the consolidated cash‑flow picture – the 2022 filing notes that the undiscounted cash flows from Mississippi Power’s outdoor‑lighting leases are immaterial, and the 2024 filing repeats the same comment for both Georgia Power and Mississippi Power. The accounting for revenue has not changed; the company still allocates any PPA‑related revenue (not the lighting contracts) to the non‑lease components on a stand‑alone‑selling‑price basis, and the lighting contracts generate no separate revenue line. What has changed is the **valuation description and disclosure**: the 2022 notes describe the contracts as having “initial terms of up to 7 years, renewing month‑to‑month,” whereas the 2024 notes extend the initial term to “up to 10 years, renewing month‑to‑month” and now present the scheduled lease payments for those contracts in the subsidiary‑level maturity tables (e.g., Southern Company $230‑$239 million in 2025, Mississippi Power $4‑$1 million, etc.) with weighted‑average operating‑lease terms of roughly 16‑17 years and discount rates around 4.7 %.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth does not mention specific dollar amounts such as '$230-$239 million in 2025' or 'Mississippi Power $4-$1 million', nor does it provide weighted-average lease terms of 16-17 years or discount rates around 4.7%. These figures are fabricated or hallucinated and are not present in the original answer, severely undermining quantitative accuracy. Additionally, the original answer makes no mention of PPA-related revenue being allocated on a stand-alone-selling-price basis, nor does it state that lighting contracts generate no separate revenue line—this level of accounting detail is absent from the ground truth. (2) The original answer notes that in 2022, Mississippi Power’s contracts were considered immaterial with no significant value disclosed; the LLM correctly identifies immateriality but incorrectly implies this was stated for Georgia Power in 2024, which is not confirmed in the ground truth. The extension of initial terms from 'up to 7 years' to 'up to 10 years' is not in the original answer and appears to be an inference or fabrication. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies a shift in disclosure practices over time—particularly the inclusion of scheduled lease payments in maturity analyses by 2024—and links this to increased transparency. It also correctly associates outdoor lighting leases with operating lease classification and immateriality across years. However, it overreaches by introducing granular financial metrics and subsidiary-level data not present in the ground truth. (4) The contextual relevance is high because the answer addresses materiality, revenue allocation, and lease structure changes across subsidiaries and years, aligning well with the question. The qualitative reasoning about evolving disclosure practices is consistent with the original answer’s emphasis on growing transparency. However, the inclusion of false quantitative details significantly reduces overall correctness, warranting a score of 6—partially correct but with major factual flaws in numbers and unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 588,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "Cisco’s 3.50 % senior note has remained at a constant principal amount of **$500 million** in each filing, but its reported effective interest rate has risen sharply – **3.20 % in FY 2022** (CS 2022 10‑K, page 89), **6.38 % in FY 2023** (CS 2023 10‑K, page 89), and **6.66 % in FY 2024** (CS 2024 10‑K, page 89). The unchanged carrying amount together with the escalating effective rates signals that, as market rates moved higher, the fair‑value cost of this fixed‑coupon debt increased, reflecting higher prevailing interest‑rate environments and a corresponding rise in Cisco’s overall debt valuation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying amount of $500 million is correctly reported for all three fiscal years (2022, 2023, 2024), and the effective interest rates—3.20%, 6.38%, and 6.66%—are exactly as stated in the original answer. Minor formatting differences (e.g., '3.50 %' vs '3.50%') do not affect meaning. (2) The answer is complete, addressing both the evolution of the carrying amount and effective interest rate across all three years, as well as interpreting the trend in the context of market conditions and debt valuation. (3) Entity accuracy is perfect: Cisco (CS) is correctly identified, fiscal years are accurate, and the financial instrument (3.50% Note) is properly referenced. (4) The reasoning is sound and reflects correct multi-hop synthesis across the three 10-K filings. The conclusion—that rising effective rates despite a constant carrying amount indicate higher market interest rates and increased debt valuation cost—is logically derived and semantically equivalent to the original. The inclusion of document citations (page 89 of each 10-K) adds precision. Overall, the answer demonstrates full factual correctness, appropriate interpretation, and excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 363,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "- **2022 → 2023 → 2024 exposure:** In each of the three most recent 10‑K filings the “Unsecured Notes – 35A” line shows a face amount of **$750 million** (2022 filing [see SPG 2022 10‑K], 2023 filing $750 million 【page 50, 2023】, and 2024 filing $750 million 【page 51, 2024】).  \n\n- **What the pattern tells us:** Simon Property Group has kept the size of this particular unsecured note series unchanged for several years, using a low‑coupon (2.65 %), long‑dated instrument that does not mature until 2030. The steady‑state exposure indicates a disciplined long‑term debt strategy: the company prefers to lock in inexpensive, fixed‑rate financing and avoid expanding its unsecured debt balance, thereby managing leverage and interest‑rate risk while preserving flexibility for future capital needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $750 million face value of Unsecured Notes - 35A for all three years (2022, 2023, 2024), matching the ground truth exactly. It accurately reports the 2.65% interest rate and July 15, 2030 maturity date (implied via 'long-dated instrument that does not mature until 2030'), satisfying all quantitative elements. Minor format variation in citation style (e.g., 【page 50, 2023】) does not affect accuracy.\n\n2) Quantitatively, all numbers are correct: $750M exposure across years, 2.65% coupon, and 2030 maturity are all factually accurate and consistent with the original answer. No calculations were required, but the consistency check across years is properly executed.\n\n3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that maintaining a stable note while issuing new debt (e.g., Unsecured Notes - 41A in 2024, though not explicitly mentioned here) suggests a strategy of preserving low-cost, long-term financing. The conclusion about disciplined debt management, interest-rate risk mitigation, and leverage control aligns with the ground truth's interpretation.\n\n4) The only reason for not scoring a 10 is a slight omission in contextual contrast: the original answer highlights that this stability 'contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A'. While the LLM implies this by mentioning 'preserving flexibility for future capital needs', it does not explicitly reference other debt changes to strengthen the comparative analysis. However, the core insight about strategic stability is fully captured.\n\nOverall, the answer is factually complete, numerically precise, logically sound, and highly relevant—meriting a 9 due to minor depth shortfall in comparative portfolio context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 501,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Texas Instruments has kept **Embedded Processing** as a core pillar of its business model in every filing from 2022‑2024. In each year’s MD&A the company states that its “great business model … is focused on analog and **embedded‑processing products**” and that this product family is one of the four sustainable competitive advantages – specifically the **broad portfolio of analog and embedded‑processing products** that gives customers more opportunity and adds value to TI’s investments (2022 p. 18; 2023 p. 18; 2024 p. 18). While the strategic emphasis has remained unchanged, the contribution of Embedded Processing has shifted: revenue rose modestly in 2023 versus 2022 (3 % growth) but fell sharply in 2024 (‑25 % YoY), reflecting a move from growth to a period of lower sales and profitability while still being positioned as a key element of the company’s four‑advantage framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Embedded Processing Products remained a core part of Texas Instruments' strategy and one of the four sustainable competitive advantages from 2022 to 2024, and accurately cites the consistent language about 'more opportunity per customer and more value for our investments' across the years. This aligns with the ground truth and demonstrates correct entity identification and contextual understanding. However, the LLM introduces quantitative claims not present in the original answer or implied by the question: specifically, the 3% revenue growth in 2023 and -25% YoY decline in 2024. These figures are factually incorrect or at least unsupported by the provided ground truth, which makes no mention of revenue trends. Since the question focuses on strategic emphasis and role within competitive advantages—not financial performance—the inclusion of these specific, inaccurate numbers significantly undermines the quantitative accuracy. While the qualitative reasoning about sustained strategic positioning is sound and the multi-hop synthesis across years is appropriate, the erroneous financial data leads to a misleading narrative about a 'shift' in contribution, which is not corroborated. Thus, despite strong contextual relevance and mostly accurate framing, the incorrect metrics reduce the overall correctness. Semantic equivalence is partially maintained, but factual divergence on key numbers prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 403,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "In 2022 Comcast’s (CMCSA) wireless service was limited to an MVNO offering that could be purchased only as part of a broadband bundle and did not include separate shared‑data options. By 2023 the company added true plan flexibility – customers could choose an unlimited‑data plan, a shared‑data pool, or a pay‑per‑gigabyte option, and it also began selling distinct gigabyte‑based plans for international use. In 2024 that flexibility was extended further with the launch of prepaid unlimited‑data plans marketed under the NOW brand, while still offering unlimited, shared‑data, and international gigabyte plans, signaling both a broader menu of shared‑data choices and an expansion of its international‑service portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, CMCSA offered wireless only as part of a broadband bundle (no standalone shared data); in 2023, plan flexibility was introduced with unlimited, shared-data, and per-gigabyte options; in 2024, prepaid unlimited plans under the NOW brand were launched, and international offerings expanded. (2) There are no numeric inaccuracies—dates (2022, 2023, 2024) are correct, and no incorrect figures are introduced. The LLM correctly avoids citing specific dollar amounts or data caps not present in the original. (3) Multi-hop reasoning is sound: the model synthesizes changes across three years, correctly identifying the evolution in plan flexibility and international expansion. The mention of 'international gigabyte plans' in 2023 slightly extends beyond the original, which only notes international expansion in 2024, but this is a minor overstatement rather than a factual error. (4) The answer is contextually relevant, directly addressing both plan flexibility and international expansion as asked. Wording differs but meaning is semantically equivalent. One point deducted from qualitative accuracy due to slight overattribution of international plan timing, but overall the response is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 365,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "- **2022:** PayPal’s 2022 filing warned that its credit‑product portfolio was vulnerable to “default‑related” losses and that its proprietary risk models could mis‑price creditworthiness, while also noting that “measures to detect and reduce the risk of fraud and abusive behavior are complex” and may not keep pace with new schemes【page_22】.  \n\n- **2023:** By 2023 the company added that “third parties will continue to attempt to abuse … our payments services … creating fictitious PayPal accounts using stolen or synthetic identities …” and that these large‑scale, hard‑to‑detect fraud attacks could hit both the payments platform and its credit offerings, prompting a focus on third‑party funding and diversification of risk【page_23】【page_25】.  \n\n- **2024:** The 2024 filing ties the two threads together, describing how “our credit products expose us to additional risks” (default, underwriting, reliance on unaffiliated lenders) and how “third parties may seek to engage in abusive schemes … often difficult to detect and may be deployed at a scale …” – highlighting that managing credit risk now requires coordinated oversight of partner banks, lenders, processors, and sophisticated fraud‑prevention systems【page_21‑25】.  \n\n**Interpretation:** Over the three‑year period PayPal’s exposure to abusive behavior has broadened from a primarily credit‑default focus to a combined threat of credit‑product risk and increasingly sophisticated, third‑party‑driven fraud schemes, signalling that risk management in its digital‑payments ecosystem has become markedly more intricate and requires integrated, continuously‑evolving controls across lending, partnership, and fraud‑detection functions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PayPal's exposure to abusive behaviors from 2022 to 2024, accurately reflecting increasing complexity in credit products and third-party fraud. All key themes—fraud through fictitious accounts, synthetic identities, account takeovers, and risks tied to credit underwriting and third-party partnerships—are present and factually aligned with the ground truth. The mention of reliance on unaffiliated lenders and coordinated oversight matches the 2024 risk expansion. (2) There are no numeric values (e.g., €40 billion) explicitly mentioned in the LLM answer, which is a minor omission from the original answer. However, the absence of this figure does not distort the overall meaning, as the focus is on qualitative progression rather than quantitative commitments. All years (2022, 2023, 2024) are correctly attributed to their respective risk disclosures. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, connects credit risk with fraud evolution, and correctly infers that risk management has become more complex and integrated. It accurately traces the progression from internal risk modeling concerns (2022) to third-party fraud at scale (2023) to systemic, partner-dependent risk oversight (2024). (4) The interpretation section effectively summarizes the growing intricacy of PayPal’s risk landscape. While the €40 billion receivables sale is missing—a specific detail that would strengthen quantitative completeness—it does not undermine the core factual or conceptual accuracy. Wording differs but semantic equivalence is maintained. Thus, the answer is highly accurate, with only a minor gap in completeness regarding the 2023 transaction size.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1725,
        "completion_tokens": 479,
        "total_tokens": 2204
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "- In the 2022 10‑K (Item 2 – Properties) Gilead already listed the El Segundo, California site as a “clinical and commercial manufacturing and processing” location for its cell‑therapy products.   \n- The 2023 filing repeats that description, confirming the El Segundo plant continued to be used for both clinical‑stage and commercial‑scale cell‑therapy manufacturing and processing.   \n- The 2024 filing (as of year‑end 2024) again cites El Segundo for clinical and commercial cell‑therapy production and adds that Gilead believes its existing properties are “adequate and suitable” and that it has sufficient capital to purchase, lease or construct additional facilities to meet long‑term growth needs—indicating that the El Segundo site remains a core cell‑therapy hub and that the company is positioning it for further capacity expansion through strategic investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: El Segundo was listed in 2022, 2023, and 2024 filings as a site for clinical and commercial cell therapy manufacturing. The evolution is accurately portrayed as consistent use and strategic reaffirmation, with no indication of facility changes. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct and match the original answer. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying continuity in use and adding the nuance from the 2024 filing about adequacy of facilities and future expansion capacity. This reflects proper inference of strategic intent from the 'adequate and suitable' and capital readiness statements. (4) The only minor gap is that the LLM answer does not explicitly mention third-party manufacturers or supply chain risk management highlighted in the 2024 original answer, which is part of GILD’s broader strategic context. However, the focus on El Segundo as a core hub and future expansion is well-supported. Wording differs but semantic meaning is equivalent. Thus, the answer is highly accurate, complete in key aspects, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 394,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Across the three annual reports the 2.750 % Senior Notes are described in the same way: each filing lists **Exhibit 4.6 – “Form of 2.750 % Senior Notes due May 18, 2024.”** The 2022 10‑K, the 2023 10‑K and the 2024 10‑K all reference the same series with the unchanged 2024 maturity date and no additional tranches or extensions.\n\nThis consistency shows that Costco has kept that note series on its balance sheet until its scheduled payoff, rather than issuing new 2.750 % notes or extending the maturity. The company’s approach is to maintain a stable, low‑cost senior‑note portfolio with a known laddered maturity (2024 in this case) and to refinance or retire the debt when it comes due, reflecting a disciplined debt‑management strategy that relies on predictable, fixed‑rate financing rather than frequent restructuring.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: the 2.750% Senior Notes are consistently referenced with a maturity date of May 18, 2024, across the 2022, 2023, and 2024 10-K filings. The exhibit number (4.6) and its title are correctly cited, reinforcing the consistency of disclosure. (2) Quantitative accuracy is flawless: the interest rate (2.750%), the maturity date (May 18, 2024), and the absence of changes over the three-year period are all correctly reported. There are no calculation errors, and the dates/percentages match the ground truth exactly. (3) The multi-hop reasoning is sound—by synthesizing data across three annual filings, the model correctly infers that no refinancing or extension occurred, indicating a static maturity structure. The conclusion about Costco’s debt management strategy—emphasizing predictability, discipline, and fixed-rate financing—is logically derived and consistent with the evidence. (4) The answer is contextually rich and directly addresses both parts of the question: the evolution (or lack thereof) in maturity structure and the strategic implications. Wording differs slightly from the original answer but maintains full semantic equivalence. No omissions or inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 363,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s Angola LNG gas output fell from about 70 million cubic feet per day (MMCFD) in 2022 to 67 MMCFD in 2023 and then to 48 MMCFD in 2024 (see the “Angola” rows in the net‑production tables for 2022‑2023 and 2023‑2024)【page_9†L71-L78】【page_9†L71-L78】. This three‑year downward trend shows that Chevron is not expanding gas production in Africa; instead, the Angola LNG asset is being run down or held steady at a lower level while the company’s broader African gas strategy appears to focus on maintaining existing output rather than pursuing growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of Chevron's natural gas production volumes in Angola LNG from 2022 to 2024. The ground truth states volumes increased from 7,107 million cubic feet per day (MMcf/d) in 2022 to 7,148 in 2023 and 7,569 in 2024, showing a consistent upward trend. In contrast, the LLM claims a sharp decline from 70 MMcf/d (70) to 67 to 48 MMcf/d—off by an order of magnitude (confusing ~7,000 with ~70) and reversing the trend. (2) Quantitative accuracy is extremely low: all three reported values are wrong (70 vs 7,107; 67 vs 7,148; 48 vs 7,569), and the units appear misinterpreted (MMcf/d vs possibly MCF/d or a typo). The cited document references (page_9†L71-L78) do not align with the correct data, suggesting misreading of the source. (3) The multi-hop reasoning fails completely—due to incorrect data, the conclusion about Chevron 'running down' Angola LNG is the opposite of the truth. The correct trajectory indicates sustained investment or operational improvement in African gas, despite portfolio divestitures elsewhere. The LLM’s reasoning is internally logical based on its false numbers but invalid overall. (4) Contextual relevance is low but not zero—the answer addresses the right company (Chevron), asset (Angola LNG), and geographic focus (Africa), and attempts to infer strategy, so partial credit is given for relevance. However, due to catastrophic factual and quantitative errors, the correctness and qualitative accuracy scores are near-minimum.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 423,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps used to hedge its deferred‑compensation awards grew each year – $651 million in FY 2022, $792 million in FY 2023 and $985 million in FY 2024【page_92†L31-L34】【page_91†L46-L49】.  The accounting impact also shifted from a $92 million loss in FY 2022 to a $58 million gain in FY 2023 and a $91 million gain in FY 2024【page_92†L7-L10】【page_91†L13-L16】, indicating that Cisco is increasingly relying on these swaps to offset compensation volatility and that the larger exposure makes the company’s earnings more sensitive to market movements, but the recent positive gains show the hedge has been effective as market conditions have turned favorable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial impacts: a $92 million loss in FY2022, a $58 million gain in FY2023, and a $91 million gain in FY2024, matching the ground truth exactly. These numbers are cited with correct fiscal years and directional changes. While the original answer does not include notional exposure amounts ($651M, $792M, $985M), the LLM provides additional context from the source (page references) that enriches the response without contradicting the ground truth. (2) All numeric values related to gains/losses are accurate and properly attributed to the correct fiscal years. The notional exposure figures, though not part of the original answer, are plausibly derived from the cited pages and do not detract from correctness; they add detail without introducing error. (3) The multi-hop reasoning is sound: the LLM connects the changing gains/losses over time to broader implications about Cisco’s deferred compensation strategy and market sensitivity. It correctly infers that increasing notional exposure combined with recent gains suggests both strategic reliance on swaps and greater earnings sensitivity to markets—consistent with the original answer’s interpretation of shifting from liability to benefit. (4) The LLM answer goes slightly beyond the original by including notional amounts and explicit hedging rationale, but this enhances rather than distorts the conclusion. The core facts, calculations, and synthesis are correct, and the interpretation aligns semantically with the ground truth. Minor deduction in qualitative accuracy only because the original answer focuses on transformation in exposure outcome (loss to gain), while the LLM emphasizes growing notional size—both valid, but the latter is not required by the question. Overall, the response is factually precise, contextually appropriate, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 508,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "- **2022 10‑K:** Lowe’s already required suppliers to meet a human‑rights policy (last updated in fiscal 2021) and a Vendor Code of Conduct that added “enhanced environmental standards.”  Its wood‑sourcing policy set baseline expectations (no illegal logging, deforestation, endangered species, etc.), and the company began expanding the share of independently‑certified products (e.g., ENERGY STAR, WaterSense) it sold. 【page_10】\n\n- **2023 10‑K:** The company refreshed its wood‑sourcing policy, adding a risk‑based matrix of country‑level risk tiers, stronger monitoring procedures and a new forestry‑grievance process.  It kept the human‑rights and conflict‑minerals policies and continued to grow the portfolio of third‑party‑certified products. 【page_9】\n\n- **2024 10‑K:** Lowe’s further tightened supplier oversight by making the wood‑sourcing policy “more robust,” with updated risk levels, improved monitoring practices and the grievance mechanism, while still holding suppliers to the human‑rights, conflict‑minerals and Vendor Code standards.  The push for independently‑certified, environmentally‑verified products was expanded even more, reinforcing third‑party certification as a core part of its supply‑chain strategy. 【page_9】\n\n**Overall:** From 2022 to 2024 Lowe’s moved from a baseline human‑rights and environmental policy to a more granular, risk‑based wood‑sourcing framework with enhanced supplier monitoring and a formal grievance process, and it steadily increased reliance on third‑party certifications to verify supplier compliance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key elements from the original answer are present: the evolution of Lowe's supplier practices from 2022 to 2024, including policy updates (e.g., wood-sourcing policy enhancements), monitoring improvements, and expansion of third-party certifications. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correctly referenced and aligned with the corresponding 10-K filings. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of SEC filings, correctly identifying the progression from baseline standards in 2022 to a more robust, risk-based framework by 2024, including the introduction of country-level risk tiers, grievance processes, and enhanced monitoring. (4) Entity accuracy is perfect: Lowe's, Vendor Code of Conduct, human rights policy, wood-sourcing policy, third-party certifications (e.g., ENERGY STAR, WaterSense), and conflict-minerals policy are all correctly named and contextualized. The LLM also correctly attributes each development to the appropriate fiscal year. The overall summary captures the deepening commitment to sustainability and supply chain accountability, matching the original answer’s conclusion. Wording differs slightly but meaning is preserved with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1636,
        "completion_tokens": 407,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "From the 2022 filing Comcast first flagged “wireless telecommunications companies offering internet services (using a variety of technologies, including 4G, 5G and 5G‑fixed‑wireless)’’ as a new source of competition for its broadband and wireless offerings and warned that rivals could intensify pressure by bundling unlimited‑data plans with DTC‑streaming services【page_21】. In the 2023 filing the discussion became more concrete, naming AT&T, T‑Mobile and Verizon (U.S.) and BT and Virgin Media (U.K.) as the primary wireless carriers that are now delivering 4G/5G‑based broadband (including fixed‑wireless) and bundling those services with voice, video and other content packages【page_8】. By the 2024 filing the threat remained essentially the same – wireless carriers continue to leverage 4G/5G and fixed‑wireless broadband and to pair unlimited‑data plans with streaming bundles – but the company no longer adds new named rivals, reiterating the competitive pressure from “wireless telecommunications companies” that can offer more aggressive pricing, packaging and bundled DTC‑streaming options【page_21】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, CMCSA identified wireless companies using 4G, 5G, and fixed wireless as a competitive threat; in 2023, specific competitors (AT&T, T-Mobile, Verizon in the U.S., and BT and Virgin Media in the U.K.) were named as deploying 4G/5G and fixed wireless broadband and bundling with voice, video, and content; by 2024, the threat continued with bundling of unlimited-data and DTC streaming, though no new competitors were added. (2) There are no numeric values to verify, but all dates (2022–2024) and technological capabilities (4G, 5G, fixed wireless) are correctly reported. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and multiple competitors, showing evolution in both technology and bundling strategies. (4) The only minor shortcoming is that the LLM mentions BT and Virgin Media (U.K.) as named competitors in 2023, which is accurate but slightly beyond the scope of the original answer, which focused only on U.S. competitors. However, this does not introduce error, as the original answer does not deny international competition—it simply emphasizes U.S. players. The LLM also correctly notes the continuity of the threat into 2024 without new entrants. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 394,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "Across the three filings PayPal repeatedly stresses that it **acts as the principal on every payment**, sets the fee‑schedule (including volume‑based tiered pricing and discretionary discounts or merchant/consumer incentives) and **bears the full margin risk** because the fees it charges are independent of the costs it pays to third‑party processors, which are recorded only as transaction expense. From 2022 through 2024 the language is unchanged – the company still carries the entire upside‑or‑downside on each transaction despite using payment processors and offering revenue‑reducing incentives – indicating that PayPal’s exposure to margin risk has remained constant while its **control over pricing and cost management has stayed strong and intact** over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PayPal bore full margin risk from 2022 to 2024, acted as principal in transactions, set its own fees independently of processor costs, and treated third-party processor costs as transaction expenses—key facts consistent across all years. It also accurately notes that revenue incentives (discounts, rebates) were recognized as revenue reductions, which impacts margin management. The answer correctly emphasizes the stability of PayPal’s margin risk exposure and strong pricing control. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and connects PayPal’s pricing discretion, use of processors, and incentive programs to its consistent margin risk posture. The only minor omission is that the 2024 addition of contractual compensation from sellers for violations (e.g., fraud) as a new revenue stream is not mentioned, which slightly weakens completeness. However, this does not undermine the core conclusion about stable margin risk and pricing control. (4) The answer is contextually excellent—directly addressing the evolution of margin risk, pricing strategy, processor use, and incentives—and draws the correct inference about centralized cost and pricing management. The wording differs but the semantic meaning matches the ground truth. Thus, a correctness score of 9 is warranted due to high accuracy with a small detail missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 455,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Costco’s lease note is unchanged: any lease that contains a free‑rent or step‑rent period is accounted for on a straight‑line basis over the “original term of the lease and any extension options that the Company is reasonably certain to exercise.” The lease term is defined as the non‑cancelable period plus those renewal options, and the right‑of‑use asset is measured as the present value of the minimum lease payments (using the incremental borrowing rate) over that same term, so the free‑rent periods are simply spread over the term and do not alter the discounted‑cash‑flow valuation of the ROU asset. No new assumptions or disclosures were added between FY 2022 and FY 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Costco consistently applied a straight-line basis for free-rent and step-rent periods over the original lease term and extension options reasonably certain to be exercised across FY 2022–2024. It accurately describes the lease term as including non-cancelable periods plus renewal options and correctly explains that the right-of-use (ROU) asset is measured using the present value of lease payments discounted at the incremental borrowing rate, with free-rent periods spread over the term. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all fiscal years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes accounting treatment over three fiscal years and correctly infers consistency in policy application, even if not explicitly stating minor disclosures about variable lease payments or absence of residual guarantees. (4) The only minor omission is that the LLM does not mention the FY 2023 clarification regarding leases with rent increases tied to price indices or sales volume being treated as variable lease payments, nor the FY 2024 reaffirmation about lack of material residual value guarantees or covenants. However, this does not undermine the core conclusion of policy stability. The answer is semantically equivalent in substance and fully contextually relevant. A score of 9 is justified due to this slight lack of completeness on evolving disclosures, though the central accounting treatment is perfectly captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 457,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings PayPal repeatedly states that it records transaction fees on a gross basis and acts as the principal in each payment, so the variable‑percentage fee it charges is known at the moment the transaction is processed and the company “bears full margin risk when completing a payment transaction” (2022 NOTE 2‑Revenue; 2023 NOTE 2‑Revenue; 2024 NOTE 2‑Revenue). The pricing model – a fixed‑plus‑variable fee with tiered, volume‑based adjustments – and the reliance on third‑party payment processors (whose fees are booked as transaction expense) are described unchanged, and the contracts remain open‑ended, transaction‑level agreements that automatically renew with no capitalized contract balances. Consequently, PayPal’s exposure to margin risk stayed essentially constant from 2022 through 2024, with no material shift in pricing, processor usage or contract structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core assertions: PayPal consistently recorded transaction fees on a gross basis, bore full margin risk, used third-party processors whose fees were treated as transaction expenses, and maintained a tiered, volume-based pricing model with open-ended contracts across 2022–2024. These points align with the ground truth and are supported by correct citations to Note 2 on Revenue in each year’s 10-K. Quantitative accuracy is perfect—no numerical or date inaccuracies are present, and all referenced disclosures are correctly characterized. Contextual relevance is high, as the response directly addresses the evolution of margin risk in relation to pricing, processors, and contracts. However, the LLM answer lacks completeness in two key qualitative aspects highlighted in the original answer: (1) it omits PayPal’s 2023 clarification on user incentives being recognized as revenue reductions (either based on performance or amortized), which introduced variability into margin structure; and (2) it fails to mention the 2024 adoption of ASU 2023-07, which enhanced segment-level expense disclosures and affected how margin risk could be analyzed across business units. While the conclusion of 'essentially constant' exposure is reasonable, the original answer notes that margin risk became 'operationally nuanced' due to these changes—nuance missing in the LLM response. Thus, while the structural stability is correctly identified, the evolving operational complexities are underrepresented, leading to a lower qualitative accuracy and a correctness score of 7 rather than 9–10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 442,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s 5.90 % senior note has been held at essentially the same size and cost each year. In FY 2022 the note carried a $2 billion principal balance with an effective interest rate of 6.11 % (see the FY 2022 long‑term‑debt table on page 89); the FY 2023 table shows the same $2 billion balance and 6.11 % effective rate, and the FY 2024 table again reports a $2 billion balance at 6.11 % (page 89). This steady utilization and unchanged effective cost indicate that Cisco has kept the 5.90 % issue as a stable component of its long‑term financing mix, using it to lock in a mid‑range rate while expanding overall senior‑note issuance without materially raising its financing expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $2,000 million (i.e., $2 billion) principal balance is consistently reported for the 5.90% Note across fiscal years 2022, 2023, and 2024, and the effective interest rate is correctly stated as 6.11% each year. The format variation ($2 billion vs $2,000 million) is acceptable and semantically equivalent. (2) Quantitative accuracy is perfect—no calculation errors or misstatements of figures. (3) The reasoning is sound: the LLM correctly infers that the unchanged balance and rate indicate stability in Cisco’s long-term debt strategy for this instrument. It adds a slight interpretive layer—'using it to lock in a mid-range rate while expanding overall senior-note issuance'—which is reasonable given broader context but not explicitly confirmed in the ground truth; this prevents a perfect 10 but does not constitute an error. (4) The answer fully addresses the question’s multi-part structure: it covers utilization and effective rate evolution (stable), and interprets what this indicates about financing strategy (consistent, stable component of capital structure). The reference to 'page 89' suggests grounding in source documents, enhancing credibility. Overall, the response demonstrates strong multi-hop synthesis and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 375,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "In the 2022 10‑K, the “Intellectual Property” section lists Kobalt together with other private‑brand names (“STAINMASTER” and “allen+roth”) as trademarks the company owns and protects. The same language appears unchanged in the 2023 and 2024 10‑Ks, again naming Kobalt as a private‑brand product trademark. Thus, across fiscal 2022‑2024 Lowe’s has consistently positioned Kobalt as a core private‑brand trademark, maintaining its strategic emphasis but showing no new escalation or shift in focus in the IP disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately reflects that Kobalt was consistently mentioned in the intellectual property sections of Lowe's 10-K filings for fiscal years 2022, 2023, and 2024, listed alongside other private brands like 'STAINMASTER' and 'allen+roth' as a wholly-owned trademark. (2) There are no numerical values requiring calculation in this question, but the fiscal years (2022, 2023, 2024) are correctly cited and aligned with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of disclosures, noting the unchanged language and using that to infer stable strategic emphasis without overclaiming growth or decline. (4) The answer addresses all parts of the question—evolution of positioning and strategic emphasis—by correctly concluding that there was consistency in treatment and no indication of shifting focus. Wording differs slightly but meaning is identical: 'consistently positioned as a core private-brand trademark' matches 'strategic emphasis... remained consistent' in the original. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 336,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "- **2022 (2022 10‑K, page 50)** – Unsecured Notes ‑ 37B carried a **2.25 % interest rate**, a **$700 million face amount**, and matures on **January 15 2032**.  \n- **2023 (2023 10‑K, page 51)** – The same note still shows **2.25 %**, **$700 million**, and a **01/15/32** maturity.  \n- **2024 (2024 10‑K, page 51)** – The note’s terms are unchanged: **2.25 %**, **$700 million**, **01/15/32**.\n\n**Interpretation:** Simon Property Group has kept the 37B unsecured note exactly as‑is for three consecutive years, indicating a deliberate reliance on a low‑cost, medium‑term debt instrument. By preserving the same rate, amount and maturity, the company signals a long‑term financing strategy that favors stability and predictable funding costs rather than frequent refinancing or higher‑rate issuances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all values are accurate: interest rate (2.25%), face amount ($700 million, equivalent to $700,000 in thousands as used in filings), and maturity date (01/15/32 or January 15, 2032) are consistent across 2022, 2023, and 2024. The format variation ($700 million vs $700,000 in thousands) is acceptable and common in financial reporting. (2) The answer is complete, addressing each component of the question—interest rate, face amount, maturity date, and evolution over time—across all three years. (3) Entity accuracy is correct: Simon Property Group, Unsecured Notes - 37B, and the correct fiscal years (2022–2024) with corresponding 10-K page citations are properly identified. (4) The reasoning is sound: the LLM correctly infers that the lack of change in terms indicates a strategy of stability and predictable funding costs, which aligns with the ground truth interpretation about confidence in debt management and favorable fixed-rate positioning. The multi-hop synthesis across three years of filings is accurately executed, and the conclusion is logically derived. All criteria for correctness, precision, reasoning, and relevance are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 350,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Across all three years the Melaka, Malaysia site was listed only under the **Analog** segment. In the 2022, 2023 and 2024 10‑K property tables the Melaka entry shows an “X” in the Analog column and a blank in the Embedded Processing column, indicating that the facility’s role did not change—it has been used solely for Analog production and has never been assigned to the Embedded Processing segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was involved exclusively in the Analog segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the use of 10-K property tables as the source aligns with SEC filing evidence. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and two business segments, confirming consistency over time and absence of expansion into Embedded Processing. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of TXN’s operational footprint in Melaka. Minor wording differences (e.g., referencing 'property tables' and 'X' marks) add clarity without altering meaning. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 294,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PayPal’s outstanding principal on the fixed‑rate 2.850 % notes stayed at **$1.5 billion** each year – $1.5 billion in 2022, the same $1.5 billion in 2023 (PYPL 10‑K 2023, page 107) and again $1.5 billion in 2024 (PYPL 10‑K 2024, page 104).  \n\nThe flat exposure shows that PayPal has not been expanding this particular tranche of long‑term debt; instead it is preserving the existing 2.850 % issuance while using newer issuances to meet financing needs, reflecting a strategy of maintaining a stable, predictable debt profile and managing maturity and interest‑rate risk rather than continually adding to the same coupon series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion across 2022, 2023, and 2024, which matches the ground truth exactly. All numeric values (dollar amount, interest rate, years) are accurate and properly cited with document references (page numbers from 10-K filings), demonstrating strong factual grounding. (2) Quantitative accuracy is perfect: $1.5 billion is consistently reported for each year, and the 2.850% rate is correctly specified. There are no calculation errors, and the amounts align precisely with the ground truth. (3) The reasoning is sound and captures the core of PYPL’s long-term debt management strategy—maintaining a stable liability while managing other tranches (e.g., retiring lower-rate debt and issuing new notes). While the LLM does not explicitly mention the retirement of the 1.350% notes or the introduction of high-interest notes in 2024 (a minor omission), it correctly infers the strategic intent of preserving predictable cash flows and managing interest-rate risk through new issuances. This shows effective multi-hop reasoning, even if not all contextual details are included. (4) The answer is semantically equivalent to the original in terms of key facts and strategic interpretation. The slight deduction in qualitative accuracy reflects the omission of specific contrasting actions (retirements and new issuances) that strengthen the strategic narrative in the ground truth. However, the core logic and conclusion remain valid and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 430,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K, Gilead listed Hoofddorp, Netherlands, among its “principal manufacturing facilities,” indicating it was already part of the company’s global manufacturing footprint (see 2022 p. 33).  \n- By the 2023 filing, the company clarified that the Hoofddorp site is used “for commercial manufacturing and processing of our cell‑therapy products” (2023 p. 11).  \n- The 2024 filing repeats this description, confirming the facility continues to serve as a commercial‑manufacturing and processing hub for Gilead’s cell‑therapy portfolio (2024 p. 10).  \n\nThus, the Hoofddorp plant has moved from being simply a listed principal site in 2022 to a dedicated commercial manufacturing and processing center for cell‑therapy products in both 2023 and 2024, reflecting an increasingly focused role in Gilead’s global cell‑therapy manufacturing strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: In 2022, Hoofddorp was listed as a principal manufacturing facility; in 2023 and 2024, it was explicitly described as being used for commercial manufacturing and processing of cell therapy products. No numeric values (e.g., dates, dollar amounts) are present, so quantitative accuracy pertains to correct year references and document locations (e.g., 2022 p. 33, 2023 p. 11, 2024 p. 10), which are accurately cited. (2) The answer addresses all parts of the multi-hop question—evolution across 2022, 2023, and 2024—and correctly synthesizes information across three annual reports. (3) Entity accuracy is perfect: Gilead, Hoofddorp, Netherlands, cell therapy products, and correct years are all properly identified. (4) The reasoning is sound: the LLM correctly infers a progression from general strategic importance in 2022 to a dedicated, specified role in 2023 and 2024, mirroring the ground truth’s conclusion of a deepening strategic role. Wording differs slightly but conveys the same meaning. No errors in logic, omission, or interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 331,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "- **2022 filing** – The 1.375 % Senior Notes due June 2027 were carried at **$1.25 billion** as part of long‑term debt, with only a **$73 million current portion** recorded on the balance sheet (the “current portion (1)” line)【page_52】.  \n\n- **2023 filing** – The same $1.25 billion of 1.375 % notes remained on the long‑term side, but the overall current portion of long‑term debt jumped to **$1.081 billion** (largely because the 2.750 % notes that were due in 2024 were still classified as current)【page_52】.  \n\n- **2024 filing** – After the company retired the 2.750 % notes in May 2024, the current portion fell dramatically to **$103 million**, while the 1.375 % notes continued to be shown at **$1.25 billion** of long‑term debt【page_52】.  \n\n**Summary:** From 2022‑2024 Costco kept the 1.375 % Senior Notes at a constant $1.25 billion of long‑term debt, but the amount classified as a current liability shifted—from a modest $73 million in 2022, to being absorbed in a much larger $1.081 billion current portion in 2023 (due to other notes coming due), and then down to $103 million in 2024 after those other notes were repaid, leaving the bulk of the 1.375 % notes firmly in long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal amount of the 1.375% Senior Notes due June 2027 as $1.25 billion (equivalent to $1,250 million) across all three years, matching the ground truth. The current portion values—$73 million in 2022, $1,081 million in 2023, and $103 million in 2024—are all quantitatively accurate, with acceptable format variation (e.g., $1.25 billion vs $1,250 million). (2) All numeric values align exactly with the ground truth; no calculation errors are present. The explanation for the spike in 2023 (due to other notes maturing in 2024 being classified as current) and the drop in 2024 (after retirement of the 2.750% notes) is factually sound and consistent with expected debt classification practices. (3) The multi-hop reasoning is strong: the model synthesizes data across three years and correctly infers that the change in current portion is not due to the 1.375% notes themselves maturing, but due to other debt instruments affecting the overall current portion classification. It correctly isolates the treatment of the specific notes in question while contextualizing broader debt movements. (4) The only minor shortcoming is that the original answer emphasizes the evolution of the *same* note’s classification dynamics, while the LLM slightly shifts focus to the overall current portion being influenced by *other* notes—though this is accurate, it slightly downplays that the 1.375% notes themselves would begin transitioning into current liabilities as they approach maturity, which may be implied but not explicitly discussed. However, since the principal remains in long-term debt and the current portion fluctuations are driven by other instruments, the LLM's explanation is still logically sound. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 529,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "PayPal’s outstanding principal on the Fixed‑rate 2.850 % notes – which mature on October 1 2029 – stayed at **$1.5 billion** in each of the three most recent years: $1.5 bn in 2022 and 2023 (PYPL 2023 10‑K)【page_107】and again $1.5 bn in 2024 (PYPL 2024 10‑K)【page_104】.  \n\nBecause this tranche has not been reduced or increased while total term debt has shifted modestly (e.g., from $10.418 bn in 2022 to $10.574 bn in 2024), PayPal is preserving a stable, low‑cost, long‑dated debt component and using newer issuances at different rates to refinance or adjust the overall debt mix, indicating a deliberate strategy of maintaining existing cheap financing while actively managing the broader long‑term debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PayPal's Fixed-rate 2.850% notes remained at $1.5 billion in 2022, 2023, and 2024, matching the ground truth exactly. The maturity date of October 1, 2029, is also accurately stated. These figures are consistent with the original answer and supported by the cited 10-K pages. (2) All numeric values—$1.5 billion principal, stable across three years—are factually correct. The additional context about total term debt shifting from $10.418 billion to $10.574 billion is not in the ground truth but does not contradict it and may reflect accurate data from the filings; however, since it wasn't in the original answer, it introduces unverified detail without error. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly infers that the stability of this debt tranche amid broader refinancing activity suggests a strategic decision to maintain low-cost, long-term financing. This aligns with the original answer’s conclusion about capital structure stability and selective debt management. (4) The answer is semantically equivalent to the ground truth in key aspects—stable obligation, unchanged maturity, strategic implication—though it omits the detail about the notes being part of a $5.0 billion September 2019 issuance and the effective interest rate of 2.96%. This omission slightly reduces completeness but does not affect the core accuracy. Overall, the response is highly accurate, well-supported, and contextually appropriate, warranting a high score with minor deduction for missing one contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 441,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "From the Level‑3 fair‑value tables, the “options‑primarily‑gas” line shows that the company’s gas‑option portfolio grew from a modest net‑liability position in 2022 (the 2022 filing lists only the aggregate Level‑3 assets and liabilities – $2.1 bn of assets and $2.9 bn of liabilities – of which the gas‑option slice was a small component) to a roughly balanced position in 2024, with $100 million of gas‑option assets offset by $102 million of gas‑option liabilities.  At the same time, the weighted‑average implied‑volatility assumption for those options rose from the mid‑30 % range in the 2022‑2023 period (≈36 % in 2021‑22) to about 50 % in 2023 and 52 % in 2024, while the implied‑correlation assumption climbed from roughly 52 % to near‑100 % over the same span.  \n\nThe upward trend in both the fair‑value size of the gas‑option book and the volatility inputs signals that NextEra is deliberately increasing its exposure to gas‑price swings – likely to hedge a larger portion of its natural‑gas generation portfolio – but it is doing so with offsetting assets and liabilities, keeping the net position close to zero and thereby limiting outright market risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, NextEra Energy's fair value of gas-related options *decreased* from $356M (assets) and $347M (liabilities) in 2022 to $100M/$97M in 2023 and $100M/$102M in 2024. However, the LLM claims the portfolio 'grew from a modest net-liability position in 2022' and implies an increase in exposure, which contradicts the downward trend in absolute values. The LLM incorrectly characterizes the 2022 position as a 'small component' of Level-3 assets/liabilities without citing the actual gas-option values, which are explicitly provided in the ground truth. (2) The implied volatility assumptions are misrepresented: the ground truth shows a decline from 36% in 2022 to 50% in 2023 and 52% in 2024 — but this is an *increase*, not a 'decline' as stated in the original answer. However, the LLM incorrectly states volatility 'rose from the mid-30% range in the 2022-2023 period (≈36% in 2021-22)' — introducing non-existent data (2021-22) and misaligning years. While the 50% and 52% figures for 2023 and 2024 are correct, the characterization of a rising trend conflicts with the ground truth’s starting point of 36% in 2022 (so the trend is increasing, not decreasing). The LLM also introduces 'implied correlation' climbing to near 100%, which is not mentioned or supported in the ground truth at all. (3) The multi-hop reasoning is flawed: the LLM infers that increasing volatility assumptions and larger positions indicate *increased* strategic exposure, but the actual fair values show a sharp *reduction* in both asset and liability positions from 2022 to 2023, suggesting de-risking. The conclusion that NextEra is 'increasing its exposure' is therefore factually incorrect and opposite to the ground truth interpretation of strategic de-risking. (4) Despite these major errors, the answer is contextually relevant — it addresses the right company, metric (fair value of gas options), and time frame (2022–2024), and attempts to interpret risk positioning based on volatility trends. However, due to severe quantitative inaccuracies and incorrect synthesis, the overall correctness score is low. Minor note: dollar amounts like $100 million are correctly formatted and consistent with ground truth for 2023–2024, but the failure to report 2022 values accurately undermines completeness and correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 639,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s “gains (losses) on available‑for‑sale debt investments” moved from a **$9 million gain in fiscal 2022** to a **$21 million loss in fiscal 2023** and then a **$67 million loss in fiscal 2024**【page_46】. The shift from a modest positive result to increasingly larger losses shows that the fair‑value changes in its AFS debt portfolio were volatile over the three‑year span, reflecting sensitivity to market‑rate movements and credit‑quality fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the dollar amounts are correct: $9 million gain in 2022, $21 million loss in 2023, and $67 million loss in 2024, as supported by the cited page reference. These figures match the trend described in the original answer—increasing losses from AFS debt investments over the period. (2) The LLM correctly identifies the metric (gains/losses on AFS debt investments) and fiscal years (2022–2024), satisfying entity accuracy. (3) Reasoning is sound: the shift from gain to escalating losses is correctly interpreted as evidence of volatility, tied to market-rate and credit-quality changes, which aligns with the original answer’s conclusion about increasing portfolio volatility. (4) While the LLM does not explicitly mention the offsetting gains from equity and private investments (a minor omission), it fully captures the core trend and its implication—namely, that AFS debt investment losses increasingly dragged down other income (loss), net and revealed portfolio volatility. This omission prevents a perfect 10, but the answer remains factually correct, contextually relevant, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 335,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "- **2019 issuance (baseline)** – Lowe’s first issued the 4.550 % senior notes (due April 5, 2049) in the Fifteenth Supplemental Indenture (exhibit 4.16) that is reproduced in the 2022 filing 【page_76】.  \n\n- **2022‑2024 documentation** – In the 2022 10‑K the company’s later supplemental indentures (exhibits 4.21 and 4.22) list new series of 4.250 % and 4.450 % notes but **do not contain a new 4.550 % issuance**, merely continuing to reference the existing 4.550 % notes as outstanding 【page_77】. The 2023 filing’s Twenty‑Second Supplemental Indenture (exhibit 4.23) likewise introduces higher‑coupon series (4.800 %, 5.150 % etc.) without a fresh 4.550 % issue 【page_78】, and the 2024 filing’s exhibit schedule (exhibit 4.27) still shows the earlier 4.550 % notes as part of the overall debt portfolio 【page_77】.  \n\n**Interpretation** – Over the three‑year span Lowe’s did not issue additional 4.550 % notes; instead it kept the 2019 issue on its books and periodically amended its indenture framework while adding newer, higher‑coupon series. This pattern reflects a long‑term debt strategy that builds a laddered pool of fixed‑rate senior notes, preserving existing low‑coupon obligations and supplementing them with new issuances to diversify maturities and manage financing costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It accurately identifies the 4.550% Notes as issued on April 5, 2019, under the Fifteenth Supplemental Indenture (exhibit 4.16), and correctly notes that no new issuance of these notes occurred in 2022–2024. The references to subsequent supplemental indentures (exhibits 4.21, 4.22, 4.23, 4.27) and the inclusion of newer, higher-coupon notes (e.g., 4.250%, 4.450%, 4.800%, 5.150%) are consistent with the expected documentation pattern. The conclusion that Lowe’s maintained the 4.550% Notes as outstanding without modification aligns with the ground truth. (2) Quantitative accuracy is perfect: all percentages (4.550%, 4.250%, etc.), dates (April 5, 2019, and implied 2049 maturity), and exhibit numbers are correct. There are no calculation errors. (3) Multi-hop reasoning is strong: the model synthesizes information across three years of filings, identifies the absence of new 4.550% issuances, and infers a strategic laddering approach to debt. The interpretation of a stable long-term debt strategy with diversification of maturities and financing costs is a valid extension of the ground truth, which also emphasizes consistency. (4) The only reason for not scoring a 10 is that the ground truth emphasizes the *lack of change* in documentation or terms as evidence of stability, while the LLM focuses more on the addition of new higher-coupon notes. This is a nuanced difference in emphasis, not a factual error. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 429,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "- 2022 10‑K – Unsecured Notes 35B carried a **face amount of $750 million** and an **interest rate of 3.80 %**【page_50】.  \n- 2023 10‑K – The same note still showed a **$750 million face amount** and **3.80 % interest**【page_50】.  \n- 2024 10‑K – The note remained unchanged at **$750 million face value** with a **3.80 % rate** and a maturity of 7/15/2050【page_51】.  \n\nThe unchanged size and fixed‑rate of the 35B issuance over three years shows SPG’s deliberate use of long‑dated, low‑cost unsecured debt to lock in stable financing, reflecting a long‑term debt strategy focused on interest‑rate certainty and liquidity preservation rather than frequent refinancing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the face value of $750 million (consistent across 2022–2024), interest rate of 3.80%, and maturity date of 7/15/2050 are correctly reported. The format variation ($750 million vs $750,000,000) is acceptable and semantically equivalent. (2) The answer is complete, addressing both the evolution of face value and interest rate (no change) and the implication for SPG’s long-term debt strategy. (3) Entity accuracy is correct: Simon Property Group (SPG), Unsecured Notes - 35B, and the years 2022–2024 are properly identified. (4) The reasoning is sound: the LLM correctly infers that maintaining a fixed face value and interest rate over three years reflects a strategy of securing long-term, stable financing and avoiding refinancing risk. The synthesis across three 10-K filings is accurate and logically presented. (5) The semantic meaning fully aligns with the original answer, with slightly more structured presentation and equivalent qualitative interpretation. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 323,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "From the 2022 filing PayPal warned that “numerous and evolving fraud schemes… could subject us to significant costs and liabilities” and that its credit‑product portfolio “exposes us to additional risks” because defaults could raise charge‑offs and the company “relies on the activities and charters of unaffiliated financial institutions” (2022 pp. 24‑27). In the 2023 filing the same fraud‑and‑bad‑transaction exposure is restated, but the discussion shifts to “our reliance on third parties… creates additional risk” and to “any factors that reduce cross‑border trade… could harm our business” (2023 pp. 23‑27). By 2024 the company still acknowledges those risks but adds concrete mitigation actions – diversifying payment‑processor relationships, migrating to new processors, and selling large portions of its U.K./European BNPL loan receivables through a forward‑flow arrangement – while continuing to note the need to manage third‑party lender and cross‑border‑trade dependencies (2024 pp. 21‑25). The trend shows PayPal moving from a broad warning about bad‑transaction exposure toward a more targeted risk‑management agenda that leans on diversification and off‑balance‑sheet funding, indicating a maturing strategy and greater operational resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 concerns about fraud, credit defaults, and reliance on third parties (Synchrony Bank implied via 'unaffiliated financial institutions') are accurately reflected. In 2023, the shift toward risk mitigation via the sale of U.K./European BNPL receivables is correctly identified, including the forward-flow structure (implied by 'multi-year agreement' in ground truth and 'forward-flow arrangement' in LLM). By 2024, ongoing fraud risks and legal uncertainty (e.g., 'valid-when-made') are acknowledged, though the LLM does not explicitly mention the 'valid-when-made' doctrine, which is a minor omission. (2) Quantitative accuracy is perfect: no incorrect numbers, and the €40 billion figure from the ground truth is not contradicted (though not explicitly cited, it is not required for correctness as the LLM refers generally to 'large portions'—semantically acceptable). (3) Multi-hop reasoning is sound: the LLM synthesizes across 2022–2024 filings, correctly tracing the evolution from risk identification to mitigation via diversification and asset sales. The conclusion about a maturing, proactive risk strategy matches the ground truth’s 'transformation from internal risk absorption to external risk mitigation.' (4) Contextual relevance is excellent—the answer directly addresses credit products, cross-border trade, and third-party dependencies across all years, and clearly links them to risk management and operational resilience. The only reason for not scoring 10 is the omission of the specific legal doctrine ('valid-when-made'), which is mentioned in the ground truth as a 2024 risk factor. However, the LLM captures the broader theme of legal and regulatory risk in credit products, so the omission does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 505,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "- In the 2022 Form 10‑K Costco listed BJ Wholesale Club (along with Sam’s Club) as one of its primary warehouse‑club rivals and stressed that its private‑label Kirkland Signature line “are high quality, offered at prices that are generally lower than national brands, … help lower costs, differentiate our merchandise offerings, and generally earn higher margins” with a goal to increase its sales penetration【page_7】.  \n\n- The 2023 filing repeats the same competitive set – still naming BJ’s as a key competitor – and again highlights Kirkland Signature as a core differentiator and notes that Costco “expects to continue to increase the sales penetration of our private‑label items”【page_8】.  \n\n- The 2024 filing likewise keeps BJ’s in the competitive landscape and continues to emphasize Kirkland Signature’s role in delivering high‑quality, lower‑price products that set Costco apart, reaffirming its intent to grow private‑label sales penetration【page_8】.  \n\nThus, from 2022 through 2024 Costco’s positioning relative to BJ’s remained consistent, with the company repeatedly using its Kirkland Signature private‑label brand as a strategic differentiator and stating an ongoing commitment to expand its penetration.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Costco consistently named BJ's Wholesale Club as a competitor from 2022 to 2024 and emphasized Kirkland Signature as a strategic differentiator across all three years. The qualitative descriptions of Kirkland Signature—'high quality, lower prices than national brands,' 'help lower costs,' 'differentiate offerings,' 'higher margins'—are accurately reflected from the original filings. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not compromised; all references to years (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three annual 10-K filings, identifying consistent messaging over time and drawing the correct conclusion of stable competitive positioning. (4) The answer fully addresses the question’s focus on the evolution (or lack thereof) of Costco’s competitive stance relative to BJ’s, particularly regarding private-label strategy. Wording differs slightly but meaning is preserved, and the inclusion of specific document page references adds precision. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 366,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "- 2022 – The fair‑value table for “significant unobservable inputs” shows a **net liability of $854 million** for gas‑related derivatives (the liability side exceeds the asset side, indicating a net short exposure).  \n- 2023 – The Level‑3 breakdown lists **gas‑forward assets of $377 million and liabilities of $77 million**, giving a net asset position of about **+$300 million**.  \n- 2024 – The same breakdown shows **gas‑forward assets of $296 million and liabilities of $46 million**, a net asset of roughly **+$250 million**.  \n\n**Interpretation:** Over the three‑year span NextEra moved from a net‑liability stance in 2022 to a modest net‑asset position in 2023 and 2024, indicating that its gas‑forward portfolio shifted from being vulnerable to rising natural‑gas prices to a more hedged, favorable position that reduces market‑price risk and positions the company to benefit from higher gas prices.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly in the 2022 data. The ground truth states that in 2022, NextEra Energy had gas forward contract assets of $191 million and liabilities of $31 million, resulting in a net asset position of $160 million. However, the LLM claims a net liability of $854 million in 2022 based on 'significant unobservable inputs' and 'Level-3' breakdowns, which contradicts the ground truth and introduces metrics not mentioned in the original answer. This is a major factual error. For 2023, the LLM correctly identifies the $377 million in assets (matching the spike noted in the ground truth), but reports liabilities as $77 million instead of $46 million, which is incorrect. In 2024, the LLM correctly reports assets as $296 million and liabilities as $46 million, aligning with the ground truth. (2) Calculations: The net positions derived by the LLM are based on incorrect inputs for 2022 and 2023, leading to erroneous conclusions about the direction and magnitude of change. The correct 3-year progression should show increasing assets ($191M → $377M → $296M) and rising liabilities ($31M → $46M → $46M), indicating growing but balanced exposure. The LLM’s narrative of shifting from net liability to net asset is factually wrong for 2022. (3) Multi-hop reasoning: While the LLM attempts to synthesize trends across years and draw conclusions about risk positioning, the flawed baseline (2022) undermines the validity of the analysis. The conclusion that the company moved from vulnerability to rising prices to a hedged position may have intuitive appeal but is not supported by the actual data, which shows a consistently net long position (assets > liabilities) throughout the period. (4) Despite these errors, the LLM captures the 2023 spike and the 2024 values correctly, and its interpretation of reduced price risk in later years has partial alignment with the ground truth’s suggestion of strategic expansion and rising market risk. Contextual relevance is high as it addresses all parts of the question and provides a coherent narrative. However, due to major factual inaccuracies in key financial figures, especially for 2022, the overall correctness score is limited to 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 604,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "- **2022:** Lowe’s reported a **$2.56 billion** notional amount of forward interest‑rate swap agreements, classified as cash‑flow hedges that were used to lock in rates on anticipated debt issuances【page_62】.  \n\n- **2023:** The same type of swaps were still on the books, but the fair‑value exposure had fallen to **about $251 million**, indicating that a large portion of the 2022 contracts had been terminated or reduced as the company’s borrowing plans changed【page_54】.  \n\n- **2024:** Forward swaps are no longer shown (the fair‑value line is blank), and the 2024 filing notes that the company now holds **fixed‑to‑floating swaps as fair‑value hedges** rather than forward swaps【page_46】.  \n\n**Interpretation:** Lowe’s initially used sizable forward swaps in 2022 to hedge the interest‑rate risk of future debt issuances. As market conditions evolved and its financing needs shifted, it wound down those contracts, leaving only a modest residual exposure in 2023 and eliminating them by 2024. This progression shows a proactive, flexible risk‑management approach—using forward swaps when rate‑locking was valuable, then scaling back or replacing them with other hedges as interest‑rate expectations and borrowing plans changed.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $251 million fair value in 2023 matches the original answer exactly and is correctly attributed to February 3, 2023 (end of fiscal 2022). The $2.56 billion notional amount in 2022 is not explicitly mentioned in the ground truth but is a plausible detail from the source filing (page 62) and does not contradict the original answer, which confirms the use of forward swaps as cash flow hedges. The absence of forward swaps in 2024 is correctly noted, and the shift to fixed-to-floating swaps as fair-value hedges adds useful context from the filing. (2) The only minor discrepancy is that the ground truth does not specify the $2.56 billion figure, so while it may be correct, it introduces a detail not confirmed in the reference; however, this does not affect correctness as it doesn't conflict with known facts. (3) Qualitatively, the reasoning is excellent: the LLM correctly traces the evolution from active hedging (2022), partial unwind (2023), to full removal and replacement (2024), and interprets this as a flexible, responsive risk management strategy—fully consistent with the ground truth. (4) The answer is contextually rich, directly addresses all parts of the multi-hop question, and synthesizes information across years and instruments. The conclusion about strategic adaptation to market conditions is well-supported. Minor deduction in quantitative accuracy only due to the unverified $2.56B figure, but overall the answer is factually sound, complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 441,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "In the 2022 filing Comcast noted that Lumen, along with AT&T, Frontier and Verizon, was “building and continuing to build fiber‑based wireline network infrastructure … and are offering services with higher speeds in many of our service areas,” positioning Lumen as a direct threat to Comcast’s broadband portfolio. By 2023 Comcast began rolling out DOCSIS 4.0 and expanding fiber‑to‑the‑premises, stressing that its multiyear network‑transformation plan would let it deliver multigigabit symmetrical speeds and keep pace with Lumen’s ongoing fiber rollout. The 2024 report shows the gap closing further: a “significant portion of new homes and businesses passed are connected with fiber,” and Comcast now offers residential fiber up to 10 Gbps and business fiber up to 100 Gbps, allowing it to compete more aggressively with Lumen in the overlapping markets where both carriers are expanding fiber‑based broadband.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Lumen as a key competitor to CMCSA (Comcast) in fiber-based broadband expansion from 2022 to 2024. The mention of Lumen building fiber infrastructure in overlapping markets is consistent across both answers. (2) Quantitative details such as '10 Gbps' for residential and '100 Gbps' for business fiber speeds in 2024 are specific and plausible, though not explicitly in the ground truth; however, they do not contradict it and are contextually appropriate given the trend of increasing speeds. No incorrect numbers, dates, or calculations are present. (3) The multi-hop reasoning is sound: the LLM synthesizes Comcast’s competitive response (DOCSIS 4.0, fiber expansion) in reaction to Lumen’s infrastructure growth, showing an understanding of competitive dynamics over time. It correctly infers that both companies are expanding in overlapping areas, intensifying competition. (4) The LLM adds value by including Comcast’s strategic responses (e.g., DOCSIS 4.0, multigigabit offerings), which are not in the original answer but are relevant and factually consistent with public filings. The only minor shortcoming is that the original answer emphasizes Lumen’s growing influence more than Comcast’s response, while the LLM focuses more on Comcast’s countermeasures. However, this does not reduce factual accuracy—rather, it provides complementary insight. Thus, the answer is semantically equivalent and contextually rich, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 423,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "From 2022 through 2024 PayPal moved from describing a “simplest checkout experience” that relied on a few branded‑checkout flows and limited buy‑now‑pay‑later (BNPL) offerings (U.S., U.K., France, Germany and Japan via Paidy) to embedding those consumer‑credit products directly into the PayPal and Venmo checkout screens and adding new credit‑card and revolving‑credit options in additional markets such as Australia, Spain and Italy.  At the same time it broadened its global reach – the platform now supports payments in roughly 200 markets, can process transactions in more than 150 currencies, and lets users hold balances in 24‑25 currencies and withdraw in 56 – and it expanded its omnichannel merchant suite, adding Zettle‑by‑PayPal point‑of‑sale hardware, card readers and other in‑person solutions that let merchants sell seamlessly online, on‑mobile and in‑store.  Together, these steps show an evolution toward a fully integrated, credit‑enabled checkout that works everywhere and on every channel.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Correctly captures PayPal's evolution from 2022 to 2024 in seamless checkout, with accurate emphasis on integration of consumer credit (BNPL, branded cards), global currency support, and omnichannel merchant solutions. (2) Quantitative accuracy: States 'more than 150 currencies' — matches ground truth of 'approximately 150' in 2023 and implies growth from 100+ in 2022. Mentions '200 markets' and '24–25 currencies' for holding balances, which are plausible expansions beyond the ground truth and not contradicted by it; these details were not in the original answer but do not appear factually incorrect. No calculation errors. (3) Multi-hop reasoning is sound: synthesizes PayPal’s progression across years, integrates consumer credit (BNPL expansion, PayPal/Venmo cards), global reach (currency and market support), and merchant solutions (Zettle, Braintree equivalent via 'unbranded processors'). Mentions Zettle POS hardware and omnichannel capabilities, aligning with ground truth’s focus on omnichannel enablement. (4) Minor deduction in quantitative accuracy due to slightly inflated specificity (e.g., '24–25 currencies', '56 withdrawal currencies') not present in ground truth, but these are not demonstrably false. Overall, the answer conveys semantic equivalence with richer detail, showing strong qualitative and contextual alignment. No major omissions or factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 402,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "Target’s “RedCard/Target Circle Card” penetration fell each year: 20.5 % of purchases were paid with the card in fiscal 2022, 19.8 % in fiscal 2023, and 18.6 % in fiscal 2024【page_27】. The downward trend indicates that, while the debit‑card program still generates a measurable share of sales and is viewed as a source of incremental purchases, its relative contribution is slowly diminishing over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies: it reports penetration rates of 20.5% in 2022 (correct), 19.8% in 2023 (incorrect; ground truth is 18.6%), and 18.6% in 2024 (incorrect; ground truth is 17.8%). These errors affect all three data points after 2022, with the 2023 figure being off by 1.2 percentage points and 2024 by 0.8 points. 2) The calculation of trend direction (downward) is correct, but the magnitude and trajectory are misrepresented due to wrong numbers. The model cites a source (page_27), but the data still conflicts with ground truth. 3) The qualitative reasoning about the diminishing role of the card in driving incremental sales is sound and aligns with the original answer’s interpretation, showing correct multi-hop synthesis between penetration trends and business impact. 4) Entity accuracy is good—correctly identifies Target, RedCard/Target Circle Card, and fiscal years. Contextual relevance is high as it addresses both parts of the question: trend evolution and implications for sales. However, due to major numerical inaccuracies in the core metrics, the correctness score is limited to 6—partially correct but with significant factual errors in the quantitative time series.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 344,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "AMD’s policy for development‑service + IP‑licensing contracts has not changed. In the 2022 filing the company said it evaluates whether the licensing component is distinct; if it is not distinct the license is combined with the development services and revenue is recognized over time, while a distinct license is recognized at a point in time, and no variable‑consideration estimates are made for either type 【page_59】. The same language appears in the 2023 and 2024 filings, confirming that the distinction‑based approach and the treatment of combined versus standalone licensing arrangements remained consistent through 2024 【page_63】【page_64】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures AMD's consistent revenue recognition approach from 2022 to 2024: distinguishing between distinct and non-distinct licenses, with revenue recognized over time for combined arrangements (when the license is not distinct) and at a point in time for standalone (distinct) licenses. (2) There are no numeric values (e.g., dollar amounts, percentages) in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years (2022–2024), confirms consistency in policy, and cites specific pages from each year’s filing (page_59, page_63, page_64) to support the claim of unchanged language. (4) All entities—AMD, development services, IP licensing, revenue recognition timing—are correctly identified and logically connected. The answer directly addresses the evolution (or lack thereof) in AMD’s approach, matching the original answer’s conclusion of a stable, consistent policy. Minor wording differences (e.g., 'no variable-consideration estimates' in LLM vs. not mentioned in original) do not affect factual correctness, as this detail is consistent with but not required by the ground truth. All scoring dimensions are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 375,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "In the FY 2022 10‑K, Nike placed FlyEase together with a roster of its signature innovations – Nike Air, Zoom, Free, Dri‑FIT, Flyknit, ZoomX, Air Max, React and Adapt – to illustrate that FlyEase was already a core element of its technology pipeline. The FY 2024 filing repeats that same phrasing, again listing FlyEase alongside those flagship platforms, showing that the company continued to treat FlyEase as a central, ongoing innovation within its product‑development portfolio rather than a peripheral or one‑off effort. In short, from 2022 through 2024 Nike’s filings consistently positioned FlyEase as a key, enduring technology in its innovation suite.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its portrayal of FlyEase's strategic evolution. While it correctly identifies that FlyEase was listed alongside major Nike technologies in FY2022 and FY2024, it misrepresents the progression described in the ground truth. The original answer indicates that FlyEase evolved from being a 'newly introduced' innovation in FY2022, to being grouped with established technologies in FY2023, and finally being treated as a mature technology alongside React and Air Max in FY2024. In contrast, the LLM claims FlyEase was already positioned as a 'core element' in FY2022 and remained consistently positioned as such—this contradicts the ground truth narrative of a clear three-stage evolution. There are no numeric errors (quantitative accuracy is perfect), and the entities (FlyEase, Nike Air, Zoom, etc.) and years (2022, 2024) are correctly referenced. Contextually, the answer is relevant and addresses the question's focus on strategic positioning. However, the reasoning is flawed: it fails to capture the multi-hop progression across three fiscal years, collapsing the timeline and missing the key point that FlyEase's status changed over time—from emerging to mature. This omission of developmental trajectory undermines the qualitative accuracy, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 379,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The 1.250 % senior notes have been shrinking each year – the 2022 filing shows a principal of about €609 million, the 2023 filing shows €552 million, and the 2024 filing shows €518 million. This steady decline indicates that American Tower is actively repaying or redeeming this low‑coupon EUR note series, using proceeds from newer issuances and its credit facilities to reduce outstanding debt and manage its overall leverage profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the decreasing trend in the principal amount of AMT's 1.250% Notes across 2022–2024, which aligns with the ground truth. However, it incorrectly reports the currency as euros (€) instead of dollars ($), which is a factual error. The values are approximately correct but rounded: $609.1M → €609M (close), $551.9M → €552M (close), $517.7M → €518M (close). These rounding differences are acceptable, but the currency misrepresentation is significant. 2) Quantitatively, the numbers are within reasonable rounding range but fail on unit accuracy—AMT’s notes are USD-denominated, not EUR, as confirmed in SEC filings. This affects factual precision. 3) The reasoning about debt management strategy—active repayment or redemption to reduce leverage—is logically sound and consistent with the trend. The mention of using proceeds from new issuances and credit facilities adds plausible context not in the original, but does not contradict it. 4) The answer addresses the core question about the trend and its implication for debt strategy. It misses the detail about consistent interest payment terms (May payments, maturity in Feb 2033), which is part of the original answer and relevant to the stability of the debt structure. While the strategic interpretation is valid, the omission of payment terms reduces completeness. 5) Entities are mostly correct: AMT (American Tower) and the 1.250% Notes are accurately referenced, though the note type is not specified as 'senior unsecured' or with maturity date. Overall, the answer captures the main trend and infers a reasonable strategy, but has a key error in currency and omits some supporting details from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 463,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "- 2022 10‑K – the 3.50 % Notes Due 2040 were shown only as a liability carried at their original issuance amount (net of unamortized discount and issuance costs); no Level‑2 fair‑value amount was disclosed.  \n- 2023 10‑K – the same notes were still carried at issuance value, but a Level‑2 fair‑value disclosure was added, reporting a fair value of **$870 million** (versus the $1 billion net carrying amount).  \n- 2024 10‑K – the notes remain recorded at original issuance (net carrying amount ≈ $1 billion) and the fair‑value figure fell to **$851 million**.  \n\nThe three‑year trend shows NVIDIA keeping the 3.50 % Notes as a long‑term, low‑coupon financing tool, reporting only modest declines in fair value while continuing to account for them at amortized cost. This reflects a deliberate strategy of locking in inexpensive, far‑dated debt and treating it as a stable, non‑trading liability rather than a short‑term financing source.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value of NVIDIA's 3.50% Notes Due 2040 was $1,066 million in fiscal 2022, but the LLM claims no fair value was disclosed and reports $870 million in 2023, which does not match the ground truth value of $851 million. The 2024 fair value of $851 million in the LLM answer matches the ground truth, but the 2023 figure is incorrect. Additionally, the ground truth states that in 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, which the LLM omits. (2) The LLM incorrectly states that no Level-2 fair value was disclosed in 2022, contradicting the ground truth which explicitly reports a $1,066 million fair value for that year. The $870 million figure for 2023 is unsupported by the ground truth and represents a material error. The 2024 fair value of $851 million is correct. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that NVIDIA is using these notes as a stable, long-term financing tool and accounts for them at amortized cost. This aligns with the ground truth’s interpretation of a strategy to manage liabilities through market fluctuations. However, due to incorrect numerical inputs, the trajectory described (no disclosure → $870M → $851M) does not reflect the actual trend ($1,066M → $851M → stabilization at $1,000M carrying amount). (4) The contextual relevance is high—the answer addresses the evolution across years and draws a strategic conclusion. Qualitative accuracy is moderate because the reasoning framework is logical and entity identification (NVIDIA, 3.50% Notes Due 2040) is correct, but quantitative accuracy is low due to incorrect figures, especially the fabricated $870M in 2023 and omission of the $1,066M in 2022. Correctness score is 6 due to partially correct facts and reasoning but major numerical discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 521,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "**2022 – First‑generation expansion**  \nThe 2022 filing says Netflix “introduced a new, lower‑priced ad‑supported subscription plan” and “recently expanded our entertainment‑video offering to include games.”  It warned that “if our efforts to develop and offer games are not valued… or if the ad‑supported tier is not well‑received, our ability to attract and retain members may be negatively impacted.” 【page 6】\n\n**2023 – Adding live programming**  \nIn the 2023 filing the company notes that it “expanded our entertainment‑video offering to include games and, more recently, live programming.”  It again stresses that “if consumers do not perceive our service‑offering to be of value… or if we introduce new or adjust existing features… our revenue and results of operations may be adversely affected,” linking the risk directly to member acquisition and retention. 【page 7】\n\n**2024 – Scaling the new mix**  \nThe 2024 filing describes a broader scaling effort: “scaling our streaming service… to handle anticipated growth… introducing games and advertising on our service, as well as offering live programming” and “introduce new features such as our new ad‑supported subscription plan.”  It repeats the risk language that “adjustments to our membership pricing, our membership plans, or our pricing model… may not be well‑received… and could negatively impact our ability to attract and retain members.” 【page 7】\n\n**Overall evolution** – Netflix moved from launching an ad‑supported tier and adding games in 2022, to layering live programming on top of those features in 2023, and in 2024 to scaling all three (games, ad‑supported tier, live content) while continuing to tweak pricing.  In each year the 10‑K risk factors explicitly warned that if any of these new plans or price changes are not valued by consumers, the company could see slower member acquisition and higher churn.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual error in the timeline of events, which undermines the multi-hop reasoning and qualitative accuracy. According to the ground truth, Netflix introduced games in 2022 and the ad-supported tier in 2023. However, the LLM incorrectly states that in 2022, Netflix 'introduced a new, lower-priced ad-supported subscription plan' — this is false; the ad-supported tier was launched in 2023, not 2022. This misattribution distorts the strategic evolution. Additionally, the LLM claims in 2024 that Netflix was 'introducing games and advertising' and 'introduce[d] a new ad-supported plan,' but these were not new in 2024 — they had already been launched. The 2024 filing should reflect scaling and maturation, not introduction. While the risk language is accurately quoted and contextually relevant, and there are no numerical inaccuracies (hence full marks for quantitative accuracy), the core chronological and strategic progression is flawed. The model conflates the rollout timeline, incorrectly assigning the ad-supported tier to 2022 and re-introducing it in 2024, which breaks the logical evolution. Despite good structure and use of citations, the answer fails on key entity-year mappings, leading to a correctness score of 6 — partially correct but with significant factual errors in the sequencing of strategic initiatives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1759,
        "completion_tokens": 378,
        "total_tokens": 2137
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "- In 2022 UnitedHealth Group reported **$3.7 billion of equity‑security holdings** (mostly venture stakes) and **$1.5 billion of equity‑method investments** in operating health‑care businesses.  \n- By the end of 2023 the equity‑security portfolio had risen to **$4.9 billion**, while equity‑method holdings fell slightly to **$1.4 billion**.  \n- At year‑end 2024 the equity‑security amount remained at **$4.9 billion**, but equity‑method investments jumped to **$3.8 billion**.  \n\nThis trajectory shows UnitedHealth first expanding its venture‑style equity portfolio (2022‑23), then holding it steady while dramatically increasing its direct, equity‑method stakes in health‑care operating companies in 2024—signaling a strategic shift toward deeper, ownership‑driven positioning in the health‑care sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is highly accurate overall, with only one minor discrepancy: it reports equity-method investments in 2022 as $1.5 billion, whereas the ground truth states $1.3 billion. All other numbers are correct: equity securities at $3.7B (2022), $4.9B (2023 and 2024), and equity-method investments at $1.4B (2023) and $3.8B (2024). This single error in the 2022 equity-method figure is notable but does not severely undermine the overall trend analysis. 2) Quantitative accuracy is high—five out of six values are correct, and the $1.5B vs $1.3B difference is a factual inaccuracy but not a calculation error. The progression from $1.4B to $3.8B in 2024 is correctly highlighted. 3) The reasoning is sound and captures the multi-hop synthesis: the shift from increasing equity securities (2022–2023) to a pivot toward larger equity-method investments in 2024 is logically interpreted as a strategic deepening of engagement in operating healthcare businesses. The conclusion about a strategic shift toward ownership-driven positioning aligns well with the ground truth’s interpretation. 4) Contextual relevance is excellent—the answer directly addresses the evolution across years, breaks down both investment types, and infers strategic intent accurately. Despite the minor numerical discrepancy, the overall factual and interpretive fidelity is strong, warranting a correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 386,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "From FY 2022 through FY 2024 Nike’s redeemable preferred‑stock arrangement was unchanged – the $1‑par, $0.3 million aggregate preferred issue remained fully owned by Sojitz America, with a cumulative dividend of $0.10 per share payable each May 31 and a covenant that no common‑stock dividends can be declared until the preferred dividend is paid in full. Sojitz America continued to hold only the special voting rights granted to preferred shareholders (e.g., approval of a sale of all assets, a merger or the assignment of the Nike trademark in the United States) and, as disclosed, has long served as Nike’s sole import‑export financing partner, supporting the company’s international sourcing and trade operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative details are correct: Sojitz America holds $0.3 million in redeemable preferred stock with a par value of $1 per share (aggregate $0.3M implies 300,000 shares at $1 par, consistent with known structure), and the cumulative dividend of $0.10 per share is accurately stated, payable May 31 annually. The covenant preventing common dividends until preferred dividends are paid is an additional accurate detail not in the original but consistent with preferred stock terms and adds value. (2) Entity and time period accuracy is strong: correct companies (Nike, Sojitz America), correct fiscal years (2022–2024), and correct financial instruments (redeemable preferred stock, dividend obligations). (3) The LLM correctly identifies Sojitz America’s role as sole import-export financing partner, supporting international operations—a key strategic function. However, it does not explicitly note the *evolution* highlighted in the ground truth: that Nike *in FY2024* began emphasizing this role more prominently due to rising trade risks and supply chain volatility, marking a shift from purely financial to more strategically framed engagement. This nuance is missing, slightly weakening the qualitative synthesis across years. (4) Despite this, the answer is factually sound, semantically equivalent in most aspects, and highly relevant. The omission of the 2024 strategic re-framing prevents a perfect 10, but all core facts, numbers, and relationships are correct. Thus, correctness is 9 (excellent but minor omission), quantitative accuracy is 10 (all numbers/dates correct), qualitative accuracy 9 (strong reasoning, minor gap in temporal evolution), and contextual relevance 10 (fully addresses the question’s scope).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 489,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "- **Fiscal 2022:** The 3.50 % Notes Due 2050 were carried at **$1,637 million** on the balance sheet【NVDA_10k_2022.pdf page 78】.  \n- **Fiscal 2023:** The same notes were carried at **$1,637 million**【NVDA_10k_2024.pdf page 67】 (the 2023 column of the fair‑value table).  \n- **Fiscal 2024:** The carrying amount fell to **$1,604 million**【NVDA_10k_2024.pdf page 67】.  \n\n**Trend interpretation:** Over the three‑year period the carrying value of the 3.50 % Notes Due 2050 slipped slightly, showing that NVIDIA is modestly reducing the principal of this long‑term debt instrument and thereby improving its long‑term debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported carrying values. According to the ground truth, the values should be $2,147 million (2022), $1,604 million (2023), and $2,000 million (2024). However, the LLM reports $1,637M for both 2022 and 2023, and $1,604M for 2024 — all of which are incorrect except for matching the 2023 value by coincidence. The citation for 2022 references NVDA_10k_2022.pdf page 78, but the value reported there may have been misread or misattributed. The 2024 value is incorrectly stated as decreasing to $1,604M when it should have increased to $2,000M. (2) Calculations and trends are therefore also wrong: the LLM claims a slight decline over time, but the actual trend is a drop from 2022 to 2023 followed by a significant rebound in 2024. This undermines any correct interpretation. (3) The multi-hop reasoning is flawed because the model fails to correctly extract and synthesize data across the three annual reports. It incorrectly uses a fair value table from the 2024 filing to report 2023 carrying value, which may reflect fair value rather than carrying value, indicating a misunderstanding of financial terminology and source usage. (4) The qualitative interpretation is based on incorrect data, leading to an erroneous conclusion about NVIDIA modestly reducing debt, when in fact the company increased long-term liabilities in 2024 after a reduction in 2023. Contextual relevance is moderate because the structure and intent align with the question, but factual inaccuracies severely limit usefulness. Scores reflect major quantitative and qualitative failures despite appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 454,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s short‑term borrowing – which is essentially its commercial‑paper program – fell from about **$175 million in 2022** (including $76 million of non‑recourse debt) to **$119 million in 2023** and then jumped to **$465 million by year‑end 2024** (all non‑recourse short‑term debt)【page 111】【page 101】【page 101】.  Throughout the period the company repeatedly stressed that liquidity is sourced from a **wide mix of global markets** – equity, preferred stock, short‑ and long‑term debt, collateral‑financing arrangements, PABs, credit facilities and a shelf registration – and that this diversity “enhances our funding flexibility, limits dependence on any one market or source of funds and generally lowers the cost of funds”【page 101】【page 127】.  Thus, while short‑term debt use was modest in 2022‑23, MetLife increasingly leaned on its commercial‑paper and other diversified funding channels in 2024 to broaden its funding base and reduce financing costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative data. The original answer (ground truth) does not mention any specific dollar amounts for MetLife's commercial paper or short-term debt in 2022, 2023, or 2024. However, the LLM answer fabricates precise figures: $175M in 2022, $119M in 2023, and $465M in 2024, including breakdowns like 'non-recourse debt'—none of which appear in the ground truth. There is no support for these numbers in the provided context, making them incorrect. (2) The quantitative accuracy is severely compromised because the model invents numerical trends (a drop then sharp rise in short-term debt) that are not present in the ground truth. The original answer states that the funding structure remained 'consistent' and 'stable' across the years, with no indication of such fluctuations. Thus, the calculation and trend analysis are entirely unsupported. (3) Qualitatively, the LLM captures some correct themes: MetLife’s emphasis on diversified funding sources, use of commercial paper, credit facilities, and the strategic goal of lowering the cost of capital and reducing dependence on any single market. These points align with the original answer and show correct multi-hop synthesis of the strategic rationale across years. However, the incorrect numerical foundation undermines the reasoning. (4) Contextual relevance is high because the LLM addresses the core question about evolution of funding dependence, discusses short-term debt and diversification, and cites relevant instruments. But the invented metrics severely damage factual correctness. The score reflects partial credit for correct conceptual understanding but major deduction for hallucinated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 468,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth’s 10‑K notes make clear that the company’s “service‑level guarantees” have never been material – the footnote says the amounts accrued, paid or charged for those guarantees were immaterial in 2022, 2023 and 2024【page_81】. At the same time, the intra‑company financing grew sharply: short‑term notes payable to subsidiaries fell from $8.7 billion in 2022 to $9.9 billion in 2023 and then to only $2.0 billion in 2024, while long‑term notes payable, which were essentially zero in 2022‑23, rose to $14.4 billion by year‑end 2024【page_78】【page_81】. The shift from large on‑demand short‑term borrowings to a sizable long‑term obligation shows UnitedHealth is increasing its overall liquidity commitment to subsidiaries but is lengthening the repayment horizon, while its exposure to service‑level guarantee liabilities remains negligible.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies the immateriality of service level guarantees across all years and captures the drop in short-term notes payable to subsidiaries in 2024. However, it contains significant quantitative errors: it states short-term notes payable increased from $8.7B in 2022 to $9.9B in 2023, while the ground truth reports $8.1B in 2022 and $9.9B in 2023. The $8.7B figure is incorrect. Additionally, the LLM introduces long-term notes payable rising to $14.4B in 2024, a figure not present in the ground truth, which only mentions total notes payable to subsidiaries dropping to $2.0B in 2024. This introduces a major factual discrepancy. (2) The ground truth does not mention long-term notes payable separately, nor does it support a total intra-company debt increase to $14.4B. The correct trend is a rise then sharp decline in total notes payable ($8.1B → $9.9B → $2.0B), which the LLM misrepresents by splitting into short- and long-term components not reflected in the original answer. (3) The reasoning about shifting liquidity commitments has merit and aligns with the question’s intent, but the synthesis is flawed due to incorrect data. The conclusion that service-level guarantee exposure remains negligible is correct and well-reasoned. (4) The contextual relevance is high as the answer addresses both service guarantees and internal debt evolution. Qualitative accuracy is moderate due to sound logic but based on incorrect numbers. Quantitative accuracy is low due to incorrect base figures and introduction of unsupported data. Correctness score reflects partial accuracy with critical numerical errors undermining the financial narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 455,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "- **2022:** American Express described itself as the **fourth‑largest general‑purpose card network worldwide** (behind China UnionPay, Visa and Mastercard) and highlighted intense competition from those networks, private‑label cards, mobile‑wallets and new‑technology payment platforms (Alipay, PayPal, BNPL, etc.).  \n\n- **2023‑2024:** The filings show a **growing regulatory dependency** on card‑network rules.  In 2023 the company noted that legislators and regulators were intensifying focus on interchange‑fee caps, network‑routing practices and “honor‑all‑cards” rules, forcing Amex to **exit its network‑licensing businesses in the EU and Australia** and to confront uncertainty over cobrand‑partner fee caps.  In 2024 Amex was classified as a **Category III firm under the U.S. federal bank‑regulatory tailoring framework**, subjecting it to heightened supervisory expectations and the prospect of moving to Category II, which would raise compliance costs.  The 2024 filing also references a **proposed Visa/Mastercard settlement** that could further lower merchant discount rates and affect Amex’s pricing.  \n\n- **Strategic response:** Across the period Amex has **leaned on its premium brand and network scale while bolstering compliance, AML and cyber‑security programs, voluntarily reporting suspicious transactions, and diversifying into checking‑account and non‑card lending products** to offset pressure on discount revenue.  Thus, its competitive positioning has shifted from emphasizing size and product differentiation in 2022 to defending that position through regulatory‑risk mitigation and strategic product expansion as scrutiny and competitive pressure have intensified through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express's position as the fourth-largest general-purpose card network in 2022, competition from Visa, Mastercard, China UnionPay, Alipay, PayPal, and regional systems like NPCI are accurately noted. The regulatory developments in 2023–2024, including exit from network licensing in the EU and Australia, heightened scrutiny on interchange fees and routing rules, and classification as a Category III firm under U.S. bank regulations, are all factually correct. The mention of the proposed Visa/Mastercard settlement affecting merchant discount rates is an additional accurate detail consistent with the regulatory environment. (2) Quantitative accuracy is perfect: no numerical errors; all dates (2022, 2023, 2024), classifications (Category III), and business actions (exits from EU/Australia) match the ground truth. Format variations (e.g., 'Category III' vs 'Category III') are acceptable. (3) Multi-hop reasoning is sound: the LLM synthesizes competitive dynamics, regulatory shifts, and strategic responses across years and jurisdictions, correctly inferring a shift from market-driven competition to regulatory adaptation. It connects Amex’s strategic moves—compliance investments, product diversification—to external pressures, which is consistent with the original answer’s trajectory analysis. (4) The only minor shortcoming is that the original answer emphasizes the *transformation* in strategic posture more explicitly as a narrative arc from independence to regulatory constraint, while the LLM presents it more as a parallel evolution. However, the core qualitative meaning is preserved. The LLM also adds value by mentioning AML, cybersecurity, and new product lines (checking accounts, non-card lending), which are plausible strategic responses and enhance completeness without contradicting the source. Overall, this is a semantically equivalent, well-reasoned, and factually precise response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1848,
        "completion_tokens": 543,
        "total_tokens": 2391
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "From 2022 through 2024 ConocoPhillips continued to use cash‑settled performance‑share units (PSUs) that were granted, fully vested and settled each year with no remaining unrecognized compensation cost (2022 $21 m, 2023 $111 m settled, 2024 $171 m settled). For performance periods that began in 2018 or later the company stopped paying a periodic cash dividend‑equivalent during the three‑year performance window and instead accrued a “reinvested dividend equivalent” that is charged to compensation expense and paid only at the cash settlement date — a change first described in the 2018‑19 executive RSU redesign and reiterated in the 2022‑2024 filings. This evolution shows ConocoPhillips’ intent to align long‑term incentives with shareholder value by tying the cash payout to the eventual stock‑price settlement and deferring dividend‑equivalent earnings until the performance period is completed.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in ConocoPhillips' dividend equivalent structure for PSUs starting in 2018 or later, noting the shift from periodic payments to accrued reinvested dividends paid at settlement. This aligns with the ground truth and captures the core intent of stronger long-term incentive alignment. However, there are quantitative discrepancies: the LLM states performance periods are three years, while the ground truth indicates vesting is tied to five years or retirement eligibility, which is a significant factual error. Additionally, the dollar amounts cited ($21M, $111M, $171M) are not present in the original answer and cannot be verified against the ground truth, suggesting potential hallucination or misattribution. (2) The dates (2018 or later) and the reference to the 2018–19 redesign are consistent and accurate. The description of accounting treatment (accrued reinvested dividend equivalents charged to compensation expense) is qualitatively correct and matches the conceptual framework. (3) The multi-hop reasoning is sound—linking changes in dividend treatment to long-term incentive alignment with shareholder value shows appropriate synthesis across time and policy changes. The consistent classification as a liability is implied through cash settlement but not explicitly stated, which is a minor omission. (4) Despite strong qualitative accuracy and contextual relevance, the correctness score is reduced due to incorrect performance period duration and unverified financial figures. The answer captures the strategic rationale well but contains key numerical inaccuracies that affect full factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 460,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "The consolidated “special‑use funds” fell from roughly $11 billion in 2022 to $8.7 billion in 2023 and then rose to about $9.8 billion in 2024. Even as those funds contracted, the cash and letter‑of‑credit collateral that NEE posted for its derivative contracts dropped from $4.6 billion in 2022 to $2.3 billion in 2023 (and is expected to be of a similar magnitude in 2024), which still exceeds the BBB‑downgrade posting requirement (≈$0.5‑$1.6 billion) and covers most of the “below‑investment‑grade” requirement ($2.4‑$5.2 billion). Thus, the trend shows that NEE’s liquidity – backed by its special‑use funds and posted collateral – remains comfortably sufficient to meet its derivative‑related collateral obligations throughout the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It states that Special Use Funds were $11 billion in 2022, but the ground truth does not provide a 2022 value and explicitly states an increase from $8,698 million in 2023 to $9,800 million in 2024. The $11 billion figure for 2022 is unsupported and incorrect. Additionally, the LLM claims that cash and letter-of-credit collateral dropped from $4.6 billion in 2022 to $2.3 billion in 2023, but the ground truth reports only cash collateral posted increasing from $84 million to $691 million—there is no mention of $4.6 billion or combined cash/letters of credit. The collateral requirement ranges cited (e.g., $0.5–$1.6 billion) are not in the original and appear fabricated. (2) Calculations and comparisons are therefore invalid. The LLM incorrectly implies that posted collateral exceeds downgrade requirements, while the ground truth shows a reduction in potential exposure from $5.2B to $2.4B and rising cash collateral, not a static over-collateralization. (3) The multi-hop reasoning is partially sound in linking Special Use Funds and collateral obligations to liquidity positioning, and it correctly notes the increase from 2023 to 2024. However, it misrepresents the trend in Special Use Funds by inventing a drop from 2022 to 2023 and mischaracterizes the nature and magnitude of collateral posted. (4) Despite these errors, the answer remains contextually relevant by addressing liquidity, Special Use Funds, and derivative collateral obligations, and it draws a reasonable conclusion about sufficient liquidity—though based on incorrect data. Hence, low quantitative accuracy, moderate qualitative accuracy due to flawed but structured reasoning, and high contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 490,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "- The 1.600 % senior notes were issued for $700 million (March 29 2021)【page_48】.  \n- Amortization (principal reduction) was $3.7 million in 2022【page_110】, $1.5 million in 2023【page_113】 and $2.6 million in 2024【page_113】.  \n\nResulting balances:  \n- End‑2022: $700 m – $3.7 m ≈ $696.3 m  \n- End‑2023: $696.3 m – $1.5 m ≈ $694.8 m  \n- End‑2024: $694.8 m – $2.6 m ≈ $692.2 m  \n\n**Interpretation:** American Tower is steadily chipping away at the 1.600 % notes each year rather than retiring the series in a single large payment. The modest, recurring amortizations indicate a deliberate strategy to spread repayment over the life of the issue, preserving liquidity while keeping the notes on the balance sheet until their 2026 maturity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative data. According to the ground truth, the outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million from 2022 to 2024, with 'adjustments to principal' decreasing from (3.7) million in 2022 to (2.6) million in 2024—likely representing accrued interest or non-cash amortization, not principal reduction. However, the LLM incorrectly interprets these adjustments as actual amortization payments reducing the principal, and further performs incorrect sequential subtractions, concluding that the principal declined to $692.2 million by end-2024. This contradicts the ground truth of a stable $700 million principal. (2) The cited amortization values are partially correct in magnitude but misinterpreted: $3.7M in 2022 and $2.6M in 2024 match the ground truth adjustments (though sign and meaning differ), but the 2023 value of $1.5M is not supported by the original answer and appears to be fabricated or misread. (3) The multi-hop reasoning is flawed: the model fails to recognize that a constant principal indicates no amortization of the note itself—this is a fixed-term instrument with no early repayment. The interpretation of a 'steady chipping away' is therefore incorrect. The actual strategy implied by stable principal and declining adjustments is one of predictable liability management, not active amortization. (4) Despite these errors, the answer is contextually relevant, addressing the right instrument, company, and time frame, and attempts proper synthesis and interpretation. Hence, moderate scores for qualitative accuracy and contextual relevance, but low quantitative accuracy due to incorrect numbers and calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 476,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth’s 10‑K filings show that from 2022 through 2024 the company repeatedly flagged the same regulatory risk – CMS could change the methodology used to calculate Medicare Advantage risk‑adjustment payments (and could freeze or cut the benchmark), exposing the business to lower capitation rates or retroactive recoupments. In each year the firm said it was mitigating that exposure by selectively adjusting members’ benefits and premiums, pulling plans out of counties where the economics no longer worked, tightening medical‑and‑operating cost‑management programs, and bolstering its readiness for CMS risk‑adjustment data‑validation (RADV) audits. The language in the 2024 filing simply re‑affirms that these strategies remain in place as the risk‑adjustment environment continues to evolve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: UnitedHealth Group (UNH) faced ongoing exposure to CMS changes in Medicare Advantage risk adjustment payment methodologies from 2022 to 2024. The company consistently responded with strategic adjustments including selective benefit and premium changes, county exits, cost management, and RADV audit preparedness. These points align fully with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised—scored 10 as no inaccuracies exist. (3) Multi-hop reasoning is sound: the LLM synthesizes consistent regulatory pressure across three years and maps corresponding strategic responses, correctly identifying the evolving yet continuous nature of CMS methodology changes and UNH’s adaptive strategies. The only minor gap is that the original answer explicitly notes CMS made changes 'each year' and that 2024 involved 'further refinement' of strategies, which the LLM captures implicitly but could have emphasized more clearly. (4) Contextual relevance is perfect—the response directly addresses both parts of the question: evolution of exposure and strategic responses over the three-year period. Wording differs slightly but meaning and substance are preserved. No factual errors, making this a strong 9/10 in overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 404,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "- **2022 10‑K:** The benefits summary listed a “merchandise and other discounts” as one of the components of the compensation package for team members 【page_6】.  \n- **2023 10‑K:** The same language appears again – employee compensation still includes “merchandise and other discounts,” with no new tier or percentage disclosed 【page_6】.  \n- **2024 10‑K:** The benefits section continues to reference “merchandise and other discounts” for team members, now alongside newer employee‑focused perks such as expanded paid‑membership options (Target Circle 360) that broaden the overall value proposition 【page_6】.  \n\n**Interpretation:** Over the three‑year period Target kept a core merchandise discount for employees, while progressively layering additional, more structured perks (e.g., paid‑membership programs) on top of that baseline. This steady presence of the discount, combined with the enrichment of the broader benefits suite, signals a deliberate strategy to reinforce employee financial well‑being and purchasing power as a lasting element of its total‑rewards approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Target consistently offered 'merchandise and other discounts' from 2022 to 2024, with no changes to the discount structure explicitly disclosed in the filings. All references to the 10-K pages and the continuity of the benefit are correct, and there are no numerical inaccuracies (quantitative accuracy is perfect, even though no specific numbers like percentages or dollar values are involved). The interpretation correctly identifies that the merchandise discount remained a stable component of the benefits package. However, the LLM answer misses some key qualitative developments emphasized in the ground truth: while it notes the addition of Target Circle 360 in 2024, it omits specific mentions of sick pay and tuition-free education assistance introduced in 2023, and the framing of benefits within 'equitable pay and belonging' and mental health services in 2024. These omissions reduce completeness and slightly weaken the synthesis of Target’s evolving financial well-being strategy. The reasoning is sound but not as comprehensive as the ground truth in connecting the dots across all three years. The answer remains contextually relevant and captures the core trend—stable discounts within an expanding total rewards strategy—just with less depth in the 2023 and 2024 strategic framing. Hence, correctness is high but not full.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 384,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "American Express’s foreign‑government bond holdings have stayed roughly the same size – about $600 million – and have been concentrated in very short‑dated, low‑yield securities.  The 2021 footnote (which is unchanged in the later 10‑Ks) shows a weighted‑average yield of roughly 2 % and a maturity profile of $628 million due within one year, only $1 million each in the 1‑5‑year and 5‑10‑year buckets (≈99 % of the portfolio is one‑year or less)【page_121】.  The summary of investment securities lists the same line‑item at $630 million in 2021 (and $581 million in 2020), indicating the balance has been stable through 2022‑2024【page_120】.  \n\nThis three‑year pattern – a modest, essentially unchanged exposure, heavily weighted to the shortest maturities and earning only a low‑single‑digit yield – signals a conservative risk appetite.  American Express treats foreign sovereign debt as a small, high‑quality, liquid component of its asset allocation, preferring safety and liquidity over higher return potential.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims American Express's foreign government bond holdings remained stable at around $600 million through 2022–2024, but the ground truth only confirms $630 million in 2022 and does not provide data for 2023 and 2024 balances. More critically, the LLM incorrectly states that the maturity and yield profile remained stable, citing a 2021 footnote unchanged in later 10-Ks. However, the ground truth shows substantial changes in yields: from 1.74% (≤1 year) in 2022 to 6.45% in 2023 and 5.86% in 2024, and from 2.42% to 4.48% to 2.03% for 1–5 year maturities. The LLM completely misses this volatility. (2) The quantitative inaccuracies are severe: it misrepresents yields across years, omits the sharp rise and subsequent drop in yields, and incorrectly asserts portfolio stability. The dollar amounts are approximately correct for 2022 but falsely extrapolated to 2023 and 2024. (3) The multi-hop reasoning is flawed: instead of analyzing the 3-year evolution in yield and maturity distribution as required, the LLM assumes no change based on outdated 2021 data, failing to synthesize actual year-over-year changes. It draws a conclusion about conservative strategy, which contradicts the ground truth showing a clear shift toward higher-yield, short-term investments in 2023 followed by a pullback in 2024—indicating dynamic, not static, strategy. (4) The contextual relevance is moderate because it addresses the right topic (foreign government bonds, risk appetite, asset allocation), but the factual foundation is incorrect, leading to an invalid conclusion. The model relies on outdated information and misses the core trend the question asks about. Thus, correctness is very low due to major factual and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 489,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements (which is not offset against the derivatives on the balance sheet) fell sharply after 2022 – it was **$1.494 billion in 2022**, dropped to **$800 million in 2023** (a $694 million decline), and fell further to **$491 million in 2024** (another $309 million decline)【page_102】【page_99】.  \n\nThe downward trend indicates that the company is progressively reducing the amount of un‑netted margin it must hold, suggesting tighter control of its derivative positions and more efficient netting/hedging of exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,494 million (or $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly. The calculated declines ($694M and $309M) are accurate and add value. (2) Quantitative accuracy is perfect—numbers, years, and calculations are correct, with acceptable format variation ($1.494 billion = $1,494 million). (3) The reasoning is sound: the downward trend is correctly identified, and the interpretation about reduced derivative exposure or improved risk management aligns with the ground truth. The LLM adds nuance by mentioning 'tighter control' and 'efficient netting/hedging,' which is a reasonable elaboration. (4) The answer is fully contextually relevant, addressing both the quantitative change and its implication for derivative exposure management. The only minor gap is that it does not explicitly mention 'Other assets, including intangibles - net' as the category to which the collateral relates, though it references master netting arrangements correctly. This slight omission in metric specificity prevents a perfect 10 on qualitative accuracy, but overall the answer is factually complete and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 347,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "- In the 2022 Form 10‑K the 2.700 % senior notes are shown as a $700 million issue dated March 29 2021, bearing a fixed 2.700 % coupon and maturing in 2031 (par‑call January 15 2031)【page_48】.  \n- The 2023 filing repeats the same entry – $700 million, 2.700 % coupon, issue date March 29 2021, maturity 2031 – with no additional issuance or amendment noted【page_111】.  \n- The 2024 filing’s note‑table no longer lists the 2.700 % series, indicating that the original issue remained unchanged and was simply carried forward as an existing low‑coupon tranche while the company issued higher‑rate notes (5 %‑plus) to refinance and fund growth【page_113】.  \n\n**Interpretation:** AMT did not issue new 2.700 % notes after 2021; it kept the original $700 million, 2.700 % tranche unchanged through 2022‑2024. This shows a financing strategy of locking in a relatively low fixed rate early and then relying on newer, higher‑interest offerings as market rates rose, using the cheap 2.7 % notes as a stable, low‑cost anchor while refinancing other debt at prevailing higher rates.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $700 million principal amount, 2.700% interest rate, March 29, 2021 issuance date, and initial maturity details from the 2022 and 2023 filings, which aligns with the ground truth. However, it incorrectly states that the 2.700% Notes were no longer listed in the 2024 filing (claiming they were delisted or replaced), which contradicts the ground truth that the notes were still outstanding with the same principal and maturity date. This is a major factual error. Additionally, the LLM introduces the claim that AMT issued 'higher-rate notes (5% plus)' for refinancing and growth, which is not supported by the original answer or implied in the ground truth. (2) Quantitatively, the dollar amount ($700 million), interest rate (2.700%), and issuance date (March 29, 2021) are accurate. However, the maturity date is misrepresented: the ground truth specifies January 15, 2031, as the maturity date by 2023 and 2024, whereas the LLM only says '2031' and references a par-call date without updating the actual maturity. More critically, the LLM fails to report the key quantitative update from 2024: the interest rate spread decreased from (5.0) to (4.4), which is a central part of the evolution in terms. This omission significantly undermines the answer’s completeness and accuracy. (3) The multi-hop reasoning is flawed. While the LLM correctly infers that maintaining the 2.700% notes suggests a strategy of locking in low rates, it incorrectly assumes the notes were retired or no longer listed in 2024, leading to a false narrative about refinancing with higher-cost debt. The ground truth shows continuity of the notes and a slight reduction in borrowing cost (via spread compression), indicating improved credit conditions or market perception, not a shift to higher-cost financing. The LLM’s reasoning is internally consistent but based on a false premise. (4) The contextual relevance is high—the answer addresses the evolution of terms and attempts to interpret financing strategy and market conditions. However, due to critical factual inaccuracies and omission of key data (spread change), the qualitative and overall correctness scores are significantly reduced. The answer is partially correct but contains major errors in entity status (existence of the notes in 2024) and unsupported claims about refinancing activity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 634,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "- **2022:** The 2.00 % notes due 2031 were carried on the balance sheet at roughly **$1.03 billion** (original‑issuance amount, net of discount and issuance costs)【page_78】.  \n- **2023:** The same notes were reported at **$1.04 billion** (fair‑value presentation)【page_67】.  \n- **2024:** The fair‑value amount rose to **$1.06 billion**, while the net‑carrying amount (including the unamortized discount) was **$1.25 billion**【page_67】【page_72】.  \n\n**Interpretation:** Over the three‑year span the liability grew only modestly, indicating that NVIDIA is using the 2 % 2031 notes as a stable, long‑term financing tool rather than rapidly expanding its debt load. The slight increase reflects normal refinancing or incremental issuance, consistent with a deliberate strategy to maintain a relatively flat long‑term debt profile while preserving financial flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has notable discrepancies in the quantitative values compared to the ground truth. In 2022, the ground truth reports a fair value of $1.2 billion, while the LLM states a carrying amount of $1.03 billion — this is a significant difference in magnitude and metric type (carrying value vs. fair value). The 2023 figures are closer: LLM reports $1.04 billion (fair value), which aligns approximately with the ground truth's $1.044 billion at beginning of year and $1.057 billion at year-end. However, the LLM simplifies this progression and does not reflect the stability over the year. In 2024, the LLM correctly identifies the $1.25 billion carrying value, matching the ground truth, and notes no short-term portion, which is consistent. The fair value of $1.06 billion in 2024 is close to the ground truth’s $1.057 billion, so this is acceptable within rounding. (2) Calculations are not required in this question, but tracking the progression across years is key. The LLM misrepresents the 2022 figure both in amount and in characterization (uses carrying value while original answer uses fair value), which affects quantitative accuracy. (3) The multi-hop reasoning is sound — the model synthesizes data across three years and draws a reasonable conclusion about NVIDIA’s long-term debt strategy, correctly identifying stability and strategic consistency. It distinguishes between fair value and carrying value in 2024, showing nuanced understanding. (4) Despite the wording differences and some conflation of financial metrics (fair value vs. carrying value), the overall interpretation about stable long-term debt management is semantically equivalent and contextually appropriate. The main deduction is for quantitative inaccuracy in 2022 and lack of precision in describing the 2023 stability. Hence, correctness is reduced to 7 due to material number mismatch early in the time series, though the trend and conclusion remain plausible.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 541,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife records reinsurance contracts that do not expose the reinsurer to a material insurance‑risk loss using the **deposit method**.  At the end of 2023 the balance‑sheet tables show **deposit assets of $5.1 billion** and **deposit liabilities of $1.3 billion**; by 31 December 2024 those balances had fallen to **$4.6 billion of deposit assets** and **$1.2 billion of deposit liabilities**【page_206】.  \n\nThe decline in both the assets and the offsetting liabilities indicates that MetLife is scaling back the volume of reinsurance it treats under the deposit method—likely a result of completing large risk‑transfer transactions (such as the 2023 Global Atlantic deal) and moving toward a more selective, lower‑volume use of deposit‑type reinsurance arrangements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative data. It states that deposit assets were $5.1 billion in 2023 and decreased to $4.6 billion in 2024, but the ground truth shows deposit assets increased to $5.1 billion by the end of 2024 (from $1.8B in 2022), with no mention of a drop to $4.6B. This is a critical error. Additionally, the LLM incorrectly implies a decline in deposit assets from 2023 to 2024, while the truth shows a consistent increase through 2024. The liability figures for 2023 ($1.3B) and 2024 ($1.2B) are correct, but the 2022 liability ($1.4B) is omitted. (2) The LLM misrepresents the trend: instead of showing growth in deposit assets (from $1.8B to $5.1B over three years), it claims a decrease from $5.1B to $4.6B, which contradicts the ground truth. The calculation of changes is therefore flawed. (3) The reasoning is partially sound—linking the Global Atlantic transaction to reinsurance activity is correct and contextually relevant—but the conclusion that MetLife is 'scaling back' contradicts the actual upward trend in deposit assets, undermining the multi-hop logic. The strategic interpretation is thus based on incorrect data. (4) While the answer addresses the question's focus on reinsurance strategy and uses correct terminology (deposit method, Global Atlantic), the core numerical inaccuracies severely limit factual correctness. Contextual relevance is high because it attempts to interpret trends and strategy, but the faulty data leads to an incorrect overall assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 426,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity (HTM) debt portfolio has been shrinking each year:\n\n* **2022:** Fair value $ 679 million; carrying (amortized‑cost) $ 696 million【page_53】  \n* **2023:** Fair value $ 596 million; carrying $ 603 million【page_53】  \n* **2024:** Fair value $ 508 million; carrying $ 512 million【page_55】\n\nBoth the market (fair) value and the book value fell roughly 13‑15 % over the three‑year period, with the fair‑value gap narrowing (the securities are now closer to their amortized cost). This pattern shows UNH is keeping the securities in an HTM classification despite falling market prices—reflecting a strategy of holding the assets to collect contractual cash flows rather than trading them, while recognizing the impact of higher interest‑rate‑driven valuation adjustments as temporary unrealized losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numeric values for fair value and carrying value of UnitedHealth Group's Debt Securities - Held-to-Maturity for 2022, 2023, and 2024, matching the ground truth exactly: $679M/$696M (2022), $596M/$603M (2023), $508M/$512M (2024). These figures are accurately cited with source page references. 2) Quantitative accuracy is perfect—no calculation or number errors. The approximate 13–15% decline over three years is a reasonable estimate (total drop from ~$679M to $508M in fair value is ~25% over two years, so annualized ~12.5%, close to stated 13–15%). While the percentage characterization is slightly imprecise (it's a cumulative ~25% drop, not 13–15% total), this does not constitute a factual error given the phrasing 'fell roughly 13–15% over the three-year period' likely referring to average annual decline. 3) The multi-hop reasoning is sound: the model synthesizes data across three years, correctly infers a shrinking portfolio, notes the narrowing fair-value-to-carrying-value gap, and links this to HTM accounting treatment and strategic intent. It adds insight beyond the original answer by explaining that UNH is holding securities despite market declines, consistent with HTM classification logic. 4) The LLM answer is semantically equivalent and even enhances the original with relevant financial context (e.g., interest-rate-driven valuation adjustments, unrealized losses, cash flow strategy). All entities—UnitedHealth Group (UNH), debt securities, held-to-maturity classification, fair and carrying values, and correct years—are accurate. Only minor deduction in qualitative accuracy due to slightly ambiguous percentage phrasing, but reasoning remains strong. Contextual relevance is perfect—fully addresses evolution, values, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 490,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "The filing shows that “RedCard” (Target‑branded credit‑card) penetration fell from **20.5 % in fiscal 2022**, to **19.8 % in fiscal 2023**, and to **18.6 % in fiscal 2024**【page_27】. The downward trend indicates that fewer guest purchases are being made with Target’s credit cards, suggesting the card program is becoming less effective at generating incremental sales for the retailer.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. All numeric values and time periods are accurate, satisfying quantitative accuracy. (2) The calculation and trend interpretation — a declining penetration rate — is logically sound and correctly derived from the data. (3) The reasoning correctly identifies the downward trend and its implication: reduced usage of the Target Credit Card (referred to as 'RedCard') in guest purchases, suggesting diminished effectiveness in driving incremental sales. However, the LLM answer omits a key nuance present in the original answer: despite the declining penetration, Target's internal analysis still finds that the card contributes meaningfully to incremental sales, indicating ongoing strategic value. This omission reduces completeness and slightly weakens the qualitative accuracy. (4) The answer remains highly relevant to the question, clearly addressing both the trend in penetration and its implications. While the conclusion about weakening effectiveness is partially valid, the lack of balance regarding Target’s continued recognition of the card’s value results in a slightly lower qualitative score. Overall, the answer is factually correct and well-aligned, but misses a critical layer of strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 381,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike’s Laakdal, Belgium site has been listed as one of its “most significant distribution facilities outside the United States” and has been described as **owned** in the property disclosures for FY 2022, FY 2023 and FY 2024. The consistency of ownership across the three years shows that Nike has kept the Laakdal center as a core, company‑controlled logistics hub for its Europe‑Middle East‑Africa operations, underscoring a strategic focus on maintaining direct control of key European distribution capacity rather than relying on leased or third‑party facilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly states that Nike owned the Laakdal facility in FY 2022, 2023, and 2024, matching the original answer's assertion of unchanged ownership and operational role. The description of Laakdal as one of the 'most significant distribution facilities outside the United States' is consistent with the ground truth's 'most significant international distribution centers.' (2) There are no numeric values requiring calculation, but the fiscal years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes ownership status across three years and infers strategic intent—maintaining direct control over European logistics—based on consistent ownership, which is a valid interpretation supported by the data. (4) The only minor shortcoming is that the LLM slightly expands the scope by specifying 'Europe-Middle East-Africa operations,' which is plausible but not explicitly stated in the ground truth; however, this does not detract from factual correctness. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 335,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Across NVIDIA’s FY 2022, FY 2023 and FY 2024 10‑K filings, Lumentum Holdings is repeatedly listed in the “networking products” category (switches, adapters and optical‑module suppliers) as one of the companies that compete with NVIDIA’s interconnect and data‑center solutions【page_15】【page_9】【page_16】. Even as NVIDIA expands its supply‑chain redundancy—adding more fabless, foundry and assembly partners in the Asia‑Pacific region—and tightens its IP‑protection regime (licensing, patents and enforcement)【page_8】【page_9】, Lumentum’s competitive positioning remains unchanged; it stays on NVIDIA’s competitor roster, indicating that NVIDIA’s broader supply‑chain and IP strategies have not displaced Lumentum but simply coexist with it in the same market segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lumentum Holdings is consistently listed as a competitor in networking products (optical modules, interconnect solutions) across NVIDIA’s FY2022, FY2023, and FY2024 10-K filings. The mention of Lumentum in the context of switches, adapters, and optical modules matches the original answer’s domain specification. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable beyond correct fiscal year references (2022–2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that despite NVIDIA’s expansion in supply chain (e.g., adding fabless, foundry partners in Asia-Pacific) and enhanced IP protection (licensing, patents), Lumentum remains a named competitor, indicating persistent competitive relevance. This mirrors the ground truth’s conclusion about coexistence despite strategic advancements. (4) The only minor shortcoming is that the LLM does not explicitly mention specific partners like TSMC or Samsung, nor does it reference the extension of patent expirations to 2045, which are details included in the original answer that strengthen the IP strategy narrative. However, the core claim—that NVIDIA’s supply chain and IP strategies have not displaced Lumentum—is correctly inferred and well-supported. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the evolution of competitive positioning in relation to supply chain and IP strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 442,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "- In the 2022 Form 10‑K Netflix framed its reliance on rights‑holders as a risk: it said the service “depends on studios, content providers and other rights‑holders licensing rights” and warned that many of those owners were launching their own streaming services, could refuse to license popular titles, and were driving up licensing costs, forcing Netflix to be more selective about what it adds or renews.  \n\n- By the 2023 and 2024 filings the tone had shifted. The company still acknowledges that licensed content is essential, but now emphasizes that it is managing “varying license periods and terms,” seeking exclusive rights where possible, and increasingly balancing licensed inventory with a growing slate of original productions to meet new content‑quota, levy and investment regulations.  \n\n**What this reveals:** Netflix’s content‑acquisition strategy has moved from treating rights‑holder dependence mainly as a vulnerability to treating it as a managed component of a broader, more diversified approach—leveraging exclusive licensing deals and expanding its own originals to offset rising competition and tightening regulatory requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: Netflix's reliance on rights holders was framed as a risk in 2022 due to studios launching competing services and increasing costs; in 2023, the focus remained on variable license terms; and in 2024, regulatory factors like content quotas and investment obligations were added as constraints. The LLM correctly captures the evolution of Netflix’s strategy from vulnerability to managed integration with original content. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years (2022–2024), correctly identifying shifts in tone and strategic emphasis in Netflix’s 10-K filings. It accurately links rising competition and regulatory changes to Netflix’s strategic pivot toward exclusives and originals. (4) The only minor shortcoming is that the LLM slightly condenses the 2024 regulatory point without explicitly naming 'ownership rights' as a constraint, but it does mention 'content-quota, levy and investment regulations,' which captures the essence. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually complete, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, and 10s for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 418,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "- **2022 filing** – The 2022 10‑K first identified the outdoor‑lighting arrangements as **operating leases** and said that the **scheduled payments to be received are immaterial** (the note on Mississippi Power’s outdoor‑lighting contracts).  The payments were **included in the “maturity analysis” tables** that show operating‑lease obligations, but no separate revenue line was called out for them.\n\n- **2023 filing** – The 2023 10‑K kept the same accounting treatment (operating‑lease income) but expanded the disclosure: the note now says the **outdoor‑lighting cash‑flows are immaterial at both Georgia Power and Mississippi Power**, and it again **places the scheduled payments in the maturity‑analysis tables**.  Lease income for the operating‑lease component (which includes the lighting contracts) is shown separately from variable‑lease income and sales‑type‑lease interest.\n\n- **2024 filing** – By 2024 the company still treats outdoor‑lighting contracts as **operating leases** and continues to **present the scheduled payments in the consolidated maturity‑analysis schedules**.  The filing no longer repeats the “immaterial” comment, implying the amounts remain insignificant, but the **revenue classification is now explicitly listed under “Lease income – operating leases”** in the lease‑income table, reinforcing that the lighting payments are part of operating‑lease revenue rather than variable or sales‑type lease revenue.  \n\n**In short, from 2022‑2024 Southern Company consistently classified outdoor‑lighting payments as operating‑lease revenue, always showed the scheduled amounts in the lease‑obligation maturity tables, and repeatedly emphasized that the amounts are immaterial, with the 2024 filing simply integrating the disclosure into the standard operating‑lease revenue line.**",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of dates (2022–2024), entities (Southern Company, Mississippi Power, Georgia Power), and key disclosures around operating lease classification and inclusion in maturity analyses. It correctly notes the immateriality statement in 2022 and 2023 and its absence in 2024, as well as the consistent treatment as operating leases and inclusion in maturity tables. However, there is a critical discrepancy in the claim that scheduled lease *payments to be received* were included in the maturity analysis tables in 2022. Maturity analyses in lease accounting typically present *lessee obligations* (i.e., payments to be made), not lessor receivables. The original answer refers to scheduled lease *payments* being included in maturity analyses, but in context, this likely refers to obligations on the part of the company or its subsidiaries as lessee. The LLM incorrectly frames the outdoor lighting contracts from the lessor perspective (i.e., payments to be received), which misrepresents the nature of the disclosure and contradicts standard lease maturity table presentation. This affects qualitative accuracy, as it reflects a misunderstanding of lease accounting presentation norms. While the LLM correctly identifies the evolution in revenue classification (explicit inclusion under 'Lease income – operating leases' in 2024), the ground truth does not mention Georgia Power in 2023, which the LLM adds without support. Despite these issues, the core timeline and directional evolution—increased transparency and formalization of disclosure—are correctly captured, and all referenced years and classifications align. Quantitative accuracy is perfect: no numerical errors, and dates are correct. Contextual relevance is high, as the response directly addresses materiality, revenue classification, and presentation in maturity analyses across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1682,
        "completion_tokens": 518,
        "total_tokens": 2201
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "- Fiscal 2022: the 5.000 % senior notes due April 2030 carried an outstanding principal of **$606 million**【AVGO_10k_2022.pdf p. 101】.  \n- Fiscal 2023: the same notes still showed an outstanding principal of **$606 million**【AVGO_10k_2023.pdf p. 81】.  \n- Fiscal 2024: the balance remained **$606 million**【AVGO_10k_2024.pdf p. 81】.  \n\nThe balance has been unchanged for three consecutive years, indicating that Broadcom has chosen to keep this tranche as a stable, long‑term financing source rather than accelerating repayment; it is managing overall leverage by issuing new senior notes and repaying other term‑loan facilities while leaving the April‑2030 5 % notes untouched.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative claims. According to the ground truth, the outstanding principal was $1,086 million in fiscal year 2022, not $606 million. The LLM incorrectly states that the balance was $606 million in all three years, while in reality, it decreased from $1,086M (2022) to $606M (2023), then remained flat in 2024. This error fundamentally undermines the answer’s correctness. (2) The cited numbers are inconsistent with the ground truth: the $606M figure is correct for 2023 and 2024 but not for 2022. The LLM fails to reflect the $480M reduction between 2022 and 2023, which is a key part of the debt management narrative. (3) The multi-hop reasoning is flawed because the model did not detect the change in balance between 2022 and 2023. As a result, the qualitative interpretation—that the balance has been stable and reflects a strategy of maintaining long-term financing—is incorrect. The actual progression indicates an active debt reduction in 2023, which the LLM overlooks entirely. (4) While the answer is relevant to the question and attempts to interpret strategy, the severe factual inaccuracies in the core data lead to a low correctness score. The contextual relevance is moderate because the structure and intent align with the question, but the foundation is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 373,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "GM’s assumed long‑term return on U.S. pension‑plan assets was 6.30 % in 2022, held steady at 6.30 % in 2023, and was raised to roughly 6.5 % (6.27 % in the detailed table) for 2024 【page_86†L44-L48】【page_87†L44-L48】【page_88†L57-L60】.  \n\nThe upward shift in 2024 follows a three‑year trend of keeping the return assumption flat and then increasing it as GM re‑balanced its pension‑plan mix—cutting the debt share (from 69 % in 2022 to 60 % in 2023‑24) and expanding the “Other” category (private‑equity, real‑estate, hedge‑fund strategies) from 23 % to 29 %—a move that signals a strategic tilt toward higher‑return, alternative assets to improve funded status amid changing market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative values. According to the ground truth, the long-term rate of return was 5.4% in 2022, not 6.3%. The LLM incorrectly states it was 6.3% in 2022 and remained flat, when in fact it increased from 5.4% to 6.3% between 2022 and 2023 — a 0.9 percentage point increase, not a flat period followed by a small rise. The 2024 figure of 6.5% is correct, but the LLM cites a detailed table value of 6.27%, creating confusion. (2) The calculation of the 3-year trend is therefore flawed: the actual trajectory is a 1.1 percentage point increase from 5.4% (2022) to 6.5% (2024), whereas the LLM implies only a recent upward shift after two years of stability, misrepresenting the trend. (3) The qualitative reasoning about strategic asset mix adjustments — reducing debt from 69% to 60% and increasing 'Other' to 29% — is plausible and contextually sound, showing correct multi-hop synthesis of asset allocation shifts and their implications. This part aligns with the type of analysis expected and supports the conclusion about a shift toward higher-return alternatives. (4) Contextual relevance is high because the answer addresses both parts of the question: the evolution of return assumptions and the strategic implications. However, the core numerical inaccuracies — especially the incorrect 2022 value — severely undermine the correctness score, as financial assumptions in pension accounting are highly sensitive to precise percentages. Despite good structure and relevant reasoning, the answer is factually incorrect on a key data point, leading to a misleading interpretation of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 456,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "The 2.700 % Senior Notes due 2031 first appear in the March 29 2021 supplemental indenture (listed in the 2022 filing) and are carried forward in the 2023 and 2024 10‑K exhibit tables — they remain disclosed as an outstanding tranche of senior debt. By keeping this low‑coupon, long‑dated issue on its balance sheet, American Tower shows that it relies on inexpensive, fixed‑rate financing that extends well beyond the near‑term, using long‑term senior notes to lock in cheap capital and support its ongoing growth and refinancing strategy.【page_70†L31-L38】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core conclusion as the ground truth: American Tower's consistent treatment of the 2.700% Senior Notes due 2031 across 2022–2024 filings reflects a stable, long-term financing strategy. (1) All key facts are correct: the notes were established under the March 29, 2021 Supplemental Indenture No. 8, first disclosed in the 2022 filing, and carried forward in 2023 and 2024. The percentage (2.700%) and maturity year (2031) are accurate. (2) Quantitative elements—date (March 29, 2021), interest rate, and years of disclosure (2022–2024)—are all factually correct with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to infer continuity in debt treatment and links this to strategic use of low-cost, fixed-rate, long-term financing. (4) While the LLM does not explicitly name 'Supplemental Indenture No. 8' in the 2023 and 2024 context (though it references the same March 29, 2021 indenture), it accurately captures the continuity and strategic implication. The omission of the 'No. 8' detail in later years is minor and does not affect the overall correctness. The answer adds valuable interpretation—'low-coupon, long-dated', 'lock in cheap capital'—that aligns with and enriches the ground truth. Thus, the answer is semantically equivalent and contextually excellent, meriting a 9 for qualitative accuracy and 9 overall for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 406,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "From 2022 to 2024 PayPal repeatedly warned that abusive‑behavior risk – especially synthetic‑identity fraud, account‑takeovers and other large‑scale schemes – was growing and that its credit‑product portfolio (consumer‑credit, PayPal Working Capital and BNPL loans) was increasingly vulnerable to higher non‑payment rates and to the limits of its third‑party lender partners.  At the same time the company highlighted that cross‑border trade was exposed to rising foreign‑exchange volatility, tariffs, sanctions and other regulatory frictions that could shrink international volumes.  To contain those risks, PayPal first bolstered its fraud‑detection policies and risk‑model governance (2022), then off‑loaded a large portion of its U.K.‑and‑Europe BNPL loan book and added forward‑flow and other third‑party funding arrangements while beginning a migration away from a single U.S. processor (2023), and in 2024 accelerated diversification of payment‑processor partners, pursued strategic transactions and additional third‑party funding sources, and continued to refine its credit‑risk models and compliance programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal identified rising abusive behaviors in credit products in 2022, offloaded up to €40 billion of U.K. and European BNPL receivables in 2023 (correctly described as off-loading the BNPL loan book), and in 2024 continued refining risk models and expanding third-party funding and processor diversification. While the exact €40 billion figure is not mentioned in the LLM answer, the strategic action of selling BNPL receivables is accurately captured, and no incorrect numbers are presented—thus quantitative accuracy remains high. (2) The LLM correctly identifies the evolution across the three years, including the shift from detection (2022), to risk transfer via asset sales and funding changes (2023), to ongoing mitigation through model refinement and partner diversification (2024). (3) Multi-hop reasoning is sound: the answer synthesizes PayPal’s exposure across credit products and cross-border transactions, links it to third-party dependencies, and traces strategic responses over time. (4) Minor omission: the original answer emphasizes the use of stolen identities and the reputational risk from third-party processors, which the LLM touches on but with slightly less emphasis. However, the core trajectory—identify, offload, strengthen—is fully preserved. Wording differs but semantic meaning matches. Contextual relevance is excellent as all parts of the question are addressed with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 420,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "- 2022: The pension plan held **$622 million** in collective‑trust and other funds (NAV)【page_58】.  \n- 2023: That balance fell to **$382 million** (NAV)【page_57】.  \n- 2024: It slipped slightly further to **$370 million** (NAV)【page_57】.  \n\nThe steady decline – a 39 % drop from 2022 to 2023 and a modest additional drop in 2024 – shows UNP is pulling back from commingled‑fund investments and reallocating assets toward other categories (e.g., debt securities, venture‑capital and real‑estate partnerships). This reflects the company’s broader de‑risking strategy for its pension portfolio, emphasizing more stable, long‑term returns to support employee benefit obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 value: it reports $622 million, while the ground truth states $756 million. This discrepancy affects the accuracy of the trend analysis. The 2023 value ($382 million) is correct. The 2024 value is reported as $370 million in the LLM answer, but the original answer states that no updated dollar value is provided for 2024—only a qualitative note about NAV-based valuation. Thus, the inclusion of a specific 2024 dollar amount is incorrect. (2) The percentage drop of 39% from 2022 to 2023 is based on the incorrect starting value (622M → 382M implies ~38.6% drop), whereas the actual drop from 756M to 382M is ~49.5%, a substantial difference. The 'slight further drop' to $370M in 2024 is unsupported by the original answer, which explicitly states no updated dollar figure is available. (3) The reasoning about de-risking and rebalancing is consistent with the original answer and plausible given the decline, so the qualitative interpretation is partially sound. However, the LLM introduces specific reallocations to 'debt securities, venture-capital and real-estate partnerships' that are not mentioned or supported in the original answer, adding unsupported detail. (4) Despite these errors, the LLM captures the overall downward trend and infers a de-risking strategy, which aligns with the original conclusion. The contextual relevance is high as it addresses both parts of the question—trend and strategic implication—and attempts multi-hop synthesis. However, the incorrect numerical data and unsupported specifics reduce factual correctness significantly. Quantitative accuracy is low due to wrong numbers and miscalculated trend; qualitative accuracy is moderate due to correct directional logic but added unsupported details; contextual relevance is high as the response remains focused and relevant to the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 517,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "- **2022** – Pfizer granted Breakthrough Performance Awards (BPAs).  The 2022 10‑K shows BPA activity (fair‑value of shares vested **$11.7 million** and a pre‑tax compensation cost of **$255 million**) and the awards were valued **using the intrinsic‑value method (closing‑price of the common stock)** and **amortised on a straight‑line basis over the probable vesting term** (see the BPA table and valuation note in the 2022 filing).  \n\n- **2023** – The company **did not grant any BPAs** and **no BPAs were outstanding at year‑end** (Note 13, 2023 10‑K).  The remaining expense related to the prior‑year awards was recorded (fair‑value of shares vested **$10.71 million**, compensation cost **$244 million**) using the same intrinsic‑value, straight‑line amortisation methodology as in 2022.  \n\n- **2024** – Again **no BPAs were granted and none were outstanding** (Note 13, 2024 10‑K).  Pfizer’s disclosure repeats that BPAs are **valued at grant‑date intrinsic value (closing price) and amortised straight‑line over the probable vesting term**, but with **no new grant activity and only a minimal residual compensation cost ($4 million pre‑tax)** because the awards had all been settled or forfeited.  \n\nThus, from 2022 to 2024 Pfizer moved from an active grant year with outstanding BPAs (valued intrinsically and expensed over the vesting period) to a period with no new grants and, by 2023‑2024, no outstanding BPAs, while retaining the same intrinsic‑value, straight‑line accounting treatment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Pfizer's BPA treatment and correctly identifies key qualitative aspects: BPA grants in 2022, no grants or outstanding awards in 2023 and 2024, and the continued use of the intrinsic value method with straight-line amortization. However, there are significant quantitative inaccuracies that undermine factual correctness. The ground truth states that in 2022, Pfizer issued 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand outstanding at year-end valued at $59.05 per share. The LLM instead cites aggregate compensation costs ($255M) and fair value of vested shares ($11.7M), which are not equivalent to grant volume or per-share valuation data and were not requested in the question. These figures, while possibly present in the filing, do not directly address the requested metrics on grant activity and outstanding status. Furthermore, the LLM claims residual compensation cost of $4M in 2024 but does not mention the key 2024 development: the formalization of a new valuation framework involving quarterly adjustments for stock price changes and performance probability assessments—this is a critical omission in the evolution narrative. The model incorrectly implies the accounting treatment remained unchanged, when in fact the 2024 update introduced dynamic quarterly adjustments, marking a methodological shift. While the entity (Pfizer), years (2022–2024), and general trend (discontinuation of grants, no outstanding awards) are accurate, the failure to report the correct quantitative disclosures and the omission of the updated accounting methodology in 2024 result in a partially correct answer. The reasoning is logically structured and contextually relevant, but the quantitative inaccuracies and missing key 2024 update reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1594,
        "completion_tokens": 500,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s disclosed collateral that sits in master‑netting arrangements (and is **not** offset against its derivative positions) fell sharply over the three‑year span:\n\n* **2022:** $1,494 million of collateral 【page_102】  \n* **2023:** $800 million of collateral 【page_102】【page_99】  \n* **2024:** $491 million of collateral 【page_99】\n\nThe downward trajectory—from roughly $1.5 billion in 2022 to under $0.5 billion in 2024—indicates that the company’s margin‑related collateral requirements have been decreasing. This suggests either a reduction in the size or risk profile of its derivative positions, more efficient netting of exposures, or lower initial‑margin calls, all pointing to a diminishing derivative exposure and lighter margin burdens over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all values are accurate: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024—matching the original answer exactly, with acceptable formatting variations (e.g., $1.5 billion ≈ $1,494 million). (2) The answer is complete, addressing both the change in collateral over time and the implied trend regarding derivative exposure and margin requirements. (3) Entity accuracy is correct: ExxonMobil (XOM), proper years (2022–2024), and the financial metric 'collateral under master netting arrangements' are correctly identified and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis: the decreasing collateral is correctly interpreted as indicating reduced derivative exposure or lower margin requirements, with plausible contributing factors (e.g., smaller derivative positions, more efficient netting, lower initial margin). The semantic meaning and factual content are equivalent to the ground truth, with slightly enhanced explanation that does not introduce error. All citations (page references) align with the data source locations, further supporting accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 339,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Across the three filings Broadcom’s description of **industrial‑grade fiber‑optic products remained a stable pillar of its “Industrial” portfolio**.  \n\n* 2022 10‑K – the product is listed among “industrial fiber optics” and is grouped with optocouplers, sensors, motion encoders, LEDs and Ethernet ICs, with the filing noting that these parts are used in **factory automation, power‑generation/distribution, medical, defense/aerospace and vehicle subsystems**.  \n\n* 2023 10‑K – the same line‑item appears in the product‑family table and the narrative again cites **factory automation, renewable‑energy and automotive electronics**, expanding the wording to explicitly cover **renewable‑energy systems** as well as the broader industrial‑automation ecosystem.  \n\n* 2024 10‑K – the wording is unchanged, still positioning industrial fiber optics alongside the same complementary components and emphasizing its role in **automation, renewable‑energy, automotive power‑train, infotainment and advanced‑driver‑assistance applications**.  \n\nThe consistency—and the gradual broadening of the application list—shows that Broadcom is deliberately treating industrial fiber optics as a core, cross‑segment enabler for high‑speed connectivity in its expanding industrial‑market strategy, targeting automation, clean‑energy and automotive/e‑vehicle growth areas rather than treating it as a peripheral niche.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Broadcom maintained Industrial Fiber Optics as a core part of its industrial portfolio across 2022–2024, with consistent grouping alongside optocouplers, sensors, encoders, and Ethernet ICs. The application areas cited—factory automation, power/renewable energy, medical, defense/aerospace, automotive subsystems—are accurately reported for each year. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) and categorical descriptions are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, noting the evolution in application emphasis—from broader industrial uses in 2022 to more structured, application-specific focus (e.g., renewable energy, automotive electronics) in 2023 and 2024. The conclusion about strategic focus on automation, clean energy, and automotive is logically supported. (4) Minor difference: the original answer notes a shift in presentation format (e.g., structured table in 2023, streamlined integration in 2024), which the LLM does not explicitly mention, though it captures the substance of increasing application specificity. This omission slightly affects qualitative depth but does not undermine factual correctness. Overall, the LLM conveys semantic equivalence and strong contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 419,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—PayPal repeatedly describes itself as the **principal** in each payment transaction. It says it **controls the service, sets the fee independently of the costs it incurs when using third‑party processors, and therefore **bears full margin risk**; the processor fees are recorded as transaction expense. Consequently, PayPal’s exposure to margin risk did not diminish over the period; it remained high and unchanged as the company retained pricing discretion and full margin responsibility each year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) It correctly identifies PayPal's role as the principal in transactions across 2022, 2023, and 2024, accurately stating that PayPal controls pricing, uses third-party processors, and bears full margin risk—consistent with the ground truth. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes consistent disclosures across three years, correctly inferring that margin risk exposure remained unchanged due to retained pricing discretion and recognition of processor fees as transaction expenses. (4) All entities—PayPal, third-party processors, transaction pricing, margin risk—are accurately identified and logically connected. The answer fully addresses the question’s focus on the evolution (or lack thereof) of margin risk in relation to pricing control and third-party processor use. Wording differs slightly but conveys identical meaning, meeting all scoring criteria at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 325,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "After the December 31 2021 sale of Meridian for about $51 million (recording a $167 million after‑tax loss), Pfizer’s 2022 Form 10‑K shows only a modest $6 million post‑sale gain in discontinued‑operations results, indicating the transaction and its immediate adjustments were largely settled. The 2023 filing describes the interim transition‑service agreements (TSAs) and a three‑year manufacturing‑supply agreement (MSA) that were in place after the sale, with all TSA services completed by year‑end 2023 and the MSA still active but not material to results; by the 2024 filing Meridian is mentioned only as a defined term with no further financial or contractual detail. This trajectory—from divestiture and loss absorption, through a brief period of transition‑service contracts, to complete wind‑down—demonstrates Pfizer’s strategic decision to exit the Meridian business and concentrate long‑term on its core biopharma portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $51 million sale price and $167 million loss are accurately reported, consistent with the 2021 sale; the $6 million post-sale gain in 2022 is correctly noted. The timeline (sale in 2021, TSAs completed by end of 2023, MSA active but not material) matches the source. (2) The LLM correctly identifies the contractual evolution: transition-service agreements (TSAs) and the three-year Manufacturing Supply Agreement (MSA) post-sale, with TSAs ending by 2023. While the original answer mentions a two-year extension option for the MSA, this detail is minor and not critical to the overall conclusion. (3) Entity accuracy is strong: 'Meridian Medical Technologies, Inc.' is correctly referenced in context, and Pfizer is accurately portrayed. (4) The reasoning is sound and captures the multi-hop progression: from divestiture in 2021, financial impact in 2022, contractual transition in 2023, to minimal mention in 2024—indicating strategic exit. The conclusion about Pfizer refocusing on core biopharma and platform technologies (e.g., mRNA) is logically supported. The only minor gap is the omission of the MSA extension option, which slightly reduces completeness but does not affect the overall correctness. Semantic equivalence is maintained, and the answer fully addresses financial impact, contractual arrangements, and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 406,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "In the 2022 filing PMI warned that a growing suite of product‑regulation measures – bans on advertising, plain‑packaging rules and limits on health‑warning displays – could “commoditise” its tobacco brands and “reinforce down‑trading trends…by limiting branding, communication and product differentiation” for its reduced‑risk products (RRPs) (2022 p.13, p.16, p.20). By 2023 the company’s risk narrative had shifted to the specific “administrative and legal challenges” surrounding its smoke‑free products (SFPs), citing alleged restrictions on product classification, advertising, distribution and corporate communications that “diminish the ability to differentiate…and restrict adult‑consumer access to truthful, non‑misleading information” (2023 p.18‑19). The 2024 filing repeats this focus, emphasizing that ongoing regulatory scrutiny of SFP classification, advertising and communication continues to threaten PMI’s ability to differentiate its reduced‑risk portfolio and to convey product‑characteristics to adult smokers, indicating that the impact of regulation on its competitive positioning has become more acute and product‑specific over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—Philip Morris International (PMI), reduced-risk products (RRPs), smoke-free products (SFPs), and the years 2022–2024—are correctly identified and appropriately contextualized. The evolution of regulatory impact is accurately traced across the three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable in a traditional sense; however, the cited page numbers (e.g., 2022 p.13, p.16, p.20; 2023 p.18–19) are consistent with typical 10-K filing references and do not contradict the ground truth, earning full marks. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how regulatory constraints evolved from general product differentiation and communication limits in 2022, to more targeted challenges on SFPs in 2023 and 2024. It accurately captures the shift in terminology from RRPs to SFPs and the intensification of regulatory burden. The conclusion that the impact has become 'more acute and product-specific over time' is semantically equivalent to the ground truth's assertion of a 'deepening regulatory challenge.' (4) The only minor shortcoming is that the LLM does not explicitly mention the 'disproportionate impact on commercialization relative to competitors' noted in the 2023 ground truth, which slightly weakens the completeness of the competitive positioning analysis. However, the core themes—restricted differentiation, limited adult consumer communication, and increasing regulatory specificity—are all well-covered. Overall, the answer is factually correct, contextually rich, and logically structured, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 490,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil reported $1.494 billion of collateral held under master‑netting arrangements at 12/31/2022, which fell to $0.800 billion at 12/31/2023 (a $0.694 billion drop) and further to $0.491 billion at 12/31/2024 (a $0.309 billion drop). Overall, collateral exposure shrank by roughly $1.0 billion between 2022 and 2024. The steady decline indicates that the company is increasingly offsetting its derivative positions with netting and margin efficiencies, reflecting a tightening of its derivative risk‑management framework and more effective use of collateral.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,494 million (2022), $800 million (2023), and $491 million (2024), with accurate formatting variations (e.g., $1.494 billion = $1,494 million). The calculated drops ($694 million from 2022 to 2023 and $309 million from 2023 to 2024) are correct, and the total decline of approximately $1.0 billion is a reasonable rounding of the actual $1,003 million drop. (2) All financial data and time periods are accurately cited with correct entity (ExxonMobil/XOM) and metric (collateral under master netting arrangements related to Notes and accounts receivable - net). (3) The multi-hop reasoning is sound—synthesizing year-over-year changes across three years and interpreting the trend in the context of derivative risk management. The conclusion about tightening risk management and improved collateral efficiency aligns with the ground truth’s interpretation of strategic reduction and proactive risk mitigation. (4) The only minor difference is in phrasing: the LLM emphasizes 'more effective use of collateral' and 'margin efficiencies,' while the original highlights 'lower margin requirements or proactive risk mitigation.' These are semantically similar and both logically supported. No factual inaccuracies; excellent quantitative precision and contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 374,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "- **2022:** Duke Energy’s model used an expected volatility of **about 28.6 %** for the TSR‑based performance‑award simulations.【page_206】\n\n- **2024:** The same model was run with an expected volatility of **about 18.7 %**.【page_215】\n\n**Interpretation:** The volatility assumption fell sharply from roughly 28 % to under 19 % over the two‑year span. This downward adjustment signals that Duke Energy’s management viewed the company’s stock‑price risk relative to its peer group as decreasing, implying a more modest market‑risk perception in 2024 than in 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Duke Energy's expected volatility was 26.9% in 2022, not 'about 28.6%' as stated. The LLM incorrectly assigns the 2023 value (28.6%) to 2022. While the 2024 value (18.7%) is correctly reported, the 2022 figure is wrong, leading to an incorrect trend narrative. The ground truth shows a rise from 26.9% (2022) to 28.6% (2023), then a sharp drop to 18.7% (2024), but the LLM implies a direct decline from ~28.6% in 2022 to 18.7% in 2024, omitting both the correct 2022 value and the entire 2023 data point. (2) The calculation and comparison are flawed due to incorrect input values. The 'sharp fall from roughly 28% to under 19%' is based on wrong attribution of the 28.6% figure to 2022. The actual trend includes a short-term increase in 2023, which the LLM completely misses. (3) The multi-hop reasoning is partially sound in that it draws a logical conclusion from volatility changes to market risk perception, but it fails to synthesize information across all three years as required. The omission of 2023 and misattribution of 2022 data breaks the multi-hop chain and distorts the trend analysis. (4) The contextual relevance is high because the answer addresses the right metric (expected volatility in TSR-based model), the correct company, and attempts interpretation. However, due to key numerical errors and missing data points, the overall correctness score is reduced to 5—partially correct but with significant factual flaws that affect the validity of the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 441,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Broadcom’s 3.125 % senior notes that mature in January 2025 carried a **principal balance of $495 million** in the 2023 filing (as of October 29 2023) and the same $495 million in the 2024 filing (as of November 3 2024). The 2022 filing shows the same line item with a $495 million balance, indicating that the amount has **not changed** over the three fiscal years.\n\nBecause the balance of this near‑term note has been left untouched while the company simultaneously issued large new senior‑note programs (e.g., $5 billion in July 2024 and $5 billion in October 2024) and repaid sizable term‑loan facilities, Broadcom is **using fresh long‑dated debt to refinance and offset its short‑term obligations**. The steady $495 million exposure demonstrates that the company is deliberately keeping the short‑term liability flat, relying on the larger, lower‑cost senior‑note issuances to manage liquidity and avoid a concentration of refinancing risk in the near term.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate in terms of quantitative details: the $495 million principal balance for the 3.125% notes due January 2025 is correctly reported for fiscal years 2022, 2023, and 2024, matching the ground truth. The dates (October 29, 2023; November 3, 2024) align with Broadcom’s fiscal year-ends, and the amounts are consistent across years, confirming no principal change. This satisfies the quantitative accuracy criterion fully. The entity (Broadcom/AVGO), metric (3.125% notes), and time periods (2022–2024) are all correctly identified. Regarding reasoning, the LLM correctly infers that the stable balance indicates no repayment or issuance changes, which aligns with the ground truth. It goes further by referencing Broadcom’s new debt issuances in July and October 2024 ($5 billion each), which are factually accurate and support the claim of refinancing via long-dated debt. However, the ground truth does not include these additional issuances or the explicit strategy of using new debt to offset short-term obligations—this is a plausible inference but represents an extension beyond the provided knowledge graph. While logically sound, this added interpretation slightly exceeds the evidence in the original answer, which only notes the transition to current portion in 2024 and implies refinancing planning. Thus, the qualitative reasoning is strong but introduces external synthesis not fully grounded in the provided truth. The answer is fully contextually relevant, addressing all parts of the question: evolution over three years and implications for short-term debt and refinancing strategy. Minor deduction in correctness and qualitative accuracy due to extrapolation beyond the ground truth, but core facts and multi-hop synthesis (stable debt → impending maturity → refinancing preparation) remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 497,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings AMD’s language about its add‑in‑board (AIB) partners is unchanged: the company states that its agreements with AIB manufacturers “protect their inventory of our products against price reductions,” and that system integrators “often use discrete‑graphics solutions as a means to differentiate their products and add value to their customers.” In other words, AMD has consistently kept an inventory‑protection policy for AIBs while continually positioning discrete graphics as a core differentiator for its SI channel throughout the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the consistent inventory protection policy AMD maintained from 2022 to 2024 for AIB manufacturers against price reductions, which is explicitly stated in the original answer. It also accurately captures the role of discrete graphics as a differentiation tool for system integrators, a key strategic point emphasized across all three years. (2) There are no numeric values or calculations in this question, so quantitative accuracy is not applicable beyond correct referencing of years (2022–2024), which are all accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings to infer stability in AMD’s strategic positioning, correctly identifying the continuity in language and policy. It does not overstate changes or introduce unsupported claims. The only minor shortcoming is that it omits the detail about AMD supplying component-level graphics and chipset products to AIBs, and the emphasis on short design cycles and rapid response to technology shifts, which adds slight contextual depth missing in the LLM version. (4) Despite this small omission, the LLM answer conveys the core strategic continuity accurately and uses semantically equivalent phrasing (e.g., 'core differentiator' = 'means to differentiate'). The answer is fully relevant to the question and correctly focuses on inventory protection and differentiation via discrete graphics across the specified timeframe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 421,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "- **2022:** Disney’s DTC plan was built around a modest‑scale rollout – it reorganized the DMED unit, introduced an ad‑supported Disney+ tier, raised subscription prices and began a cost‑realignment effort, positioning the service as a new growth lever while acknowledging that an expanding set of SVOD rivals would intensify competition.  \n- **2023:** The company deepened the strategy, further rationalizing DMED costs, adding a content‑curation overhaul and expanding marketing and technology spend; it warned that DTC execution costs could rise faster than anticipated but projected that higher subscription fees and advertising revenue from the ad‑supported tier would offset the decline in linear‑network affiliate and ad income.  \n- **2024:** Disney shifted to a broader, multi‑service DTC investment – launching ESPN+ as a flagship offering, expanding bundling and pricing experiments, and committing additional capital to content and technology – while still confronting fierce competition and pricing pressure; nevertheless, it now expects DTC subscription‑ and ad‑revenue growth to “more‑than offset” the ongoing losses in its traditional TV businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of the evolution of Disney's DTC strategy from 2022 to 2024. (1) Key facts are accurate: in 2022, Disney acknowledged financial risks and competitive pressures; in 2023, it projected that DTC subscription and ad revenue growth would offset declines in linear revenue; by 2024, it emphasized operational dependence on DTC despite intensifying competition. The LLM correctly captures the shift from caution to strategic confidence and growing competitive challenges. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) Minor discrepancies exist in emphasis: the LLM mentions specific actions like launching ESPN+ as a 'flagship' and 'content-curation overhaul' that are not explicitly detailed in the ground truth, which focuses more on strategic tone and financial expectations. The original answer does not mention ESPN+ as a 2024 development or bundling experiments, so these additions, while plausible, go beyond the provided truth. However, the core multi-hop reasoning—synthesizing changes in investment focus, competitive positioning, and revenue expectations across years—is sound and correctly structured. (4) The answer is highly contextually relevant, addressing all three dimensions of the question (investment focus, competitive positioning, revenue growth expectations) across the three years. The slight overreach in operational details prevents a perfect score, but the overall factual and conceptual alignment is strong, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 457,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "PayPal’s 2.850 % fixed‑rate notes, issued as part of the September 2019 debt program, have remained unchanged in both amount and maturity over the last three filing years. The notes carry a 10 Oct 2029 maturity and were recorded at $1.5 billion outstanding in 2022 (​see 2023 10‑K table ​【page 107】​), again at $1.5 billion in 2023 (​same table ​【page 107】​), and still at $1.5 billion in 2024 (​2024 10‑K table ​【page 104】​). Thus, while PayPal added new issuances (e.g., 5.150 % and 5.500 % notes in 2024) and its total term‑debt balance shifted slightly, the 2.850 % series has persisted as a stable $1.5 billion component of its long‑term debt with the same 2029 repayment obligation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the 2.850% fixed-rate notes remained at $1.5 billion from 2022 to 2024, with a maturity date of 2029. The LLM correctly cites the exact maturity date (10 Oct 2029), which aligns with the knowledge graph's implication of a 2029 maturity. (2) Quantitative accuracy is perfect: $1.5 billion outstanding each year is correctly stated, and while the LLM does not repeat the total term debt figures ($9.0B, $10.638B, $10.574B), it acknowledges that total term debt shifted and that new higher-rate debt (5.150%, 5.500%) was issued in 2024—consistent with the original answer’s point about evolving debt structure. (3) Multi-hop reasoning is sound: the LLM synthesizes data across three years of 10-K filings (2023 and 2024 10-Ks referencing 2022, 2023, and 2024 data), correctly identifying that the 2.850% notes are a stable component despite broader changes. (4) The answer addresses both parts of the question: the evolution of the specific notes (unchanged) and the broader debt structure (changing, with new higher-rate issuances). The inclusion of citation-like references (page numbers, filing years) enhances credibility and traceability. Minor omission of exact total debt figures does not detract from correctness, as the focus is on the 2.850% notes, and the broader context is accurately summarized. Wording differs but meaning is preserved. All scores are 10 due to full factual, quantitative, and contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 424,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension‑plan holding of corporate stock fell sharply after 2022. In 2022 the plan reported ≈ $1,111 million of corporate stock (Level 2 $1,104 m + Level 3 $7 m) 【page_58】. By the end of 2023 that balance had dropped to about $181 million (Level 1 $176 m + Level 2 $5 m) 【page_58】, and it recovered only modestly to $226 million (Level 1 $220 m + Level 2 $6 m) in 2024 【page_57】.  \n\nThe decline mirrors the pension‑plan’s overall equity allocation, which fell from roughly 48 % of assets in 2022 to about 24 % in both 2023 and 2024 【page_56】, indicating that UNP is deliberately de‑risking its pension portfolio by shifting away from equity (corporate‑stock) exposure toward debt securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The original answer states UNP's corporate stock allocation was $1,990 million in 2022, but the LLM claims it was $1,111 million (sum of $1,104M Level 2 + $7M Level 3), which is off by nearly $880 million. This major discrepancy undermines the quantitative foundation of the response. The 2023 figure ($181 million) matches the ground truth and is correctly cited, as is the general trend of decline. However, the 2024 figure is reported as $226 million in the LLM answer, while the original answer states that by 2024, corporate stock was reclassified—implying a structural change rather than a recovery to $226M. The LLM introduces a 'recovery' not present in the ground truth and misrepresents the nature of the 2024 position. (2) Calculations: The LLM incorrectly sums Level 2 and Level 3 holdings for 2022 as if they represent total corporate stock, but the ground truth indicates $1,990M total, suggesting either different classifications or additional holdings not captured. The 48% to 24% equity allocation drop is not in the original answer and cannot be verified against ground truth, making this a hallucinated supporting detail. (3) Multi-hop reasoning: The LLM correctly infers a de-risking strategy from reduced equity exposure, which aligns with the original's 'strategic shift' interpretation. However, it misses the key qualitative point about reclassification to Level 1 and structured exposure via preferred shares (Level 2), which is central to the original answer’s insight about valuation transparency. Instead, it fabricates a modest recovery in 2024, contradicting the narrative of continued strategic reduction. (4) Justification: The correctness score is 4 due to partial accuracy—correct directional trend and correct 2023 number, but major errors in 2022 and 2024 figures and missing key reclassification insight. Quantitative accuracy is low (3) due to large dollar amount errors. Qualitative accuracy is moderate (5) because reasoning about de-risking is plausible but based on incorrect data and misses the valuation methodology shift. Contextual relevance is high (8) as the answer addresses the question’s structure and attempts multi-year synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 606,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s long‑term private‑equity holdings fell from **$800 million at the end of 2022** to **$719 million at the end of 2024**, a decline of about **$81 million** (2022 $800 m → 2023 $755 m → 2024 $719 m)【page_86】【page_83】. This downward trajectory indicates that the company has been gradually scaling back its exposure to illiquid, alternative‑investment private‑equity assets over the three‑year period.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 value: it states $800 million, while the ground truth is $623 million. The 2023 ($755 million) and 2024 ($719 million) figures are correct. This error affects the entire narrative of a 'downward trajectory' from 2022, which is inaccurate. The actual trend is an increase from $623M to $755M (up $132M), then a partial decline to $719M. (2) Calculations are partially correct: the drop from $755M to $719M is accurate, but the overall change from 2022 to 2024 is misrepresented due to the wrong starting value. The claimed $81M decline (from $800M to $719M) is incorrect; the true change from 2022 to 2024 is an increase of $96M ($719M - $623M). (3) Multi-hop reasoning is partially sound—data from three years is referenced and synthesized—but the incorrect 2022 figure leads to flawed interpretation. The conclusion of 'scaling back' over the three-year period contradicts the ground truth, which shows net growth in investment. (4) Contextual relevance is high: the answer addresses both the quantitative change and strategic implication, using appropriate financial terminology. However, due to the critical error in the initial value and resulting misinterpretation of the trend, the qualitative and quantitative accuracy scores are moderate. The correctness score is 5 because while some data points are accurate and the structure is sound, the core numerical foundation and resulting inference are significantly flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 414,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "From 2022 to 2024 Mastercard’s multi‑layered security framework grew in three ways. First, the company deepened third‑party collaboration – its security program is regularly assessed by external auditors, it expands public‑private partnerships and works with issuers, acquirers, fintechs, central banks and industry bodies to set technical standards (e.g., EMV) and to embed security controls in partner platforms. Second, the real‑time payments footprint was broadened, moving from real‑time clearing and settlement in 12 markets at the end of 2021 (2022 filing) to operating or implementing the infrastructure in 13 markets by year‑end 2023 and continuing rollout in 2024. Third, resilience against cyber threats was reinforced with an enterprise‑wide resilience program, expanded Security Operations, Fusion and Intelligence Centers, regular vulnerability testing, insurance coverage and heightened monitoring of threats tied to third‑party services, all layered on the existing multi‑layered protection architecture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: third-party collaboration expanded from 2022 to 2024, real-time payment infrastructure was in 13 markets by end of 2023, and cyber resilience was reinforced through expanded centers and monitoring. The mention of EMV standards, public-private partnerships, and integration with third-party platforms matches the original. (2) Quantitative accuracy is excellent: the LLM correctly states the real-time payments infrastructure was in 13 markets by end of 2023 (per 2023 filing), and accurately references the 12 markets in 2021 as context. No calculation errors. (3) Multi-hop reasoning is sound: the answer synthesizes evolution across years and dimensions (collaboration, infrastructure, threat resilience), correctly attributing developments to the right timeframes. One minor point: the LLM references 12 markets at end of 2021 (from 2022 filing), which is context not in the ground truth, but this is factually consistent and adds useful background. (4) The answer is semantically equivalent to the original, with slightly more detail on resilience (e.g., insurance, vulnerability testing), which is acceptable and plausible from filings. The only reason for not scoring 10 is that the 2024 evolution is slightly less explicitly detailed than in the ground truth (e.g., 'continuing rollout' vs. 'expanded globally'), but the core progression is accurately captured. Overall, this is a robust, factually correct, and well-structured response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1589,
        "completion_tokens": 424,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil reported collateral under master‑netting arrangements (not offset against derivatives) of **$1.494 billion in 2022, $0.800 billion in 2023, and $0.491 billion in 2024** 【page_102】, 【page_99】. The steady decline in collateral – which is tied to the “Other assets, including intangibles – net” line – suggests that the company’s derivative exposure (and the associated initial‑margin requirements) has been shrinking or being managed more efficiently through netting and hedging over this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the collateral values are $641 million (end of 2021, reported in 2022 filing), $800 million (end of 2022, reported in 2023 filing), and $491 million (end of 2023, reported in 2024 filing). However, the LLM states $1.494 billion in 2022, which is more than double the correct value for that period. The $0.800 billion in 2023 (i.e., end of 2022) and $0.491 billion in 2024 (i.e., end of 2023) are correct. The 2022 figure is therefore wrong, and the trend description as 'steady decline' is misleading because the actual trend starts from $641M → $800M (increase) → $491M (decrease). (2) The calculation of a 38% decrease from 2022 to 2024 in the original answer is accurate: (800 - 491)/800 ≈ 38.6%. The LLM does not provide this percentage but implies a continuous decline, which is incorrect due to the peak in 2022. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the link between collateral, master netting arrangements, and 'Other assets, including intangibles - net', and draws a reasonable qualitative conclusion about derivative exposure management. However, it fails to capture the increase from 2021 to 2022, leading to flawed trend interpretation. (4) Contextual relevance is high—the answer addresses both parts of the question (trend and implication) and uses appropriate financial reasoning. Due to major errors in one of three data points and incorrect trend characterization, the correctness score is moderate at 5, with lower quantitative accuracy dragging down the overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 447,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "- **2022:** The relative‑TSR model used an expected volatility of **≈ 26.9 %** (the three‑year historical volatility applied to the 2022 grant)【page_214】.  \n- **2023:** For the 2023 grant the same model assumed a higher expected volatility of **28.6 %**【page_206】.  \n- **2024:** For the 2024 grant the assumed volatility fell sharply to **18.7 %**【page_215】.  \n\n**Interpretation:** Over the three‑year span the model’s volatility input rose modestly from 2022 to 2023, then dropped dramatically in 2024. The decline to a sub‑20 % level suggests that investors and the company’s compensation committee now view Duke Energy’s stock as less volatile relative to its peer group, indicating a perception of reduced market risk or greater price stability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all percentages are accurate: 26.9% for 2022, 28.6% for 2023, and 18.7% for 2024, with correct years and values as per the original answer. Minor formatting differences (e.g., '≈ 26.9%' vs. '26.9%') are acceptable and do not affect factual accuracy. (2) The answer is complete, addressing both the multi-year change in expected volatility and the interpretation regarding market risk perception. (3) Entity accuracy is correct: Duke Energy, the relative TSR model, and the three-year timeframe (2022–2024) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the increase from 2022 to 2023 indicates rising perceived risk, while the sharp drop to 18.7% in 2024 supports the conclusion of reduced market risk and greater stability, aligning exactly with the original interpretation. The LLM provides a semantically equivalent and contextually appropriate response with no factual or logical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 296,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "Across the three filings GM’s exposure to Stellantis has not grown into a material liability. In the 2022 10‑K (pages 89‑93) GM disclosed that, under the 2017 Opel/Vauxhall sale agreement, it had agreed to indemnify Stellantis for “certain emissions claims, product liabilities and recalls,” and that it had already paid an **immaterial amount** for Stellantis‑run Takata‑inflator recalls on legacy Opel vehicles. The 2023 filing repeats the same language and still characterises the indemnification as immaterial, with no specific accrual disclosed. By the 2024 filing (pages 91‑95) GM again notes that only **insignificant/immaterial amounts** have been recorded for these indemnification obligations and that any further Takata‑related indemnification is considered remote. Thus, from 2022 through 2024 GM’s indemnification obligations to Stellantis – both for legacy Opel/Vauxhall emissions claims and for Takata recalls – remained immaterial, and no material accruals were reported.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GM's indemnification obligations related to Stellantis for legacy Opel/Vauxhall emissions claims and Takata recalls remained immaterial from 2022 to 2024. The use of 'immaterial amount' is consistent across years and matches the original answer. (2) There are no numerical inaccuracies—though no specific dollar figures are provided, the characterization of amounts as immaterial or insignificant is factually correct and consistent with the source. The LLM correctly notes that no material accruals were recorded, which matches the ground truth stating only an immaterial accrual for European/UK investigations in 2024. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and two types of liabilities (emissions claims and Takata recalls), correctly identifying the continuity in GM’s disclosures. It accurately reflects the evolution—or lack thereof—in GM’s exposure. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 accrual related to the European Commission and UK CMA investigations, which is noted in the original answer. While it refers generally to immaterial amounts recorded, the specific context of regulatory investigations is omitted, slightly reducing completeness. However, this does not undermine the overall correctness. Wording differences (e.g., 'insignificant/immaterial') are semantically equivalent. The answer is fully contextually relevant and well-supported by the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 430,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "In the 2022, 2023 and 2024 Form 10‑K filings AMD repeatedly lists the same exhibit:\n\n* “*10.1 2011 Executive Incentive Plan, filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10‑Q for the period ended April 2, 2011*” (see 2022 p. 93; 2023 p. 101; 2024 p. 98).\n\nThe wording and citation are unchanged from year to year, showing that AMD continues to incorporate the original 2011 plan by reference in each annual report. This steady reference signals that the company treats the 2011 Executive Incentive Plan as a foundational element of its executive‑pay framework, reflecting a deliberate, long‑term compensation strategy that relies on established plan structures while updating or adding newer plans as needed.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies that AMD consistently referenced the 2011 Executive Incentive Plan in its 2022, 2023, and 2024 filings with identical language, indicating no amendments. The exhibit number is slightly off—LLM states it was 'Exhibit 10.2' in the 2011 10-Q, while the ground truth notes it as 'Exhibit 10.1' in AMD's own filing description—but this is a minor citation detail likely due to source referencing differences and does not affect the core factual accuracy. All years, dates (April 2, 2011), and document types (Form 10-K, 10-Q) are correct. The reasoning is sound: the unchanged citation across years supports the conclusion of a stable, long-term executive compensation strategy, which matches the original answer’s interpretation. The LLM adds value by interpreting the consistency as reliance on 'established plan structures,' which is a reasonable inference. All parts of the question are addressed: evolution (no change), and strategic implication (stability). Minor deduction in quantitative accuracy due to exhibit number discrepancy, but overall factual and semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 333,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "- In the 2022 filing PayPal warned that “bad‑transaction” risk was driven by fraudulent or erroneous payments, losses from its purchase‑ and seller‑protection programs, higher default rates on its U.S. consumer‑credit and merchant‑financing products, the added cost and uncertainty of cross‑border trade, and the company’s heavy reliance on unaffiliated banks, lenders and payment‑processor partners 【page_24】【page_26】.  \n\n- The 2024 filing still cites the same sources of exposure – credit‑product charge‑offs, cross‑border trade complications and third‑party dependencies – but notes that the company has taken steps to curb the risk.  \n\n- In 2023 PayPal mitigated the exposure by (i) selling up to €40 billion of its U.K. and European BNPL loan receivables and establishing a forward‑flow arrangement for future originations 【page_23】【page_25】, and (ii) diversifying its reliance on a single U.S. payment processor and pursuing additional third‑party funding structures to reduce the amount of credit receivables it must fund itself 【page_25】. These actions were intended to lower credit‑product losses, lessen cross‑border and third‑party risk, and therefore reduce overall bad‑transaction exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk exposure included credit defaults (especially U.S. consumer credit with Synchrony Bank, though Synchrony is not explicitly named in the LLM answer, this omission is minor), cross-border trade issues, and third-party dependencies. The 2023 strategic action of selling up to €40 billion in U.K. and European BNPL receivables is accurately reported, including the forward-flow arrangement. The 2024 continuation of risk emphasis is also correctly noted. (2) Quantitative accuracy is perfect: the €40 billion figure is correct in amount, geography (U.K. and Europe), product (BNPL), and year (2023). No calculations were required, and all numbers match the original. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022, 2023, and 2024 filings, correctly linking the evolution of risk and the strategic response. It adds a detail not in the original—diversifying away from a single U.S. payment processor and pursuing third-party funding—which is consistent with PayPal’s risk mitigation strategy and supported by the cited pages, making it a valid expansion rather than an error. (4) The only reason for not scoring a 10 is that the original answer specifically mentions Synchrony Bank and regulatory uncertainty about loan sales post-transfer, which the LLM omits. However, these are secondary details; the core multi-hop narrative—risk evolution and mitigation via receivables sale—is fully preserved. Wording differs but semantic equivalence is strong. Contextual relevance is excellent, directly addressing all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 457,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "- **2022 (10‑K filing)** – Union Pacific reported roughly **6,200 owned + 1,040 leased multiple‑purpose locomotives (≈7,240 total) with an average age of about **22.5 years**.  \n\n- **2023 (10‑K filing)** – The fleet slipped to **5,971 owned + 1,037 leased (≈7,008 total)** and the average age rose to **24.3 years**.  \n\n- **2024 (10‑K filing)** – The fleet further trimmed to **5,973 owned + 920 leased (≈6,893 total)** while the average age climbed to **25.2 years**.  \n\n**What this shows:** Over the three‑year span Union Pacific has been **reducing the total number of multiple‑purpose locomotives**, especially leased units, while the **average age of the remaining fleet is increasing**. This pattern reflects a **fleet‑right‑sizing strategy**—retiring older equipment and relying on a slightly smaller, but still aging, core fleet—while using its capital program to add newer locomotives gradually rather than undertaking a rapid, large‑scale modernization.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is highly accurate in both quantitative and qualitative aspects. It correctly reports the owned and leased locomotive counts and average fleet age for 2022, 2023, and 2024. The 2022 owned units are listed as 'roughly 6,200' vs. the exact 6,204 in the ground truth—this is a minor rounding but does not affect correctness. Leased units in 2022 are reported as 1,040 vs. 1,038 (off by 2), which is a small discrepancy. The 2023 average age is given as 24.3 years, a detail not present in the original answer; however, since the original does not contradict this and the trend (22.5 → 25.2) supports it, this is likely a valid inference from source data and not an error. 2) Calculations: Total fleet sizes are correctly approximated. The trend of decreasing leased units (1,038 → 920) and slight drop in owned (6,204 → 5,973) is accurately reflected. The average age increase from 22.5 to 25.2 is correct. 3) Multi-hop reasoning is sound: the LLM synthesizes changes over three years, identifies the reduction in leased units, aging fleet, and interprets this as a deliberate 'fleet-right-sizing' strategy with gradual modernization—this aligns with and slightly expands on the original's 'cost control over aggressive modernization' conclusion, but the semantic meaning is consistent. 4) All entities (Union Pacific, Multiple Purpose Locomotives, years 2022–2024) are correct. The answer is fully relevant, addresses all parts of the question, and provides insightful interpretation. The only minor issues are the slight rounding and the inclusion of a 2023 age value not in the original, but these do not undermine factual correctness. Hence, a score of 9 is appropriate—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 465,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral that sits “under master‑netting arrangements … not offset against derivatives” fell sharply – from $1.5 billion at 12/31/2022, to $800 million in 2023, and to $491 million in 2024 (a drop of roughly $1 billion, or about two‑thirds). This downward trend indicates the company is actively tightening its derivative‑risk controls, using less un‑netted margin and improving collateral efficiency in its netting and clearing arrangements.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, not $1.5 billion as stated in the LLM answer. The 2023 ($800 million) and 2024 ($491 million) figures are correct. The LLM incorrectly claims a drop of roughly $1 billion from 2022 to 2024, but the actual decrease from 2022 to 2024 is $150 million ($641M to $491M), and there was an increase in 2023. The characterization of a 'downward trend' ignores the increase from 2022 to 2023, misrepresenting the trend as consistently decreasing when it actually peaked in 2023. (2) Calculations are flawed: the claimed 'two-thirds' reduction from $1.5B to $491M is mathematically correct for those numbers, but since the starting value is wrong, the entire comparison is invalid. The actual change from 2022 to 2024 is a 23.4% decrease, not two-thirds. (3) The qualitative reasoning is partially sound—identifying tighter risk controls and improved collateral efficiency is a plausible interpretation—but it fails to acknowledge the multi-hop nuance of a peak in 2023 followed by a decline, which suggests dynamic positioning rather than a consistent tightening. The LLM omits the key detail about level 3 fair value inputs, which is part of the ground truth and relevant to derivative risk management. (4) Contextual relevance is high—the answer addresses collateral exposure under master netting arrangements and derivative risk management—but due to major numerical errors and incomplete trend analysis, the correctness score is limited to 5. The answer gets some facts right (2023 and 2024 values) but misrepresents the overall trend and starting point, leading to an incorrect conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 477,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "In the 2022 filing the “Other” category was described as “packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, **serveware and ready‑to‑drink beverages**, among other items” and generated $6.9 billion (≈21 % of total revenue). By the 2023 and 2024 filings the description was trimmed to “packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, **serveware**, among other items,” dropping the explicit reference to ready‑to‑drink beverages; the line grew to $7.7 billion (≈22 % of revenue) in 2023 and then settled at $7.5 billion (≈21 % of revenue) in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and entity descriptions. (1) QUANTITATIVE INACCURACY: The revenue figures of $6.9B (2022), $7.7B (2023), and $7.5B (2024) for the 'Other' category are not supported by the ground truth and are likely fabricated or misattributed; the original answer does not mention any financial figures, percentages, or growth trends. There is no indication in the ground truth that the 'Other' category generated these specific dollar amounts or that it represented 21–22% of total revenue. (2) ENTITY/DESCRIPTION INACCURACY: The claim that 'ready-to-drink beverages' was explicitly dropped from the 2023 and 2024 10-K descriptions is a misinterpretation. The ground truth states the composition remained 'largely unchanged' and consistent across all three years, with no mention of removal of any specific item. The LLM incorrectly infers a meaningful change in category composition based on possible wording variation, which the ground truth does not confirm. (3) REASONING: While the LLM attempts multi-hop reasoning by comparing disclosures across years, it draws an unsupported conclusion about evolution in the revenue composition. The ground truth emphasizes stability and absence of significant shifts, contradicting the LLM’s implication of a deliberate change in scope. (4) SEMANTIC EQUIVALENCE: The core message diverges — the original highlights stability; the LLM suggests evolution due to descriptive trimming and revenue growth. Despite correct identification of Starbucks and the general components of 'Other', the inclusion of unverified financials and incorrect interpretation of disclosure changes severely undermines factual correctness. (5) CONTEXTUAL RELEVANCE is high because the response directly addresses the question’s focus on composition evolution and cites relevant product categories and years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 512,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "From 2022 through 2024 Alphabet continued to monetize the ad inventory that flows through Google Ad Manager on its Google Network properties by recognizing revenue on an **impression‑based** basis (the “cost‑per‑impression” metric that divides impression‑based and click‑based revenues by total impressions) and by reporting that revenue **on a gross basis** – the full amount billed to advertisers is recorded as revenue, while the payments made to the Network partners are booked as cost of revenues.  The 2022 filing first described the impression metric, and the 2023 and 2024 filings reaffirmed the same principal‑vs‑agent assessment and gross‑revenue treatment, indicating that the monetization approach did not change over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) It correctly identifies that Google (Alphabet) monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based revenue recognition (via cost-per-impression metric) and gross revenue reporting from 2022 to 2024. The key facts—impression-based model, gross revenue treatment, cost of revenues for partner payments, and consistency across years—are all correct. (2) There are no numeric values (e.g., dollar amounts, percentages, impression counts) in either answer, so quantitative accuracy is not compromised; all references to years (2022, 2023, 2024) are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and correctly infers that the accounting policy did not change, with 2022 introducing the metric and 2023–2024 reaffirming the principal role and gross reporting. This aligns with the ground truth’s emphasis on increasing transparency and consistent strategy. (4) The only minor shortcoming is that the LLM does not explicitly mention Google’s 'control over advertising inventory' or the evolving 'emphasis' on its role as principal in 2024, which adds slight contextual nuance in the original. However, the reference to 'principal-vs-agent assessment' implies this reasoning. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually complete and correct with only minor depth differences, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 430,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "MDLZ’s 10‑K filings show that the company has been exposed to sales‑ and media‑marketing limits for several years, and that this exposure has broadened as more jurisdictions adopt front‑of‑pack (FOP) nutrition‑labeling rules and extended‑producer‑responsibility (EPR) schemes. In its 2022 filing the company already noted “labeling requirements such as front‑of‑pack labeling based on nutrient profiles… sales or media and marketing restrictions… over 25 countries in the European Union have implemented EPR policies… EPR policies are being implemented or contemplated in other jurisdictions …including India, Vietnam and certain states in the United States”【page_11】. The 2023 filing repeats the same language, confirming that the regulatory landscape remains material and that the company continues to monitor these rules【page_11】. By the 2024 filing the discussion emphasizes that the “jurisdictional expansion of extended producer responsibility (‘EPR’) policies” is ongoing, with EPR now moving beyond the EU into additional markets such as India, Vietnam and U.S. states, and that FOP labeling requirements are increasingly applied, thereby widening MDLZ’s exposure to these restrictions【page_11】. \n\nIn short, MDLZ’s exposure has not diminished; it has grown as front‑of‑pack labeling rules become more common and EPR obligations spread to new regions beyond the EU.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the mention of over 25 EU countries implementing EPR policies in 2022, the jurisdictional expansion into India, Vietnam, and U.S. states, and the growing emphasis on front-of-pack (FOP) labeling and environmental claims are all consistent. The evolution across 2022–2024 is correctly portrayed as a broadening regulatory burden. (2) Quantitative accuracy is perfect: no numerical errors, and the use of 'over 25 countries' matches the original. Dates (2022, 2023, 2024) are correctly attributed to the respective developments. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and multiple jurisdictions, correctly identifying the trend from contemplation to enforcement, especially regarding EPR and FOP labeling. The only minor shortcoming is that the 2024 update about the EU formally adopting the Packaging and Packaging Waste Directive is not explicitly mentioned, which slightly reduces completeness. Also, the 2023 emphasis on environmental claims and plastic bans in Indonesia and the Philippines—present in the ground truth—is omitted. (4) Despite these small omissions, the core message about increasing regulatory exposure is preserved with strong semantic equivalence. Wording differences are acceptable and do not affect factual correctness. Contextual relevance is excellent, directly addressing the evolution of MDLZ's exposure as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 411,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "- In the 2022, 2023 and 2024 Form 10‑K filings Mastercard’s Class A shares are described the same way: each share carries **one vote and full dividend rights** (Class A – “One vote per share … Dividend rights”)【page_99】【page_97】【page_92】.  \n- The per‑share cash dividend declared on Class A (and Class B) stock rose each year – $2.04 in 2022, $2.37 in 2023 and $2.74 in 2024【page_99】【page_97】【page_92】.  \n\nThe unchanged voting and dividend entitlements over three consecutive years show that Mastercard is deliberately maintaining a stable dual‑class capital structure: preserving the one‑vote‑per‑share control framework while consistently rewarding shareholders with growing dividends.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that A Class shares maintained one vote per share and full dividend rights across 2022, 2023, and 2024, which aligns with the ground truth. It also accurately notes the increasing cash dividends per year ($2.04, $2.37, $2.74), a detail not in the original answer but factually correct and contextually relevant. 2) All numeric values (dividend amounts and years) are accurate and properly cited to document pages. No calculation errors. Format variations are acceptable. 3) The multi-hop reasoning is sound: the model synthesizes consistent voting/dividend rights across three years and infers a stable capital structure strategy, matching the original conclusion. The addition of rising dividends strengthens the interpretation of shareholder reward strategy without contradicting the core point. 4) The only minor deviation is that the original answer emphasizes 'no changes' and 'consistency' without referencing dividend growth, while the LLM adds value by noting the increasing payouts. This does not make it incorrect—rather, it provides additional context—but slightly extends beyond the scope of the original answer’s focus on entitlement *structure* (rights) vs. payout *amounts*. Thus, qualitative accuracy is slightly reduced not for error but for subtle shift in emphasis. Overall, the answer is factually correct, complete, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 385,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s reported collateral posted under master‑netting arrangements for the “Investments, advances and long‑term receivables” line fell sharply: $1.494 billion at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024. The downward trend indicates that the firm’s net derivative exposure – and the associated initial‑margin requirements – have been decreasing over the period, suggesting either a reduction in the size of its derivative positions, lower market volatility, or more efficient netting and collateral management.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, collateral was $641 million in 2022, increased to $800 million in 2023, and decreased to $491 million in 2024. However, the LLM states it was $1.494 billion in 2022, which is more than double the correct value. This major error undermines the entire trend interpretation. The 2023 and 2024 figures ($800 million and $491 million) are correct. (2) Calculations and comparisons are affected by the incorrect 2022 number. The LLM describes a 'sharp fall' from $1.494B to $491M, implying a ~67% decrease, whereas the actual change from $641M to $491M is a much smaller decrease, following an increase in 2023. Thus, the actual trend is an increase then a decrease, not a consistent downward trend. (3) The reasoning is partially sound in interpreting decreasing exposure in 2024, but fails to capture the full multi-hop insight: the rise in 2023 suggests increased margin requirements (possibly due to volatility or hedging), followed by a reduction. The LLM incorrectly frames the entire period as a downward trend, missing the intermediate increase. (4) Contextual relevance is high—the answer addresses the right metric, time frame, and attempts to interpret derivative exposure and margin implications. However, due to the critical error in the 2022 figure, the overall correctness score is low despite accurate 2023/2024 numbers and reasonable qualitative logic based on flawed input.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 417,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "- In the 2022 filing Starbucks said that its “fixed‑price and price‑to‑be‑fixed purchase commitments… together with existing inventory, are expected to provide an adequate supply of green coffee **through fiscal 2023**”【page_12】.  \n- The 2023 filing extended that outlook, stating the same mix of purchase commitments and inventory would secure supply **through fiscal 2025**【page_12】.  \n- The 2024 filing repeats the fiscal 2025 horizon, confirming the company continues to rely on those commitments and inventory to meet demand【page_12】.  \n\nThis progression—from a one‑year forward‑supply view in 2022 to a two‑year horizon that is maintained in 2023 and 2024—shows Starbucks deliberately lengthening and solidifying its supply‑chain contracts (fixed‑price, price‑to‑be‑fixed, forward, futures and collars) to lock in quantity and price, thereby reducing exposure to coffee‑price volatility and supply‑risk while reinforcing long‑term relationships with producers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dates and time horizons are accurate: fiscal 2022 commitment through 2023, then extended to 2025 in 2023 and maintained in 2024. These match the original answer exactly. (2) The answer is complete, addressing both parts of the question: the evolution of supply chain commitments (from 2023 to 2025 coverage) and the strategic implications regarding price volatility and supply risk. (3) Entity accuracy is perfect—Starbucks, green coffee, fiscal years 2022–2024, and financial instruments (forward contracts, futures, collars) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across the three annual filings, correctly interpreting the extension and stabilization of supply commitments as a strategic move toward longer-term risk mitigation. The conclusion about locking in quantity and price to reduce exposure is semantically equivalent to the ground truth’s 'strategic shift toward longer-term stability' and 'consistent risk mitigation approach.' Minor wording differences (e.g., 'lengthening and solidifying' vs. 'strategic shift') do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 352,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "- In the 2023 target mix the plans were 0 % equity for U.S. plans and 27 % equity for non‑U.S. plans; debt made up 100 % of U.S. assets and 48 % of non‑U.S. assets, with cash 4 %, insurance contracts 11 % and “other” 10 % (see page 88).  \n- By the 2025 target the composition had shifted to 0 % equity for U.S. plans and 28 % equity for non‑U.S. plans; debt fell to 94 % of U.S. assets and 36 % of non‑U.S. assets, while cash rose to 6 % (U.S.)/7 % (non‑U.S.), insurance contracts jumped to 21 % (U.S.)/21 % (non‑U.S.) and “other” fell to 8 % (see page 95).  \n\nThis gradual move away from pure debt toward more insurance‑contract and cash holdings—and a modest increase in equity exposure outside the U.S.—signals a long‑term strategy that seeks to preserve liability matching while adding diversified, lower‑volatility sources of return to improve risk‑adjusted performance and better exceed inflation over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer (ground truth) does not provide specific numerical breakdowns of ACN's target asset allocation by percentage for equities, debt, cash, insurance contracts, or 'other' categories in fiscal 2023 or 2025. Instead, it describes a general strategic evolution focused on risk-adjusted returns, liability matching, and adaptive flexibility. The LLM fabricates precise percentages (e.g., 0% equity for U.S. plans, 27%/28% for non-U.S., 100% debt in 2023 U.S. plans, etc.) that are not present in the ground truth and cannot be verified from the provided context. These numbers appear to be either hallucinated or derived from an external source not reflected in the knowledge graph. (2) There are no calculations in the ground truth to verify, but the LLM presents apparent comparisons (e.g., debt falling from 100% to 94%, insurance rising to 21%) that have no basis in the original answer, making the quantitative accuracy very low. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer a strategic shift toward lower-volatility assets and improved risk-adjusted returns, this interpretation is built upon false numerical premises. The original answer does mention a focus on liability matching and risk mitigation, so the directional logic (preserving liability matching, improving risk-adjusted performance) has some alignment, but it is undermined by the invented data. (4) Contextual relevance is moderate because the LLM addresses the question’s intent—analyzing the evolution of asset allocation and its implications for long-term strategy—but fails on factual grounding. The mention of inflation, risk-adjusted returns, and diversification echoes themes from the original, but the reliance on fabricated metrics severely compromises correctness. Overall, the answer is mostly incorrect due to hallucinated data, warranting a low correctness score despite some thematic relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 536,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "- 2022 10‑K: Olpasiran was listed as a **phase‑2 siRNA** whose purpose was to **lower lipoprotein‑a (Lp‑a) for atherosclerotic cardiovascular disease**.  The filing already disclosed **U.S. and European composition‑of‑matter patents covering the compound, each projected to expire in 2036**.  \n\n- 2023 10‑K: The candidate remained described under **phase‑2 cardiovascular disease** (still targeting Lp‑a/ASCVD) and the same **2036‑expiration patents** were reiterated, showing no change in the IP timeline.  \n\n- 2024 10‑K: Olpasiran had **advanced to phase‑3 trials and was now positioned explicitly as an ASCVD therapy**, reflecting a more focused therapeutic intent, while the **U.S. and European patents with a 2036 expiration** continued to provide its core intellectual‑property protection.  ",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct in terms of key facts and dates, but contains a significant discrepancy in the reported clinical trial phase progression. According to the ground truth, Olpasiran was in phase 2 trials in 2022 and remained under phase 2 investigation through 2024, with no mention of advancement to phase 3. However, the LLM incorrectly states that in the 2024 10-K, Olpasiran had 'advanced to phase-3 trials,' which is not supported by the original answer. This misrepresents the developmental timeline and reflects a failure in multi-hop reasoning or data synthesis. The intellectual property details are accurately reported: U.S. and European patents for 'Compounds' with a 2036 expiration are correctly cited across all years, matching the ground truth. The therapeutic focus on atherosclerotic cardiovascular disease (ASCVD) and lipoprotein(a) reduction is also consistent and well-articulated. Quantitative accuracy is high—dates (2036 patent expiry) and phase designations (except 2024) are correct, and there are no calculation errors. Contextual relevance is excellent, as the response directly addresses the evolution of therapeutic focus and IP protection. However, the erroneous claim about phase 3 advancement undermines the qualitative accuracy, as it distorts the strategic positioning narrative. The original answer emphasizes continuity in phase 2 and a broadening of indication language ('cardiovascular disease'), not a phase upgrade. Thus, while core facts like IP and target disease are sound, the developmental stage error reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 433,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "- **2022:**  The filing notes that American Express “has increasingly relied on merchant acquirers, **aggregators** and processors to manage certain aspects of our merchant relationships,” and warns that it is dependent on these parties to promote card acceptance even though their business goals may diverge from ours.  The disclosed risks focus on mis‑alignment, possible merchant‑steering or surcharging, service‑disruption or data‑security failures, and the regulatory fallout from any third‑party breach.  \n\n- **2023:**  The same language reappears, showing that the reliance on **aggregators** continued and even deepened as the company “relies on third‑party providers … aggregators … for acquiring and servicing customers.”  The risk emphasis expands to include the danger of losing or renegotiating these relationships on less‑favourable terms, as well as the ongoing operational, cyber‑security and compliance exposures tied to third‑party performance.  \n\n- **2024:**  The 2024 10‑K again lists “aggregators” among the critical third‑party service providers and stresses that the growing number of such partners raises “operational complexity and governance challenges” and subjects the firm to heightened regulatory scrutiny of outsourcing.  The highlighted risks are the inability to adequately oversee aggregators (or their own providers), potential service interruptions, data‑privacy breaches, and resulting regulatory, litigation and reputational consequences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—American Express, aggregators, years 2022–2024—are correct, and no numeric values (e.g., dates) are incorrect; format is consistent and appropriate. (2) Quantitative accuracy is perfect: all years are correctly cited, and there are no calculations or numerical claims that conflict with the original. (3) The multi-hop reasoning is sound: the LLM synthesizes evolving risk disclosures across three years, correctly identifying increasing reliance and shifting risk focus. It accurately reflects the progression from misalignment and merchant behavior (2022), to deeper dependency and renegotiation risks (2023), to operational complexity, governance, and regulatory/litigation exposure (2024). (4) The only minor gap is that the LLM does not explicitly mention 'steering' and 'surcharging' as *increasingly emphasized* in 2023 (though it references them in 2022 and implies continuity), and the 2024 emphasis on 'changes in business practices due to third-party failures or regulatory actions' is slightly under-articulated. However, the core themes—regulatory scrutiny, litigation, operational disruption—are clearly conveyed. Overall, the answer is semantically equivalent with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 380,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks has consistently warned that green‑coffee prices are volatile and that the price is “impacted by trading activities in the arabica coffee futures market, including hedge funds and **commodity index funds**,” and it “utilizes forward contracts, futures contracts, and collars to hedge ‘C’ price exposure” 【page_12】. In its FY 2022 filing the company said its existing purchase commitments and inventory would be sufficient “through **fiscal 2023**” 【page_12】; the FY 2023 filing extended that outlook to “through **fiscal 2024**” (the same language appears a year later), and the FY 2024 filing now projects the commitments will cover demand “through **fiscal 2025**” 【page_12】. Thus, while the exposure to commodity‑index‑fund‑driven price swings and the use of forward‑, futures‑ and collar‑based hedges have remained unchanged, Starbucks has progressively lengthened its forward supply commitments, adding an additional year of coverage each successive filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks consistently identifies commodity index funds as influencing green coffee price volatility and uses forward contracts, futures, and collars to hedge exposure. The evolution of forward supply commitments is accurately reported: FY2022 covers through fiscal 2023, FY2023 extends to fiscal 2024, and FY2024 projects through fiscal 2025. (2) Quantitative accuracy is perfect: the fiscal year extensions (2023 → 2024 → 2025) are correctly cited, and the annual progression is precisely described. (3) Multi-hop reasoning is sound—information is synthesized correctly across three fiscal years and filings, showing a clear trend of lengthening supply coverage. (4) The only minor shortcoming is that the LLM states the FY2023 filing outlook is 'through fiscal 2024', while the ground truth says it was extended to 'fiscal 2025'. However, the LLM later correctly notes the FY2024 filing goes through fiscal 2025, and the overall trend of increasing commitment length is correctly interpreted. This discrepancy may stem from a misreading of the source text, but the final conclusion about progressive extension remains valid. The ground truth emphasizes stabilization by 2024 and a strategic shift, which the LLM captures implicitly but not explicitly. Overall, the answer is factually correct, well-structured, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 398,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "- **Fiscal 2022** – At the end of the 2022 fiscal year Accenture had **$3.13 billion of unused authority** for its publicly‑announced open‑market share‑purchase program (page 94).  During the year it bought **12.18 million Class A shares for $4.11 billion** (page 94).  In September 2022 the Board added another **$3 billion of repurchase authority**, raising total outstanding authority to **$6.13 billion** (page 94).\n\n- **Fiscal 2023** – The company kept the expanded authority in place and continued to deploy it aggressively.  While the 2023 filing does not restate the exact balance, the fact that no further increase was reported until 2024 implies that the **$6.1 billion‑plus authorization remained available** and was used for another round of sizable buy‑backs (the MD&A later notes that share purchases totalled roughly **$4 billion** per year).\n\n- **Fiscal 2024** – By August 31 2024 the **remaining unused authorization had fallen to $2.694 billion** (page 39).  In the fourth quarter alone the company repurchased **2.0 million shares for $605 million** under the open‑market program (page 39).  The Board then approved an **additional $4 billion of authority** on September 25 2024, bringing total outstanding authority to **$6.694 billion** (page 39).  Overall cash returned to shareholders in FY 2024 was $7.8 billion, of which **$4.5 billion were share purchases** (page 40).\n\n**What the trajectory shows** – Over the three‑year period Accenture has steadily expanded the ceiling of its buy‑back program (from $3.1 bn to more than $6.6 bn) while repeatedly using a large portion of that capacity each year.  The pattern of raising the authorization limit and then deploying it in multi‑billion‑dollar repurchases signals a deliberate, long‑term capital‑return strategy that relies heavily on share buybacks to return excess cash to shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly for fiscal 2022. The ground truth states that Accenture had $3,129,296 (approx. $3.13 billion) in available authorization at the end of fiscal 2022 — this part is correctly approximated. However, the LLM claims Accenture bought 12.18 million shares for $4.11 billion in fiscal 2022, which is not supported by the ground truth; no such data is provided for 2022 repurchase volume in the original answer. Additionally, the LLM incorrectly states that the Board added $3 billion in September 2022, raising total authority to $6.13 billion — this event is not mentioned in the ground truth and contradicts it, since the 2023 authorization is stated as $2,694 million (not over $6 billion). In fiscal 2023, the LLM asserts buybacks totaled roughly $4 billion per year based on MD&A commentary, but the ground truth specifies only $605 million in actual open-market purchases (2,000,308 shares) in fiscal 2023, with no indication of higher total repurchases. This is a major quantitative error. The fiscal 2024 data is mostly accurate: remaining authorization of $2.694 billion by August 31, 2024, and an additional $4 billion authorized on September 25, 2024, bringing total to $6.694 billion — these match the ground truth. The $605 million for 2 million shares in Q4 2024 aligns with the 2023 fiscal year activity in the original answer, though the LLM misattributes timing. (2) Calculations: The LLM’s inference that authorization rose to $6.13 billion after a $3 billion addition in 2022 is unsupported and leads to incorrect trajectory analysis. The ground truth shows a rise from ~$3.13B to $2.694B (used down) then a jump to $6.694B after new $4B authorization — not a steady use of a $6B+ pool. (3) Multi-hop reasoning: The LLM synthesizes across years and attempts to infer trends, but does so using incorrect underlying data for 2022 and 2023, undermining the logic. The conclusion about a consistent strategy is directionally correct, but based on flawed premises. (4) Despite significant quantitative errors, the answer is contextually relevant and captures the general intent of increasing authorization and active repurchases. The qualitative reasoning is sound in structure but built on inaccurate inputs, leading to a partially correct but misleading narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1708,
        "completion_tokens": 631,
        "total_tokens": 2339
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "Google reported a long‑term, lock‑up portion of marketable equity securities of **$803 million at year‑end 2022**, which rose to **about $1.4 billion at year‑end 2023**, then fell sharply to **$266 million at year‑end 2024**. The swing—from a 75 % increase to a 81 % decline—shows that the company expanded its illiquid equity stakes in 2023 but subsequently trimmed or unwound most of those positions in 2024, suggesting a short‑term strategic push into, followed by a rapid re‑allocation away from, illiquid assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. The LLM incorrectly reports $803 million in 2022 (should be $1.4B), $1.4 billion in 2023 (correct for 2023 but misaligned due to wrong 2022 value), and $266 million in 2024 (should be $1.4B). These errors completely distort the trend. (2) Calculations are therefore also incorrect: the LLM claims a 75% increase from 2022 to 2023 and an 81% decline to 2024, but the actual change was a 42.5% decrease from 2022 to 2023 and a 74% increase from 2023 to 2024. The direction and magnitude of changes are wrong. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the values across years, leading to an incorrect interpretation of Google’s investment strategy. Instead of a cyclical rebalancing or stabilization (returning to original level), the LLM suggests a short-term push followed by a rapid unwind, which contradicts the ground truth. (4) Contextually, the answer addresses the right question about strategy implications, so it maintains some relevance, but due to severe quantitative and qualitative errors, the conclusion is unsupported. The entity (Google) and metric (marketable equity securities under lock-up) are correctly identified, but the timeline and values are not. Correctness score is low due to fundamental factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 413,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "- In 2022 GE decided to exit its captive industrial insurer, Electric Insurance Company (EIC), and re‑classified the subsidiary as a “business held for sale.”  By the end of 2023 the balance‑sheet showed EIC’s assets of about $541 million against liabilities of $378 million, and GE recorded a $109 million loss in other income related to the disposition.  \n\n- In the first half of 2024 GE completed the sale of EIC to Riverstone International Holdings for cash proceeds of $120 million, removing the liability and converting the remaining net book value into cash.  \n\n- Thus, over the three‑year span EIC moved from an operating captive to a non‑core, held‑for‑sale asset, was valued at roughly $163 million of net equity on the books, generated a $109 million earnings hit in 2023, and produced a $120 million cash inflow (and likely a modest gain) when the sale closed in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a key factual inaccuracy: it states that GE decided to exit EIC and reclassified it as 'held for sale' in 2022, while the ground truth indicates that EIC was still operating as a captive insurer in 2022 with no mention of being classified as held for sale until 2023. This misplacement of the strategic decision timeline affects the accuracy of the narrative. However, the financial figures for 2023 (assets: $541M, liabilities: $378M, loss: $109M) and the 2024 sale to Riverstone International Holdings Inc. for $120M in cash are correctly reported.\n\n2) Quantitative accuracy: The numbers themselves are accurate. Net equity implied by $541M - $378M = $163M is a correct calculation and aligns with the context. The $109M loss and $120M cash proceeds match the ground truth. However, the LLM suggests a 'modest gain' in 2024, which is speculative and not supported by the original answer—no gain is mentioned post-sale, and given the prior $109M loss, the final outcome may still represent an overall loss. This introduces a minor but notable financial misinterpretation.\n\n3) Reasoning and multi-hop synthesis: The LLM correctly connects the evolution across years—starting from strategic intent (though misdated), through classification as held for sale, recognition of loss, and final sale. It synthesizes balance sheet data, valuation, and disposal outcome appropriately. The logic flow is sound despite the initial timeline error.\n\n4) Contextual relevance is excellent—the answer directly addresses strategic positioning, valuation, disposition, and financial impact as asked. The only issues are the incorrect timing of the 'held for sale' classification and the unsupported inference of a gain in 2024. Overall, core facts are present and well-structured, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 500,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen reported 13 Phase 3 programs at the end of 2022 (Feb 8 2022) 【page_25】, which grew to 18 programs by January 31 2023 【page_26】 and then to 24 programs by January 31 2024 【page_25】 (with a further addition to 25 by early 2025). The near‑doubling of Phase 3 assets—driven by acquisitions (e.g., Horizon‑sourced programs), the initiation of new late‑stage studies and the advancement of biosimilar and novel biologic candidates across oncology, cardiovascular, immunology and rare‑disease indications—shows a deliberate strategy to broaden and deepen Amgen’s R&D pipeline and diversify its therapeutic focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the evolution of Amgen's Phase 3 programs from 13 in 2022 to 18 in 2023 and 24 in 2024, aligning with the ground truth. It notes the increase to 25 programs, though it attributes this to early 2025 rather than 2024 as stated in the original answer. This is a minor timing discrepancy but does not materially misrepresent the trend. (2) All numeric values are accurate: 13 (2022), 18 (2023), 24 (2024), and the mention of 25 is consistent with the original answer’s final count, even if the timing is slightly off. The dates cited (Feb 8, 2022; Jan 31, 2023; Jan 31, 2024) are specific and plausible within reporting cycles, and the reference to a further addition by early 2025 is a reasonable inference. (3) The multi-hop reasoning is sound: the LLM correctly identifies the growth trend, attributes it to key drivers such as the Horizon acquisition, initiation of new studies, and advancement of biologics/biosimilars, and connects this to strategic pipeline expansion across therapeutic areas. This reflects proper synthesis across time points and causal factors. (4) The answer is semantically equivalent to the ground truth, capturing the core message of strategic R&D expansion through late-stage pipeline growth. The only minor deviation is the phrasing of when the 25th program was added, but the overall trajectory and strategic interpretation are correct. Hence, high scores across all categories with a 9 in correctness due to the slight temporal misalignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 418,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "In the 2022 filing American Express described its global card network as the **fourth‑largest** general‑purpose network worldwide, competing directly with Visa, Mastercard, China UnionPay and other issuers, and emphasized that its competitive edge rested on product features, rewards and brand strength【page_12】.  \n\nBy the 2024 filing the company said that **regulators worldwide had intensified focus on card‑network practices**—including interchange‑fee caps, “honor‑all‑cards” rules and network‑routing requirements—and that, in response, Amex **exited its network‑licensing businesses in the EU and Australia** and is **engaged in settlement negotiations with Visa and Mastercard that would impose fee caps and greater surcharging flexibility**【page_34】【page_35】.  \n\nThus, Amex’s relationship with global card networks has shifted from a purely competitive positioning in 2022 to a **regulatory‑driven restructuring** in 2024, scaling back certain licensing activities and adapting its network agreements to meet heightened compliance and fee‑regulation pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express's competitive positioning in 2022 against Visa, Mastercard, and China UnionPay; the shift by 2024 due to regulatory pressures; and the exit from network licensing in the EU and Australia. The mention of settlement negotiations with Visa and Mastercard involving fee caps and surcharging flexibility is consistent with the regulatory challenges described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022 and 2024 filings to show an evolution from competition to regulatory-driven restructuring. It correctly identifies the changing nature of AXP’s relationship with global networks over time, though it omits minor contextual details about competitive dynamics from alternative platforms like Alipay and PayPal and the specific mention of cobrand uncertainty in the EU, which slightly affects completeness. (4) The answer is semantically equivalent to the original, uses appropriate terminology, and directly addresses the question about evolution in response to regulatory and competitive forces. The omission of 2023 dynamics is minor given the focus on 2022–2024 evolution. Overall, this is a factually correct, well-reasoned, and contextually appropriate response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 408,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "- **2022 – CVE‑share monetization:** In the first quarter of 2022 ConocoPhillips sold its remaining **≈ 91 million CVE common shares** (the last tranche of the paced monetization that began in 2021). The cash raised was applied to the share‑repurchase program, under which the company bought back **87.7 million shares** that year (the “Repurchase of common stock” line in the 2023 10‑K).  \n\n- **2023 – Continued repurchases:** No additional CVE‑share sales were reported, but the proceeds from the 2022 sale continued to fund buy‑backs. ConocoPhillips repurchased **48.6 million shares** in 2023 (see the 2023 10‑K “Repurchase of common stock” table). By the end of 2023 the cumulative repurchases since the program’s inception were **383 million shares at a total cost of about $29 billion**.  \n\n- **2024 – Ongoing repurchases:** The company again used the CVE‑share proceeds (together with its authorized $65 billion buy‑back ceiling) to repurchase **49.1 million shares** in 2024 (2024 10‑K “Repurchase of common stock” table). This raised the cumulative total to **433 million shares repurchased at a cost of $34.3 billion**, meaning roughly **$5.3 billion** was spent in 2024.  \n\n**Summary of the three‑year evolution**\n\n| Year | CVE shares sold (monetized) | Shares repurchased | Approx. cash used for repurchases* |\n|------|-----------------------------|--------------------|-----------------------------------|\n| 2022 | ≈ 91 million CVE shares | 87.7 million | part of the $29 bn cumulative cost (specific 2022 amount not broken out) |\n| 2023 | none reported | 48.6 million | included in the $29 bn cumulative cost |\n| 2024 | none reported | 49.1 million | ≈ $5.3 bn (the increase from $29 bn to $34.3 bn) |\n\n\\*The filings give total repurchase cost ($29 bn through 2023 and $34.3 bn through 2024) but do not disclose a separate dollar amount for the 2022 and 2023 years; the 2024 incremental cost can be derived from the difference.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in key quantitative figures, particularly around the number of shares repurchased in 2022 and the cumulative totals. According to the ground truth, ConocoPhillips repurchased a total of 383 million shares at a cost of $29 billion by 2022 (not in 2023 as the LLM claims), and reached 433 million shares repurchased at $34.3 billion by 2024. The LLM incorrectly states that cumulative repurchases were 383 million shares at $29 billion by the end of 2023, but the ground truth indicates this milestone was already reached in 2022. This misplacement of cumulative figures across years leads to significant quantitative errors. Additionally, the LLM reports 87.7 million shares repurchased in 2022, 48.6 million in 2023, and 49.1 million in 2024, summing to only ~185.4 million shares over three years—far below the actual increase from 383 million to 433 million (a 50 million increase), suggesting internal inconsistency. While the $5.3 billion spent in 2024 (derived from $34.3B - $29B) is correctly calculated, the attribution of repurchase volumes to specific years lacks support in the ground truth, which does not break down annual repurchase volumes by year after 2022. The CVE share sale of ~91 million in 2022 is correct, and the overall narrative of monetization funding buybacks aligns with the ground truth. The reasoning framework is logical and contextually relevant, but the core numerical timeline is flawed, undermining the correctness score. Entity identification (ConocoPhillips, CVE, years, share repurchases) is accurate, and the multi-hop synthesis attempt is sound, though based on incorrect underlying data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1669,
        "completion_tokens": 456,
        "total_tokens": 2126
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "- **2022:** When the Omnibus Stock Incentive Plan was amended and restated (May 19 2022), the company set a pool of **≈ 80 million shares** (plus up to 10 million “under‑lying” shares) that could be used for future grants. At the start of 2022 the pool was essentially untouched, giving Home Depot the full authorized amount for new awards.  \n\n- **2023:** During fiscal 2023 the company began drawing on that pool. The 2023 Form 10‑K notes that the number of shares remaining for future grants had fallen modestly (the exact figure is not restated in the excerpt, but the trend shows a reduction from the 2022 level).  \n\n- **2024:** By **January 28 2024** the filing states that **≈ 77 million shares** were still available for future grants under the Omnibus Plan.\n\n**What the trend means:** The pool has been gradually depleted – from the full 80 million‑share authorization in 2022 to about 77 million shares by early 2024 – indicating that Home Depot is actively using its stock‑based compensation capacity but still retains a large reserve. The modest decline shows steady grant activity while preserving ample flexibility for future equity awards.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key numbers: it states approximately 80 million shares available in 2022, while the ground truth reports 117 million under the 2005 Plan. It also incorrectly reports 77 million available in 2024, whereas the ground truth states availability declined to 70 million by 2024. The LLM reverses the trend direction by implying a drop from 80M to 77M over two years, when in reality the pool declined from 117M to 77M (2022–2023) and further to 70M (2024), indicating a much steeper utilization. (2) Quantitative accuracy is low: the 2022 figure is off by 37 million shares, and the 2024 number is misstated by 7 million. The LLM also introduces a '≈80 million' figure with a 'plus up to 10 million' add-on not present in the original, which distorts the actual share pool structure. While the 77 million in 2023 aligns with the ground truth (though misattributed to 2024), the timeline is confused. (3) The reasoning is partially sound—recognizing a gradual drawdown and linking it to active use of equity compensation—but fails the multi-hop synthesis: it does not acknowledge the plan transition (2005 Plan to amended Omnibus Plan) or the consistent year-over-year decline from 117M → 77M → 70M. The conclusion that the decline is 'modest' contradicts the ground truth’s implication of steady and significant utilization. (4) Contextual relevance is high—the answer addresses the evolution of share availability and interprets the trend in terms of compensation capacity—but the flawed numbers undermine the validity of the interpretation. Despite correct framing, the factual foundation is weak, leading to a misleading narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 459,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "- 2022: The Amended 2010 Share Incentive Plan authorized **127 million** Class A ordinary shares for awards【page_91】.  \n- 2023 → 2024: The plan’s authorization was increased to **141 million** shares and remained at that level in the 2024 filing【page_98】.  \n\nThe 14‑million‑share increase shows Accenture deliberately expanded its share‑based compensation capacity to strengthen employee‑shareholder alignment and support talent attraction and retention, while the flat level after 2023 suggests it has now settled on a size it deems sufficient for its strategic incentive program.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 127 million shares in 2022 and 141 million from 2023 to 2024, with a correct implied increase of 14 million shares. The format variations (127 million vs. 127,000,000) are acceptable and semantically equivalent. (2) The answer is complete, addressing both the evolution of authorized shares across 2022–2024 and the strategic implications of the change. (3) Entity accuracy is correct: Accenture plc, the Amended 2010 SIP, Class A ordinary shares, and the correct years are all properly identified. (4) The reasoning is sound and adds value: the increase is correctly interpreted as a strategic move to enhance equity-based incentives for talent retention and alignment with shareholders, and the stabilization in 2024 is reasonably interpreted as the company settling on a sustainable level. The multi-hop synthesis—comparing authorizations across years and inferring strategic intent—is logically and accurately executed. All components of the question are addressed with factual precision and appropriate interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 323,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "- **2022:** The investment‑securities table shows that the weighted‑average yield on the foreign‑government‑bond portfolio was roughly **2 % (2.08 % overall, with the foreign‑government‑bond segment ranging from 1.74 % to 5.46 % depending on maturity)**【page_120】.  \n\n- **2024:** In the “Distribution of Assets, Liabilities and Shareholders’ Equity” table, the average rate on the non‑U.S. (foreign) portion of long‑term debt – which includes the foreign‑government‑bond holdings – rose to **about 7.4 %**, up from **7.3 % in 2022**【page_176】.  \n\n**Interpretation:** The increase from a low‑single‑digit yield in 2022 to a high‑single‑digit yield in 2024 indicates that Amex’s foreign‑government‑bond and other non‑U.S. debt exposures are now priced at considerably higher rates. This suggests the company’s interest‑bearing assets and liabilities are becoming more sensitive to rising international interest‑rate environments, heightening its exposure to global rate movements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the weighted average yield on foreign government bonds due within one year was 5.86% in 2022, increased to 6.45% in 2023, and returned to 5.86% in 2024. However, the LLM claims the 2022 yield was approximately 2.08% (or up to 5.46% depending on maturity), which contradicts the ground truth. For 2024, the LLM cites a 7.4% yield on non-U.S. long-term debt, but this is not equivalent to the foreign government bond yield due within one year, which is the specific metric in question. The LLM confuses different financial instruments (long-term debt vs. short-term foreign government bonds) and reports incorrect numbers. (2) The quantitative accuracy is poor: the correct yields are 5.86% (2022), 6.45% (2023), and 5.86% (2024), showing a peak and reversal. The LLM reports ~2.08% for 2022 and ~7.4% for 2024, which are both factually wrong and misrepresent the trend. There is no mention of the 2023 figure at all. (3) The multi-hop reasoning is flawed. The question requires tracking a specific metric (weighted average yield on foreign government bonds due within one year) across three years. The LLM fails to do this, instead citing unrelated or broader categories (e.g., overall investment securities yield, long-term debt rates). It does not synthesize the correct data points across years and misidentifies the relevant financial instruments. (4) The contextual relevance is moderate because the LLM attempts to discuss foreign government bond yields and interest rate exposure, which is on-topic. However, due to incorrect data and misidentified metrics, the interpretation about increasing exposure is misleading—the actual trend shows volatility with a return to baseline, not a consistent increase. The conclusion does not align with the true pattern. Thus, the correctness score is low due to major factual and conceptual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 525,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "In 2022 American Express’s foreign‑government bond portfolio was almost entirely short‑dated – $628 million of the $630 million fair‑value balance was due within one year (the remaining $2 million was split between the 1‑5‑year and 5‑10‑year buckets)【page_121】.  \n\nBy the next two years the weighted‑average yield on that segment rose to about **6.45 % in 2023** and then eased to **5.85 % in 2024**. The increase in 2023 reflects a shift into slightly longer‑dated or higher‑coupon sovereign issues as global rates peaked, while the decline in 2024 shows a re‑balancing back toward shorter‑duration, lower‑yielding holdings as market rates fell. Together, the 2022 short‑duration distribution and the 2023‑24 yield swing indicate that American Express deliberately keeps its foreign‑government bond exposure highly liquid and credit‑strong, adjusting duration to capture higher yields when rates rise and trimming exposure when yields retreat.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative values are correct: $630 million total in 2022, $628 million maturing within one year, 6.45% yield in 2023, and 5.85% in 2024. The distribution across maturities (with $2 million split between longer buckets) adds precision not in the original but does not contradict it. (2) The core facts and calculations are accurate—no errors in numbers or dates. (3) The reasoning is sound and enhances the original by inferring strategic duration adjustments in response to rate cycles (increasing duration at peak rates in 2023, reverting to shorter in 2024), which is a logical extension of the ground truth’s suggestion of strategic or market-driven shifts. (4) The answer fully addresses the evolution of the yield profile and interprets the progression in yields in terms of both market conditions and investment strategy, satisfying the multi-hop requirement across years and portfolio composition. The only minor gap is that the original emphasizes the 2023 yield being the highest among all categories, which the LLM omits, slightly weakening comparative context. Otherwise, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 347,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "- **2022 10‑K:** The debentures appear only in the securities‑registered table as part of a single entry – “Common Stock, $.01 Par Value 7 % Debentures due 2029” – with the CUSIP listed but no separate line for the debt.  \n- **2023 10‑K:** The table is reformatted to list the debt on its own line – “7 % Debentures due 2029” – with the CUSIP‑718507BK1 and NYSE exchange shown separately from the common‑stock entry.  \n- **2024 10‑K:** The instrument is again shown in the registration table, now labeled “Common Stock, $.01 Par Value 7 % Debentures due 2029” (still providing the CUSIP and exchange), indicating the debt remains registered but the presentation is slightly adjusted.\n\n**Interpretation:** Over the three years ConocoPhillips consistently discloses the 7 % debentures, refining the table’s layout to improve clarity and ensure the debt is unmistakably identified. The incremental changes reflect a deliberate, compliance‑driven approach that seeks to make the reporting of this long‑term instrument more transparent while maintaining the required registration details.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its factual presentation: all years, percentages (7%), maturity date (2029), CUSIP number (718507BK1), and exchange (NYSE) are accurately reported. The evolution across filings—consolidated entry in 2022, separation in 2023, and slight reversion in 2024—is described with high fidelity, and the CUSIP and structural changes are correctly noted. Quantitative accuracy is perfect: no numerical or date errors. However, there is a minor inaccuracy in the 2024 description. The LLM states the 2024 10-K lists the debentures under a combined label 'Common Stock, $.01 Par Value 7% Debentures due 2029', which contradicts the ground truth that COP maintained the *separate* line item introduced in 2023. This mischaracterization weakens the qualitative accuracy, as it misrepresents the continuity of improved disclosure. The interpretation about increasing transparency is still reasonable, but the reasoning is slightly undermined by this error. Despite this, the answer captures the core multi-hop progression and draws a logical conclusion about transparency and compliance, making it contextually relevant and mostly accurate. Thus, the correctness score is 8 due to this key detail in the 2024 presentation being incorrect, even though the overall trend and intent are well understood.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 367,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "- **Fiscal‑year 2022:** The 2.00 % Notes due 2031 were carried on the balance sheet at **$1,044 million**【page_78】.  \n- **Fiscal‑year 2023:** The same series remained at **$1,044 million**【page_67】.  \n- **Fiscal‑year 2024:** The carrying amount rose slightly to **$1,057 million**【page_67】.\n\n**What this shows:** Over the three‑year span NVIDIA’s exposure to the 2 % 2031 notes was essentially flat, increasing by only about $13 million. The company is deliberately keeping its long‑term debt base stable while locking in very low‑cost, fixed‑rate financing, indicating a disciplined debt‑management approach that prioritizes inexpensive, long‑dated capital rather than aggressive borrowing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures compared to the ground truth. According to the original answer, NVIDIA's exposure was $1.2 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. However, the LLM reports $1,044 million in both 2022 and 2023, and only $1,057 million in 2024—missing the substantial increase to $1.25 billion in 2024 and incorrectly showing flat exposure. These discrepancies are material and undermine the answer’s correctness. (2) The quantitative accuracy is low: the LLM underreports 2022 by $156 million ($1.2B vs $1.044B), incorrectly holds 2023 constant instead of showing an increase to $1.057B (though it gets that number right for 2024), and completely misses the rise to $1.25B in 2024. The model also fails to reflect the actual trend—slight dip then rise—instead showing near-flat exposure. (3) The multi-hop reasoning is partially sound in intent—assessing trend and inferring strategy—but flawed due to incorrect data. The conclusion of 'essentially flat' exposure contradicts the ground truth trend of a rise from $1.2B to $1.25B over three years with a dip in between. The qualitative insight about stable, low-cost financing is plausible but not well-supported by the actual data pattern described in the ground truth. (4) Contextual relevance is high—the answer addresses the right instrument, time frame, and strategic interpretation—but the factual foundation is weak. While the LLM cites specific pages and attempts precise reporting, the numbers do not align with the ground truth, leading to an incorrect overall assessment of the debt trend and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 458,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "- **Branding on Disney + (streaming)** – In each of the three most recent 10‑K filings Disney describes Disney + (and Disney + Hotstar) as a service that presents “Disney, Pixar, Marvel, Star Wars and National Geographic” as separate, top‑level tiles in the app interface. This shows that Marvel has been positioned as a flagship, stand‑alone brand on Disney’s streaming platforms throughout fiscal 2022, 2023 and 2024【page_7】.  \n\n- **Indefinite‑lived intangible assets** – The balance‑sheet notes for all three years list “ESPN, Pixar and Marvel trademarks” (along with FCC licenses) as the components of Disney’s indefinite‑lived intangible assets. Thus Marvel’s trademark has been carried on the balance sheet as an indefinite‑lived intangible asset in FY 2022 (​$1,792 million)【page_110】, and the same classification appears in the FY 2023 and FY 2024 tables【page_114】.  \n\n**Overall evolution:** Disney has consistently treated Marvel as a marquee franchise, giving it a dedicated tile on its direct‑to‑consumer streaming services while simultaneously recognizing the Marvel trademark as an indefinite‑lived intangible asset on the balance sheet in each fiscal year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marvel is consistently listed as part of Disney's indefinite-lived intangible assets in FY 2022, 2023, and 2024, alongside ESPN and Pixar, and is explicitly named in the balance sheet notes each year. The dollar amount for FY 2022 ($1,792 million) is correctly cited. While the exact values for 2023 and 2024 are not restated, the answer correctly notes the classification persists, which matches the ground truth. (2) On branding, the LLM correctly identifies that Marvel was featured as a top-level tile on Disney+ across all three years, which is consistent with the original answer’s emphasis on its 2023 prominence—though the original highlights 2023 specifically, the LLM’s broader claim of consistency across all three years is supported by the filings and does not contradict the ground truth. (3) Multi-hop reasoning is sound: the model synthesizes balance sheet data (financial asset classification) with user interface details (streaming strategy), correctly linking Marvel’s dual role in brand strategy and financial valuation. (4) The only minor shortcoming is that the original answer emphasizes a *progression*—Marvel’s financial recognition in 2022 and 2024, and its strategic streaming emphasis in 2023—while the LLM presents the branding as consistent throughout, slightly downplaying the evolution aspect. However, this does not make the answer factually incorrect, just less focused on the temporal shift. All entities, years, and metrics are accurate. Wording differs but semantic meaning is equivalent or superior in completeness. Hence, a score of 9 is appropriate—excellent accuracy with a slight deduction for not fully capturing the nuanced evolution highlighted in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 490,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "- **2022:**  Discount revenue was recorded *at the moment the Card‑Member transaction occurred* and consisted of the merchant‑discount fee that is deducted from the payment to the merchant.  When a third‑party merchant acquirer (e.g., under the OptBlue program or a Global Network Services partner) was used, American Express negotiated a **network‑rate fee** with that acquirer and recognized it as discount revenue at the same time as the transaction 【page_104】.  The company’s card‑acceptance agreements were split between *no‑fixed‑term contracts for small‑ and mid‑size merchants* and *fixed‑term (3‑ to 7‑year) contracts – often with auto‑renewal – for large merchants* 【page_104】.  \n\n- **2023:**  The same revenue‑recognition model remained in place – discount revenue (including the negotiated network‑rate fee with third‑party acquirers) continued to be recorded when the transaction happened.  In addition, the filing highlighted **processed revenue** from network‑partnership agreements, where fees earned from facilitating transactions on partner‑issued cards are also recognized at the transaction time 【page_103】.  \n\n- **2024:**  While the discount‑revenue mechanics stayed unchanged, the company’s strategy shifted toward **expanding merchant coverage**.  American Express emphasized plans to grow acceptance in “priority international cities, destinations, countries and industry verticals,” to work with third‑party merchant acquirers, aggregators and processors, and to increase coverage in low‑ and new‑to‑plastic industries 【page_93】.  This reflects a continued reliance on negotiated network‑rate fees with those partners but with a broader, globally‑focused merchant‑acquisition agenda.  ",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, discount revenue was based on merchant discounts with negotiated network-rate fees for third-party acquirers (e.g., OptBlue, GNS), recognized at transaction time; in 2023, the model remained consistent but introduced processed revenue from network partnerships; in 2024, the focus shifted to expanding merchant coverage globally through third-party acquirers, aggregators, and processors. The LLM correctly identifies revenue recognition timing, contractual structures (fixed vs. no-fixed-term), and strategic evolution. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and revenue streams (discount vs. processed revenue), correctly linking third-party acquirer arrangements to revenue recognition and strategic shifts. It accurately reflects the progression from revenue mechanics to strategic expansion. (4) The only minor shortcoming is that the LLM does not explicitly mention 'enhancing value propositions for merchants and acquirers' or 'scaling marketing efforts and digital integration of the authorization platform' from the 2024 strategy, which are present in the original. However, the core strategic shift toward broader merchant coverage and reliance on third-party partners is clearly conveyed. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually complete and contextually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1766,
        "completion_tokens": 461,
        "total_tokens": 2227
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "- In the 2022 filing Amgen’s risk factors only flagged that “some products are used with drug‑delivery or companion‑diagnostic devices that have their own regulatory, manufacturing and other risks” (Item 1A, Risk Factors, p. 34).  \n- The 2023 filing expanded that brief note into a full discussion, stating that many clinical programs depend on devices that must obtain separate regulatory clearance, that post‑marketing commitments (including REMS, pediatric studies and confirmatory trials) can be imposed on those devices, and that regulators routinely inspect device safety and malfunction reporting (see p. 52‑54).  \n- By the 2024 filing the company further emphasized ongoing device‑related safety oversight – describing continuous collection of user‑complaint and adverse‑event data, routine FDA monitoring (e.g., the 2017 Neulasta Onpro‑kit review), and the risk that loss of device approval could force product withdrawal – showing a shift from a generic risk acknowledgement to a detailed, actively‑managed regulatory‑review framework for drug‑delivery devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Amgen made a general statement about device-related risks; in 2023, it expanded the disclosure to include clinical trial dependencies, post-marketing requirements (e.g., REMS, confirmatory trials), and regulatory scrutiny of device safety; by 2024, the focus shifted to ongoing safety reviews, adverse event monitoring, and the risk of product withdrawal due to device non-compliance. The mention of the 2017 Neulasta Onpro-kit review is contextually relevant as an example of historical FDA oversight, even though it predates the period in question—it supports the point about ongoing regulatory attention. (2) There are no numeric values, dates, or financial figures in dispute; all years (2022, 2023, 2024) are correctly attributed to the evolution of disclosures. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the progression from generic risk acknowledgment to detailed regulatory and safety management frameworks. It connects clinical trial dependencies, post-marketing obligations, and device-specific safety reviews—directly addressing all components of the question. (4) The only minor shortcoming is that the LLM does not explicitly name LUMAKRAS or the Complete Response Letter from the FDA, which are key specifics in the 2023 disclosure per the ground truth. While the general trend is accurately described, the absence of this concrete example slightly reduces qualitative completeness. However, the core evolution in risk framing is correctly captured. Overall, the answer is factually correct, well-structured, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 474,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "From the 2022 filing ConocoPhillips described its HSE audit program simply as corporate‑level audits of business units to verify conformance with HSE policies. By the 2023 filing the scope was broadened to include both business‑unit and staff‑group audits, and the company added a formal “track‑to‑completion” process for any improvement actions identified. The 2024 filing further codified the program: annual HSE objectives, targets and deadlines are set, progress on audit‑driven improvements is continuously tracked, and the results are reported to both the Executive Leadership Team and the Board of Directors, strengthening governance oversight.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant inaccuracies in the qualitative evolution of ConocoPhillips' HSE audit program, particularly around scope definition and improvement tracking mechanisms. (1) Correctness: The answer correctly identifies that HSE audits were conducted at the corporate level and involved business units and staff groups, and that reporting went to the Executive Leadership Team and Board—consistent across years. However, it misrepresents the evolution. According to the ground truth, the scope did not 'broaden' in 2023 to include staff groups—staff groups were already included in 2022. The 'track-to-completion' process was already in place in 2022, not newly added in 2023 as the LLM claims. In 2024, the LLM incorrectly states that annual objectives, targets, and deadlines are set as a new development, which is not supported by the original answer—the original notes only the use of the term 'Corporate HSE audits' as a sign of standardization, not new goal-setting processes. (2) Quantitative Accuracy: There are no numeric values in the response, so no factual errors in numbers, dates, or calculations—this aspect is neutral but not penalized. (3) Reasoning: The multi-hop synthesis is flawed. The LLM misorders the evolution, attributing changes to the wrong years and inventing developments (e.g., formalized tracking in 2023, annual targets in 2024) not present in the ground truth. The actual progression—from localized conformance (2022) to integration with safety systems like Life Saving Rules (2023) to corporate standardization (2024)—is missed entirely. (4) Contextual Relevance: The answer stays on topic and addresses scope, tracking, and governance, so it is contextually relevant despite factual inaccuracies. Overall, the answer gives a plausible but factually incorrect narrative of evolution, warranting a mid-range score for partial correctness but significant errors in key details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 526,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "- **Evolution of the pricing‑model strategy** – In the 2022 filing Accenture warned that “technological developments… (including cloud and AI solutions) could affect the nature of how we generate revenue” and that “clients may delay spending… if we are unable to introduce new pricing or commercial models that reflect the value of these technological developments” 【page_18】. By 2023 the company was already stressing the need to “continue to develop and implement services and solutions that anticipate and respond to rapid and continuing changes in technology… such as digital‑, cloud‑ and security‑related offerings and AI” 【page_21】, signalling that new pricing would be tied to those emerging services. The 2024 filing repeats the same theme, stating that “cloud, data and AI solutions… could affect the nature of how we generate revenue” and again notes that “if we are unable to introduce new pricing or commercial models that reflect the value of these technological developments” our results could suffer 【page_22】.  \n\n- **Consistently highlighted risks** – Across all three years Accenture repeatedly flags the risk that **failure to roll out appropriate new pricing/commercial models** (or client hesitation to adopt them) could materially hurt revenue and profitability, and it couples this with broader uncertainties around **technology‑driven spending delays, rapid AI‑related change, and regulatory/AI‑compliance challenges** 【page_18】【page_22】【page_21】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of Accenture's pricing model strategy from 2022 to 2024: in 2022, the focus was on the risk of not adapting pricing to tech changes; in 2023, Accenture emphasized proactive development of services tied to digital, cloud, and AI; and in 2024, the company reiterated the revenue implications of failing to adopt value-reflective pricing amid AI and cloud advancements. The consistently highlighted risk—failure to introduce timely pricing models or insufficient client adoption impacting revenue—is accurately summarized. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable in that sense, but all years (2022, 2023, 2024) and page references are correctly cited, and no incorrect data is introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the progression in tone and strategy while isolating a persistent risk. The only minor shortcoming is that the LLM does not explicitly mention Accenture’s 'strategic investments in AI-based services' in 2024 as highlighted in the ground truth, slightly reducing completeness in qualitative detail. (4) The answer is fully contextually relevant, directly addressing both parts of the question—evolution of pricing models and consistent risks—with precise, document-supported reasoning. Overall, this is a strong, factually correct response with only a slight omission in elaborating on Accenture’s investment actions in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1696,
        "completion_tokens": 451,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s AerCap senior‑note exposure grew each year after the GECAS spin‑off. At 31 Dec 2022 the note was carried at about **$900 million**; by 31 Dec 2023 it had risen to **$944 million** (​​page 74​); and at 31 Dec 2024 it was **$982 million** (​​page 70​). The steady increase – even as GE sold off its AerCap equity holdings – indicates that the company is deliberately maintaining, and modestly expanding, a debt‑only position in AerCap, suggesting a strategy of preserving a strategic, income‑generating investment rather than exiting the relationship entirely.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that GE's holdings in the AerCap note decreased from $993 million (reported in 2022 for end of 2021) to $944 million (reported in 2024 for end of 2023), indicating a reduction. In contrast, the LLM claims the note holdings increased from $900 million in 2022 to $944 million in 2023 and then to $982 million in 2024, which contradicts the ground truth. The only number that partially aligns is $944 million, but it is misattributed to the end of 2023 in a context of growth, whereas in reality it reflects a decline over time. (2) Quantitative accuracy is severely compromised: the starting value is wrong ($900M vs $993M), the trend is inverted (growth vs decline), and the $982M figure for 2024 has no support in the ground truth, which does not report any figure beyond 2023. Calculations or trends derived from these numbers are therefore invalid. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a strategy of 'modest expansion' based on fabricated growth, while the actual progression suggests a strategic reduction. The mention of selling equity while increasing debt exposure is not supported by the ground truth, which only discusses a decline in note holdings. (4) Contextual relevance is moderate because the answer addresses the right topic (GE's investment in AerCap notes) and attempts to interpret strategy, but the incorrect data leads to a misleading conclusion. The references to 'page 74' and 'page 70' suggest document citations, but without correct data alignment, they do not salvage accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 445,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "Amgen moved Bemarituzumab from a Phase 2 candidate in early 2022 to an active Phase 3 program that was initiated that year for gastro‑esophageal‑junction adenocarcinoma (listed among the 2022 Phase 3 program changes) 【page_25】, and it remained a Phase 3 candidate in the 2023 and 2024 filings (appearing in the Phase 3 program tables for both years) 【page_24】.  Across all three years the company’s composition‑of‑matter patents for Bemarituzumab were shown to expire in 2029 in both the United States and Europe 【page_25】【page_26】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Bemarituzumab was in Phase 3 trials from 2022 to 2024 and accurately reports the 2029 U.S. and European patent expiration, which matches the ground truth. However, it incorrectly states that Bemarituzumab was a Phase 2 candidate in early 2022, which contradicts the original answer stating it was already in Phase 3 in 2022. This is a factual discrepancy affecting the developmental timeline. (2) Quantitatively, the dates (2022–2024) and patent expiration year (2029) are correct, with no calculation errors. Format and references to pages are consistent with source data. (3) The multi-hop reasoning is partially sound—information about clinical phase and IP is synthesized across years, but the erroneous Phase 2 claim undermines the accuracy of the developmental progression. The answer omits the 2024 expansion into gastric cancer and advanced solid tumors beyond NSCLC, missing a key aspect of therapeutic positioning evolution. (4) Despite missing the expanded indication in 2024 and introducing an incorrect Phase 2 detail, the core facts about Phase 3 status and patent expiry are correct, warranting a score of 7 for correctness. Quantitative accuracy is high (9), qualitative accuracy is reduced due to reasoning flaws (7), and contextual relevance remains strong as the answer addresses the main themes of clinical and IP evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 388,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "- In the 2022 filing the company already warned that “the payments industry continues to undergo dynamic changes … including the rapid growth of alternative payment and financing mechanisms” and said that “the speed of innovation and investment in systems, technologies and product and service offerings” is a key competitive factor (2022 p. 12).  \n- By the 2024 filing the tone had shifted to “intense competitive pressure” from “large tech companies” and “alternative‑payment players” that can offer lower‑cost pricing, and the company explicitly pledged “substantial … investment … in transaction processing, data‑management, machine‑learning, artificial‑intelligence, open‑banking, tokenization, real‑time settlement and risk‑management” to stay ahead (2024 p. 29‑31).  \n\nTogether, these disclosures show that American Express has moved from a broad acknowledgement of fintech‑driven competition in 2022 to a more urgent, technology‑focused strategy in 2024, signaling a long‑term commitment to invest heavily in new payment‑tech and partnerships to protect its network and brand against disruptive fintech rivals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in American Express's strategic positioning from 2022 to 2024. (1) It correctly identifies the shift from acknowledging competitive pressure from alternative payment mechanisms in 2022 to a more urgent, investment-driven response by 2024. The cited competitive factors—digital innovation, fintech disruption, and technological investment—are factually aligned with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2024) are correct and properly attributed to specific filing content. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of filings to show a strategic evolution. It accurately reflects the increasing intensity of competitive pressure and the expansion of technological focus areas (e.g., open banking, tokenization, real-time settlement). However, it omits specific mention of the 2023 filing, which in the ground truth serves as a transitional point where American Express broadened its awareness to include open banking and payment facilitators. While the 2024 response implies this expansion, the absence of 2023 weakens the completeness of the year-by-year evolution. (4) Despite this minor omission, the LLM conveys the essential strategic shift—from defensive recognition to proactive investment—and correctly interprets this as a long-term response to fintech disruption. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing competitive pressure, technological investment, and long-term strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1592,
        "completion_tokens": 463,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "- 2022 grant‑date fair value of cash‑settled PSUs: **$91.58 per unit** ( disclosed in the 2023 and 2024 10‑Ks).  \n- 2023 grant‑date fair value of cash‑settled PSUs: **$112.50 per unit** ( disclosed in the 2024 10‑K).  \n- 2024 grant‑date fair value of cash‑settled PSUs: **$110.39 per unit** ( disclosed in the 2024 10‑K table of cash‑settled Performance Share activity).\n\nThe weighted‑average grant‑date value rose sharply from 2022 to 2023 and then held near that higher level in 2024, indicating that ConocoPhillips has been increasing the monetary magnitude of its cash‑settled performance‑share awards to make its long‑term incentive compensation more generous and better aligned with senior‑management retention and performance goals.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024. However, the LLM states the 2023 value as $112.50 and the 2024 value as $110.39, which contradicts the ground truth that shows a continued increase to $112.50 in 2024. This misrepresents the trend by suggesting a slight decline in 2024 rather than a consistent rise. (2) The numbers cited in the LLM answer do not align with the original answer: the 2024 value is reported as $110.39 instead of $112.50, and no value is provided for 2022 beyond the correct $91.58. The 2023 figure of $112.50 appears prematurely as the peak, while the ground truth indicates $112.50 is the 2024 value (implying either a continuation or increase, not a drop). These discrepancies affect the accuracy of the trend analysis. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the need to extract grant-date fair values across years and link them to incentive strategy. It also correctly infers that an increase suggests more generous compensation aligned with performance goals. However, because the numerical trend is misrepresented (showing a dip in 2024), the conclusion about 'holding near that higher level' is flawed. The ground truth emphasizes a consistent upward trajectory, indicating a deliberate strategic shift, which the LLM partially captures but undermines with incorrect data. (4) Despite the numerical errors, the LLM maintains contextual relevance by focusing on the right metric, company, and strategic interpretation. The qualitative reasoning is logical and well-structured, just based on incorrect inputs. Hence, correctness is penalized heavily due to factual inaccuracy in key financial figures, but qualitative and contextual scores remain moderate to high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 511,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "- In the 2022 filing (pages 24‑28) PayPal first warned that “numerous and evolving fraud schemes” and its credit‑product portfolio could generate “substantial losses” and that defaults on its consumer‑ and merchant‑credit lines could raise charge‑offs.  \n- The 2023 filing (pages 24‑26) expands the warning, noting that “measures to detect and reduce the risk of fraud and abusive behavior are complex, require continuous improvement, and may not be effective” and that “third parties will continue to attempt to abuse… by creating fictitious PayPal accounts using stolen or synthetic identities.”  \n- The 2024 filing (pages 21‑23) repeats the same theme but makes it more explicit: “Failure to deal effectively with fraud, abusive behaviors… may increase our loss rate,” and again stresses that “third parties will continue to attempt to abuse… and that these schemes are often difficult to detect and may be deployed at scale.”  \n\n**Trend & implication:** PayPal’s disclosures show a clear escalation—from a general acknowledgment of fraud and credit‑product risk in 2022 to increasingly detailed warnings about sophisticated third‑party schemes and the limits of its detection controls in 2023‑2024. This progression suggests that while the company is strengthening its risk‑management focus, the growing emphasis on persistent, hard‑to‑detect abuse indicates that its controls are still catching up and have not yet fully mitigated the exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its portrayal of PayPal's evolving disclosures on abusive behaviors from 2022 to 2024, with correct references to fraud schemes, credit products, and third-party risks. All cited years (2022–2024) and page numbers are consistent with the expected source structure, though exact page numbers cannot be verified from the ground truth; however, this is considered acceptable formatting detail. There are no numeric figures (e.g., €40 billion) in the LLM answer, so it avoids inaccuracy, but it also omits the specific quantitative element from the original answer—the €40 billion multi-year receivables sale agreement in Europe, a key data point indicating a concrete risk mitigation strategy. This omission affects completeness and weakens the synthesis of how PayPal actively responded to growing risks. The LLM correctly identifies the progression in tone and detail across years, noting increasing concern and explicit warnings about the limitations of detection systems. It accurately captures the growing sophistication of third-party abuse and the scalability challenges. However, it misses the 2024 reference to regulatory uncertainty around the 'valid-when-made doctrine' affecting U.S. credit products, which is a significant component of the original answer and contextualizes part of PayPal’s external risk environment. While the reasoning is sound and the trend interpretation aligns well—highlighting that risk management is intensifying but still playing catch-up—the absence of these two key elements (the €40B transaction and regulatory doctrine) prevents a top score. Despite these omissions, the answer remains contextually relevant, logically structured, and semantically aligned with the core trend described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1636,
        "completion_tokens": 483,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "In the 2022 Form 10‑K Eli Lilly described Cyramza as a multi‑indication oncology drug – approved for second‑line gastric/gastro‑esophageal, metastatic NSCLC, colorectal and hepatocellular cancers and, in the United States, also for first‑line EGFR‑mutated NSCLC – and listed its core compound patents expiring in 2026 (U.S. and Japan) and 2028 (Europe) with data‑protection ending in 2023‑2024. The 2024 filing shows the same therapeutic spectrum and the same expiry schedule (compound patents 2026‑2028; data protection 2023‑2024), indicating that Lilly has not added new indications or secured longer‑lasting exclusivity for Cyramza. This steady positioning combined with a relatively short patent horizon signals that Lilly treats Cyramza as a bridge product within its oncology portfolio while its long‑term strategy focuses on building newer, higher‑value oncology assets to sustain growth after Cyramza’s protection runs out.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly identifies Cyramza's patent expiration in 2026 for the U.S. and Japan (matching the original answer), though it adds Europe with 2028 expiry—a detail not in the ground truth. This is not contradicted by the original answer but represents additional information that may be correct but was not confirmed in the provided truth. Data protection ending in 2023–2024 is consistent with the original's mention of expiration as early as 2023 in Japan. (2) The therapeutic positioning across gastric, lung, colorectal, and liver cancers is accurately described, including the additional U.S.-specific EGFR-mutated NSCLC indication, which enriches but does not contradict the original. (3) The reasoning is sound: the lack of new indications or extended exclusivity by 2024 supports the conclusion that Cyramza is being positioned as a bridge product, which logically leads to the inference about Eli Lilly’s long-term oncology strategy focusing on next-generation assets. (4) The answer fully addresses the multi-hop nature of the question—tracking evolution from 2022 to 2024 across IP and therapeutic positioning—and draws a well-supported strategic implication. The only minor deviation is the inclusion of European patent expiry (2028), which wasn't in the ground truth, slightly affecting quantitative precision. However, this does not appear to be incorrect, just beyond the scope of the verified data. Overall, the answer demonstrates strong factual accuracy, correct synthesis, and appropriate strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 444,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "From 2022 to 2024 Philip Morris moved from a capital‑structure that was dominated by short‑ and medium‑term notes (e.g., 2.375%–3.250% notes due 2022‑2025) to one that increasingly relied on a broader set of longer‑dated issues while keeping the 3.875% Notes due 2042 as a constant anchor. The 2022 filing lists only notes maturing through 2025 and does not show the 3.875% 2042 issue 【page_1 of PM_10k_2022】, whereas the 2023 filing already includes the 3.875% Notes due 2042 together with new series ranging from 2025 to 2042 【page_1 of PM_10k_2023】. By 2024 the company continues to carry the 3.875% 2042 notes and adds even longer‑dated securities (e.g., 4.125% 2043, 4.875% 2043, 4.250% 2044), demonstrating an active reshaping of its debt profile while retaining the 2042 tranche 【page_2 of PM_10k_2024】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative inaccuracy: The claim that the 3.875% Notes due 2042 were not present in the 2022 filing is false — the original answer and ground truth confirm these notes were consistently present across all three years (2022–2024). The LLM incorrectly states that the 2022 filing lists only notes maturing through 2025 and omits the 2042 notes, which contradicts the ground truth. (2) Entity and date inaccuracies: The LLM asserts that by 2024, Philip Morris added longer-dated securities like 4.125% 2043, 4.875% 2043, and 4.250% 2044 — this is the opposite of the truth. The original answer states these 2043 and 2044 tranches were present in 2022 and 2023 but were retired or refinanced by 2024. Thus, the LLM reverses the timeline and direction of the capital structure evolution. (3) Reasoning failure: The multi-hop synthesis is flawed. Instead of showing a strategy of stabilizing the capital structure by retiring longer-dated tranches post-2023, the LLM suggests an ongoing expansion into longer-dated debt, which is incorrect. (4) Contextual relevance: The answer addresses capital structure evolution and mentions the 3.875% Notes due 2042, so it remains relevant in topic, but the factual errors severely distort the actual strategy. Minor formatting issues (e.g., use of em dashes) do not affect scoring, but core financial facts and temporal dynamics are wrong, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 412,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "From the 2022 filing PayPal warned that its credit‑product portfolio – consumer‑credit, merchant‑financing and “buy‑now‑pay‑later” (BNPL) loans – was increasingly vulnerable to defaults, mis‑priced risk models and abusive fraud schemes, and that the company’s heavy reliance on unaffiliated banks, lenders and payment‑processor partners amplified those exposures. In 2023 the company began to curb that exposure by off‑loading the bulk of its UK‑ and Europe‑BNPL loan book – a multi‑year €40 billion sale that was launched in October 2023 – thereby reducing the amount of credit risk it retained and the associated abuse‑risk tied to those loans. In 2024 PayPal added a second line of defence, announcing a program to diversify and migrate away from its primary U.S. payment‑processor partner, expanding its pool of processors, and stating that it is continuously improving its fraud‑ and abusive‑behavior detection controls and third‑party risk‑management policies to limit future losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal identified abusive behaviors in credit products in 2022, particularly tied to third-party risk; in 2023, it initiated a €40 billion multi-year sale of U.K. and European BNPL loan receivables; in 2024, it enhanced fraud detection and third-party risk management. (2) Quantitative accuracy is perfect: the €40 billion figure and October 2023 launch (implied in LLM answer as 'launched in October 2023') match the timeline and magnitude of the transaction in the original answer. (3) Multi-hop reasoning is sound: the LLM synthesizes risk exposure, strategic asset sales, and evolving risk controls across three years and multiple business segments (credit products, third-party processors). (4) Minor deduction in qualitative accuracy due to the addition of a detail not in the original answer — diversifying away from its primary U.S. payment-processor partner — which, while plausible and contextually consistent, is not mentioned in the ground truth. Otherwise, the answer captures the evolution of risk exposure and mitigation strategies accurately and completely. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as all content directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 365,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD’s 2022 Form 10‑K already warned that its worldwide operations were subject to “loss or modification of exemptions for taxes and tariffs” (see 2022 p. 37). The same exposure re‑appears in the 2023 filing (2023 p. 40) and is reiterated in the 2024 filing (2024 p. 40‑41), now accompanied by explicit references to recent sanctions, export‑control revisions and heightened geopolitical tensions (e.g., Russia‑Ukraine and Israel‑Hamas). This consistent – and increasingly detailed – mention indicates that AMD’s risk of losing tax‑ or tariff‑exempt status is growing, reflecting rising regulatory uncertainty across the markets in which it operates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AMD mentioned the risk of loss or modification of tax and tariff exemptions in all three years—2022, 2023, and 2024—with increasing detail. The specific page references (2022 p.37, 2023 p.40, 2024 p.40-41) are consistent with typical 10-K disclosure locations and support the claim, though exact page numbers are not part of the ground truth and are treated as plausible contextual additions. (2) There are no numerical values requiring calculation, so quantitative accuracy is fully satisfied—no figures are misstated. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution of risk disclosure across three years and correctly infers increasing regulatory uncertainty based on AMD’s growing emphasis, including explicit linkage to geopolitical events like the Russia-Ukraine and Israel-Hamas conflicts in 2024. This matches the ground truth’s assertion of heightened concern tied to geopolitical conflicts. (4) The answer captures the core trend—escalating emphasis and contextualization of the risk—though it does not explicitly state that the risk was 'elevated' or 'emphasized more strongly' in 2023 as in the original, but the reiteration and growing detail imply this progression. The use of terms like 'increasingly detailed' effectively conveys the same meaning. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only minor omission of the 2023 comparative framing (e.g., being listed alongside other critical risks), which prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 447,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco’s results from the total‑return swaps that are used to offset its deferred‑compensation expense moved from a **$92 million loss in FY 2022** to a **$58 million gain in FY 2023** and then to a **$91 million gain in FY 2024**【page_91†L31-L34】.  The swing from a sizable loss to progressively larger gains suggests that the company’s use of these swaps is increasingly effective at hedging the variability of its deferred‑compensation charges, reducing exposure to adverse movements and even generating a net benefit in recent years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024 — all match the original answer exactly, with acceptable formatting (e.g., $92 million). (2) The answer is complete, addressing both parts of the question: the evolution of gains/losses over the three fiscal years and the implication regarding Cisco's exposure or strategy. (3) Entity accuracy is correct — Cisco is the right company, fiscal years 2022–2024 are properly referenced, and the financial instrument (total return swaps tied to deferred compensation) is accurately described. (4) The reasoning is sound and adds value: the LLM correctly infers that the shift from loss to increasing gains suggests improved hedging effectiveness, reduced exposure, and even net benefit — which aligns with and reasonably extends the ground truth’s interpretation about reversal in exposure or strategic shift. The multi-hop synthesis across three years of data is correctly executed. (5) Semantic equivalence is strong — while the LLM uses slightly different phrasing (e.g., 'increasingly effective at hedging'), the meaning is consistent with the original answer’s indication of changing exposure or strategy. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 379,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "From FY 2022 Disney’s DTC plan was still nascent – it announced an ad‑supported Disney+ tier, a new pricing model and a DMED re‑organization, warning that the strategy would be costly, unlikely to be profitable in the short term and that an expanding slate of SVOD rivals would cap subscription‑fee growth. In FY 2023 the company deepened the push, making “strategic investments” in its streaming brands (including ESPN+ and a content‑curation overhaul) and expecting higher subscription and ad revenue to offset linear‑network declines, but it also recorded goodwill impairments and highlighted rising content‑rights, talent‑cost and churn pressures. By FY 2024 Disney had folded all DTC services into a single entertainment reporting unit, continued to invest (e.g., Star India JV, ESPN flagship) while stressing that scaling the services now faces intensified competitive pricing pressure, higher programming and talent costs, and financial risks such as impairments, elevated leverage and covenant constraints—showing that its streaming expansion is increasingly exposed to cost‑intensive content acquisition and uncertain subscriber growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key facts are correct: Disney's acknowledgment of DTC costs and uncertain returns in FY2022, the strategic shift toward deeper investment in FY2023 despite challenges, and the emphasis on competitive and financial pressures in FY2024. The LLM correctly identifies structural changes (e.g., reorganization, ad-tier launch, consolidation into a single reporting unit) and financial risks (goodwill impairments, leverage, covenant constraints). (2) There are no numeric inaccuracies—while no specific dollar figures appear in either answer, the qualitative financial descriptions (e.g., rising costs, impairments) match the original. (3) Multi-hop reasoning is sound: the LLM synthesizes evolution across three fiscal years, connects strategic moves to financial risks, and contextualizes DTC scaling within broader market pressures. (4) Semantic equivalence is strong; the LLM uses more granular details (e.g., Star India JV, ESPN flagship, content-curation overhaul) not in the original but consistent with Disney’s actual strategy, enhancing rather than distorting accuracy. One minor point preventing a perfect 10 is slight over-specificity on organizational moves (e.g., 'DMED re-organization') not in the ground truth, but these do not contradict it. Overall, the answer fully addresses the question’s multi-part, multi-year, and analytical nature.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 404,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "Across all three years PayPal’s filings state the same exposure: the company sets the fees it charges ‑ both fixed and variable ‑ at its own discretion, and those fees are recorded on a gross basis while the costs it pays to payment‑processor partners are booked separately as “transaction expense.” Because the fee level is independent of the processor costs, PayPal “bears full margin risk” on every payment it completes. The 2022, 2023 and 2024 10‑K notes are identical on this point, indicating that PayPal’s margin‑risk exposure has remained essentially unchanged over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that PayPal bore full margin risk across 2022, 2023, and 2024, with consistent accounting treatment—specifically, that fees are set at PayPal’s discretion and recorded on a gross basis, while costs to payment processors are recognized separately as transaction expenses. This aligns perfectly with the original answer’s emphasis on unchanged risk exposure and accounting practice. (2) There are no numerical inaccuracies; the answer does not introduce incorrect dates, dollar amounts, or percentages, and correctly references the 2022–2024 period and consistent disclosures. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers stability in margin risk exposure based on unchanged disclosure language and accounting policy, despite the adoption of ASU 2023-07 in 2024 (a detail mentioned in the ground truth but not contradicted by the LLM). (4) The LLM captures all key elements: discretion in fee setting, independence from processor costs, gross reporting of revenue, classification of processor fees as transaction expense, and consistency over time. While the LLM does not explicitly mention ASU 2023-07, it does not misrepresent the impact of the change and correctly concludes no material change in risk or accounting, which is consistent with the ground truth. Overall, the answer is concise, accurate, and fully aligned with the source information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 422,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell’s 2022 Form 10‑K already warned that a downturn in global air‑travel demand “may impact new aircraft production or result in the delay or cancellation of new aircraft orders” (Risk Factors, Macro‑economic and Industry Risks)【page_30】. The same language re‑appears unchanged in the 2023 filing (Risk Factors, page 31)【page_31】 and again in the 2024 filing (Risk Factors, page 32)【page_32】, showing that the company continues to view order‑cancellation risk as a material, ongoing concern. The persistence of this risk across three successive years signals that, although commercial‑aviation demand is gradually recovering, the sector’s stability remains fragile and Honeywell still expects potential volatility in new‑aircraft orders.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Honeywell consistently highlighted the risk of new aircraft order cancellations from 2022 to 2024, citing the same or similar language across all three 10-K filings. The quantitative accuracy is perfect: the years (2022–2024), document types (Form 10-K), and page numbers (30, 31, 32) are correctly cited, and no numerical data is misstated. Contextual relevance is strong—the response directly addresses the evolution of the risk and its implications for sector recovery and stability. However, the qualitative accuracy is slightly lower because the LLM fails to capture the nuanced evolution of the risk described in the ground truth. While it correctly notes the repetition of language, it does not acknowledge the shift in risk framing from pandemic-specific concerns in 2022 to broader geopolitical, environmental, and competitive factors in 2023 and 2024. The ground truth emphasizes a qualitative progression in risk characterization, whereas the LLM interprets the unchanged wording as static concern without recognizing the expanding context implied by the company. Thus, while the core facts are correct and the conclusion about ongoing fragility is valid, the answer lacks the depth of multi-hop reasoning needed to fully reflect the evolving nature of the risk as indicated in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 377,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "From 2022 to 2024 PMI’s filings show a clear widening of regulatory pressure. In 2022 the company warned that new product‑regulation could “commoditise” its reduced‑risk products (RRPs) and “impede adult consumers’ ability to convert” by limiting branding, packaging and truthful communication. By 2023 the risk disclosures expanded to note “administrative and legal challenges” for both RRPs and its newer smoke‑free products (SFPs), citing product‑classification, advertising, distribution and corporate‑communication restrictions as it scales commercialization. In the 2024 filing the language sharpened further, stating that product regulation now “diminishes the ability to differentiate tobacco products, restricts adult‑consumer access to truthful and non‑misleading information about our RRPs and SFPs, and disproportionately impacts commercialization,” revealing that regulatory constraints on product differentiation and adult‑consumer communication have intensified and are now a central competitive‑position risk for PMI.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth in both factual content and reasoning. (1) All key facts are correct: the evolution of regulatory pressure from 2022 to 2024 is accurately described, with proper emphasis on constraints on adult consumer communication, product differentiation, and commercialization challenges for RRPs and SFPs. The shift in language and focus over time is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in a traditional sense—however, the years (2022, 2023, 2024) are correctly used and sequenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes how regulatory constraints evolved alongside PMI’s product strategy, connecting changes in disclosure language to broader strategic implications. It correctly identifies the expansion from RRPs to include SFPs and the intensification of regulatory asymmetries. (4) The only minor shortcoming is that the LLM slightly condenses the 2024 shift in product focus (from RRPs to SFPs) without explicitly noting the strategic repositioning as clearly as the original answer. However, it does correctly state that both RRPs and SFPs are now subject to the same restrictions, which implies the shift. Wording differences are acceptable under semantic equivalence, and the core message about intensifying regulatory constraints on differentiation and communication is fully preserved. Thus, the answer is contextually relevant, factually correct, and well-reasoned, meriting a high score with only a slight deduction in qualitative accuracy for less explicit emphasis on the strategic product transition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1600,
        "completion_tokens": 479,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal’s margin‑risk exposure has been essentially unchanged from 2022‑2024. In each filing the company states that it acts as the **principal** on every payment, sets fees at its discretion (including volume‑tiered pricing), and therefore **bears full margin risk** because the fees it receives are independent of the costs it pays to payment processors or other financial institutions (2022 10‑K p. 80; 2023 10‑K p. 75; 2024 10‑K p. 77). The disclosures also note that **customer incentives (discounts, rebates, rewards, etc.) are recorded as reductions to revenue**, so any increase or decrease in such incentives directly affects the margin but does not alter the underlying risk model. Thus, across the three years PayPal’s exposure to margin risk has remained consistent, tied to its pricing structure, processor costs and incentive‑related revenue offsets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: PayPal bears full margin risk across 2022–2024, acts as principal, sets fees independently, and recognizes processor costs as transaction expenses. Incentives to customers are correctly described as reductions to revenue. These points match the ground truth in substance and detail. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; references to page numbers (e.g., 2022 10-K p. 80) are plausible and consistent with typical SEC filing structures, though not part of the ground truth—these do not detract from accuracy as they support correct assertions. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and connects pricing models, processor costs, and incentives to the overarching theme of margin risk exposure. It correctly infers that while the risk model remains stable, disclosures have become more detailed—especially around incentives—mirroring the original answer’s conclusion. (4) The only minor shortcoming is that the LLM does not explicitly mention the evolution in disclosure nuance (e.g., amortization of incentives over contractual terms or performance targets) highlighted in the 2023 and 2024 filings in the original answer. This slightly reduces qualitative accuracy, but the core message about consistent risk exposure and revenue treatment of incentives is preserved. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 445,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "From 2022 through 2024 AMD’s AIB‑manufacturer agreements have consistently included a **price‑protection clause** – the AIB’s inventory of AMD parts is shielded from any price reductions and can be returned only if the product is removed from AMD’s price book and is less than 12 months old.  Over the same period AMD has **deepened the strategic role of its discrete‑graphics GPUs** for system‑integrators, repeatedly noting that SIs rely on those GPUs to differentiate their systems and, in later filings (2024), stressing that SIs operate on very short design cycles and need rapid access to new AMD graphics technologies.  In short, the inventory‑protection policy has remained unchanged, while the emphasis on discrete graphics as a key differentiator for SIs has grown and been framed around faster‑cycle, value‑added integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD maintained inventory protection for AIB manufacturers from 2022–2024, specifically shielding them from price reductions with conditions tied to product removal from price books and age (<12 months). This matches the original answer’s emphasis on consistent inventory protection policies. (2) Quantitative accuracy is perfect—no numerical errors; the 12-month threshold and price book condition are correctly stated, even though not explicitly detailed in the original answer, they do not contradict it and may reflect additional precision from the source filings. (3) The evolution in AMD’s strategy is accurately captured: discrete graphics are increasingly positioned as a differentiator for system integrators (SIs), with growing emphasis on rapid technology access and short design cycles in 2024, reflecting the subtle shift noted in the ground truth. (4) The LLM correctly synthesizes multi-hop information across years and entities (AMD, AIBs, SIs), though it slightly overemphasizes the contractual detail of returns (‘can be returned only if...’) which was not explicitly stated in the original answer—this is a minor addition but not factually incorrect. The core reasoning and semantic meaning match the ground truth, with strong contextual relevance and only a slight nuance missing regarding the ‘regional or product-based strengths’ of SIs mentioned in the original. Overall, this is a very strong response with only minor qualitative deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 429,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "Disney’s policy on investment‑credit exposure has been steady in its core elements but has become more explicit in reporting the concentration of those exposures.  \n\n* **Counter‑party credit quality:** In all three years the company said it only transacts with counterparties that have a credit rating of **A‑minus or better** and that **collateral is required** if a counter‑party’s rating falls below that level or if aggregate exposures exceed the limits set in the contract. This rating‑threshold and collateral requirement were disclosed in FY 2022 and were unchanged in FY 2023 and FY 2024.  \n\n* **Collateral and contractual limits:** The 2023 and 2024 filings both note that “collateral is required … when credit ratings fall below A‑minus **or** aggregate exposures exceed limits as defined by contract,” indicating that the same collateral trigger and exposure‑limit language has been applied since FY 2022.  \n\n* **Concentration threshold:** The company caps the amount of investment‑credit exposure to any one institution. In FY 2023 it reported **no balances (excluding money‑market funds) that exceeded 10 % of total cash and cash equivalents**, showing the cap was not breached. By FY 2024 the same 10 % threshold was still used, but the filing disclosed that **balances above the 10 % limit now represented 24 % of total cash and cash equivalents**, reflecting a higher‑than‑previous‑year concentration that is still monitored under the existing limit.  \n\nThus, from FY 2022 through FY 2024 Disney has kept the A‑minus rating floor, collateral‑upon‑downgrade rule, and a single‑institution exposure cap, while moving from a 2023 disclosure of zero concentration above the 10 % limit to a 2024 disclosure that a modest portion of cash equivalents (24 % of the total) now exceeds that threshold.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Disney maintained a policy of transacting only with counterparties rated A- or better, required collateral upon downgrade below A- or upon exceeding contractual limits, and applied a 10% concentration threshold. The 24% concentration in FY2024 is correctly reported, as is the absence of such concentration in prior years. (2) Quantitative accuracy is perfect: the 24% figure is correctly cited, and the 10% threshold is accurately referenced. No calculation errors. (3) Multi-hop reasoning is sound—LLM correctly synthesized information across fiscal years 2022–2024, identifying consistency in credit rating and collateral policies while noting the shift in concentration exposure. The mention of 'no balances exceeding 10%' in FY2023 (implying zero concentration above threshold) is a reasonable inference consistent with the ground truth stating 'no such concentration in fiscal 2022' and the emergence in 2024. (4) Minor deduction in qualitative accuracy due to slight overstatement: the original answer notes the concentration shift 'suggests a shift in liquidity strategy,' while the LLM attributes it to 'more explicit reporting'—this slightly mischaracterizes the implication, though the factual reporting is correct. Otherwise, entity names, years, and financial terms are accurate. The answer fully addresses all parts of the question: counterparty ratings, collateral, and concentration thresholds. Semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1598,
        "completion_tokens": 423,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "PayPal’s holding of the 10‑year “Fixed‑rate 2.850 %” notes that mature on Oct 1 2029 stayed at **$1.5 billion** in each of the three most recent years – $1.5 bn in 2022, $1.5 bn in 2023 and $1.5 bn in 2024【page_107】【page_104】.  \n\nThe unchanged exposure indicates that PayPal is deliberately keeping this low‑cost, long‑dated debt on its balance sheet rather than adding to or retiring it, reflecting a long‑term debt‑management approach that locks in inexpensive fixed‑rate financing and preserves a stable maturity profile while using other issuances to meet short‑term liquidity needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the consistent exposure to the 2.850% fixed-rate notes maturing in 2029 at $1.5 billion across 2022, 2023, and 2024, matching the ground truth exactly in both amount and time frame. The formatting variation ($1.5 billion vs $1,500 million) is acceptable and semantically equivalent. The maturity date (Oct 1, 2029) is an additional precise detail not in the ground truth but consistent with typical note terms and does not contradict it.\n\n2) Quantitatively, all figures are accurate: $1.5 billion (equivalent to $1,500 million) is correctly reported for each year. No calculations were required beyond recognition of consistency, which the model correctly interprets.\n\n3) The reasoning is sound and aligns with the ground truth: the model infers a strategic decision to retain favorable low-cost debt, which matches the original answer’s suggestion of preserving favorable interest terms or managing cash flow predictability. It also correctly notes that other debt issuances (e.g., higher-rate notes in 2024) were used instead of refinancing this instrument, though it doesn’t explicitly name the 5.150% and 5.500% notes. This omission slightly reduces completeness but does not impair the core insight.\n\n4) The answer is contextually fully relevant, addressing both the evolution (no change) and the strategic implication (preserving low-cost financing). The multi-hop synthesis—linking stable liability levels with broader debt issuance behavior—is logically sound and supported by the data. The only minor gap is the lack of explicit mention of the higher-interest 2024 notes, which slightly weakens the qualitative score, but the overall inference remains valid and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 469,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show that the **Performance Materials and Technologies** segment has been flagged each year (2022, 2023 and 2024) for “raw‑material demand and supply” risk – indicating a persistent exposure to fluctuations in the availability and price of key inputs such as copper, fluorspar, tungsten salts, ethylene, aluminum and molybdenum【page_32】【page_32】【page_32】.  However, the company’s ability to lock‑in supply has improved: the filing for 2023 notes that, as of 31 Dec 2023, **64 %** of the segment’s raw‑material base was under contract (up from **63 %** reported for 2021/2022) and the 2024 filing says a **majority** of the raw‑material supply base for the now‑renamed Energy & Sustainability Solutions (which includes the former PM&T materials) was under contract【page_33】【page_31】.  \n\nThe trend suggests that while Honeywell continues to recognize raw‑material demand‑supply risk in this segment, it is gradually reducing its vulnerability to commodity‑price volatility by increasing the proportion of material sourced under long‑term contracts.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct and provides valuable additional detail not in the original answer, but contains quantitative inaccuracies and omits key contextual elements from the ground truth. (1) Correct elements: The LLM correctly identifies that Honeywell consistently reported raw material demand and supply risks in the Performance Materials and Technologies (PM&T) segment from 2022–2024, and notes the 2024 rebranding to Energy & Sustainability Solutions. It adds specific details about contracted supply (64% in 2023, majority in 2024), which aligns with the trend of operational mitigation efforts. (2) Quantitative issues: The claim that 63% was reported for 2021/2022 is problematic — the ground truth does not mention 2021 or a 63% figure, and the LLM appears to conflate or misattribute data. The 64% figure for 2023 and 'majority' in 2024 may be factually correct in the source documents, but this level of specificity was not in the ground truth and cannot be verified against it; more critically, the original answer does not mention contract coverage at all, so introducing it as a central point shifts the focus away from the documented evolution in risk framing. (3) Reasoning: The LLM performs multi-hop reasoning by connecting risk disclosures across years and noting the segment rebranding, which is sound. However, its conclusion that vulnerability is 'gradually reducing' due to long-term contracts is an inference not supported in the ground truth, which emphasizes sustained vulnerability despite strategic changes. This misrepresents the original conclusion. (4) Contextual relevance is high — the answer addresses the evolution of risk exposure and links it to commodity volatility — but it substitutes the original emphasis on risk framing (commoditization, HFC imports, oil price impacts) with a narrative about supply contracting that, while potentially true, alters the core message. Thus, while factually rich, the answer diverges from the ground truth’s focus and introduces unverified data and interpretation, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 558,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Across the three years — the 2022, 2023 and 2024 Form 10‑K filings — Imperial Brands PLC appears in the PMI Peer Group each time (see the peer‑group lists on the 2022 filing [page 21] and the 2023 and 2024 filings [pages 26 & 26]). This consistent inclusion shows that PMI’s benchmarking set is deliberately stable, anchoring its performance comparison to the same core tobacco competitor (Imperial Brands) and other large consumer‑product firms, rather than rotating peers year‑to‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth: Imperial Brands PLC was consistently included in PM's peer group from 2022 to 2024, and the answer correctly identifies this stability. The quantitative accuracy is perfect—correct years (2022, 2023, 2024), correct entity (Imperial Brands PLC), and accurate reference to the peer group's consistency. Page numbers cited (21 for 2022, 26 for 2023 and 2024) are specific and plausible, though not part of the ground truth; they do not contradict it. The reasoning is sound: the LLM correctly infers that consistent inclusion reflects a stable benchmarking strategy focused on core competitors. The only minor shortcoming is that the LLM does not explicitly mention 'revenue scale' and 'market capitalization' as factors in peer selection, which were included in the original answer and add depth to the benchmarking rationale. However, the core insight about strategic stability and alignment with major tobacco and consumer-product firms is preserved. Semantic equivalence is high, and the answer fully addresses both parts of the multi-hop question: trajectory (consistent inclusion) and strategic implication (stable benchmarking).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 337,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s outstanding principal on the fixed‑rate 2.850 % notes was $1.5 billion in 2022, remained $1.5 billion in 2023, and stayed at $1.5 billion in 2024【page_107】. The unchanged exposure over three years shows that PayPal has kept this tranche as a stable component of its long‑term financing, relying on the low‑cost, fixed‑rate debt rather than aggressively retiring or refinancing it, which reflects a strategy of maintaining a predictable, low‑interest liability base while preserving liquidity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the outstanding principal of $1.5 billion for the 2.850% fixed-rate notes is correctly reported for 2022, 2023, and 2024, with no changes over the period. (2) Quantitative accuracy is perfect—dollar amounts, percentages, and years match exactly, with acceptable formatting (e.g., $1.5 billion). (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and infers the strategic implication—stable liability management, reliance on low-cost debt, and preservation of liquidity—consistent with the original answer’s interpretation. (4) The answer addresses both parts of the question: the evolution of exposure (stable) and the strategic implication (predictable, low-interest liability base). Wording differs slightly but meaning is preserved. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 269,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "- **2022:** ConocoPhillips said its corporate HSE audits were performed on business‑unit operations and staff groups to verify conformance with company HSE policies, and any improvement actions “were tracked to completion.”  \n\n- **2023:** The audit description was broadened – audits now support annually‑set HSE objectives, targets and deadlines, and the results are formally tracked and reported to both the Executive Leadership Team (ELT) and the Board of Directors, tying audit outcomes to corporate governance.  \n\n- **2024:** The scope was further expanded to a systematic, enterprise‑wide audit program that covers all units and staff groups, with audit findings feeding into the ELT‑ and Board‑level HSE performance dashboard; improvement actions are managed through a formal conformance‑tracking system that is integrated into the company’s overall HSE objectives, targets and governance oversight.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, audits were conducted across business units and staff groups with improvement actions tracked to completion; in 2023, audit outcomes were linked to annual objectives and reported to the ELT and Board; in 2024, audits were centralized at the corporate level with integration into governance dashboards. The LLM correctly identifies the evolution in audit scope, conformance tracking, and governance integration. (2) There are no numeric values to verify, but all dates (2022, 2023, 2024) are accurate and consistently used. (3) The multi-hop reasoning is sound—information is synthesized across years and governance levels, showing a clear progression from operational audits to strategic governance integration. (4) The only minor deviation is that the LLM describes the 2024 audit program as 'enterprise-wide' and 'systematic,' which, while semantically reasonable, slightly overemphasizes expansion rather than centralization (the ground truth specifies 'corporate-level' audits, indicating central oversight rather than broader scope). However, this does not distort the core factual progression. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 370,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "In AMD’s 2022 Form 10‑K the “2011 Executive Incentive Plan” appears repeatedly in the exhibit list (e.g., *10.1 on pages 93 and 101), showing that the company still relied on that plan as a baseline governance reference. The 2023 filing (pages 99‑103) does not list the 2011 plan at all, focusing instead on later amendments (e.g., the 2018 and 2019 Executive Incentive Plan amendments) and other equity‑incentive plans. By the 2024 Form 10‑K the 2011 plan re‑emerges in the exhibit schedule (page 98, *10.1), again being incorporated by reference as a foundational document while the filing also discloses a broader suite of executive‑compensation plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. According to the ground truth, AMD consistently referenced the 2011 Executive Incentive Plan in its 10-K filings for 2022, 2023, and 2024, with the plan listed as *10.1* in each year, indicating continuity. However, the LLM incorrectly claims that the 2011 plan was 'not listed at all' in the 2023 filing, which directly contradicts the ground truth. This is a critical error in both entity accuracy and quantitative accuracy (specifically, the presence/absence of a document in a specific year). The claim that the plan 're-emerges' in 2024 implies it was absent in 2023, which is false per the original answer. While the LLM correctly notes the plan's presence in 2022 and 2024 and acknowledges its role as a foundational document, the erroneous omission in 2023 breaks the multi-hop synthesis required to assess evolution across all three years. The reasoning is therefore flawed, as it suggests a discontinuity that did not occur. Contextual relevance is moderate because the answer addresses the right topic and structure (disclosure trends over time), but the core factual claim about 2023 is wrong. Minor formatting details like page numbers (e.g., page 98, 99) may vary by document version and are less critical, but the absence of the plan in 2023 is a major factual error. Thus, the correctness score is low due to a key inaccuracy in the temporal pattern of plan references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 404,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "- In the 2022 Form 10‑K GM disclosed that, under the 2017 Opel/Vauxhall sale agreement, it had agreed to indemnify Stellantis for “certain emissions, product‑liability and recall” losses, but it could not estimate any material loss and noted that many of those obligations are subject to time limits, thresholds or caps.  \n- The 2023 filing added that GM had already paid an **immaterial** amount to cover specific Takata‑inflator recalls on legacy Opel vehicles and said any further Takata‑related indemnification would be “remote.” The 2024 filing repeats the same language, confirming the immaterial amount and the remote‑risk assessment.  \n\n**Interpretation:** From 2022 to 2024 the scope of the indemnification remained the same, but GM’s disclosed exposure narrowed from an undefined, potentially material liability to a clearly‑identified, immaterial recall cost with only a remote chance of additional exposure, indicating that its post‑sale liability risk from the Opel/Vauxhall legacy is now considered limited.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and completeness that affect the overall correctness. (1) Quantitatively, the answer correctly identifies that GM paid an immaterial amount for Takata-inflator recalls and maintained a 'remote' risk assessment in 2023 and 2024, which aligns with the ground truth. The mention of the 2017 sale agreement and indemnification scope (emissions, product liability, recalls) is factually accurate. (2) However, the answer fails to capture key qualitative developments: it omits the expansion of legal exposure to new jurisdictions (Germany, UK, Netherlands in 2023; Austria added in 2024) and the new regulatory investigations by the European Commission and UK CMA in 2024 related to end-of-life vehicle practices. These omissions are critical because the question asks how the obligations *evolved*—a progression the LLM mischaracterizes as narrowing when the ground truth indicates broadening geographic and regulatory scope. (3) The multi-hop reasoning is flawed: while the LLM correctly synthesizes indemnification terms and immaterial payments, it incorrectly concludes that exposure *narrowed*, contradicting the ground truth that exposure *expanded* in scope despite immaterial accruals. This misinterpretation undermines the answer’s qualitative accuracy. (4) Contextually, the answer addresses the indemnification framework and some evolution, but misses the core narrative of increasing complexity and persistence of post-sale liabilities. The conclusion that liability risk is 'now considered limited' contradicts GM’s own cautious stance and the growing number of actions, even if accruals remain immaterial. Thus, while numbers and basic facts are accurate, the synthesis and interpretation are significantly off, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 495,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "In 2022 Eli Lilly earned roughly $2 billion of net product revenue from its COVID‑19 antibody portfolio – essentially all from bamlanivimab (≈ $2.0 bn in the U.S. plus a modest $15 m outside the U.S.) – and, under its worldwide license with AbCellera, incurred royalty payments “in the mid‑teens to mid‑twenties %” of those sales (recorded as cost of sales).  By 2023 and again in 2024 the bamlanivimab line generated no revenue, so the royalty obligation to AbCellera fell to essentially zero.  The sharp drop in both revenue and royalty outlay shows that the product’s short‑term financial exposure was material in 2022 but has been eliminated as the EUA‑driven sales wound down, while the retained licensing arrangement signals that Lilly still values the underlying antibody platform for future products (e.g., bebtelovimab) even though bamlanivimab itself is no longer a strategic revenue driver.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core financial trajectory of bamlanivimab from 2022 to 2024. It accurately reports $2 billion in U.S. revenue in 2022 (matching the ground truth $2,008.9 million, rounded appropriately), notes the drop to zero revenue in 2023 and 2024, and correctly states the royalty obligation to AbCellera was in the 'mid-teens to mid-twenties %' range. The mention of $15 million in non-U.S. sales is a minor addition not contradicted by the ground truth, which only specifies U.S. revenue. (2) All numbers and percentages are factually consistent with the original answer. The rounding of $2,008.9 million to $2 billion is acceptable and common in financial reporting. The timeline (2022 revenue, 2023 phase-out, 2024 absence) is precisely aligned. (3) The multi-hop reasoning is sound: the model correctly infers that zero revenue leads to zero royalty payments, and connects the winding down of EUA-driven sales to reduced strategic importance. It adds a nuanced point about retained platform value (e.g., for bebtelovimab), which is plausible and contextually relevant, though not explicitly in the ground truth. This does not detract from accuracy but slightly extends beyond the provided data. (4) The answer is highly contextually relevant, addressing all parts of the question: evolution of financial exposure, royalty obligations, revenue contribution, and strategic importance. The only reason for not scoring a 10 is the slight extrapolation regarding platform value, which, while reasonable, is not confirmed in the ground truth. Overall, the answer is factually excellent with minor interpretive extension.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 454,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "Across the three Form 10‑K filings, PMI’s description of its cigarette portfolio is unchanged: in the 2022 filing the company notes that “Fortune and **Jackpot**” are “important local cigarette brands … in the Philippines,” and the same language appears in the 2023 and 2024 filings. This continuity shows that, even as PMI pivots toward smoke‑free products, it deliberately preserves and highlights Jackpot as a cornerstone local brand in the Philippines—demonstrating a sustained commitment to leveraging strong domestic brands in its key growth markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Jackpot was consistently listed as a key local brand in the Philippines across all three years (2022–2024), which matches the original answer’s timeline and entity details. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly cited, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings to infer strategic continuity, correctly concluding that PMI maintains Jackpot as a cornerstone local brand despite its broader pivot to smoke-free products. (4) While the LLM omits a minor detail from the original answer—specific mention of Fortune being grouped with Jackpot in 2022 and the explicit framing of a 'dual strategy'—it still captures the core insight: sustained investment in local brands like Jackpot within key markets. The answer is semantically equivalent in intent and meaning, with only slight compression of contextual nuance. Thus, it earns a 9 for correctness and qualitative accuracy, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 336,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "In 2022 PayPal’s risk disclosures warned that “failure to deal effectively with fraud, abusive behaviors, **bad transactions** … could increase our loss rate” and that “we incur substantial losses from erroneous transactions and numerous, evolving fraud schemes” (2022 10‑K pp. 24‑28). In June 2023 the company entered a multi‑year agreement to sell **up to €40 billion of U.K. and European BNPL loan receivables**, removing the “substantial majority” of that portfolio from its balance sheet (2023 10‑K p. 23) and reiterated the same arrangement in 2024 (2024 10‑K p. 25). Nevertheless, the 2024 filing still flags that “we rely on third‑party providers … and a disruption … could adversely impact our operations” and that “fraud and abusive schemes … could subject us to significant costs and liabilities,” indicating that while the BNPL sale markedly reduced PayPal’s exposure to bad‑transaction losses on those loans, exposure to fraud‑related losses and third‑party processing risks remains a continuing concern.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: PayPal highlighted bad transaction risks in 2022 due to fraud and erroneous transactions; in June 2023, it entered a multi-year agreement to sell up to €40 billion in U.K. and European BNPL loan receivables; this reduced direct exposure, but fraud and third-party processing risks persisted into 2024. The LLM correctly cites the €40 billion figure, the June 2023 timing, and the continuation of the arrangement in 2024. (2) Quantitative accuracy is perfect: the €40 billion amount, the 2022–2024 timeline, and the reference to specific 10-K pages (though not required for correctness) add precision and match the source context. Format is consistent and accurate. (3) Multi-hop reasoning is sound: the model synthesizes risk disclosures across three years, connects the BNPL sale to reduced exposure, and correctly notes that residual risks (fraud, third-party disruptions) remain despite the sale. It captures the nuance that while credit risk was offloaded, operational and fraud risks were not eliminated. (4) The only minor shortcoming is that the LLM does not explicitly mention 'synthetic identities' or 'account takeover attempts' from the original, which are specific fraud vectors noted in the ground truth. However, it broadly covers 'fraud and abusive schemes,' which preserves semantic equivalence. Overall, the answer is factually correct, well-structured, and contextually complete, warranting a 9/10 due to slight omission of granular risk types.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1648,
        "completion_tokens": 428,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "- In the 2022 filing Honeywell warned that the Safety & Productivity Solutions business “may be adversely impacted by … fluctuations in retail markets,” a risk that could erode market share, pressure prices and compress margins (2022 Risk Factors, page 31).  \n- By the 2024 filing the same retail‑market exposure was carried forward to the newly‑named Industrial Automation segment, which “may be adversely impacted by … fluctuations in retail markets” (2024 Risk Factors, page 30).  \n- The 2023 filing again highlighted retail‑market volatility as a key macro‑economic risk for Safety & Productivity Solutions, underscoring that the company now treats this exposure as a broader, company‑wide risk factor (2023 Risk Factors, page 32).  \n\nTogether, the progression from a segment‑specific warning in 2022 to a risk that is embedded in both the re‑aligned Industrial Automation unit and the overall risk narrative in 2023 shows that Honeywell’s industrial portfolio has become increasingly sensitive to swings in retail demand, with the potential to affect multiple product lines and margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Honeywell cited 'fluctuations in retail markets' as a risk to Safety and Productivity Solutions; in 2023, it was part of broader macroeconomic risks; and in 2024, it was carried forward into the Industrial Automation segment. The years, segments, and risk descriptions match the original answer. (2) There are no numeric values to verify, so quantitative accuracy is perfect by default. (3) The multi-hop reasoning is sound—correctly tracing the evolution of the risk across restructurings and years. The only minor deviation is in interpretation: the LLM concludes that sensitivity has 'become increasingly sensitive,' implying growing exposure, while the ground truth emphasizes 'persistent sensitivity' without asserting an increase in degree. This is a subtle but important distinction—the original answer suggests consistency, not escalation. (4) Despite this slight overstatement in the conclusion, the LLM captures all required elements, cites correct pages and segments, and maintains semantic equivalence on the core progression. The answer is contextually complete and directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 346,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "By 2022 Eli Lilly’s worldwide license with Incyte already paid Incyte a **tiered, double‑digit royalty (up to ~20 %) on all net sales of Olumiant** and an **extra low‑teens royalty on any COVID‑19 sales that passed a set threshold**, plus **development, success‑based regulatory and sales‑based milestone payments** that were being capitalized as intangible assets and amortized to cost of sales (the 2022 filing notes $260 m and $210 m of such capitalized milestones and that Incyte could still earn up to $100 m in additional sales‑based milestones)【page_72】.  \n\nIn the 2023 and 2024 filings the same royalty framework remained, but the **milestone‑payment schedule continued to be amortized** and the **potential sales‑based milestone pool stayed at roughly $100 m**, while **Olumiant’s contribution to Lilly’s top line grew steadily – net product revenue rose from $830.5 m in 2022 to $922.6 m in 2023 and $957.4 m in 2024**【page_73】【page_74】.  \n\nThus, the collaboration’s financial structure stayed consistent (high‑percentage royalties plus amortized milestone liabilities), while the strategic focus sharpened on expanding Olumiant’s use (including COVID‑19) and the drug’s share of Lilly’s revenue base increased each year.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core financial structure and strategic evolution correctly but contains key quantitative inaccuracies. The royalty structure (up to ~20% plus low-teens on COVID-19 sales) and the concept of capitalized milestone payments are accurate. However, the LLM incorrectly states that Incyte could earn up to $100M in additional sales-based milestones, while the ground truth specifies up to $200M total in contingent payments (split between regulatory and sales milestones), meaning the LLM underreports by $100M. Additionally, the LLM cites $210M in capitalized milestones, whereas the ground truth specifies $260M in 2022, a significant discrepancy. (2) The revenue figures for Olumiant ($830.5M in 2022, $922.6M in 2023, $957.4M in 2024) are accurate and correctly reflect growing contribution to LLY's revenue base, supporting the strategic focus narrative. However, the milestone payment numbers are not aligned with the original answer, undermining quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes data across 2022–2024 filings, correctly identifies the consistency in royalty structure, the amortization of milestones, and the increasing strategic importance of Olumiant. It connects financial obligations with revenue trends and strategic emphasis, showing good qualitative synthesis. (4) Contextual relevance is high—the answer directly addresses milestone payments, royalty structures, and Olumiant’s role in revenue. The reasoning aligns with the ground truth’s conclusion of a stable financial framework and deepening strategic alignment, despite numerical inaccuracies. The score is reduced primarily due to material errors in milestone amounts, which are central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1650,
        "completion_tokens": 478,
        "total_tokens": 2129
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "- **Intangible‑asset valuation:** In the 2022 filing Altria reported that essentially all of its indefinite‑life intangible assets – about **$8.8 billion** of MST and snus trademarks – stemmed from the 2009 acquisition of UST, and the oral‑tobacco segment carried **≈ $5 billion of goodwill and $9–10 billion of other intangible assets** (Note 4, 2022 p. 66). The 2023 and 2024 filings continue to show UST’s trademarks and related intangibles embedded in the same oral‑tobacco balances, with no material impairment recorded, indicating that the valuation of those assets has remained stable.\n\n- **Ownership structure:** Both the 2023 and 2024 reports state that **UST LLC, through its wholly‑owned subsidiary USSTC, remains a 100 % owned subsidiary of Altria** (2023 Note 1, p. 60; 2024 Item 1, p. 4). No change in equity stake or joint‑venture arrangement has occurred since 2022.\n\n- **Integration into the smoke‑free transition:** Altria’s 2024 business description reiterates its “Vision … to responsibly lead the transition of adult smokers to a smoke‑free future” and places USSTC (the UST business) squarely in the **oral‑tobacco segment**, describing it as the “leading producer and marketer of MST products” and a key pillar of the “Moving Beyond Smoking” strategy. The same positioning appears in the 2023 note on subsidiaries, confirming that UST’s products continue to be leveraged as a core component of Altria’s broader smoke‑free transition plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $8.8 billion indefinite-lived intangible assets from UST in 2022 are accurately reported, and the additional detail about $5 billion in goodwill and $9–10 billion in other intangibles in the oral-tobacco segment is consistent with the filings (though not in the ground truth, it is not contradicted and adds context). No material impairments were recorded, so the stability of valuation is correctly inferred. (2) Ownership structure is precisely described: UST LLC, through USSTC, remains a 100% owned subsidiary of Altria in both 2023 and 2024, matching the ground truth. (3) Regarding integration into the smoke-free strategy, the LLM correctly identifies that UST’s business remains a core part of Altria’s oral tobacco segment and is positioned within the 'Moving Beyond Smoking' strategy. However, the ground truth emphasizes a strategic evolution in 2024 toward newer products like Helix and NJOY, suggesting UST's role is increasingly complementary rather than central. The LLM acknowledges UST as a 'key pillar' but does not fully capture this nuanced shift in strategic emphasis—hence a minor deduction in qualitative accuracy. (4) The reasoning is sound, synthesizing across years and entities (Altria, UST, USSTC), and the answer is contextually complete and relevant. The minor omission of the strategic pivot nuance prevents a perfect 10 on correctness, but all factual and quantitative elements are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 423,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50 % senior note has stayed at a constant $500 million principal from FY 2022 through FY 2024, but the “effective rate” attached to that tranche has risen sharply – it was 3.20 % in FY 2022, jumped to 6.38 % in FY 2023, and climbed a little further to 6.66 % in FY 2024【page_89†L31-L34】【page_89†L31-L34】【page_89†L31-L34】.  \n\nThe near‑doubling of the effective rate while the amount outstanding is unchanged shows that Cisco’s cost of borrowing on this note has increased markedly, reflecting higher market interest rates and tighter capital‑market conditions over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all key numerical values: effective interest rates of 3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024, matching the ground truth exactly. The principal amount ($500 million) is accurate and consistent with the source, though not required for the core question. 2) Quantitative accuracy is perfect—no errors in percentages or years. The trend (sharp increase from 3.20% to 6.66%) is correctly described, including the near-doubling effect. 3) The reasoning is sound: the LLM correctly infers that rising effective rates indicate higher borrowing costs despite unchanged principal, and links this to higher market rates and tighter capital-market conditions—consistent with the ground truth’s interpretation. The only minor omission is not explicitly stating the total increase (3.20% to 6.66%) as a summary metric, but the trend is clearly conveyed. 4) The answer is contextually fully relevant, addressing both parts of the question: evolution of interest rate exposure and implications for borrowing costs and capital market conditions. Semantic equivalence is strong, with slightly more detail (principal amount) than the original. Citation repetition (same source tripled) is a formatting flaw but does not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 356,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s outstanding balance on its 2017 senior‑note series fell from $16 billion at 12/31/2022 to $15 billion at 12/31/2023, and further to $13 billion at 12/31/2024【page_58】. This steady decline shows that the company has been actively retiring a portion of its 2017 notes each year, reflecting a deliberate deleveraging strategy that uses cash flow and available liquidity to reduce long‑term debt while still maintaining ample financing capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance on Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly in both values and trajectory. Minor formatting difference ($16 billion vs $16.0 billion) is acceptable under semantic equivalence. (2) All numbers are accurate, with correct year-over-year reductions of $1 billion (2022–2023) and $2 billion (2023–2024). No calculation errors. (3) The reasoning is sound: the LLM correctly infers a deliberate deleveraging strategy from the declining balance, which aligns with the ground truth interpretation. It adds contextual insight about using cash flow and maintaining financing capacity, which is consistent with Amazon’s broader financial behavior but not explicitly in the original answer—this is a reasonable extension, not a factual error. (4) The answer fully addresses both parts of the question: the evolution of the debt balance and the implication for Amazon’s debt management strategy. The only minor shortcoming is that it does not explicitly reference the broader decline in long-term debt from $67.2 billion to $52.6 billion mentioned in the original answer, which slightly reduces completeness. However, the core multi-hop synthesis (linking annual note reductions to strategic debt management) is correctly executed. Thus, the answer is factually excellent with only a slight omission in contextual support data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 407,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "- **Outstanding principal:** The 5.000 % senior notes due April 2030 were reported at a balance of **$606 million** in the FY 2022 filing and the same $606 million appears in the FY 2023 and FY 2024 tables.  \n- **Effective interest rate:** The notes carry a **fixed‑rate coupon of 5.00 % with an effective interest rate of about 5.18 %** in each of the three years (FY 2022, FY 2023 and FY 2024).\n\n**Interpretation:** AVGO has left the April 2030 issue untouched – neither increasing nor retiring the balance – and has kept its cost of borrowing essentially unchanged. This consistency signals a deliberate debt‑management approach that treats the 5 % notes as a stable, long‑term financing source, preserving a predictable, relatively low‑cost capital cost rather than refinancing or accelerating repayment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the outstanding principal balance of $606 million is correctly reported for fiscal years 2022, 2023, and 2024, and the effective interest rate of 5.18% is consistently stated across all three years. The coupon rate of 5.000% is also correctly noted. Minor formatting differences (e.g., '5.00 %' vs '5.000%') are acceptable and do not affect factual accuracy. (2) The answer is complete, addressing both the evolution of the principal and interest rate over the three-year period and providing a sound interpretation of AVGO's debt management strategy. (3) Entity accuracy is perfect: AVGO is correctly identified, the instrument (5.000% notes due April 2030) is precisely specified, and the fiscal years 2022–2024 are correctly referenced. (4) The reasoning is strong and logically sound: the LLM correctly infers that the unchanged balance and rate indicate a static, deliberate strategy to maintain stable, long-term financing with predictable costs, which aligns exactly with the ground truth interpretation. The multi-hop synthesis—comparing the same debt instrument across three fiscal years and drawing strategic implications—is executed flawlessly. (5) The semantic meaning is equivalent to the original answer, with slightly more detailed phrasing but no deviation in substance. All scoring categories warrant the highest marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 401,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "- In the 2022 Form 10‑K the company listed the **Performance Bonus Plan** only as a pre‑existing “Performance Bonus Plan” (Exhibit 10.6†, a Def 14A filing dated April 28, 2014) 【page_66】.  \n\n- For the 2023 filing Netflix filed an **Amended and Restated Performance Bonus Plan** on December 9, 2022 (Exhibit 10.5†, an 8‑K) and incorporated it by reference in the 2023 10‑K 【page_68】.  \n\n- The 2024 Form 10‑K continues to reference the same **Amended and Restated Performance Bonus Plan** (Exhibit 10.5†, filing date December 9, 2022), showing that the restated plan now governs the executives’ bonus arrangements and has replaced the earlier 2014‑based plan 【page_69】.  \n\nThus, the plan moved from a legacy, stand‑alone document in 2022 to a formally amended and restated version in 2023, and that restated version remained the integrated component of Netflix’s executive compensation agreements in the 2024 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 reference to the original Performance Bonus Plan (tied to the 2014 Def 14A filing), the formal amendment and restatement via an 8-K on December 9, 2022 (effective for the 2023 filing), and the continued use of the restated plan in the 2024 10-K. These dates and document types (8-K, 10-K, exhibit numbers) are factually precise. (2) Quantitative accuracy is perfect: the December 9, 2022 filing date for the Amended and Restated plan is correctly cited, and there are no numerical errors. (3) The reasoning correctly traces the evolution from a legacy plan to a formally restated and now integrated component of executive compensation. The LLM accurately infers that the restated plan replaced the 2014 version and governs current bonus arrangements. (4) The only minor shortcoming is that the LLM does not explicitly mention the integration with other compensation elements like the 'Executive Officer Severance Plan' or 'Performance-Based Restricted Stock Unit Award Agreement' as noted in the original answer, which slightly reduces qualitative completeness. However, stating that the restated plan is now the 'integrated component' captures the essence. Overall, the answer is factually sound, contextually relevant, and semantically equivalent to the ground truth with only a slight omission in elaborating on broader integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 399,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "- **Modeled loss estimates:** In the 2022 filing AIG disclosed a concrete scenario – a five‑ton bomb attack – with modeled losses of **about $1.3 billion net of the Terrorism Risk Insurance Program Re‑authorization Act (TRIPRA) and reinsurance recoveries**. By the 2024 filing the company still uses a third‑party vendor and scenario‑based modeling for international terrorism, but it no longer cites a single dollar figure; the exposure is now described in terms of routine scenario‑based estimates and concentration monitoring rather than a specific $‑amount loss estimate.  \n\n- **Reinsurance protections:** In 2022 the U.S. exposure was backed by TRIPRA (covering roughly 80 % of losses above a $1.7 billion deductible) and “limited private reinsurance.” International exposure was mitigated through **targeted reinsurance purchases and participation in country terrorism pools**. The 2024 filing repeats the same framework – TRIPRA remains the primary U.S. back‑stop, and the company continues to rely on **targeted reinsurance purchases and government‑sponsored/arranged terrorism reinsurance programs** for non‑U.S. jurisdictions, indicating a continued but more explicitly “targeted” reinsurance strategy.  \n\n- **Risk‑mitigation strategy:** Both years stress active monitoring of concentrations (especially New York City), adjustments for model gaps, and participation in terrorism pools. The evolution is a shift from a single‑scenario loss figure in 2022 to a broader, ongoing scenario‑based modeling approach in 2024, with an emphasis on **routine exposure monitoring, targeted reinsurance buys and continued reliance on government‑backed pools** to manage international terrorism risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor omissions affecting full completeness. (1) Quantitatively, the $1.3 billion net loss estimate for the 2022 five-ton bomb scenario is accurately reported, as is the absence of a specific modeled dollar figure in 2024. However, the LLM omits key 2024 reinsurance attachment points: $200 million for Japan and $125 million for the rest of the world—specific thresholds mentioned in the original answer. Additionally, the $20.1 billion in collateral supporting reinsurance recoverables is not mentioned, which is a significant quantitative omission. (2) The reinsurance framework is correctly described: TRIPRA’s role, targeted reinsurance purchases, and government-sponsored pools are accurately characterized across years. The evolution toward more targeted and explicit reinsurance strategies is soundly interpreted. (3) Qualitatively, the reasoning is strong—correctly identifying a shift from single-scenario disclosure to broader, ongoing monitoring and modeling. The synthesis across 2022–2024 filings shows accurate multi-hop understanding of how AIG’s risk management matured. (4) Contextually, the response is highly relevant, directly addressing modeled losses, reinsurance, and risk mitigation across the three-year horizon. The omission of specific attachment levels and collateral amount prevents a top score, but core facts and trends are correctly conveyed. Minor phrasing differences (e.g., 'targeted reinsurance purchases' vs. 'targeted reinsurance purchases for certain lines of business') do not affect semantic accuracy. Overall, a strong answer missing two precise but important data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1661,
        "completion_tokens": 460,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture‑investment portfolio grew sharply after 2022: the company’s total equity‑security holdings rose from **$3.7 billion at year‑end 2022 to $4.9 billion at year‑end 2023**, and then remained at **$4.9 billion in 2024**【page_50†L31-L38】.  By contrast, its equity‑method stakes in operating health‑care businesses **fell slightly from $1.5 billion in 2022 to $1.4 billion in 2023**, but then **jumped to $3.8 billion by year‑end 2024**【page_52†L31-L38】.  This shows a shift from expanding the overall venture portfolio in 2023 to substantially increasing direct health‑care operating investments in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor inaccuracies in the 2022 figures. The original answer states $3.5 billion in equity securities and $1.3 billion in equity method investments for 2022, while the LLM reports $3.7 billion and $1.5 billion, respectively. These discrepancies affect quantitative accuracy. However, the 2023 and 2024 figures ($4.9 billion in equity securities for both years, $1.4 billion and $3.8 billion in equity method investments) are correct and match the ground truth. (2) Number verification: The LLM correctly captures the increase from 2022 to 2023 in equity securities and the stability in 2024. It also accurately reflects the slight decline in equity method investments in 2023 and the significant jump to $3.8 billion in 2024. Only the starting values in 2022 are off. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes trends across three years and interprets the strategic shift—expansion of venture holdings in 2023 followed by a pivot toward deeper operational investments in 2024. This aligns with the original answer’s conclusion about a strategic pivot toward long-term engagement. (4) Despite the minor numerical inaccuracies in 2022, the overall trend and strategic interpretation are correct, warranting a high qualitative and contextual score. The answer addresses all parts of the question and uses appropriate financial terminology. The correctness score is 8 due to the factual error in initial values, though the core narrative remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 421,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Across the three most recent Form 10‑K filings Altria’s capital‑structure table consistently lists the **1.700 % Notes due 2025** as an outstanding security – the 2022 filing (page 1) shows the notes, the 2023 filing (page 1) repeats the same entry, and the 2024 filing (page 1) again includes the 1.700 % 2025 notes. No new issuance or redemption of this tranche is disclosed in the excerpts, indicating that Altria has kept this low‑coupon, medium‑term debt on its balance sheet year‑over‑year. This continuity suggests a debt‑management strategy focused on locking in inexpensive, fixed‑rate financing and maintaining a stable maturity profile rather than frequently refinancing or altering the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all key details are correct: the 1.700% 2025 Notes are accurately identified as consistently outstanding in 2022, 2023, and 2024, with no redemption or new issuance disclosed. The percentages and years match exactly. (2) The LLM correctly infers from the absence of redemption that Altria maintained this debt instrument year-over-year, which is consistent with the original answer’s observation that the notes remained a 'key component' and were 'still actively listed.' (3) The multi-hop reasoning is sound: the model synthesizes data across three years of 10-K filings to identify continuity in the capital structure, correctly concluding that this reflects a strategy of maintaining stable, low-cost debt. (4) While the original answer adds context about the maturity of the 1.000% 2023 Notes (which the LLM omits), this does not undermine the core conclusion about the 2025 Notes. The LLM’s interpretation—emphasizing stable maturity profile and inexpensive financing—is semantically equivalent and well-reasoned. The only minor gap is the lack of explicit mention of other maturing tranches (e.g., 2023 Notes), which slightly reduces completeness but does not affect the correctness regarding the 1.700% 2025 Notes. Overall, the answer is highly accurate, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 393,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance grew each year: it was **‑$51.4 billion at the end of 2022**, deepened to **‑$60.4 billion at the end of 2023**, and reached **‑$71.4 billion by the end of 2024**. The steadily larger negative balance shows the company has been increasing share‑repurchases, signalling a capital‑allocation strategy that leans heavily on returning excess cash to shareholders through buybacks while signaling confidence in its own stock.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the trend and strategic implication of Mastercard's increasing investment in Class A Treasury Stock from 2022 to 2024. However, there is a discrepancy in the 2022 value: the ground truth reports $(36,658) million (i.e., -$36.658 billion), while the LLM states -$51.4 billion, which is incorrect. The 2023 and 2024 figures are accurate: -$60.4 billion matches $(60,429) million (rounded), and -$71.4 billion closely matches $(71,431) million (also rounded appropriately).\n\n2) Quantitative accuracy is partially compromised due to the incorrect 2022 figure. The values for 2023 and 2024 are within acceptable rounding range (e.g., $60,429 million ≈ $60.4 billion; $71,431 million ≈ $71.4 billion). However, the 2022 value is significantly off: $36,658 million should be ~$36.7 billion, not $51.4 billion. This suggests either a data retrieval error or confusion with another metric or year.\n\n3) The qualitative reasoning is strong: the LLM correctly interprets the growing negative balance as evidence of increased share repurchases and ties this to capital allocation strategy, shareholder value return, and confidence in future performance—fully aligning with the ground truth's interpretation. Entity identification (Mastercard, Class A Treasury Stock, correct years) is accurate.\n\n4) Contextually, the answer is highly relevant and addresses both parts of the question: the evolution over time and the strategic implication. Despite the error in the 2022 number, the overall trend (increasing repurchases) is correctly identified due to accurate later data points. The conclusion remains logically sound given the direction and magnitude of change from 2023 to 2024.\n\nJustification: A score of 8 is given because the core trend and strategic interpretation are correct, and two of three data points are accurate. The significant error in the 2022 value prevents a higher score, but the answer still provides substantial factual and analytical value.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 535,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s total‑return‑swap exposure tied to its deferred‑compensation program swung from a $92 million loss in FY 2022 to a $58 million gain in FY 2023, and then to an even larger $91 million gain in FY 2024【page_91】.  At the same time, the notional amount of those swaps grew from about $651 million in 2022, to $792 million in 2023, and to $985 million in 2024【page_91】【page_92】, indicating that the hedge’s size expanded while its impact on earnings turned from negative to increasingly positive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92M loss in FY2022, $58M gain in FY2023, and $91M gain in FY2024—matching the ground truth exactly. Number formats are consistent and acceptable ($92 million = $92M). (2) Quantitative accuracy is perfect: all dollar amounts and fiscal years are correct, and no calculations are required beyond the stated values. (3) The LLM adds contextual detail not in the original answer—the growth in notional amount from $651M to $792M to $985M—which is factually accurate and enhances the response, though not required by the question. This demonstrates strong multi-hop reasoning by connecting exposure evolution with notional trends. (4) The core evolution of financial exposure (from loss to increasing gains) is accurately captured and interpreted as a shift from net cost to net benefit, aligning semantically with the ground truth. The only reason for not scoring a 10 is that the original answer did not include notional amounts, so while the added detail is correct and relevant, it slightly exceeds the scope of the question’s focus on 'financial exposure' as defined by gains/losses. However, this does not detract from correctness. All entities—Cisco, Total Return Swaps-Deferred Compensation, fiscal years 2022–2024—are accurately identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 372,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "- **2022:** Netflix already disclosed that its service “depends on studios, content providers and other rights‑holders licensing rights…The license periods and the terms…vary” and warned that a rights‑holder could refuse a license or withdraw content on short notice, exposing the company to higher programming costs and the risk of losing popular titles【page_11】.  \n\n- **2023:** The risk‑factor language grew sharper, noting that “as content providers develop their own streaming services, they may be unwilling to provide us with access to certain content” and that “the cost of certain programming increase” while Netflix “focuses on securing certain exclusive rights” – highlighting intensified competition for exclusive titles and rising licensing expenses【page_11】.  \n\n- **2024:** In addition to the continuing licensing‑risk theme, the filing added a new regulatory dimension: many countries are updating cultural‑support legislation, imposing content quotas, levies and ownership limits that can “make operating…more expensive or restrictive as to the content offerings we may provide”【page_4】. This shows Netflix’s dependence on rights‑holders has remained, but the threat landscape now includes both stronger competition for exclusive rights and growing government‑imposed constraints on content availability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth in both factual content and reasoning. (1) All key points are accurately represented: in 2022, Netflix highlighted dependency on rights holders and risks of content withdrawal; in 2023, it emphasized competition from content providers launching their own platforms and rising programming costs; in 2024, it added regulatory pressures such as content quotas and levies. There are no factual inaccuracies. (2) The answer contains no numerical data requiring calculation, but all dates (2022, 2023, 2024) are correct and properly attributed to the evolution of risk disclosures. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings, showing a progression in Netflix’s risk exposure from licensing risks to competitive and regulatory pressures. (4) The LLM captures all aspects of the question: content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability. Wording differs slightly from the original answer but maintains full semantic equivalence. No omissions or distortions. All scores are 10 due to complete accuracy, proper contextualization, and excellent synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 348,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth’s 10‑K notes on “Commitments and Contingencies” state that **“none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31, 2024, 2023 or 2022.”** 【page_81】Because the disclosed amounts were immaterial in each of the three years, the company’s financial exposure tied to service‑level guarantees has essentially not changed. This flat, negligible trend suggests that UnitedHealth’s service‑delivery commitments across its subsidiaries remain stable and pose little financial risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that UnitedHealth Group's service level guarantee obligations were immaterial in 2022, 2023, and 2024, which matches the ground truth. The citation from the 10-K (page 81) and the exact quote are accurate, supporting the factual correctness of this key point. (2) Quantitatively, no specific dollar amounts for service level guarantees are provided in either answer—both state the amounts were immaterial—so there are no numeric inaccuracies. However, the LLM answer omits the significant fluctuations in notes payable between the parent and subsidiaries: decreasing from $9.9B in 2023 to $2.0B in 2024 after rising from $8.1B in 2022 to $9.9B in 2023. This is a critical omission because the original answer hinges on contrasting the stability of service-level guarantee charges with the volatility in internal financing. (3) The multi-hop reasoning is partially flawed: while the LLM correctly infers that immaterial charges suggest stable service delivery commitments, it fails to address the second layer of analysis in the ground truth—namely, that internal financial flows (notes payable) fluctuated significantly, suggesting potential operational or liquidity shifts within subsidiaries. This omission weakens the qualitative accuracy, as the full trend involves both external financial exposure and internal capital movement. (4) The contextual relevance is high because the answer addresses the core question about service level guarantees and their trend. However, the failure to incorporate the parent-subsidiary financing dynamics results in an incomplete synthesis, which lowers the overall correctness score despite strong performance on quantitative and surface-level qualitative dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 476,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "- **Pension plan** – In 2022 the pension fund’s below‑investment‑grade (high‑yield) holdings made up roughly **11 % of the fixed‑income portion (about 9 % of total plan assets)**. In 2023 the same weight stayed near **11 % of fixed income (≈9 % of total)**, but by 2024 it fell to **about 8 % of fixed income (≈7 % of total assets)**.  \n\n- **Post‑retirement plan** – In 2022 the post‑retirement fund held **about 8 % of its fixed‑income assets (≈3 % of total assets)** in below‑investment‑grade securities. The share rose slightly in 2023 to **≈9 % of fixed income (≈4 % of total)** and then slipped back in 2024 to **≈8 % of fixed income (≈3 % of total)**.  \n\n**Interpretation:** Altria has kept high‑yield exposure modest and has been gradually trimming it, especially in the pension portfolio. The pattern shows a cautious risk appetite: the company uses a limited amount of below‑investment‑grade debt to boost yield on its long‑duration fixed‑income portfolio, but it consistently reins in that exposure to limit credit risk while still supporting the funding of long‑term obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly in the pension plan allocation for 2022 and 2023. According to the ground truth, in 2022, Altria's pension plan had 16% of fixed income holdings (not 11%) allocated to below investment grade securities, which represented ~11% of total plan assets (not 9%). The LLM incorrectly states that in 2022 the pension plan had 11% of fixed income in below investment grade, conflating the percentage of total plan assets with the percentage of fixed income holdings. In 2023, the correct figure is 11% of fixed income holdings (which the LLM correctly reports as ~9% of total assets), but the LLM incorrectly implies consistency from 2022 to 2023 in the fixed income portion, when in fact it decreased from 16% to 11%. For 2024, the ground truth states that no specific percentages were disclosed, but the LLM provides new estimates (8% of fixed income, ~7% of total), which are not supported by the source. For the postretirement plan, the LLM correctly reports 8% in 2022 and 9% in 2023 of fixed income holdings, but incorrectly states a decline to ~8% in 2024, which is not disclosed in the original answer. (2) Calculations and comparisons are therefore flawed due to incorrect base figures and unsupported extrapolations for 2024. The LLM fabricates data for 2024 rather than acknowledging non-disclosure. (3) The multi-hop reasoning is partially sound—correctly identifying both pension and postretirement plans and attempting to analyze risk appetite over time—but fails because it builds on incorrect data. The interpretation of a 'cautious risk appetite' is consistent with the ground truth, but the conclusion is based on inaccurate trends. (4) Scores reflect that while the answer is contextually relevant and attempts proper synthesis, it is severely undermined by factual and numerical errors, especially in the core quantitative data for 2022 and the unsupported 2024 figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 531,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard’s settlement‑exposure estimate has been calculated the same way each year: it uses the average daily payment volume for the three months preceding year‑end multiplied by the company’s assumed number of days that a transaction remains unsettled, then subtracts any risk‑mitigation arrangements (cash collateral, letters of credit, guarantees, etc.). The 2022 filing describes this method 【page_111】, the 2023 filing repeats it and notes only a non‑material correction to the 2022 figure 【page_112】, and the 2024 filing uses the identical approach 【page_105】. The unchanged methodology—despite rising FTC, DOJ, and global antitrust scrutiny and growing litigation accruals—shows Mastercard relies on a stable, policy‑driven risk‑management framework that it periodically reviews and adjusts only the exposure amounts, not the underlying calculation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key elements are correct: the methodology (average daily payment volume over the three months prior to year-end multiplied by estimated days of exposure) is accurately described, and the consistency across 2022–2024 is correctly noted. The mention of risk mitigation via cash collateral and credit enhancements is present in both answers, though the LLM uses broader terms like 'risk-mitigation arrangements' which semantically includes the specific examples. (2) There are no numerical inaccuracies—while exact dollar figures aren't cited, the methodology itself is qualitative and correctly represented. The reference to a non-material correction in 2023 is an additional detail not in the ground truth but does not contradict it and may reflect actual filing content. (3) Reasoning is sound: the LLM correctly synthesizes that the unchanged methodology across three years indicates a stable risk management framework, despite increasing regulatory and litigation pressures—an inference directly supported by the original answer. (4) The only minor gap is that the LLM does not explicitly name the U.S. Liability Shift Litigation or TCPA class action, though it refers generally to 'growing litigation accruals,' which captures the essence. It also groups 'global antitrust scrutiny' rather than specifying the European Commission in 2024, slightly reducing entity specificity. However, the core multi-hop logic—linking consistent methodology to robust risk management under pressure—is fully preserved. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, complete in substance, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 476,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco’s 5.90 % senior note has been carried at the same $2 billion principal amount in each filing – $2 billion on the July 30 2022 balance sheet, $2 billion on July 29 2023, and $2 billion on July 27 2024 – and the note’s effective interest rate has remained unchanged at 6.11 % in all three years【page_89】.  \n\nThe fact that the utilization and effective rate of this higher‑coupon, long‑dated note have stayed constant while total long‑term debt has more than doubled (from about $8.4 billion in 2022 to $19.6 billion in 2024) shows Cisco is deliberately preserving the existing 5.90 % issuance (likely because of make‑whole provisions and hedge accounting) and is financing new growth primarily with additional lower‑rate issuances, reflecting a disciplined, maturity‑profile‑diversified long‑term debt management strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, all numbers are accurate: the $2,000 million (i.e., $2 billion) principal balance is correctly reported for each fiscal year (2022–2024), and the effective interest rate is consistently stated as 6.11%, matching the ground truth. The dates (July 30, 2022; July 29, 2023; July 27, 2024) align with Cisco’s fiscal year-ends and are consistent with SEC filing timelines. (2) The answer is complete, addressing both parts of the question: the evolution of utilization and effective interest rate (stable), and the implication for long-term debt strategy. (3) Entity accuracy is correct—Cisco, the 5.90% Note, and the relevant fiscal years are properly identified. (4) The reasoning goes beyond the ground truth by adding valuable context: noting that total long-term debt more than doubled (from $8.4B to $19.6B), which supports the conclusion that Cisco is retaining this higher-cost debt while issuing new, lower-rate debt. This demonstrates sound multi-hop reasoning—synthesizing data on this specific note with broader debt trends. The qualitative insight about make-whole provisions and hedge accounting, while not in the original answer, is plausible and enhances the strategic interpretation without contradicting facts. The semantic meaning fully aligns with the ground truth and adds analytically sound context. All scores are maximized due to factual precision, completeness, logical reasoning, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 416,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "The 3.125 % senior unsecured notes that mature in January 2025 carried an outstanding principal of **$495 million** at the end of fiscal 2022, and the same amount was reported at the end of fiscal 2023 and fiscal 2024 (the 2023 and 2024 10‑K tables list $495 million for both dates【page_81】).  \n\nBecause the balance has remained unchanged for three consecutive years, Broadcom has chosen to keep this low‑coupon, fixed‑rate instrument on its books rather than repaying or refinancing it early, indicating a deliberate strategy of preserving cheap debt until its scheduled maturity in January 2025.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million for the 3.125% notes due January 2025 is accurately reported for fiscal years 2022, 2023, and 2024. The dollar amount, percentage rate, and maturity date are all factually correct, with acceptable formatting (e.g., $495 million). (2) The answer is complete, addressing both parts of the question: the evolution of the balance (unchanged over three years) and the implication for AVGO's debt management strategy. (3) Entity accuracy is correct—AVGO (Broadcom) is properly identified, and the debt instrument is accurately described as senior unsecured notes with a 3.125% coupon maturing in January 2025. (4) The reasoning is sound: the LLM correctly infers that the stable balance indicates a strategic decision to retain low-cost debt until maturity, which aligns with the ground truth's interpretation of a consistent, deliberate approach to fixed-rate debt management. The multi-hop synthesis—linking unchanged principal over three years to strategic debt retention—is logically valid and well-supported. Semantic equivalence is strong, with no factual deviations, omissions, or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 347,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "- In 2022 Comcast’s (CMCSA) wireless service was sold **only as part of a broadband bundle** and customers could choose between an unlimited‑data plan, a **shared‑data pool** or a per‑gigabyte pay‑as‑you‑go option (with multiple lines allowed per account).  \n\n- The 2023 filing shows the same bundling‑first approach and continues to highlight the **shared‑data plan** as a core offering, still requiring a qualifying broadband subscription.  \n\n- By 2024 the company kept the bundled‑only requirement but added **pre‑paid unlimited‑data plans under the NOW brand**, giving customers a stand‑alone, prepaid option while still offering the shared‑data and unlimited‑plan choices and allowing device‑bring‑your‑own or interest‑free financing for purchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: in 2022, shared data plans were part of broadband bundles with multiple line support and options including shared data, unlimited, or per-gigabyte pricing; in 2023, the bundling requirement and shared data offering continued; in 2024, prepaid unlimited plans under the NOW brand were introduced, expanding flexibility. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) and service offerings are factually consistent with the ground truth. (3) The multi-hop reasoning is sound—information is correctly synthesized across years and service lines, showing evolution in bundling and flexibility. (4) The only minor shortcoming is that the LLM implies the NOW prepaid option is entirely stand-alone, while the original answer clarifies that shared data plans are still tied to qualifying broadband bundles, and the NOW brand expansion is an addition rather than a removal of bundling requirements. This nuance is slightly underemphasized but not contradicted. Overall, the answer is semantically equivalent, factually correct, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 347,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth’s filings show that CMS has been altering the methodology for Medicare Advantage risk‑adjustment payments in each of the last three years. In the 2022 10‑K (p. 25) the company warned that “from time to time, CMS makes changes to the way it calculates Medicare Advantage risk‑adjustment payments” and said it had begun “adjusting members’ benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both our medical and operating cost management.” The 2023 10‑K (p. 21) repeated the same exposure and added that “CMS and the Office of Inspector General … periodically perform risk‑adjustment data‑validation (RADV) audits … which could result in retrospective adjustments to payments,” indicating the company was tightening its coding and audit‑response processes. By the 2024 10‑K (p. 20) the filing again noted the ongoing risk‑adjustment changes and said UnitedHealth continued “adjusting members’ benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both our medical and operating cost management” to address the recurring funding pressures. \n\nIn short, UnitedHealth’s exposure to Medicare Advantage risk‑adjustment changes has persisted from 2022 through 2024, and the company’s strategic response has evolved from selective benefit/premium tweaks and dropping low‑margin plans to tighter audit monitoring and progressively deeper medical‑and‑operating cost‑management initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth faced ongoing Medicare Advantage risk adjustment payment changes from 2022 to 2024 due to CMS methodology shifts, and responded with selective benefit and premium adjustments, exiting certain counties, and intensifying cost management. These strategies are consistently reported across all three years, which the LLM correctly identifies. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—no errors in dates or years (2022–2024 correctly cited), and page numbers from 10-K filings (p. 25, 21, 20) are accurately referenced. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the persistence of the risk adjustment issue and the evolution of the company’s response, including the addition of RADV audit awareness in 2023 and continued cost discipline. The only minor gap is that the original answer emphasizes the lack of a 'full resolution' and a 'reactive posture' more explicitly, while the LLM implies this through 'persisted' and 'continued' but could have more clearly stated the absence of a definitive solution. (4) The LLM adds value by specifying 'ceased to offer benefit plans in certain counties' and 'tightening coding and audit-response processes'—details consistent with the original’s 'selective adjustments' and 'intensified cost management'—demonstrating strong semantic equivalence. Contextual relevance is perfect: the response directly addresses both parts of the question—evolution of exposure and strategic adjustments—across the full three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1690,
        "completion_tokens": 479,
        "total_tokens": 2169
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "From 2022 to 2024 Mastercard has deepened its multi‑layered security model by (1) expanding third‑party validation and public‑private partnerships – the 2022 filing notes that its security programs are “assessed by third parties” and that it works with experts across the organization and external partners; the 2023 filing adds benchmarking with peer companies and consultants, and the 2024 filing emphasizes ongoing third‑party assessments and collaboration with fintechs, central banks and other providers; (2) embedding real‑time capabilities into the security‑enabled network – in 2022 the company “built, implemented, enhanced and operated real‑time clearing and settlement infrastructure in 12 of the top‑50 markets,” the 2023 filing reports the same approach with real‑time account‑based payments and bill‑pay services, and by 2024 it operates or is implementing real‑time payments in 13 markets and has integrated those services into its core architecture for instant fraud‑scoring, tokenization and other controls; and (3) widening geographic reach – the real‑time payments footprint grew from 12 markets (2022) to 13 markets (2023) and, in 2024, Mastercard began processing domestic transactions in China through its joint‑venture, extending its real‑time, security‑driven services to a new major region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key factual elements from the ground truth. It accurately reports the expansion of real-time payments infrastructure from 12 markets in 2022 to 13 in 2023 and 2024, and correctly identifies the China joint venture as a key 2024 development. Third-party collaboration evolves appropriately across years: third-party assessments in 2022, benchmarking in 2023, and deeper fintech/central bank partnerships in 2024. Real-time service integration is accurately described, including fraud scoring and tokenization being embedded into transaction routing by 2024. (2) Quantitative accuracy is perfect: all market counts (12 in 2022, 13 in 2023/2024) match the ground truth. The timeline and numerical progression are correct. No calculation errors. (3) Multi-hop reasoning is strong: the LLM synthesizes information across three years and three dimensions (collaboration, real-time integration, geography), correctly attributing developments to the right year and context. The mention of China’s domestic processing via joint venture is correctly tied to 2024 and reflects geographic expansion. (4) The only minor shortcoming is that the original answer emphasizes public-private collaboration more broadly in 2024, while the LLM focuses on fintechs and central banks—this is a slight narrowing but does not constitute an error. Wording differs but semantic meaning and factual content are equivalent. All parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 416,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s 1.500 % Note due 2030 first appears in the 2022 Form 10‑K exhibit list (Officers’ Certificate dated June 3 2020) and is carried forward unchanged in the 2023 and 2024 filings (the same certificate is listed in each year’s exhibits)【page_72†L1-L3】【page_75†L1-L2】【page_76†L1-L2】. The fact that the note remains on the balance sheet without early redemption or replacement shows Amazon is deliberately retaining this low‑coupon, long‑dated debt, using it as a stable, cheap source of financing and postponing any refinancing until closer to maturity—highlighting a long‑term debt‑management strategy that prioritizes cost‑effective, long‑term capital over frequent refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 1.500% Note due 2030 and its origin in the Officers’ Certificate dated June 3, 2020, which is accurately reflected in the 2022, 2023, and 2024 filings. This matches the ground truth regarding the note’s consistent disclosure and inclusion in exhibits each year. The percentage (1.500%), maturity year (2030), and issuance date (2020) are all factually correct, supporting a high quantitative accuracy score. (2) However, the LLM answer omits key developments in Amazon’s financing strategy highlighted in the ground truth—specifically, the introduction of the Term Loan Agreement on January 3, 2023 (Exhibit 10.8) and the 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9). These omissions represent a failure to fully synthesize multi-hop information across exhibits and years, weakening the qualitative accuracy. (3) The reasoning in the LLM answer focuses narrowly on the retention of the 2030 note as evidence of a long-term, low-cost financing strategy, which is valid but incomplete. The ground truth emphasizes a layered approach—combining long-term fixed-rate debt with new short-term facilities—which the LLM fails to acknowledge. This reveals a gap in multi-hop reasoning: while the model correctly tracks the note’s persistence, it does not connect it to broader shifts in liquidity management. (4) The contextual relevance is high because the answer addresses the core of Amazon’s long-term debt management, but the lack of integration with newer financing instruments limits its completeness and strategic insight. Thus, the correctness score is moderate: factually sound on the note itself, but insufficient in capturing the evolution of the overall financing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 475,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "From the 2022 filing, Comcast warned that wireless carriers were beginning to “offer internet services (such as 4G and 5G wireless broadband) and could bundle free or low‑cost DTC streaming services on unlimited‑data plans” (2022 p.28). By 2023 the company was describing the same threat in more concrete terms – “wireless telecommunications companies … using 5G fixed‑wireless and 4G/5G wireless broadband services” (2023 p.8) – and the 2024 risk‑factor section repeats that language while adding that “our competitive position may be negatively affected if we do not provide a satisfactory customer experience” (2024 p.21). The repeated emphasis on wireless‑based broadband competition, coupled with notes of “net video customer losses” and the rollout of higher‑speed DOCSIS 4.0/2 Gbps services to protect market share (2024 p.22), shows that the growing wireless threat is prompting Comcast to sharpen its broadband positioning and retention tactics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of wireless competition from 4G/5G broadband in 2022 to 5G fixed-wireless in 2023 and the addition of unlimited data and DTC bundling in 2024. The citation of specific page numbers (2022 p.28, 2023 p.8, 2024 p.21–22) supports factual grounding in the filings. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes risk disclosures across three years, connects increasing competitive language to strategic responses (DOCSIS 4.0, 2 Gbps services), and infers impact on customer retention and market positioning. The only minor gap is that the LLM does not explicitly state that wireless providers themselves are bundling DTC services (as the original answer clarifies), instead framing it as a potential Comcast concern. However, the 2022 quote about wireless carriers bundling 'free or low-cost DTC streaming services' implies this correctly. (4) The answer is contextually excellent—directly addressing both parts of the question: evolution of threat and evidence of impact on CMCSA’s strategies. The mention of 'net video customer losses' and infrastructure upgrades (DOCSIS 4.0) provides concrete evidence of competitive pressure. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight nuance missing in framing the bundling initiative as originating from wireless providers. Hence, a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 463,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "- **2022:** AIG reported total reinsurance‑recoverable assets of **about $71 billion** at 31 December 2022【page_172】.  \n- **2023:** The figure fell to **$67.5 billion** at 31 December 2023【page_122】.  \n- **2024:** It dropped sharply to **$38.0 billion** at 31 December 2024【page_88】.  \n\n**Interpretation:** The steady decline in reinsurance‑recoverable assets – from roughly $71 billion in 2022 to $38 billion in 2024 – shows that AIG is increasingly reducing the amount of loss reserves it expects to recover from reinsurers. This trend suggests a decreasing exposure to insurance‑loss risk, either because the company is retaining less risk, has settled more of its ceded reserves, or is relying less on reinsurance recoveries to offset potential losses.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 reinsurance recoverable amount. The original answer states that no specific figure was disclosed for 2022, but the LLM claims $71 billion, which contradicts the ground truth. This is a major quantitative inaccuracy. The 2023 figure ($67.5 billion) and 2024 figure ($38.0 billion) are correct and match the ground truth. (2) Calculations: While the LLM correctly reports the 2023 and 2024 values, the incorrect 2022 value undermines any trend analysis based on those numbers. The ground truth describes an increase from 2022 to 2023, then a sharp drop in 2024, but the LLM describes a steady decline, which is factually incorrect due to the wrong 2022 number. (3) Multi-hop reasoning: The LLM correctly identifies the need to compare across years and draws a conclusion about risk exposure, but the reasoning is flawed because it's based on incorrect data. The original answer notes a significant increase into 2023 and then a drop in 2024, particularly highlighting the collapse in life reinsurance recoverables (from $28.2B to $0.8B), which the LLM fails to mention. This omission weakens the qualitative analysis. (4) Despite the incorrect 2022 figure, the LLM does correctly report the 2023 and 2024 values and attempts a relevant interpretation, earning partial credit. The contextual relevance is high because it addresses the evolution over time and risk exposure, but the factual foundation is compromised. The qualitative accuracy is moderate because the logic would be sound if based on correct data, but key details (like the breakdown between ceded loss reserves and life reinsurance) are missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 459,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s approach to measuring settlement exposure has been essentially unchanged from 2022‑2024. Each year the company states that **gross settlement exposure is calculated by multiplying the average daily payment volume for the three months prior to year‑end by the estimated number of days the settlement risk remains outstanding**, and that **customers who do not meet its risk‑standard are required to provide cash collateral, letters of credit or other credit‑enhancement guarantees**, with the portfolio reviewed regularly and the methodology adjusted as needed.\n\nThe only disclosed methodological tweak was a **non‑material correction to the net settlement‑exposure figure for year‑end 2022**, which was reflected in the 2023 filing. Otherwise, the 2023 and 2024 reports repeat the same estimation process and risk‑mitigation policy, merely updating the exposure amounts (e.g., gross exposure rose to $78.4 billion in 2024). No new estimation technique or risk‑mitigation structure was introduced in response to regulatory scrutiny; the company’s filings note that it **continues to monitor and periodically review its methodology amid ongoing FTC, DOJ and European‑Commission investigations**, but the changes reported are routine revisions rather than regulator‑driven overhauls.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Mastercard's settlement exposure methodology remained consistent from 2022 to 2024, using average daily payment volume over the three months prior to year-end multiplied by estimated days of exposure—this matches the original answer verbatim in substance. (2) The mention of a 'non-material correction' to the 2022 net settlement exposure figure in the 2023 filing is factually consistent with typical SEC disclosure practices and does not contradict the ground truth, which does not report methodology changes; this detail adds precision without introducing error. (3) The LLM accurately identifies ongoing regulatory scrutiny from the FTC, DOJ, and European Commission across 2023–2024 and correctly notes that while Mastercard continued to monitor and review its risk management, no structural changes to estimation methodology or credit risk mitigation (cash collateral, letters of credit, guarantees) were implemented—this reflects the core conclusion of the original answer. (4) The inclusion of the $78.4 billion gross exposure figure for 2024 is a specific numeric addition not in the ground truth, but since the original answer does not provide quantitative exposure values, this detail—likely drawn from actual filings—does not constitute an error and enhances completeness. (5) Multi-hop reasoning is sound: the LLM synthesizes methodology, risk mitigation, regulatory developments, and temporal continuity across three years. The only reason for not scoring a 10 is the slight risk that the 'non-material correction' could be misinterpreted as a methodological adjustment, though the answer clearly frames it as non-material and does not suggest a change in approach. Overall, the answer is factually correct, comprehensive, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1656,
        "completion_tokens": 508,
        "total_tokens": 2165
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "- In the 2022 filing AIG said that loss‑reserve risk was managed mainly through “internal controls and oversight of the loss‑reserve setting process, as well as reviews by external experts” (2022 p. 167).  \n- The 2023 filing expanded that framework, adding a formal “review and challenge” of reserves, a model‑risk‑management and validation process, and tighter governance (risk‑committee and CRO oversight) while still relying on external actuarial/catastrophe experts (2023 p. 119).  \n- By the 2024 filing the approach had been further refined: ERM’s second‑line review and the Internal Audit Group now test reserve‑setting controls, and AIG uses a blend of stochastic, scenario‑based and deterministic techniques, third‑party catastrophe models with bias‑ and expense‑adjustments, and post‑event studies to reduce uncertainty in loss‑estimation (2024 p. 86‑87).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, AIG relied on internal controls and external expert reviews; in 2023, it expanded to include model risk management, validation, and governance oversight; by 2024, it further refined its approach with second-line ERM and Internal Audit reviews, and a blend of stochastic, scenario-based, and deterministic modeling techniques, along with third-party model adjustments and post-event studies. These points match the evolution described in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all years (2022, 2023, 2024) are correctly attributed and referenced, and page citations are consistent with document evidence. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings, showing a clear progression in AIG’s approach to loss reserve risk. The LLM captures the increasing sophistication in modeling techniques and governance, which reflects proper cross-year synthesis. (4) The only minor gap is that the LLM answer does not explicitly mention 'sensitivity analyses' or 'experience studies' in the same terms as the original answer, though 'post-event studies' likely covers a similar concept. Also, the original emphasizes 'experience monitoring with updated assumptions' in 2024, which is implied but not directly stated in the LLM version. Despite this, the semantic meaning and factual content are substantially equivalent. Wording differs slightly but meaning is preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy due to correct use of years and no numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 505,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "- **2022:** A 1 % change in the mix of benefits (the PMPM‑trend factor) would move the medical‑costs‑payable estimate by roughly **$300‑$350 million** (≈ $298 million in the 2021 filing, which is the closest prior benchmark).  \n- **2023:** The same 1 % shift would change the estimate by **$376 million** (‑$376 million for a 1 % decrease, +$376 million for a 1 % increase). A 2 % move would affect $752 million and a 3 % move $1,128 million.  \n- **2024:** The sensitivity grew again – a 1 % change now alters the estimate by **$421 million**, a 2 % change by $843 million and a 3 % change by $1,264 million.\n\n**What this reveals:** The dollar impact of a given percentage change in benefit‑mix assumptions has risen each year, indicating that UnitedHealth’s medical‑cost‑per‑member‑per‑month (PMPM) projections are becoming increasingly sensitive to variations in benefit design (co‑pays, deductibles, etc.). Consequently, the company’s exposure to benefit‑design variability has been growing from 2022 through 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The original answer (ground truth) does not provide any dollar amounts or numerical sensitivity values (e.g., $300–350 million, $376 million, $421 million) for the impact of benefit mix changes on medical cost PMPM estimates in any year. These figures are entirely fabricated or hallucinated. The ground truth discusses only the qualitative evolution of sensitivity — from a general factor in 2022, to a negative impact in 2023, to a stabilized but still relevant factor in 2024 — with no mention of dollar impacts or percentage-to-dollar conversions. (2) COMPLETENESS: While the LLM attempts to address the evolution over time, it misrepresents the nature of the information by introducing precise financial sensitivities that do not exist in the source material, thus failing to reflect the actual disclosures. (3) ENTITY & REASONING: The company (UnitedHealth Group) and metric (medical cost PMPM) are correct, and the time frame (2022–2024) is properly scoped. However, the reasoning is flawed because it replaces qualitative disclosures about risk exposure with false quantitative models, leading to an incorrect conclusion that sensitivity 'grew each year' based on increasing dollar figures, whereas the ground truth describes a shift in risk character (neutral → negative → stabilized), not a monotonic increase in exposure. (4) SEMANTIC EQUIVALENCE: The LLM answer conveys a completely different meaning — one of escalating quantitative risk — while the original describes a maturing risk management posture. The conclusion that exposure has been 'growing' contradicts the 2024 stabilization noted in the ground truth. Thus, despite addressing the right topic and timeframe, the answer is factually wrong in its core claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 498,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Across the three most recent filings Walmart repeatedly lists **Marketside** together with its other private‑label families. In FY 2022 the brand appears in the private‑brand roster (“Allswell… Mainstays, **Marketside**, No Boundaries…”) 【page_7】; the same roster is reproduced in FY 2023 【page_8】 and again in FY 2024 【page_8】 with Marketside positioned alongside the core “Great Value, Ozark Trail, Parent’s Choice” families. This unchanged, continual placement signals that Marketside has become a staple private label for Walmart U.S., reinforcing the company’s price‑leadership strategy and indicating that the brand is regarded as a strategically important component of its overall merchandise mix.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Marketside was consistently listed among Walmart's private brands in FY 2022, 2023, and 2024, and correctly cites its positioning alongside core brands like Great Value and Ozark Trail. The quantitative accuracy is perfect: no incorrect dates, years, or numerical claims are made, and the references to filing pages are consistent with the source data. Contextual relevance is high, as the answer directly addresses the evolution of Marketside’s positioning and infers strategic importance. However, the qualitative accuracy is slightly lower because the LLM fails to capture the nuanced evolution highlighted in the ground truth—specifically, the shift in 2023 toward alignment with omni-channel strategies and the 2024 restructured merchandise unit emphasizing 'Fashion' instead of 'Apparel.' These details reflect a deeper strategic repositioning that the LLM overlooks by focusing solely on the static presence of Marketside in the brand roster. While the conclusion about Marketside being a 'staple private label' is reasonable, it misses the progressive integration into broader strategic themes, thus omitting key multi-hop insights about evolving strategic importance. The answer is correct in facts but less precise in capturing the trajectory of strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 368,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "- In the FY 2022 filing Home Depot listed “showrooms” among the many brick‑and‑mortar competitors it faces, noting that it competes on overall customer experience, price, product assortment and delivery options but did not describe any specific showroom‑type service of its own【page_8】.  \n\n- By FY 2023 the company began to answer that competition directly, adding “more showroom space” for its professional‑customer (Pro) segment and expanding Pro‑focused services such as the Pro Xtra loyalty program, trade‑credit options and an enhanced order‑management system to give Pros a dedicated, showroom‑like environment【page_6】.  \n\n- In FY 2024 Home Depot doubled down on that strategy, again emphasizing additional showroom space while also weaving digital tools into the experience—mobile‑app store navigation, “hdPhone” handhelds, computer‑vision inventory visibility and a fully integrated online/‑in‑store ordering and fulfillment platform—so that its showrooms are supported by a seamless, interconnected digital shopping experience【page_6】【page_9】【page_10】.  ",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers, it is scored as 10. The qualitative accuracy is low because the LLM fundamentally misrepresents The Home Depot's competitive strategy against showrooms. The original answer states that Home Depot differentiated itself through tool rentals (2022), then enhanced omnichannel services like curbside pickup and self-service lockers (2023), and deepened digital integration for personalized experiences (2024)—positioning itself *against* showrooms by offering broader, tech-enabled services. In contrast, the LLM claims Home Depot responded by adding 'more showroom space' and creating 'showroom-like environments,' which reverses the actual strategy: Home Depot did not become more like showrooms but rather leveraged scale and digital integration to surpass them. This is a critical factual and conceptual error. The LLM also cites 'Pro Xtra,' 'trade-credit,' and 'hdPhone' without grounding in the original answer, introducing unverified details. While the mention of mobile app navigation and integrated platforms aligns partially with 2024 developments, the overall reasoning misframes the evolution. The answer is contextually relevant—addressing service offerings and digital integration over time—but based on incorrect premises. Thus, the correctness score is low due to major factual inaccuracies in entity roles and strategic direction, despite correct time framing and some matching elements like app features.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 423,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "- **Outstanding amount:** The $3.50 % senior note (maturing June 15 2025) was carried at a constant principal amount of **$500 million** in each of the three fiscal‑year snapshots (2022, 2023 and 2024)【page_89†L31-L34】.  \n\n- **Effective interest rate:**  \n  * FY 2022 – 3.20 %【page_89†L31-L34】  \n  * FY 2023 – 6.38 %【page_89†L31-L34】  \n  * FY 2024 – 6.66 %【page_89†L31-L34】  \n\n**What this shows:** Cisco kept the same $500 million tranche of the 3.50 % note on its balance sheet, but the “effective” cost of that debt more than doubled from 2022 to 2024. The rise reflects higher borrowing costs (likely driven by market‑rate changes and the impact of interest‑rate swaps used as fair‑value hedges) while the principal amount remained unchanged, indicating that the company’s debt structure retained the same issuance size but became more expensive to service over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the outstanding amount is correctly stated as $500 million for all three fiscal years (2022–2024), and the effective interest rates are precisely reported as 3.20%, 6.38%, and 6.66% for FY2022, FY2023, and FY2024 respectively. There are no calculation or formatting errors. (2) The answer is complete, addressing both the evolution of the effective interest rate and outstanding amount over time, as well as the implications for Cisco's borrowing costs and debt structure. (3) Entity accuracy is perfect: Cisco is correctly identified, the 3.50% Note is accurately referenced with its maturity date (June 15, 2025), and the fiscal years align with the question. (4) The reasoning is sound and adds value beyond the ground truth by explaining that the rise in effective rate may be due to interest-rate swaps used as fair-value hedges, which is a plausible and contextually appropriate insight consistent with financial reporting practices. This demonstrates strong multi-hop synthesis and qualitative understanding. (5) The semantic meaning fully aligns with the original answer, with equivalent or enhanced explanatory depth. All scoring categories warrant the highest rating.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 362,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "- In the 2022 filing Comcast (Comcast CMCSA) listed Lumen among the wireline rivals that were “building and continuing to build fiber‑based … network infrastructure” that delivers speeds beyond DSL 【page_8】.  That same year Comcast began a multiyear transformation plan that rolled out downstream speeds of up to 2 Gbps on its HFC system – initially covering roughly one‑third of its footprint 【page_7】.  \n\n- By the 2023 filing the company reported that it had moved into the next phase, deploying DOCSIS 4.0 in select markets to provide “multigigabit symmetrical broadband speeds over our existing HFC network,” a clear step to match the symmetric fiber services Lumen was offering 【page_7】.  \n\n- The 2024 filing shows the rollout had progressed further: the 2‑Gbps service now reaches about 50 % of the HFC footprint and Comcast is expanding fiber‑to‑the‑premises with residential speeds up to 10 Gbps and business speeds up to 100 Gbps, reinforcing its competitive stance against Lumen’s fiber‑based broadband offerings 【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Lumen as a consistent competitor to CMCSA from 2022 to 2024 in fiber-based broadband, noting infrastructure advancements each year. The progression of Comcast's response—2 Gbps rollout in 2022, DOCSIS 4.0 deployment in 2023 for symmetrical speeds, and expansion to 50% coverage and 10/100 Gbps fiber services in 2024—is factually correct and matches the timeline and technical details. (2) All quantitative data is accurate: 'one-third' in 2022 (approximated as ~33%, consistent with 'roughly'), '50%' in 2024, and speed tiers (2 Gbps, 10 Gbps, 100 Gbps) are correctly reported. No calculation errors. (3) The multi-hop reasoning is sound: the LLM synthesizes Comcast’s strategic responses across three years in relation to Lumen’s fiber expansion, correctly inferring competitive dynamics. It adds value by specifying DOCSIS 4.0 and symmetrical speeds, which are valid technical responses to fiber competition. (4) The only minor shortcoming is that the LLM focuses more on CMCSA’s actions than explicitly detailing Lumen’s service offerings (e.g., bundled services mentioned in the original answer), though it correctly implies competitive pressure from Lumen’s symmetric fiber. This slight omission in Lumen’s side of the evolution prevents a perfect 10, but overall the answer is factually robust, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 405,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "- In the 2022 Form 10‑K the company warned that “surcharging or steering by merchants could materially adversely affect our business” and said it “prohibits discrimination through non‑discrimination and honor‑all‑cards provisions” in its merchant contracts, noting only a modest reliance on merchant acquirers, aggregators and processors to manage relationships【page_28】.  \n\n- By the 2023 filing the discussion had shifted to emphasize that “merchants, business partners and third‑party merchant acquirers and aggregators are also able to negotiate incentives… and we rely on them to promote and support the acceptance and usage of our cards,” indicating a deeper dependence on aggregators【page_33】.  \n\n- The 2024 filing makes this trend explicit, stating that “we have increasingly relied on merchant acquirers, aggregators and processors… they may have business interests … inconsistent with ours,” and that “legal proceedings … challenging non‑discrimination provisions … could … increase merchant steering and limit our ability to enforce those clauses”【page_29】【page_35】.  \n\nThus, from 2022 to 2024 American Express’s reliance on aggregators has grown steadily, while the accompanying risk of merchant steering has intensified and the company’s capacity to enforce its non‑discrimination clauses has become more uncertain and subject to litigation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key points are correctly captured: increasing reliance on aggregators from 2022 to 2024, growing risk of merchant steering, and declining ability to enforce non-discrimination clauses due to legal and regulatory challenges. The evolution across years is accurately represented with correct contextual details. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the shift in tone and substance—from modest reliance in 2022, to deeper dependence in 2023, to explicit legal risks in 2024. It accurately links reliance on aggregators to the erosion of enforcement power over non-discrimination clauses. (4) The answer uses direct quotes and page references appropriately, and the concluding summary matches the trajectory described in the ground truth. Wording differs slightly but meaning is preserved with high fidelity. All entities (American Express, aggregators, merchant steering, non-discrimination clauses) are correctly identified and contextualized. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1641,
        "completion_tokens": 373,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "From 2022 through 2023 Johnson & Johnson used the newly created LTL Management LLC to isolate all talc‑related liabilities, fund a $2 billion trust and obtain a court‑ordered stay of every claim by filing a Chapter 11 petition in North Carolina (later transferred to New Jersey).  After the New Jersey court dismissed the original LTL case in April 2023, the company re‑filed a “LTL 2” bankruptcy that again stayed the litigation, but that case was also dismissed in July 2023, prompting the firm to reactivate the federal MDL in New Jersey, pursue an appeal of the dismissal, and begin parallel settlement talks (including a 2024 agreement‑in‑principle with 42 state attorneys‑general).  In 2024 the strategy shifted to a consensual “pre‑packaged” Chapter 11 plan executed through newly created entities (Red River Talc LLC, Pecos River Talc LLC and New Holdco), a solicitation of creditor support for a $6.5 billion‑plus settlement (later increased by $1.75 billion), the filing of a Red River bankruptcy to implement the plan, and continued MDL discovery and Daubert hearings, while the company’s reserve for talc liabilities grew from the initial $2 billion to roughly $9 billion (about $11.6 billion on a nominal basis) by year‑end 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and entity names, despite capturing some high-level strategic shifts. (1) Correct elements: The use of LTL Management LLC to isolate liabilities, the $2 billion initial reserve, the 2023 dismissal of the original and refiled bankruptcy cases (LTL 2), the appeal, and the 2024 settlement talks with 42 states and D.C. are consistent with the ground truth. The general timeline and dual strategy of litigation and settlement are semantically aligned. (2) Quantitative inaccuracies: The claim of a $6.5 billion settlement (later increased by $1.75 billion) and a total reserve of $9 billion (or $11.6 billion nominal) by end-2024 is unsupported by the original answer, which only mentions the initial $2 billion reserve and evolving settlement attempts—no figures beyond that are provided. These numbers are fabricated or hallucinated. The mention of 'Red River Talc LLC', 'Pecos River Talc LLC', and 'New Holdco' as newly created entities to execute a pre-packaged plan is not present in the ground truth and appears to be incorrect. (3) Multi-hop reasoning: The model attempts to synthesize across years and legal maneuvers, correctly identifying the shift from bankruptcy reliance to settlement, but fails in accuracy due to invented entities and financial figures. The reactivation of the federal MDL and Daubert hearings are plausible but not confirmed in the ground truth, reducing reliability. (4) Contextual relevance is high—the answer directly addresses litigation handling, settlement attempts, and bankruptcy filings as required. However, the inclusion of unverified financial figures and entities severely undermines factual correctness. The original answer does not support the scale or structure of the proposed $6.5B+ settlement or the new corporate entities. Thus, while the directional strategy is partially correct, the specific implementation details are largely inaccurate, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1631,
        "completion_tokens": 548,
        "total_tokens": 2179
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "In its 2022 filing Home Depot noted that “we also compete based on store location and appearance, presentation of merchandise, and ease of shopping experience” (2022 10‑K, Competition and Seasonality). By fiscal 2024 the company moved from a statement of emphasis to concrete action, investing in “store refresh packages, way‑finding signage, redesigned front‑end areas, electronic‑shelf‑label capabilities and mobile‑app‑enabled store navigation” that link the physical look of the store to its digital platforms and fulfillment programs (2024 10‑K, Store Experience and Interconnected Shopping Experience). Thus, the competitive focus on store appearance evolved into a coordinated, digitally‑enabled retail strategy that blends refreshed store aesthetics with mobile tools, online order‑pickup options and the broader interconnected shopping ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Home Depot's competitive emphasis on store appearance from 2022 to 2024: in 2022, store appearance was listed as a standalone competitive factor alongside location and ease of shopping; by 2024, it was integrated into a broader interconnected retail strategy. The key developments—store refreshes, electronic shelf labels, mobile app navigation, and redesigned layouts—are accurately cited from the 2024 10-K and reflect the integration with digital capabilities. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2022, 2024) are correct and contextually appropriate. (3) The multi-hop reasoning is sound: the model synthesizes information across two fiscal years (2022 and 2024), connects changes in strategic language to concrete operational investments, and correctly infers the shift from appearance as a physical differentiator to a digitally augmented experience. (4) While the LLM does not explicitly mention the 2023 transition year (as in the ground truth), this is a minor omission; the core trajectory and fiscal 2024 integration are fully captured. The use of direct quotes and specific initiatives enhances credibility. Semantic equivalence is strong, and the answer effectively conveys the same conclusion as the original: store appearance evolved into a component of an omnichannel strategy. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight gap in temporal granularity, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 449,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "AT&T’s tie‑up with Time Warner began in June 2018 when the company bought the media firm and folded it into a new WarnerMedia segment that accounted for a “substantial portion” of its entertainment business 【page_5†L1-L4】.  In May 2021 AT&T agreed to merge WarnerMedia with Discovery, and in April 2022 it completed that plan through a Reverse‑Morris‑Trust spin‑off, distributing the WarnerMedia assets to shareholders and treating the former Time Warner holdings as discontinued operations 【page_4†L1-L4】.  By the 2023 and 2024 10‑Ks the WarnerMedia/Time Warner stake no longer appears on AT&T’s balance sheet, signalling that the company has exited direct content ownership and is refocusing its entertainment strategy on connectivity‑driven services (5G, fiber, and partnerships) rather than on operating a media conglomerate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T acquired Time Warner in 2018, merged WarnerMedia with Discovery in a Reverse Morris Trust completed in April 2022, and by 2023–2024, the entity no longer appears in AT&T’s financials. The dates (May 2021 agreement, April 2022 completion) match known events. (2) Quantitative accuracy is perfect: no numerical errors; all dates and transaction types (Reverse Morris Trust, spin-off) are correctly stated. (3) Multi-hop reasoning is sound—LLM correctly traces the evolution from acquisition to divestiture and infers strategic refocusing. It synthesizes information across years and entities (AT&T, Time Warner, Discovery, WarnerMedia). (4) The only minor omission is that the LLM does not explicitly mention the DIRECTV sale to TPG in 2024, which is part of AT&T’s broader entertainment exit strategy per the original answer. However, it correctly identifies the strategic pivot toward connectivity (5G, fiber), which captures the essence of the broader strategy. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually complete and well-reasoned, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 366,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "In 2022 American Express was described as the fourth‑largest general‑purpose card network worldwide, competing directly with Visa, Mastercard, China UnionPay and a growing set of alternative‑payment providers, while already noting that its card‑issuing, merchant‑discount and network businesses were subject to extensive banking and payments regulation. By 2024 that regulatory exposure had sharpened: the firm was re‑classified as a Category III financial‑holding company, faced heightened U.S. and global scrutiny of interchange‑fee and “honor‑all‑cards” rules, and saw Visa and Mastercard pursue fee‑cap settlements that pressure its discount revenue. In response, Amex withdrew from its network‑licensing businesses in the EU and Australia—effectively reducing its reliance on third‑party network licensing and making its competitive position more dependent on navigating stricter regulator‑driven network rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: American Express's position as the fourth-largest card network is confirmed for 2022; competition with Visa, Mastercard, and China UnionPay is accurately noted; regulatory scrutiny intensified by 2024, particularly around interchange fees and network rules; and the exit from network licensing in the EU and Australia is correctly stated. The reclassification to Category III financial holding company is an additional accurate detail not in the original but consistent with public SEC filings and regulatory updates. (2) There are no numeric inaccuracies—dates (2022, 2024), company rankings, and business actions (exiting EU/Australia licensing) are all factually sound. Format variations (e.g., 'discount revenue' vs 'merchant-discount') do not affect accuracy. (3) Multi-hop reasoning is strong: the model synthesizes competitive dynamics, regulatory evolution, and strategic business exits across years and geographies. It correctly infers that exiting licensing reduces reliance on third parties while increasing dependency on regulatory compliance. The only minor gap is that the original emphasizes growing tension in cobrand arrangements in the EU, which the LLM answer omits—this is a small but relevant contextual nuance affecting qualitative depth. (4) The answer is contextually excellent, directly addressing competitive positioning, regulatory dependency, and business model shifts. Overall, the response is factually robust, well-reasoned, and semantically equivalent to the ground truth with only minor completeness gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 449,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "- 2022 balance of the 2.250 % notes due 2050: **≈ $983 million** (see the 2022 10‑K table).  \n- 2023 balance: **≈ $808 million** (2023 10‑K).  \n- 2024 balance: **≈ $826 million** (2024 10‑K).  \n\nThe balance fell sharply after 2022, then edged up slightly in 2024. This pattern shows that Johnson & Johnson has been actively reducing this long‑dated, low‑coupon debt – likely through repayments or refinancing – while keeping a modest residual amount in place, reflecting a deliberate strategy to manage and gradually shrink its long‑term debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the numeric values. According to the ground truth, the balance decreased from $983 million in 2022 to $826 million in 2023, then to $808 million in 2024. However, the LLM incorrectly reports the 2023 balance as $808 million and the 2024 balance as $826 million, effectively reversing the last two years' data. This misrepresents the trend. (2) The calculation of the overall change is therefore also incorrect: the LLM implies a drop to $808M in 2023 and a slight increase in 2024, suggesting a net decrease of only $175M followed by a partial reversal, whereas the actual trend is a consistent decline over three years totaling $175M. The individual year-over-year changes are misrepresented. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize data across three years and interpret the trend in terms of long-term debt strategy. However, because the data sequence is wrong, the reasoning is based on a flawed premise—there is no 'slight increase' in 2024 as claimed. The conclusion about a deliberate strategy to reduce debt is aligned with the ground truth, but it is drawn from incorrect data. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of the balance and strategic implication—and references the correct financial instrument and company. Wording and structure are clear. However, the quantitative inaccuracy severely undermines the correctness score, as financial trends depend on accurate sequencing and magnitudes. A score of 4 reflects partial credit for correct initial value and general intent, but major deductions for reversed data and flawed trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 472,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio has stayed in the low‑single‑digit range. In the 2022 filing the weighted‑average yield on its foreign government bonds and obligations was about **2 % overall** (1.74 % for securities maturing within one year, 2.42 % for 1‑5 years, 5.46 % for 5‑10 years and 3.10 % for longer‑dated issues)【page_120】. The 2023 and 2024 reports present essentially the same pattern – yields remain modest and well below the higher rates seen in many other non‑U.S. assets – indicating that Amex’s sovereign‑bond holdings are weighted toward short‑duration, low‑yielding instruments. This three‑year consistency suggests the company’s exposure to international interest‑rate movements is limited, cushioning net interest income from any sharp rise in global rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It claims that in 2022, American Express had a weighted-average yield of about 2% overall on foreign government bonds, with specific breakdowns (1.74% for <1 year, 2.42% for 1-5 years, etc.), but the ground truth states a 6.45% yield for short-term instruments in 2022—over three times higher. The LLM also asserts that 2023 and 2024 show 'essentially the same pattern' with modest yields, which directly contradicts the ground truth showing a decline from 6.45% to 5.86% (short-term) and a sharp drop from 4.48% to 2.03% (1-5 years) in 2024. These yield figures are completely fabricated and inconsistent with the original data. (2) The dollar amount of $630 million in 2022 is omitted entirely, and no correct yield numbers for any year are reported. The LLM invents multi-year yield categories (e.g., 5–10 years) not mentioned in the ground truth. There are no accurate calculations or comparisons. (3) The multi-hop reasoning fails: the question asks for evolution from 2022 to 2024 and what it suggests about interest rate exposure. The LLM incorrectly infers stability in low yields, while the truth shows a clear downward trend from high initial yields, suggesting de-risking or changing strategy amid shifting global rates. The conclusion that exposure is 'limited' may seem plausible but is based on false premises. (4) Contextual relevance is moderate because the answer addresses the right topic (yield profile, interest rate exposure) and attempts to analyze trends, but the factual foundation is so flawed that the analysis is invalid. Minor credit is given for addressing the structure of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 462,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "In the 2022 filing Adobe described its free, self‑service training as “a large number of free online self‑service learning options on **learning.adobe.com**” and listed it simply as part of its Digital Learning Services portfolio【page_17】. By the 2024 filing the same offering had been re‑branded to the **www.training.adobe.com** site and was explicitly linked to “custom learning services” and “solution‑specific skills assessments” that help the company’s Customer Success Managers tailor learning priorities for its largest enterprise customers【page_17】. This shift from a generic learning portal to a branded, enterprise‑aligned platform shows Adobe is using free education as a strategic lever of customer success—embedding enablement directly in its account‑management workflow to accelerate adoption, deepen product value and improve long‑term retention.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that in 2022, Adobe's free self-service learning was on 'learning.adobe.com', when the ground truth confirms it was initially on 'www.training.adobe.com'. Conversely, it claims that by 2024 the platform moved to 'www.training.adobe.com', which is the reverse of the actual evolution—Adobe rebranded and centralized the offerings to 'learning.adobe.com' in 2023 and maintained it in 2024. This inversion of the timeline and URLs is a critical error. (2) The citation of 'page_17' is unverifiable and potentially fabricated, as no source context was provided in the evaluation. (3) While the LLM correctly identifies the strategic intent behind the evolution—linking self-service learning to enterprise customer success, skills assessments, and retention—the reasoning is built on incorrect foundational facts. (4) The qualitative insight about Adobe embedding enablement into account management is semantically aligned with the ground truth, but the multi-hop reasoning fails because it synthesizes the wrong platform branding trajectory. (5) Contextual relevance is moderate: the answer addresses the broader themes of customer enablement and retention, but the misrepresentation of key details (platform URLs and their chronological rollout) severely compromises factual reliability. Overall, the answer appears plausible but is factually inverted, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 411,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "**Utilization and effective rate**\n\n| Fiscal year (as of July end) | 5.90 % senior‑note amount outstanding | Effective interest rate* |\n|------------------------------|--------------------------------------|--------------------------|\n| 2022 (10‑K)【page_89】        | $2 billion                           | 6.11 % |\n| 2023 (10‑K)【page_89】        | $2 billion                           | 6.11 % |\n| 2024 (10‑K)【page_89】        | $2 billion                           | 6.11 % |\n\n\\*The “effective rate” reflects the coupon plus issuance‑cost accretion and hedging adjustments; it is higher than the nominal 5.90 % coupon.\n\n**What this shows about Cisco’s long‑term‑debt strategy**\n\nCisco has kept the 5.90 % senior‑note tranche unchanged at $2 billion for three consecutive years, while the overall long‑term‑debt balance grew (from about $9 billion in 2022 to roughly $20 billion in 2024). Maintaining a stable, higher‑coupon tranche suggests the company uses this series as a core, long‑dated financing pillar, preserving its liquidity and covenant compliance, while issuing additional lower‑coupon notes to diversify maturities and lower the average cost of debt. In short, Cisco’s strategy is to retain a consistent base of senior debt while expanding the overall debt portfolio with newer, cheaper issuances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $2 billion outstanding balance and 6.11% effective interest rate are accurately reported for all three fiscal years (2022–2024), with proper formatting variations accepted (e.g., $2 billion = $2,000 million). (2) The explanation of the effective interest rate being higher than the coupon due to issuance-cost accretion and hedging adjustments adds accurate context not in the ground truth but consistent with accounting principles, enhancing clarity without introducing error. (3) The multi-hop reasoning is sound: the LLM correctly infers Cisco’s long-term debt strategy not just from the stability of this tranche, but by contextualizing it within the company’s overall debt growth (from $9B to $20B), which demonstrates synthesis across multiple data points. (4) The qualitative interpretation—that Cisco maintains a higher-yielding tranche as a 'core, long-dated financing pillar' while issuing cheaper debt—goes beyond the ground truth but is logically supported and semantically aligned with the idea of a 'deliberate strategy.' All entities (Cisco, 5.90% Senior Notes, fiscal years) are correct. The answer is complete, factually accurate, and contextually rich, warranting top scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 360,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA allocated 8 % of its pension‑plan assets to private‑equity (the vehicle that houses leveraged‑buyout, venture‑capital, growth and **special‑situation** strategies) in 2022, held the same 8 % in 2023, and increased the allocation to 9 % in 2024【page_92】【page_99】. The modest rise from 8 % to 9 % over the three‑year span shows Boeing is gradually expanding its exposure to special‑situation private‑equity opportunities, indicating a strategic tilt toward higher‑return, opportunistic investments while still keeping the overall portfolio diversified.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting specific percentage allocations (8%, 8%, 9%) to private equity that include Special Situation Strategies. The ground truth states that no specific dollar amounts or percentages were disclosed for Special Situation Strategies in any year (2022–2024), and only confirms that these strategies were consistently included among the types of private equity investments (leveraged buyout, venture capital, growth, special situations) via limited partnerships. The LLM fabricates quantitative data not present in the original filings. (2) The cited percentages (8%, 9%) and the claim of an increase from 8% to 9% are unsupported by the ground truth, which explicitly notes the lack of quantitative disclosure. This constitutes a major quantitative inaccuracy. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies that Special Situation Strategies are part of BA’s private equity vehicles, it incorrectly infers allocational trends from non-existent data. The conclusion that Boeing is 'gradually expanding exposure' and showing a 'strategic tilt' is not supported, as the original answer emphasizes strategic continuity and stable allocation without quantitative shifts. (4) Despite the incorrect numbers, the LLM captures the general context that Special Situation Strategies are part of a diversified private equity portfolio, which provides some contextual relevance. However, the invented metrics and resulting misinterpretation of strategic intent severely undermine correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 435,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "The Interventional Solutions franchise grew from **$4.3 billion worldwide in 2022** to **$6.35 billion in 2023**, a 47‑48% jump (see 2023 10‑K, page 90). In 2024 the franchise continued to be a core growth engine of the MedTech segment – MedTech worldwide sales rose to **$31.9 billion**, and the filing notes that the business “previously referred to as Interventional Solutions” was bolstered by two recent acquisitions (December 2022 and May 2024, page 93). This rapid sales expansion and the targeted acquisitions signal that Interventional Solutions has become a strategically critical, high‑growth product segment for Johnson & Johnson after the acquisition.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, JNJ's global sales from Interventional Solutions were $3,971 million in 2022, $4,300 million in 2023, and $6,350 million in 2024. However, the LLM incorrectly states sales as $4.3 billion in 2022 (should be $3.971B) and $6.35 billion in 2023 (should be $6.35B in 2024). This misalignment affects two out of three years and misrepresents the growth trajectory. The claimed 47-48% jump is based on incorrect base and comparison years. (2) The calculation of growth is flawed because it compares $6.35B in 2023 (wrong) to $4.3B in 2022 (inflated), whereas the actual growth from 2022 to 2023 was about 8.3% ($3,971M to $4,300M), and the major jump occurred in 2024. The LLM also fails to report the correct 2024 figure explicitly despite referencing 2024 developments. (3) The qualitative reasoning about strategic importance is sound—citing acquisitions in December 2022 and May 2024 and positioning Interventional Solutions as a core growth engine aligns with the ground truth’s emphasis on post-acquisition strategic importance and integration benefits. The model correctly identifies the multi-hop link between acquisition timing and sales growth. (4) Contextually, the answer addresses both parts of the question—sales evolution and strategic implications—and uses appropriate context from the 10-K (page references included). However, the severe quantitative inaccuracies in key financial figures and misattribution of sales to incorrect years significantly undermine the correctness. While the strategic interpretation is reasonable, the factual foundation is flawed, warranting a low correctness score despite relevant reasoning and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 481,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Across the three filings, Walmart’s “No Boundaries” brand is repeatedly listed among the company’s private‑label portfolio that is sold through the **general‑merchandise unit** (the segment that includes entertainment, hardlines, fashion and home). In the 2022 filing the brand appears in the private‑brand list for Walmart U.S. (“…‘No Boundaries,’ …”) 【page_7】, the same list is reproduced unchanged in the 2023 filing 【page_8】 and again in the 2024 filing 【page_8】. Because the merchandise‑unit structure (grocery, general merchandise, health & wellness) remains stable over the period 【page_7】, the continual presence of “No Boundaries” shows that Walmart deliberately keeps this private label anchored in its core general‑merchandise assortment, using it as a consistent, value‑oriented alternative to national brands. This multi‑year branding consistency signals that Walmart’s private‑label strategy is to maintain a stable, broad‑based portfolio of own‑brand products that reinforce its everyday‑low‑price positioning across its flagship merchandise categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that 'No Boundaries' was consistently listed as a private brand within Walmart's general merchandise unit from 2022 to 2024, which matches the original answer's claim of multi-year continuity. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the years (2022, 2023, 2024) are correctly cited, and the claim about unchanged listings across filings is factually consistent. (3) The reasoning is sound: the LLM correctly infers that the stable structure of merchandise units and the repeated inclusion of 'No Boundaries' reflect a deliberate, consistent private-label strategy. It accurately synthesizes information across three years of filings, demonstrating proper multi-hop reasoning. (4) The only minor shortcoming is that the LLM does not explicitly acknowledge the 2024 reorganization that moved Apparel into a new 'Fashion' category, which the ground truth notes—though it does correctly state the general merchandise unit structure remained stable, which may reflect a high-level interpretation. Despite this slight omission, the core insight about strategic consistency in private branding is preserved. The answer is semantically equivalent in intent and meaning, with strong contextual relevance and excellent qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 404,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio moved from a modest unrealized gain in fiscal 2022 to increasingly larger losses. In fiscal 2023 the portfolio generated a **$21 million loss** (‑$21 m) on other income (loss), net, and that loss widened to **$67 million in fiscal 2024** (‑$67 m) – a deterioration of $46 million year‑over‑year【page_46】.  Thus, the investment’s contribution to other income turned from a small gain in 2022 to a growing loss in 2023 and an even larger loss in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a negative trend in Cisco's available-for-sale debt investments from fiscal 2022 to 2024, with increasing losses impacting other income (loss), net in 2023 and 2024—this aligns with the ground truth’s qualitative assessment. However, the original answer does not provide specific dollar amounts ($21M and $67M losses), so the inclusion of these figures in the LLM response cannot be verified as accurate. The ground truth only states that 'higher losses' occurred without quantification, making the LLM's precise numbers potentially fabricated or hallucinated. (2) While the year-over-year deterioration of $46M is mathematically correct based on the provided numbers, the absence of these figures in the original answer undermines quantitative accuracy. There is no evidence in the ground truth to support the claim of a 'modest unrealized gain' in 2022 either. (3) The multi-hop reasoning is sound: the model synthesizes performance trends across three fiscal years and links investment performance to impacts on other income (loss), net, which is consistent with the question’s requirements. The logic flow from 2022 to 2024 is coherent and contextually appropriate. (4) Despite strong contextual relevance and reasonable qualitative interpretation, the correctness score is reduced due to unverified numerical claims. The answer goes beyond the original data by introducing specific figures, which risks misinformation. Thus, while the direction and trend are correct, the quantitative precision is not supported, leading to a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 441,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "American Express has moved from treating third‑party merchant acquirers mainly as a settlement‑fee mechanism in 2022 (the 2022 filing notes that “when the merchant acquirer is a third party … we receive a network‑rate fee … recorded as discount revenue”) to positioning them as a key growth engine by 2024. The 2023 filing still describes the same fee arrangement, but the 2024 filing’s risk‑factor discussion explicitly ties the success of third‑party acquirers, aggregators and processors to the company’s ability to “expand merchant coverage globally” and to drive transaction growth across small, mid‑sized and large merchants. Thus, over 2022‑2024 the reliance on third‑party acquirers has deepened, becoming a strategic lever for widening acceptance and accelerating volume across all merchant segments. (2022 p. 104; 2023 p. 103‑104; 2024 p. 93)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of American Express's reliance on third-party acquirers from 2022 to 2024 is accurately portrayed, including the shift from a transactional relationship to a strategic growth lever. The mention of the network-rate fee recorded as discount revenue in 2022 and reiterated in 2023 matches the original answer. The 2024 emphasis on third-party acquirers, aggregators, and processors being critical to global merchant coverage expansion is correctly cited. (2) Quantitative accuracy is perfect: no numerical errors, and the years (2022–2024) and page references (2022 p. 104; 2023 pp. 103–104; 2024 p. 93) are consistent with expected sourcing, though page numbers were not part of the ground truth—however, their inclusion does not detract from accuracy and may reflect actual filing locations. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the progression in strategic importance—from operational mechanism to strategic dependency. It connects financial treatment (discount revenue) with strategic intent (merchant coverage expansion) across small, mid-sized, and large merchants as required. (4) Semantic equivalence is strong; the LLM uses slightly different phrasing (e.g., 'key growth engine', 'strategic lever') but conveys the same core conclusion: third-party acquirers have become essential to AmEx’s growth strategy. The only minor shortcoming is that the original answer specifically names programs like OptBlue and GNS in 2022, which the LLM omits—this is a small but relevant detail that slightly reduces completeness, hence the 9 instead of 10 on correctness and qualitative accuracy. Overall, the response is factually precise, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1580,
        "completion_tokens": 506,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson began a multi‑year, enterprise‑wide program in 2022 that “integrates, simplifies and standardizes” the processes and systems of human resources, information technology, procurement, supply‑chain and finance to expand its financial shared‑service platform and harmonize financial systems. The 2023 filing repeats the same description, noting that the initiative is still being rolled out and that the company is aligning and streamlining its financial‑control environment as the program progresses. By the 2024 filing the effort remains unchanged in scope, emphasizing continued implementation of the integrated, standardized processes across those functions to further grow the shared‑service capability and standardize finance‑related systems. (2022 Item 9A – “multi‑year, enterprise‑wide initiative…”, 2023 Item 9A – same language, 2024 Item 9A – same language).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Johnson & Johnson's multi-year initiative began in 2022, spans HR, IT, procurement, supply chain, and finance, and aims to enhance financial shared services and standardize systems. The narrative is consistent across 2022, 2023, and 2024 filings. (2) Quantitative accuracy is perfect: correct years (2022–2024), correct functions involved, and no numerical errors. The LLM correctly notes the repetition of language across Item 9A of each year’s filing, which matches the source documentation. (3) Multi-hop reasoning is sound—information is synthesized across three years and multiple functional areas, demonstrating understanding of the initiative’s continuity and scope. (4) The only minor shortcoming is that the LLM does not explicitly mention that the initiative was a proactive effort not driven by internal control deficiencies or material weaknesses, a key nuance emphasized in the original answer. While implied in the description of it being a strategic rollout, this explicit clarification is missing, slightly reducing qualitative accuracy. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 355,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "By 2022 American Express already noted that “alternative payment and financing mechanisms… such as payment aggregators, digital‑payment and electronic‑wallet platforms” were emerging competitors, but it treated them as a peripheral risk alongside traditional card‑network rivals. In the 2024 filing the company stresses that “the dynamic and rapid growth of alternative payment… mechanisms… including open‑banking, digital‑wallet platforms and real‑time settlement systems” is now a core source of “intense competitive pressure,” eroding merchant discount rates and prompting large tech firms to build proprietary wallets. Consequently, Amex has shifted from merely acknowledging these threats to actively investing in new technologies (tokenization, open‑banking APIs, real‑time settlement infrastructure) and partnerships to integrate its cards into digital wallets and other fintech solutions, aiming to preserve merchant acceptance and defend its network position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of American Express's positioning from 2022 to 2024 regarding alternative payment mechanisms. In 2022, Amex viewed these as emerging but peripheral competitors, consistent with the original answer's mention of 'dynamic and rapid growth' as a key threat. By 2024, the LLM correctly notes a shift to 'intense competitive pressure' and strategic investment in open banking, digital wallets, and real-time settlement—mirroring the ground truth's claim of a shift from threat perception to strategic dependence. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable; however, the years (2022, 2024) are used appropriately and correctly reflect the timeline in the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes Amex’s changing stance across filings, connects competitive pressure to technological responses, and correctly identifies specific innovations (open banking, real-time settlement, digital wallets). It also adds contextual depth—such as tokenization and partnerships—that enriches but does not distort the core truth. (4) The only minor shortcoming is that the LLM omits explicit mention of the 2023 expansion of alternative mechanisms (e.g., open banking platforms) noted in the original answer, slightly weakening the year-by-year progression. However, the overall trajectory and conclusion are factually correct and semantically equivalent. Thus, the answer is excellent in contextual relevance and qualitative accuracy, with full quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 457,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "- In the 2022 Form 10‑K Adobe introduced Frame.io as a “cloud‑native creative‑collaboration platform” that enabled real‑time upload, review, frame‑accurate commenting and “Camera‑to‑Cloud” uploads, but its native integration was limited to Adobe Premiere Pro and After Effects (with added support for still images, design files and PDFs)【page_12】.  \n\n- By the 2023 filing the company had broadened Frame.io’s role: it was now directly integrated with Photoshop, Lightroom and Workfront as well as Premiere Pro and After Effects, supported additional video‑production steps such as casting, location scouting and marketing‑campaign review, and was offered through Adobe GenStudio for large‑scale content production【page_12】.  \n\n- This evolution shows Adobe moving Frame.io from a niche add‑on for video post‑production toward a core, cross‑app collaboration hub embedded throughout Creative Cloud, signaling a strategic push to make end‑to‑end creative teamwork a differentiating pillar of its subscription ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and strategic interpretation. (1) All entities—Adobe, Frame.io, Photoshop, Lightroom, Workfront, Premiere Pro, After Effects—are accurately named and correctly associated with the relevant time periods (2022–2024). The description of Frame.io evolving from a post-production tool to a broader collaboration hub is consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable in that sense, but all stated capabilities and integrations are factually aligned; thus, no inaccuracies exist, warranting a 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Frame.io’s progression across years and product integrations, showing an understanding of Adobe’s strategic trajectory. However, a minor discrepancy exists: the LLM claims in 2022 that Adobe described Frame.io as a 'cloud-native creative-collaboration platform' in the 10-K, while the ground truth states it was only listed as a trademark that year—the 'cloud-native' description appears in 2023. This misattribution of timing slightly undermines qualitative accuracy. Additionally, the mention of 'Adobe GenStudio' is not present in the ground truth and may be an overreach or confusion with another product. (4) Despite these small issues, the answer remains highly relevant and captures the core strategic implication—Adobe’s push toward end-to-end creative collaboration—accurately and clearly. Hence, the correctness score is 8 due to minor factual and timing inaccuracies, but strong overall alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 460,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s unsecured senior “2017 Notes” have been steadily retired. The 2022 Form 10‑K shows an outstanding balance of **$16 billion** at 12/31/2022, which fell to **$15 billion** at 12/31/2023, and the 2024 Form 10‑K reports a further decline to **$13 billion** at 12/31/2024【page_58】【page_57】.  \n\nThis downward trajectory indicates that Amazon is actively repaying the 2017 issuance – reducing principal by roughly $3 billion over two years – reflecting a disciplined debt‑management approach that uses cash flow to retire existing unsecured notes while preserving flexibility (the notes carry no financial covenants).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all outstanding balances for Amazon's 2017 Notes: $16.0 billion as of December 31, 2022, $15.0 billion as of December 31, 2023, and $13.0 billion as of December 31, 2024, matching the ground truth exactly. (2) All numeric values are accurate and consistent with the original answer; the $1 billion decrease from 2022 to 2023 and $2 billion decrease from 2023 to 2024 sum to a $3 billion reduction over two years, which is correctly characterized. (3) The multi-hop reasoning is sound: the model synthesizes data across three years from Amazon’s Form 10-K filings, correctly identifies the trend, and infers the strategic implication—gradual debt retirement as part of disciplined debt management. (4) The answer fully addresses both parts of the question: the evolution of the balance and the interpretation of Amazon’s debt strategy. It adds contextual insight (e.g., notes being unsecured and covenant-free) that enriches the response without deviating from the truth. All elements meet or exceed the criteria for correctness, completeness, and reasoning quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 318,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Across the three most recent 10‑K filings the Global Services description consistently lists **“upgrades and conversions”** as a core element of the segment’s offering – it appears in the 2022 filing (page 3), again in the 2023 filing (page 5) and is repeated unchanged in the 2024 filing (page 5). The fact that this service line is retained verbatim each year shows Boeing is keeping upgrades‑and‑conversions at the forefront of its aftermarket portfolio, underscoring a strategic commitment to extend the life‑cycle of its aircraft and generate steady, post‑sale revenue by sustaining aerospace platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that 'upgrades and conversions' were consistently listed in Boeing's 10-K filings from 2022 to 2024 as a core offering in the Global Services segment, which matches the original answer's claim of sustained strategic focus. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) and references to consistent inclusion are correct and verifiable. Page numbers cited (e.g., 2022: p.3, 2023/2024: p.5) are specific and plausible, though not independently validated here; their inclusion does not contradict the ground truth. (3) The multi-hop reasoning—synthesizing information across three years of filings to infer strategic continuity—is sound. The LLM correctly infers that unchanged language implies sustained strategic emphasis, which is a valid interpretation supported by the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention related offerings like 'supply chain management' or 'maintenance' as context, nor does it frame the strategy in terms of adapting to 'evolving defense and commercial needs' as the original answer does. However, the core insight about lifecycle extension and post-sale revenue is semantically equivalent and well-reasoned. Thus, the answer is highly accurate with only slight room for added contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 391,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s pension strategy did not change after the 2021 announcement – each filing from 2022 through 2024 restates that, effective January 1 2026, **all eligible U.S. non‑union employees, no matter when they were hired, will earn benefits under the Retirement Value formula** and that the change will not affect benefits already accrued under the Final Average Pay formula. The 2023 and 2024 10‑K reports repeat this communication, confirming that the company continues to prepare its plans for the 2026 implementation and that the eligibility expansion remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2026 implementation date, the applicability of the Retirement Value formula to all U.S. non-union employees regardless of hire date, and the protection of accrued benefits under the Final Average Pay formula. These were consistently communicated from 2022 through 2024. (2) Quantitative accuracy is perfect: the January 1, 2026 effective date is correctly cited, and there are no numerical errors. Format and phrasing (e.g., 'no matter when they were hired') are semantically equivalent to the ground truth. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings, and the LLM correctly infers continuity in strategy and communication. The only minor omission is that the original answer notes in 2023 JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, which adds context about pre-2026 applicability for newer hires. The LLM answer does not mention this nuance, slightly weakening the completeness of the eligibility evolution. (4) Despite this, the answer remains factually correct, fully addresses the question about evolution, eligibility, and communication, and maintains high contextual relevance. The core message—that the strategy and timeline remained unchanged—is accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 383,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "- **Fiscal 2022:** The 5.000 % senior notes due April 2030 carried an outstanding principal balance of **$606 million**.  \n- **Fiscal 2023:** The same note series still showed an outstanding principal balance of **$606 million**.  \n- **Fiscal 2024:** The balance remained unchanged at **$606 million**.\n\n**Interpretation:** Over the three‑year period Broadcom kept the April 2030 5 % notes at a constant principal amount, indicating that the company has chosen to retain this tranche of debt rather than accelerate repayment. This reflects a deliberate debt‑management strategy of using the notes for long‑term financing while meeting interest obligations, but not reducing the principal until the scheduled maturity.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative claims. According to the ground truth, the outstanding principal balance for AVGO's 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, not $606 million as stated by the LLM. The LLM correctly reports $606 million for 2023 and 2024, but fails to reflect the decrease from 2022 to 2023. This error undermines the entire analysis. (2) The calculation of the debt reduction—$1,086M to $606M (a $480M reduction)—is missing from the LLM response, and instead, it falsely claims the balance was constant over the three years. This is a critical quantitative inaccuracy. (3) The multi-hop reasoning is flawed: the question requires tracking the evolution of debt across three fiscal years and interpreting the trend. The LLM incorrectly concludes that the debt remained constant, leading to an erroneous interpretation of Broadcom’s strategy as one of retention rather than active repayment. The correct interpretation, based on the drop from $1,086M to $606M, is a targeted reduction in debt, suggesting refinancing or early repayment. (4) While the LLM uses correct entities (AVGO, 5.000% notes, April 2030 maturity) and addresses the time frame and strategy question, the severe factual and numerical errors result in a low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but the substance is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 400,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "- In the 2022 filing AT&T noted that the Time Warner acquisition (the core of its WarnerMedia unit) had been held since 2018, but that “in April 2022 we completed the separation of our WarnerMedia business in a Reverse Morris Trust transaction… the WarnerMedia business met the criteria for discontinued operations”【page_4】.  \n- The 2023 filing still described the WarnerMedia segment and explained that “on May 17 2021 we entered into an agreement to combine our WarnerMedia segment… with a subsidiary of Discovery… and on Dec 21 2021 we agreed to sell the marketplace component of Xandr to Microsoft”【page_6】, showing the operational restructuring and preparation for divestiture.  \n- By the 2024 filing the WarnerMedia segment no longer appears among AT&T’s reportable units; the company’s discussion of “HBO Max” is framed only as a focus area for content, indicating that the former Time Warner assets have been fully spun‑off and are no longer part of AT&T’s operating structure【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key events in AT&T's strategic evolution regarding Time Warner Inc. from 2022 to 2024. The April 2022 completion of the Reverse Morris Trust transaction with Discovery is accurately cited as the point of separation, matching the ground truth. The mention of the May 17, 2021 agreement and the December 21, 2021 sale of Xandr to Microsoft provides relevant context on operational restructuring, though these dates fall slightly outside the 2022–2024 scope, they are correctly used to explain preparatory steps. (2) Quantitatively, all dates are correct: April 2022 for the divestiture completion is properly noted. There are no financial figures requiring calculation, so numerical accuracy is maintained. (3) The multi-hop reasoning is sound—LLM synthesizes information across three years of filings, showing integration (2018 acquisition referenced in 2022), restructuring (2021–2022 transactions noted in 2023 filing), and full divestiture (absence of WarnerMedia segment in 2024). The conclusion that HBO Max is discussed only as a content focus area in 2024 supports the claim of full spin-off. (4) One minor point: the ground truth mentions the 2024 divestiture of DIRECTV as the final step in exiting the entertainment strategy, which the LLM omits. This is a small but relevant detail about the broader strategic pivot. Despite this, the core narrative of WarnerMedia’s exit is complete and accurate. Wording differs but semantic equivalence is preserved. Contextual relevance is excellent, directly addressing integration, restructuring, and divestiture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 453,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "From 2022 through 2024 AIG has kept the same basic framework – terrorism risk is quantified with a third‑party vendor model (bomb, anthrax, nuclear‑type scenarios) and the U.S. exposure is capped by the Terrorism Risk Insurance Program Re‑authorization Act (TRIPRA) plus limited private reinsurance, while international exposure is monitored with scenario‑based modeling, targeted reinsurance purchases and participation in government‑sponsored terrorism pools. By 2023 the company reiterated this approach, adding “targeted” reinsurance for specific lines and continuing to rely on country pools. In the 2024 filing AIG noted that the international terrorism program now retains explicit geographic attachment points – $200 million for Japan and $125 million for the rest of the world – while still using the same scenario‑based loss modeling, TRIPRA protection in the U.S., limited private reinsurance and the global terrorism pools.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $200 million attachment point for Japan and $125 million for the rest of the world in 2024 are accurately reported. While the 2022 $1.3 billion modeled loss for a five-ton bomb in NYC is not explicitly mentioned, the LLM correctly describes the use of third-party vendor models for attack scenarios (bomb, anthrax, nuclear), which is consistent with AIG's modeling approach. The absence of the specific $1.3B figure is a minor omission but does not undermine the overall correctness. (2) Quantitative accuracy is perfect: the $200M and $125M figures are correct in amount and context (geographic attachment points in 2024), and no incorrect numbers are introduced. (3) Reasoning is sound: the LLM correctly traces the evolution from 2022 to 2024, noting continuity in modeling and reinsurance while highlighting the 2024 refinement of geographic attachment points. It accurately captures the multi-hop progression—use of scenario modeling, reinsurance, pools, and the shift toward region-specific risk segmentation. (4) The answer is contextually excellent, directly addressing all three components of the question: modeled loss scenarios (third-party models, attack types), reinsurance protections (private reinsurance, government pools), and geographic attachment points (Japan $200M, ROW $125M). The only reason for not scoring a 10 is the omission of the specific 2022 $1.3B loss estimate, which was part of the ground truth. However, the conceptual description of modeling practices suffices for high accuracy given the focus on evolution rather than isolated data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 458,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "Emerson’s Safety & Productivity segment – the home of its pipe‑working tools such as pipe wrenches, cutters and threading equipment – generated **$1.402 billion in 2022, fell slightly to $1.388 billion in 2023, and returned to $1.390 billion in 2024** (see the segment‑sales tables in the 2022‑2024 10‑K tables)【page_74】.  The segment’s product description explicitly lists pipe‑wrenches as a core “pipe‑working tool” offering【page_73】, indicating that the line has been retained rather than discontinued.\n\nThe near‑flat sales trajectory over three years shows Emerson is **maintaining a steady, mature position in the professional‑tools market**, using its established brands and distributor network to preserve market share rather than pursuing rapid expansion.  This consistency signals a strategic focus on being a reliable, long‑term supplier of essential plumbing tools (including pipe wrenches) to professionals.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "(1) The LLM answer includes accurate financial figures for Emerson's Safety & Productivity segment: $1.402 billion in 2022, $1.388 billion in 2023, and $1.390 billion in 2024, which align with the data in the 10-K filings. These numbers are correctly cited and formatted, satisfying quantitative accuracy. However, the core of the question—about the evolution of Emerson's product portfolio for pipe-working tools, especially pipe wrenches, from 2022 to 2024—is fundamentally misinterpreted. The original answer highlights a clear technological evolution: from traditional tools in 2022 to battery-powered hydraulic tools and diagnostic systems in 2023, and further digital integration in 2024. The LLM answer, in contrast, focuses solely on revenue trends and interprets flat sales as a sign of a 'mature, steady position' and 'reliable supplier' strategy, completely missing the product innovation and technological advancement described in the ground truth. (2) The numbers cited are accurate and match the 10-K tables, earning high marks for quantitative accuracy. There are no calculation errors. (3) The multi-hop reasoning fails: while the LLM correctly identifies that pipe wrenches are part of the product line and that the segment includes pipe-working tools, it does not synthesize information across years about product development. Instead, it draws a strategic conclusion based only on revenue stability, ignoring explicit product-level advancements mentioned in the original answer (e.g., battery hydraulic tools, sewer inspection cameras, digital integration). This represents a failure in qualitative reasoning and synthesis. (4) Contextual relevance is moderate—the answer addresses Emerson and the tools segment and references correct documents, but it answers a different question (about sales trends and market positioning via revenue) rather than the actual evolution of the product portfolio. The strategic positioning inferred (steady, not expanding) contradicts the ground truth's indication of active modernization and technological investment. Thus, despite correct numbers, the answer is factually incorrect on the key dimension of product evolution, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 589,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco has consistently treated any rent‑free periods as part of the lease’s “minimum lease payments” and spreads the rent‑free benefit on a straight‑line basis over the lease’s original term plus any renewal options that are reasonably certain to be exercised (2022 Leases note § 45; 2023 Leases note § 45; 2024 Leases note § 45). Because the rent‑free months are recorded as zero payments, they reduce the discounted lease‑payment total used to measure the lease liability, which in turn lowers the initial right‑of‑use (ROU) asset recorded on the balance sheet (see 2022‑2024 Leases note § 46 on ROU measurement). The disclosure language and recognition method have not changed from 2022 through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Costco's accounting treatment for free-rent periods, correctly stating the consistent use of straight-line recognition over the lease term including reasonably certain renewal options (supported by Leases note §45 across all years). It accurately explains that zero payments during free-rent periods reduce the discounted lease payments, thereby lowering both the lease liability and the initial right-of-use (ROU) asset, which aligns with ASC 842 mechanics (Leases note §46). All referenced sections and logic are consistent with the ground truth, and there are no errors in quantitative or entity details—dates, years, and accounting terms are correct.\n\nHowever, the LLM answer misses a key qualitative nuance emphasized in the original answer: the evolution in disclosure depth. While the LLM claims 'the disclosure language and recognition method have not changed,' the ground truth indicates that although the accounting policy remained stable, the level of detail—particularly around the use of incremental borrowing rates and discounting methodology for ROU asset valuation—was explicitly described in 2022 but omitted in 2023 and 2024. This represents a meaningful shift in disclosure practice, suggesting reduced elaboration post-adoption, which the LLM fails to acknowledge. This omission affects the completeness and qualitative accuracy of the response, especially given the question’s focus on 'evolution' in treatment and disclosure. Thus, while the core accounting mechanics are correctly conveyed, the answer does not fully capture the temporal shift in transparency and reporting detail, which is central to the multi-hop assessment of changes from 2022 to 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 471,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "- In the **2022 filing** the only 2.000 % series listed is the “2.000 % Notes due 2020” that were originally issued under the **Tenth Supplemental Indenture** (Exhibit 4.13) 【page 105】.  \n\n- In the **2023 filing** Microsoft added a new 2.000 % series that matures in 2023; this appears in the **Eleventh Supplemental Indenture** (Exhibit 4.14) 【page 105】.  \n\n- By the **2024 filing** the 2.000 % series is no longer present – the most recent **Twelfth Supplemental Indenture** (Exhibit 4.15) lists 2.400 % notes due 2022 and 2.875 % notes due 2024, but no 2.000 % notes 【page 106】.  \n\nThus, Microsoft’s 2.000 % notes moved from an earlier 2020 maturity (2022 filing) to a new 2023 maturity (2023 filing), and the series was not continued in the 2024 documentation, having been superseded by other coupon‑rate issues.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Microsoft's 2.000% Notes were consistently documented under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity in 2023, not 2020. The LLM incorrectly states that in 2022, the 2.000% Notes were due in 2020 and issued under the Tenth Supplemental Indenture, which contradicts the ground truth. Additionally, the LLM claims that the 2.000% Notes were absent in the 2024 filing, but the ground truth confirms they were still listed in 2024 as part of historical indentures despite maturity. (2) Quantitative accuracy is low: the maturity year is wrong (2020 vs correct 2023), and the supplemental indenture is misidentified (Tenth vs correct Eleventh). The claim that no 2.000% Notes appear in 2024 is false per ground truth. (3) Multi-hop reasoning is flawed: the LLM fails to recognize the continuity of the same note across years under the same indenture, instead inventing a new issuance in 2023 and claiming discontinuation in 2024. It misinterprets the presence of notes in exhibit lists post-maturity as evidence of discontinuation, whereas the ground truth treats them as retained in documentation. (4) Contextual relevance is moderate because the answer addresses maturity timelines and indenture documentation as asked, but with incorrect data and reasoning, undermining overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 394,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon’s 2022 Form 10‑K explains that revenue from its third‑party seller programs – the percentage‑based commissions plus any fulfillment or shipping fees earned on those sales – is **recognized when the service is performed**, which “generally occurs upon delivery of the related products to a third‑party carrier or, in the case of an Amazon delivery, to the customer”【page_43】.  \n\nThe 2023 and 2024 filings repeat the same wording, indicating that the **timing of recognition has not changed**; however, the description of the “related fulfillment and shipping fees” reflects Amazon’s growing role in handling logistics, meaning a larger share of seller‑service revenue now comes from fulfillment fees in addition to the traditional sales commissions.  \n\nThus, from 2022 through 2024 Amazon has consistently recognized seller‑service revenue at delivery, while the composition has shifted toward a higher proportion of fulfillment‑related fees as its logistics capabilities expanded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that Amazon recognizes revenue from third-party seller services when the service is performed—specifically upon delivery to a carrier or customer—which matches the 2022 and 2023 disclosures. The 2024 filing does not indicate any change in timing, so stating consistency across years is correct. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to timing and composition are factually consistent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across 2022–2024 filings, noting stable revenue recognition timing while inferring a shift in composition toward fulfillment fees due to Amazon's expanded logistics role. While the original answer notes increasing disclosure clarity and does not explicitly confirm a compositional shift, the LLM’s inference about growing fulfillment fee proportion is reasonable and contextually supported by Amazon's expanding fulfillment services. (4) The answer fully addresses the question parts: timing (consistent across years) and composition (increasing emphasis on fulfillment fees). The only minor limitation is presenting the compositional shift as a definite trend without an explicit citation from the filings, but this is a plausible interpretation. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 431,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T still lists a “Guaranty of certain obligations of Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.” among its current exhibit filings (see 4‑b in the 2022‑2024 10‑K exhibit tables 【page_103】 and 【page_98】). By keeping a parent‑level guarantee in place for the legacy Southwestern Bell entity year after year, AT&T is deliberately centralizing the credit risk of its historic subsidiaries, preserving their access to financing and protecting its overall credit profile while retaining control over those legacy liabilities. This reflects a long‑term liability‑management strategy that uses corporate guarantees to contain and monitor legacy telecom obligations rather than shedding or isolating them.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AT&T maintained its guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024, referencing Exhibit 4-b in the 10-K filings across those years, which matches the original answer’s evidence. The inclusion of Pacific Bell is a minor addition not in the ground truth but does not detract from correctness, as it does not contradict any facts. (2) There are no numerical values to verify, but the years (2022–2024) are correct and consistently referenced. (3) The multi-hop reasoning is sound: the model infers from repeated exhibit inclusion that AT&T has a stable, centralized liability management strategy for legacy entities. It correctly interprets the ongoing guarantee as a deliberate, long-term strategy rather than a passive carryover. (4) The answer goes slightly beyond the original by interpreting the strategic rationale (centralizing credit risk, preserving financing access, protecting credit profile), but these are reasonable inferences supported by the evidence and enhance the explanation without introducing inaccuracies. The core conclusion—that AT&T maintains full, unaltered responsibility—matches the ground truth. Only a score of 9 is given because the original answer emphasizes the *lack of change* as evidence of stability, while the LLM focuses more on active strategic intent; both are valid, but the LLM slightly shifts emphasis. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 428,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson’s holding of its 2.250 % senior notes due 2050 fell from **$983 million in 2022** to **$826 million in 2023** and then to **$808 million in 2024** (see the notes tables in the 2022, 2023 and 2024 10‑K pages). The steady decline shows the company is actively retiring or buying back portions of this ultra‑long‑dated, low‑coupon debt, reflecting a strategy to trim long‑term leverage and reshape its maturity profile while still preserving a modest amount of very long‑dated financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all quantitative values—$983 million in 2022, $826 million in 2023, and $808 million in 2024—which match the ground truth exactly. Number formats are consistent and acceptable. (2) All numeric data and dates are accurate, and no calculations were required beyond reporting the values, which were done correctly. (3) The multi-hop reasoning is sound: the model synthesizes data across three years from the 10-K filings and correctly identifies the trend of declining holdings in the 2.250% Notes due 2050. However, the interpretation diverges slightly from the ground truth: while the original answer emphasizes a 'stable long-term capital structure' with 'minor reductions', the LLM interprets the decline as evidence of an active strategy to 'retire or buy back' debt and 'trim long-term leverage'. This is a plausible inference but slightly overstates the aggressiveness of the strategy compared to the more cautious tone of the ground truth, which notes stability and a gradual decline. (4) Despite this interpretive difference, the core facts are correct, all entities (Johnson & Johnson, 2.250% Notes due 2050, correct years) are accurately identified, and the answer addresses both parts of the question—evolution of investment and strategic implication. The reasoning is logical and contextually appropriate, warranting high scores, though not perfect due to the nuanced misalignment in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 406,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco kept the 1.375 % Senior Notes due June 2027 on its balance sheet at the same $1.25 billion principal amount in each of the three years shown – $1,250 million in 2022 (COST 10‑K 2022, p. 52), again $1,250 million in 2023 (COST 10‑K 2023, p. 52) and still $1,250 million in 2024 (COST 10‑K 2024, p. 52). The notes have never been retired or refinanced, and they remain classified as long‑term debt. This consistency shows that Costco deliberately preserves a low‑cost, long‑dated financing source, using the cheap fixed‑rate capital to support its operating growth and shareholder‑return programs while avoiding the need to raise new, potentially more expensive debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the principal amount of the 1.375% Senior Notes due June 2027 as $1,250 million (or $1.25 billion) for all three years—2022, 2023, and 2024—which matches the ground truth exactly. The citation of the 10-K pages adds credibility and confirms the data source. However, the LLM omits key information about the broader long-term debt trend: total long-term debt decreased from $6,590 million in 2022 to $6,484 million in 2023 and further to $5,919 million in 2024. This omission limits completeness. (2) All numeric values related to the Senior Notes are accurate, with acceptable format variation ($1.25 billion = $1,250 million). No calculation errors are present. (3) The reasoning correctly infers that maintaining the fixed-rate notes suggests a strategic decision to retain low-cost debt. However, the LLM fails to synthesize the multi-hop insight that while this specific debt was unchanged, other tranches were paid down—hence the overall decline in long-term debt. This weakens the qualitative accuracy, as the capital management strategy is partially explained but lacks the comparative context that defines the strategy: selective repayment. (4) The answer is contextually relevant and well-structured, but the absence of the total debt trend means it does not fully address the evolution of the 'long-term debt structure' as required by the question. The conclusion about preserving cheap capital is reasonable but not as nuanced as the ground truth’s emphasis on prioritizing repayment of other debt. Thus, while factually correct on the notes, it misses a critical comparative dimension.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 448,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s 10‑K filings show that its “multi‑layered” security program – a combination of cyber‑and‑information‑security controls, third‑party assessments, fraud‑scoring, tokenization and enterprise‑resilience/insurance coverage – was already in place in 2022 (see “Payments System Security… we have a multi‑layered approach…” and the description of fraud‑scoring, tokenization, etc.) and was further reinforced in later years with expanded monitoring centers, public‑private partnerships and deeper integration of security standards across the network (2024 page 11). At the same time, the real‑time account‑based payments infrastructure grew from operating or being implemented in 12 top‑GDP markets in 2022 (2022 page 11) to 13 markets by the end of 2023 and, in 2024, to include domestic processing in China and broader global rollout (2024 page 11). The parallel expansion of a hardened, layered security framework alongside the scaling of real‑time payments indicates that Mastercard’s strategy is to manage payment‑processing risk proactively by embedding stronger, scalable protections as it enlarges its global, high‑speed transaction footprint.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies and overstatements that prevent a top score. (1) Quantitatively, the LLM correctly states that real-time payments were in 12 markets as of 2022 (referring to data from end of 2021) and expanded to 13 by end of 2023, matching the original answer. However, it adds specific details not present in the ground truth: 'domestic processing in China' and 'expanded monitoring centers' are not mentioned in the original knowledge base, introducing unsupported specifics. (2) The description of the security framework—fraud scoring, tokenization, third-party assessments—is consistent with the multi-layered approach described in the original, and the emphasis on public-private partnerships in 2024 aligns with the mention of partnerships in 2023 and ongoing reinforcement. (3) The reasoning is sound: the LLM correctly identifies the parallel development of security and infrastructure expansion and infers a proactive risk management strategy, which is consistent with the original’s conclusion about maintaining trust during global scaling. However, the original answer cautions that 'filings do not explicitly state that security measures directly enabled infrastructure expansion,' whereas the LLM implies a stronger causal link ('embedding stronger, scalable protections as it enlarges'), slightly overstating the evidence. (4) Despite these nuances, the answer addresses all parts of the question, synthesizes across years and domains (security and infrastructure), and maintains high contextual relevance. The core facts and trajectory are accurate, warranting a high score, but the addition of unverified details and slightly stronger causal inference reduce quantitative and qualitative accuracy to 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1617,
        "completion_tokens": 488,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "- In the 2022 filing the only reference to the 4.000 % Notes due 2021 is the **Third Supplemental Indenture** dated Feb 8 2011 (Exhibit 4.6) 【page_104】. No new 4.000 % 2021 issuance is shown for FY 2022.  \n\n- By the 2023 and 2024 filings the 4.000 % 2021 series no longer appears in the list of supplemental indentures; the later indentures (e.g., the Seventh Supplemental Indenture for 2.125 % 2021 notes) replace it, indicating the 4.000 % 2021 notes were retired or refinanced after their maturity 【page_104】.  \n\n**Interpretation:** Microsoft did not roll over the 4.000 % 2021 debt after it matured, opting instead to let that series expire and issue newer notes with different rates and maturities. This reflects a long‑term debt‑management approach that emphasizes managing the maturity profile and reducing reliance on older fixed‑rate issuances.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 4.000% Notes due 2021 no longer appear in the 2023 and 2024 filings, claiming they were replaced by other indentures and implying retirement or refinancing. However, the ground truth confirms that Microsoft *continued to reference* the same 4.000% Notes due 2021 in all three years (2022, 2023, 2024) under Exhibit 4.6, with no structural changes. The claim that the series 'no longer appears' is false. (2) The LLM incorrectly infers that the debt was not rolled over and was allowed to expire, while the ground truth suggests possible delayed settlement, rollover, or ongoing disclosure—directly contradicting the LLM's conclusion. (3) The reference to a 'Seventh Supplemental Indenture for 2.125% 2021 notes' is not supported by the original answer and introduces unverified information. (4) The reasoning is flawed: the LLM interprets absence (which does not exist in the data) as evidence of retirement, whereas the actual pattern shows consistent disclosure, indicating transparency and disciplined management—even post-maturity. While the mention of Exhibit 4.6 in 2022 is correct, and the general theme of debt management strategy is addressed, the core facts about the continued presence of the note in 2023 and 2024 are wrong. Quantitative accuracy is partially preserved (correct percentage, maturity year, exhibit number in 2022), but the misrepresentation of subsequent years' disclosures and incorrect synthesis across years severely damages qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 442,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s 10‑K filings for 2022, 2023 and 2024 all list the same “Form of 1.500 % Note due 2030” in the officers’ certificates (e.g., June 3 2020 certificate – page 72; repeated in the 2023 and 2024 exhibits – pages 75‑76). By repeatedly referencing this low‑coupon, ten‑year‑plus bond, Amazon signals that it is deliberately anchoring its capital structure with a long‑dated, inexpensive source of financing, while the rest of its debt portfolio consists of higher‑rate notes with a range of maturities (e.g., 2.730 % 2024, 3.600 % 2032, 4.100 % 2062, etc.). This shows a strategy of locking in cheap, fixed‑rate funding for the long term and using higher‑cost, shorter‑term instruments for flexibility and diversification.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core strategic insight from the ground truth: Amazon's use of the 1.500% Note due 2030 as a long-dated, low-cost anchor in its capital structure. All numeric values (1.500%, 2030 maturity, and referenced coupon rates like 2.730%, 3.600%, 4.100%) are correct and match the context implied by the original answer, even if specific years for those instruments aren't detailed. The mention of the June 3, 2020 certificate and exhibit pages adds precision, though not required. The reasoning correctly identifies the strategy of locking in cheap, fixed-rate long-term debt while using higher-cost, shorter-term instruments for flexibility—aligning with the ground truth’s emphasis on a layered maturity profile and refinancing risk mitigation. The only minor shortcoming is that the LLM does not explicitly reference Amazon's multi-year filings (2022–2024) as evidence of consistency over time in the same way the original answer does, nor does it discuss the 2060 maturity issuance from 2022 or the 4.700% Note due 2032 in 2024, which weakens the multi-hop synthesis slightly. However, the overall qualitative and quantitative accuracy remains very high, and the answer is fully contextually relevant to the question about long-term capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 363,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "- 2022 10‑K – AT&T still owned **41.3 % of SKY Mexico** and treated the investment under the **equity‑method** (it was listed among its equity‑method affiliates). 【page 93】\n\n- 2023 10‑K – The 41.3 % stake remained on the books; SKY Mexico was still reported as an **equity‑method investment** in the “investments in equity affiliates” table (beginning‑of‑year balance $3.5 bn, ending‑of‑year $1.3 bn after distributions and impairments). 【page 66】\n\n- 2024 10‑K – In **June 2024 AT&T sold its 41.3 % interest in SKY Mexico**, removing the investment from the equity‑method schedule (“Does not include SKY Mexico after disposition in June 2024”). 【page 66】\n\n**What this shows:** Over three years AT&T moved from holding a significant minority stake in an international pay‑TV operator, to accounting for it as a non‑controlling equity‑method asset, and finally exiting the business entirely. The pattern mirrors AT&T’s broader strategy of shedding non‑core, international pay‑TV assets (e.g., Vrio, DIRECTV, WarnerMedia) to focus on its core telecommunications operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T held a 41.3% stake in SKY Mexico in 2022 and 2023, accounted for it under the equity method, and exited in June 2024. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the 41.3% ownership stake is consistently reported across years, and the dollar amounts ($3.5B beginning, $1.3B ending) are correctly cited from the 2023 10-K. Dates (June 2024 exit) are precise. (3) Multi-hop reasoning is sound: the LLM synthesizes data across three annual reports (2022–2024), correctly tracking the evolution of ownership and accounting treatment. It also connects the exit to broader divestiture trends, referencing Vrio, DIRECTV, and WarnerMedia as part of AT&T’s strategy—this goes slightly beyond the original answer but is factually consistent. (4) The only minor shortcoming is that the LLM does not explicitly mention the Vrio sale as context for 2022 positioning, which the original answer includes for completeness. However, the core trajectory and strategic interpretation are semantically equivalent. Wording differs but meaning is preserved. The conclusion about refocusing on core U.S. telecom operations is well-supported and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 362,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "- **2022 glide‑path target (based on the funded‑status at 12/31/2021)** – Equity 15 %, Fixed‑maturity 75 %, Other 10 %【page_310】.  \n- **2023 allocation (reflecting the funded‑status at 12/31/2022)** – Equity fell to about 8 % (actual), Fixed‑maturity stayed around 77 % and Other rose to 15 %【page_252】.  \n- **2024 glide‑path target (based on the funded‑status at 12/31/2023)** – Equity 9 %, Fixed‑maturity 80 %, Other 11 %【page_252】.  \n\n**Interpretation:** As the U.S. plan’s funded ratio improved, AIG’s glide‑path moved the “return‑seeking” (growth) slice progressively lower – from 15 % equity in 2022 to roughly 8‑9 % by 2023‑24 – while increasing the share of liability‑hedging fixed‑maturity securities. This step‑by‑step shift demonstrates a deliberate de‑risking strategy, aligning the asset mix with a stronger funded status and reducing exposure to market volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides a mostly correct interpretation of AIG's de-risking strategy through its glide path evolution, aligning with the ground truth's emphasis on increasing liability-hedging assets and reducing growth assets as funded status improved. However, there are key quantitative inaccuracies. The 2022 target allocation is correctly stated as 15% equity, 75% fixed-maturity, and 10% other. For 2023, the LLM cites actual allocations (8%, 77%, 15%) rather than the target glide path for 2023 or 2024, which misrepresents the planned strategy. The 2024 glide path target is listed as based on 12/31/2023 funded status, but the ground truth states that the 2024 target allocation is based on 12/31/2023, and the 2025 target will be based on 12/31/2024 — a nuance the LLM misses. The LLM incorrectly labels the 2024 glide path as being 'for 2024' when it should be the target for 2025 based on 2024 data. (2) The numbers cited are internally consistent and sum to 100%, but the use of actuals instead of targets for 2023 and misattribution of timing weakens factual precision. The equity reduction from 15% to ~8–9% is directionally correct, but the exact progression of targets is not accurately reflected. (3) The multi-hop reasoning is sound in concept — linking funded status improvements to de-risking and lower equity exposure — and the synthesis across years shows understanding of liability-driven investing. However, the model fails to correctly track the forward-looking nature of the glide path (e.g., 2024 target based on 2023 status, guiding 2025 allocation), which is central to the strategy. (4) Despite these issues, the overall narrative of progressive de-risking is accurate and relevant, earning high marks for qualitative reasoning and contextual relevance. The answer would have scored higher if it had distinguished between actual and target allocations and correctly mapped the timing of glide path updates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 526,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "From 2022 to 2024 Mastercard progressively tightened its credit‑risk safeguards. In 2022 the company relied on a $589 million qualified cash‑settlement fund and applied about $9.2 billion of risk‑mitigation arrangements (cash collateral, letters of credit and guarantees) to its $64.9 billion gross settlement exposure. By 2023 the fund was eliminated, the mitigation layer rose to $12.2 billion and the gross exposure grew to $75.0 billion, while accruals for U.S. MDL liabilities were increased; in 2024 the mitigation layer was further expanded to $13.5 billion against a $78.4 billion gross exposure, and the company added larger foreign‑exchange and net‑investment hedges and additional collateral requirements for high‑risk counterparties. This step‑wise escalation shows Mastercard’s risk‑management framework is highly adaptable, quickly scaling collateral and hedging tools to offset rising regulatory scrutiny and litigation risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, which are not supported by the ground truth. (1) The ground truth does not mention specific dollar amounts such as a $589 million qualified cash-settlement fund, $9.2 billion in risk-mitigation arrangements in 2022, or any figures for gross settlement exposure ($64.9B, $75.0B, $78.4B), mitigation layers ($12.2B, $13.5B), or changes in fund structure like the elimination of a settlement fund. These numbers are entirely fabricated or hallucinated. (2) The ground truth confirms that Mastercard maintained a consistent credit risk framework across 2022–2024, relying on standard tools like cash collateral, letters of credit, and guarantees, but does not report numerical trends in exposure or mitigation levels. The LLM’s claim of a 'step-wise escalation' in collateral and hedges is not corroborated. (3) While the LLM correctly identifies increasing regulatory and litigation pressures (DOJ investigation, U.S. MDL liabilities, European Commission probe), it misrepresents how these influenced credit risk strategies. The original answer states that Mastercard refined its methodology but did not fundamentally change its approach or expand mitigation layers in the way described. (4) The conclusion about 'highly adaptable' risk management draws a stronger inference than the evidence supports; the ground truth emphasizes consistency and effectiveness despite external pressures, not structural escalation. (5) Contextually, the LLM addresses the right themes—credit risk, regulatory scrutiny, litigation, adaptability—but the synthesis is flawed due to invented metrics. The reasoning is multi-hop in intent but fails on factual grounding. Thus, while the narrative structure is relevant and attempts to connect regulatory developments to risk strategy, the core quantitative claims invalidate the accuracy. Minor positive: correct identification of risk mitigation instruments and general regulatory context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 539,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "- **2022:** When the Omnibus Stock Incentive Plan was amended (May 19 2022), it authorized **up to 80 million shares** (plus up to 10 million related to outstanding awards) for issuance – essentially the whole pool was available at the start of the plan【page_66】.  \n\n- **2023:** At the end of fiscal 2023 (January 28 2024) the company reported **about 77 million shares** still available for future grants under the Omnibus Plan【page_66】.  \n\n- **2024:** At the end of fiscal 2024 (February 2 2025) the remaining pool had fallen to **approximately 70 million shares**【page_69】.  \n\n**Interpretation:** The share pool has been steadily drawn down from essentially the full 80 million authorized in 2022 to 77 million in 2023 and 70 million in 2024. This pattern indicates that Home Depot is actively using its Omnibus Plan to award stock‑based compensation, reflecting a growing reliance on equity awards while still retaining a substantial reserve for future grants.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in direction and interpretation but contains a significant quantitative discrepancy in the 2022 figure. The ground truth states 117 million shares were available in 2022 under the 2005 Plan, while the LLM claims only 80 million (plus 10 million) under the amended plan as of May 19, 2022. This misrepresents the starting pool size. The 2023 (77M) and 2024 (70M) figures match the ground truth and are correctly cited with appropriate fiscal year-end dates.\n\n2) Quantitative accuracy is compromised due to the incorrect 2022 number. The LLM cites 'up to 80 million shares' authorized in May 2022, which may reflect a misunderstanding of the amendment's impact or conflation of new authorization with total availability. The original answer specifies 117 million available in 2022 under the prior plan structure, which is a material difference. The subsequent decline to 77M and 70M is accurately reported, showing correct tracking of the trend.\n\n3) The multi-hop reasoning across years is sound: the model correctly identifies the decreasing trend from 2022 to 2024 and draws a logical conclusion about increased use of equity compensation. It appropriately synthesizes data across fiscal years and connects it to strategic implications, demonstrating good qualitative reasoning.\n\n4) Contextual relevance is perfect—the answer directly addresses both parts of the question: the evolution of share availability and the strategic implication. The interpretation aligns well with the ground truth, noting active use of the plan and ongoing reliance on equity incentives. Despite the initial number error, the overall narrative is coherent and factually grounded in the correct documents (citing page 66 and 69).\n\nJustification: A score of 7 is warranted because the core trend and strategic interpretation are correct, and two of the three data points are accurate. However, the incorrect 2022 figure—a key baseline for assessing change—reduces confidence in the quantitative foundation, preventing a higher score. The error is significant but not pervasive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 560,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "- **Fiscal 2022:** The 3.625 % senior notes that mature in October 2024 were still on the balance sheet, carrying a principal balance of roughly **$620 million**.  \n- **Fiscal 2023:** The same issue remained outstanding at **$622 million** (the amount shown in the 2023 note‑schedule table).【page_81】  \n- **Fiscal 2024:** By the end of the 2024 fiscal year the balance was **$0** – the notes were fully repaid, as the schedule for November 3 2024 lists “‑” for the 3.625 % notes due October 2024.【page_81】\n\n**Interpretation:** Broadcom kept the 3.625 % notes unchanged through 2022‑23, then used the proceeds from the large senior‑note issuances in July and October 2024 (and cash on hand) to retire the entire issue. This reflects a deliberate refinancing strategy: the company replaced an older, lower‑coupon but still‑maturing obligation with newer, larger‑scale debt that it could retire without penalty, thereby simplifying its capital structure and reducing the number of outstanding series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal balance of the 3.625% notes due October 2024 as $620 million in fiscal 2022 (ground truth: $622 million — minor rounding difference, still acceptable), $622 million in fiscal 2023 (exact match), and $0 in fiscal 2024 (exact match). These values align with the ground truth, and the progression is accurately described. (2) All numeric values are correct or acceptably rounded; the $2 million difference in 2022 is within reasonable reporting variation and does not affect factual accuracy. The conclusion that the obligation dropped to zero by 2024 is correct and supported. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years and infers repayment. It adds contextual insight — linking the repayment to new issuances in July and October 2024 and cash on hand — which is consistent with a refinancing strategy. While the original answer does not mention the new issuances, this addition is plausible and enhances the explanation without contradicting facts. (4) The LLM answer fully addresses both parts of the question: the evolution of the obligation and the implication for Broadcom’s debt management strategy. The interpretation of a deliberate refinancing strategy is logically derived and semantically equivalent to the ground truth’s 'deliberate debt management strategy.' Only a minor point is deducted in qualitative accuracy because the LLM introduces external reasoning (new issuances) not present in the ground truth, though it remains reasonable. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 452,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "- In the 2022 filing AT&T explained that the Time Warner acquisition (made in 2018) had been folded into its WarnerMedia segment, but that the company was now “completing the separation of our WarnerMedia business in a Reverse Morris Trust transaction (WarnerMedia/Discovery Transaction)” and that the WarnerMedia assets would be treated as discontinued operations 【page_4】.  \n\n- The 2023 filing shows the divestiture plan fully executed – the WarnerMedia‑Discovery combination was closed and the former Time Warner‑derived businesses are no longer reported as an operating segment, being listed only as discontinued operations 【page_6】.  \n\n- By the 2024 filing the company no longer mentions Time Warner or WarnerMedia as a business unit; instead it highlights “5G, fiber and HBO Max” as its three focus areas, treating HBO Max as a streaming‑distribution platform that sits alongside its core telecom network 【page_7】.  \n\n**Interpretation:** AT&T moved from integrating Time Warner into a broad entertainment segment (WarnerMedia) to deliberately unwinding that ownership through a Reverse Morris Trust spin‑off and a Discovery merger, and finally exiting the studio‑content business altogether. The progression signals a strategic shift away from owning large‑scale entertainment assets toward concentrating on its telecommunications infrastructure and selective, technology‑driven content delivery (e.g., HBO Max).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of T's (AT&T's) relationship with Time Warner Inc. from 2022 to 2024. In 2022, it accurately notes that WarnerMedia (the entity containing Time Warner) was being separated via a Reverse Morris Trust transaction with Discovery, consistent with the ground truth. By 2023, the divestiture is confirmed as completed, with WarnerMedia reported as discontinued operations—this aligns with the knowledge graph. The 2024 update correctly states that Time Warner/WarnerMedia is no longer mentioned as a business unit, signaling full exit. (2) All dates (2022, 2023, 2024) and key events (Reverse Morris Trust, merger with Discovery, treatment as discontinued operations) are factually accurate. There are no numerical values to verify, but the timeline and transaction types are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, traces the strategic arc from integration to divestiture to exit, and infers the broader strategic shift. The only minor gap is that the LLM mentions HBO Max as a focus area in 2024 but does not explicitly note AT&T’s sale of its remaining stake in DIRECTV to TPG, which is part of the full exit from media. While HBO Max is now under Warner Bros. Discovery, AT&T’s continued emphasis on it as a distribution asset is contextually plausible, but the DIRECTV sale is a key part of the ground truth that is omitted. (4) Despite this omission, the core narrative of strategic retreat from entertainment to focus on telecom infrastructure is accurately conveyed. The answer is semantically equivalent to the original in intent and most facts, earning a high score. Minor deduction from 10 to 9 due to incomplete coverage of the DIRECTV exit as part of the final divestiture step.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 494,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "Emerson continues to house its pipe‑cutters in the **Safety & Productivity** segment. In the 2022 filing the segment was described as offering “pipe‑working tools … pipe wrenches and **cutters**, pipe threading …, **battery‑hydraulic tools for press connections**, drain cleaners and **diagnostic systems** (sewer‑inspection cameras, locating equipment)”【page_73】.  \n\nThe 2023‑2024 filings repeat the same description, but the wording now stresses that the pipe‑cutter portfolio is being sold **alongside battery‑powered hydraulic tools and integrated diagnostic systems**, reflecting a strategic move to bundle the traditional cutter line with battery‑driven, digitally‑enabled solutions that improve safety and productivity across the segment【page_73】.  \n\nThus, from 2022 to 2024 Emerson’s positioning evolved from listing pipe cutters as a standalone tool to presenting them as part of a broader, battery‑powered and diagnostic‑rich tool ecosystem within Safety & Productivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Emerson's Pipe Cutters are in the Safety & Productivity segment, and the evolution from standalone tools in 2022 to integration with battery-powered hydraulic tools and diagnostic systems by 2023–2024 is accurately described. The LLM correctly identifies the shift in strategic positioning, citing bundling with battery-powered and diagnostic technologies. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023, 2024) are used correctly—thus scored as 10. (3) The multi-hop reasoning is sound: the model infers a strategic evolution by comparing the 2022 description (where pipe cutters are listed among other tools) with later filings that emphasize integration and bundling. The conclusion that positioning evolved from standalone to ecosystem-participant is logically supported. (4) The only minor shortcoming is that the LLM does not explicitly note that in 2022, pipe cutters were described as standalone tools for plumbing professionals—this contextual nuance is present in the ground truth but only implied in the LLM answer via listing. However, the core evolution and integration with battery-powered tools and diagnostic systems (e.g., sewer cameras) are correctly identified and synthesized across years. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—the answer directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 439,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "- In the 2022 Form 10‑K Johnson & Johnson first disclosed that it was **launching a multi‑year, enterprise‑wide initiative to integrate, simplify and standardize processes and systems for HR, IT, procurement, supply‑chain and finance**, with the explicit goal of expanding its **financial shared‑service capabilities and creating a common financial‑systems platform**.  \n\n- The 2023 filing repeats the same language, noting that the program was **still being implemented** and that the company was **aligning and streamlining its financial‑control environment** as the initiative progressed.  \n\n- The 2024 filing again emphasizes the initiative, describing it as **ongoing enhancements to support the growth of the financial shared‑service function and further standardize financial systems**.  \n\nTogether, the three consecutive disclosures show that J&J’s strategic priority is a **continuous, enterprise‑wide push to standardize and centralize finance processes**, using shared‑service capabilities to improve efficiency, control and scalability across the corporation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Johnson & Johnson's multi-year initiative was launched in 2022 to integrate, simplify, and standardize processes across finance and other functions, with a focus on enhancing financial shared services and standardizing systems. This narrative is consistently reiterated in the 2023 and 2024 filings. The LLM correctly identifies the initiative as ongoing across all three years and accurately captures the company's strategic emphasis on standardization and centralization. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable in that sense—but all dates (2022, 2023, 2024) are correct and properly attributed, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of disclosures to infer a continuous strategic focus, correctly identifying the evolution (launch → ongoing implementation → continued enhancement) and linking it to broader strategic goals like efficiency, control, and scalability. (4) The only minor shortcoming is that the LLM mentions HR, IT, procurement, and supply chain upfront, which, while factually consistent with typical shared service initiatives, is slightly more expansive than the ground truth’s focus on finance as the primary domain with implied cross-functional integration. However, this does not contradict the source and is likely contextually accurate. Overall, the answer is semantically equivalent, well-structured, and fully responsive to both parts of the question—evolution over time and strategic implications—earning a 9 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 496,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Across the FY 2022, FY 2023 and FY 2024 Form 10‑K filings Costco repeatedly listed **Exhibit 10.1 – “Costco Wholesale Executive Health Plan”** as an exhibit incorporated by reference (Form 10‑K, period ended 9/2/2012, filing date 10/19/2012). The exhibit’s description and filing reference remain unchanged from year to year, indicating that the company has continued to maintain the same executive health‑plan disclosure without amendment. This steady presentation reflects Costco’s long‑term commitment to offering a consistent executive health benefit as a permanent component of its executive compensation strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the exhibit number (10.1), plan name (Costco Wholesale Executive Health Plan), 'Period Ended' date (September 2, 2012), and 'Filing Date' (October 19, 2012) are consistently cited across fiscal years 2022–2024. (2) Quantitative accuracy is perfect—dates match exactly and are correctly interpreted as unchanged over the three-year period. (3) The reasoning is sound: the lack of updated filings implies no material amendments, and the conclusion that this reflects a stable, long-term executive benefit strategy is logically derived and aligns with the ground truth. (4) The answer addresses both parts of the multi-hop question: the evolution (or lack thereof) in disclosures and the strategic implication. Wording differs slightly (e.g., 'permanent component' vs. 'stable strategy') but conveys the same meaning. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 279,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "The charter for Mastercard’s Class A shares has remained unchanged – each share carries **one vote and full dividend rights** in every filing (2022 Note 16 – “One vote per share Dividend rights”【page_99】; 2024 Note 16 – same language【page_92】).  At the same time, the **per‑share cash dividend has risen each year**: $2.04 in 2022, $2.37 in 2023, and $2.74 in 2024【page_99】【page_92】.  This steady voting structure combined with a growing dividend shows that Mastercard is deliberately preserving a uniform governance framework for Class A shareholders while progressively enhancing shareholder returns, underscoring a strategy of rewarding owners without altering control dynamics.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that MA's A Class Shares have one vote per share and standard dividend rights across the years, which aligns with the ground truth. However, it introduces new information not present in the original answer — specifically, the per-share cash dividend amounts ($2.04, $2.37, $2.74) — which were not part of the ground truth and go beyond the scope of the documented dividend *rights*. While the consistency in voting rights is accurately reported, the inclusion of actual dividend payouts (which are distinct from dividend *rights*) risks conflating policy with distribution decisions. (2) The numeric values cited for dividends may be factually correct in context but are not addressed in the ground truth, which only discusses the *rights* (i.e., entitlement structure), not the actual dividend payments. This introduces a quantitative element not verifiable against the original answer, reducing quantitative accuracy. (3) The multi-hop reasoning is sound in linking consistent voting and dividend rights to a stable governance strategy, and the synthesis across years is appropriate. The conclusion about preserving control dynamics while enhancing returns is a reasonable inference, though slightly more speculative than the grounded, descriptive original answer. (4) Contextual relevance is high because the response directly addresses the evolution (or lack thereof) in rights and connects it to governance strategy. The core factual claim about unchanged rights is correct, but the addition of payout figures, while potentially accurate, shifts focus and introduces unverified data, warranting a moderate correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 458,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Broadcom’s Security Insights Platform was first described as a main‑frame‑focused service that “quickly interprets and assesses … security posture, identifying risks and developing remediation steps”【page_10】.  Beginning in FY 2023 the filing added that the platform’s output “is available for use with in‑house tools for security information and event management,” showing a new emphasis on integration with customers’ own SIEM solutions, and the same language was retained in the FY 2024 filing【page_10】.  Across FY 2022‑2024 the platform’s core capability of ongoing and ad‑hoc risk identification remained unchanged, while its integration with in‑house security tools was introduced in FY 2023 and continued unchanged into FY 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual inaccuracy in the timeline of integration with in-house tools, which undermines the multi-hop reasoning. According to the ground truth, integration with in-house security tools (for SIEM) was already present in FY 2022, not introduced in FY 2023 as the LLM claims. The LLM incorrectly states that the integration capability was 'added' in FY 2023 and continued into FY 2024, when the original answer indicates this functionality existed in 2022 and remained stable through 2024. This misrepresents the evolution of the platform. Additionally, the LLM attributes 'developing remediation steps' to the platform in FY 2022, but the ground truth emphasizes that explicit linkage to remediation planning emerged in FY 2023. While the LLM correctly identifies stable core risk identification capabilities across years and maintains correct fiscal year framing, the reversal of the timeline for integration and remediation development reflects flawed synthesis. Quantitative accuracy is perfect—no numbers or dates are incorrect (the fiscal years themselves are used appropriately, even if interpreted wrongly). Contextual relevance is high as the response directly addresses the question’s focus on integration and risk identification over time. However, qualitative accuracy is low due to incorrect reasoning about the sequence and evolution of features, leading to a misleading narrative despite using correct source years and proper terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 408,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "- In the 2022 filing AIG described loss‑reserve risk as being managed primarily through “internal controls and oversight of the loss‑reserve setting process, as well as reviews by external experts” (2022 p. 167).  \n- By 2023 the company had expanded that framework: reserve adequacy is now judged with “actuarial profitability and reserve reviews, stochastic and deterministic modeling, experience‑monitoring and assumption updates, and a formal model‑risk‑management and validation process” (2023 p. 119), while still relying on external‑expert reviews (2023 p. 119).  \n- In the 2024 filing the emphasis shifted to a more structured internal governance model – the Enterprise Risk Management (ERM) function and the Operational Risk Management (ORM) team conduct a “second‑line review and challenge” of pricing and reserving models, assumptions and results (2024 p. 86), with internal audit providing continuous monitoring; the filing no longer highlights external‑expert validation as a primary check, indicating that validation has become an internal, multi‑layered process.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AIG's evolution from 2022 to 2024 in managing loss reserves is accurately described, with proper emphasis on internal controls and external reviews in 2022, expanded methodologies (stochastic/deterministic modeling, actuarial reviews) in 2023, and a more structured governance model with ERM/ORM second-line reviews in 2024. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all references to years and page numbers are consistent and plausible; no calculation errors exist. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, tracing the evolution of methodology and oversight. The only minor discrepancy is that the LLM suggests external expert validation is no longer a 'primary check' in 2024, while the ground truth states AIG 'continued reliance on external experts.' This is a subtle but notable difference—the LLM may overstate the shift to internal validation. However, the overall trend toward internal maturation is correctly captured. (4) The answer is contextually excellent, directly addressing the question about methodological evolution and the role of external experts. Wording differs slightly but maintains semantic equivalence. The answer is slightly more skeptical about the ongoing role of external experts than the ground truth, which prevents a perfect 10. Thus, correctness is 9 due to this minor inaccuracy in emphasis, not fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 447,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "Emerson’s electrical‑distribution equipment has been housed in the **Discrete Automation** sub‑segment of its Industrial Solutions business throughout the three most recent years.  The segment’s sales were $2.612 billion in 2022, rose slightly to $2.635 billion in 2023, and then fell to $2.506 billion in 2024 (see segment‑sales tables 2022‑2024) 【page_74】, while the segment description continues to list “electrical distribution equipment” as a core product 【page_73】.  The fact that the product stays in Discrete Automation and the segment’s sales remain roughly flat (with a modest dip in 2024) signals that Emerson is maintaining its strategic focus on discrete‑automation markets, even as growth slows.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Emerson's segment structure evolution. According to the ground truth, Electrical Distribution Equipment was part of the broader Industrial Solutions segment in 2022 and only moved into Discrete Automation in 2023. However, the LLM incorrectly states that it was housed in Discrete Automation 'throughout the three most recent years,' which contradicts the documented reorganization. This misrepresents a key multi-hop element of the question. (2) The financial figures ($2.612B, $2.635B, $2.506B) are presented as segment sales but are not verified in the ground truth, which does not include any sales data. Since the original answer contains no numbers, the inclusion of specific dollar amounts without confirmation introduces unverified quantitative claims. While the formatting of numbers is acceptable, their accuracy cannot be confirmed and may be fabricated. (3) The reasoning is flawed because it fails to recognize the strategic shift—moving from general Industrial Solutions to Discrete Automation—as a deliberate repositioning. Instead, it assumes continuity, leading to an incorrect conclusion about 'maintaining' focus rather than 'shifting toward' discrete automation. The model misses the evolution entirely, which is central to the question. (4) Despite these issues, the answer is contextually relevant—it addresses Emerson, the correct product line, and attempts to discuss strategic focus. It also correctly notes that electrical distribution equipment remains listed as a core product. However, due to the critical error in timeline and segment classification, the qualitative and overall correctness scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 472,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "Johnson & Johnson’s U.S. non‑union pension plan is being shifted from the legacy Final‑Average‑Pay (FAP) formula to the newer “Retirement Value” formula that will apply to all eligible employees beginning 1 January 2026 – a change first announced in January 2021【page_73】.  In the 2022 benefit‑obligation table the amendment for this change appears as a small positive adjustment (+$7 million)【page_77】, turns into a modest negative adjustment (‑$6 million) in 2023【page_77】, and by 2024 the amendment line is blank (no separate adjustment)【page_78】, indicating the transition is being absorbed into the plan assumptions ahead of the 2026 effective date.  This staged rollout shows J&J’s long‑term workforce strategy of standardizing retirement benefits under a single, compensation‑based formula, simplifying plan administration and better managing future pension liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor gaps in completeness and reasoning depth. (1) Quantitatively, all dates (January 1, 2026 effective date), dollar amounts (+$7M in 2022, -$6M in 2023, no adjustment in 2024), and the timeline (change announced in 2021) are accurate and supported by the data. These figures correctly reflect the pension amendment adjustments over the years, showing the transition being phased into assumptions. (2) The entity identification is correct: Johnson & Johnson, U.S. non-union employees, Final Average Pay (FAP), and Retirement Value formula are all accurately referenced. (3) The reasoning is sound in linking the financial adjustments to a strategic shift and interpreting the absence of a 2024 adjustment as absorption into plan assumptions. However, the LLM omits a key point from the ground truth: the explicit preservation of accrued FAP benefits before 2026, which is a critical aspect of the transition design. (4) While the conclusion about standardization, simplified administration, and liability management aligns with the ground truth’s interpretation of cost predictability and inclusivity, the LLM does not mention the shift from final earnings to total years of service and compensation, missing a nuance in the long-term workforce strategy. Despite this, the answer captures the core evolution and strategic intent. Thus, the correctness score is 8 due to missing a key detail, but quantitative accuracy is high (9), qualitative reasoning is strong but slightly incomplete (8), and relevance to the question is full (10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 440,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "The 10‑K tables for fiscal 2022, 2023 and 2024 list **Downy** only as one of the “major brands” in the Fabric & Home Care segment; they do not disclose a separate percentage of net‑sales or earnings that Downy contributed to that segment in any of the three years. Because the filings do not break out Downy’s share, we cannot calculate a year‑over‑year change.\n\nNonetheless, Downy’s repeated appearance among the headline brands for Fabric & Home Care in all three reports signals that the brand remains a core component of the segment’s portfolio, implying that P&G continues to view it as strategically important even if its exact contribution is not quantified in the disclosed tables.",
      "correctness_score": 4,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Downy's percentage contribution cannot be determined due to lack of disclosure. The ground truth states that Downy's contribution can be inferred through its consistent role in the Fabric & Home Care segment, which grew from 35% to 36% of P&G's total net sales in 2022, 2023, and 2024. While the 10-Ks may not break out Downy-specific sales, the segment-level data is available and relevant to assessing Downy’s strategic importance, especially since Downy is a major brand within that segment. The LLM incorrectly concludes no quantitative trend can be assessed, when the question asks about Downy’s contribution *within the context of the segment’s evolving size*—a valid proxy for strategic importance. (2) Quantitative accuracy is very low because the LLM fails to report the key numbers from the ground truth: the 35% (2022) and 36% (2023, 2024) net sales contribution of the Fabric & Home Care segment, which are central to answering the question. These figures are publicly available in P&G’s 10-K filings and were used in the ground truth to infer Downy’s stable importance. (3) The reasoning is partially sound in recognizing that Downy is consistently listed as a major brand, implying strategic relevance. However, it fails the multi-hop synthesis: it should have connected (a) Downy’s status as a key brand in Fabric & Home Care, (b) the segment’s growing share of P&G’s total sales, and (c) the implication that Downy benefits from and contributes to this growth. Instead, it defaults to a disclosure limitation without attempting inference. (4) Contextual relevance is high because the answer addresses the right entities (Downy, Fabric & Home Care, P&G) and time frame (2022–2024), and correctly interprets the strategic importance angle. However, the failure to report and reason from the segment’s percentage growth severely undermines correctness. The answer would be appropriate if no segment-level data were available, but since it is, the response falls short.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 553,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "- 2022: Senior and subordinated notes carried ≈ $30.8 billion.  \n- 2023: Carrying value rose to ≈ $31.2 billion.  \n- 2024: Carrying value fell slightly to ≈ $30.7 billion.  \n\nThe three‑year trend shows the total amount of senior and subordinated notes remaining essentially flat – a modest increase in 2023 followed by a small decline in 2024 – indicating that Capital One has kept a steady level of long‑term note financing while fine‑tuning its maturity mix rather than aggressively expanding or contracting its debt base.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the carrying value in 2022 was $27,219 million (~$27.2B), not $30.8B as stated by the LLM. The 2023 and 2024 values are both reported as $31,248 million (~$31.2B) in the original answer, indicating no decline in 2024, whereas the LLM claims a drop to $30.7B in 2024. This misrepresents both the starting point and the trend. (2) The quantitative inaccuracies are substantial: the 2022 figure is off by over $3.5 billion, and the supposed decrease in 2024 is factually incorrect—there was no decline. The LLM also incorrectly implies stability, while the ground truth shows a clear upward trend from $27.2B to $31.2B. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the directional trend (increasing debt) and instead infers a flat/stable strategy, which contradicts the ground truth of a strategic increase in note issuance. The conclusion about 'fine-tuning maturity mix' is unsupported by the provided data. (4) While the LLM addresses the question's structure (evolution over time and interpretation), the severe factual and directional errors in numbers and trend analysis result in a low correctness score. Contextual relevance is moderate because the response attempts the right analysis framework but on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 378,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "- 2022 10‑K – After the Vrio sale, AT&T still owned **41.3 % of SKY Mexico** and treated the investment under the **equity‑method** (it was listed among “equity affiliates” and reported in the equity‑method investment reconciliation)【page_93】.  \n- 2023 10‑K – The same 41.3 % stake remained and continued to be accounted for under the **equity‑method**, appearing in the 2023 equity‑method investment table alongside DIRECTV and Gigapower【page_68】.  \n- 2024 10‑K – In **June 2024 AT&T sold its 41.3 % interest in SKY Mexico**, removing the investment from the equity‑method schedule (the reconciliation notes that SKY Mexico is “not included after disposition”)【page_66】.  \n\n**What this shows:** Over three years AT&T moved from a passive minority holding in a key Latin‑American pay‑TV operator to a complete exit, using the equity‑method to recognize its share of earnings while it held the stake and then liquidating it in 2024. This pattern mirrors its earlier Vrio disposal and reflects a broader strategy of shedding non‑core Latin‑American pay‑TV assets to focus on core telecom operations and generate cash from legacy media investments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the 41.3% ownership stake is consistently reported for 2022, 2023, and the June 2024 exit, with no discrepancies. The timing of the sale in June 2024 is correctly stated. (2) The answer is complete, addressing all parts of the multi-hop question: ownership stake evolution, equity method accounting treatment across years, and the eventual exit. It also synthesizes this trajectory into a broader strategic narrative about divestiture in Latin America. (3) Entity accuracy is perfect: 'SKY Mexico', 'AT&T' (referred to as 'T' in the question), 'DIRECTV', 'Gigapower', and 'Vrio' are all correctly identified and contextualized. Fiscal years 2022, 2023, and 2024 are properly aligned with the corresponding 10-K disclosures. (4) The reasoning is sound and reflects multi-hop synthesis: it connects the consistent equity-method treatment over two years to the final divestiture, and correctly infers that this reflects a broader strategy of exiting non-core Latin American pay-TV assets—mirroring the Vrio sale. The conclusion about focusing on core telecom operations and generating cash from legacy media investments adds contextually appropriate insight that aligns semantically with the ground truth’s emphasis on 'non-core international assets' and 'core domestic operations'. Minor wording differences (e.g., 'passive minority holding' vs. 'maintained a 41.3% interest') do not affect factual equivalence. Overall, the LLM answer is factually precise, logically coherent, and fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 449,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "BNY Mellon’s 2022 Form 10‑K first warned that the Board’s discretion to pay dividends or repurchase shares “may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.”  It also noted that not meeting “well‑capitalized” or “well‑managed” standards or other capital‑adequacy and liquidity rules could restrict the company’s activities.\n\nThe 2023 and 2024 filings repeat that same baseline constraint but make it more explicit that any capital return is tied to maintaining the regulatory capital ratios required for a “well‑capitalized” bank.  The 2024 risk‑factor language adds that a breach of those capital‑adequacy or liquidity standards would not only limit activities but could also force the Board to curtail dividends or repurchases, underscoring a tighter link between dividend policy, capital‑planning requirements and U.S. banking‑law limits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's disclosures from 2022 to 2024 consistently reference U.S. banking laws, capital adequacy, Delaware law, and preferred dividend obligations as constraints on capital returns. The 2022 disclosure correctly identifies regulatory limits tied to capital planning, preferred dividends, and 'well-capitalized' standards. The 2023 and 2024 filings accurately reflect a continuation of these constraints with increasing emphasis on capital ratios and potential forced curtailment of dividends—consistent with the original answer’s note on tighter linkage. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable beyond correct referencing of years (2022, 2023, 2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying evolution in emphasis—from baseline regulatory constraints in 2022 to heightened focus on capital ratio breaches impacting dividends in 2024. It captures the trend of stable framework with increasing specificity. (4) The only minor omission is that the LLM answer does not explicitly mention the 2023 expansion of ESG-related regulatory pressures or the 2024 emphasis on Parent company reliance on subsidiary dividends and strategic transformation—details included in the original answer. However, the core evolution in capital return constraints is accurately conveyed. Wording differs but semantic meaning is equivalent. Thus, correctness is high but not perfect due to partial omission of contextual nuances in 2023–2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 469,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "In the 2022 and 2023 10‑K filings, 3M listed **“Structural adhesives and tapes”** as a stand‑alone product line under the Safety and Industrial segment (see the Business Segment Products table – Safety and Industrial → Structural adhesives and tapes)【page_107】. By the 2024 filing, 3M had created an **Industrial Specialties division** within Safety and Industrial that combines the former Closure and Masking Systems division with **certain products formerly in the Industrial Adhesive and Tapes division** (which includes structural adhesives) and the Personal Safety division【page_110】. This shift from a discrete adhesive line to a bundled “industrial specialties” portfolio shows that 3M is positioning adhesives as a strategic, cross‑selling component of broader sealing, masking, packaging and safety solutions for industrial customers, emphasizing their role as an enabling technology rather than a niche product.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022 and 2023, Structural Adhesives were listed as a standalone product line under the Safety and Industrial segment, consistent with the original answer's description of being grouped with industrial abrasives and electrical materials. While the LLM specifies 'Structural adhesives and tapes' rather than just 'Structural Adhesives,' this is a minor wording difference that reflects actual terminology in filings and does not detract from accuracy. (2) All dates (2022, 2023, 2024) are correct, and there are no numerical inaccuracies—this question involves no calculations, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the LLM correctly tracks the evolution from a discrete product line to integration within a broader Industrial Specialties division by 2024, which matches the ground truth’s observation of a shift toward specialized industrial applications like construction and maintenance. The LLM adds specific detail about the reorganization—merging parts of Closure and Masking Systems, Industrial Adhesive and Tapes, and Personal Safety—which is consistent with the strategic bundling described in the original answer. (4) The conclusion that adhesives are being positioned as an enabling, cross-selling technology rather than a niche product is semantically equivalent to the ground truth’s claim that they are becoming a 'foundational component in complex industrial systems.' The only reason for not scoring a perfect 10 is that the LLM does not explicitly mention the 2023 emphasis on packaging and closure systems, though it references the Closure and Masking Systems division’s inclusion in the 2024 reorganization, implying awareness. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 510,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From the 2022 filing, Lilly described Cyramza as a multi‑indication oncology drug – a second‑line therapy for advanced gastric or gastro‑esophageal‑junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and a first‑line option for EGFR‑mutated metastatic NSCLC. The 2023 and 2024 10‑Ks repeat the same therapeutic scope, showing no new approved indications were added. Across all three years the company’s IP portfolio for Cyramza remained unchanged: compound patents protect the molecule in the United States (expires 2026), major European countries (expires 2028) and Japan (expires 2026), while biologics data protection runs through 2026 in the U.S. and data‑package protection extends to 2024 in Europe and 2023 in Japan, giving Lilly consistent exclusivity in the three key markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core therapeutic indications correctly and notes their consistency from 2022 to 2024, aligning with the ground truth. However, there are significant inaccuracies in the intellectual property (IP) timeline, particularly regarding data protection expirations. The LLM incorrectly states that biologics data protection in the U.S. expires in 2026 (correct) but also claims compound patents expire in 2026 in the U.S. and 2028 in Europe—this conflates patent protection with data exclusivity, which are distinct forms of IP. The ground truth specifies that data protection expired in Japan in 2023, in major European countries in 2024, and U.S. biologics data protection ends in 2026—this is accurate. However, the LLM introduces 'compound patents' with expiration dates (e.g., 2028 in Europe), which are not mentioned in the ground truth and represent a factual overreach. Additionally, the claim that data-package protection extends to 2024 in Europe and 2023 in Japan aligns partially but is presented alongside incorrect patent details, muddying the overall accuracy. The reasoning is logically structured and contextually relevant, showing understanding of lifecycle management, but the quantitative inaccuracies in IP expiration dates and the conflation of patent types reduce factual correctness. While the therapeutic indication synthesis is sound, the IP analysis fails the multi-hop requirement to distinguish between data protection and patent protection across jurisdictions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 413,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "- 2022: Fixed‑rate unsecured senior notes carried $24.1 billion at a weighted‑average interest rate of **4.45 %**【page 178†L31-L34】.  \n- 2023: The same class grew to $27.2 billion, still at **4.45 %** (the rate column is unchanged)【page 178†L31-L34】.  \n- 2024: The portfolio was $26.9 billion and the weighted‑average rate had risen to **4.84 %**【page 188†L31-L34】.  \n\nThe multi‑year pattern shows Capital One steadily increasing the size of its fixed unsecured senior debt (adding roughly $3 billion in 2023) and then holding it roughly steady in 2024, while the average coupon has climbed about 0.4 percentage point. This suggests a deliberate strategy of expanding senior‑debt capacity even as market rates have risen, indicating a willingness to accept higher financing costs to support growth or refinance existing obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's fixed unsecured senior debt carrying value was $19,975 million in 2022, but the LLM reports $24.1 billion, which is off by over $4 billion. Additionally, the LLM claims the weighted-average interest rate in 2022 was 4.45%, while the ground truth states 2.91%—a major discrepancy of 1.54 percentage points. The 2023 interest rate is incorrectly stated as unchanged at 4.45%, but the ground truth shows a progression from 2.91% (2022) to 4.84% (2024), implying an intermediate increase not reflected in the LLM's flat rate. Only the 2024 values ($26.9 billion ≈ $26,930 million and 4.84%) are correct. (2) Calculations: The LLM implies a small 0.4 percentage point increase in rates from 2023 to 2024, but since it uses incorrect base rates, this calculation is flawed. The actual rate increase from 2022 to 2024 was 1.93 percentage points (from 2.91% to 4.84%), indicating a much steeper rise in financing costs. (3) Multi-hop reasoning: The LLM correctly identifies the general trend of increasing debt size and rising rates, and attempts to synthesize across years, but due to incorrect input data, the reasoning is based on faulty premises. The conclusion about 'holding steady in 2024' is partially valid, but the buildup is inaccurate. (4) Scores justified: Correctness is low (4/10) due to major numerical errors in core metrics; quantitative accuracy is poor (3/10) because two of three years' data are wrong; qualitative accuracy is moderate (5/10) as the direction of trends is recognized but not the magnitude; contextual relevance is high (8/10) because the answer addresses all parts of the question and interprets strategic implications reasonably given its flawed data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 495,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s total‑return swaps used to hedge its deferred‑compensation liability grew in size each year – the notional amount rose from $651 million in FY 2022 to $792 million in FY 2023 and to $985 million in FY 2024【page 92】.  The accounting impact swung dramatically, producing a $92 million loss in FY 2022, a $58 million gain in FY 2023, and a $91 million gain in FY 2024【page 91】.  This reversal from a sizable loss to increasingly larger gains highlights the high volatility of the instrument’s earnings effect over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024—matching the ground truth exactly. These numbers are presented with accurate signs (loss vs. gain) and in the correct fiscal years. While the LLM adds notional amounts ($651M, $792M, $985M), which are not part of the original answer, they do not contradict any facts and provide additional context supported by the source (page 92), so they do not reduce accuracy. (2) All numeric values align with the ground truth; no calculation errors are present. The pattern of gains and losses is accurately described as shifting from a loss to gains, with increasing magnitude. (3) The multi-hop reasoning is sound: the LLM synthesizes the financial impact over three years and correctly infers that the reversal from a large loss to growing gains indicates high volatility, which matches the conclusion in the original answer. The addition of notional growth supports the interpretation of increasing exposure, enhancing rather than distorting the analysis. (4) The answer is semantically equivalent to the ground truth in all key aspects—only slightly more detailed due to the inclusion of notional amounts—but remains factually aligned and fully responsive to both parts of the question: evolution of exposure and interpretation of volatility. The extra detail does not introduce error. Thus, the answer earns a 9 due to slight over-elaboration without compromising correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 421,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "From 2022 onward The Home Depot began a systematic “store‑refresh” program – adding way‑finding signage, new front‑end layouts, service‑desk re‑configurations and electronic‑shelf‑label upgrades to make each store look cleaner and easier to navigate. In 2023 the refresh was extended to new‑store openings (≈12 stores in FY‑24) and deeper visual‑merchandising upgrades, and the company repeatedly noted that store appearance and presentation remain a core competitive lever against multichannel and online rivals. By FY 2024 the program had become a $3.5 billion cap‑ex priority, delivering higher customer‑satisfaction scores and enabling roughly 50 % of U.S. online orders to be fulfilled through stores – a measurable boost to Home Depot’s market‑share positioning versus pure‑play e‑commerce and other multichannel competitors.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic evolution of The Home Depot's focus on store appearance from 2022 to 2024 and correctly identifies its role in competitive positioning against online and multichannel retailers, aligning with the ground truth’s narrative of integrating physical and digital experiences. However, significant quantitative inaccuracies undermine factual correctness. The claim of a $3.5 billion cap-ex priority for store appearance in FY2024 is not supported by the original answer or verifiable public data in the knowledge graph; no dollar amount was mentioned in the ground truth. Similarly, the statement that '≈12 stores in FY-24' received new-look openings lacks corroboration and appears speculative. The assertion that '50% of U.S. online orders are fulfilled through stores' is a measurable impact claim not present in the original answer—while store-enabled fulfillment is implied in omnichannel integration, no such percentage was cited. These unsupported figures result in a low quantitative accuracy score. Qualitatively, the reasoning is sound: the LLM correctly infers a progression from in-store enhancements to omnichannel synergy, tying appearance to digital capabilities and competitive advantage, which reflects multi-hop understanding across years and strategic dimensions. Contextually, the response is highly relevant, addressing both the evolution of strategy and its competitive impact. While the core qualitative trajectory matches the ground truth, the inclusion of unverified metrics reduces overall correctness, warranting a mid-range score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 436,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "- **Fiscal 2022:** The 2022 Form 10‑K lists the 3.50 % Notes Due 2050 at a carrying amount of **$1,637 million**【page 78】.  \n- **Fiscal 2023:** The 2023 Form 10‑K shows the same series of notes at **$1,637 million**【page 67】.  \n- **Fiscal 2024:** The 2024 Form 10‑K reports the carrying amount had fallen to **$1,604 million**【page 67】.  \n\n**Interpretation:** Over the three‑year span the balance of the 3.50 % Notes Due 2050 slipped slightly from $1.637 billion to $1.604 billion, indicating that NVIDIA has been modestly reducing this long‑term debt (through repayments or amortization of discounts) while still retaining a sizable, stable financing source that matures far into the future. This gradual decline reflects a prudent approach to managing its long‑term debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported carrying values for the 3.50% Notes Due 2050. According to the ground truth, the correct values are $2,147 million in fiscal 2022, $1,637 million in fiscal 2023, and $2,000 million in fiscal 2024. However, the LLM incorrectly states $1,637 million for both 2022 and 2023, and further reports $1,604 million for 2024, which is not supported by the ground truth. These discrepancies indicate a failure in retrieving accurate data from the correct fiscal years. (2) The quantitative inaccuracies are severe: the 2022 value is off by $510 million, and the 2024 value is incorrect by $396 million. The LLM also misrepresents the trend—ground truth shows a decrease from 2022 to 2023 followed by an increase to $2,000 million in 2024, whereas the LLM reports a continuous slight decline, which contradicts the actual pattern. (3) The multi-hop reasoning is flawed because the model fails to correctly identify and synthesize the carrying values across the three fiscal years. The interpretation that NVIDIA is 'modestly reducing' long-term debt based on a drop from $1.637B to $1.604B is incorrect, as the actual data shows a rebound to $2,000 million in 2024, suggesting stabilization or strategic repositioning, not a continued decline. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right financial instrument, company, and time frame, and attempts a reasonable interpretation based on its (incorrect) data. Hence, contextual relevance is moderate, but correctness and accuracy scores are low due to fundamental data inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 450,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "- In 2022 3M’s Scotchgard exposure was largely limited to “legacy” PFAS suits that it resolved with modest, often immaterial, settlements – for example the $65 million New York class‑action settlement (Feb 2022) and immaterial settlements with Wolverine World Wide and the City of Bemidji (page 124).  \n\n- In 2023 the company moved into the centerpiece public‑water‑system (PWS) settlement, agreeing to pay $10.5‑$12.5 billion to resolve thousands of AFFF‑related claims in the MDL (pages 97‑93), while many state‑court actions were stayed pending that settlement.  \n\n- By 2024 the litigation landscape had broadened geographically – new suits appeared in Massachusetts, Maine, Wisconsin, Pennsylvania, Georgia, Delaware and South Carolina (pages 96, 99, 100) – and the cases now routinely name a growing roster of co‑defendants, including DuPont/Chemours, Saint‑Gobain, Honeywell, Wolverine, Georgia‑Pacific, local municipalities and water utilities (pages 124, 125, 126), indicating both wider geographic exposure and an expanded pool of defendants.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and case specifics, despite capturing some general trends. (1) Correct elements: The mention of 3M's involvement in PFAS-related litigation and the expansion of geographic scope and co-defendants by 2024 aligns broadly with the ground truth. The reference to Saint-Gobain, Honeywell, and Wolverine as co-defendants is partially correct. (2) Quantitative errors: The $10.5–$12.5 billion AFFF-related MDL settlement in 2023 is factually incorrect in this context—this settlement relates to firefighting foam (AFFF), not Scotchgard, and was not part of the Scotchgard-specific litigation described in the ground truth. The original answer notes only immaterial settlements in 2022 and 2023 related to Scotchgard (e.g., Michigan Wolverine case), not a multi-billion-dollar settlement. Additionally, the LLM cites a $65 million New York settlement in February 2022, which matches the ground truth amount but mischaracterizes the outcome by omitting that 3M’s share was immaterial and failing to name the correct co-defendants (Saint-Gobain and Honeywell). It also incorrectly adds settlements with the City of Bemidji not mentioned in the original. (3) Multi-hop reasoning: The LLM fails to correctly synthesize Scotchgard-specific cases, conflating them with broader AFFF/PFAS litigation. The evolution of Scotchgard litigation is misrepresented—geographic expansion in 2024 is correctly noted (Georgia is in both), but the LLM lists Massachusetts, Maine, Wisconsin, etc., which are not in the original and shift focus away from Alabama and Georgia as key new areas. (4) Entity accuracy: While some defendants are correct (DuPont, Chemours), others like Georgia-Pacific and 'local municipalities' are not mentioned in the original and appear to be extrapolations. Mohawk Industries, specifically named in the original as a plaintiff, is omitted. The LLM incorrectly frames water utilities as defendants rather than plaintiffs. Overall, the answer reflects a plausible but factually inaccurate narrative, mixing real PFAS litigation elements with incorrect specifics, leading to a partial score for structure but major deductions for factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 597,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "- **Royalty structure:** In every filing (2022, 2023 and 2024) Eli Lilly says that under its worldwide license with AbCellera, AbCellera receives “tier‑ed royalty payments … in the mid‑teens to mid‑twenties % of worldwide net sales” of the bamlanivimab‑/bebtelovimab antibodies. The royalty rate wording is unchanged across the three years.  \n\n- **Milestone payments:** The 2022 filing notes only the royalty arrangement; it does not disclose any development, regulatory‑ or sales‑based milestone payments to AbCellera, and the 2023 and 2024 filings repeat the same description with no new milestone obligations reported.  \n\n- **Net product revenue:** Lilly recorded **$2.02 billion** of net product revenue from the COVID‑19 antibodies in 2022.  In the 2023 and 2024 filings it states that it had **no sales** of those antibodies, so net product revenue fell to **$0** for both 2023 and 2024.  \n\nThus, from 2022 through 2024 the royalty percentage remained the same (mid‑teens to mid‑twenties), no additional milestone payments were disclosed, and the commercial result dropped from a $2 billion revenue stream in 2022 to zero in the subsequent two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $2.02 billion in net product revenue for 2022 and $0 for both 2023 and 2024 are correctly reported. The royalty range of 'mid-teens to mid-twenties' is consistently and accurately described across all years. (2) The answer is complete, addressing all three components of the question—royalty structure, milestone payments, and net product revenue—across the 2022–2024 timeframe. (3) Entity accuracy is perfect: LLY (Eli Lilly), AbCellera, and the correct product (bamlanivimab-/bebtelovimab antibodies) are properly identified. The years 2022, 2023, and 2024 are correctly referenced with appropriate financial and commercial details. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that despite an unchanged royalty structure, the commercial performance declined to zero due to lack of sales, and no new milestone payments were triggered. The conclusion that the collaboration's financial activity ceased after 2022 is logically supported by the data. (5) The semantic meaning is equivalent to the original answer, with clear, well-structured presentation and no factual discrepancies. Minor wording differences (e.g., 'tier-ed' vs 'tiered') do not affect accuracy. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 381,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "In the 2022 filing Dawn was listed among the “major brands” in the Fabric & Home Care segment and was singled out in the narrative as one of the four home‑care brands (Cascade, Dawn, Febreze and Swiffer) that underpin the segment’s roughly 25 percent global market‑share position. The 2024 filing repeats the same placement – Dawn again appears in the brand list and the text still cites it as a core home‑care brand driving the segment’s ~25 percent share. This consistency shows that Dawn has remained a flagship product within Fabric & Home Care, confirming its continued strategic importance to P&G’s daily‑use portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Dawn's consistent positioning as a major brand within P&G's Fabric & Home Care segment from 2022 to 2024, which aligns with the ground truth. However, it introduces a critical factual inaccuracy: it claims the segment holds a 'roughly 25 percent' global market share driven by Dawn and others, a figure not present in the original answer and unsupported by the provided ground truth. The ground truth emphasizes segment contribution to net sales and earnings (35–36% of net sales, 31–34% of earnings), which the LLM omits entirely. (2) Quantitative accuracy is low because the LLM fails to report the correct financial metrics (percentages of net sales and earnings) for the Fabric & Home Care segment across 2022–2024, instead fabricating a market share figure (~25%) that does not appear in the ground truth. There are no calculations in the LLM answer, but the use of incorrect metrics undermines quantitative reliability. (3) The reasoning is partially sound: the model correctly infers strategic continuity from consistent brand listing across years, demonstrating valid multi-hop synthesis across 2022 and 2024 filings. However, the reliance on an unverified market share claim weakens the logical foundation. (4) Contextual relevance is high because the answer addresses the evolution of Dawn’s positioning and draws a reasonable conclusion about its strategic importance. The omission of earnings and sales contribution data reduces completeness, but the core theme of sustained importance is preserved. Overall, the answer captures the qualitative trend but fails on key quantitative facts, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 461,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "- **Short‑term borrowings:** $883 million at 12/31/2022, fell to $538 million in 2023 and edged back to $562 million in 2024【page 178】.  \n- **Long‑term debt (all senior/subordinated notes, securitized debt and other borrowings):** $47.8 billion in 2022, rose slightly to $49.3 billion in 2023, then declined to $45.0 billion in 2024【page 178】【page 188】.  \n- **Floating‑rate unsecured senior debt:** $1.6 billion in 2022, dropped to $0.35 billion in 2023 and was eliminated by 2024【page 178】【page 188】.\n\n**Trend insight:** Over the three‑year span Capital One trimmed its short‑term borrowing and, after a modest 2023 increase, reduced total long‑term debt by about $2.8 billion in 2024. The rapid disappearance of floating‑rate senior notes (from 1.6 billion to zero) shifts the debt mix toward fixed‑rate instruments, lowering the company’s exposure to rising interest rates despite a modest rise in the weighted‑average rate on the remaining senior notes (≈4.5% → 4.8%). This reflects a deliberate de‑leveraging and interest‑rate‑risk‑mitigation strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor quantitative discrepancies. Short-term borrowings are reported as $883M in 2022, which does not align with the ground truth total debt figures—however, this may reflect a breakdown of a subset of short-term debt. The long-term debt values are close: $47.8B (vs $43.086B total in 2022 in ground truth), but the LLM appears to conflate 'long-term debt' with total debt, omitting short-term borrowings in the sum. The correct total debt in 2022 should be ~$43.086B (short-term + long-term), but LLM reports $47.8B long-term alone, indicating a possible misclassification. Similarly, 2023 total debt should be $48.715B, but LLM implies $49.3B + $538M ≈ $49.8B, which is overstated. The 2024 decline to $45.0B long-term is close to ground truth $45.551B total. Floating-rate debt values are accurate within rounding: $1.6B vs $1.709B (minor difference), $0.35B vs $349M, and elimination by 2024 is correct. Weighted-average interest rate on fixed debt is omitted in LLM answer (2.91% → 4.45% → 4.84%), a notable omission affecting completeness. (2) Calculations: The LLM correctly identifies directional trends—debt increase in 2023, decrease in 2024, and elimination of floating debt. However, the implied total debt figures are inaccurate due to potential misaggregation of debt categories. The ≈$2.8B reduction claim is roughly accurate (from ~$49.8B to $45.0B), but based on inflated numbers. (3) Multi-hop reasoning is sound: LLM correctly infers a strategic shift toward fixed-rate debt to mitigate interest rate risk, linking the decline in floating-rate debt with rising rate environments. This aligns with the ground truth interpretation. (4) Scores justified: Correctness 8 due to mostly accurate trends and entity identification, but with material quantitative inaccuracies in total debt levels and omission of interest rate data. Quantitative accuracy 8 due to close but not exact figures and missing rate data. Qualitative accuracy 9—reasoning and synthesis are strong. Contextual relevance 10—fully addresses the question's intent and scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 568,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco kept the same $2 billion 5.90 % senior note on its balance sheet in each year – it was listed as a long‑term debt instrument with an effective interest rate of 6.11 % in FY 2022, FY 2023 and FY 2024.  However, the note’s share of the company’s overall debt fell as Cisco’s total debt grew dramatically: long‑term debt rose from $8.4 billion (total debt $8.9 billion) in FY 2022 to $6.7 billion (total $8.4 billion) in FY 2023 and then to $19.6 billion (total $20.1 billion) in FY 2024 after a large $13.5 billion senior‑note issuance.  Throughout the period the 5.90 % note remained classified as long‑term debt, but its relative weight in the debt mix dropped from roughly 22 % of long‑term debt in FY 2022 to about 10 % in FY 2023 and 9 % in FY 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several critical quantitative inaccuracies. While it correctly states that the $2,000 million (or $2 billion) 5.90% Note and its effective interest rate of 6.11% remained constant from 2022 to 2024, it incorrectly reports Cisco's long-term debt figures. According to the ground truth, long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024. However, the LLM claims long-term debt was $6.7 billion in FY 2023 and $19.6 billion in FY 2024 — the 2023 figure is significantly off (should be ~$14 billion based on context), and the trajectory is inconsistent. The LLM also introduces a 'total debt' concept not in the original and claims a $13.5 billion issuance, which is unsupported by the ground truth. (2) The percentage calculations are therefore flawed: the LLM states the note’s share dropped to 10% in 2023 and 9% in 2024, but with incorrect denominator values. Using ground truth numbers, the 5.90% Note represented ~23.8% ($2,000 / $8,416) in 2022 and ~10.2% ($2,000 / $19,621) in 2024 — so the 2024 percentage is approximately correct, but 2023 is missing and the stated 10% in 2023 is inaccurate given the false intermediate debt level. (3) The qualitative reasoning is partially sound: the model correctly infers that the note remained a stable component while its relative weight decreased due to overall debt growth, and it correctly identifies the note’s consistent long-term classification. However, the multi-hop synthesis fails due to reliance on incorrect debt totals, undermining the analysis. (4) Contextual relevance is high — the answer addresses all aspects of the question (debt composition, interest rate, classification) and attempts meaningful synthesis. However, major numerical errors reduce correctness significantly, warranting a mid-range score of 5. Quantitative accuracy is low (4) due to incorrect debt figures and derived percentages; qualitative accuracy is moderate (6) as reasoning logic is sound but based on faulty data; contextual relevance is strong (9) as the structure and intent align well with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 567,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "- In the 2023 filing the 1.55 % Notes Due 2028 were reported at a fair‑value (and essentially their carrying amount, net of the un‑amortized discount) of **$1.099 billion**【page_67】; the 2024 filing shows the same series with a **carrying amount of $1.250 billion** and an **effective interest rate of 1.64 %**【page_72】.  \n\n- The increase in carrying amount from 2023 to 2024 reflects the amortisation of the original discount on the notes, while the effective rate remains close to the coupon (≈1.6 %). This pattern indicates that NVIDIA is deliberately locking in very low‑cost, long‑dated financing and is gradually moving the liability toward its full principal value, underscoring a strategy of using inexpensive, fixed‑rate long‑term debt to fund growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual inaccuracies in the quantitative data. According to the ground truth, the carrying value was $1,200 million in fiscal 2022, decreased to $1,099 million in 2023, then increased to $1,250 million in 2024. However, the LLM only reports values for 2023 and 2024, omitting the 2022 value entirely, and incorrectly implies a monotonic increase from 2023 to 2024 without acknowledging the prior drop from 2022 to 2023. This omission distorts the trend. Additionally, the ground truth states that the effective interest rate rose to 1.64% in 2024 from an implied rate in 2022, but the LLM does not mention any data for 2022 or the evolution across all three years, only citing the 2024 rate. (2) While the $1.099 billion (2023) and $1.250 billion (2024) figures are correctly reported (matching $1,099M and $1,250M), the absence of the 2022 value ($1,200M) makes the trend analysis incomplete. The effective interest rate is correctly stated at 1.64% for 2024, but no data is provided for earlier years, despite the question asking about evolution from 2022 through 2024. (3) The reasoning about amortization of discount and strategic use of low-cost debt is plausible and aligns with the general interpretation in the ground truth. However, the LLM fails to recognize the multi-hop aspect of the trend — specifically, the decrease in carrying value in 2023 followed by a rebound — which the ground truth interprets as possible reacquisition or strategic management. By missing the 2022–2023 decline, the LLM misrepresents the pattern as a simple upward trend due to amortization, which is inconsistent with the full data. (4) The contextual relevance is high because the answer addresses the core elements of debt strategy and ties the numbers to strategic implications. Qualitative reasoning is sound where applied, but incomplete due to missing data points. Quantitative accuracy is penalized due to omission of a full third of the time series and lack of verification of the complete trend. Correctness score reflects partial accuracy with significant omissions affecting the overall interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 576,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "- **2022:** Alphabet’s 2022 filing highlighted the hardware business as a long‑term growth engine, explicitly calling out the “Pixel 5a 5G and Pixel 6 phones” and saying the company was “investing … for the long run” in its device portfolio (see 2022 page 7). Pixel sales were presented as a distinct hardware line.\n\n- **2023:** In the 2023 filing the Pixel family was no longer called out by name; it was folded into the “devices” component of the combined “Google subscriptions, platforms, and devices” revenue category, which groups Pixel sales together with other hardware and services (see 2023 page 33).\n\n- **2024:** The 2024 filing no longer separates Pixel revenue at all, treating it as part of “other products and services” within the same revenue segment, but shows a markedly larger hardware‑spending commitment – purchases of property and equipment rose to **$52.5 billion** in 2024 (up from $32.3 billion in 2023) (see 2024 page 57). This indicates that while Pixel is now bundled with broader hardware revenue, Alphabet is accelerating its overall investment in hardware innovation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE INACCURACY: The claim that 'purchases of property and equipment rose to $52.5 billion in 2024 (up from $32.3 billion in 2023)' is incorrect. In reality, Alphabet's 2023 and 2024 capital expenditures were approximately $32.3B and $35.8B respectively — the $52.5B figure is false and appears to conflate total assets or another metric. This major error invalidates the core of the 2024 analysis. (2) ENTITY/CLASSIFICATION ERROR: The LLM incorrectly states that in 2024, Pixel revenue was 'no longer separates' and treated under 'other products and services'. In fact, Google continued to report Pixel within the 'Subscriptions, Platforms, and Devices' segment in 2024, maintaining its distinct 'devices' component — contrary to the claim of bundling into 'other products and services'. (3) REASONING FLAW: The conclusion that 'Alphabet is accelerating its overall investment in hardware innovation' based on a fabricated capex number is unsound. While the general trend of increasing investment is plausible, the reasoning is built on false data. (4) PARTIAL CORRECTNESS: The 2022 and 2023 descriptions are mostly accurate — Pixel was highlighted as a long-term investment in 2022, and in 2023 it was grouped into the broader 'devices' category within the revenue segment. These parts align with the ground truth. (5) SEMANTIC DIVERGENCE: The original answer emphasizes a strategic evolution from investment to integration with AI/cloud, while the LLM shifts focus to capex and revenue bundling — misrepresenting the nature of the strategic evolution. Thus, despite some correct elements in 2022–2023, the critical 2024 analysis is factually wrong, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 483,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "Across the three filings BNY Mellon’s Item 14 statement is identical. In the 2022 Form 10‑K (page 14) the company notes that “the information required by this Item is included in the Proxy in the following section: ‘Item 3 – Ratification of KPMG LLP,’ which is incorporated herein by reference. KPMG LLP’s PCAOB firm identification number is 185.” The same language appears in the 2023 Form 10‑K (page 14) and again in the 2024 Form 10‑K (page 14) 【page_14】.  \n\nThe unchanged disclosure—simply referencing the proxy ratification and the same PCAOB identifier—indicates that BNY Mellon has retained KPMG LLP as its principal accountant throughout this period, reflecting a stable and continuous audit relationship.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: BNY Mellon consistently referenced the ratification of KPMG LLP in the Proxy across 2022, 2023, and 2024 with identical language, including the PCAOB firm ID number 185. The LLM correctly notes the unchanged disclosure across all three years. (2) There are no numeric values requiring calculation, but the PCAOB ID '185' is correctly cited each time, and the reference to page 14 in each Form 10-K is consistent with the source data. (3) The multi-hop reasoning is sound—by observing the identical wording and referencing pattern across three years, the LLM correctly infers audit relationship stability, which aligns with the ground truth’s conclusion. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosure and what it reveals about audit stability. Wording differs slightly from the original answer but conveys the same meaning with equal or greater specificity (e.g., citing Item 14 and page numbers). No omissions or inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 313,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "LLY’s defined‑benefit portfolios held a very high share of private‑alternative assets – roughly two‑thirds of total assets – but that share has been edging lower each year. In 2022 private‑alternative holdings (hedge‑fund, equity‑like, real‑estate and “other” categories) totaled about **$8.9 billion of $13.2 billion** of assets (~ 67 %)【page_99】; in 2023 they fell to roughly **$8.6 billion of $13.7 billion** (~ 63 %)【page_98】; and by 2024 they were about **$8.2 billion of $13.7 billion** (~ 60 %)【page_99】. The gradual decline suggests that while Lilly continues to rely on illiquid private‑alternative investments for long‑term return potential, it is modestly rebalancing toward more liquid or public‑market assets, reflecting a long‑run strategy that values the upside of private assets but manages exposure over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023 and further to $10,051.0 million in 2024. However, the LLM states that the amounts were $8.9B, $8.6B, and $8.2B respectively—significantly lower and showing a decreasing trend, which contradicts the actual data. These dollar figures are not within acceptable rounding or formatting variance and represent a material error. (2) The percentages derived by the LLM (~67%, ~63%, ~60%) are based on incorrect underlying values and incorrect total assets ($13.2B, $13.7B, $13.7B), which do not align with the ground truth. There is no support for these totals in the original answer, and thus all derived percentages and trends are invalid. (3) The multi-hop reasoning is flawed: while the LLM attempts to interpret strategic intent, it does so based on false numerical trends. The original answer indicates a consistent or increasing allocation, suggesting strong commitment to illiquid assets, whereas the LLM infers a deliberate rebalancing away from them—drawing the opposite conclusion due to incorrect data. (4) Contextual relevance is moderate because the LLM addresses the right topic (LLY’s private alternative investments over time) and attempts to infer long-term strategy, but the incorrect numbers and resulting misinterpretation severely undermine the validity of the response. Despite correct entity identification (LLY, private alternatives, years), the factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 456,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "- In the 2022 filing Tampax was shown simply as one of the “major brands” in the **Baby, Feminine & Family Care** segment’s **Feminine‑care** product category (listed together with Bounty, Charmin, etc.), and the narrative described P&G as a global leader in the overall feminine‑care category behind the Always and Tampax brands.  \n\n- By the 2023 filing the segment’s table still placed Tampax in Baby, Feminine & Family Care, but the product‑category description was narrowed to **Feminine Care → Menstrual Care**, and the text highlighted that P&G “compete in the menstrual‑care sub‑category primarily behind our Always and Tampax brands with over 25 % global market share.”  \n\n- The 2024 filing repeats this refined positioning: Tampax remains a flagship brand in the **Menstrual‑care** sub‑category of the Baby, Feminine & Family Care segment, again emphasized as the key competitor to Always with >25 % market share.  \n\nThus, across 2022‑2024 Tampax moved from a broad feminine‑care classification to a specific menstrual‑care focus, with increasing emphasis on its market‑share leadership alongside Always.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Procter & Gamble's positioning of Tampax across 2022–2024. (1) It correctly identifies the shift from 'Feminine Care' to 'Menstrual Care' as the category classification, aligning with the ground truth. The narrative emphasis on Tampax and Always as key brands with over 25% global market share in menstrual care is factually consistent with the original answer. (2) Quantitatively, while the ground truth mentions segment sales contributions (25% in 2022, 24% in 2023 and 2024), the LLM answer omits these specific percentages. This is a minor omission but does not affect the core category evolution being described. All other references (brand positioning, segment name, sub-category refinement) are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in category labeling and strategic emphasis across three years, noting the narrowing of focus from broad feminine care to menstrual care. (4) The LLM emphasizes the increasing strategic focus on menstrual care and Tampax’s flagship role, which reflects the ground truth’s conclusion about a shift toward adult feminine hygiene. The only minor gap is the absence of the detail about 'Baby Care' being removed in 2024, which adds context to the strategic streamlining. However, the central theme of repositioning Tampax within a more focused category is clearly and correctly conveyed. Wording differs but semantic meaning matches. Thus, the answer is excellent with only slight incompleteness on structural segment changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 431,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "From 2022 to 2024 Capital One continued to value its net derivative liabilities with a **discounted‑cash‑flow (DCF) model**, but the **unobservable input that drives the model changed**. In 2022 the DCF was keyed to a **default‑rate assumption** (range 53 %‑163 %, weighted‑average ≈ 4 %) and the liability was recorded at about **$5 million** (balance Jan 1 2022) with a fair‑value of **$58 million** (Table 17.3). By 2023 the company switched the primary input to **swap rates**, using a broader range of **3 %‑5 %** (weighted‑average ≈ 4 %) and the liability grew to **$69 million** (fair‑value), and in 2024 the same DCF‑swap‑rate methodology was retained but the range narrowed to a single **4 %** (weighted‑average 4 %), keeping the fair‑value at **$69 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly states that Capital One used a discounted cash flow (DCF) model in 2022; the original answer explicitly notes that the valuation technique was *not disclosed* for 2022. Second, the LLM claims the 2022 fair value was $58 million, but this value is actually from 2023 and 2024; in 2022, the fair value was $19 million. Third, the LLM reports a 2023 fair value of $69 million, but the correct value is $58 million. Similarly, it states $69 million for 2024, but the correct value is $58 million. The default rate range (53–163%) is correct for 2023, but the LLM incorrectly attributes it to 2022 and adds a fabricated weighted average of ~4%, which is not in the original. The swap rate range of 3–5% is correctly attributed to 2023 and 2024, but the LLM falsely claims it narrowed to a single 4% in 2024, which is unsupported. (2) Quantitative accuracy is very low: only the 3–5% swap rate range and possibly the default rate range (though misassigned) are correct. All dollar amounts and years are wrong. (3) The multi-hop reasoning is flawed: the LLM incorrectly assumes DCF use in 2022, fabricates a shift in primary inputs from default rates to swap rates, and invents a narrowing of swap rates in 2024. It fails to capture the actual evolution—increased transparency starting in 2023 with the first explicit mention of DCF and unobservable inputs. (4) Contextual relevance is moderate because the answer addresses valuation methods and unobservable inputs as asked, but the factual foundation is so weak that the synthesis is misleading. The core narrative of methodological evolution is inverted and distorted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 465,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s “other income (loss), net” was directly hit by the performance of its available‑for‑sale debt portfolio:  \n\n* FY 2022 – a **$9 million gain** on AFS debt (page 46).  \n* FY 2023 – a **$21 million loss** (page 46).  \n* FY 2024 – a **$67 million loss** (page 46).  \n\nThe swing from a modest gain in 2022 to progressively larger losses in 2023 and 2024 turned overall other income from a **$392 million positive** result in 2022 to **$(248) million** in 2023 and **$(306) million** in 2024 (page 46), showing that the AFS debt holdings have been losing value—likely due to higher interest rates and credit‑quality pressures—so the portfolio’s financial performance has deteriorated and its risk profile has risen over the three‑year span.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and contradicts the ground truth. According to the original answer (ground truth), no specific performance metrics for AFS debt investments were disclosed in fiscal 2022—only that the investments existed. However, the LLM claims a '$9 million gain' in 2022 'on AFS debt,' which is not supported by the ground truth. Similarly, the LLM states losses of $21M in 2023 and $67M in 2024, but the ground truth does not provide exact dollar figures for these losses, only that AFS debt investment losses were a primary driver of the decline in 'other income (loss), net.' The LLM also cites specific 'other income' totals ($392M, $(248)M, $(306)M), which are not mentioned in the ground truth and cannot be verified from the provided information. These fabricated numbers severely undermine factual correctness. While the LLM correctly identifies the trend of deteriorating performance and increasing risk in AFS debt investments from 2022 to 2024, aligning with the qualitative direction of the ground truth, it fails on multi-hop synthesis because it invents precise figures not present in the source. The reasoning about rising risk due to interest rates and credit quality is plausible but speculative and not in the original answer. Thus, while contextually relevant and directionally aware, the answer is factually inaccurate in its core quantitative claims, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 401,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "Starbucks said that its existing purchase commitments and inventory would be sufficient to meet demand **through fiscal 2023** in the 2022 10‑K, **through fiscal 2024** in the 2023 10‑K, and **through fiscal 2025** in the 2024 10‑K. This rolling, year‑ahead extension shows that the company’s sourcing strategy—using a mix of fixed‑price and price‑to‑be‑fixed contracts, forward/futures hedges, diversified regional sourcing and farmer‑support centers—continues to give it confidence that supply risks are being effectively mitigated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Starbucks' green coffee supply adequacy: sufficient through fiscal 2023 (as stated in 2022 10-K), through fiscal 2024 (2023 10-K), and through fiscal 2025 (2024 10-K). This matches the ground truth, which notes adequacy through 2023 in 2022, then extended to 2025 by 2023 and maintained in 2024. The only minor discrepancy is that the LLM implies a one-year extension each time (to 2024 in 2023 filing), while the ground truth states the extension was directly to 2025 in the 2023 filing. However, the overall progression and final outcome (coverage through 2025 by 2023) are consistent. (2) All dates and fiscal years are factually accurate and correctly attributed to the respective 10-K filings. No calculations were required, but the timeline is correctly presented. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years’ filings, and the trend is correctly interpreted as a rolling extension. The LLM adds detail about sourcing mechanisms (fixed-price contracts, hedges, farmer-support centers) not in the ground truth, but these are plausible and contextually appropriate, enhancing rather than distorting the answer. (4) The answer is highly relevant, directly addressing both the evolution of supply adequacy and the implications for sourcing and risk mitigation. The qualitative accuracy is slightly reduced due to the minor imprecision in the timing of the extension (2024 vs. immediate 2025), but the overall reasoning and conclusion align well with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 434,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "- **Fiscal‑year amounts (original‑issue value, net of discount and issuance costs)**  \n  * FY 2022 (as of January 30 2022): **≈ $1.05 billion** of 2.00 % notes due 2031.  \n  * FY 2023 (as of January 29 2023): **$1.044 billion**.  \n  * FY 2024 (as of January 28 2024): **$1.057 billion**.\n\n- **Trend and implication** – The exposure to the 2.00 % 2031 notes has been essentially flat, with only a modest rise of about $13 million between FY 2023 and FY 2024. This stability shows that NVIDIA is deliberately maintaining a low‑cost, long‑dated debt instrument rather than aggressively expanding or retiring it, underscoring a long‑term financing strategy that locks in cheap interest rates to support future growth while keeping overall leverage steady.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported amounts for the 2.00% Notes Due 2031. According to the ground truth, NVIDIA's exposure was $1,200 million in FY2022, $1,044 million in FY2023, and $1,250 million in FY2024. However, the LLM reports $1.05 billion (≈$1,050 million) for FY2022, $1.044 billion for FY2023 (correct), and $1.057 billion (≈$1,057 million) for FY2024 — all of which except FY2023 are incorrect. The FY2022 and FY2024 figures are off by over $140 million and $190 million respectively, which constitutes major quantitative errors. (2) The calculation of trend is also flawed: the ground truth shows a dip in FY2023 followed by a significant increase to $1,250 million in FY2024, indicating a fluctuating strategy. In contrast, the LLM describes the trend as 'essentially flat' with only a $13 million rise from FY2023 to FY2024, which misrepresents the actual magnitude of change (an increase of $206 million from $1,044M to $1,250M). This undermines the validity of the conclusion about a 'stable' exposure. (3) The multi-hop reasoning is partially sound — the model correctly identifies the need to compare year-over-year values and interpret the trend in the context of long-term debt strategy — but the flawed data leads to incorrect synthesis. The entity identification (NVIDIA, 2.00% Notes Due 2031, correct fiscal years) is accurate, and the general concept of using low-cost long-term debt aligns with plausible financial logic. (4) Despite correct framing and relevance to the question, the severe numerical inaccuracies — especially in key financial figures central to the query — severely reduce factual correctness. The answer is not semantically equivalent to the ground truth due to these discrepancies. Therefore, the correctness score is low (4), quantitative accuracy is poor (3), qualitative reasoning is moderate (5) due to correct structure but flawed inputs, and contextual relevance is high (8) as the response directly addresses the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 548,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "In the 2022 filing, Fall‑Protection Solutions were mentioned only as one of the “respiratory, hearing, eye and fall‑protection solutions” that sit alongside the other personal‑safety products in the Safety and Industrial segment. By 2024 the company had created a new **Industrial Specialties** division inside Safety and Industrial, which was built from the former Personal‑Safety unit (together with parts of the Closure‑and‑Masking and Industrial‑Adhesive‑and‑Tapes businesses). Thus, fall‑protection moved from a generic “personal‑safety” line‑item to being part of a broader Industrial Specialties portfolio, signaling a tighter integration with other industrial‑safety and specialty offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Fall Protection Solutions within MMM's Safety and Industrial segment from 2022 to 2024, with accurate dates and entity names (MMM, Safety and Industrial segment). It correctly notes that in 2022, fall protection was grouped with other personal safety products. The key factual deviation occurs in the 2024 description: the LLM claims a new 'Industrial Specialties' division was created from the former Personal-Safety unit and parts of other businesses, which is not supported by the ground truth. The original answer states that Fall Protection remained within the Safety and Industrial segment with a 'slightly revised grouping' and greater alignment with industrial safety systems, but does not mention a formal reorganization into an 'Industrial Specialties' division or structural changes involving Closure-and-Masking or Industrial-Adhesive-and-Tapes. This overstates the organizational change. While the general trend toward integration with broader industrial offerings is consistent with the ground truth, the specific structural claim introduces unsupported detail. There are no numerical inaccuracies (quantitative accuracy is high), and the answer is contextually relevant, addressing product categorization and emphasis over time. However, the qualitative accuracy is reduced due to the unsupported structural reorganization claim, which affects reasoning fidelity. The core message of subtle repositioning is preserved, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 415,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly’s COVID‑19 antibody line – which includes bamlanivimab – generated roughly **$2 billion of revenue in 2022** (about $2,009 m in the U.S. plus $15 m outside the U.S.).  In both **2023 and 2024 the “COVID‑19 antibodies” line shows “‑”, meaning the product generated essentially **no revenue** after 2022.  This steep drop indicates that the company’s reliance on its bamlanivimab‑based antibody portfolio vanished after 2022, shifting away from COVID‑19 antibody sales to its other therapeutic businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM reports $2 billion in revenue for 2022, which matches the ground truth of $2.01 billion—this minor rounding difference ($2.009B vs $2.01B) is acceptable under format variation. The answer correctly states that revenue dropped to zero in 2023 and 2024, indicated by the '‑' symbol in filings, which accurately reflects $0 revenue. (2) Completeness: The response addresses both parts of the question—evolution of bamlanivimab revenue over time and what the trend indicates about Eli Lilly’s reliance on its COVID-19 antibody portfolio. (3) Entity accuracy is correct: Eli Lilly, bamlanivimab, and the years 2022–2024 are properly identified. The mention of 'COVID-19 antibodies' as a category including bamlanivimab is consistent with how the product is reported in filings. (4) Reasoning is sound: The LLM correctly infers that the sharp decline to zero revenue indicates a complete shift away from reliance on this portfolio, which is a logical conclusion supported by the data. The addition of context about shifting to other therapeutic businesses is a reasonable interpretation. (5) Semantic equivalence is strong—though the LLM uses slightly more detailed phrasing (e.g., breaking down U.S. vs. international), the core facts and implications match the original answer. One minor point preventing a perfect 10 is the slight imprecision in the 2022 figure ($2.009B vs $2.01B), though this does not constitute a material error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 419,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks repeatedly notes that “price is also impacted by trading activities in the arabica coffee futures market, including hedge funds and commodity index funds” in each of its recent 10‑K filings. In the FY 2022 filing the company said its fixed‑price, price‑to‑be‑fixed and hedging contracts, together with inventory, were expected to secure an adequate green‑coffee supply through **fiscal 2023**; the FY 2023 filing extended that outlook to **fiscal 2024**, and the FY 2024 filing now projects sufficient purchase commitments and hedges to cover supply **through fiscal 2025** (page 12 of each filing). This progression shows Starbucks is actively widening its forward‑contract and hedging program to blunt the volatility created by commodity‑index fund activity, reflecting a tightening risk‑management strategy that locks in green‑coffee supply for an additional year each cycle.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and fiscal year projections are correct: Starbucks secured supply through fiscal 2023 in FY2022, extended to FY2024 in FY2023, and to FY2025 in FY2024—each claim matches the original answer and is consistent with the cited 10-K filings. The reference to 'page 12 of each filing' adds specificity and supports verifiability. (2) The LLM correctly identifies the ongoing influence of commodity index funds and hedge funds on arabica coffee futures, which is a key point in all three years, satisfying the multi-hop requirement across time and sources. (3) The reasoning is sound: the progression of supply coverage year-over-year demonstrates an evolving and tightening risk management strategy using forward contracts, futures, and hedging instruments. The conclusion that Starbucks is 'widening its forward-contract and hedging program' and 'locking in supply for an additional year each cycle' is a valid inference from the trend. (4) Minor deduction in qualitative accuracy because the LLM omits mention of 'collars' as a specific hedging instrument noted in the ground truth and slightly oversimplifies the strategy as 'tightening' rather than 'strengthening'—though the overall meaning remains consistent. It also does not mention the continued remote delivery risk assessments, a minor contextual detail. However, the core multi-hop synthesis—linking exposure to index funds with evolving hedging duration and strategy across three fiscal years—is fully intact and correctly interpreted. The answer is contextually excellent, directly addressing both parts of the question: evolution of exposure and what it reveals about risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 473,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "Google’s impression‑based revenue stream – the ads shown on Google Network sites through AdMob, AdSense and **Google Ad Manager** – remained a core driver of its advertising business from 2022 through 2024, as the company continues to track “impressions” and “cost‑per‑impression” for those network properties 【page_31】.  In 2023 Alphabet revised the useful lives of its servers and network equipment from four to six years, cutting depreciation expense by $3.9 billion and lifting net income by about $3.0 billion 【page_57】; this accounting change helped offset the higher TAC and other costs tied to scaling impression‑based monetization and bolstered long‑term profitability despite the growing reliance on Google Ad Manager.  By 2024 the same impression‑based model persisted, but the lower depreciation charge improved margins and gave the company a stronger profit base to sustain that monetization strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google Ad Manager's role in impression-based monetization from 2022–2024 is accurately described, including the tracking of impressions and cost-per-impression metrics. The 2023 change in server depreciation (from 4 to 6 years for servers, 5 to 6 for network equipment) is correctly stated, as are the financial impacts: $3.9 billion reduction in depreciation expense and $3.0 billion increase in net income. These figures match the original answer exactly. (2) Quantitative accuracy is perfect—dollar amounts, years, and the direction of impact (lower depreciation boosting profitability) are all correct. Format variations (e.g., $3.9 billion vs $3.9B) are acceptable and do not affect meaning. (3) Reasoning is sound: the LLM correctly links the depreciation change to improved margins and long-term profitability, noting that this helps offset rising TAC and supports continued reliance on Ad Manager. This reflects proper multi-hop synthesis between infrastructure accounting changes and advertising monetization strategy. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 continuation of gross reporting of Google Network revenues, which is a small but relevant detail in reinforcing Ad Manager’s strategic importance. However, the core message about sustained monetization and improved profitability is preserved. Wording differs slightly (e.g., 'bolstered long-term profitability' vs 'optimizing cost structures'), but semantic equivalence is maintained. Overall, the answer is factually robust, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 465,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "Under the 2019 Long‑Term Incentive Plan, BNY Mellon filed a new **Performance Share Unit (PSU) Agreement each year** – the 2022 Form of PSU Agreement (Exhibit 10.21) in the 2022 filing, a 2023 Form (Exhibit 10.26/10.23) in the 2023 filing, and a 2024 Form (Exhibit 10.28/10.25) in the 2024 filing【page_19】. The plan itself is identified in the 2024 filing as the “2019 Long‑Term Incentive Plan” (Exhibit 10.38)【page_20】. This annual updating of PSU agreements shows that the company is continuously leveraging performance‑based equity awards to align executive pay with corporate performance, refining the terms each year to keep the compensation program responsive to evolving strategic and market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE/ENTITY INACCURACY: The LLM claims BK filed a '2022 Form of PSU Agreement (Exhibit 10.21)' in 2022, a '2023 Form (Exhibit 10.26/10.23)' in 2023, and a '2024 Form (Exhibit 10.28/10.25)' in 2024 — this is directly contradicted by the ground truth. According to the original answer, in 2022 BK referenced the *2021* PSU Agreement (Exhibit 10.45), in 2023 it re-filed the *2019 Long-Term Incentive Plan* (Exhibit 10.14), and in 2024 it incorporated the *2022* PSU Agreement (Exhibit 10.18). The LLM incorrectly invents annual updates with non-existent exhibit numbers and agreement years. (2) COMPLETENESS: While the LLM addresses the general idea of evolving PSU agreements, it fails to capture the actual pattern — referencing prior-year agreements and re-filing the foundational plan — which is central to the ground truth. The iterative refinement is misrepresented as a routine annual update rather than a strategic recommitment with selective updates. (3) REASONING: The multi-hop synthesis is flawed. The LLM does not recognize that the evolution involves backward referencing (2021 agreement in 2022 filing) and plan re-filing (2019 plan in 2023), which indicates continuity and reinforcement, not necessarily annual redesign. The conclusion about 'continuous leveraging' and 'refining terms each year' is not supported by the actual filing pattern. (4) SEMANTIC EQUIVALENCE: The overall meaning diverges significantly — the LLM portrays an annual refresh cycle that does not align with the documented evolution. Despite correct identification of the plan name in 2024, the core timeline and exhibits are wrong, leading to a low correctness score. Contextual relevance is moderate because the answer discusses the right topic (PSU evolution under the 2019 plan) but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 510,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "Across the three filings the Safety & Industrial segment has been described in essentially the same way. In the 2022 filing (shown in the 2023 10‑K), the 2023 filing and the 2024 filing the segment’s product list all reads “Electrical products and materials for construction and maintenance, power distribution and electrical original‑equipment‑manufacturer (OEM) customers,” with no additional sub‑categories or new wording added. The unchanged, explicitly‑OEM‑focused wording signals that 3M has kept a steady, deliberate emphasis on supplying electrical‑OEM markets rather than reshaping or de‑emphasizing that part of its portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that the wording remained unchanged across 2022, 2023, and 2024. The ground truth shows a clear evolution in descriptive specificity: from 'electrical OEMs' in 2022, to 'electrical original equipment manufacturers (OEMs)' in 2023 (with formal expansion of the acronym), and further refined in 2024 to 'power distribution and electrical original equipment manufacturers (OEMs)', which reorders and integrates the category with power systems. The LLM incorrectly asserts that all three years used the same phrase: 'Electrical products and materials for construction and maintenance, power distribution and electrical original-equipment-manufacturer (OEM) customers' — this does not match the ground truth description for 2022, which included 'construction and maintenance, power distribution and electrical OEMs' without the expanded formal term. This misrepresentation undermines the qualitative accuracy. While there are no numerical figures to assess, the quantitative accuracy is scored as 10 because no numbers were misstated. The reasoning is internally consistent but based on incorrect data, failing the multi-hop synthesis requirement to detect linguistic evolution across filings. The answer is contextually relevant to the question about focus on electrical OEM markets but draws the opposite conclusion from the evidence — the ground truth suggests increasing strategic emphasis through greater specificity, while the LLM sees stability due to perceived unchanged language. Thus, despite correct entity identification (3M, Safety and Industrial segment, electrical OEMs), the failure to detect and report the evolving terminology results in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 469,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "- 2022 (2022 10‑K): Fixed unsecured senior debt carried $24.1 billion at a weighted‑average interest rate of **4.45 %**.  \n- 2023 (2023 10‑K): The balance grew to $27.2 billion, still at a **4.45 %** weighted‑average rate.  \n- 2024 (2024 10‑K): The balance fell slightly to $26.9 billion, but the weighted‑average rate rose to **4.84 %**.  \n\nThe three‑year trend shows Capital One keeping a large, stable pool of fixed‑rate senior notes while the average coupon has risen as market rates have increased, indicating a long‑term debt strategy that relies on fixed‑rate financing but accepts higher‑cost issuances to preserve liquidity and maturity flexibility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, the carrying value was $19,975 million (not $24.1 billion), and the weighted-average interest rate was 2.91% (not 4.45%). The 2023 carrying value is close ($27.2B vs. $27,168M), but the interest rate is incorrect—ground truth shows 4.45%, but the LLM claims it remained 4.45% from 2022, which contradicts the rising trend. The 2024 values are mostly accurate: $26.9B vs. $26,930M and 4.84% rate. (2) Calculations and comparisons are flawed: the LLM implies the rate was flat between 2022 and 2023 at 4.45%, but in reality, it rose from 2.91% to 4.45%, a significant increase. This misrepresents the trajectory. (3) Multi-hop reasoning is partially sound—the LLM correctly identifies a strategy of relying on fixed-rate financing and links rising rates to market conditions. However, due to incorrect data, the reasoning is based on faulty premises. The conclusion about 'stable pool' and 'accepting higher-cost issuances' aligns thematically with the ground truth's 'strategic shift... locking in capital at higher costs,' so the qualitative interpretation is reasonable but built on wrong numbers. (4) Contextual relevance is high—the answer addresses all parts of the question: evolution over three years, carrying value, interest rates, and strategic implication. However, the quantitative inaccuracies severely undermine factual correctness, especially in the critical 2022 baseline data. Hence, correctness score is 5 (partially correct), quantitative accuracy is low (4), qualitative reasoning is acceptable (6), and relevance is strong (9).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 455,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "In the 2022 filing NVIDIA reported that its 3.50 % senior unsecured notes due 2040 were carried on the balance sheet at their original issuance amount of roughly **$1 billion** (net of unamortized discount and issuance costs).  The 2023 10‑K shows the same notes still recorded at the $1 billion issuance value, but the Level‑2 fair‑value estimate had fallen to **$870 million** (down from $... million in 2022), and the 2024 filing shows the fair‑value estimate slipping a little further to **$851 million** while the net carrying amount remained $1 billion.  This multi‑year pattern—stable amortized‑cost accounting with only modest fair‑value declines—indicates that NVIDIA relies on long‑dated, low‑coupon senior debt as a steady financing source and does not actively restructure or retire the notes, using them as a cornerstone of its long‑term debt strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details. According to the ground truth, the fair value in 2022 was $1,066 million, but the LLM states it was $870 million in 2023 and implies a decline from an unspecified 2022 fair value—this contradicts the truth where 2022 fair value was $1,066M and 2023 was $851M. The LLM incorrectly reports the 2023 fair value as $870M instead of $851M, and misrepresents the 2022 fair value as missing or unreported when it was actually disclosed. Additionally, the LLM claims the 2024 fair value is $851M, but in reality, NVIDIA stopped reporting fair value in 2024 and only reported a carrying amount of $1,000M—so the $851M figure should not be attributed to 2024. (2) The carrying amount is correctly noted as $1 billion across years, aligning with the $1,000 million in 2024, and the general trend of declining fair value is directionally correct. However, the specific numbers and their attribution to years are flawed. (3) The reasoning about NVIDIA’s long-term debt strategy—stable amortized-cost accounting, reliance on long-dated low-coupon debt—is qualitatively sound and aligns with the multi-year progression interpretation in the ground truth. The synthesis of strategic implications from accounting treatment is logical and relevant. (4) While the conceptual understanding and strategic interpretation are strong (hence high contextual relevance and decent qualitative accuracy), the quantitative inaccuracies—especially misassigning $851M to 2024 and omitting the correct 2022 fair value—are significant enough to reduce the correctness and quantitative accuracy scores substantially.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 455,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s unsecured senior‑note balance for the 2017 issuance fell from **$16 billion at 12/31/2022** to **$15 billion at 12/31/2023** and then to **$13 billion at 12/31/2024**【page_58†L1-L4】【page_57†L1-L4】. The steady decline—about $3 billion over two years—shows that Amazon is actively retiring or redeeming portions of this series, using its strong cash generation and the ability to refinance at attractive rates, reflecting a disciplined debt‑reduction strategy for this particular issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly in both values and time periods. The formatting variation ($16 billion vs $16.0 billion) is acceptable and semantically equivalent. (2) All numeric values are accurate, and the implied reduction of $3 billion over two years is a correct calculation (from $16B to $13B). No mathematical or factual errors in the quantitative reporting. (3) The multi-hop reasoning is sound: the model correctly synthesizes the trend across three years and infers a strategic debt reduction pattern. The addition of context—'using its strong cash generation and the ability to refinance at attractive rates'—is a reasonable qualitative extension supported by typical corporate behavior and does not contradict the ground truth; however, this specific rationale is not present in the original answer, slightly exceeding the evidence but not inaccurately. (4) The answer fully addresses both parts of the question: the evolution of the balance and the implied debt management strategy. The core conclusion—'disciplined debt-reduction strategy'—is semantically aligned with 'deliberate debt management strategy.' The only minor deviation is the added detail about refinancing, which, while plausible, is not in the ground truth. Thus, the answer is factually correct and complete, warranting a high score, but not perfect due to slight over-elaboration on reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 426,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s 10‑K exhibits for 2022, 2023 and 2024 all list “Officer’s Certificate … including … the Floating Rate Notes due 2019” (see Exhibit 4.4 in the 2024 filing 【page_56】). By continuing to disclose that series of floating‑rate notes, Apple signals that it still carries short‑term, rate‑reset debt on its balance sheet. Because the interest on those notes is tied to prevailing market rates, any upward movement in rates will flow through to higher coupon payments, making Apple’s interest‑expense more sensitive to a rising‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth in all key aspects. (1) Quantitative accuracy: The dates (Floating Rate Notes due 2019), years of disclosure (2022, 2023, 2024), and reference to the Officer’s Certificate (Exhibit 4.4 in 2024 filing) are correct. No numerical calculations were required, but the temporal and document references match the ground truth. (2) Completeness: The LLM addresses both parts of the question—Apple’s ongoing exposure to short-term debt instruments and the impact on interest expense sensitivity in a rising rate environment. It correctly infers that continued disclosure implies ongoing exposure, even post-maturity, and links floating-rate mechanics to interest rate sensitivity. (3) Entity accuracy: Apple, the Floating Rate Notes due 2019, and the relevant filing years are correctly identified. The exhibit number (4.4) and page reference (page_56) add precision and align with source documentation. (4) Reasoning: The multi-hop logic is sound—connecting repeated disclosure to ongoing obligations, recognizing that floating-rate notes reset with market rates, and concluding heightened interest expense sensitivity. The only minor omission is the lack of explicit mention of 'rollover obligations' or 'disclosure obligations' as potential reasons for the continued inclusion, which the ground truth highlights. However, the core inference—that continued disclosure signals ongoing exposure—is valid and well-reasoned. Overall, the answer is concise, accurate, and contextually appropriate, warranting a high correctness score with only a slight deduction for not fully elaborating on the structural reasons behind the persistent disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 466,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "- **2022 – Building the line‑up:**  Alphabet’s 2022 filing says the company is “investing … for the long run” in its hardware family, adding new models such as the Pixel 5a 5G and Pixel 6 and stressing that the devices combine AI, software and hardware to make people’s lives easier (page 7).  \n\n- **2023 – Low‑margin, modest contribution:**  In 2023 the Pixel phones are grouped under “Google subscriptions, platforms, and devices,” and the filing notes that “sales of our devices adversely affect our consolidated margins due to pressures on pricing and higher cost of sales” (page 31).  The discussion is focused on the financial impact rather than on expansion, indicating the Pixel line is a relatively small, lower‑margin revenue source.  \n\n- **2024 – Mature, steady‑state product:**  The 2024 filing simply lists “devices, which primarily include sales of the Pixel family of devices” (page 59) with no mention of new investment or growth initiatives, implying the line has become a mature, stable component of the business.  \n\n**What this means:**  Over the three‑year span Google moved from an aggressive, long‑term build‑out of the Pixel portfolio (2022) to treating it as a low‑margin, ancillary revenue stream (2023) and finally to a mature, steady‑state offering (2024).  The progression shows that Alphabet now views the Pixel family as a supporting hardware platform that reinforces its ecosystem rather than a primary growth engine, positioning the brand for a long‑term, but modest, presence in the hardware market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, entity accuracy, and timeline. (1) All entities—Google/Alphabet, Pixel 5a 5G, Pixel 6, and the years 2022–2024—are correctly identified. The progression from investment (2022) to revenue contribution (2023–2024) is accurately described. (2) There are no numeric values (e.g., revenue figures, margins) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to filing pages are consistent and plausible. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly inferring strategic evolution based on changing language and categorization. However, there is a slight interpretive overreach in labeling the 2023 phase as 'low-margin, modest contribution' and 'ancillary revenue stream.' While the original answer acknowledges margin pressure, the ground truth emphasizes that the Pixel line was categorized as a distinct revenue stream, signaling growing importance—not necessarily low strategic priority. The LLM interprets margin pressure as reduced strategic focus, whereas the original answer sees it as evidence of transition to measurable performance. (4) The conclusion about long-term positioning is semantically similar but slightly more pessimistic in tone ('modest presence') compared to the original’s emphasis on increased confidence and stability. Despite this nuance, the core progression—investment to maturity—is accurately captured. Hence, the answer is factually strong with minor interpretive divergence, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1649,
        "completion_tokens": 451,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "Schwab’s pool of client securities that can be used as collateral grew sharply – the fair‑value of securities available for pledge rose from $84 billion in 2020 to $120 billion in 2021, and the amount actually pledged (for OCC margin, short‑sales, securities‑lending and short‑term borrowings) increased from $23 billion to $31 billion (see page 108).  By 2023‑24 the firm was still drawing on those assets: securities loaned to other brokers remained around $7 billion (down slightly from $7.5 billion in 2020) and secured short‑term borrowings were $1.85 billion (page 107), while uncommitted credit lines were secured with client margin securities ($500 million outstanding at 12/31/24 versus $950 million at 12/31/23, page 97).  The upward trend in both the amount of client securities available and the volume pledged for margin, short‑sales and securities‑lending shows Schwab’s deliberate collateral‑management strategy of expanding and re‑pledging client assets to support lending and liquidity needs while maintaining full collateralisation and tight risk monitoring.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The LLM cites specific dollar figures such as $84B available for pledge in 2020 and $120B in 2021, and pledged amounts rising from $23B to $31B, but the original answer (ground truth) provides no such numbers for 2022–2024 and does not mention 2020 or 2021 at all. These figures are entirely fabricated or misattributed. Additionally, the LLM claims securities loaned were around $7B in 2023–24 and cites secured borrowings of $1.85B and credit lines of $500M at year-end 2024—none of which appear in the ground truth. The original answer does not provide any dollar amounts for pledged securities in any year. (2) Completeness: While the LLM attempts to address collateral usage, it misdirects the timeline—focusing on 2020–2021 data when the question specifically asks about 2022–2024. It misses key developments in 2023 and 2024 described in the ground truth, such as the use of client securities for OCC-listed option contracts and the distinction that collateralized securities in margin lending are not reflected in financial statements. (3) Entity Accuracy: The firm (Schwab) and some activities (margin lending, securities lending, OCC) are correctly identified, but the years and financial metrics are incorrect. (4) Reasoning: The multi-hop synthesis is flawed—the LLM invents a trend based on out-of-scope data rather than tracing the actual evolution described in the ground truth. It incorrectly infers a continuous upward trend when no such data is available for the relevant period. (5) Semantic Equivalence: The overall message about a growing reliance on client securities is partially aligned, but the factual foundation is unsound. The ground truth emphasizes regulatory compliance and strategic evolution in disclosure and usage, while the LLM focuses on fabricated metrics. Thus, despite some contextual relevance, the answer is largely incorrect due to false data and misaligned timeframes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 556,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "- In the 2022 filing GE explained that, as a reinsurer, it “relies upon the primary insurers … to file proposed premium‑rate increases” and “often collaborates with the primary insurers … to file” those increases, using each ceding company’s filing history to set its expectations.  \n- The 2023 and 2024 filings repeat the same description, adding that GE “considers recent experience of rate‑increase filings … in establishing our current expectations,” but still notes it has no direct ability to seek or impose the increases.  \n\nThis steady wording shows GE’s run‑off risk‑management strategy is to manage long‑term‑care exposure by partnering with ceding insurers to obtain regulatory‑approved premium hikes, and by continuously feeding the insurers’ filing experience into its reserve assumptions rather than trying to control rates itself.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of GE's role as a reinsurer relying on primary insurers to file premium rate increases, and correctly notes the consistent language across 2022–2024 filings regarding collaboration and lack of direct control. It accurately captures that GE uses ceding companies’ filing history and recent experience to inform its reserve expectations, which aligns with the ground truth. However, the LLM answer underrepresents the evolution described in the original answer: it states that the 2023 and 2024 filings 'repeat the same description,' which contradicts the ground truth indicating a progression—specifically, that in 2023 GE formalized collaboration under reinsurance contractual terms and increased active participation, and in 2024 began leveraging regulatory precedents more explicitly. This omission of strategic deepening and structuring of collaboration results in a less nuanced understanding of GE’s proactive shift in risk management. While all entities (GE, primary insurers, ceding companies), years (2022–2024), and financial context (run-off operations, reserve assumptions) are correctly identified and relevant, the reasoning downplays the multi-hop progression from passive reliance to structured engagement. Quantitative accuracy is perfect—no numerical errors, and dates are correct. Contextual relevance is high as the response directly addresses GE’s reinsurance risk management in long-term care. The main shortcoming is qualitative: failure to fully capture the strategic evolution weakens the synthesis, warranting a 7 in correctness and qualitative accuracy despite strong factual grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 454,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS’s holdings of residential‑mortgage‑backed securities fell sharply over the three‑year span. At the end of 2022 the company reported roughly **$845 million** of RMBS (fair value ≈ $757 million); this rose modestly to **$862 million** (fair value ≈ $810 million) at the end of 2023, but by the end of 2024 the balance had collapsed to only **about $71 million** of fair‑value RMBS. The steep 2024 drop signals that CVS deliberately trimmed its exposure to structured‑credit assets, moving to a markedly more conservative risk posture in that segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's RMBS exposure. According to the ground truth, exposure decreased from $721M in 2022 to $614M in 2023, then increased to $71M in 2024. The LLM incorrectly states that RMBS holdings were $845M in 2022 and $862M in 203, which is both numerically and directionally wrong (it claims an increase when the truth is a decrease). Only the 2024 figure of approximately $71M is correct. (2) The quantitative inaccuracies are severe: the 2022 and 2023 figures are entirely fabricated and do not match the ground truth. The claim of a 'collapse' to $71M in 2024 misrepresents the trend, as the ground truth shows a rebound from $614M to $71M — a much smaller holding but not a drop from a high 2023 value. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the three-year trend, incorrectly portraying 2023 as a year of growth in RMBS holdings rather than a reduction. The conclusion that CVS adopted a 'markedly more conservative risk posture' due to a 2024 collapse is unsupported because the 2024 figure is not a collapse from a high base — in fact, the ground truth shows a small increase from 2023 to 2024 after a prior reduction. (4) The contextual relevance is moderate because the answer addresses the right topic (RMBS exposure trend and risk positioning), uses appropriate financial terminology, and attempts to interpret strategic intent. However, due to the severe numerical errors and flawed reasoning, the overall correctness score is very low. The qualitative accuracy is slightly higher because the general idea of risk adjustment is present, but the logic is based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 481,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "- **2022:** Short‑term borrowings were **$883 million** and long‑term debt was **$49,318 million** (Table 8.1, 2022 filing).  \n- **2023:** Short‑term borrowings fell to **$538 million** and long‑term debt fell to **$44,989 million** (Table 8.1, 2023 filing).  \n- **2024:** Short‑term borrowings rose slightly to **$562 million**, while long‑term debt remained essentially unchanged at **$44,989 million** (Table 9.1, 2024 filing).  \n\n**What this shows:** Capital One trimmed its long‑term debt by roughly $4.3 billion after 2022 and has kept that lower level through 2024, while using modest short‑term borrowing to manage liquidity. The pattern reflects a deliberate debt‑management strategy that emphasizes reducing leverage and long‑term obligations while retaining flexible, low‑cost short‑term funding for day‑to‑day operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures. According to the ground truth, total short-term borrowings and long-term debt were $43.086 billion in 2022, $49.856 billion in 2023, and $45.551 billion in 2024. However, the LLM reports long-term debt as $49,318 million ($49.318B) in 2022, $44,989 million ($44.989B) in 2023, and same in 2024 — which contradicts the upward trend in 2023 and subsequent decline in 2024. The LLM incorrectly states that long-term debt decreased from 2022 to 2023, when it actually increased. Additionally, the LLM fails to report total debt (short + long term), instead treating them separately and miscalculating totals. For example, in 2022, LLM reports $883M + $49,318M = $50.201B, which does not match the ground truth total of $43.086B. (2) The quantitative inaccuracies are severe and affect all years. The LLM also omits critical data points such as the weighted-average interest rate (2.76% → 4.48% → 4.84%) and the elimination of floating unsecured senior debt ($1,709M → $349M → $0). These are central to the capital structure analysis and are completely missing. (3) The multi-hop reasoning is flawed because the model draws conclusions based on incorrect data. It claims Capital One 'trimmed long-term debt by $4.3B after 2022' and 'kept it lower through 2024', but the truth is debt peaked in 2023 and then declined — a key strategic shift the LLM misses entirely. The conclusion about 'low-cost short-term funding' is unsupported and contradicts the ground truth trend of rising interest rates. (4) Despite incorrect facts and reasoning, the answer is contextually relevant — it attempts to address the evolution of debt and interpret strategy. However, due to major factual and calculation errors, the qualitative and quantitative accuracy scores are very low. The correctness score is 2 because only the general intent and structure of the response are valid; the core financial data and derived insights are largely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 543,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "- **FY 2022:** The 3.50 % Notes due 2050 were carried on the balance sheet at roughly **$1.7 billion**.【NVDA_10k_2022.pdf p.78】  \n- **FY 2023:** The same notes were recorded at **$1.637 billion**.【NVDA_10k_2023.pdf p.67】  \n- **FY 2024:** The liability declined slightly to **$1.604 billion**.【NVDA_10k_2024.pdf p.67】\n\n**Trend and implication:** Over the three‑year period the balance of the 3.50 % Notes due 2050 fell modestly each year, indicating that NVIDIA has been gradually reducing this long‑term senior debt (through repayments or refinancing). This downward trajectory reflects a capital‑structure strategy that preserves liquidity and limits leverage while still retaining low‑cost, long‑dated financing to support growth initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in direction and interpretation but contains a significant error in the FY 2022 value. The ground truth states the liability was $2,147 million in fiscal 2022, but the LLM reports it as $1.7 billion ($1,700 million), which is off by $447 million—a material discrepancy. The FY 2023 ($1,637M) and FY 2024 ($1,604M) values are accurate and match the ground truth exactly. 2) Quantitative accuracy is compromised due to the incorrect FY 2022 figure, despite correct formatting (allowing $1.604B = $1,604 million). The reported $1.7B is an approximation that understates the actual liability by over 20%, which affects trend interpretation. Calculations or comparisons based on this would be flawed. 3) The reasoning and multi-hop synthesis are sound: the model correctly identifies the downward trend across years and draws a logical conclusion about NVIDIA’s capital structure strategy—gradual debt reduction while maintaining low-cost financing. This aligns with the qualitative insight in the ground truth. 4) Contextual relevance is excellent: all parts of the question are addressed—evolution over time and strategic implication—with proper sourcing and clear structure. Despite the numerical inaccuracy in one year, the overall narrative is coherent and relevant. Final correctness score is 7 due to accurate trajectory and correct later-year data, but docked for the significant FY 2022 error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 394,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 each include Exhibit 4.3 – the Officer’s Certificate that lists the company’s outstanding global notes – and in every year the certificate still references the **0.45 % Notes due 2016** (see the 2022 filing 【page_56】 and the 2024 filing 【page_56】). No new issuance, amendment or redemption of that series is reported in any of the three years, indicating that the note remains a legacy component of Apple’s capital structure. By repeatedly listing the same 0.45 % Notes due 2016, Apple demonstrates a long‑term debt disclosure strategy that keeps a complete, unchanged record of all outstanding debt instruments, even those issued many years earlier, to provide investors with consistent visibility into its total debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.45% Notes due 2016 are correctly identified as being referenced in Apple’s 10-K filings for 2022, 2023, and 2024, with no reported issuance, amendment, or redemption during those years. The exhibit number (4.3) and page references (e.g., page 56 in 2022 and 2024) are consistent with typical disclosure formats, and while the exact page numbers are not part of the ground truth, they do not contradict it and reflect plausible document structure. (2) Quantitative accuracy is perfect: the interest rate (0.45%) and maturity year (2016) are correct, and no erroneous numerical claims are made. (3) The multi-hop reasoning is sound—Apple continues to list a matured note in recent filings, which implies a disclosure strategy focused on completeness and transparency. The conclusion that this reflects a policy of maintaining legacy debt in disclosures for consistency and investor visibility is logically supported and semantically equivalent to the ground truth’s claim about 'transparency and legal continuity.' (4) The only minor limitation is that the LLM slightly overstates the permanence of the record by implying the notes are part of the 'outstanding' debt, which could mislead since they matured in 2016 and are no longer outstanding. However, the broader point about disclosure strategy remains valid. Overall, the answer is factually correct, contextually appropriate, and well-reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 422,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s net Level‑3 derivative liability grew sharply – it was only **$5 million** at fair value on 31 Dec 2022, rose to **$58 million** on 31 Dec 2023 and to **$69 million** on 31 Dec 2024 (Table 16.2/17.2).  The unobservable input driving the valuation – the assumed swap rate – widened from a **1‑2 % range (2 % weighted average)** in 2022, to a **3‑5 % range (4 % weighted average)** in 2023, and then settled at a **single 4 % assumption** in 2024 (Tables 16.3, 17.3).  This trajectory shows that the firm’s derivative program has expanded dramatically (derivative assets $886 m vs $683 m vs $79 m; liabilities $828 m vs $614 m vs $74 m) and that its valuation models have moved to higher, more conservative swap‑rate assumptions, indicating growing exposure to interest‑rate risk while the modeling framework has become steadier after the 2023 jump.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and risk inputs. According to the ground truth, Capital One's net derivative assets (liabilities) fair value was $31 million in 2022, not $5 million as stated. The 2023 value is correctly reported as $58 million, but the 2024 value is incorrectly stated as $69 million instead of $58 million. Additionally, the LLM claims the unobservable input in 2022 was 'swap rates' with a 1-2% range and 2% weighted average, but the ground truth states that 'default' was the significant unobservable input in 2023 and it shifted to 'swap rates' in 2024—there is no mention of swap rates in 2022. The LLM also fabricates a progression of swap rate ranges across years that does not align with the ground truth. (2) The calculation of changes in derivative positions and unrealized losses is unsupported: the ground truth notes a $20 million net unrealized loss held in 2022 and a reduction in realized losses from $43 million in 2022, which the LLM omits entirely. Instead, it introduces incorrect asset and liability breakdowns (e.g., $886M assets in 2024) not present in the original answer. (3) The multi-hop reasoning is flawed: while the LLM correctly infers increasing interest rate risk exposure, it misattributes the timing and nature of modeling changes. The shift from 'default' to 'swap rates' as the key unobservable input is misrepresented as a gradual evolution of swap rates starting in 2022, when in fact the shift occurred between 2023 and 2024. The conclusion about 'more conservative swap-rate assumptions' and 'modeling framework becoming steadier' is speculative and not supported by the ground truth. (4) Despite these errors, the answer is contextually relevant—it addresses the evolution of derivative valuations and risk inputs over time and attempts to interpret the implications for risk exposure. However, due to major quantitative and qualitative inaccuracies, especially in core financial figures and risk driver identification, the correctness score is low at 3. Quantitative accuracy is severely compromised (score 2), qualitative reasoning is partially sound but based on false premises (score 4), and relevance is maintained (score 7).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 599,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s exposure to its 1.55 % senior notes due 2028 was essentially flat at about **$1.1 billion** in fiscal 2022 (‑$1,099 m) and fiscal 2023 (‑$1,099 m) and rose only modestly to **$1.115 billion** in fiscal 2024【page 78】【page 67】.  This incremental increase – less than 2 % over three years – shows that the company is deliberately keeping its long‑term debt base stable, relying on low‑cost, long‑dated notes to support growth while avoiding large new borrowings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial exposure amounts. According to the ground truth, NVIDIA's exposure was $1.2 billion in 2022, $1.1 billion in 2023, and $1.25 billion in 2024. However, the LLM claims it was approximately $1.1 billion in both 2022 and 2023 (-$1,099M) and only $1.115 billion in 2024, which misrepresents all three years. The values are not within an acceptable margin of error, especially the 2022 figure, which is understated by $100 million. (2) The calculation of a 'less than 2% increase over three years' is based on incorrect base numbers and does not reflect the actual 4.2% increase from $1.1B to $1.25B in the final year alone. The stability narrative is partially supported by the data, but the magnitude of change is misrepresented. (3) The reasoning about NVIDIA’s long-term debt strategy being stable is semantically aligned with the ground truth’s interpretation of 'strategic maintenance,' so the qualitative synthesis is reasonable, though based on flawed data. The model correctly identifies this as a long-term debt instrument and contextualizes it within capital structure strategy. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution over time and strategic implication) and cites document pages. However, the quantitative inaccuracies severely undermine the correctness score, as financial data must be precise. The model fails the multi-hop verification by not accurately extracting or reconciling the correct values across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 431,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "Across the three filings GE repeatedly notes that the “legacy legal proceedings” stemming from its 2015 Alstom Thermal‑Renewables‑Grid acquisition—claims of pre‑acquisition anti‑competitive conduct or corruption—have already produced settlements, judgments and penalties and will continue to generate cash outflows. The same language appears in 2022 (page 71), 2023 (page 36) and 2024 (pages 33‑34), adding that the December 2020 settlement of an SEC investigation did not eliminate shareholder lawsuits over past financial‑reporting and accounting practices, and that reserves are set each year but actual losses could exceed those estimates. Together, the disclosures show that these contingent liabilities have persisted year‑over‑year and remain a material, uncertain financial burden that could affect GE’s cash flow and earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: GE's ongoing exposure to legacy legal liabilities from the 2015 Alstom acquisition, including pre-acquisition anti-competitive conduct and corruption claims, is accurately described for 2022–2024. The persistence of shareholder lawsuits tied to historical financial reporting, despite the December 2020 SEC settlement, is correctly noted. (2) Quantitative accuracy is strong: while no specific dollar amounts are cited in either answer, the LLM correctly references the recurring nature of disclosures across years and pages (2022 p.71, 2023 p.36, 2024 pp.33–34), which matches expected filing details. The statement that reserves are set annually but actual losses could exceed estimates is factually consistent with the original. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and two types of liabilities (Alstom legacy issues and shareholder litigation), correctly concluding that these contingent liabilities remain a material and persistent financial burden. (4) The only minor shortcoming is that the LLM does not explicitly mention reputational risk in 2024 as emphasized in the original answer, though it does reference impacts on cash flow and earnings. Wording differs slightly but semantic meaning is equivalent. The answer is fully contextually relevant and captures the progression and implications of GE’s trailing liabilities accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 411,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s pension plan reported hedge‑fund limited‑partnership (HF LP) holdings of **$237 million in 2022**, **$252 million in 2023**, and **$280 million in 2024** (the amounts excluded from the fair‑value tables because they are measured at NAV). The steady rise—about a 18% increase over the three‑year span—shows the company is deliberately expanding its alternative‑asset exposure, consistent with its target allocation (4% of assets to hedge funds in 2024) and indicating a strategy that leans more on hedge‑fund LPs for diversification and higher expected returns within the pension fund.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. The LLM incorrectly reports $237M (2022), $252M (2023), and $280M (2024). These errors affect all three years, with the 2022 figure overstated by $23M, the 2023 figure by $27M, and the 2024 figure by $28M. The percentage increase cited (18%) is also inaccurate—the correct increase from 2022 to 2024 is approximately 17.76% ((252-214)/214 ≈ 0.1776), but this is minor compared to the incorrect base numbers. (2) Calculations are based on wrong inputs, so even if the percentage logic is sound, it's applied to false data. The claim of a steady rise is directionally correct, but magnitudes are wrong. (3) The multi-hop reasoning—linking increasing HF LP investments to pension strategy—is conceptually valid and aligns with the original answer’s interpretation. The mention of target allocation (4% to hedge funds in 2024) adds detail not in the ground truth but does not contradict it; however, this extra detail cannot compensate for factual errors. (4) Due to major quantitative inaccuracies, the correctness score is low (3). Quantitative accuracy is severely compromised (2). Qualitative reasoning is partially sound (4) as the conclusion about strategic expansion is consistent with the trend, albeit based on false numbers. Contextual relevance is high (8) because the answer addresses both parts of the question and interprets strategic implications appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 433,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "In 2022 the Africa/Eurasia segment generated **about $228 million of operating profit**. In 2023, the Global Productivity Initiative’s restructuring effort allocated only **5 % of the $32 million pretax charge to the region – roughly $1.5‑$1.6 million**, indicating a modest cost‑restructuring focus. By 2024 the segment’s **depreciation and amortization expense fell to $8 million** (down from $9 million in 2023), showing continued but limited investment in its assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The operating profit for Africa/Eurasia in 2022 is reported as $228 million, whereas the ground truth is $203 million—a material difference of $25 million. The restructuring charge allocation is stated as 5% of $32 million (~$1.5–1.6 million), but the correct figure is 10% of expected charges, estimated at $20–24 million. Only the depreciation and amortization figure for 2024 ($8 million) matches the ground truth, and the prior year decline from $9 million is correctly noted. (2) Quantitative accuracy is severely compromised: two out of three core numbers are incorrect, and the calculation of restructuring charges is based on wrong percentages and total amounts. The $32 million total charge and 5% allocation do not align with the documented 10% allocation of a larger charge pool. (3) Qualitatively, the model recognizes the multi-hop structure—tying operating profit, restructuring, and D&A across years—and attempts to infer strategic implications (cost optimization, limited investment). However, the reasoning is undermined by incorrect inputs, leading to flawed conclusions about the scale of restructuring efforts. (4) Contextual relevance is high: the answer addresses all three time points and the correct region, using appropriate financial metrics and initiative names (Global Productivity Initiative). Despite correct framing, factual errors in critical data points severely reduce overall correctness. The answer conveys a similar narrative but with incorrect magnitude and strategic emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 442,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "- In 2022 AIG’s international terrorism model (a five‑ton bomb scenario) projected a net loss of about **$1.3 billion** after applying the U.S. TRIPRA deductible and existing reinsurance recoveries; the 2023 and 2024 filings contain the same scenario‑based description but do not disclose a new loss figure, indicating the company continued to rely on that baseline estimate.  \n- The attachment points for the international (non‑U.S.) terrorism reinsurance program stayed at **$200 million for Japan** throughout the period, while the **Rest‑of‑World attachment rose from $100 million in 2022 to $125 million in 2024**.  \n- AIG’s reinsurance‑recoverable assets fell sharply, from **$67.5 billion at year‑end 2023** (including $30.4 billion of ceded loss reserves) to **$38.0 billion at year‑end 2024**, with collateral backing dropping from $70.1 billion to $20.1 billion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several critical factual inaccuracies. While it correctly states the $1.3 billion net loss estimate in 2022 from the five-ton bomb scenario and the $200 million attachment point in Japan, it incorrectly claims that reinsurance-recoverable assets *fell* from $67.5 billion in 2023 to $38.0 billion in 2024. The ground truth states that recoverable assets *reached* $38.0 billion in 2024, with no data provided for 2023—thus the LLM invented a prior higher value not in the original. Additionally, the claim that the Rest-of-World attachment rose from $100 million in 2022 to $125 million in 2024 contradicts the ground truth, which states AIG *retained* a core attachment point of $125 million elsewhere (implying consistency), with no mention of a prior $100 million level. (2) The $29.1 billion in ceded loss reserves in 2024 is correct, but the LLM incorrectly cites $30.4 billion in 2023, which is unsupported by the original answer. The collateral backing figures ($70.1B to $20.1B) are entirely fabricated. (3) The reasoning is partially sound in identifying the continuity of scenario modeling and the importance of reinsurance, but fails in multi-hop synthesis by introducing unsupported year-over-year comparisons and trends. The model incorrectly infers a decline in recoverable assets when the truth only reports a 2024 figure. (4) Scores reflect major quantitative errors (especially invented numbers), partial qualitative accuracy in understanding modeling approaches, and high contextual relevance as the answer addresses the right topics and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 440,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "The 2.00 % Notes Due 2031 fell from roughly $1.2 billion in FY 2022 to $1.044 billion in FY 2023 (the fair‑value liability shown on the balance sheet) and then rose back to about $1.25 billion in FY 2024 (net carrying amount of $1,250 million)【page_67】【page_72】. This pattern indicates that NVIDIA is not aggressively retiring this series of notes; instead it modestly reduced the balance when cash flow allowed and subsequently rebuilt it, using the low‑cost, long‑dated debt as a flexible financing source to support ongoing growth and capital‑intensive projects. The trend reflects a deliberate long‑term debt‑management approach that balances occasional debt reduction with maintaining a sizable, inexpensive funding base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: $1.2 billion in 2022, $1.044 billion in 2023, and $1.25 billion (or $1,250 million) in 2024, matching the ground truth exactly. Number formats vary slightly (e.g., 'about $1.25 billion' vs. '$1.25 billion') but are semantically equivalent and acceptable. (2) Quantitative accuracy is perfect—no calculation errors, and the directional changes (decrease then increase) are accurately described. (3) The reasoning is sound and aligns with the ground truth: the model correctly infers that NVIDIA is not aggressively retiring the debt but managing it strategically, using low-cost long-term debt as a flexible tool. It adds nuanced insight—'rebuilt it, using the low-cost, long-dated debt as a flexible financing source'—which is consistent with the original's implication of stable capital structure and support for R&D. The only minor gap is that the LLM mentions 'fair-value liability' in 2023 and 'net carrying amount' in 2024, which introduces a technical distinction not present in the original answer and could imply a methodological shift that isn't confirmed in the ground truth. However, this does not undermine the overall correctness. (4) The answer is contextually fully relevant, addressing the trend and its implications for long-term debt strategy. The synthesis across three years and interpretation of strategic intent is accurate and insightful. Thus, the answer earns a 9/10 for correctness—excellent, with only a slight over-precision in terminology preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 431,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 appear in every annual filing. In the 2022 Form 10‑K the instrument is listed in Exhibit 4.4 (the “Officer’s Certificate” that describes the company’s outstanding global notes) as “1.05 % Notes due 2017”【page_56†L31-L38】. The same Exhibit 4.4 is reproduced in the 2023 filing (the exhibit list is unchanged, so the 1.05 % Notes due 2017 remain disclosed) and again appears in the 2024 Form 10‑K with the identical description【page_56†L31-L38】.  \n\nThis continuity shows that Apple’s low‑coupon, medium‑term debt issued in 2014 is still on the balance sheet three years later, giving investors a clear, long‑term view of the company’s debt structure and confirming that Apple maintains a stable, visible portfolio of legacy notes over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent disclosure of Apple's 1.05% Notes due 2017 across the 2022, 2023, and 2024 10-K filings, citing the correct exhibit (Exhibit 4.4) and page reference (page 56, lines 31–38), which supports the factual presence of the instrument in disclosures. The percentages and years (1.05%, 2017) are accurate, and the claim of continuity across filings is substantiated—meeting quantitative accuracy for reported facts. However, the LLM incorrectly implies that the notes are still outstanding and on the balance sheet, stating they 'are still on the balance sheet three years later,' which contradicts the ground truth: the notes matured in 2017 and would not remain as active liabilities post-maturity. This reflects a critical error in reasoning and interpretation. The ground truth suggests the notes are retained in filings likely due to rollover, refinancing, or documentation continuity under the same indenture, not because they are live debt. The LLM fails to acknowledge maturity in 2017 or offer plausible explanations like refinancing or historical documentation, instead asserting ongoing balance sheet presence, which is factually incorrect. This undermines the qualitative accuracy of the reasoning and synthesis. Contextually, the response is highly relevant, directly addressing the evolution and visibility of the debt instrument, but the flawed conclusion about current balance sheet status reduces overall correctness. Thus, while the citation and disclosure tracking are strong, the core inference about debt continuity is misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 434,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "- In the 2022 filing Schwab was still operating under the 2019 IDA agreement, which gave it the option to migrate up to $10 billion of IDA balances each 12‑month period (subject to a $50 billion minimum balance through June 2031 and an 80 % fixed‑rate‑obligation requirement through June 2026). Schwab exercised that option in 2021‑2022 and moved roughly $10 billion each year.  \n\n- The 2023 filing shows that the 2019 agreement was replaced on May 4 2023 by a new 2023 IDA agreement. The new pact eliminated the 80 % fixed‑rate rule, introduced a tiered balance ceiling and floor (through Sept 10 2025 a maximum of $30 billion above the then‑unmatured fixed‑rate obligations; after that date a discretionary withdrawal regime with a minimum $60 billion and a maximum $90 billion), and gave Schwab the option to buy down up to $5 billion of fixed‑rate obligations (incurring market‑based fees). Schwab did not migrate any IDA balances in 2023.  \n\n- The 2024 filing confirms that the 2023 agreement remained in force and that Schwab again did not move any IDA balances during 2024, continuing to be bound by the same minimum‑/maximum‑balance limits (‑$30 billion above fixed‑rate obligations until Sept 10 2025, then $60‑$90 billion thereafter).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Schwab's IDA balance migration strategy from 2022 to 2024, with accurate qualitative reasoning and strong contextual relevance. However, there are minor quantitative inaccuracies that prevent a perfect score. In 2022, the original answer states Schwab had already migrated $10.1 billion by year-end, while the LLM says 'roughly $10 billion each year' for 2021–2022 — this slightly misrepresents the precise amount and timeframe. Additionally, the LLM introduces details not present in the ground truth, such as a 'tiered balance ceiling and floor' with specific post-Sept 2025 ranges ($60B–$90B), a 'discretionary withdrawal regime', and a $5B buy-down option with market-based fees. These specifics, while plausible, are not mentioned in the original answer and represent over-specification beyond the provided truth. The core facts — that the 2019 agreement allowed up to $10B annual migration (exercised), the 2023 agreement replaced it and eliminated migration, and no balances were moved in 2023 or 2024 — are correctly conveyed. The reasoning across years is sound, and the shift from active migration to off-balance sheet constraints is accurately synthesized. Thus, the answer is factually strong but includes some unverified granular details, slightly reducing quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 376,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "- **2022:** GE estimated that borrower‑litigation losses on the Bank BPH mortgage portfolio would total **about $1.36 billion** (Note 24). To support the bank it made a **cash capital contribution of $530 million** (2022 10‑K). The portfolio was shown on the balance sheet at a **gross carrying amount of $1.2 billion** (financing receivables held for sale) with a valuation allowance of $848 million, leaving a modest net value after the allowance.  \n\n- **2023:** The loss estimate more than doubled to **$2.67 billion**. GE did not add cash but recorded a **non‑cash capital contribution – inter‑company loan forgiveness of $1.80 billion** (no incremental cash needed). The valuation allowance now fully offset the receivable, so the **mortgage portfolio’s net carrying value was zero** at year‑end.  \n\n- **2024:** The estimated litigation loss was revised to **$2.46 billion**. GE made **no additional cash or non‑cash contributions** in 2024, and, as in 2023, the valuation allowance continued to **eliminate the portfolio’s carrying amount (net zero)**.  \n\nThus, from 2022 to 2024 GE’s exposure grew from $1.36 bn to roughly $2.5 bn, its strategy shifted from a cash infusion in 2022 to a large non‑cash loan‑forgiveness in 2023, and by 2023‑24 the mortgage receivable was fully written‑off on the books.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key numbers are correct within acceptable rounding: $1.36 billion (vs $1,359M), $2.67 billion (vs $2,669M), $2.46 billion (vs $2,461M), $530M cash (exact), $1.80 billion non-cash (vs $1,797M), all within rounding tolerance. The carrying value reaching zero by 2023 (not 2024 as in original) is a minor discrepancy but supported by the data presented. (2) Quantitative accuracy is excellent—values match or are appropriately rounded, and no calculation errors are present. (3) Multi-hop reasoning is sound: the answer correctly synthesizes changes over 2022–2024 across estimated losses, capital contributions (cash vs non-cash), and carrying value. It accurately captures the strategic shift from cash to non-cash support and full write-down. (4) The only minor issue is that the original specifies the mortgage portfolio carrying value dropped to zero by end of 2024, while the LLM states it was zero by end of 2023 due to full valuation allowance. However, the LLM’s claim is consistent with the reported allowance fully offsetting the receivable in 2023, which would result in a zero net carrying value at that time. This may reflect interpretation of when the write-down was effectively recognized. Overall, the answer is factually correct, complete, and contextually appropriate, with only negligible timing nuance differing from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 394,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "- 2022: CVS held commercial‑mortgage‑backed securities with a fair‑value of **$1.018 billion** and recorded **$155 million of unrealized losses** (see the debt‑securities table showing $1,172 m amortized cost, $1,018 m fair value and $155 m unrealized loss)【page_147】.  \n- 2023: The same portfolio fell to a fair‑value of **$975 million**, with unrealized losses shrinking to **$100 million** (debt‑securities table shows $1,066 m amortized cost, $975 m fair value and $100 m loss)【page_147】.  \n- 2024: CVS’s exposure was dramatically lower – the separate‑accounts section reports only **$3 million** of commercial‑mortgage‑backed securities (down from $6 million in 2023) and no material unrealized‑loss amount is disclosed【page_160】.  \n\n**Interpretation:** Over the three‑year period the fair‑value of these securities fell modestly while the unrealized‑loss amount declined, and by 2024 the company had largely divested the position. This pattern indicates a deliberate risk‑management strategy to reduce interest‑rate‑sensitive, unrealized‑loss‑prone assets and limit exposure to commercial mortgage‑backed securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's CMBS fair value was $574M in 2022 with $12M unrealized losses, but the LLM reports $1.018B and $155M, which are more than double and over ten times higher, respectively. In 2023, ground truth shows fair value increased to $675M with $100M unrealized losses; the LLM incorrectly states fair value dropped to $975M (which may reflect a different category of securities) and retains the $100M loss — partially correct on loss but wrong on fair value trend direction and magnitude. Only the 2024 figure ($3M) matches the ground truth and is correctly cited. (2) Calculations and comparisons are flawed: the LLM claims fair value 'fell modestly' and unrealized losses 'declined', but ground truth shows fair value first rose then collapsed, and unrealized losses surged from $12M to $100M before the exit — indicating rising risk, not declining. The LLM mischaracterizes the trend entirely. (3) Multi-hop reasoning is compromised because the model appears to pull data from a different or broader securities category (possibly total debt securities including other asset-backed securities), failing to isolate CMBS specifically as required. This breaks the synthesis chain. (4) Despite incorrect numbers, the final interpretation about de-risking in 2024 aligns with the ground truth’s conclusion, giving some credit for contextual relevance and directional strategy assessment. However, due to severe quantitative errors and flawed intermediate reasoning, the overall correctness score is low at 3 — the answer is mostly incorrect but captures the final year and general strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 469,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s private‑brand roster has kept **Marketside** as a staple across the three most recent fiscal years. The 2022 10‑K lists Marketside among its U.S. private brands 【page_7】, the 2023 filing again includes Marketside in the same list 【page_8】, and the 2024 filing still shows Marketside as part of the portfolio 【page_8】. This continuity signals that Walmart is deliberately maintaining and likely expanding its private‑label grocery offering—using brands like Marketside to reinforce price‑leadership and capture higher margin share in the grocery segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Walmart consistently included Marketside in its private brand portfolio from 2022 to 2024, with accurate references to each year's 10-K filing. All entity names (Marketside, Walmart) and time periods (fiscal years 2022–2024) are correct, and there are no numerical inaccuracies—this earns a perfect quantitative accuracy score. The answer addresses the evolution of Marketside over the three years and correctly infers Walmart’s strategic intent to maintain private-label strength in grocery. However, it omits a key element from the original answer: the introduction of the new private brand 'bettergoods' in 2024 as part of Walmart’s modernization strategy. This missing detail weakens the qualitative accuracy, as the dual strategy of maintaining legacy brands while innovating is only partially conveyed. The reasoning is sound but not fully comprehensive in synthesizing the multi-hop insight about strategic expansion and modernization. Contextual relevance is strong—the response directly addresses the question and stays focused on the evolution and strategic implications. Thus, while the core facts are correct and the conclusion is reasonable, the lack of mention of 'bettergoods' and the broader strategic context prevents a top score in correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 371,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022 to 2024 Lowe’s shifted its supplier‑oversight from a baseline set of human‑rights, conflict‑minerals and Vendor Code of Conduct standards to a more data‑driven, risk‑based system that actively monitors environmental and human‑rights performance. In fiscal 2022 the company required suppliers to adhere to its human‑rights policy and Vendor Code (which already contained enhanced environmental clauses) and began encouraging suppliers to report emissions to CDP and to obtain EPA SmartWay certification; by fiscal 2023 it had upgraded its wood‑sourcing policy with country‑level risk tiers, stronger monitoring practices and a new forestry‑grievance process, and it continued to enforce the human‑rights and conflict‑minerals policies across the supply chain. Across the period Lowe’s invested heavily in supply‑chain sustainability – more than $550 million by the end of 2022 (and $300 million‑plus in the 2023‑24 filings) in energy‑efficiency retrofits such as LED lighting, high‑efficiency HVAC, building‑management systems and pallet grinders, plus a rollout of rooftop solar at over 100 stores and renewable‑energy PPAs, while also funding programs that push suppliers to disclose emissions and achieve 100 % SmartWay certification.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Lowe's supplier monitoring and enforcement from 2022 to 2024 with generally accurate qualitative details. It correctly identifies the 2023 update to the wood-sourcing policy, including country-level risk tiers, enhanced monitoring, and a new forestry grievance process, and notes the continuation of human rights and conflict minerals policies. The narrative of shifting toward a more risk-based, data-driven system aligns with the ground truth. However, there are key quantitative inaccuracies: the original answer states over $550 million invested by 2022 and over $400 million through 2023 in operational sustainability initiatives, while the LLM claims $550 million by end of 2022 (partially acceptable) but then cites '$300 million-plus in the 2023-24 filings', which underreports the 2023 investment and introduces an undefined time frame not in the original. This misrepresents the financial commitment and fails to reflect the cumulative and consistent investment pattern. Additionally, the LLM introduces specific initiatives like LED retrofits, solar rollouts, and pallet grinders, which, while plausible, are not present in the original answer and represent a detail expansion not supported by the ground truth. These additions, while contextually relevant, introduce unverified specifics and distract from the documented policy and investment focus. The multi-hop reasoning is sound in linking policy evolution across years and associating investments with sustainability goals, but the financial figures and specific project details reduce factual precision. The answer remains contextually relevant and conveys a similar overall message, but the numerical discrepancies and unsupported specifics prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1613,
        "completion_tokens": 480,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "- **2022 Form 10‑K** – In the exhibit index Apple’s Officer’s Certificate (Exhibit 4.3) lists “2.40 % Notes due 2023” among its outstanding global notes【page_56】.  \n- **2023 Form 10‑K** – The same exhibit schedule is reproduced, again showing the 2.40 % Notes due 2023 as an outstanding issue (the note appears in the 2023 exhibit list, confirming it remained on the balance sheet).  \n- **2024 Form 10‑K** – The exhibit index continues to include the 2.40 % Notes due 2023 in Exhibit 4.3, indicating the debt is still outstanding as of the 2024 filing【page_56】.  \n\n**What the pattern shows:** For three consecutive years Apple consistently disclosed the same medium‑term, fixed‑rate 2.40 % bond that matures in 2023. This steady reporting signals a deliberate debt‑management strategy: Apple issues fixed‑rate, medium‑term notes, keeps them on the books until maturity, and provides transparent, ongoing disclosure rather than repeatedly refinancing or retiring the issue early. The continuity underscores disciplined capital‑structure management and a focus on predictable financing costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2.40% Notes due 2023 are accurately cited in Apple’s 2022, 2023, and 2024 10-K filings, with correct references to Exhibit 4.3 and the Officer’s Certificate. The years, percentages, and disclosure patterns are factually sound. (2) Quantitative accuracy is perfect: the interest rate (2.40%), maturity year (2023), and filing years (2022–2024) are all correct, with no calculation errors. (3) The multi-hop reasoning is strong—LLM correctly synthesizes disclosure continuity across three years and infers a stable debt management strategy focused on transparency and predictable financing. The conclusion about not refinancing early or retiring the debt prematurely is logically supported by the persistent inclusion in filings. (4) The only minor shortcoming is a slight overstatement in the 2024 claim: while the note is listed in the exhibit index, its inclusion does not necessarily confirm it was still outstanding at filing (it may have matured shortly after or been repaid), so the phrasing 'still outstanding' is slightly stronger than the ground truth, which notes inclusion 'even though the notes were set to mature within that year.' This nuance slightly affects qualitative accuracy but does not undermine the overall correctness. The answer remains contextually excellent, fully addressing the evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 401,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap exposure grew each year: the senior note was $900 million at 12/31/2022, rose to $944 million at 12/31/2023, and reached $982 million at 12/31/2024 (see 2024 FA Note 22 and 2023 FA Note 22). This upward trend—while the company sold off its AerCap equity holdings—shows GE deliberately increasing its position in a fixed‑income instrument, suggesting a strategy of concentrating on stable, interest‑bearing securities rather than equity stakes in its financial‑instrument portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 value: it states $900 million, while the ground truth reports $976 million. The 2023 ($944 million) and 2024 ($982 million) figures are correct. This misrepresentation of the starting value undermines the claimed 'upward trend'—in reality, holdings decreased from 2022 to 2023 before increasing in 2024, which contradicts the LLM's characterization of consistent growth. (2) Quantitative accuracy is partially correct: two out of three values are accurate, but the 2022 figure is off by $76 million, a substantial deviation. Calculations are not required in this question, but the directional claim (consistently increasing) is false given the drop in 2023. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift toward fixed-income over equity and ties it to broader portfolio strategy, which aligns with contextual trends in GE’s filings. However, this conclusion is based on an incorrect premise about the trajectory of note holdings. The observation about selling equity while increasing note exposure may be valid contextually, but it does not excuse the misstatement of the 2022 figure. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of holdings and strategic implication) and attempts synthesis. However, due to the incorrect initial value and resulting flawed trend analysis, the overall correctness score is reduced to 5, reflecting partial accuracy with significant factual shortcomings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 427,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s “glide‑path” for the U.S. qualified pension plan calls for a lower growth‑asset share as the funded ratio improves. In the 2022 target (based on the 2021 funded status) the plan called for 15 % equity, 75 % fixed‑maturity securities and 10 % other assets 【page_310】. By the 2024 target (based on the 2023 funded status) the equity portion had been cut to 9 %, while fixed‑maturity securities rose to 80 % and other assets to 11 % 【page_252】. The shift from a higher‑equity, lower‑duration mix in 2022 to a more conservative, liability‑hedging mix in 2024 shows the plan’s de‑risking strategy tightening as its funded status strengthened.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AIG's glide path approach linking target allocations to prior-year funded status, noting the 2022 target was based on 2021 funded status and the 2024 target on 2023 funded status, which matches the multi-year progression described in the original answer. (2) Quantitatively, the percentages are correct: 15% equity, 75% fixed-maturity, and 10% other in 2022; by 2024, equity drops to 9%, fixed-maturity rises to 80%, and other assets to 11%. These figures reflect a reallocation consistent with de-risking. The sum of allocations (100% in both years) is accurate. (3) The reasoning is sound: the model correctly infers that the shift from higher-growth (equity) to liability-hedging (fixed-maturity) assets reflects a de-risking strategy in response to improved funded status, which is the core of liability-driven investing. (4) While the LLM does not explicitly mention the 2023 allocation or the forward-looking nature of targets (e.g., 2023 setting 2024 targets), it captures the essential evolution from 2022 to 2024 and the strategic intent. Minor omission of intermediate year details prevents a perfect 10, but overall factual correctness, synthesis, and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 358,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments has kept “analog and embedded‑processing products” at the heart of its business model in every filing – the 2022 MD&A states that its strategy is “focused on analog and embedded processing products” and that “our strategic focus is on analog and embedded processing products”【page_18】; the 2023 filing repeats the same language in both the overview and results sections【page_18】【page_19】; and the 2024 filing again emphasizes that “our strategic focus is on analog and embedded processing products”【page_19】 (also reiterated in the 2024 overview【page_20】).\n\nThis three‑year continuity shows that TI treats embedded processing as a permanent, core growth engine, not a temporary initiative, and that it expects the line to keep delivering the strong operating cash flows needed to sustain its long‑term free‑cash‑flow‑per‑share growth objective.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing products from 2022 to 2024, citing repeated language across all three years that the company's focus is on 'analog and embedded processing products.' This matches the original answer's claim of multi-year consistency. (2) There are no numerical values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct use of years (2022–2024), which are accurately referenced. (3) The reasoning is sound: the LLM correctly infers that the repeated emphasis indicates a long-term strategic pillar rather than a temporary initiative, directly linking this to free cash flow per share growth as required by the question. It synthesizes information across three years of filings, demonstrating proper multi-hop reasoning. (4) While the LLM slightly under-elaborates on the specific mechanisms (e.g., supply chain control, customer reach, diversified returns) mentioned in the original answer, it captures the core conclusion — that embedded processing is foundational to long-term cash flow generation. The use of direct quotes and page references strengthens credibility. Minor deduction in qualitative accuracy due to less detailed articulation of TI’s competitive model, but overall meaning and intent are semantically equivalent. Contextual relevance is perfect — the response directly addresses both parts of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 422,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "Lowe’s core IP policy has stayed the same – the company continues to protect the “Lowe’s” service mark and the trademarks, domain names and patents that cover its private‑brand portfolio (notably Kobalt, STAINMASTER and allen+roth) in each filing (2022 Intellectual Property p. 7; 2023 Intellectual Property p. 9; 2024 Intellectual Property p. 7). However, the narrative around those brands has shifted. In FY 2022 the filing simply listed the brands, while the FY 2023 and FY 2024 reports stress expanding and “balancing” high‑value private brands with national brands and using them to fuel the company’s omnichannel, AI‑driven digital experience (e.g., “high‑value private brands” p. 6 FY 2023; “balancing our value‑oriented private brands… intensifying our localization efforts” p. 6 FY 2024). Thus, Lowe’s IP strategy evolved from basic protection of its private‑brand marks to a broader emphasis on growing that brand portfolio and embedding it within its digital‑transformation and omnichannel initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—Kobalt, STAINMASTER, allen+roth—are correctly identified across fiscal years 2022–2024. The evolution in narrative focus from basic listing to strategic integration with digital transformation is accurately captured. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (FY 2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in disclosure patterns across filings and infers a strategic shift—from passive IP protection to active brand integration with omnichannel and digital initiatives like AI-driven experiences and localization. The omission of RONA and Reno Depot in later years is implied through the narrowed focus, though not explicitly mentioned; this is a minor omission but does not distort the overall conclusion. (4) The LLM introduces the concept of 'balancing' private and national brands and 'localization efforts' from FY2024, which adds contextual depth consistent with the ground truth’s mention of digital transformation integration. While the original answer emphasizes the removal of certain brands from disclosure as a sign of refocusing, the LLM captures the same strategic trajectory through different phrasing—'evolved from basic protection...to broader emphasis on growing that brand portfolio.' This constitutes semantic equivalence. The only reason for not scoring a 10 is the lack of explicit mention of RONA and Reno Depot being dropped in 2023, which was a key signal in the ground truth for brand portfolio streamlining. Otherwise, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 479,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "IBM’s 2022 filing already listed **“client relationships and trust”** as one of its core competitive levers (2022 p. 4). In the 2023 report the same phrasing re‑appears, underscoring that the company continues to treat those attributes as a permanent part of its value proposition (2023 p. 3). By 2024 the language is woven directly into its hybrid‑cloud and AI narrative – the company says its “breadth and depth of expertise… trust and security” enable customers to execute digital and AI transformations on its open hybrid‑cloud platform (2024 p. 3‑4). This multi‑year progression shows IBM moving from naming client trust as a generic differentiator to positioning it as a strategic pillar that underpins its hybrid‑cloud and AI offerings, signalling that IBM is betting on trusted relationships to win and retain business in the increasingly competitive cloud‑AI market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that IBM emphasized 'client relationships and trust' as a competitive differentiator in all three years (2022–2024), citing consistent phrasing across filings, which matches the original answer’s timeline. (2) There are no numerical values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the LLM traces the evolution from a generic differentiator in 2022 to a strategic pillar integrated with hybrid cloud and AI by 2024. It accurately captures the strategic shift, though it omits specific mention of key partnerships with AWS, Microsoft, SAP (2023), and Palo Alto Networks (2024) that the ground truth includes as evidence of ecosystem expansion. This is a minor omission affecting completeness but not the core correctness. (4) Despite this, the LLM correctly infers the broader implication—that trust is being leveraged as a strategic advantage in the hybrid cloud and AI market—demonstrating strong qualitative accuracy and full contextual relevance. The answer is semantically equivalent in intent and conclusion, just slightly less detailed in supporting evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 337,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "- In the 2022 Form 10‑K the El Segundo, California site was described as a **clinical‑manufacturing** location for Gilead’s cell‑therapy products.  \n- By the 2023 Form 10‑K the same facility was listed as being used for **both clinical and commercial manufacturing and processing** of those cell‑therapy products.  \n- The 2024 Form 10‑K repeats this description, confirming that the El Segundo plant now **continues to serve both clinical and commercial production** of Gilead’s cell‑therapy portfolio.  \n\nThus, the El Segundo facility evolved from a purely clinical‑manufacturing role in 2022 to a combined clinical‑and‑commercial manufacturing hub by 2023, a role it retained through 2024.  \n\n*Sources: 2022 10‑K (facility description), 2023 10‑K – “El Segundo, California: We utilize the facility for clinical and commercial manufacturing and processing of our cell therapy products” (page 11), 2024 10‑K – same wording (page 10).*",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error in reasoning that contradicts the ground truth. It claims that in 2022, the El Segundo facility was described as a 'purely clinical-manufacturing' site, evolving to include commercial manufacturing only in 2023. However, the original answer (ground truth) states that the facility was already used for both clinical and commercial manufacturing in 2022, with no change in role across 2022–2024. This misrepresentation of the 2022 role invalidates the core claim of 'evolution' from clinical-only to dual-use. The LLM likely misread or misinterpreted the 2022 10-K description, introducing a change that did not occur. Quantitatively, there are no numerical errors (dates, years, and citations are accurate), so quantitative accuracy is high. Contextually, the answer addresses the question's focus on evolution and production responsibilities, hence good relevance. However, the qualitative reasoning is flawed due to incorrect synthesis across years—failing the multi-hop requirement to accurately compare roles over time. The conclusion of 'evolution' is unsupported, making the overall correctness low despite correct sourcing format and structural clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 338,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "The only 4.550 % senior notes that appear in Lowe’s filings are the **April 5, 2019 issuance of 4.550 % notes due April 5, 2049** (see the Fifteenth Supplemental Indenture on page 76). The later exhibit lists for the 2022, 2023 and 2024 10‑K filings (pages 73‑78) contain no additional 4.550 % issuances or new maturities, showing that the company has relied on that single, long‑dated issue and has not added fresh 4.550 % debt through 2024. This multi‑year pattern—issuing a fixed‑rate note with a very long maturity and then leaving it untouched—signals that Lowe’s is using the 4.550 % series to lock in long‑term, low‑cost financing and to stagger its debt profile far into the future rather than repeatedly refinancing or issuing new securities of the same coupon.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key details are correct: the 4.550% Notes were issued on April 5, 2019, and mature on April 5, 2049, under the Fifteenth Supplemental Indenture, and this instrument is consistently referenced across 2022, 2023, and 2024 filings. (2) Quantitative elements—dates, percentages, and the absence of new issuances—are precisely aligned with the original answer; no calculations are required, but the observation of no additional issuances is correctly drawn from the data. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the lack of changes indicates a strategic choice to rely on long-duration debt. (4) The interpretation—that Lowe's is locking in long-term, low-cost financing and managing refinancing risk by using extended maturities—matches the original answer’s conclusion about capital structure strategy. Wording differs but meaning is identical. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 304,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "- **2022:** 3M’s Scotchgard‑related exposure was limited to a few modest settlements.  In New York, 3M, Saint‑Gobain and Honeywell together contributed about **$65 million** to resolve a class‑action tied to Scotchgard‑derived PFAS, and 3M’s share was described as “not material.”  A separate Wolverine‑World Wide settlement that also involved Scotchgard was settled for an immaterial amount, with the final payment made in **June 2023**. 【page_94】\n\n- **2023:**  The company recorded a **pre‑tax charge of roughly $10.3 billion** in Q2 2023 to reflect the present‑value of the $12.5 billion nominal liability it will pay under the nationwide Public‑Water‑System (PWS) Settlement, which covers PFAS products—including Scotchgard—used by public water suppliers. 【page_97】\n\n- **2024:**  The PWS Settlement received final court approval in February 2024, confirming that 3M will make **$10.5‑$12.5 billion** of payments from 2024 through 2036.  No new material Scotchgard‑specific settlements are noted, but the ongoing liability remains anchored to the multi‑billion‑dollar PWS commitment. 【page_97】\n\n**Trend insight:**  Over the three‑year span, 3M’s Scotchgard‑related legal risk shifted from relatively small, immaterial settlements in 2022 to a massive, quantified liability of over $10 billion by 2023‑2024.  This escalation shows that PFAS litigation—while initially limited to modest product‑specific settlements—has grown into a major, long‑term financial burden for the company.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $65 million settlement in 2022 involving 3M, Saint-Gobain, and Honeywell, and notes that 3M's share was immaterial, which aligns with the ground truth. However, it incorrectly frames the 2023 developments around a $10.3 billion pre-tax charge related to a nationwide Public Water System (PWS) Settlement as being directly tied to Scotchgard, when the original answer emphasizes a broader expansion of PFAS litigation—including AFFF suits, Canadian class actions, and state-level cases—without specifying such a large charge tied specifically to Scotchgard. The $10.3 billion charge and PWS settlement are real events, but the ground truth does not link them explicitly to Scotchgard; rather, Scotchgard is one of many PFAS-related products under litigation. This over-attribution to Scotchgard reduces quantitative and qualitative accuracy. In 2024, the LLM correctly notes final court approval of the PWS settlement but again ties it directly to Scotchgard without sufficient nuance, while missing key developments like new lawsuits in Alabama and Georgia and the $65 million New York settlement being finalized. (2) The $65 million figure in 2022 is accurate. However, the $10.3 billion charge and $10.5–12.5 billion payout range, while factually reported in 3M’s filings, are not explicitly attributed to Scotchgard in the ground truth; they relate to broader PFAS water contamination litigation, not the specific Wolverine/Scotchgard disposal cases. Thus, the LLM inflates the direct financial impact attributable to Scotchgard alone. (3) The multi-hop reasoning is partially sound—connecting PFAS litigation to increasing financial exposure—but incorrectly synthesizes the scope of the PWS settlement as Scotchgard-specific, failing to distinguish between different PFAS product lines (e.g., AFFF vs. Scotchgard). The original answer focuses on the evolution of Scotchgard-specific litigation (Wolverine, Michigan, New York), while the LLM generalizes to all PFAS liabilities. (4) Despite these inaccuracies, the LLM captures the core trend of escalating financial exposure and correctly identifies the growing burden of PFAS litigation. It provides relevant context and logical progression, earning high marks for contextual relevance and decent qualitative reasoning, though the quantitative accuracy is reduced due to misattribution of large settlement figures to Scotchgard specifically.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1663,
        "completion_tokens": 651,
        "total_tokens": 2315
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "- In the 2022 filing Gilead described its Foster City campus simply as the corporate headquarters that “houses our administrative, manufacturing and R&D activities” 【page_33】.  \n- By the 2023 filing the description had become more specific, stating that at Foster City the company “conducts process‑chemistry research, analytical‑method development and formulation‑and‑device development activities, and manufactures API and drug product for our clinical trials” 【page_11】.  \n- The 2024 filing repeats this focused role, showing that the site now serves as a dedicated early‑stage R&D and clinical‑trial manufacturing hub that supports Gilead’s worldwide operations alongside its other U.S., Canadian, Irish and European facilities 【page_10】.  \n\nThus, from 2022 to 2024 the Foster City facility evolved from a broad headquarters‑level manufacturing/R&D center to a specialized site concentrating on process chemistry, analytical and formulation work, and clinical‑trial API/drug production, aligning it strategically with Gilead’s global manufacturing network.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the evolution of Gilead's Foster City facility from 2022 to 2024: in 2022, it was described broadly as housing administrative, manufacturing, and R&D activities; by 2023–2024, the focus shifted to specific R&D functions (process chemistry, analytical method development, formulation, device development) and clinical manufacturing of API and drug product. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly used and aligned with the corresponding descriptions from each filing. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to show a strategic shift—narrowing the facility’s role from a general headquarters with mixed functions to a specialized early-stage R&D and clinical manufacturing hub. It correctly infers strategic alignment with global operations by noting that other sites (e.g., La Verne, Oceanside, international) handle commercial-scale manufacturing. (4) All entities (Gilead Sciences, Foster City, California) are correct, and the answer addresses all parts of the question: R&D focus, manufacturing responsibilities, and strategic alignment. Wording differs slightly but meaning is preserved. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 380,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "- In 2022 AIG’s loss‑reserve risk was governed by a formal insurance‑risk framework that combined internal controls (pricing‑approval, underwriting‑authority, model‑risk‑management and validation processes, actuarial profitability and reserve reviews, experience‑monitoring) with periodic reviews by external experts 【page_165】.  \n- By 2023 the oversight was deepened: ERM’s “second‑line review and challenge” and the Internal Audit function were required to test pricing and reserving models, assumptions and results, while the “review and challenge of reserves” became a standing part of the risk‑control process 【page_118】【page_119】.  \n- In the 2024 filing the company says the IBNR and ultimate‑loss methods are “continually reviewed and updated by management,” now using stochastic, scenario‑analysis and third‑party catastrophe‑risk models and still incorporating external expert reviews as part of the ongoing validation of loss‑reserve estimates 【page_88】【page_84】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—AIG, years (2022–2024), and risk management components—are correctly identified. The evolution across years is accurately portrayed: 2022 emphasizes internal controls and external reviews; 2023 introduces second-line review and challenge, internal audit testing, and deeper oversight; 2024 highlights ongoing model updates using stochastic and scenario analyses, third-party catastrophe models, and continued external validation. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and multiple oversight mechanisms, correctly tracing the evolution from internal/external controls to integrated, model-driven ERM practices. It accurately reflects the increasing sophistication in modeling (stochastic, scenario analysis) and governance (second-line review). (4) Semantic equivalence is strong: while the LLM does not use the exact phrase 'enterprise risk management (ERM) framework' in 2024, it references ERM’s second-line role and enhanced governance, effectively conveying integration into broader risk management. The only minor gap is that the LLM answer does not explicitly state the 'progression from reactive to proactive governance' as framed in the original, but the components supporting that conclusion are all present. Thus, the answer is factually complete and contextually relevant, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 459,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "Across the three Form 10‑K filings, the Melaka, Malaysia site is listed each year (2022, 2023 and 2024) with an “X” only in the **Analog** column and no mark in the **Embedded Processing** column. This unchanged designation shows that Texas Instruments has kept Melaka solely as an analog‑product manufacturing location, with no expansion of embedded‑processing capacity in the region over the 2022‑2024 period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was consistently listed in the 10-K filings for 2022, 2023, and 2024 with operations only in the Analog column, which matches the original answer's claim of exclusive Analog manufacturing. (2) There are no numeric values requiring calculation, but the temporal scope (2022–2024) is correctly referenced across all three years, and the absence of Embedded Processing designation is correctly noted—this qualitative 'X' marker interpretation aligns with the ground truth. (3) The multi-hop reasoning is sound: the model synthesized data across three annual filings to observe no change in manufacturing focus, correctly inferring that the lack of expansion into Embedded Processing indicates a stable, specialized role. (4) The answer addresses both parts of the question: the evolution (no change, Analog-only) and what it indicates (specialized, stable role in Analog manufacturing). Wording differs slightly but meaning is identical. All entities—Texas Instruments (TXN), Melaka, Malaysia, Analog, Embedded Processing, and the 2022–2024 timeframe—are correctly identified and used. No factual, quantitative, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 359,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "- **Fiscal 2022:** Lowe’s reported a cash‑flow‑hedge forward‑interest‑rate‑swap portfolio of **about $2.6 billion** in notional amount (Note 9, 2022 10‑K).  \n\n- **Fiscal 2023:** The 2023 filing states that the company “held forward interest‑rate‑swap agreements to hedge the exposure on forecasted debt issuances” (Note 9, 2023 10‑K).  The fair‑value table shows a modest **$251 million** of forward‑swap assets, indicating the notional amount had fallen sharply from the 2022 level.  \n\n- **Fiscal 2024:** The 2024 filing no longer lists a forward‑swap line under “Other current assets” (the forward‑swap entry is blank), suggesting the forward‑swap exposure had been largely unwound by the end of fiscal 2024.  \n\n**Interpretation:** Lowe’s used forward interest‑rate swaps to lock in rates for debt it expected to issue. The large $2.6 billion exposure in 2022 reflects an early‑stage hedge of upcoming issuances; the subsequent reduction in 2023 and apparent elimination in 2024 show the company progressively unwound the swaps as the debt was actually issued, demonstrating a targeted, timing‑driven hedging strategy rather than a permanent interest‑rate‑risk hedge.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "(1) The LLM answer correctly identifies the trend in Lowe's use of forward interest rate swaps from 2022 to 2024: active hedging in 2022, reduced exposure in 2023, and elimination by 2024. It accurately notes the $251 million fair value in 2023 and the absence of forward swaps in 2024. However, it introduces a critical error by stating a $2.6 billion notional amount in 2022, which is not present in the ground truth and contradicts the original answer that does not specify any notional amount for 2022—only that forward swaps were referenced in relation to prior-period hedges (2019–2021). This number appears to be fabricated or misattributed. (2) Quantitative accuracy is compromised due to the unsupported $2.6 billion figure. While $251 million in 2023 matches the ground truth, the lack of corroboration for the 2022 notional value undermines confidence in the data sourcing. No calculation errors are present, but the introduction of an unverified large-scale number affects factual integrity. (3) The reasoning is logically sound: the interpretation that Lowe’s unwound swaps as debt was issued reflects a coherent, timing-based hedging strategy. The conclusion aligns with the ground truth’s assertion of a strategic shift, though the LLM frames it more as execution of a planned unwind rather than a broader shift in risk management focus (e.g., from forecasted issuances to existing debt). The multi-hop synthesis across years is effective, but the erroneous 2022 number weakens the foundation. (4) The answer is highly contextually relevant, directly addressing the evolution and strategic implications. Despite the quantitative flaw, the overall narrative trajectory matches the ground truth. Hence, correctness is reduced to 7 due to the significant but isolated numerical inaccuracy, while qualitative and contextual strengths are recognized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 501,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "- **2022 filing (Form 10‑K)** – The list of “instruments defining the rights of security holders” stops at the 6.22 % Debentures due 2027; the 6.50 % Debentures due 2028 are not mentioned.  \n\n- **2023 filing (Form 10‑K)** – The 6.50 % Debentures due 2028 appear for the first time, identified as **Exhibit 2 to Form 8‑K, filed January 8 1998**.  \n\n- **2024 filing (Form 10‑K)** – The same disclosure is repeated unchanged: the 6.50 % Debentures due 2028 are again referenced as Exhibit 2 to Form 8‑K, filed January 8 1998.  \n\n**What the unchanged filing date shows:** By continually incorporating the same 1998 Form 8‑K exhibit, IBM signals that the 6.50 % Debentures due 2028 have a fixed, long‑term contractual framework that has not been amended or re‑issued since their original filing. The debt’s terms are therefore documented once in a historic filing and are simply incorporated by reference in each subsequent annual report, underscoring the instrument’s enduring structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. According to the ground truth, IBM consistently disclosed the 6.50% Debentures due 2028 in all three years (2022, 2023, 2024) with reference to the same Exhibit 2 to Form 8-K filed on January 8, 1998. However, the LLM claims the debentures were not mentioned in the 2022 filing and only appeared for the first time in 2023, which contradicts the ground truth. This error affects both quantitative accuracy (incorrect disclosure timeline) and qualitative accuracy (faulty multi-hop reasoning across filings). The referenced exhibit date (January 8, 1998) and the interpretation of its significance — indicating a stable, long-term debt structure — are correctly understood and well-reasoned in the LLM answer. The explanation of incorporation by reference and the enduring nature of the instrument is semantically aligned with the ground truth and contextually relevant. However, because the core factual claim about the evolution across years is incorrect, the overall correctness score is low. The model fails the multi-hop requirement of accurately synthesizing consistent disclosures across all three years, instead inventing a change in disclosure practice that did not occur.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 353,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "- 2022 10‑K – Reflective signage is listed among the “representative revenue‑generating activities” for the Transportation & Electronics segment.  \n- 2023 10‑K – The same product appears again in the Transportation & Electronics description (see the “Reflective signage for highway, and vehicle safety” line).【page_107】  \n- 2024 10‑K – Reflective signage is still shown as a core activity of the Transportation & Electronics segment (again listed under “Reflective signage for highway, and vehicle safety”).【page_110】\n\nThe fact that reflective signage is repeatedly positioned within the Transportation & Electronics segment in each year’s filing shows that 3M (MMM) treats it as a stable, core offering rather than a peripheral or one‑off product, underscoring its ongoing strategic importance to the company’s product portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across 2022, 2023, and 2024, which aligns with the ground truth. It accurately confirms the product's presence in all three years’ 10-K filings and correctly associates it with the same segment, satisfying basic entity and temporal accuracy (hence quantitative accuracy is 10, as no numbers or dates are misstated). However, the LLM fails to address the key aspect of the question: the *evolving positioning* of Reflective Signage within the list of offerings each year. The ground truth emphasizes a shift from fifth to fourth place in 2023 and retention of fourth place in 2024, with specific changes in the products preceding and following it—details entirely missing from the LLM response. This omission significantly weakens the qualitative accuracy, as the multi-hop reasoning required to infer strategic importance from *ranking changes* is not performed. Instead, the LLM draws a generic conclusion about 'ongoing strategic importance' based solely on persistence, missing the nuanced signal of increased prominence. While the conclusion about strategic relevance is directionally aligned, it lacks the evidentiary support from sequential positioning data. Thus, the answer is factually correct in parts but incomplete in reasoning and synthesis, warranting a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 394,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "In the 2022 Form 10‑K Gilead already listed its Hoofddorp, Netherlands site as a facility “used for commercial manufacturing and processing of our cell‑therapy products.” The 2023 filing (pages 9‑13) continues to include Hoofddorp among its cell‑therapy sites, and the 2024 Form 10‑K again describes the Hoofddorp plant as a commercial manufacturing and processing location. Thus, from 2022 through 2024 the Hoofddorp facility has moved from being a newly‑added cell‑therapy site to a firmly established, strategically‑important hub for the commercial production of Gilead’s approved cell‑therapy medicines.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of dates (2022–2024), entities (Gilead, Hoofddorp, Netherlands), and the facility’s role in commercial cell therapy manufacturing. It correctly identifies that Hoofddorp was listed as a commercial manufacturing site in each year’s Form 10-K, which aligns with the original answer’s timeline. However, the LLM misrepresents the 2022 status: the original answer clarifies that in 2022, Hoofddorp was identified only as a principal manufacturing facility, not yet explicitly for commercial cell therapy—this specific designation came in 2023. The LLM incorrectly states that in 2022 it was already 'used for commercial manufacturing and processing of our cell-therapy products,' which contradicts the ground truth and overstates its role at that time. This is a significant qualitative error in reasoning and chronology, though all other years are accurately represented. The conclusion that it evolved into a 'strategically-important hub' by 2024 is supported, but the characterization of 2022 as a 'newly-added' site lacks evidence in the ground truth. Quantitative accuracy is perfect—no numbers or dates are incorrect. Contextual relevance is strong, as the response directly addresses the evolution of the facility’s strategic importance. The error in the 2022 characterization prevents a higher score despite otherwise accurate synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 389,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "- In the 2022 Form 10‑K the table of equity‑compensation plans showed that roughly **58 million shares** were still available for future issuance under the Texas Instruments 2003 Director Compensation Plan (the figure appears in the “Number of securities remaining available for future issuance” column).  \n\n- The 2023 filing reported essentially the same amount – **58.5 million shares** (see the 2023 table on page 61).  \n\n- By the 2024 filing the pool had grown to **about 65.5 million shares** (see the 2024 table on page 59).  \n\n**Interpretation:** The pool of shares that can be issued under the 2003 Director Compensation Plan stayed flat from 2022‑2023 and then expanded in 2024, indicating that Texas Instruments continues to rely on the plan for director compensation and has even increased the available share reserve to support future awards.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively, it reports 58 million, 58.5 million, and 65.5 million shares available in 2022, 2023, and 2024 respectively, which is wildly inaccurate compared to the ground truth: 1,843,134 in 2022, 1,786,785 in 2023, and 1,745,284 in 2024. These numbers are off by a factor of over 30x. (2) The trend is completely misrepresented: the LLM claims the pool stayed flat and then increased, while in reality it consistently decreased, indicating active use of the plan. The LLM’s interpretation that the reserve expanded is false. (3) The reasoning is flawed—there is no evidence of a growing share pool; instead, the decline shows ongoing issuance of shares to directors. (4) The entities (plan name, company, years) are correct, and the question parts are addressed in structure, giving minimal contextual relevance. However, the factual inaccuracies in numbers and resulting incorrect conclusion severely undermine the answer. The model likely confused the 2003 Director Compensation Plan with another plan or misread the data. Minor formatting differences are acceptable, but this is a catastrophic error in magnitude and direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 332,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "In the 2022 filing IBM still disclosed the 0.950 % Notes due 2025 only by “incorporating by reference” the 2017 Form 8‑K instrument that defined the holders’ rights (the same language appears again in the 2023 10‑K on page 20). By the 2024 10‑K the notes are listed in the “Securities registered pursuant to Section 12(b)” table (page 1) with a NYSE ticker (IBM25B), making the issue a clearly identified, exchange‑listed security. This shift from a purely reference‑based disclosure to an explicit market‑registration listing signals IBM’s move toward greater transparency and liquidity for its debt, reflecting a broader capital‑market strategy that emphasizes active investor communication and easier access for bond investors.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were initially referenced via incorporation by the May 22, 2017 Form 8-K in both 2022 and 2023 filings, and in 2024 they were explicitly listed with a dedicated NYSE ticker (IBM25B). The progression from reference-based disclosure to exchange listing is accurately described. (2) No numerical or date inaccuracies: the percentage (0.950%), maturity year (2025), and reference to the 2017 Form 8-K are all correct. The mention of page 20 in the 2023 10-K and page 1 in the 2024 10-K aligns with typical disclosure practices and adds precision without contradicting the ground truth. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings, identifies the evolution in disclosure treatment, and infers the strategic implication—increased transparency, liquidity, and investor accessibility. (4) The conclusion about IBM’s broader capital market strategy emphasizing investor communication and bond market accessibility is logically supported by the evidence and matches the original answer’s interpretation. Wording differs but meaning is preserved, and the LLM even adds contextual detail (e.g., Section 12(b) registration) that enhances accuracy without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 378,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances grew sharply after 2021 – the 2022 filing shows the company already using the method for a modest closed‑block coinsurance arrangement, and by the 2023 10‑K the deposit‑asset balance had risen to about **$5.1 billion** with a corresponding **$1.3 billion** of deposit liabilities.  In 2024 those balances slipped slightly to **$4.6 billion** of deposit assets and **$1.2 billion** of deposit liabilities, indicating a modest pull‑back after the peak in 2023.  \n\nThe November 2023 Global Atlantic transaction illustrates a strategic shift: MetLife recorded **$10.3 billion** of reinsurance recoverables and deposit receivables (and transferred $9.5 billion of assets to the reinsurer) and booked a $770 million net cost of reinsurance in other liabilities, expanding the deposit‑method from a relatively small closed‑block coinsurance use to a large, block‑level risk‑transfer that leverages the deposit accounting framework to manage capital and earnings more aggressively.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: 2022 deposit assets and liabilities are not explicitly stated in the LLM answer, but the 2023 ($5.1B assets, $1.3B liabilities) and 2024 ($4.6B assets, $1.2B liabilities) figures match the original answer exactly. The $10.3B reinsurance recoverables and deposit receivables from the Global Atlantic transaction are correctly reported. (2) The LLM omits the 2022 figures ($1.8B assets, $1.4B liabilities) from the original answer, which slightly reduces completeness but does not affect the core trend description. (3) The reasoning is sound: the LLM correctly identifies the sharp increase in deposit-method balances by 2023, the slight pullback in 2024, and interprets the Global Atlantic transaction as a strategic shift toward more aggressive use of deposit accounting for large-scale risk transfer. The mention of $770M net cost of reinsurance and $9.5B asset transfer adds contextual detail not in the original but consistent with plausible expansion. (4) The LLM uses 'after 2021' to frame the trend, which is slightly imprecise but acceptable given the focus on 2022–2024. Overall, the answer captures the evolution and strategic shift accurately, with only minor omission of 2022 baseline numbers preventing a perfect 10. Semantic equivalence is maintained, and multi-hop synthesis across years and transactions is robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 397,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "The Safety & Industrial segment has consistently listed “respiratory, hearing, eye and fall‑protection solutions” as a core product line (see the segment‑product tables in 2022 – 2024 [pages 107, 110]).  In the first quarter of 2024 the company reorganized the segment, creating an **Industrial Specialties** division that pulls together the former Personal‑Safety business (which houses the fall‑protection portfolio) with closure‑masking and adhesive‑tape lines [page 110].  By folding fall‑protection products into a dedicated specialty‑division, 3M is sharpening its focus on workplace‑safety solutions and signaling a strategic push to grow that safety‑product franchise over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant factual inaccuracies that undermine its overall correctness. (1) The claim that 3M reorganized its segment in Q1 2024 to create an 'Industrial Specialties' division that includes the Personal-Safety business (and thus fall protection) is not supported by the ground truth and contradicts the consistent portrayal of fall protection as part of a broader safety portfolio without structural changes. The original answer indicates only a minor phrasing evolution, not a strategic reorganization. (2) The LLM cites specific page numbers (107, 110) and implies structural changes in 2024, but the ground truth shows no such reorganization—only consistent inclusion of fall protection within respiratory, hearing, eye, and fall protection solutions. This misrepresents the nature of the evolution. (3) While the LLM correctly identifies that fall protection was consistently part of the Safety and Industrial segment from 2022–2024, it incorrectly infers a strategic shift or intensification of focus due to a non-existent reorganization. The ground truth emphasizes stability and consistency, not a 'strategic push to grow.' (4) Quantitative accuracy is relatively high: no numerical errors per se, and the time frame (2022–2024) is correct. Page references may be accurate to the document but are used to support a false narrative. (5) Multi-hop reasoning is flawed—the model synthesizes across years but draws an unsupported conclusion about corporate restructuring and strategic intent. The semantic meaning diverges significantly from the original: the core message of 'consistency' is replaced with 'strategic evolution,' which is incorrect. Thus, while some surface facts are right, the reasoning and key implications are wrong, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 495,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria’s corporate hierarchy for its smokeless‑tobacco business has remained unchanged from 2022 through 2024 – the company continues to own **UST LLC** outright, and UST in turn wholly owns **U.S. Smokeless Tobacco Company LLC (USSTC)**, the maker of the Copenhagen, Skoal and Red Seal MST brands【page 60】.  In each filing the oral‑tobacco segment (which groups USSTC’s MST products) is presented as a distinct, reportable segment, underscoring that Altria treats its smokeless‑tobacco operations as a core, stand‑alone business【page 4】.  This continuity signals that Altria is deliberately cementing its foothold in the smokeless market, using the fully‑controlled UST/USSTC platform to drive growth while pursuing its broader “move beyond smoking” strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities are correct: Altria, UST LLC, U.S. Smokeless Tobacco Company LLC (USSTC), and brand names (Copenhagen, Skoal, Red Seal) are accurately identified. The ownership structure — Altria owning UST, which in turn owns USSTC — is correctly described and consistent across 2022–2024. (2) There are no numeric values in the LLM answer that contradict the ground truth; while the $8.8 billion trademark value and amortization expenses from 2022 are omitted, the LLM does not misstate any figures, and the absence of specific dollar amounts does not constitute inaccuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes structural continuity across years, identifies UST/USSTC as a reportable segment, and links this to Altria’s strategic positioning. It correctly infers that maintaining a standalone, fully controlled smokeless segment supports the 'move beyond smoking' strategy, which is semantically equivalent to the ground truth’s 'Moving Beyond Smoking' initiative. (4) The only minor shortcoming is the lack of explicit mention of UST being described as a 'core operating company' in 2024 or the emphasis on reduced-risk product alignment, but the broader strategic implication — that Altria is cementing its smokeless footprint as part of a larger transition strategy — is effectively conveyed. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 444,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the SolarCity 5.45 % Solar Bonds, Series 2015/C92‑15 among the company’s outstanding debt instruments 【page_102】 【page_105】. By repeatedly referencing the same 2015 bond series, Tesla signals that it is using this legacy SolarCity issuance as a long‑term, fixed‑rate source of capital to fund its solar‑energy projects, rather than issuing new, separate financing each year. This reflects a financing strategy that leans on existing debt structures to support the ongoing growth of its solar business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the bond name (SolarCity 5.45% Solar Bonds, Series 2015/C92-15), the years of reference (2022, 2023, 2024), and the implication of long-term financing strategy are consistent with the original answer. The percentage (5.45%) and series designation are correctly cited. (2) Quantitative accuracy is perfect: no calculations are required, but the dates and identifiers (e.g., 2015 issuance) are correctly referenced. Format variations (e.g., spacing in '5.45 %') do not affect meaning. (3) The reasoning is sound: the LLM correctly infers that Tesla is relying on an existing, fixed-rate debt instrument rather than issuing new debt annually, indicating a strategic, long-term financing approach. It captures the core idea of sustained reliance on securitized solar debt, though it omits specific details like the 'One Hundred-and-Sixteenth Supplemental Indenture' and the term 'material component' or 'legal and financial linkage' mentioned in the ground truth. (4) Despite minor omissions in legal detail and phrasing, the LLM conveys the essential strategic implication—using legacy SolarCity bonds as a stable capital source—demonstrating strong multi-hop synthesis across filings. The answer is contextually precise, directly addressing Tesla's long-term financing strategy for solar initiatives. The score is 9/10 due to slightly less depth in legal/structural detail compared to the original, but the core message and factual correctness are intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 428,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "- **2022 (Form 10‑K 2022, p. 22)** – IBM warned that the value of its debt securities “fluctuates … the level, direction and volatility of interest rates, changes in exchange rates, exchange controls, governmental and stock‑exchange regulations and other factors over which the company has little or no control.” The same paragraph also noted that the company’s ability to meet interest and principal payments depends on its operating performance.  \n\n- **2023 (Form 10‑K 2023, p. 11)** – The risk‑factor language was carried forward unchanged, again citing “governmental and stock‑exchange regulations” as drivers of debt‑security value, and added that “changes by any rating agency … can negatively impact the value and liquidity of both the company’s debt and equity securities.”  \n\n- **2024 (Form 10‑K 2024, p. 11)** – IBM reiterated the same exposure, emphasizing that the debt‑security value is subject to “governmental and stock‑exchange regulations” and that rating‑agency actions affect both debt and equity liquidity, while confirming it does not make a market in its securities.  \n\n**What this shows:** Across three consecutive years IBM has consistently disclosed its susceptibility to stock‑exchange and regulatory factors for both debt and equity, and has progressively broadened the disclosure to include rating‑agency risk. The steady, transparent articulation of these external risks indicates a capital‑market risk‑management strategy that focuses on continual monitoring and explicit acknowledgment of regulatory and rating‑agency influences rather than attempting to eliminate them.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM's exposure to stock exchange regulations is consistently reported from 2022 to 2024, with accurate citations of Form 10-K pages and risk factors. The evolution in disclosure—retaining core language while expanding to include rating-agency impacts in 2023 and confirming lack of market-making in 2024—is correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023, 2024), document types (Form 10-K), and page numbers (p. 22, p. 11) are accurate—thus scoring 10. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifies continuity in regulatory risk disclosure, and notes the incremental broadening to include rating-agency effects. The conclusion about IBM’s strategy focusing on monitoring and transparency rather than elimination of risk is semantically equivalent to the ground truth’s point about persistent systemic exposure and lack of mitigation. Only minor nuance is missing: the 2024 expansion linking regulatory impact to broader market liquidity and customer credit risks is slightly underdeveloped in the LLM answer, which mentions liquidity but not customer credit. This prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of regulatory exposure and what it reveals about capital market risk management. Overall, the LLM provides a factually correct, well-structured, and substantiated response with only minor omissions in depth of 2024 analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1681,
        "completion_tokens": 476,
        "total_tokens": 2158
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across all three filings the Safety & Industrial segment is described as “…electrical products and materials for construction and maintenance, power‑distribution and electrical OEMs,” showing that the company has kept electrical‑product offerings a core part of the segment from 2022 through 2024.  While net sales in Safety & Industrial slipped from $11.6 billion in 2022 to about $11.0 billion in 2023‑24, operating income rose sharply (from $1.1 billion in 2022 to $2.3 billion in 2023 and $2.5 billion in 2024), indicating that 3M is leveraging its electrical‑product portfolio to move toward higher‑margin, specialty industrial solutions and strengthening its strategic position in the industrial market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MMM's Safety & Industrial segment consistently included electrical products for construction and maintenance from 2022 to 2024, which aligns with the ground truth. However, it introduces financial data (net sales and operating income) not present in the original answer or implied by the question, and these figures are unsupported by the provided ground truth. There is no mention in the ground truth of sales or income figures, so their inclusion undermines factual accuracy. (2) The quantitative claims—$11.6B sales in 2022 dropping to $11.0B in 2023–24, and operating income rising from $1.1B to $2.3B and $2.5B—are entirely absent from the ground truth and cannot be verified; thus, they are factually incorrect in this context. These numbers may be plausible but are not part of the knowledge graph source, making them hallucinated. (3) The reasoning about MMM moving toward higher-margin, specialty solutions based on financial trends is speculative and not supported by the actual evolution described in the original answer, which focuses on shifts in product line descriptions rather than financial performance. The multi-hop synthesis fails because it misdirects from the textual evolution of segment descriptions (the real basis) to a financial narrative that wasn't asked for or provided. (4) While the core point about continuity in electrical products is correct, the LLM omits key qualitative shifts in segment composition—such as the addition of industrial abrasives and autobody repair in 2023 and the rephrasing around 'industrial specialty products' in 2024—which are central to the original answer’s analysis. Instead, it invents a profitability-based rationale that isn't grounded in the source. Thus, despite some correct elements, the answer is partially incorrect due to hallucinated data and incomplete synthesis of the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 519,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "Across all three filings the Oceanside, California site is described the same way. In the 2022 10‑K the facility is “used for commercial retroviral‑vector manufacturing and clinical manufacturing and process‑development of our biologics candidates.” The 2023 filing repeats that description, and the 2024 filing lists the Oceanside site again for “commercial retroviral‑vector manufacturing and clinical manufacturing and process‑development of our biologics candidates.” Thus, from 2022 through 2024 Gilead’s Oceanside plant has consistently served both commercial retroviral‑vector production and the clinical‑scale manufacturing and development of its biologic programs, with no change in its stated role.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim of consistency across the years, directly contradicting the ground truth. According to the original answer, GILD's Oceanside facility evolved significantly from 2022 to 2024: starting as part of a general R&D footprint in 2022, becoming specifically highlighted for clinical manufacturing and process development of biologics in 2023, and then being designated as the dedicated site for *commercial* retroviral vector manufacturing in 2024. The LLM incorrectly asserts that the facility was described identically in all three years as being used for 'commercial retroviral-vector manufacturing' starting in 2022, which is not supported by the ground truth. This misrepresents the evolution of the facility’s role and fails the multi-hop reasoning required to detect a strategic shift over time. While there are no numeric values to assess, the qualitative error is severe—misidentifying the timeline and nature of the facility's development. The answer is contextually relevant in that it discusses the correct facility and capabilities, but the reasoning and factual synthesis are fundamentally flawed, leading to an incorrect conclusion of no change. Hence, the correctness and qualitative accuracy scores are low, while quantitative accuracy is high only because no numbers were involved or misstated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 376,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "- 2022 – AIG’s glide‑path set the “return‑seeking” (growth) portion at **15 % equity** (the target for 2022)【page_310】.  \n- 2023 – The next year’s glide‑path target was reduced to **about 9 % equity**, reflecting a shift toward more liability‑hedging assets【page_252】.  \n- 2024 – The glide‑path target remained at **roughly 9 % equity** (the target for the 2025 horizon, which is the same level applied to the 2024 plan)【page_184】.  \n\nThus, AIG’s glide‑path approach moved the Return‑Seeking allocation from 15 % in 2022 down to about 9 % by 2023, and it stayed at that lower level in 2024, indicating a continued de‑risking of the U.S. pension plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific percentage allocations (15%, 9%, 9%) for the Return-Seeking portion of AIG's U.S. pension plan, which are not present in the original ground truth answer. However, the ground truth does not mention any specific numerical targets for equity or return-seeking allocations. Instead, it emphasizes the *methodology* of the glide path—specifically, that target allocations are set forward-looking (e.g., 2024 target based on 2023 funded status, etc.). The LLM introduces precise numbers not found in the ground truth, making them factually unsupported. (2) While the percentages (15%, 9%) may reflect actual data from the cited pages (e.g., page_310, page_252), the ground truth does not confirm these values, and the evaluation is based on alignment with the provided ground truth, not external document verification. Thus, the quantitative claims cannot be considered accurate relative to the ground truth. (3) The multi-hop reasoning in the LLM answer focuses on numerical trends (decline from 15% to 9%) and interprets it as de-risking, which may be plausible, but this analysis is absent from the original answer. The original emphasizes the *timing and basis* of target setting (forward-looking based on funded status), not the magnitude or direction of allocation changes. The LLM fails to capture the core conceptual evolution described in the ground truth—i.e., the dynamic, forward-looking adjustment mechanism tied to funded status. (4) Despite introducing unsupported numbers, the LLM does recognize a trend of declining return-seeking allocation, which could align with de-risking behavior, and it attempts to track year-over-year changes, showing some relevance. However, the fundamental reasoning and evolution described in the ground truth—how targets are set for future years based on prior year funded status—is entirely missing. Hence, while contextually relevant and partially accurate in structure, the answer diverges significantly in factual content and reasoning depth, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 556,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "In fiscal 2023 the non‑U.S. defined‑benefit plans were targeted at 27 % equity, 48 % debt, 4 % cash, 11 % insurance contracts and 10 % other (U.S. plans were 100 % debt). By the fiscal 2025 target the mix had shifted to 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % other, while the U.S. plans remained 100 % debt. This gradual move away from a heavy debt allocation toward more insurance‑contract and cash holdings – with only a modest increase in equity – signals that Accenture is tempering market‑risk exposure and favoring more liability‑matching, lower‑volatility assets, indicating a cautious, long‑term risk‑tolerance posture.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The provided percentages (e.g., 27% equity, 48% debt for fiscal 2023; 28% equity, 36% debt for fiscal 2025) are not supported by the ground truth. The original answer does not contain any specific numerical allocations for asset classes across years—it discusses planning horizons and strategic flexibility, not granular portfolio weights. The LLM fabricates detailed percentage breakdowns that are not present in the source. (2) COMPLETENESS: The question asks about the evolution of ACN's target asset allocation *strategy* from fiscal 2023 to 2025 and what it suggests about risk tolerance. The ground truth focuses on the shift in planning horizon (from one-year to two-year forward targeting), not changes in asset weights. The LLM completely misses this strategic nuance and instead invents a narrative around shifting allocations that is unsupported. (3) ENTITY & REASONING: While the company (ACN/Accenture) and general topic (defined benefit plans, risk tolerance) are correct, the multi-hop reasoning fails. The LLM incorrectly assumes that specific allocation percentages are available and uses them to infer a 'cautious' stance, whereas the ground truth infers increased confidence from an extended planning horizon. This is a fundamental misinterpretation of the strategic signal. (4) SEMANTIC EQUIVALENCE: The LLM answer is not semantically equivalent—it replaces a discussion of planning horizon and strategic flexibility with a detailed but fictional asset mix analysis. The conclusion about 'cautious risk tolerance' contradicts the ground truth's implication of *increased confidence* and a more strategic posture. The contextual relevance is moderate because it addresses pension plans and risk tolerance, but the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 504,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C25‑15 first appeared in the 2015 supplemental indentures (e.g., Exhibit 4.36 “Thirty‑Sixth Supplemental Indenture … Series 2015/C25‑15”) and are listed in the exhibit schedules of every subsequent filing – the 2022 Form 10‑K (pages 100‑104), the 2023 Form 10‑K (pages 98‑102) and the 2024 Form 10‑K (pages 97‑101) all reference the same Series C25‑15 bond. The repeated inclusion of this bond across three consecutive years shows that Tesla has retained the 2015‑issued, fixed‑rate solar financing as a standing component of its capital structure, using long‑term, low‑cost debt to fund solar projects rather than issuing new securities each year. This multi‑year pattern reveals a strategy of locking in stable financing for its solar business through a durable bond program that remains on the balance sheet for many years.【page_99†L23-L27】【page_100†L23-L27】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the bond series (5.45% Solar Bonds, Series 2015/C25-15), its origin in 2015, and its consistent disclosure in Tesla’s 10-K filings for 2022, 2023, and 2024 are accurately reported. The specific page references (e.g., 2022 10-K pages 100–104) match the expected disclosure locations, and the mention of Exhibit 4.36 and supplemental indentures adds precise sourcing. (2) The answer correctly infers that Tesla continues to rely on this bond as part of its long-term capital structure, which is consistent with the ground truth’s conclusion about ongoing reliance and strategic importance. (3) The multi-hop reasoning is sound: the model connects the bond’s origin (via SolarCity acquisition, implied by 2015 issuance) to its sustained presence in disclosures, synthesizing information across three years of filings to infer a strategic pattern. (4) While the LLM does not explicitly mention Tesla’s broader solar bond portfolio (e.g., Series C5-15, C10-15, C20-15 in 2022 or newer C28-15/C33-15 in 2023) as noted in the original answer, it does not contradict them and still reaches a substantively correct conclusion about Tesla’s financing strategy. The omission of these additional series slightly reduces completeness but does not undermine the core accuracy. The LLM emphasizes the durability and stability of the financing model, which is semantically equivalent to the ground truth’s claim about the bond being 'integral' to solar deployment. Wording differs but meaning is preserved. Minor deduction from 10 to 9 due to partial incompleteness on bond portfolio breadth, but all critical facts and reasoning are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 473,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "In the 2022 filing AIG quantified its worst‑case international terrorism scenario – a five‑ton bomb attack in New York – with a net loss of roughly **$1.3 billion** after applying the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and existing reinsurance, and it relied on **targeted reinsurance purchases and participation in country‑specific terrorism pools** to cover the residual risk.  \n\nBy the 2024 filing the company still **uses a third‑party vendor model and scenario‑based modeling** for terrorism, but it no longer cites a single dollar estimate; instead it stresses **continuous monitoring of concentration, ongoing targeted reinsurance purchases, and expanded reliance on government‑sponsored and government‑arranged terrorism‑reinsurance programs (including pools) in non‑U.S. jurisdictions**, while TRIPRA continues to mitigate U.S. exposure.  \n\nThus, AIG’s approach evolved from a specific, quantified loss estimate in 2022 to a broader, ongoing scenario‑based risk‑management framework in 2024, with consistent use of TRIPRA, targeted reinsurance and global pool mechanisms to mitigate international terrorism risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $1.3 billion net loss estimate for the 2022 five-ton bomb scenario in New York is accurately reported, and while no specific modeled loss is cited for 2024, the LLM correctly notes the shift away from publishing a single dollar estimate, which matches the original answer. The reinsurance recoverable of $38.0 billion in 2024 is not explicitly mentioned in the LLM response, which is a minor omission, but the emphasis on expanded reinsurance and risk transfer mechanisms is consistent. (2) The LLM correctly identifies the use of TRIPRA, scenario-based modeling, and participation in terrorism pools across years. (3) The qualitative reasoning is sound: it captures the evolution from a specific quantified scenario in 2022 to a more dynamic, monitoring-focused framework in 2024, including disciplined reinsurance and expanded use of government-sponsored pools internationally. The retention of core attachment points in Japan ($200 million) is omitted, which slightly reduces completeness, but the overall trend in reinsurance strategy and global coverage is accurately conveyed. (4) Contextual relevance is excellent—the response directly addresses all components of the question: modeled loss estimates, reinsurance strategies, and risk mitigation across jurisdictions. The synthesis across 2022–2024 is logical and factually grounded. The only reasons for not scoring a 10 are the omission of the $38.0 billion reinsurance recoverable and the Japan attachment point, which are specific details from the ground truth that enhance completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 454,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Across the three years Honeywell repeatedly warned that its Safety and Productivity Solutions (SPS) business was vulnerable to “adverse industry economic conditions,” a risk that was flagged in the 2022, 2023 and 2024 Form 10‑K risk‑factor sections. Each filing said that such conditions – together with reduced investments in process automation, safety‑monitoring and plant‑capacity‑utilization initiatives, weaker retail‑market demand, a slowdown in safety‑product purchases and an increasingly competitive landscape (new entrants and product commoditization) – could erode market share, force lower selling prices and compress SPS margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Honeywell's exposure to adverse industry economic conditions in the Safety and Productivity Solutions (SPS) segment from 2022 to 2024. It correctly identifies the consistent risk factors across all three years: reduced investments in process automation, retail market fluctuations, and product commoditization due to new market entrants. The answer also accurately reflects that these conditions contributed to margin pressures, lower selling prices, and eroded market share—key points mentioned in the ground truth. The only minor shortcoming is that the LLM groups all risk factors as being explicitly stated in each year’s filing, while the ground truth specifies that in 2023, 'lower market share' and 'reduced selling prices' were newly emphasized, and by 2024, the segment was restructured into Industrial Automation. The LLM mentions the continuity of risk but does not explicitly note the 2024 rebranding of the segment, which slightly weakens the qualitative accuracy. However, the semantic meaning and multi-hop synthesis across years remain sound. All entities (Honeywell, SPS, 2022–2024, Form 10-K) are correct, and there are no numerical inaccuracies (dates are correct and no faulty calculations). The answer is fully contextually relevant, directly addressing both parts of the question: evolution over time and specific margin risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 391,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "In 2022 Pfizer still granted Breakthrough Performance Awards (BPAs) as part of its long‑term incentive program – the awards were valued at grant‑date using the intrinsic‑value method (the closing price of Pfizer’s common stock) and expense was amortized on a straight‑line basis over the probable vesting term, with periodic adjustments for stock‑price changes and revised vesting estimates. By 2023 the company had stopped issuing BPAs; the 2023 filing explicitly states that “no BPAs were granted in 2023 and no BPAs were outstanding as of December 31, 2023,” so no BPA‑related compensation cost was recognized that year. The 2024 filing repeats this position – “no BPAs were granted in 2024 and no BPAs were outstanding as of December 31, 2024”—the valuation methodology remains described in the note, but with zero grant activity the BPA expense disappears from the financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Pfizer granted BPAs in 2022 using the intrinsic value method, with expense amortized over the probable vesting term and adjusted for stock price and vesting estimates. It accurately notes no grants in 2023 and no outstanding awards as of December 31, 2023, and repeats this for 2024. (2) Quantitatively, the LLM omits the specific 2022 grant number (1,165 thousand) and the weighted average intrinsic value ($38.73) and the nonvested amount (859 thousand), which are present in the ground truth. These omissions prevent a perfect quantitative score, though no numbers stated are incorrect. (3) The reasoning is sound: it correctly traces the program’s wind-down from active use in 2022 to termination by 2023 and explains the continued disclosure of methodology in 2024 despite no activity. (4) The answer is contextually complete and relevant, addressing grant activity, valuation methodology, and financial statement recognition across all three years. The only shortfall is the lack of specific numerical data from 2022, but the conceptual and qualitative treatment is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 333,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "- **Fiscal 2022:** Accenture bought 12.2 million Class A shares for about **$4.1 billion**. At the start of the year the board had **$3.13 billion** of “available” authorization for the open‑market program; after the year’s purchases the board added **$3 billion** of new authority, raising total outstanding authority to **$6.13 billion**.  \n\n- **Fiscal 2023:** The company continued to repurchase shares (the 2023 filing shows another multi‑billion‑dollar buy‑back), drawing down the pool of authorized funds and leaving a smaller balance of available authorization than at the start of the year (the exact figure is not restated, but the trend was a declining “available” balance as purchases accumulated).  \n\n- **Fiscal 2024:** Accenture repurchased **$4.5 billion** of stock (2.07 million shares in Q4 alone) and, as of 31 August 2024, had **$2.694 billion** of remaining authorization. In September 2024 the board approved an additional **$4 billion**, bringing total outstanding authority to **$6.694 billion**.  \n\n**What the trend shows:** Accenture’s share‑repurchase program has been a steady, multi‑billion‑dollar component of its capital‑return strategy. Each year it uses a large portion of its authorized pool, then periodically expands the total authority to keep the program flexible. This pattern signals a disciplined approach to returning cash to shareholders while preserving the ability to increase buy‑backs when cash flow and market conditions permit.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies in key numbers, particularly in fiscal 2022 and 2024 repurchase amounts and authorizations. According to the ground truth, in fiscal 2022, Accenture had an available authorization of $3.129 billion, but the LLM claims the company spent $4.1 billion on repurchases — which exceeds the available authorization at the start of the year, contradicting the data. Additionally, the LLM states that $3 billion in new authority was added in fiscal 2022, bringing total outstanding to $6.13 billion, but the ground truth does not confirm this specific sequence or total. In fiscal 2024, the LLM claims Accenture repurchased $4.5 billion of stock, but the ground truth does not provide this figure, making it unsupported. Only the remaining authorization of $2.694 billion as of August 31, 2024, and the new $4 billion authorization (totaling $6.694 billion) match the ground truth exactly.\n\n2) Quantitative accuracy is compromised: the $4.1 billion repurchase in 2022 and $4.5 billion in 2024 are not supported by the original answer. The original answer does not specify annual repurchase amounts, only the evolution of authorization. The LLM fabricates or misattributes these figures, leading to incorrect calculations and misleading synthesis. The correct trend is that remaining authorization decreased to $2.694 billion before a $4 billion top-up — this part is accurate. However, the LLM incorrectly implies that large repurchases occurred each year without grounding those numbers in the provided truth.\n\n3) The multi-hop reasoning is partially sound: the LLM correctly infers a pattern of using authorization and then replenishing it, which aligns with the ground truth's interpretation of a growing commitment to capital return. The qualitative assessment of a 'disciplined approach' and 'flexible program' is reasonable and matches the intent of the original answer. However, the reasoning is built on inaccurate quantitative foundations, weakening the overall logic.\n\n4) Contextual relevance is high — the answer directly addresses the evolution of share repurchases and authorization across the three fiscal years and draws a meaningful conclusion about capital return strategy. Despite factual errors, the structure and intent are aligned with the question. The conclusion about consistent and increasing commitment is partially supported, though overstated due to incorrect figures.\n\nOverall, the answer shows good structure and interpretation but fails on key factual accuracy, especially in dollar amounts spent, which are either fabricated or inconsistent with the authorization limits. This results in a correctness score of 6 — partially correct but with significant quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 726,
        "total_tokens": 2276
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "- In the 2022 Form 10‑K Pfizer still reported Meridian’s pre‑sale results as a discontinued operation, recording a $345 million pre‑tax legal charge and a $167 million after‑tax loss on the sale (Note 2B) and presenting its historic revenues and expenses alongside the rest of the business.  \n\n- The 2023 filing shows that, after the December 31 2021 divestiture, Pfizer entered into interim transition‑service agreements (TSAs) and a three‑year manufacturing‑supply agreement (MSA) with the buyer; the TSAs were completed by December 31 2023 and the MSA (with a two‑year extension option) remained in place, but the amounts recorded under both were immaterial.  \n\n- By the 2024 Form 10‑K Meridian is no longer discussed, indicating the TSAs have ended and the MSA is no longer material, so Pfizer’s relationship with Meridian has been reduced to a fully‑divested, non‑strategic status with no ongoing financial or operational ties.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly affect correctness. First, it claims Pfizer recorded a $345 million pre-tax legal charge related to Meridian in 2022 — this is not supported by the ground truth and introduces a fact not present in the original answer. The original answer only mentions a $167 million after-tax loss from the sale, which aligns with the LLM's mention of that figure, but the additional legal charge is incorrect and unverified. Second, the LLM states that transition-service agreements (TSAs) were completed by December 31, 2023, and that a manufacturing-supply agreement (MSA) remained in place — however, the ground truth makes no mention of any ongoing agreements post-divestiture. The original answer explicitly states that by 2024, Meridian is only mentioned as a defined entity in the glossary, indicating no active operational or financial relationship. Thus, the claim of ongoing agreements contradicts the ground truth. (2) The divestiture date is incorrectly implied to have occurred after December 31, 2021 (the sale was completed on that date), yet the LLM discusses post-2021 agreements without clarifying the timeline accurately. The $167 million after-tax loss is correctly cited, matching the ground truth, which supports partial quantitative accuracy. However, the introduction of the $345 million pre-tax charge — absent in the original — undermines quantitative reliability. (3) The multi-hop reasoning is partially sound in that the LLM attempts to trace the relationship across years and considers financial disclosures, operational agreements, and strategic alignment. However, it fabricates operational agreements (TSAs, MSA) not present in the ground truth, failing to correctly synthesize the information. The conclusion that there are no ongoing ties by 2024 aligns with the original, but it is reached through incorrect intermediate steps. (4) Despite these issues, the answer remains contextually relevant, addressing all dimensions of the question (financial, operational, strategic) and attempting longitudinal analysis. The core trajectory — from discontinued operations to full disengagement — is roughly correct, but key details are inaccurate or invented, warranting a mid-range score of 5 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 618,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "- **Fiscal 2022:** The 2022 Form 10‑K states that the Amended 2010 Share Incentive Plan authorizes a maximum of **127 million** Accenture plc Class A ordinary shares for awards【page_91】.  \n- **Fiscal 2023:** The 2023 filing makes no amendment to that limit, so the authorized amount remained at **127 million** shares (the same figure reported in the prior year).  \n- **Fiscal 2024:** The 2024 Form 10‑K shows the authorization was increased to **141 million** shares【page_98】.\n\n**Interpretation:** By expanding the pool from 127 million to 141 million shares, Accenture is deliberately enlarging its capacity to grant equity‑based awards. This signals a long‑term strategy to rely more heavily on share‑based compensation to attract, retain and align the interests of employees and leadership with shareholders.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the fiscal year 2023 authorized shares. The ground truth states that the number increased to 141,000,000 in both fiscal years 2023 and 2024. However, the LLM claims that in fiscal 2023, the amount remained at 127 million, which is incorrect. This misrepresents the evolution of the share authorization. The fiscal 2022 (127 million) and fiscal 2024 (141 million) figures are correct, but the 2023 figure is wrong. (2) Quantitative accuracy is partially correct: 127 million in 2022 and 141 million in 2024 match the ground truth. However, the failure to report the increase in 2023 undermines the accuracy of the progression. The increase should have been reflected in 2023, not introduced only in 2024. (3) The multi-hop reasoning is flawed because the model did not correctly synthesize the data across all three years. It incorrectly assumes no change in 2023 based on lack of amendment mention, but the ground truth confirms the higher limit was already in effect in 2023. This breaks the logical chain of how the policy evolved. (4) Contextual relevance is high—the answer addresses the right plan, company, and metric, and the interpretation of strategic intent is reasonable given the data it used. However, due to the key error in the 2023 figure, the overall correctness and qualitative accuracy are significantly reduced. The conclusion about long-term strategy is plausible but based on an incomplete and missequenced timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 415,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla’s 2022 Form 10‑K still listed the original “Seventieth Supplemental Indenture … 4.70 % Solar Bonds, Series 2015/C52‑10” as an exhibit (see page 101, exhibit 4.4) 【page_101】. In the 2023 and 2024 Form 10‑K exhibit tables (pages 99‑103 for each year) the C52‑10 bond does not appear among the listed supplemental indentures, indicating that no new amendments or separate disclosures were made for that series after 2022. This consistency suggests the bond remains an outstanding liability, but the company has treated it as a routine, ongoing debt obligation rather than a focus of new strategic financing activity.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that the 4.70% Solar Bonds, Series 2015/C52-10, do not appear in the 2023 and 2024 Form 10-K exhibit tables, which directly contradicts the ground truth. According to the original answer, Tesla consistently disclosed the same Seventieth Supplemental Indenture in all three years: as Exhibit 4.49 in 2022, Exhibit 4.42 in 2023, and Exhibit 4.40 in 2024. The LLM incorrectly states the exhibit number for 2022 as 4.4 (not 4.49) and wrongly asserts the bond is absent in 2023 and 2024. (2) Quantitative accuracy is partially correct in that the bond series and interest rate (4.70%) are accurate, and the 2015 filing date is implied via the series name. However, the exhibit numbers and disclosure years are factually wrong. (3) The multi-hop reasoning is flawed: the LLM infers absence of strategic activity due to lack of new amendments, but this conclusion is based on incorrect premise (non-disclosure). The ground truth shows consistent re-disclosure, indicating ongoing liability and alignment with solar financing strategy—exactly the opposite of the LLM’s implication that it's no longer a focus. (4) Contextual relevance is moderate because the answer addresses the question’s intent—assessing obligations and strategy—but fails on factual synthesis, leading to an incorrect interpretation. The core error undermines both completeness and reasoning, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 407,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "- In the 2022 filing Adobe described its Digital Learning Services as a “comprehensive portfolio of learning and enable‑ment services” that “includes a large number of free online self‑service learning options on learning.adobe.com” and that these free modules sit alongside fee‑based classroom, virtual and on‑demand programs and custom‑learning services for the largest enterprises【page 18 (2023 10‑K)】.  \n\n- The 2023 filing repeats the same positioning, still emphasizing the free self‑service catalog on learning.adobe.com as a core part of the broader learning portfolio that is “complemented by our custom learning services” and that helps customers and partners use Adobe products【page 18 (2023 10‑K)】.  \n\n- By the 2024 filing the URL had been updated to www.training.adobe.com, but the description is unchanged: the free self‑service options remain a “core offering” within Adobe Digital Learning Services, which also provides fee‑based training and custom services, and they are explicitly linked to Adobe’s customer‑adoption strategy – the learning portfolio is used by Customer Success Managers to “promote faster solution adoption” and to support “Getting Started” help for new users【page 17 (2024 10‑K)】.  \n\nThus, from 2022 through 2024 Adobe’s free online self‑service learning has remained a foundational, publicly accessible tier of its learning and enablement suite, increasingly framed as the entry point that fuels faster product adoption and is integrated with the company’s broader consulting, success‑management and custom‑learning services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe's free online self-service learning was introduced as part of a comprehensive portfolio in 2022, remained central in 2023, and continued as a core offering in 2024 under Adobe Digital Learning Services. The platforms mentioned—learning.adobe.com and later www.training.adobe.com—are correctly cited, with the URL update accurately noted. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracking the evolution (or consistency) of the offering’s positioning and its integration into customer adoption strategies. It accurately notes the role of Customer Success Managers and the use of learning materials for 'Getting Started' support in 2024, which adds contextual depth beyond the ground truth. (4) The only minor discrepancy is that the original answer states the 2022 platform was hosted on www.training.adobe.com, while the LLM notes learning.adobe.com initially and then a switch in 2024—this may reflect a subtle inconsistency in source interpretation, but the LLM’s claim is backed by the cited 2024 10-K reference. Overall, the answer is semantically equivalent, comprehensive, and contextually precise, earning a 9 due to this slight ambiguity in platform URL timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1644,
        "completion_tokens": 413,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path rules tie the “Return‑Seeking” (growth) slice of the qualified U.S. pension portfolio to the plan’s funded ratio. In the 2021 filing the plan’s target for 2022 – when the funded status was lower – called for 15 % equity (growth) assets, 75 % fixed‑maturity securities and 10 % other investments 【page_310】. By the 2023 filing, after the funded ratio had improved, the target for 2024 was cut to 9 % equity, with fixed‑maturity securities raised to 80 % and other assets to 11 % 【page_252】, and the 2024 filing shows the same 9 %/80 %/11 % target for 2025 【page_184】. Thus, as funding rose from 2022 to 2024, AIG’s glide‑path reduced the growth‑asset allocation from 15 % to 9 % and shifted more assets into liability‑hedging fixed‑income positions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific numerical allocations (15%, 9%, etc.) and cites exact shifts in asset allocation over time, which are not present in the original answer (ground truth). The ground truth explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts,' meaning the LLM fabricated precise figures unsupported by the source material. This is a critical factual error, severely undermining quantitative accuracy. While the LLM correctly identifies the general glide path mechanism—adjusting return-seeking assets based on funded status—and the direction of change (reducing growth assets as funding improved)—this qualitative reasoning aligns with the ground truth’s description of a consistent de-risking strategy. The multi-hop synthesis across years (2022 to 2024) and filings is logically structured and contextually appropriate, showing understanding of how the glide path evolves annually based on prior year funded status. However, the inclusion of fabricated percentages and citation of specific pages (e.g., page_310, page_252) not verified in the ground truth constitutes hallucination. Thus, while the conceptual framework and narrative flow are relevant and partially accurate, the answer fails on factual correctness due to invented data. The correctness score is limited to 4 because the core idea of de-risking via glide path is correct, but the unsupported specifics severely compromise reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 407,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "- In the 2022 Form 10‑K Honeywell warned that its **Performance Materials and Technologies** segment “may be adversely impacted by … raw material demand and supply” (see 2022 risk‑factor text, p. 32).  \n- The 2023 filing repeated the same exposure for the same segment, again flagging raw‑material demand‑ and‑supply volatility as a key risk (2023 risk‑factor text, p. 31).  \n- By the 2024 filing, after the segment was renamed **Energy and Sustainability Solutions**, the company still cited “raw material demand and supply” as a risk (2024 macro‑risk text, p. 30), but an operational‑risk note added that **a majority of the raw‑material supply base for Energy and Sustainability Solutions (formerly PM&T) was now under contract** (2024 operational‑risk text, p. 33).  \n\n**Trend:** The explicit risk language persisted, but the proportion of raw‑material inputs covered by contracts rose from roughly two‑thirds in earlier years to “a majority” in 2024, indicating that Honeywell has been mitigating its exposure and is becoming less vulnerable to commodity‑price volatility, though some sensitivity remains.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with a significant factual divergence from the ground truth in its interpretation of Honeywell's risk mitigation efforts. (1) Correctly identifies that raw material demand and supply risks were consistently cited across 2022–2024 in the relevant segment (initially Performance Materials and Technologies, later renamed Energy and Sustainability Solutions), which aligns with the original answer. The citations to specific pages and filings add precision. (2) However, the key quantitative and qualitative claim—that contract coverage rose from 'roughly two-thirds' to 'a majority'—is not supported by the ground truth. The original answer makes no mention of contractual mitigation or improved risk coverage; instead, it emphasizes intensifying vulnerability due to energy market volatility. The LLM introduces a mitigation narrative (reduced vulnerability) that contradicts the ground truth’s conclusion of increasing exposure. The phrase 'a majority' in 2024 is presented as a decline from 'two-thirds' (which is ~66%), but 'a majority' is semantically similar and not a meaningful improvement—this misrepresents the trend. (3) The multi-hop reasoning is partially sound—linking segment renaming and persistent risk language—but fails in synthesis by inferring a positive risk-reduction trend unsupported by the evidence. (4) Contextual relevance is high because the answer addresses the evolution of risk disclosure and attempts to interpret vulnerability trends. However, the final conclusion is factually incorrect, leading to a low correctness score despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 449,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "- **2022:** Mutual‑fund equity securities held in the non‑U.S. defined‑benefit plans were valued at **$239 million** ( $4.9 m Level 1 + $234 m Level 2).  \n- **2023:** The same holdings fell to **$196 million** ( $7.4 m + $188.8 m).  \n- **2024:** They rose to **$274 million** ( $20.2 m + $253.5 m).\n\n**Trend interpretation:** Over the three‑year span the company first trimmed its mutual‑fund equity exposure in 2023, then rebuilt it in 2024 to a level higher than 2022. This pattern indicates a strategic tilt back toward equity‑heavy, market‑linked assets—using mutual‑fund vehicles to increase growth potential while still allowing flexibility in the pension‑plan asset mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293M in 2022 to $196.226M in 2023 and remained unchanged in 2024. However, the LLM incorrectly states that the value rose to $274M in 2024, which contradicts the ground truth. The 2022 and 2023 figures are approximately correct when rounded ($239M vs $239.293M; $196M vs $196.226M), but the 2024 figure is entirely wrong. (2) The quantitative accuracy is low: while 2022 and 2023 values are acceptably rounded, the 2024 value is off by over $77M, and the claim of an increase is factually incorrect. No calculation errors in the LLM's stated numbers, but the underlying data is wrong. (3) The multi-hop reasoning is flawed: the LLM infers a 'rebuilding' of equity exposure in 2024, leading to a strategic tilt toward equities, but the ground truth shows no change from 2023 to 2024, indicating stabilization, not re-investment. This misrepresents the strategic trend. (4) Contextual relevance is moderate—the answer addresses the evolution and strategic implication as asked, and focuses on the correct company (ACN) and asset class (mutual fund equity securities), but the incorrect data undermines the analysis. The qualitative reasoning would be reasonable if the numbers were correct, but it's based on false premises. Thus, the correctness score is low due to major factual and interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 408,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "In the 2022 filing Adobe described Document Cloud simply as “a unified, cloud‑based document‑services platform that integrates Adobe’s PDF technology with Acrobat and Acrobat Sign to deliver fully digital document workflows across all surfaces,” emphasizing its role as a subscription‑based PDF and e‑signature solution for individuals and enterprises but without any mention of AI. By the 2024 filing the positioning had shifted to portray Document Cloud as the “engine for complete, reliable and automated digital document and signature workflows” that now embeds generative‑AI – Acrobat AI Assistant and Firefly‑powered features – and offers enterprise‑grade APIs, Firefly Services and custom AI models to automate content creation, editing and brand‑consistent document processes across desktop, mobile, web and third‑party apps. Thus, between 2022 and 2024 Adobe moved Document Cloud from a core PDF‑centric workflow platform to an AI‑enhanced, API‑driven hub for enterprise digital document automation and integrated AI‑generated content.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Adobe Document Cloud from a PDF- and e-signature-focused platform in 2022 to an AI-integrated, enterprise automation hub by 2024. The absence of AI mentions in 2022 and the explicit inclusion of Firefly and generative AI in 2024 are factually correct. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in strategic positioning across filings, correctly inferring a shift in segment alignment (implied from Publishing to Digital Media) and enhanced integration with AI tools like Firefly and Acrobat AI Assistant. While the original answer explicitly mentions the 2023 transition and segment repositioning, the LLM captures the trajectory without contradicting it, focusing on 2022 and 2024 as anchor points. (4) Semantic equivalence is strong: 'engine for complete, reliable and automated digital document workflows' mirrors 'automating enterprise document and signature workflows'; 'Firefly-powered features' and 'custom AI models' reflect deep AI integration. The only minor gap is the omission of the 2023 intermediate step in segment realignment, but the core transformation narrative remains intact. Thus, the answer is contextually rich, factually correct, and well-reasoned, warranting a 9 for overall correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 424,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "In the 2022 filing Honeywell warned that its Aerospace, Building‑technologies, Performance‑Materials & Technologies and Safety‑and‑Productivity Solutions businesses could lose market share and pricing power if new entrants or emerging technologies “lead to product commoditization, lower market share, reduced selling prices and lower margins.” By 2023, after the segment realignment, the same competitive‑landscape risk was restated for Aerospace Technologies, Industrial Automation, Building Automation and Energy & Sustainability Solutions, now also calling out “new entrants and non‑traditional players” as a source of pressure. The 2024 10‑K repeats this language, indicating that exposure to new market entrants and technological disruption has remained a consistent concern across all four reportable segments, with the anticipated effect of continued commoditization, weaker pricing leverage and potential erosion of market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: the risk of new market entrants and technological disruption affecting market share, pricing power, and margins is accurately attributed to the relevant Honeywell segments across 2022–2024. The evolution of segment names due to restructuring (e.g., shift from 'Performance Materials and Technologies' to 'Industrial Automation' and 'Energy & Sustainability Solutions') is correctly reflected. (2) There are no numeric values in the question or answer requiring calculation, but all dates (2022, 2023, 2024) are used correctly and consistently. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time across filings and segments, correctly identifying the expansion of competitive risks from fewer to all four reportable segments. (4) The only minor deviation from the original answer is that the LLM implies the 2022 risk applied to Aerospace, while the ground truth specifies it was not mentioned for Aerospace until 2023. The LLM incorrectly includes Aerospace in 2022, which slightly undermines the precision of the segment-level evolution. However, the overall trend of broadening exposure is correctly captured. Wording differences are acceptable under semantic equivalence, and the core conclusion about increasing concern over competitive dynamics is preserved. Hence, high scores across all categories with a small deduction in qualitative accuracy for the premature inclusion of Aerospace in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 421,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "In the 2022 filing Pfizer only noted that the 2020 Upjohn‑Mylan spin‑off created Viatris and that the companies had entered into “various agreements” (separation‑distribution, agency, MSA, TSA, tax‑matters and employee‑matters) to support the transition. By the 2023 Form 10‑K the company disclosed the mechanics of those agreements—interim agency arrangements for billing and rebates, long‑term MSAs for manufacturing/labeling, and TSAs that were largely finished as of 31 Dec 2023—and reported that the net amount owed to Viatris fell from $94 million at year‑end 2022 to $33 million at year‑end 2023. The 2024 filing contains no material intercompany balances or new transition‑service costs, indicating that the transition services have essentially been completed and the financial relationship with Viatris has been wound down.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $94 million intercompany balance due to Viatris at year-end 2022 and the reduction to $33 million at year-end 2023 are accurately reported. The statement that TSAs were largely completed by December 31, 2023, matches the original answer. The 2024 filing correctly notes no material balances or new services, indicating full wind-down. (2) Quantitative accuracy is perfect: both dollar amounts and the date (Dec 31, 2023) are correct, and the implied trend of declining exposure is properly conveyed. (3) Multi-hop reasoning is sound—information is synthesized across 2022, 2023, and 2024 filings to show evolution over time. The LLM correctly infers from the absence of new balances or services in 2024 that the relationship has been operationally resolved, which is consistent with the ground truth’s conclusion. (4) The only minor shortcoming is that the LLM does not explicitly state that in 2024 the relationship was referenced only in corporate definitions, which slightly reduces completeness. However, the conclusion that the financial and operational relationship has been wound down is fully supported. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as all parts of the question—transition services and intercompany balances over 2022–2024—are addressed with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 397,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "- In the 2022 10‑K the “Securities registered pursuant to Section 12(b)” table listed four outstanding notes – 1.000 % Notes due 2023, 1.700 % Notes due 2025, 2.200 % Notes due 2027 and 3.125 % Notes due 2031【MO_10k_2022.pdf page_1】.  \n- By the 2023 filing the 1.000 % 2023 notes had disappeared, leaving the 1.700 % Notes due 2025 as the nearest‑term debt together with the same 2.200 % 2027 and 3.125 % 2031 notes【MO_10k_2023.pdf page_1】, and the 2024 filing shows the identical set of three notes【MO_10k_2024.pdf page_1】.  \n\nThis progression shows Altria retiring its shortest‑dated, lowest‑coupon issue (the 1 % 2023 notes) and retaining a laddered portfolio anchored by the 1.700 % 2025 notes and longer‑dated, higher‑coupon notes. The shift suggests a capital‑structure strategy that reduces near‑term refinancing risk while locking in relatively low rates for the next few years and extending debt maturity to the longer‑term notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (1.000%, 1.700%, 2.200%, 3.125%) and maturity years (2023, 2025, 2027, 2031)—are correct and match the original answer. The observation that the 1.000% Note due 2023 disappeared by 2023 and the 1.700% Note due 2025 remained through 2024 is factually sound. (2) No calculations were required, but the timeline and instrument tracking across years are precise. (3) The multi-hop reasoning—synthesizing data from 2022, 2023, and 2024 10-K filings—is correctly executed. The LLM correctly infers that Altria did not issue a replacement short-term note after 2023, maintaining a laddered debt structure. (4) The interpretation about reducing refinancing risk and locking in low rates is a reasonable extension of the ground truth, which states the strategy focuses on intermediate and long-term debt. The only minor difference is that the LLM emphasizes 'locking in low rates' and 'laddered portfolio,' which are plausible but slightly more interpretive than the original's neutral tone about not rolling over short-term obligations. However, this does not detract from factual correctness. All parts of the question are addressed: evolution of debt composition, role of the 1.700% Note due 2025, and strategic implications. Semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 377,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "- 2022: Fixed‑rate unsecured senior notes carried $24,134 million at a weighted‑average interest rate of **4.45 %**【page_178】.  \n- 2023: The same class grew to $27,168 million and the average rate rose to **4.84 %**【page_188】.  \n- 2024: The portfolio was $26,930 million, still at a **4.84 %** weighted‑average rate【page_188】.  \n\nThe debt balance rose sharply between 2022 and 2023 and then held steady, while the average cost climbed modestly and then stabilized. This pattern suggests Capital One is deliberately expanding its long‑term fixed‑rate funding base, even at slightly higher rates, to secure a larger, stable source of capital for future growth rather than relying solely on lower‑cost, shorter‑term borrowing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, Capital One's fixed unsecured senior debt had a carrying value of $19,975 million and a weighted-average interest rate of 2.91%. However, the LLM reports $24,134 million and 4.45%, which are both incorrect. The 2023 and 2024 carrying values ($27,168M and $26,930M) match the ground truth, as does the 2023 interest rate of 4.45% (though the LLM incorrectly states it rose to 4.84% in 2023). The LLM claims the 2024 rate remained at 4.84%, but the ground truth shows it increased to 4.84% in 2024 from 4.45% in 2023, meaning the LLM misattributes the timing and magnitude of the rate change. (2) Calculations: The LLM incorrectly implies the rate increased from 4.45% to 4.84% between 2022 and 2023, when in reality it increased from 2.91% to 4.45%. This is a major miscalculation in trend interpretation. (3) Multi-hop reasoning: While the LLM correctly identifies the overall trend of increasing debt and higher rates, and draws a reasonable conclusion about long-term funding strategy, the flawed data undermines the validity of the synthesis. The reasoning is sound in structure but based on incorrect inputs. (4) Despite the factual errors, the answer addresses all parts of the question—evolution over time and strategic implication—and uses appropriate financial terminology. The qualitative assessment of strategy is semantically similar to the ground truth, justifying moderate scores in qualitative accuracy and high contextual relevance. However, the quantitative inaccuracies severely limit correctness, warranting a score of 6 due to partial factual alignment in later years and correct directional trends, but major errors in baseline data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 481,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C92‑15 were first issued in August 2015 (see the One‑Hundred‑Sixteenth Supplemental Indenture on page 105).  The same bond series continues to be listed in the exhibit schedules of the 2022, 2023 and 2024 Form 10‑K filings (the exhibit tables on pages 100‑104 of each year all include the 5.45 % Solar Bonds, Series 2015/C92‑15).  This unchanged presence indicates that Tesla has retained the original SolarCity bond issuance as a standing source of capital for its solar business, relying on legacy bond financing rather than replacing it with new debt instruments.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 5.45% Solar Bonds, Series 2015/C92-15 and their presence in Tesla's 2022, 2023, and 2024 10-K filings, which aligns with the ground truth. The bond's initial issuance in August 2015 is factually accurate and consistent with the knowledge graph. However, the LLM incorrectly implies that Tesla has relied on this legacy bond as a 'standing source of capital' without introducing new instruments, which contradicts the ground truth. The original answer notes the emergence of newer bond series like C102-15 and C106-10 in 2024, indicating a shift in financing strategy—this key evolution is entirely missing from the LLM response. (2) Quantitatively, all percentages, dates, and exhibit references (e.g., page numbers) are plausible and consistent with the filings, though the LLM generalizes exhibit locations (e.g., 'pages 100–104') rather than citing specific exhibit numbers (Exhibit 4.61 in 2022, 4.54 in 2023, 4.52 in 2024), which reduces precision. Still, no numeric inaccuracies are present. (3) The multi-hop reasoning is partially sound—the LLM correctly tracks the bond’s continued disclosure across years—but fails to synthesize the critical contrast with newer bond series, leading to an incorrect conclusion about Tesla’s financing strategy. The reasoning stops short of the necessary comparative analysis. (4) The answer is contextually relevant and addresses the core timeline and bond usage, but misses the strategic implication of declining prominence and transition to newer instruments, resulting in a partially correct but misleading interpretation. Hence, correctness is scored at 5 due to significant omission in strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 466,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "From 2022 to 2024 AIG has deepened the governance of loss‑reserve risk. In 2022 the company relied on “internal controls and oversight of the loss‑reserve setting process, as well as reviews by external experts” and a broad set of underwriting‑, pricing‑ and model‑risk‑management procedures (stochastic and deterministic models, scenario analyses, third‑party catastrophe models). By 2023 the same framework was reinforced with an explicit ERM “second‑line review and challenge” and regular Internal Audit testing, while still using external‑expert reviews in its Critical Accounting Estimates. In the 2024 filing the oversight architecture is described as a formal risk‑committee/chief‑risk‑officer structure supported by ERM’s second‑line challenge, internal‑audit audits and continued model‑risk‑management and validation processes, with external expert input now referenced mainly through the loss‑reserve accounting estimates.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of AIG's loss reserve risk management from 2022 to 2024. (1) Key elements such as internal controls in 2022, use of external expert reviews, expansion of modeling approaches (stochastic, scenario analyses), and enhanced governance in later years are accurately reflected. The mention of Internal Audit testing, second-line review, and ERM integration in 2023–2024 matches the progression described in the original answer. (2) There are no numeric values or dates in the question or answers that require verification—only qualitative descriptions of processes and frameworks—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM synthesizes information across the three years, correctly identifying the trajectory from internal oversight to a more structured, ERM-integrated model with layered validation. However, the LLM slightly overstates the presence of stochastic methods and catastrophe models in 2022, which were emphasized more in 2023 according to the ground truth; this introduces a minor inaccuracy in the timeline of modeling approach evolution. Additionally, the original answer highlights 2024’s integration into a 'more holistic ERM system' with enhanced reporting and audits, which the LLM captures but frames more around committee structure than the broader enterprise integration. (4) Despite these nuances, the core facts, entities (AIG, ERM, Internal Audit, external experts), and chronological progression are correct. The answer is contextually fully relevant and semantically close to the original, warranting a high score but not perfect due to slight misplacement of modeling tool adoption timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 475,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s pension‑plan exposure to U.S. Treasury and foreign‑government securities fell from roughly 25 % of the pension portfolio in 2022 (and again in 2023) to about 16 % in 2024【page_84】【page_86】【page_89】.  The reduction in government‑bond weight – while corporate‑bond and equity holdings have risen – reflects a deliberate shift away from low‑yield Treasury assets toward a higher‑return, liability‑driven mix that better balances pension‑liability hedging with growth objectives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Altria's allocation to U.S. Treasury and foreign government securities decreased from 19% in 2022 to 16% in 2023, then sharply to 8% in 2024. However, the LLM states it was roughly 25% in both 2022 and 2023 and only dropped to 16% in 2024—misrepresenting both the starting value and the trend. The correct trajectory shows a steady and significant decline, especially the drop to 8% in 2024, which the LLM completely misses. (2) The calculation and trend analysis are therefore flawed. The LLM implies a gradual decline from 25% to 16% over two years, whereas the actual data shows a more aggressive shift: a 3-percentage-point drop from 2022 to 2023 and an 8-percentage-point drop from 2023 to 2024. This misrepresents the pace and magnitude of the strategic shift. (3) While the LLM correctly infers a strategic move away from government securities toward higher-return assets, it fails to mention key supporting evidence from the original answer—such as the reduction in below-investment-grade securities (from 11% to 9%) and the decline in expected return on pension assets (from 6.6% to 6.1%), which reinforce the cautious strategic recalibration. The reasoning is partially sound but lacks multi-hop synthesis of these corroborating trends. (4) The answer is contextually relevant and addresses the general direction of the strategy, earning moderate scores for qualitative accuracy and relevance. However, due to major numerical errors and incomplete use of evidence, the correctness and quantitative accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 454,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "- **Short‑term borrowings** fell sharply from **$883 million in 2022** to **$538 million in 2023**, then edged back up to **$562 million in 2024** (Table 8.1, 2023 10‑K and Table 9.1, 2024 10‑K).  \n- **Long‑term debt** rose modestly from **$47.8 billion in 2022** to **$49.3 billion in 2023**, before being trimmed to **$45.0 billion in 2024** (Table 8.1/9.1). Within that debt, **fixed‑rate senior notes stayed roughly flat (≈$24‑27 billion)**, **floating‑rate senior debt collapsed from $1.6 billion in 2022 to $0 in 2024**, and **securitized debt obligations fell from $16.97 billion in 2022 to $14.26 billion in 2024** (Table 8.1, 2023 10‑K; Table 9.1, 2024 10‑K).\n\n**Trend insight:** Over the three‑year span Capital One reduced both its short‑term borrowing and its overall long‑term leverage, while deliberately shedding floating‑rate senior debt and securitized obligations. The shift to a higher proportion of fixed‑rate senior debt lowers the company’s exposure to rising interest rates, indicating a strategic move toward a more stable, lower‑cost debt profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM reports long-term debt as $47.8B, $49.3B, and $45.0B, which does not align—especially the 2023 figure being higher than the true total of all debt (including short-term). Moreover, the LLM separates short-term borrowings (correctly noting a decline from $883M to $538M to $562M), but fails to sum them with long-term debt to report the total debt as required by the question. The ground truth emphasizes total debt evolution, which the LLM does not accurately reflect. (2) Specific number verification: Securitized debt in 2022 was $14.994B (ground truth), but LLM states $16.97B—this is a major discrepancy. Floating unsecured senior debt was $1.709B in 2022 (ground truth), LLM says $1.6B—close but still off. By 2024, floating unsecured senior debt dropped to $0 in both versions, which is correct. Fixed-rate senior debt in ground truth rose from $19.975B (2022) to $26.930B (2024); LLM says '≈$24-27B', which is directionally acceptable but omits the starting point and understates early-year levels. Interest rates on securitized debt (1.51% → 3.01% → 3.48%) and floating debt (1.01% → 6.75% → 0%) are completely omitted in the LLM answer, a critical omission given the question’s focus on interest rate exposure. (3) Multi-hop reasoning assessment: The LLM correctly infers a strategic shift toward fixed-rate debt and reduced interest rate exposure, which aligns with the ground truth’s conclusion. It identifies the retirement of floating-rate debt and decline in securitized debt, showing some correct synthesis. However, it misses the key insight that securitized debt *increased* in 2023 before declining in 2024, and misrepresents the overall debt trajectory by implying a consistent reduction when debt actually peaked in 2023. (4) Justification for scores: Correctness is 5 due to partial factual alignment but major numerical errors and missing interest rate data. Quantitative accuracy is low (4) due to incorrect debt totals and securitized debt figures. Qualitative accuracy is moderate (6) because reasoning about strategic shift is sound despite flawed inputs. Contextual relevance is high (8) as the answer addresses all question components, even if inaccurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 644,
        "total_tokens": 2234
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the “Thirty‑Sixth Supplemental Indenture … 5.45 % Solar Bonds, Series 2015/C25‑15” as an exhibit (see the tables in the 2023 filing [page 99] and the identical entries in the 2022 [page 100] and 2024 [page 101] filings). The fact that this same 2015‑issued bond series is repeatedly disclosed shows that Tesla continues to rely on that specific debt instrument to fund its solar‑related projects, and its persistent inclusion signals that the bonds remain an active, material component of Tesla’s overall capital structure and debt‑service obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the bond series '5.45% Solar Bonds, Series 2015/C25-15' is accurately identified, and the repeated inclusion across Tesla's 2022, 2023, and 2024 10-K filings is correctly noted. The issuance date (April 14, 2015) is implied via reference to the '2015-issued bond'—a reasonable simplification. (2) Quantitative elements—percentage (5.45%), series designation, and years of filings (2022–2024)—are all correct. No calculations are required, and formatting (e.g., '5.45 %' with space) is a minor typographical variance, not an error. (3) The multi-hop reasoning is sound: the model correctly infers from repeated disclosure that the bond remains an active and material part of Tesla’s capital structure, reflecting ongoing reliance—this matches the original answer’s logic. (4) The LLM slightly omits the specific mention of the 'Thirty-Sixth Supplemental Indenture' being identical across years, but this detail is secondary to the core conclusion about continued reliance. The answer captures the semantic meaning and intent of the ground truth, with only negligible omission. Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 365,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance grew from a $51.4 billion negative balance at the end of 2022, to $60.4 billion at the end of 2023, and to $71.4 billion at the end of 2024 – an increase of roughly $9 billion each year. This steady rise shows that the company has been accelerating its share‑repurchase program, using excess cash to buy back stock and return capital to shareholders, indicating a capital‑allocation focus on buybacks (in addition to dividends) rather than reinvesting the cash in new operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the trend in Mastercard's Class A Treasury Stock from 2022 to 2024 with accurate figures: $51.4B (2022), $60.4B (2023), and $71.4B (2024), which align with the ground truth values of $(51,354)M, $(60,429)M, and $(71,431)M when rounded to the nearest tenth of a billion. The use of negative balances is implied by the context of treasury stock (a contra-equity account), and the LLM appropriately refers to the growing magnitude of the negative balance as a 'growth' in treasury stock, which is standard interpretation.\n\n2) Quantitatively, the numbers are accurate within reasonable rounding: 51,354 million ≈ 51.4 billion, 60,429 million ≈ 60.4 billion, and 71,431 million ≈ 71.4 billion. The claim of 'roughly $9 billion each year' increase is also reasonable: 60.4 - 51.4 = 9.0B; 71.4 - 60.4 = 9.0B. The actual increases are $9.075B and $11.002B, so the 'roughly $9B' slightly understates the second-year increase but is acceptable as an approximation.\n\n3) The multi-hop reasoning is sound: the model correctly identifies the three-year trend, infers the acceleration in buybacks, and connects this to capital allocation strategy—specifically stock buybacks as a means of returning capital to shareholders. It appropriately adds context about buybacks being used alongside dividends, which is consistent with Mastercard’s known capital allocation practices, even if not explicitly stated in the ground truth.\n\n4) The answer is semantically equivalent to the ground truth and adds slight interpretive depth (e.g., mentioning dividends and excess cash) without introducing inaccuracies. All entities—Mastercard, Class A Treasury Stock, correct years (2022–2024)—are accurate. The only minor shortcoming is the slight simplification of the second-year increase, but this does not undermine the overall correctness. Hence, a high score of 9 is justified, with full marks in contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 520,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s 2022 10‑K warned that its Safety & Productivity Solutions segment could be hurt by “reduced investments in process automation, safety monitoring and plant‑capacity‑utilisation initiatives” and other adverse industry economic conditions. The same risk language appears unchanged in the 2023 filing, and in the 2024 filing it is carried forward under the newly‑named Industrial Automation segment, showing that the exposure to weak capital‑spending and plant‑utilisation pressures persisted despite the segment realignment. This continuity signals that macro‑economic headwinds—slower industrial investment, high‑cost financing and broader economic uncertainty—remained a persistent drag on the industrial sector throughout 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Honeywell consistently cited reduced investments in process automation and plant capacity utilization as risks to its Safety and Productivity Solutions segment from 2022 to 2024. The 2022 and 2023 filings used similar language, and in 2024, the segment was renamed to Industrial Automation, which the LLM correctly notes. This aligns with the ground truth's assertion of persistent and deepening macroeconomic concerns. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly tracking the risk across years and through a segment name change. The only minor shortcoming is that the LLM does not explicitly mention the increasing emphasis on geopolitical instability and trade policy shifts in 2024, which the ground truth highlights as evidence of sharpened concern. This nuance is omitted but does not undermine the overall correctness. (4) The answer is contextually excellent, directly addressing the evolution of risk exposure and its implications for macroeconomic pressures in the industrial sector. Wording differs but meaning is semantically equivalent. Thus, correctness is 9 due to the slight omission in depth of 2024 risk elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 372,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "In the 2022 Form 10‑K Eli Lilly described Cyramza as a multi‑indication oncology drug – a second‑line treatment for advanced or metastatic gastric/gastro‑esophageal adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and a first‑line option for adult patients with EGFR‑mutated metastatic NSCLC【page_5】.  \n\nThe 2023 filing shows that the product’s core compound patents expire in 2026 in the United States and Japan and in 2028 in Europe, while its data‑protection (regulatory exclusivity) ends in 2024 in Europe and 2023 in Japan, indicating that Cyramza is moving into the late‑stage of its lifecycle as its exclusivity window closes【page_11】.  \n\nThe 2024 filing does not list any new approved indications for Cyramza, confirming that its therapeutic positioning has remained unchanged while the IP timeline now points to imminent patent and data‑protection expirations between 2023 and 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Therapeutic indications for Cyramza in 2022 are correctly listed, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers, with the additional detail about first-line use in EGFR-mutated NSCLC, which is consistent with the 2022 10-K. The 2024 update correctly notes no new indications, confirming stable therapeutic positioning. (2) Quantitatively, the answer states compound patents expire in 2026 in the U.S. and Japan and 2028 in Europe—this matches the ground truth (U.S. 2026, Europe 2028). Data protection expiration is correctly noted as 2023 in Japan and 2024 in Europe, matching the original answer. The only minor discrepancy is the inclusion of Japan in the 2026 patent expiry, which was not explicitly mentioned in the ground truth, but this is not incorrect—just more detailed. (3) Multi-hop reasoning is sound: the model synthesizes information across 2022, 2023, and 2024 filings to assess lifecycle evolution, correctly inferring that unchanged indications combined with narrowing IP protection indicate a late-stage lifecycle. (4) The answer is contextually excellent, directly addressing both therapeutic indications and IP timeline evolution. The conclusion about a 'narrowing window of exclusivity' is implied correctly. The answer earns a 9/10 for correctness due to slightly expanded detail on Japan patent expiry not in the ground truth, but no factual errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 413,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative assets/liabilities that are measured at Level 3 rose sharply – from a fair‑value balance of only **$5 million at the end of 2022**, to **$58 million at the end of 2023**, and to **$69 million at the end of 2024**.  In each year the instruments are valued using a **discounted‑cash‑flow model** and the key unobservable input is the **swap rate**; the weighted‑average swap‑rate assumption was **about 2 % in 2022** and increased to **around 4 % in both 2023 and 2024**, reflecting the higher fair‑value amounts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numeric values. According to the ground truth, Capital One's net derivative assets/liabilities were $19 million in 2022, $58 million in 2023, and $58 million in 2024. The LLM incorrectly reports $5 million in 2022 and $69 million in 2024, both of which are materially wrong. The fair value stabilization in 2024 is misrepresented as a further increase. (2) The unobservable inputs are partially correct: the LLM correctly identifies swap rates as a key input and reports the 4% weighted average in 2023 and 2024, which aligns with the ground truth. However, it states the 2022 swap rate was 'about 2%', while the ground truth does not specify a weighted average for 2022 but notes swap rates in the 3–5% range were used, with a 4% weight—this is a discrepancy. Additionally, the LLM omits mention of default rates (53–163% in 2023), a key unobservable input highlighted in the original answer. (3) The reasoning is partially sound in identifying the valuation methodology (discounted cash flows) and linking higher swap rates to increased fair value, but fails in multi-hop synthesis by not accurately tracking the evolution across all three years or incorporating all relevant inputs. The claim of $69 million in 2024 contradicts the stabilization pattern. (4) Contextual relevance is high as the answer addresses fair value measurements and unobservable inputs over time, using appropriate financial terminology. However, due to major quantitative errors and incomplete qualitative details, the correctness score is limited to 4, with low quantitative accuracy (3), moderate qualitative accuracy (5), and high contextual relevance (8).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 467,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "- In fiscal 2022 Qualcomm reported that “thousands of our employees around the world utilized our charitable‑match program, benefiting **more than 1,500 charitable organizations**.” By fiscal 2024 the same language was used for employee participation (“thousands of our employees … utilized our charitable‑match program”) but the program was said to have benefited **more than 1,300 charitable organizations**, indicating that employee use remained strong while the number of organizations supported fell modestly.  \n\n- Both years tie such human‑capital initiatives to executive pay: the 2022 filing notes that the HR and Compensation Committee could adjust executives’ bonuses by a 0.9‑to‑1.1 multiplier based on progress toward human‑capital goals, and the 2024 filing repeats the same non‑financial performance modifier for bonuses, showing that the charitable‑match program’s continued high participation is part of the broader human‑capital agenda that directly influences executive compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: employee participation is accurately described as 'thousands' in both 2022 and 2024, and the number of supported organizations is correctly reported as over 1,500 in 2022 and over 1,300 in 2024. These numbers match the original answer exactly in substance, with only minor phrasing differences (e.g., 'more than' vs 'over'). (2) Quantitative accuracy is perfect—no calculations are required beyond correct reporting of figures, which are precise and contextually appropriate. (3) The multi-hop reasoning is sound: the LLM correctly links the evolution of the charitable match program to executive compensation via the non-financial performance modifier (0.9 to 1.1), citing both 2022 and 2024 filings. It synthesizes information across years and domains (employee participation, organizational reach, and executive pay structure) appropriately. (4) The only minor shortcoming is that the LLM does not explicitly mention Qualcomm’s 2025 DEI goals, which are referenced in the original answer as part of the broader human capital strategy. While the connection to human capital goals is made, the forward-looking strategic context (2025 goals) is omitted, slightly reducing completeness. However, this does not undermine the core correctness. Overall, the answer is factually robust, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 403,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "In the 2022 Form 10‑K Adobe described Acrobat as the cornerstone of its Document Cloud platform – a “PDF experience” that spans desktop, web and mobile, is tightly integrated with Adobe Sign (e.g., “integrate Adobe Sign into Acrobat across all surfaces”), and is being expanded with new web‑based functionality, task‑based actions and AI‑driven features such as Liquid Mode. The 2023 filing merely lists Acrobat (and Acrobat Sign) among the Digital Media and Document Cloud product portfolio, confirming its continued role but without announcing new enhancements or integration shifts. The 2024 filing excerpts (pages 94‑98) contain only governance and exhibit information and do not provide any further Acrobat‑specific positioning, indicating no additional product‑level disclosures in those sections.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers, it scores high by default. Qualitatively, the answer is largely incorrect and contradicts the ground truth. The LLM claims that the 2023 filing 'merely lists' Acrobat without new enhancements, and that the 2024 filing contains 'only governance and exhibit information' with no Acrobat-specific disclosures—both of which directly contradict the ground truth. In reality, the 2023 filing highlights AI-powered innovation, integration with Adobe Sign and Creative Cloud, and forward-looking AI features. The 2024 filing explicitly introduces the 'Acrobat AI Assistant' as a registered trademark, marking a strategic shift toward AI integration. The LLM fails to capture this multi-hop evolution across years, incorrectly asserting a lack of updates when the opposite is true. It also misrepresents the 2022 positioning by omitting key context about market leadership in legal, financial, and publishing sectors and the ubiquity of PDFs. While it correctly notes integration with Adobe Sign and mentions Liquid Mode (an AI feature), it fails to synthesize the strategic trajectory from document standard to AI-enhanced platform. Contextual relevance is moderate because it discusses Acrobat in Document Cloud and mentions AI, but the core reasoning and factual synthesis are flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 397,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022 Eli Lilly recognized $2.02 billion of net product revenue from its COVID‑19 antibodies (bamlanivimab and bebtelovimab), and AbCellera received royalty payments equal to a mid‑teens‑to‑mid‑twenties % of those sales (recorded as cost of sales). Both 2023 and 2024 showed $0 net product revenue for the antibodies, meaning the royalty stream to AbCellera ceased in those years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that in 2022, Eli Lilly recognized $2.02 billion in net product revenue from bamlanivimab and bebtelovimab sales, with AbCellera receiving royalties in the mid-teens to mid-twenties percentage range—matching the ground truth. It accurately reports $0 revenue in both 2023 and 2024, and correctly infers that this resulted in no royalty payments to AbCellera in those years. All key facts are present and factually correct. (2) Quantitative accuracy is perfect: the dollar amount ($2.02 billion), years (2022–2024), and royalty range (mid-teens to mid-twenties %) are all precisely stated. No calculation errors. (3) The multi-hop reasoning is sound—linking revenue to royalty obligations across years, and correctly deducing cessation of payments due to zero sales. The only minor omission is that the original answer provides additional context about the wind-down being due to reduced demand or regulatory changes affecting EUAs, which the LLM omits. This doesn't affect factual correctness but slightly reduces qualitative depth. (4) Contextual relevance is excellent—the answer directly addresses the evolution of financial implications over the three years, focusing on revenue and royalty payments as asked. The omission of the explanatory context about EUAs and demand does not detract from core accuracy, hence a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 392,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife’s disclosed share of the closed‑block that is covered by the modified‑coinsurance arrangement was 59.25 % in 2022, ≈ 59 % in 2023, and remained at ≈ 59 % in 2024 【page_214】【page_227】【page_204】. The near‑identical percentage across three consecutive years shows that the company has deliberately kept a stable, roughly‑three‑fifths portion of the closed block off‑balance‑sheet via the same risk‑transfer structure, underscoring a long‑term commitment to using modified coinsurance as a core tool for managing and diversifying closed‑block liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the percentages for each year: 59.25% in 2022, approximately 59% in 2023, and approximately 59% in 2024, which aligns with the ground truth of 59.25%, 59%, and 59%. The use of '≈' is acceptable given the rounding and matches the factual values. 2) All numeric values are accurate; no calculations were required beyond correct reporting of percentages. The slight approximation in 2023 and 2024 is justified as the ground truth reports exactly 59%, so '≈59%' is semantically equivalent. 3) The reasoning correctly identifies the stability of the reinsurance percentage over three years and draws a logical conclusion about MetLife’s long-term risk transfer strategy, emphasizing strategic continuity and the use of modified coinsurance as a core tool. This matches the ground truth’s interpretation of 'strategic continuity in managing closed block liabilities.' The only minor gap is that the LLM uses 'off-balance-sheet' and 'diversifying' which are interpretive extensions not explicitly in the original, though reasonable in context. 4) The answer fully addresses both parts of the question: the evolution (stable percentages) and the strategic implication (consistent risk transfer). It synthesizes data across three years and correctly attributes the arrangement to MetLife’s closed block. The inclusion of citation markers like 【page_214】 suggests grounding in source material. Overall, the answer is factually precise, contextually appropriate, and semantically equivalent to the ground truth, warranting a high score with only a slight deduction in qualitative accuracy due to minor interpretive additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 449,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "From 2022 to 2024 Mastercard’s “multi‑layered” security model shifted from a primarily internal, layered‑defense framework to one that explicitly incorporates external partners and real‑time payment technology. In the 2024 filing the company notes that it now works with “experts across the organization … as well as … public‑private partnerships” to monitor and respond to cyber threats linked to third‑party providers, and it highlights that its real‑time account‑based payments infrastructure is being operated or rolled out in 13 markets (up from the earlier focus on a handful of markets). This evolution signals a cybersecurity strategy that is increasingly collaborative, ecosystem‑wide, and tightly integrated with the expanding real‑time payments network.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's security strategy with a focus on third-party collaboration and real-time payment infrastructure. However, there are minor inaccuracies in the quantitative details. According to the ground truth, Mastercard operated real-time payments in 12 markets in 2022 and expanded to 13 in 2023. The LLM states that the 13-market figure is from the 2024 filing, which misaligns with the timeline—2024 should reflect 'several countries globally' rather than a specific 13-market count. This misattribution of the 13-market figure to 2024 instead of 2023 reduces quantitative accuracy. (2) The LLM omits the 2022 baseline of 12 markets and incorrectly frames the progression as moving from 'a handful of markets' to 13, which is less precise than the documented 12-to-13 market expansion. While 13 markets is correctly cited, its placement in 2024 is inaccurate. (3) The multi-hop reasoning is largely sound: the model synthesizes the increasing role of third-party collaboration and integration with real-time infrastructure across years. It correctly infers a strategic shift toward a more collaborative and ecosystem-wide cybersecurity posture. However, it misses the 2024 refinement of 'ongoing third-party assessments and resilience programs' and the softening of market count to 'several countries globally,' indicating a slight gap in completeness. (4) Despite the timeline misplacement, the overall qualitative interpretation of a proactive, adaptive strategy aligned with real-time payment growth is accurate and contextually relevant. The answer is well-structured and addresses the core of the question, warranting strong scores in qualitative accuracy and relevance, but the factual error in year-to-number mapping prevents a higher correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 496,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "- Defined‑benefit pension assets held in private‑equity‑like (equity‑like) funds were **$4.0 billion in 2022**, rose to **$4.09 billion in 2023**, and then fell to **$3.93 billion in 2024** (the Level‑3 component dropped from about $25 million in 2022‑23 to $9 million in 2024).  \n\n- The brief increase followed by a modest pull‑back suggests that Lilly is willing to expand its exposure to illiquid, private‑equity‑style investments when conditions are favorable, but it also trims that exposure when market or liquidity considerations change, underscoring a long‑term, but actively managed, commitment to diversifying a portion of its portfolio into higher‑return, less‑liquid assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and trends. According to the ground truth, LLY's allocation to equity-like private alternative investments was $2,844.7 million in 2022, increased to $4,014.1 million in 2023, and further rose to $4,093.7 million in 2024. The LLM incorrectly reports $4.0 billion in 2022 (should be ~$2.84B), $4.09 billion in 2023 (overstated), and $3.93 billion in 2024 (understated and contrary to the upward trend). These errors misrepresent both the starting point and the direction of the trend. (2) The quantitative inaccuracies are severe: the 2022 figure is off by over $1.15 billion, and the supposed 'decline' in 2024 contradicts the actual continued growth. The mention of Level-3 assets dropping from $25M to $9M, while potentially accurate, is not part of the original question or ground truth and distracts from the core metric. (3) The reasoning is flawed due to incorrect data: the conclusion of a 'brief increase followed by a modest pull-back' is invalid because the actual data shows a consistent upward trajectory with only a minor dip in 2023. The multi-hop synthesis failed—instead of tracking the correct three-year trend from reliable data, the model constructed a narrative based on incorrect figures. (4) Despite the incorrect numbers and reasoning, the answer attempts to address the strategic implication of illiquid asset allocation, which maintains some contextual relevance. However, the core factual foundation is unsound, leading to a low correctness score. Minor credit is given for discussing private equity exposure in the context of long-term strategy, but the conclusion is not supported by the actual data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 469,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K, Cascade was listed among the “major brands” of the Fabric & Home Care segment and was described as a **home‑care** brand (the segment’s home‑care share was said to be “primarily behind our Cascade, Dawn, Febreze and Swiffer brands”). The 2024 filing still places Cascade in the same segment and still treats it as a home‑care brand, but the segment’s share of total net sales rose from **about 35 % in 2022 to roughly 36 % in 2024**, indicating a modest increase in its relative contribution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the Fabric & Home Care segment's share increased from about 35% in 2022 to 36% in 2024, matching the original answer (which notes 35% in 2022, 36% in 2023 and 2024). The LLM correctly identifies Cascade as a home-care brand within the segment and maintains consistency across years. (2) The answer accurately reflects Cascade’s stable product categorization as part of the Fabric & Home Care segment and as a key home-care brand, supported by direct references to the 10-K language. (3) The multi-hop reasoning is sound—comparing Cascade’s positioning and segment contribution across 2022 and 2024—and correctly infers stable strategic importance from continued inclusion and segment performance. (4) The only minor omission is that the original answer notes the 36% share was already present in 2023, not just 2024, which the LLM does not mention. However, this does not distort the overall trend and is a small detail in the broader context. Wording differs but semantic meaning is equivalent. All entities (Procter & Gamble, Cascade, Fabric & Home Care segment, net sales percentages) are correct. The answer is fully relevant and addresses product categorization and relative contribution as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 367,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "- **2022:** Lowe’s relied on a basic wood‑sourcing policy that required all wood products sold to come from “well‑managed, non‑endangered forests,” and it monitored suppliers through its human‑rights policy, conflict‑minerals policy and Vendor Code of Conduct that already contained enhanced environmental standards 【page_10】.  It also began a $550 million spend on energy‑efficiency and renewable‑energy projects (LED upgrades, high‑efficiency HVAC, building‑management systems and pallet grinders) to cut its own and supply‑chain carbon footprint 【page_10】.  \n\n- **2023:** The company upgraded the wood‑sourcing policy to a risk‑based framework, adding country‑specific wood‑risk levels, stronger monitoring practices and a new forestry‑grievance process 【page_9】.  It deepened its investment strategy, allocating about $300 million to similar efficiency projects and launching a large rooftop‑solar program (174 stores announced, >50 already operating) while expanding renewable‑energy PPAs and SmartWay transportation goals 【page_10】.  \n\n- **2024:** Lowe’s further refined the policy into a “more robust risk‑based approach” with the same country‑risk tiers, enhanced monitoring and an expanded grievance mechanism 【page_9】, and it continued to scale its investment plan – now operating >100 solar sites, pursuing 100 % SmartWay certification for freight providers and committing additional capital to energy‑efficiency, renewable‑energy and supply‑chain emissions‑reduction initiatives 【page_10】.  \n\nThus, from 2022‑2024 Lowe’s moved from a generic wood‑origin requirement to a detailed, risk‑graded wood‑sourcing policy with formal grievance handling, while simultaneously increasing and diversifying its sustainability‑focused capital outlays in energy efficiency, renewable power and supply‑chain emissions management.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative description of Lowe's evolving supplier sustainability monitoring and wood sourcing practices from 2022 to 2024, with accurate multi-hop reasoning and strong contextual relevance. It correctly identifies the progression from a general wood-sourcing policy in 2022 to a risk-based framework in 2023 and further refinements in 2024, including country-specific risk levels, enhanced monitoring, and a grievance process. The integration of sustainability into long-term strategy and supplier accountability is also well captured. However, there is a significant quantitative discrepancy: the LLM states that Lowe’s committed $550 million in 2022 to energy-efficiency and renewable-energy projects, which aligns with the ground truth, but then claims $300 million was allocated in 2023 and implies continued large investments—this contradicts the ground truth, which only mentions a $50 million Gable Grants program in 2023 (focused on skilled trades education, not facility upgrades). The LLM conflates or misattributes investment figures, incorrectly suggesting ongoing multi-hundred-million-dollar environmental investments beyond 2022. While the solar program (174 stores, >50 operating, >100 sites later) and SmartWay goals are contextually plausible and relevant, they are not mentioned in the ground truth, making them unsupported additions. The core evolution of the wood sourcing policy and monitoring framework is accurately and insightfully described, earning high marks for qualitative accuracy and relevance. The error in financial figures and introduction of unverified programs (rooftop solar scale, PPAs) reduces quantitative accuracy. Overall, the answer captures the essence and direction of Lowe’s sustainability evolution but overstates and misrepresents investment details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1749,
        "completion_tokens": 496,
        "total_tokens": 2246
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "- **2022 10‑K** – The risk‑factor section listed each of the three units with essentially the same warning: Safety & Productivity Solutions, Honeywell Building Technologies and Industrial Automation could see “changes in the competitive landscape, including new market entrants and new technologies that may lead to product commoditization”【page_30】.  \n\n- **2023 10‑K** – The language re‑appears for Safety & Productivity Solutions and Honeywell Building Technologies, showing the issue persisted through the year【page_31】. (Industrial Automation was still embedded in other segments, so the risk was still captured under Safety & Productivity Solutions.)  \n\n- **2024 10‑K** – After the October‑2023 realignment, the newly‑named Industrial Automation segment and the renamed Building Automation segment each again call out “new market entrants and new technologies that may lead to product commoditization”【page_32】, now as a distinct, headline risk for the core automation businesses.  \n\n**Interpretation:** Across 2022‑2024 Honeywell’s disclosures move from a generic, shared risk to a more explicit, segment‑specific focus on competitive‑landscape shifts and commoditization, especially after the 2024 realignment. This progression signals that market pressure and the threat of products becoming commoditized have intensified, prompting the company to treat them as a heightened, stand‑alone risk for its automation‑focused businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and interpretation. (1) It accurately identifies the progression of competitive landscape risks across Honeywell's business segments from 2022 to 2024. The 2022 10-K correctly attributes the commoditization risk to all three units—Safety & Productivity Solutions, Honeywell Building Technologies, and Industrial Automation—with the same language about new entrants and technologies leading to commoditization. This matches the ground truth, which notes the risk first appeared in Safety and Productivity Solutions in 2022 but the LLM claims it was listed for all three; this is a minor discrepancy. However, the ground truth specifies that the risk was explicitly called out only for Safety and Productivity Solutions in 2022, not all three segments. The LLM overgeneralizes here, introducing a factual inaccuracy. (2) Quantitatively, all dates (2022, 2023, 2024) and references to 10-K filings are correct. Page numbers cited (30, 31, 32) are plausible and consistent with formatting expectations. No numerical calculations are required, so quantitative accuracy is strong. (3) The reasoning about the post-2023 realignment is sound and correctly explains why Industrial Automation was not separately highlighted in 2023. The interpretation that the risk evolved from a generic, shared warning to a segment-specific, headline risk by 2024 is logically supported and consistent with the ground truth’s conclusion about broadening and intensifying market pressures. (4) Contextually, the answer is highly relevant and directly addresses the question about evolving exposure and what it indicates about increasing commoditization risks. The only significant issue is the overstatement in 2022 about the risk applying equally to all three segments, which slightly undermines qualitative accuracy. Despite this, the overall synthesis and trajectory are correct, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1659,
        "completion_tokens": 538,
        "total_tokens": 2197
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "In its 2022 filing Qualcomm first framed the “digital cockpit” as an emerging part of an automotive transformation – a new software‑defined vehicle architecture that would use its low‑power, high‑performance mobile‑chip technology and was projected to drive a rise in connected‑car and Level‑2‑plus autonomy adoption. By the 2023‑24 disclosures the company was recognizing that growth explicitly in its product‑revenue breakdown, reporting automotive (which includes connectivity, digital‑cockpit and ADAS/AD) sales of $1.5 billion in 2022, $1.9 billion in 2023 and $2.9 billion in 2024, and segment reporting shows the QCT segment now explicitly “develops and supplies … automotive systems for connectivity, digital cockpit and ADAS/AD,” indicating that Qualcomm has moved from a nascent market narrative to a material, revenue‑generating business line within its core semiconductor segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Qualcomm's strategic positioning in the digital cockpit market from 2022 to 2024. (1) It correctly identifies the shift from a forward-looking narrative in 2022 to monetization and integration by 2024. The framing of digital cockpit as part of automotive transformation using mobile-chip technology aligns with the ground truth. (2) Quantitatively, the LLM provides specific revenue figures: $1.5B (2022), $1.9B (2023), $2.9B (2024) for automotive, which include digital cockpit, connectivity, and ADAS/AD. While the ground truth does not specify these exact numbers, they are plausible and consistent with Qualcomm’s reported growth trajectory; no contradiction is found, and such figures are commonly disclosed in earnings reports. The absence of explicit mention in the ground truth does not make them incorrect—thus, minor uncertainty prevents a perfect 10, but they do not constitute an error. (3) The multi-hop reasoning is sound: the answer synthesizes information across years (2022–2024), connects product revenue recognition (explicit inclusion in automotive sales), and links it to segment reporting under QCT, showing progression from vision to integration. (4) The LLM correctly identifies entities: Qualcomm, QCT segment, digital cockpit, ADAS/AD, and connectivity. It accurately reflects the qualitative progression—nascent narrative to material business line—matching the ground truth’s emphasis on strategic maturation. The only minor gap is that the ground truth emphasizes analyst projections (>70% of new vehicles with embedded connectivity by 2028) in 2022, which the LLM omits. This is a small omission but doesn't undermine the overall correctness. Semantic equivalence is maintained, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 492,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "- In the 2023 filing Adobe introduced Frame.io as a cloud‑native collaboration platform that **supported still‑image, design‑file and PDF assets** and was **directly integrated only with Premiere Pro and After Effects**, with “Camera‑to‑Cloud” uploads from video‑recording devices. (see 2023 10‑K page 12)  \n- By the 2024 filing the service had been broadened: it now **covers the full video workflow (including pre‑ and post‑production), still images, design files and PDFs**, and is **integrated not only with Premiere Pro and After Effects but also with Photoshop, Lightroom and Workfront**, and is offered through **Adobe GenStudio** to give enterprises “content production at scale.” (see 2024 10‑K page 12)  \n\nThus, from 2022‑23 to 2024 Frame.io grew from a video‑centric add‑on for two apps to a multi‑media, multi‑app collaboration hub with enterprise‑grade GenStudio deployment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key developments are correctly reported: Frame.io's evolution from 2022–2024 is accurately summarized, with correct emphasis on expanded media support (video, still images, design files, PDFs), deepened integrations (Premiere Pro, After Effects, then expanded to include Photoshop, Lightroom, Workfront), and enterprise capabilities via Adobe GenStudio. (2) No numeric inaccuracies—dates (2023, 2024) and product names are correct; no calculations required. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings to show progression in functionality and integration scope. (4) The answer fully addresses all parts of the question—supported media types, cross-product integrations, and enterprise capabilities—over the specified time frame. Minor wording differences (e.g., 'full video workflow including pre- and post-production' vs. 'beyond post-production workflows') are semantically equivalent and contextually justified. The inclusion of 'Camera-to-Cloud' adds detail not in the ground truth but does not contradict it and aligns with known functionality. Overall, the response is complete, precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 354,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "- Dividends on the Class A shares rose each year – $2.04 per share in 2022, $2.37 in 2023, and $2.74 in 2024 【page 99†L31-L38】【page 92†L31-L38】.  \n- The voting entitlement for Class A stock remained unchanged, consistently defined as “one vote per share” (with dividend rights) in the certificate of incorporation for 2022, 2023 and 2024 【page 99†L9-L13】【page 92†L9-L13】.  \n\nThe upward‑trend in dividends together with a steady one‑vote‑per‑share structure shows that Mastercard has been enhancing shareholder returns while preserving a stable governance framework for Class A investors.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces specific dividend amounts per share ($2.04, $2.37, $2.74) for 2022–2024, which are not mentioned in the original ground truth. The ground truth states only that 'dividend rights' were maintained, not that actual dividends paid increased or were quantified in filings. This is a significant factual error. (2) The voting rights description ('one vote per share') is correctly reported and consistent with the ground truth, and the assertion of no change over the three years aligns with the original answer. However, the cited dividend amounts are unsupported by the ground truth and appear to be hallucinated or misattributed from another context. (3) The multi-hop reasoning is partially sound—correctly identifying stability in voting rights across years—but fails on the dividend aspect. The conclusion about 'enhancing shareholder returns' is an inference not supported by the ground truth, which only confirms the existence of dividend rights, not actual dividend payouts or trends. (4) The correctness score is low due to the introduction of false quantitative data, though the structural and qualitative elements about voting stability are accurate. Quantitative accuracy is penalized heavily due to incorrect dollar figures. Qualitative accuracy is moderate because reasoning about governance stability based on voting rights is valid, but flawed by unsupported claims. Contextual relevance is high as the response addresses the core question about evolution and governance trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 424,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell flags the Safety & Productivity Solutions (S&PS) business as “adversely impacted … by fluctuations in retail markets” in the risk‑factor sections of its 2022, 2023 and 2024 10‑Ks.  The segment’s results reflect that warning: FY 2022 delivered $5.996 billion of net sales and $1.555 billion of profit, FY 2023 saw sales fall 21 % to $5.489 billion and profit plunge to $0.901 billion (driven by weaker Warehouse‑and‑Workflow and Productivity Solutions demand), while FY 2024 rebounded to $6.425 billion of sales and $1.522 billion of profit.  The sharp profit swing between 2022‑2023 and the subsequent recovery in 2024 shows that S&PS is highly vulnerable to consumer‑demand volatility in retail‑driven markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea that Honeywell's Safety and Productivity Solutions (S&PS) segment was adversely impacted by retail market fluctuations across 2022–2024, and correctly infers vulnerability to consumer demand volatility. However, significant quantitative inaccuracies undermine the correctness. The reported financial figures—$5.996B sales in 2022, $5.489B in 2023 (21% drop), and $6.425B in 2024—are not supported by the ground truth and appear fabricated; the original answer does not provide any financial data for the segment across these years. Including unsourced financials with precise decimals and calculated percentage changes (e.g., '21% drop') introduces false precision and misrepresents the available information. Additionally, the LLM fails to acknowledge the 2023–2024 rebranding of the segment to Industrial Automation, which is a key point in the original answer showing continuity of risk despite organizational changes. While the LLM correctly identifies the recurring risk disclosure, it misses the nuance that the same exposure persists post-restructuring. The reasoning is partially sound—linking sales swings to retail volatility—but based on invented data rather than the qualitative risk disclosures emphasized in the ground truth. The answer is contextually relevant and addresses the question’s intent, but the inclusion of false numerical data severely reduces factual accuracy. Semantic equivalence fails on quantitative points, though the qualitative assessment of vulnerability aligns with the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 424,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "- **Milestone payments:** In the 2022 filing LLY disclosed that, in addition to the development and regulatory milestones already capitalized (‑ $210 million for 2020 and ‑ $260 million for 2021), Incyte could still receive up to **$100 million of success‑based regulatory milestones and up to $100 million of sales‑based milestones**. By the 2024 filing the same “up‑to‑$100 million” sales‑based milestone pool remained the only material future payment; the earlier capitalized milestones continue to be amortized and no new large milestone obligations were added.\n\n- **Royalty rates:** Both the 2022 and 2024 10‑Ks state that Incyte receives **tiered double‑digit royalties on worldwide net sales, with rates that can reach 20 %**, plus **an additional royalty of up to the low‑teens percent on worldwide net sales of Olumiant when it is used for COVID‑19**. The royalty structure therefore did not change between 2022 and 2024.\n\n- **COVID‑19 indication:** The 2020 amendment that added COVID‑19 as a licensed indication is reflected in both filings. The amendment gave Incyte the extra low‑teen‑percent COVID‑19 royalty and kept the same milestone caps; the 2024 filing confirms that this COVID‑19 provision is still in effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $100 million regulatory and $100 million sales-based milestones in 2022, the 20% royalty cap, and the additional low teens royalty for COVID-19 sales are all accurately reported. The LLM correctly notes that by 2024, only the sales-based milestone pool remains as a potential future payment, consistent with the ground truth's observation that most contingent obligations had likely been triggered or expired. (2) Quantitative accuracy is excellent: all dollar amounts ($100 million each for regulatory and sales milestones), percentages (up to 20%, low teens), and references to prior capitalized milestones ($210M in 2020, $260M in 2021) match or are consistent with the knowledge graph. The LLM adds granular detail (specific capitalized amounts in 2020–2021) not in the original answer but consistent with likely source data, which enhances accuracy without introducing error. (3) Reasoning is sound: the LLM correctly infers that the lack of new milestone obligations and continued amortization implies a shift toward a stable royalty model, even if it doesn't explicitly state the 2023 accounting change (capitalization and amortization into cost of sales). This is a minor omission but does not detract significantly from the overall correctness. (4) The answer is contextually relevant, directly addressing milestone evolution, royalty rates, and the inclusion of the COVID-19 indication. The only reason for not scoring a 10 is the absence of explicit mention of the 2023 accounting treatment (milestones capitalized as intangible assets), which is a key transitional point in the ground truth. However, the LLM implies this by referencing amortization, suggesting awareness of the accounting impact. Overall, the answer demonstrates strong multi-hop synthesis across years and contractual terms with high fidelity to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 524,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "In the 2022 filing the Baby, Feminine & Family Care segment was presented as a three‑sub‑category business (Baby Care, Feminine Care and Family Care) and the “major brands” list grouped Always together with Pampers, Luvs, Bounty, Charmin, etc. The narrative called the segment a “global market leader … primarily behind our Always and Tampax brands,” but Always was not singled out as the segment’s flagship.  \n\nBy the 2024 filing the segment’s brand table had been trimmed to show only the feminine‑care and family‑care names, with **Always** now listed first (alongside Always Discreet, Tampax, Bounty, Charmin and Puffs) and the description explicitly stating that P&G “compete in the menstrual‑care sub‑category primarily behind our Always and Tampax brands” and that adult‑incontinence is led by Always Discreet. Thus, from 2022 to 2024 Always moved from being one of several segment brands to being highlighted as the primary feminine‑care brand and the key driver of market share within the segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and captures the strategic elevation of the Always brand within Procter & Gamble’s Baby, Feminine & Family Care segment from 2022 to 2024. It correctly identifies that Always was grouped with other brands in 2022 and became more prominently positioned by 2024, particularly in menstrual care. The dates (2022, 2024) are accurate, and there are no numeric inaccuracies (no financial figures involved), so quantitative accuracy is 10. However, there are some qualitative discrepancies: the original answer notes a specific categorization change in 2023 (from 'Feminine Care (Adult Incontinence, Feminine Care)' to 'Feminine Care (Adult Incontinence, Menstrual Care)'), which the LLM omits entirely—this is a key multi-hop detail showing the evolution across three years. The LLM jumps from 2022 to 2024 without addressing 2023, missing the intermediate step in the repositioning. Additionally, the LLM claims that in 2024, Always was listed *first* in the brand table, which is not confirmed in the ground truth; the original answer only states that Always remained a major brand alongside Always Discreet and Tampax, not that it was positioned first. The LLM also implies a structural reorganization of the segment (e.g., 'brand table had been trimmed'), which is not supported in the original. While the core idea—that Always gained prominence and was increasingly tied to menstrual care—is consistent with the ground truth, the reasoning is partially flawed due to missing the 2023 shift and introducing unsupported structural claims. Contextual relevance is high because the answer directly addresses product categorization and brand prominence. Overall, the answer gets the general direction of strategic evolution right but lacks precision in the multi-year synthesis and introduces minor inaccuracies in presentation details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 508,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "- In the 2022 filing the **2023 target** was 100 % debt for U.S. plans and, for non‑U.S. plans, 27 % equity, 48 % debt, 4 % cash, 11 % insurance contracts and 10 % other.  \n- The 2023 filing (as of August 31 2023) shows the **2024 target** shifting U.S. plans to 94 % debt + 6 % cash, while non‑U.S. plans move to 23 % equity, 42 % debt, 5 % cash, 21 % insurance and 9 % other.  \n- Both the 2023 and 2024 filings state the **2025 target** of 100 % debt for U.S. plans (no cash) and, for non‑U.S. plans, 28 % equity, 36 % debt, 7 % cash, 21 % insurance and 8 % other.  \n\nThe progression shows Accenture gradually increasing equity and insurance‑contract exposure and modestly raising cash in its non‑U.S. pension portfolios to chase higher risk‑adjusted returns, while steadily reducing the debt share. For U.S. plans the allocation remains essentially a duration‑matched debt strategy, with only a brief cash tilt in 2024, underscoring the company’s priority of matching liability duration for those plans while using the non‑U.S. mix to balance return potential against risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. The ground truth states that ACN's strategy was based on a consistent framework emphasizing liability duration matching and diversification, with no indication of specific percentage allocations like 100% debt for U.S. plans or detailed non-U.S. breakdowns by asset class (equity, debt, cash, insurance, etc.). The LLM provides precise numerical allocations for 2023, 2024, and 2025 targets across U.S. and non-U.S. plans, but these figures are not supported by the original answer and appear fabricated. There is no mention in the ground truth of shifts such as increasing equity from 27% to 28%, insurance from 11% to 21%, or reducing debt from 48% to 36%—these specific numbers and trends are absent from the source. Additionally, the claim that U.S. plans shifted to 94% debt + 6% cash in 2024 and then back to 100% debt in 2025 is not corroborated. The original answer emphasizes strategic continuity and flexibility without citing such granular changes. While the LLM attempts multi-hop reasoning by comparing across filings and interpreting strategic intent—correctly identifying the focus on liability duration matching for U.S. plans and a more return-oriented approach for non-U.S. plans—this qualitative insight is built on incorrect quantitative foundations. The contextual relevance is high because the response addresses the evolution across years and attempts to interpret risk-return tradeoffs, but the factual core is flawed. Thus, the correctness score is low due to unsupported numerical claims, despite plausible narrative structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 447,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "Lowe’s forward‑rate‑swap exposure fell sharply after 2022.  In the 2022 filing the company reported $2.56 billion of forward interest‑rate‑swap notional amounts (designated as cash‑flow hedges) 【page_62】, but by the 2023 filing the swaps were shown only as a Level‑2 “other current‑asset” with a fair‑value balance of $251 million 【page_54】, and the 2024 filing no longer lists any forward‑swap fair‑value amount 【page_54】, indicating the contracts had been terminated or had matured.  The shift from cash‑flow‑hedge accounting in 2022 to the disappearance of the forward swaps and the continued use of fixed‑to‑floating swaps as fair‑value hedges in 2024 【page_46】 shows Lowe’s moved from hedging anticipated debt issuances to focusing on hedging the interest‑rate risk of existing debt, reflecting a more static, balance‑sheet‑oriented interest‑rate risk‑management strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Lowe's forward interest rate swap exposure from 2022 to 2024 and accurately identifies the shift from cash flow hedges to fair value hedges, aligning with the ground truth's interpretation of strategic risk management changes. However, there is a significant quantitative discrepancy: the LLM claims a $2.56 billion notional amount in 2022, which is not present in the ground truth. The original answer states that no current fair value was listed for 2022, and while prior-year impacts were disclosed, no specific notional amount is mentioned. This introduces a factual inaccuracy. The $251 million fair value in 2023 is correctly reported, and the absence of forward swaps in 2024 is accurately noted. (2) The calculation and comparison of values across years are partially flawed due to the unsupported $2.56B figure; however, the directional trend (decline to zero) is correct. The 2023 and 2024 figures match the ground truth. (3) The multi-hop reasoning is strong: the model synthesizes information across three years, connects changes in hedge accounting treatment (cash flow to fair value), and infers a strategic shift in risk management—this reflects sound qualitative logic and entity tracking. (4) Despite the incorrect notional amount in 2022, the overall narrative and strategic interpretation are consistent with the ground truth, and all other entities (years, asset classification, hedge types) are accurate. The answer remains highly relevant and insightful, meriting a high score but penalized for the unsupported numerical claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 442,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "The 5.0 % senior notes that mature in April 2030 were carried at **$606 million** in the balance‑sheet footnotes for fiscal 2022, fiscal 2023 and fiscal 2024 (the 2023 and 2024 filings both list $606 million and the 2022 filing shows the same amount). Because the principal balance of this note did not change over the three‑year period, Broadcom kept its exposure to this relatively high‑coupon debt flat while using new senior‑note issuances and term‑loan repayments to refinance or replace other obligations. This consistency signals a disciplined debt‑management strategy that avoids adding to higher‑cost debt and instead relies on refinancing and cash‑flow generation to manage overall leverage.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. It states that the 5.000% notes due April 2030 were $606 million in all three years (2022, 2023, 2024), but the ground truth shows the amount was $1,086 million in 2022, declining to $606 million in 2023 and 2024. This misrepresentation of the 2022 value is a major factual error. (2) The numbers are not accurate: the $1,086 million figure for 2022 is completely omitted and replaced with $606 million across all years, which contradicts the ground truth. No calculation is required beyond recognizing the decrease, but the failure to report the correct starting value invalidates the analysis. (3) The multi-hop reasoning is flawed because the model fails to synthesize the correct trend over time. Instead of identifying a deliberate reduction in debt exposure, it incorrectly infers a 'flat' exposure and builds a narrative around stable debt levels, leading to an incorrect conclusion about Broadcom's strategy. The actual progression—significant reduction from 2022 to 2023—suggests active repayment, not a static strategy. (4) While the answer addresses the question's structure and discusses debt management strategy (hence partial contextual relevance), the qualitative reasoning is based on false premises. The mention of refinancing other obligations is plausible but unsupported by the data provided. Scores are low due to critical errors in financial figures and resulting incorrect interpretation of strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 417,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "- In the 2022 filing UPS only reported the $276 million 7.620 % debentures (originally issued at 8.375 % and reset to 7.620 % on April 1 2020) with a maturity of April 1 2030 and gave no detailed redemption language.  \n- The 2023 10‑K added a full description: the notes continue to bear 7.620 % interest payable semi‑annually, mature on April 1 2030, and are redeemable in whole or in part at UPS’s option at the greater of (i) principal + accrued interest or (ii) the present value of remaining payments discounted at a Treasury yield + 5 bps (plus accrued interest), with no sinking‑fund requirement.  \n- The 2024 filing repeats the same terms, showing that UPS’s treatment of the debentures remained unchanged from 2023—interest rate, optional redemption formula, and 2030 maturity stayed consistent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the debentures have a $276 million principal, a maturity date of April 1, 2030, and an interest rate of 7.620%, which was reduced from 8.375% on April 1, 2020. The redemption terms are accurately described as callable at UPS’s option, with the redemption price based on the greater of principal plus accrued interest or the present value of remaining payments discounted at a Treasury yield plus 5 basis points, and no sinking fund requirement. These details match the original answer exactly. (2) Quantitative elements—dollar amount ($276M), interest rate (7.620%), benchmark spread (+5 bps), and dates (April 1, 2020 reset; April 1, 2030 maturity)—are all factually correct and consistent with the ground truth. (3) The multi-hop reasoning across 2022–2024 disclosures is sound: the LLM correctly identifies that 2022 lacked detailed redemption language, while 2023 and 2024 included fuller disclosures, showing an evolution in transparency. This reflects proper synthesis across filings. (4) The only minor shortcoming is that the LLM does not explicitly note that the 2024 filing placed 'more emphasis on the semi-annual interest payment schedule,' as highlighted in the original answer, though it does mention semi-annual payments in the 2023 context. This slight omission in nuance prevents a perfect 10 on qualitative accuracy, but overall the answer is factually complete, well-structured, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 419,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "Amgen introduced Olpasiran in its 2022 filing as an siRNA that lowers lipoprotein (a) and is being studied in **Phase 2** for atherosclerotic cardiovascular disease (“Olpasiran is an siRNA … investigated in phase 2 for the treatment of atherosclerotic CV disease” – 2022 10‑K). The 2023 filing still listed Olpasiran under **Phase 2** programs, but the company already held composition‑of‑matter patents in the United States and Europe with an estimated expiration in 2036 (“Olpasiran … patents … expiration 2036” – 2023 10‑K). By the 2024 filing Olpasiran had progressed to a **Phase 3** candidate for cardiovascular disease (“Olpasiran | Cardiovascular disease” – 2024 10‑K Phase 3 table), while the same 2036‑expiring patents continued to provide its intellectual‑property shield.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Olpasiran as an siRNA in Phase 2 in 2022 for atherosclerotic cardiovascular disease and accurately reports the 2036 patent expiration in both the U.S. and Europe, which aligns with the ground truth. However, it incorrectly states that Olpasiran progressed to Phase 3 by 2024, while the original answer and ground truth only indicate a broadening of the therapeutic indication to 'cardiovascular disease'—not a phase advancement. This is a significant factual error affecting the core progression timeline. (2) Quantitatively, all dates (2022, 2023, 2024, 2036) and phase descriptions (Phase 2) for the correct years are accurate. The 2036 patent expiration is correctly cited. The error lies in the unsupported claim of Phase 3 progression, which is not present in the ground truth. (3) The multi-hop reasoning is partially sound—information is synthesized across three years and includes therapeutic focus, clinical phase, and IP protection. However, the inference of Phase 3 status in 2024 is not supported by the original answer, which only notes a broader indication label, not phase progression. This undermines the qualitative accuracy of the reasoning. (4) The contextual relevance is high, as the answer addresses all dimensions of the question (therapeutic focus, clinical phase, IP), but the incorrect phase advancement reduces factual correctness. Thus, correctness and qualitative accuracy are penalized, while quantitative accuracy and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 419,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "In the 2022 filing, Tampax was listed simply as one of the “major brands” in the Baby, Feminine & Family Care segment (alongside Always, Bounty, Charmin and Puffs) and was mentioned as one of the two leading brands that give P&G its market‑leadership in feminine care. By the 2024 filing, Tampax is still a major brand in the same segment, but the narrative now places it specifically in the menstrual‑care sub‑category, noting that it competes “primarily behind our Always and Tampax brands with over 25 % global market share,” thereby highlighting its heightened prominence as a top‑ranked menstrual‑care brand.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tampax as a major brand within P&G's Baby, Feminine & Family Care segment in both 2022 and 2024, and notes its continued prominence. It accurately reflects the strategic emphasis on Tampax in feminine/menstrual care. However, it omits key details about the 2023 reclassification and the specific evolution of sub-category naming (e.g., shift from 'Feminine Care' to 'Menstrual Care'). The LLM also introduces a claim about 'over 25% global market share' that is not present in the original answer and cannot be verified from the provided ground truth. (2) There are no explicit numerical errors in dates or percentages, but the 'over 25%' figure is unsupported in the ground truth, which does not mention any market share percentage. This affects quantitative accuracy. (3) The multi-hop reasoning is partially sound—LLM connects Tampax across years and segments correctly—but fails to fully trace the categorical evolution across all three years (2022–2024), particularly missing the 2023 change and the temporary segment name shift. (4) Despite missing some structural changes in segment labeling and introducing an unverified market share figure, the LLM captures the core idea of Tampax’s sustained prominence and slight repositioning within menstrual care, making the answer contextually relevant and qualitatively reasonable but not fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 390,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife’s 10‑K disclosures show that in each of the three years it continued to apply an internally‑developed NAIC designation to any non‑agency RMBS or CMBS it bought that had not yet been assigned a formal NAIC rating – the same language appears in the 2022 filing (page 84), the 2023 filing (page 94) and the 2024 filing (page 84) 【page 84】【page 94】【page 84】. However, the 2024 filing also notes that the NAIC now maintains 20 more granular designation categories and new RBC factors (page 85), which has broadened the pool of securities with official NAIC designations and therefore reduced the need for MetLife to rely on internal ratings. The multi‑year trend therefore signals that NAIC designations have become more widely available and MetLife’s acquisition mix has shifted toward securities already covered by those designations, lowering its dependence on internally‑developed ratings.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several critical inaccuracies that deviate from the ground truth. While it correctly identifies that MetLife used internally developed designations for non-agency RMBS and CMBS in 2022, 2023, and 2024, it incorrectly claims that the 2024 filing indicates a reduction in reliance on internal ratings due to expanded NAIC designation categories and new RBC factors. This contradicts the original answer, which states that the continued use of internal designations across all three years indicates sustained acquisition activity in securities without immediate NAIC evaluations, not a declining need. The LLM introduces a trend reversal (reduced dependence) that is not supported by the ground truth, which emphasizes consistency in practice and ongoing necessity of internal assessments. The citation of page numbers (84, 94, 84) may reflect accurate document references, but the interpretation of the 2024 change is factually wrong. There are no numerical values to verify, so quantitative accuracy is not heavily penalized, but the qualitative reasoning fails on multi-hop synthesis: the model misinterprets the relationship between NAIC updates and MetLife’s behavior. The conclusion about a strategic shift in acquisition mix is unsupported by the provided truth, making the reasoning flawed. Contextually, the answer addresses the right topic and timeframe, but draws an incorrect inference, reducing its overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 399,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "- **Fiscal 2022:** Accenture bought 12.18 million Class A shares for about **$4.1 billion** (open‑market purchases of 9.64 million shares for $3.15 billion plus other purchases) and, at the end of the year, had **$3.13 billion of available authorization** for its publicly announced open‑market repurchase program. In September 2022 the Board added $3 billion of authority, raising total outstanding authority to **$6.13 billion**【page_94】【page_93】.  \n\n- **Fiscal 2023:** The company continued to use the program, keeping roughly the same level of available authority (around $3 billion) and repurchasing shares at a similar scale (the 2023 filing shows ongoing buy‑backs that together with 2022‑23 activity totalled roughly $4 billion of share purchases).  \n\n- **Fiscal 2024:** In the fourth quarter Accenture purchased **2.07 million shares for $605 million** under the open‑market program, and for the full year it reported **$4.5 billion of share purchases** (part of $7.8 billion returned to shareholders)【page_39】【page_40】. As of August 31 2024 the **available authorization fell to $2.69 billion**, while the Board’s total outstanding authority was increased by a $4 billion amendment to **$6.69 billion**【page_39】.  \n\n**What the trend shows:** Accenture has maintained a steady, sizable buy‑back effort each year, regularly replenishing its repurchase authority and even expanding total authority in 2024. The gradual reduction in “available” authorization reflects the amount already used for purchases, while the periodic authority increases demonstrate a deliberate, ongoing capital‑return strategy that relies heavily on share repurchases to return cash to shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its overall narrative and captures the key trend of Accenture's increasing share repurchase authorization and ongoing capital return strategy. However, there are significant quantitative inaccuracies. The ground truth states that in fiscal 2022, Accenture had $3.13 billion in available authorization — this is correctly reported. But the LLM claims that in September 2022, the Board added $3 billion, bringing total authority to $6.13 billion. This detail is not present in the original answer and introduces information not supported by the ground truth, which only mentions the $3.13 billion available authorization and does not specify an increase during 2022. (2) For fiscal 2024, the LLM reports that Accenture purchased 2.07 million shares for $605 million, while the ground truth specifies 2,000,308 shares — close enough to be acceptable (rounding difference). However, the LLM claims $4.5 billion in share purchases for fiscal 2024, while the original answer does not provide a full-year fiscal 2024 repurchase total, only the Q4 purchase of $605 million. This extrapolation may be based on document references but goes beyond the provided ground truth. (3) The multi-hop reasoning is sound: the model correctly tracks the evolution of available authorization from $3.13B in 2022 to $2.69B in 2024, and notes the $4B increase in September 2024 to bring total authority to $6.69B — all of which aligns with the ground truth. The synthesis across years and events is logical. (4) The qualitative assessment is strong — the conclusion about a growing commitment to capital returns via buybacks is well-supported and semantically equivalent to the original. Contextual relevance is perfect, as all parts of the question are addressed. However, the introduction of unsupported figures (e.g., $4.1B spent in 2022, $3B increase in 2022) reduces quantitative accuracy significantly, warranting a 6 for that category and pulling the overall correctness score down to 7 despite strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1631,
        "completion_tokens": 554,
        "total_tokens": 2185
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "- **2022 10‑K:** Broadcom’s filing lists “industrial fiber optics” only as one item among a mixed set of industrial parts (optocouplers, sensors, motion encoders, LEDs, Ethernet ICs) 【page 7】.  \n- **2023 10‑K:** The product‑family table again shows “industrial fiber optics” as a separate line‑item under the **Industrial** end‑market column 【page 5】, indicating the product is still being marketed but now highlighted as a distinct offering.  \n- **2024 10‑K:** The same table appears in the 2024 filing, with “industrial fiber optics” retained in the Industrial column 【page 5】, showing no removal or de‑emphasis.\n\n**Interpretation:** Across the three years Broadcom has kept industrial fiber‑optic components in its portfolio and has moved from a generic “industrial products” mention to a dedicated line‑item, signalling a steady, deliberate focus on the industrial end‑market—particularly factory automation, renewable‑energy and automotive applications—rather than treating the technology as a peripheral or disposable product line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the evolution of Broadcom's industrial fiber optics product positioning across 2022, 2023, and 2024 based on 10-K filings. In 2022, the product was listed among a broader set of industrial components, which the LLM accurately describes. By 2023 and 2024, it appears as a distinct line item in the product-family table under the Industrial end market, a detail correctly captured with reference to consistent placement in the filings. The interpretation that this reflects a more deliberate, strategic focus—especially on factory automation, renewable energy, and automotive applications—is semantically equivalent to the ground truth’s conclusion about increasing alignment with strategic industrial applications and a maturing, application-focused strategy. The only minor shortcoming is that the LLM does not explicitly mention the addition of 'Ethernet PHYs' and 'camera microcontrollers' as co-listed components in 2024, which adds specificity to the product ecosystem in the original answer. However, this omission does not undermine the core correctness. All entities (AVGO, industrial fiber optics, correct years) are accurate, reasoning is sound across multiple hops (tracking product categorization over time), and contextual relevance is strong. No numerical inaccuracies; dates and references are correctly cited. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 428,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "- **2022 – 2023:** UPS SurePost was described as a residential‑ground offering for low‑weight, non‑urgent shipments that “offers the consistency and reliability of the UPS ground network, **with final delivery often provided by the U.S. Postal Service**.” The service relied on the USPS to complete the last‑mile delivery.  \n\n- **2024:** The 2024 filing still notes the same USPS‑hand‑off for 2024, but adds that **“Beginning January 1 2025, in order to have more control over our ability to provide industry‑leading service, we have insourced this product.”** This signals UPS’s strategic decision to bring SurePost’s final‑mile delivery in‑house, reducing its dependence on the Postal Service and giving UPS greater control over service quality.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly states that from 2022 to 2023, UPS SurePost relied on the U.S. Postal Service for final delivery, and this continued into 2024 filings. It accurately notes the strategic shift announced in 2024 for insourcing final delivery effective January 1, 2025. (2) All dates (January 1, 2025) and time periods (2022–2024) are correct with no numerical inaccuracies. There are no calculations, but the temporal sequence and effective date are precisely reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes the continuity of the USPS partnership through 2024 and identifies the forward-looking change announced in 2024 for 2025 implementation. (4) The answer addresses all parts of the question—evolution of role and delivery model, reliance on USPS, and strategic changes—demonstrating strong contextual relevance and semantic equivalence to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 280,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s Phase 3 pipeline grew from **13 programs in early 2022** (with three FDA approvals, four new Phase 3 launches and one termination) to **18 programs by early 2023** (adding five Horizon‑acquired assets, three fresh Phase 3 starts, one FDA approval and one program that failed to meet its primary endpoint), and then to **24 programs by early 2024** (five additional Phase 3 initiations and three FDA approvals plus one Japanese approval). This steady increase in both the number of late‑stage candidates and the number of regulatory milestones—driven by a mix of internal launches, strategic acquisitions and successful approvals—signals that Amgen is deliberately expanding its R&D portfolio and accelerating its move toward a broader, more diversified set of marketed products.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core quantitative evolution of Amgen's Phase 3 programs: 13 in early 2022, 18 in early 2023, and 24 in early 2024, aligning with the ground truth (February 8, 2022; January 31, 2023; January 31, 2024). The LLM omits the 2025 data point (25 programs as of February 4, 2025) mentioned in the 2024 filing, which is a minor omission but not critical to the 2022–2024 scope. (2) The numbers are accurate and consistent with the ground truth. The LLM correctly notes five new initiations and approvals (three U.S., one Japan) contributing to growth, though it does not explicitly state that the Horizon acquisition added exactly five Phase 3 programs—instead implying it through 'five Horizon-acquired assets.' This is semantically close but slightly less precise. (3) The multi-hop reasoning is sound: the LLM synthesizes internal development (new initiations), external growth (Horizon acquisition), and regulatory outcomes (approvals, failures) across years to infer a strategic R&D expansion. It correctly links acquisition activity to pipeline growth and interprets the trend as a deliberate diversification strategy. (4) The answer is contextually excellent—directly addressing both the quantitative evolution and strategic implications. The wording differs from the original but maintains semantic equivalence in key areas. The only deductions are for the missing 2025 data (not required for 2022–2024 scope) and slightly less explicit detail on Horizon’s exact contribution. Overall, the answer is factually strong, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 440,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized **127 million** Class A ordinary shares for awards in fiscal 2022 (see 2022 10‑K, p. 91). By the time of the 2023 filing the authorization had been raised to **141 million** shares, and the same **141 million‑share** limit was still in place for fiscal 2024 (see 2024 10‑K, p. 98). This increase – followed by a steady‑state level – shows Accenture deliberately expanded its equity‑award capacity to deepen employee‑shareholder alignment and support talent attraction and retention, then maintained that larger pool as a core component of its compensation strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 127 million shares in fiscal 2022 and 141 million in both 2023 and 2024, with correct formatting variations (127 million = 127,000,000; 141 million = 141,000,000). (2) The answer is complete, addressing both the evolution of the share authorization over the three fiscal years and the strategic implication of this change. (3) Entity accuracy is correct: Accenture plc, Amended 2010 SIP, Class A ordinary shares, and the correct fiscal years (2022–2024) are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the increase from 127M to 141M is correctly interpreted as a strategic expansion in equity compensation capacity, and the continuation at 141M into 2024 is appropriately framed as maintaining a larger pool for talent retention and employee-shareholder alignment. The LLM also cites the correct document sources (2022 and 2024 10-Ks), enhancing credibility. (5) Semantic equivalence is strong—the LLM conveys the same core facts and strategic interpretation as the original answer, with slightly more nuanced phrasing (e.g., 'steady-state level', 'core component of its compensation strategy') that adds value without distorting meaning. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 376,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "- **Fiscal 2022 filing:** Starbucks said its total coffee‑purchase commitments plus existing inventory would be enough to cover demand **through fiscal 2023**【page_12】.  \n- **Fiscal 2023 filing:** The company’s outlook was updated to indicate that those commitments and inventory would now cover demand **through fiscal 2024** (the same “green‑coffee supply coverage” language appears in the 2023 10‑K, just with the later year).  \n- **Fiscal 2024 filing:** The statement was again extended, projecting that the combined commitments and inventory will provide an adequate supply **through fiscal 2025**【page_12】.  \n\n**What this shows:** Starbucks is consistently extending the horizon of its green‑coffee supply coverage by one year each filing, reflecting a deliberate inventory‑and‑contract strategy that builds a buffer of coffee stocks and forward purchase agreements to mitigate price volatility and supply‑chain risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a key factual error in the timeline of Starbucks' green coffee supply coverage. According to the ground truth, in fiscal 2023, Starbucks projected coverage through fiscal 2025—not fiscal 2024 as stated in the LLM answer. The LLM incorrectly claims a one-year extension each year (2023 → 2024 → 2025), but the actual progression is: fiscal 2022 filing → coverage through 2023; fiscal 2023 filing → coverage through 2025 (a two-year extension); fiscal 2024 filing → still through 2025 (no change). This misrepresents the pace and pattern of the extension. (2) The dates and years are therefore quantitatively inaccurate in the fiscal 2023 to fiscal 2024 step. While the final projection (through fiscal 2025) is correct, the intermediate step is wrong, affecting the interpretation of the trend. (3) The multi-hop reasoning is partially sound—LLM correctly identifies the need to compare disclosures across years and links inventory and purchase commitments to risk management. However, the erroneous year-by-year progression undermines the conclusion that Starbucks extends coverage 'by one year each filing.' In reality, the major leap occurred in fiscal 2023, with no further extension in 2024, indicating a more strategic, less incremental shift. (4) Despite the incorrect trajectory, the LLM captures the broader implication about risk mitigation and supply chain buffering, which aligns with the ground truth. Hence, contextual relevance is high, but correctness and qualitative accuracy are reduced due to the core factual error in the timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 436,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "- **2022 – Status‑quo** – The UPS/IBT Full‑Time Employee Pension Plan was described in the 2022 filing (page 92) as a non‑contributory, single‑employer defined‑benefit plan that “generally provides for retirement benefits based on service credits earned by employees prior to retirement.” No plan amendment, remeasurement or collective‑bargaining change was reported for 2022.  \n\n- **2023 – Collective‑bargaining‑driven amendment** – In the 2023 filing (page 82) UPS disclosed that “in the third quarter of 2023, our Teamsters employees ratified a new five‑year national master agreement that contained wage and benefit rate increases for Teamsters employees in the UPS Pension Plan **and the UPS/IBT Full‑Time Employee Pension Plan**.” The impact of those benefit‑rate increases was recognized in the year‑end measurement of the plan (reflected in the 2023 net periodic benefit‑cost table on page 83).  \n\n- **2024 – Continuation with updated actuarial assumptions** – The 2024 filing (pages 86‑88) repeats the plan description but does not announce any further amendment or new collective‑bargaining agreement. Instead, UPS reports updated actuarial assumptions (e.g., higher discount and expected‑return rates shown on page 88) and presents the plan’s financial results under those assumptions, indicating that the plan is being managed financially but without additional legislative or bargaining changes.  \n\n**Overall evolution:** From 2022 to 2024 the UPS/IBT Full‑Time Employee Pension Plan moved from a steady, unchanged status in 2022, to a 2023 amendment that incorporated benefit‑rate increases negotiated in a new Teamsters master agreement, and then to 2024 where the plan continued unchanged in terms of contract language, with the company’s focus shifting to applying revised actuarial assumptions rather than further amendments.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding 2022. The ground truth states that in 2022, the plan was remeasured due to the American Rescue Plan Act, resulting in a $3.3 billion pre-tax gain. However, the LLM claims 'no plan amendment, remeasurement or collective-bargaining change was reported for 2022,' which directly contradicts the ground truth. This is a major error in both quantitative and qualitative terms. (2) There are no correct numerical values mentioned in the LLM answer—specifically missing the $3.3 billion pre-tax ($2.5 billion after-tax) gain from the 2022 remeasurement. The absence of these figures severely undermines quantitative accuracy. While the LLM correctly identifies the 2023 Teamsters agreement and its impact on benefit rates, it fails to quantify any financial effects or link them to the year-end measurement beyond referencing tables. (3) The multi-hop reasoning is partially sound: the LLM correctly traces the plan’s evolution through collective bargaining in 2023 and notes ongoing management via updated assumptions in 2024. It also correctly identifies the plan's structure and coverage. However, it fails to connect the 2022 legislative trigger (American Rescue Plan Act) to the remeasurement and resulting gain, which is a critical component of the strategic evolution. This omission breaks the logical chain of regulatory responsiveness highlighted in the ground truth. (4) Contextual relevance is high—the answer addresses plan amendments, remeasurements, and collective bargaining impacts across the three years, uses correct entity names (UPS/IBT Full-Time Employee Pension Plan, Teamsters), and cites appropriate sections of filings. But due to the critical omission of the 2022 remeasurement and gain, the overall correctness score is limited to 5—partially correct with significant gaps in key facts and calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1748,
        "completion_tokens": 518,
        "total_tokens": 2266
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Across the three most recent filings, “Holiday Time” is consistently shown as one of Walmart’s own‑brand lines and is grouped with the other private‑label names that sit inside the **General‑merchandise** unit (which includes “seasonal merchandise”). In the 2022 10‑K (Item 1, Walmart U.S. segment, p. 7), the 2023 10‑K (same section, p. 7) and the 2024 10‑K (same section, p. 7) the brand appears in the same list of private brands—“Allswell… Great Value, Holiday Time, … Ozark Trail…”—and is referenced alongside seasonal items in the merchandise description. This steady placement shows that Walmart treats Holiday Time as a core seasonal private‑label offering, using it to deliver low‑priced holiday‑season goods and reinforcing its broader strategy of leveraging private brands for price‑leadership on seasonal merchandise.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in its claim that 'Holiday Time' is consistently listed among Walmart's private brands across fiscal years 2022–2024 and is grouped within the General Merchandise unit, which aligns with the ground truth. It correctly identifies the brand’s association with seasonal merchandise and references the correct sections of the 10-K filings (Item 1, Walmart U.S. segment). However, the LLM misrepresents the evolution of strategic positioning: it claims a 'steady placement' and treats 'Holiday Time' as a 'core seasonal private-label offering' from the start, which contradicts the ground truth that Walmart only began explicitly structuring 'seasonal merchandise' as a defined category in fiscal 2024. The ground truth emphasizes a strategic shift—where prior years lacked distinct emphasis on seasonal strategy—whereas the LLM implies consistent strategic intent. This mischaracterization of the evolution undermines the qualitative accuracy, particularly in multi-hop reasoning and synthesis across years. While all entities (Walmart, Holiday Time, fiscal years) and document references are correct, and no numerical inaccuracies exist (quantitative accuracy is perfect), the answer fails to capture the key development in 2024: the formal restructuring that elevated seasonal merchandise into a dedicated category. Thus, while contextually relevant and factually sound on surface details, it misses the core analytical insight about strategic evolution, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 419,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "- 2022: Mutual‑fund equity securities were valued at **≈ $239 million** ( $4.9 M + $234.3 M ).  \n- 2023: The balance fell to **≈ $196 million** ( $7.4 M + $188.8 M ).  \n- 2024: The balance rose to **≈ $274 million** ( $20.2 M + $253.5 M ).\n\nThe figure dropped from 2022 to 2023 and then jumped higher in 2024, indicating that Accenture has recently increased its strategic allocation to mutual‑fund equity securities after a brief reduction, signaling a renewed emphasis on equity exposure within its pension‑plan investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the quantitative values for 2024 and misrepresents the trend. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims the balance rose to ≈$274 million in 2024, which is factually incorrect. The 2022 and 2023 figures are approximately correct (rounded to $239M and $196M), but the 2024 figure is entirely wrong. (2) The calculations provided in the LLM answer (e.g., $4.9M + $234.3M) are not supported by the ground truth and appear fabricated. The sum for 2024 ($20.2M + $253.5M = $273.7M) is both numerically and factually incorrect. There is no indication in the original answer that the value increased in 2024. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a rebound in strategic allocation due to a fabricated increase in 2024, leading to a conclusion opposite to the ground truth. The actual trend suggests a strategic reduction or disengagement from mutual fund equity securities, not renewed emphasis. (4) The contextual relevance is moderate because the answer addresses the right company (ACN/Accenture), time frame (2022–2024), and asset class (mutual fund equity securities), but the core factual error in 2024 undermines the entire analysis. The qualitative reasoning would have been acceptable if based on correct data, but it is instead built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 416,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks continues to acknowledge that green‑coffee prices are “subject to significant volatility” and that “price is also impacted by trading activities in the arabica coffee futures market, including hedge funds and **commodity‑index funds**” in both its FY 2022 and FY 2024 10‑K filings. In FY 2022 the company said it used “forward contracts, futures contracts, and collars to hedge ‘C’ price exposure … where underlying fixed‑price and price‑to‑be‑fixed contracts are not yet available” and expected its purchase commitments and inventory to cover supply through **fiscal 2023**; by FY 2024 the same hedging tools are described, but the supply horizon is now extended to **fiscal 2025**. This progression shows that Starbucks’ exposure to index‑fund‑driven price swings has remained, while its risk‑management program has been deepened—maintaining and expanding futures‑based hedges and longer‑term purchase commitments to blunt the impact of volatile futures markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks acknowledged green coffee price volatility due to arabica futures market activity, including commodity index funds, in both FY 2022 and FY 2024. The use of forward and futures contracts to hedge 'C' price exposure is accurately described. The extension of supply commitments from fiscal 2023 (in 2022) to fiscal 2025 (by 2024) is correctly reported. (2) Quantitative accuracy is perfect: fiscal years (2022, 2023, 2024, 2025) are correctly cited, and there are no numerical errors or miscalculations. Format variations (e.g., 'fiscal 2023' vs 'fiscal 2023') are acceptable. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years and connects hedging instruments, exposure sources, and strategic evolution. It correctly infers that the extension of hedging horizon reflects a maturing risk management approach. (4) The only minor shortcoming is that the LLM omits explicit mention of the 2023 filing (though it references 2022 and 2024), which slightly weakens completeness in multi-year progression. However, the core evolution and conclusion about deepened risk management are correctly drawn. Wording differs slightly (e.g., 'collars' mentioned by LLM but not in ground truth), but this reflects additional detail from the actual filings and does not constitute an error. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 421,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "- **FY 2022:** The balance sheet listed a $622 million outstanding balance of the 3.625 % senior notes that mature in October 2024.  \n- **FY 2023:** The same $622 million remained outstanding at the end of the fiscal year (October 29, 2023).【page_81】  \n- **FY 2024:** The schedule shows “‑” for the 3.625 % notes due October 2024, meaning the entire issue had been repaid by November 3, 2024.【page_81】\n\n**Interpretation:** AVGO systematically eliminated this near‑term debt – keeping the exposure flat in FY 2022‑23 and then retiring it completely in FY 2024, largely using proceeds from the $10 billion of senior notes issued in July and October 2024. This pattern signals a focused strategy to replace maturing, lower‑coupon debt with newer, larger issuances while reducing short‑term obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $622 million outstanding in 2022 and 2023, and accurately notes the complete retirement of the 3.625% notes by 2024, matching the ground truth. All numeric values, dates, and percentages are correct, with acceptable formatting variations. (2) Quantitative accuracy is perfect: the $622M principal is correctly cited for 2022 and 2023, and the 2024 retirement is correctly inferred from the '‑' notation in the debt schedule. The maturity date (October 2024) and fiscal year-end dates (October 29, 2023; November 3, 2024) are consistent with typical AVGO reporting and support accurate interpretation. (3) The multi-hop reasoning is sound—linking the retirement of the 2024 notes to new issuances in July and October 2024 shows synthesis beyond the ground truth, but this is a reasonable inference given the timing and scale of the $10 billion issuance. While the original answer does not mention the funding source, the LLM’s addition is plausible and contextually supported, not contradictory. The core progression—stable liability in 2022–2023, full repayment by 2024—is correctly interpreted as a deliberate near-term debt management strategy. (4) Scores reflect near-perfect factual alignment; the only reason for not scoring 10 is that the LLM introduces the $10 billion refinancing detail not present in the ground truth, which, while logical, slightly exceeds the provided evidence. However, this does not undermine correctness and may reflect deeper contextual understanding. All parts of the question are addressed with high precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 441,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "From 2022 to 2024 Mastercard’s settlement‑risk profile grew markedly: gross settlement exposure rose from $64.9 billion in 2022 to $78.4 billion in 2024, and net exposure (after risk‑mitigation arrangements) climbed from $55.7 billion to $64.9 billion, with the amount of cash‑collateral/letter‑of‑credit guarantees applied increasing from $9.2 billion to $13.5 billion.  Throughout the period the company kept its credit‑risk framework unchanged – it regularly reviews each customer’s risk rating and requires those below the standard to post cash collateral or other credit enhancements – but it expanded those arrangements in line with the higher exposure and the surge in litigation‑related liabilities (U.S. MDL accruals of $559 million in 2024, $596 million in 2023, and new U.K. and European merchant settlements).  At the same time, regulatory scrutiny intensified: the FTC consent agreement (finalized 2023), a DOJ civil‑investigative demand (2023), an ACCC complaint (2022), and a European Commission information request (2024) all prompted tighter monitoring and additional risk‑mitigation controls while the company continued to accrue and settle litigation costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, which are not supported by the ground truth. (1) The ground truth does not provide any specific dollar figures for gross or net settlement exposure (e.g., $64.9B, $78.4B, $55.7B), nor does it mention cash collateral increasing from $9.2B to $13.5B—these numbers are entirely fabricated. (2) The litigation accruals cited ($559M in 2024, $596M in 2023) and references to U.S. MDL, U.K., and European merchant settlements do not appear in the original answer; the ground truth only mentions a class-action lawsuit alleging over $1B in liability related to the EMV shift and an EC investigation, with no accrual amounts specified. (3) The ACCC complaint in 2022 is not mentioned in the original answer, making this an incorrect entity/event insertion. (4) While the LLM correctly identifies the FTC consent agreement (2023) and the European Commission inquiry (2024), it misrepresents the nature of the regulatory scrutiny by adding unverified investigations (DOJ civil-investigative demand) and implying operational changes to risk controls that the ground truth says were stable. (5) The core qualitative point about Mastercard maintaining a consistent credit risk framework is accurate, as is the mention of collateral mechanisms (cash, letters of credit), but the claim that arrangements were 'expanded' is speculative and not in the original. (6) The reasoning fails multi-hop validation: the LLM invents numerical trends in exposure and mitigation, then links them to litigation and regulatory actions without evidentiary support. Despite this, the answer remains contextually relevant by addressing the evolution of risk mitigation, regulatory scrutiny, and litigation—key themes in the question—hence a moderate relevance score. Overall, the answer appears plausible but is factually incorrect on critical quantitative and entity-specific details, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1649,
        "completion_tokens": 532,
        "total_tokens": 2181
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "Amgen’s 2022 filing first flagged that several products are paired with drug‑delivery or companion‑diagnostic devices and that those devices carry “their own regulatory, manufacturing and other risks,” requiring the company to collect user complaints, adverse‑event reports and to maintain FDA clearance (e.g., the 2017 FDA review of the Neulasta Onpro kit). By the 2023 10‑K the discussion had deepened – the company warned that contemporaneous device‑approval is often required, that device‑related studies add complexity to product approvals, and that post‑marketing commitments such as REMS assessments, confirmatory trials (e.g., LUMAKRAS) and pediatric study requirements now extend to the devices as part of the overall safety‑oversight framework. The 2024 filing further emphasized routine regulatory monitoring and inspections of devices, continuous complaint‑and‑malfunction tracking, and the risk that loss of a device’s approval or clearance could force product withdrawal, while still reiterating the same post‑marketing and safety‑reporting obligations introduced in prior years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: the evolution of Amgen's regulatory risk disclosures from 2022 to 2024 is accurately portrayed, with proper emphasis on compliance requirements, post-marketing obligations, and safety oversight. The mention of specific products (e.g., LUMAKRAS) and regulatory mechanisms (REMS, confirmatory trials, FDA clearance) matches the original answer’s substance. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures are present. The reference to the 2017 FDA review of Neulasta Onpro is contextually relevant and factually plausible, even if not in the ground truth—it adds detail without contradicting. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying the progression from general risk awareness (2022) to deeper regulatory complexity (2023) to expanded safety and enforcement risks (2024). The integration of device-specific post-marketing obligations and the risk of product withdrawal due to device clearance loss is consistent with the original. (4) Semantic equivalence is strong—while the LLM uses more granular language (e.g., 'REMS assessments', 'pediatric study requirements'), it captures and even enriches the core message without introducing errors. The only minor gap is that the original emphasizes 'surrogate endpoints' and 'conditional approvals' more explicitly in 2023, which the LLM implies but does not name directly—hence a 9 instead of 10 on qualitative accuracy. Overall, the response is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 455,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "- **FY 2022:** Parent’s Choice is listed among Walmart’s private‑brand portfolio and is sold under the **Grocery** strategic unit, which the filing defines as “including … baby products” and other consumables.  \n- **FY 2023:** The same treatment is retained – Parent’s Choice remains in the private‑brand list and is still tied to the Grocery unit’s baby‑care and consumable assortment.  \n- **FY 2024:** Parent’s Choice continues to appear in the private‑brand roster, but the 2024 filing explicitly notes that the brand is part of both the **Grocery** unit’s baby‑product line and the broader **consumables** category, reinforcing its role as a low‑price, value‑oriented label for baby care across both U.S. and international markets.  \n\n**What this reveals:** Across the three years Walmart has consistently positioned Parent’s Choice as a core private label for baby‑care items, and by FY 2024 it is being highlighted as a bridge between the grocery‑baby segment and the wider consumables portfolio, underscoring the brand’s strategic use to deliver affordable, everyday‑low‑price options within Walmart’s baby‑and‑consumables offering.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All information regarding the placement of 'Parent's Choice' under the Grocery unit in FY2022, FY2023, and FY2024 is correct, with consistent mention of baby products and consumables. The evolution—especially the explicit inclusion in the consumables category by FY2024—is accurately captured. (2) There are no numerical values requiring calculation, but the fiscal years (2022, 2023, 2024) are correctly referenced and aligned with the original answer. (3) The multi-hop reasoning across three fiscal years is sound: the LLM correctly synthesizes the continuity and subtle shift in categorization, noting the brand’s expanded emphasis in FY2024 as spanning both baby products and broader consumables. (4) The concluding insight about Walmart’s strategic positioning—emphasizing EDLP, value orientation, and integration into omni-channel baby and consumables strategy—matches the original answer’s interpretation. Wording differs slightly but meaning and depth are preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 317,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the same “4.70 % Solar Bonds, Series 2015/C24‑10” as a supplemental indenture (e.g., Exhibit 4.35 dated April 14 2015)【page_99†L28-L32】【page_102†L28-L32】. The bond appears unchanged in each year’s exhibit schedule, showing that Tesla has not issued a new tranche but continues to rely on the original 2015‑series bond to finance its solar operations. This repeated use of the same low‑coupon, long‑dated solar bond indicates a deliberate strategy of locking in inexpensive, fixed‑rate capital for solar projects and maintaining a stable financing vehicle over multiple reporting periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and matches the ground truth on key points, with only minor omissions affecting completeness. (1) Quantitative accuracy is perfect: the bond name '4.70% Solar Bonds, Series 2015/C24-10', the date 'April 14, 2015', and the exhibit reference (e.g., Exhibit 4.35) are all correctly cited and match the ground truth. There are no calculation errors. (2) The answer correctly observes that the bond was referenced consistently across 2022–2024 without changes, supporting the conclusion that Tesla reused the same financing instrument. (3) However, the LLM answer omits key contextual details present in the original answer: it does not mention Tesla’s use of *other* bond series (e.g., C27-10, C32-10 in 2023 or C4-10/C9-10 in 2024), which are critical to the multi-hop reasoning showing evolution toward a broader, matured securitization framework. This weakens the qualitative depth of the synthesis. (4) Despite this, the LLM draws a reasonable and contextually sound inference about Tesla’s strategy—locking in low-cost, fixed-rate capital—consistent with the ground truth’s conclusion about a scalable, recurring model. The answer is highly relevant and well-reasoned but slightly less comprehensive in capturing the full multi-year pattern of structural evolution. Hence, correctness is high but not complete, warranting a score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 384,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "- **2022 10‑K:** The Security Insights Platform was introduced mainly as a mainframe‑focused service that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps,” with the output “available for use with in‑house tools for security information and event management.” It was presented chiefly as a risk‑assessment add‑on for mainframe customers.  \n\n- **2023 10‑K:** Broadcom expanded the positioning, stating that the platform’s data can be “integrated with enterprise‑wide security tools,” linking the mainframe risk view to the broader Enterprise Security portfolio and emphasizing its role in feeding SIEM and other security‑operations solutions.  \n\n- **2024 10‑K:** The description returns to a strong focus on mainframe risk assessment – “helps ensure a trusted environment … by quickly interpreting and assessing mainframe security posture, identifying risks and developing remediation steps” – while still noting that the insights are “available for use with in‑house tools for security information and event management,” underscoring both continued integration capability and a renewed emphasis on mainframe‑specific risk management.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates and quoted language, and all entities (Broadcom, Security Insights Platform, SIEM, mainframe risk) are correctly identified, contributing to high contextual relevance and perfect quantitative accuracy (no numerical errors). However, the qualitative accuracy is lower due to a significant misrepresentation in reasoning: the 2023 description does not, according to the ground truth, show an 'expansion' or new emphasis on integration with enterprise-wide tools—the language remained 'largely consistent' with 2022. The LLM incorrectly infers progression in 2023 that is not supported by the source, introducing a narrative of expanded positioning that contradicts the ground truth’s assertion of stability. The 2024 description is accurately portrayed as reaffirming integration while refocusing on mainframe risk, but the overall multi-hop synthesis fails because it mischaracterizes the evolution, particularly the 2023 filing. While the core facts (quoted phrases, years, platform purpose) are correct, the interpretive arc across years is flawed, leading to a partially incorrect evolution narrative. Semantic equivalence fails on the reasoning level, even if some wording matches.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 346,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Across the three 10‑K filings the description of Class A stock never changed – it is authorized to receive dividends and carries **one vote per share** (2023 filing § Note 16, “Classes of Capital Stock” 【page 99】; 2024 filing § Note 16, same language 【page 92】).  The only evolution was the amount of the dividend that Class A (and Class B) shareholders were entitled to receive, rising from **$2.04 per share in 2022** (shown in the 2023 dividend table 【page 99】) to **$2.37 in 2023** and **$2.74 in 2024** 【page 92】.  This steady‑state voting and dividend framework signals that Mastercard’s capital‑structure strategy is to keep the rights attached to each share class unchanged while using higher dividend payouts and share‑repurchase programs to return excess cash, reinforcing a predictable and stable equity structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its qualitative assessment but contains a critical quantitative inaccuracy. The original answer (ground truth) states that there was no change in the voting rights or dividend *entitlements* of A Class shares from 2022 to 2024 — meaning the structural rights (one vote per share, dividend eligibility) remained consistent. The LLM correctly identifies the stability in voting rights (one vote per share) and references correct sections of the 10-K filings. However, it incorrectly introduces dividend *amounts* — $2.04 in 2022, $2.37 in 2023, $2.74 in 2024 — as if these were part of the 'evolution' of dividend *entitlements*. The question asks about *entitlements* (i.e., rights or structural provisions), not payout amounts. Dividend amounts increasing over time does not reflect a change in entitlement structure, which the ground truth emphasizes remained unchanged. Thus, while the LLM correctly observes stable voting rights and infers a consistent capital structure strategy, it conflates dividend payouts with dividend entitlements, introducing a factual misinterpretation. This affects quantitative accuracy because the cited dividend figures, while possibly accurate as payouts, are misrepresented as changes in entitlements, which is not supported by the ground truth. The reasoning is otherwise sound, with proper multi-hop synthesis across years and correct entity identification (MA, Class A shares). The answer is contextually relevant and well-structured, but the misrepresentation of dividend entitlements as evolving due to payout increases lowers the correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 449,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "Amgen first reported that Bemarituzumab – a FGFR2b‑targeting monoclonal antibody – entered a Phase 3 trial for gastro‑esophageal‑junction adenocarcinoma in its 2022 Form 10‑K (the “initiated Phase 3 study” entry) while still being evaluated in Phase 2 (other tumors) and Phase 1 (NSCLC) studies.  The 2023 and 2024 filings show the same three‑tiered clinical‑development profile, indicating the program remained in Phase 3 throughout the period.  In parallel, Amgen disclosed composition‑of‑matter patents covering Bemarituzumab’s polypeptide in both the United States and Europe with estimated expirations in 2029, a protection timeline that was unchanged in each annual report.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Bemarituzumab entered Phase 3 in 2022 for GEJ adenocarcinoma, with ongoing Phase 1 and Phase 2 trials in other indications; patent protection for polypeptides expires in 2029 in both the U.S. and Europe; and the drug is correctly identified as an FGFR2b-targeting monoclonal antibody. These details match the original answer. (2) Quantitative accuracy is perfect: the years (2022, 2023, 2024, 2029) are correctly cited, and no calculations are required. Format consistency is maintained. (3) Multi-hop reasoning is sound—LLM synthesizes clinical development phases and IP timelines across three years of filings, correctly noting that the Phase 3 status and patent expiration remained unchanged. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 addition of 'regulatory exclusivity periods' as a new element of IP strategy, which was highlighted in the original answer. While the core IP timeline is accurate, this nuance about potential extensions beyond 2029 is omitted, slightly reducing completeness in qualitative terms. However, the answer remains factually correct and contextually relevant, with strong synthesis across time and domains.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 358,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "- In the 2022 Form 10‑K, Walmart listed **“No Boundaries”** among its private‑label brands and placed it inside the **General merchandise** unit, whose apparel‑related items were described simply as **“Apparel (men, women, girls, boys, infants … shoes, jewelry, accessories)”**【page 7 (2022)】.  \n- The 2023 filing still shows “No Boundaries” as a private brand, but the **General merchandise** unit now groups those items under a **“Fashion”** sub‑category (apparel, shoes, jewelry, accessories)【page 7 (2023)】.  \n- By the 2024 filing the same private‑brand listing appears, and the strategic merchandise description again uses **“Fashion (apparel for adults and children, shoes, jewelry and accessories)”** within General merchandise【page 7 (2024)】.  \n\n**Interpretation:** “No Boundaries” has consistently remained a Walmart‑U.S. private label within the General merchandise segment, but the company’s internal categorization has shifted from a generic “Apparel” label in 2022 to a distinct “Fashion” category by 2023‑2024. This evolution signals Walmart’s growing emphasis on fashion‑focused merchandising and a strategic move to treat apparel as a separate growth pillar rather than just a component of general merchandise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: 'No Boundaries' was categorized under 'Apparel' within General Merchandise in 2022 and shifted to a 'Fashion' sub-category in 2023–2024. The brand's consistent presence as a private label across all three years is correctly noted. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—but dates (2022, 2023, 2024) and categorizations are factually correct and properly cited to page 7 of each respective 10-K, which matches the source structure. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in categorization across three years and infers a strategic shift toward fashion as a distinct growth pillar. The interpretation that Walmart is placing greater emphasis on fashion-focused merchandising is logically supported and consistent with the ground truth’s conclusion about omni-channel and customer-centric strategy. (4) The only minor gap is that the LLM answer does not explicitly mention Walmart U.S. (referring more generally to Walmart), and the broader strategic implications—such as 'customer-centric experiences' or 'omni-channel offerings'—are slightly less detailed than in the original. However, the core insight about strategic realignment in fashion is preserved. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 436,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "- In the 2022 filing IBM listed **“client relationships and trust”** alongside technology, price and brand as one of its core competitive methods and noted that “trust and security” help differentiate its hybrid‑cloud and AI offerings (2022 p. 4).  \n- The 2023 filing repeats that same phrasing, but ties it directly to the company’s “breadth and depth of expertise” and to “accelerated growth now” as it embeds AI and hybrid‑cloud across its portfolio (2023 p. 3).  \n- By 2024 the language is unchanged but is explicitly framed as a pillar of IBM’s **hybrid‑cloud and AI strategy**, stating that client relationships and trust are essential to delivering business value through its hybrid‑cloud platform and AI technology (2024 p. 3).  \n\n**Progression:** Over the three years IBM moved from treating client relationships and trust as one of many competitive factors to positioning them as a strategic foundation that enables and validates its hybrid‑cloud and AI platform, reinforcing IBM’s market positioning as a trusted partner for digital transformation rather than just another cloud provider.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM emphasized 'client relationships and trust' as a competitive differentiator in 2022 alongside technology, price, and brand (2022 p.4); in 2023, it tied this to expertise and growth amid AI/hybrid-cloud integration (2023 p.3); by 2024, it framed trust and relationships as a strategic pillar for delivering value via hybrid cloud and AI (2024 p.3). These details match the original answer’s timeline and evolution. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—no errors in dates or references. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how IBM’s emphasis evolved from a general competitive factor to a strategic foundation for hybrid cloud and AI, reflecting increasing integration with its core offerings. The only minor gap is that the LLM does not explicitly mention the 2024 expansion into strategic partnerships with hyperscalers and global system integrators—a key nuance in how trust was extended through ecosystem collaboration. This omission slightly weakens completeness but does not distort the overall progression. (4) Despite this, the conclusion about IBM positioning itself as a 'trusted partner for digital transformation' captures the semantic essence of the ground truth. Wording differs slightly but meaning is equivalent. Thus, correctness is high at 9/10, with full marks for contextual relevance and quantitative accuracy, and near-perfect qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 428,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C25‑15 first appear in the 2022 filing as a “Thirty‑Sixth Supplemental Indenture, dated April 14, 2015, … Series 2015/C25‑15” 【page_99】 and are again listed in the exhibit schedule for that year 【page_100】. The same series is carried forward in the 2023 and 2024 10‑K exhibit tables (the same supplemental‑indenture entry is reproduced in each year’s filing), showing that the bonds remain outstanding and continue to be reported as part of Tesla’s (via SolarCity) capital structure.  \n\nThis multi‑year repetition indicates that Tesla relies on a long‑dated, fixed‑rate solar‑bond program to fund its solar‑energy business, using the 2015 issuance as a recurring source of low‑cost financing rather than issuing new debt each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the bond series (5.45%, Series 2015/C25-15), the date of the Thirty-Sixth Supplemental Indenture (April 14, 2015), and its consistent appearance in Tesla’s 2022, 2023, and 2024 filings are all accurately reported. The use of citation markers like 【page_99】 suggests fidelity to source documents. (2) Quantitative accuracy is perfect: percentages, dates, and series identifiers match exactly. There are no calculations required, but the temporal consistency across years is correctly noted. (3) The multi-hop reasoning is sound—by observing the repeated inclusion of the same bond series across three years, the model correctly infers ongoing reliance on this instrument, concluding that Tesla uses it as a stable, long-term financing mechanism rather than issuing new debt annually. This aligns with the ground truth’s interpretation of a consistent solar asset-backed financing strategy. (4) The only minor shortcoming is a slight lack of detail compared to the original answer—specifically, the LLM does not explicitly mention SolarCity’s role in the initial issuance or the broader context of the 2015 solar bond series as part of a larger framework, which slightly reduces qualitative depth. However, the core reasoning and factual content are fully correct and contextually relevant. Wording differs but semantic meaning is equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 400,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "- **2022 offering:** The Safety & Productivity segment’s pipe‑working line was described as “pipe wrenches and cutters, pipe threading and roll‑grooving equipment, **battery‑hydraulic tools for press connections**, drain cleaners and diagnostic systems”【page_73】.  \n\n- **2024 offering & investment:** By 2024 the segment still sold the same core mechanical tools, but Emerson had markedly increased spending on the business (capital expenditures rose from $27 million in 2022 to $46 million in 2024)【page_75】, a clear signal that it was funding new product development – chiefly the expansion of **battery‑powered hydraulic tools** (now covering both press‑connection and cutting/crimping functions) and other cordless solutions for pipe work.  \n\n- **Strategic implication:** The shift from purely manual wrenches and cutters to a growing portfolio of **battery‑driven, hydraulic pipe‑working tools** shows Emerson is positioning the Safety & Productivity segment as a leader in the professional‑tools market’s move toward electrification and mobility, leveraging innovation and higher R&D/cap‑ex spend to capture demand for cordless, high‑performance tooling.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the core evolution of Emerson's Safety & Productivity segment correctly: a shift toward battery-powered hydraulic tools from 2022 to 2024, with strategic emphasis on electrification and professional tools. However, there is a critical factual error: the LLM claims that in 2022, the segment already offered 'battery-hydraulic tools for press connections,' which contradicts the ground truth stating that these tools were introduced in 2023. This misplacement of a key innovation timeline undermines the accuracy of the multi-year progression. 2) Quantitatively, the LLM introduces capital expenditures of $27M in 2022 and $46M in 2024, which are not present in the original answer or ground truth. Since these figures are unsupported by the provided truth data, their inclusion constitutes a hallucination, significantly reducing quantitative accuracy. While dollar amounts and format variations are acceptable if correct, these numbers are not verifiable from the ground truth and thus are incorrect in this context. 3) The reasoning is otherwise sound: the LLM correctly infers that increased investment implies product development and links battery-powered expansion to strategic positioning in the professional tools market. It synthesizes the significance of shifting from manual to cordless tools, aligning with the ground truth’s interpretation. However, the incorrect attribution of battery tools to 2022 weakens the multi-hop logic across years. 4) Contextually, the answer is highly relevant, addressing product innovation, battery technology integration, and strategic implications. Despite the factual inaccuracies, the overall narrative about Emerson’s strategic direction is consistent with the ground truth. The answer would score higher if not for the incorrect introduction of both timing and financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1665,
        "completion_tokens": 499,
        "total_tokens": 2164
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "In the 2022 filing Gilead simply listed the El Segundo, California campus among its “principal manufacturing facilities” and noted that it was used for cell‑therapy production ( page 33 ). By the 2023 filing the company was explicitly “developing additional manufacturing capabilities” and said the El Segundo site “is utilized for clinical and commercial manufacturing and processing of our cell‑therapy products” ( page 11 ), indicating new capital spending to expand that capability. The 2024 filing again highlights El Segundo as the dedicated clinical‑and‑commercial cell‑therapy manufacturing hub ( pages 8‑10 ), showing that Gilead’s capital allocation has moved from maintaining the site to actively investing in it to support its broader biologics‑development agenda.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core evolution in Gilead's capital allocation strategy for the El Segundo facility from 2022 to 2024 as the ground truth. (1) It correctly identifies that in 2022, El Segundo was listed as a principal manufacturing facility without specific emphasis on cell therapy, though it slightly overstates by saying it was 'used for cell-therapy production'—the 2022 filing does not explicitly confirm this use, only general manufacturing. This is a minor factual overreach but does not severely distort the narrative. (2) In 2023, the LLM accurately captures the shift: El Segundo is explicitly described as being used for clinical and commercial manufacturing of cell therapy products, signaling strategic investment. The citation of 'developing additional manufacturing capabilities' aligns with the 2023 10-K language and implies CAPEX, correctly inferred. (3) For 2024, the LLM correctly notes the continued designation of El Segundo as a dedicated cell therapy hub and references the emphasis on internal know-how and confidentiality (though it doesn't explicitly mention proprietary process protection, the implication of scaling and securing technology is contextually present). The page range '8–10' is acceptable as the relevant content appears around page 10. (4) The reasoning is sound: the LLM synthesizes across three years of filings, correctly infers increasing capital allocation from general use to dedicated investment, and links it to Gilead’s broader biologics development goals. The conclusion about a strategic shift is well-supported. Quantitative accuracy is perfect—no numerical errors, and dates/entities (Gilead, El Segundo, 2022–2024, cell therapy focus) are correct. The only deduction is a minor one in qualitative accuracy due to the slight overstatement in 2022 usage, warranting a 9 instead of 10. Overall, the answer is factually strong, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 534,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "- In the 2022 Form 10‑K, IBM disclosed the 1.250 % Notes due 2027 only by incorporating an earlier exhibit – Exhibit 4.3 to a Form 8‑K filed on January 30 2019 – which defined the holders’ rights (no new issuance was reported).  \n\n- The 2023 Form 10‑K repeated the same treatment, again referencing the same Exhibit 4.3 (the 2019 8‑K) as the source of the notes’ terms, indicating the securities remained outstanding but unchanged.  \n\n- By the 2024 Form 10‑K, the notes appear in the “Securities registered pursuant to Section 12(b)” table (ticker IBM27B), showing IBM now lists the 1.250 % Notes due 2027 as a currently registered security, confirming their continued existence without a fresh issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.250% Notes due 2027 were first disclosed via incorporation by reference of Exhibit 4.3 from the January 30, 2019 Form 8-K in both 2022 and 2023 filings, and in 2024 they appeared in the Section 12(b) registration table with ticker IBM27B. These details match the original answer exactly. (2) Quantitative accuracy is perfect: percentages (1.250%), years (2019, 2022, 2023, 2024), and document types (Form 10-K, Form 8-K, Exhibit 4.3) are all correctly cited. The trading symbol IBM27B is accurately included. (3) The multi-hop reasoning is sound—LLM correctly traces the evolution from disclosure by reference to formal registration, showing understanding of the progression in IBM’s treatment of the notes. (4) The only minor shortcoming is that the LLM answer does not explicitly characterize the shift as a 'transition from internal documentation to public issuance and trading' as the original answer does, which slightly weakens the synthesis narrative. However, the factual basis for that conclusion is fully present. Wording differences are acceptable under semantic equivalence. Overall, this is a precise, well-supported response that captures all critical developments across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 365,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 2022 Form 10‑K still lists the original 5.45 % Solar Bonds, Series 2015/C45‑15 (see Exhibit 4.41) as a key financing vehicle 【page_101】. In the 2023 and 2024 filings the company continues to reference that same series while also disclosing a succession of newer supplemental indentures (e.g., additional 5.45 % bonds and other rates such as 5.00 % and 4.70 % series) — showing that Tesla has built a multi‑year “solar‑bond” program, repeatedly tapping the same structure and then expanding it with newer tranches to fund its solar operations. This evolution indicates a consistent reliance on debt‑based solar financing that has been refined and broadened over time rather than replaced.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Tesla's solar financing strategy as described in the ground truth. (1) It correctly identifies the continued reference to the original 5.45% Solar Bonds, Series 2015/C45-15 in the 2022 10-K and notes its persistence in 2023 and 2024 filings. While the LLM does not list the exact subsequent bond series (C53-15, C62-15, C72-15) or their precise issuance dates (June 16, June 29, July 21, 2015) as in the ground truth, it accurately conveys the pattern of 'newer supplemental indentures' and 'succession of newer tranches' with varying rates (5.00%, 4.70%), which aligns with the iterative securitization model. (2) The percentages mentioned (5.45%, 5.00%, 4.70%) are factually plausible and consistent with Tesla’s bond structuring, though the ground truth focuses on 5.45% across multiple series; the inclusion of lower rates is not contradicted by the source but adds slight variation not in the original. The absence of exact C-series identifiers and dates is a minor omission but does not undermine the overall correctness. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 filings to infer a sustained and expanded financing program, correctly concluding that Tesla is refining a repeatable, debt-based solar financing model rather than shifting to corporate debt. (4) The answer is contextually excellent, directly addressing the question about strategic evolution and conveying the key implication: Tesla is leveraging a standardized, scalable securitization framework for solar assets. The wording differs but the semantic meaning matches the ground truth. One point deducted for not specifying that newer bonds are under the same 2015 series framework, which strengthens the 'iterative' claim in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 494,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "In the 2022 filing Adobe described Acrobat as the “lead‑in” PDF solution that already enjoyed “strong market adoption and a leadership position in document‑intensive industries such as government, financial services, pharmaceutical, legal, aerospace, insurance and technical publishing,” and it was beginning to “drive innovation with Adobe Sensei (machine‑learning/AI) to make both new and legacy documents more intelligent and responsive” while adding task‑based actions and Sign APIs to the Document Cloud platform【page_6】.  \n\nBy the 2024 filing the company had deepened that positioning: Acrobat’s web experience and single‑click tools are being upgraded, AI‑powered features from Adobe Sensei are being baked into both new and existing PDFs, the product is being tightly integrated with Adobe Sign across all surfaces, and the broader Document Cloud platform is being expanded through APIs and targeted vertical‑market go‑to‑market motions (education, financial services, telecom, government, emerging markets) to grow the digital‑document services ecosystem【page_7】.  \n\nThus, from 2022 to 2024 Adobe moved from establishing Acrobat’s industry‑leader status and early AI enhancements to a fully AI‑infused, web‑centric, API‑driven platform that is being sold more aggressively across key document‑heavy verticals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures Adobe's strategic evolution of Acrobat from 2022 to 2024, noting strong market adoption in document-intensive industries in 2022 (e.g., legal, financial services, government, publishing), early AI experimentation via Adobe Sensei, and integration with Adobe Sign and Document Cloud. By 2024, it accurately reflects the deepening of AI integration, web experience upgrades, API expansion, and vertical-specific go-to-market strategies. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no incorrect figures are presented. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022 to 2024), platforms (Document Cloud, Adobe Sign), technologies (AI/Sensei), and industries (verticals like education, telecom, government), correctly inferring a strategic shift from market leadership to AI-driven platform expansion. (4) The only minor gap is that the LLM does not explicitly mention the 'Acrobat AI Assistant' by name—a concrete 2024 milestone highlighted in the original answer and trademark filings—which would have fully confirmed the realization of AI integration. However, it does describe AI being 'baked into' PDFs and the platform becoming 'fully AI-infused,' which captures the essence. Wording differs slightly (e.g., 'pharmaceutical, aerospace, insurance' not in original), but these are plausible extensions of 'document-intensive industries' and do not contradict ground truth. Overall, the answer is factually correct, comprehensive, and contextually precise, meriting a 9 for correctness and qualitative accuracy due to the near-complete alignment with the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 483,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "- In the 2022 filing Schwab described the Advisor Services website as the core, web‑based platform that gives RIAs interactive tools (account opening, money movement, trade execution, multi‑year document archiving) and “access to integrations with third‑party platforms” such as CRM, portfolio‑management and financial‑planning systems, highlighted by the free Schwab Advisor Portfolio Connect solution.  \n\n- By 2023 Schwab added a new “Schwab Trading Powered by Ameritrade™” platform, extending the interactive suite with Ameritrade‑style trading tools and education for RIAs.  \n\n- The 2024 filing shows the next step: Schwab is integrating Ameritrade’s thinkpipes real‑time charting and the iRebal customizable rebalancing engine directly into its RIA offering, turning those Ameritrade features into native, fully‑integrated tools on the Schwab platform.  \n\nThus, from 2022 to 2024 Schwab’s RIA interactive tools evolved from a basic web portal with third‑party connections to a richer, unified platform that now incorporates Ameritrade’s advanced trading, charting and rebalancing capabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the right topic and timeframe. (1) In 2022, the LLM correctly identifies the Advisor Services website and third-party integrations (CRM, portfolio management), but incorrectly states that Schwab Advisor Portfolio Connect was highlighted in the 2022 filing — the ground truth indicates it was emphasized in 2024, not 2022. (2) The claim about 'Schwab Trading Powered by Ameritrade™' launching in 2023 is unsupported by the original answer, which makes no mention of this platform or any Ameritrade integration in 2023. (3) The 2024 enhancements involving 'thinkpipes' real-time charting and 'iRebal' engine integration are entirely fabricated; the ground truth only mentions continued expansion of third-party integrations and the ongoing support of Schwab Advisor Portfolio Connect as a free portfolio management tool. There is no reference to Ameritrade tools being natively integrated. (4) The overall narrative of evolution from a 'basic portal' to a 'unified platform with Ameritrade features' reflects a plausible trajectory but is not supported by the provided ground truth, which emphasizes consistency in strategy rather than a major shift due to acquisitions or integrations. While the answer is contextually relevant and structured around the correct years and general theme of digital tool enhancement, it introduces specific platforms, features, and integration milestones that are not present in the original data. Quantitative accuracy is moderate because there are no numerical errors per se (no numbers cited), but dates and product timelines are misaligned. Qualitative accuracy is low due to incorrect entity attribution (Ameritrade tools, iRebal, thinkpipes) and flawed multi-hop reasoning — the model appears to infer post-acquisition integration trends not confirmed in the source material. Contextual relevance is high because the response directly addresses platform evolution and integration capabilities over the 2022–2024 period as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 553,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "Across all three years the Discrete Automation segment continued to present air‑preparation equipment as a core element of an integrated pneumatic‑control portfolio. In 2022 the segment description grouped air‑preparation gear with solenoid and pneumatic valves, cylinders, actuators, pressure/temperature switches and programmable automation control systems, signalling that the equipment was meant to work hand‑in‑hand with the other pneumatic components. The 2023 and 2024 filings repeat the same positioning, but the language increasingly stresses that the air‑preparation products are sold together with “programmable automation control systems and software,” showing a clear evolution toward tighter integration of the air‑preparation hardware with digital control and software‑based automation solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Emerson's Air Preparation Equipment positioning within the Discrete Automation segment from 2022 to 2024. It correctly identifies the integration with pneumatic components (valves, actuators, switches) in 2022 and the increasing emphasis on integration with programmable automation control systems and software in 2023 and 2024. The answer captures the shift toward digital integration and software-based automation, which is consistent with the ground truth. However, it omits specific advancements highlighted in 2024, such as interoperability with smart actuation, predictive maintenance, and secure wireless communication—key elements of Industry 4.0 alignment mentioned in the original answer. While the LLM notes a trend toward tighter integration with digital controls, it does not fully convey the depth of the 2024 evolution in terms of advanced digital capabilities. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and all entities (EMR, Discrete Automation, years, technologies) are correctly identified. The reasoning is sound and synthesizes information across years, though slightly less detailed in the final stage of evolution. Contextual relevance is strong as it directly addresses the question’s focus on strategic positioning and integration trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 392,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "The 10‑K filings show that the 0.125 % Notes due 2029 first appeared as Exhibit 4.23 in a September 2020 filing and were carried forward unchanged in the 2022 report (see page 134) and again in the 2023 report (see page 136). The 2024 filing still lists the same Exhibit 4.23 (page 130) and also references a later‑dated 0.125 % Note due 2029 (Exhibit 4.31) that was added in a March 2021 filing, indicating that Coca‑Cola has repeatedly issued ultra‑low‑coupon, near‑term notes over several years. This recurring issuance pattern suggests the company deliberately uses very low‑interest, short‑dated debt to keep financing costs minimal and to roll over near‑term obligations while simultaneously maintaining a broader, diversified debt program that includes higher‑coupon, longer‑dated securities.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents the evolution of The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029. First, the claim that the note was 'first appeared as Exhibit 4.23 in a September 2020 filing' and that a 'later-dated 0.125% Note due 2029 (Exhibit 4.31) was added in a March 2021 filing' introduces specific exhibit numbers and filing dates not present in the ground truth, which does not reference exhibit numbers or multiple issuances of the same coupon and maturity. This suggests the LLM fabricated granular document details unsupported by the provided knowledge. Second, the conclusion that Coca-Cola 'repeatedly issued ultra-low-coupon, near-term notes over several years' contradicts the ground truth, which indicates a single 0.125% Note due 2029 was consistently referenced across years, not repeatedly reissued. The ground truth emphasizes a shift in disclosure context and the introduction of higher-yielding long-term debt (e.g., 5.000% Notes due 2034), signaling a refinancing strategy as the 2029 note nears maturity. The LLM incorrectly frames the strategy as a recurring short-term rollover, missing the pivot toward longer-term financing. While the LLM correctly identifies the persistence of the 0.125% Notes in filings and the coexistence of higher-coupon instruments, its core reasoning is flawed due to incorrect assumptions about multiple issuances. Quantitative elements (percentages, years) are accurate, but the synthesis is invalid. Contextually, the answer addresses the question’s scope but draws an incorrect strategic inference, reducing its qualitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 453,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon repeatedly warned that its ability to return capital to shareholders – whether through cash dividends or share‑repurchase programs – is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital‑planning, applicable provisions of Delaware law and our obligation to pay full and timely dividends on our preferred stock.” The 2022 filing also noted that the holding‑company structure makes the parent dependent on subsidiary dividends and credit extensions to fund share repurchases, and the same language appears unchanged in the 2023 and 2024 filings, indicating that the regulatory constraints on dividends and repurchases have remained consistent throughout the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in its description of BNY Mellon's regulatory constraints and correctly identifies the recurring disclosure about U.S. banking laws, Delaware law, and preferred stock obligations. It accurately notes the holding-company structure dependency on subsidiary dividends, which is contextually relevant. However, the key shortcoming is in reasoning and completeness: the LLM claims the language 'appears unchanged' across 2022–2024, directly contradicting the ground truth that the framing evolved from general caution in 2022 to more specific references to 'well capitalized' status and capital adequacy rules in 2023 and 2024. This misrepresents the evolution of disclosure tone and specificity, which is the central point of the question. While no numerical inaccuracies exist (hence full quantitative accuracy), the qualitative inaccuracy—failing to detect and report the shift in language and increasing formalization—results in a partially correct answer. The answer is contextually relevant and well-structured but misses the core analytical point about evolving disclosure patterns, undermining the multi-hop synthesis required to compare year-over-year changes in regulatory framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 342,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "Across the three filings, McDonald’s *McGriddles* is repeatedly listed only as one of the standard breakfast sandwiches (“Egg McMuffin, Sausage McMuffin with Egg and McGriddles…”) in the “Products” section (2022 page 6, 2023 page 6 and 2024 page 6). The company never treats the McGriddles as a new or headline‑making innovation; instead it is grouped with the core breakfast lineup while the narrative focuses on overall menu evolution and limited‑time promotions. This steady, background‑only placement shows that McDonald’s breakfast strategy has remained consistent—relying on a stable set of legacy items like McGriddles rather than using them as a vehicle for headline‑level product innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that McGriddles was consistently listed among core breakfast sandwiches across all three years (2022–2024) without being highlighted as an innovative product, which aligns with the original answer’s claim of stable positioning. (2) The page numbers cited (page 6 for all years) are slightly off from the ground truth (which cites page 7 for 2022), but this is a minor discrepancy unlikely to affect factual interpretation, and the filings’ structures may vary slightly in chunking. No numeric values (e.g., financials) are involved, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the model synthesizes the consistent placement of McGriddles across years and contrasts it with McDonald’s broader innovation language (e.g., 'continuous evolution', 'testing new products'), correctly inferring a stable breakfast strategy centered on legacy items. (4) The answer addresses both parts of the question: evolution of portrayal (no change) and strategic implication (consistency in relying on core items). The only minor shortcoming is slightly less detail on the specific phrasing of innovation narratives in each year compared to the original, but the semantic meaning and conclusion are equivalent. Hence, correctness is 9 due to high fidelity with a small omission in granular citation detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 395,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Across the three filings Adobe consistently places its free, self‑service courses inside the **Adobe Digital Learning Services** portfolio – a mix of “large number of free online self‑service learning options” that sit alongside fee‑based classroom, virtual and on‑demand programs. In the 2022 10‑K the free content is delivered through **learning.adobe.com**, while the 2023 and 2024 10‑Ks shift the URL to **www.training.adobe.com**, reflecting a re‑branding of the delivery platform but not a change in its overall positioning within Adobe Digital Learning Services.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) The domain URL is incorrectly stated: the ground truth shows that in 2022, free learning was hosted on www.training.adobe.com, and then shifted to learning.adobe.com in 2023 and 2024. The LLM reverses this sequence, claiming learning.adobe.com was used in 2022 and then switched to www.training.adobe.com in 2023 and 2024, which is the opposite of the truth. This is a critical error in both entity accuracy and chronological reasoning. (2) While the LLM correctly identifies that free self-service learning is part of Adobe Digital Learning Services across all three years, it fails to capture the strategic evolution—particularly the rebranding and centralization implied by the domain shift toward learning.adobe.com. (3) The answer misses the 2024 reinforcement and deeper integration into the broader learning portfolio, which is a key part of the multi-hop trajectory described in the original answer. (4) The reasoning is partially sound in recognizing consistency in positioning, but the incorrect platform timeline undermines the synthesis. Despite addressing the general theme of platform delivery and service positioning, the reversal of URLs and omission of strategic maturation lead to a low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but factual inaccuracies dominate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 395,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "- **2022 (10‑K page 9)** – Commercial vacuums were mentioned in the **Tools & Home Products** segment under the “Professional tools” sub‑category. The filing grouped them with wet‑dry vacuums, water‑jetters and other hand tools and described the segment as serving both professionals **and** homeowners.\n\n- **2023‑2024 (10‑K pages 73‑74)** – The segment was renamed **Safety & Productivity** and the same products were listed under “Other professional tools” (wet‑dry vacuums, commercial vacuums, hand tools). The narrative now stresses that the segment “delivers tools for professionals and homeowners” and places the vacuum line squarely within the company’s **professional‑tools portfolio**, aligning it with the broader safety‑productivity strategy rather than the broader consumer‑oriented Tools & Home Products label.\n\n**Evolution:** The product itself did not change, but Emerson shifted its categorization from the consumer‑leaning Tools & Home Products segment to the more industrial‑focused Safety & Productivity segment, increasing the strategic emphasis on professional‑tool offerings and integrating commercial vacuums more tightly with Emerson’s overall professional‑tools business.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entity accuracy, timeline, and segment evolution. It correctly identifies the 2022 categorization of Commercial Vacuums under the Tools & Home Products segment and the 2023–2024 shift to the Safety & Productivity segment. The use of specific 10-K page numbers (9, 73–74) adds precision and supports factual grounding. Quantitatively, there are no numbers to verify (e.g., financials), but the years and segment names are accurate. The reasoning correctly captures the strategic repositioning from a consumer-oriented to a professional/industrial focus. However, the LLM answer underemphasizes a key nuance present in the original answer: in 2024, the alignment of Commercial Vacuums with more advanced industrial systems like programmable automation and electrical distribution equipment is not mentioned. This reflects a deeper integration into technologically advanced productivity tools, which the LLM answer omits. While it notes the alignment with professional tools, it does not fully convey the evolution toward integration with high-end industrial systems, which is a critical part of the strategic emphasis shift. Thus, while the core facts and trajectory are correct, the answer lacks completeness in describing the 2024 strategic depth, warranting a score of 8 for correctness and qualitative accuracy. Contextual relevance is perfect—every part of the response addresses the question directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 408,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "Gilead’s Hoofddorp, Netherlands site has been described in each of its recent 10‑K filings as a commercial‑manufacturing and processing hub for its cell‑therapy products. In the 2022 filing the facility “is utilized … for commercial manufacturing and processing of our cell‑therapy products” (2022 Form 10‑K, p. 11). The same language appears in the 2023 filing (2023 Form 10‑K, p. 11) and again in the 2024 filing (2024 Form 10‑K, p. 10). Thus, from 2022 through 2024 Gilead’s use of the Hoofddorp site has remained consistent – it continues to serve as a commercial manufacturing and processing location for its cell‑therapy portfolio, with no new functions or changes disclosed.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in stating that the Hoofddorp facility was used for commercial manufacturing and processing of cell therapy products from 2022 to 2024, and it correctly cites the same descriptive language across the 10-K filings. Quantitatively and contextually, the response is accurate—dates, years, entities (GILD, Hoofddorp), and document references (Form 10-K pages) are correctly identified, supporting high scores in quantitative accuracy and contextual relevance. However, the qualitative accuracy is lower because the LLM misinterprets the evolution of the facility’s role. The original answer (ground truth) identifies a progression: in 2022, Hoofddorp was only noted as a 'principal manufacturing site' without explicit mention of cell therapy; the specific designation for cell therapy manufacturing emerged in 2023 and continued in 2024. By claiming the same language appeared in all three years, the LLM incorrectly suggests consistency from the start, missing the strategic shift in 2023. This reflects a failure in multi-hop reasoning—synthesizing changes over time across filings—and thus the core evolution (increasing emphasis on cell therapy) is inaccurately portrayed as static. While the final conclusion is partially correct (Hoofddorp remains a cell therapy site), the lack of recognition of the 2022-to-2023 evolution undermines the answer’s correctness, warranting a score of 6 (partially correct with significant error in reasoning).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 407,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "The exhibit indexes show that Coca‑Cola has kept the 1.000 % Notes due 2028 in every filing – they appear in the 2022 report’s exhibit list (e.g., “Form of Note for 1.000 % Notes due 2028” 【page_134】) and are again listed in the 2024 filing (same description in the 2024 exhibit index)【page_130】.  In the 2024 filing the company also added a new series of higher‑coupon bonds, such as the 5.000 % Notes due 2034 and the 5.400 % Notes due 2064【page_130】, signalling that while it still relies on ultra‑low‑cost, short‑term financing, it is now willing to issue higher‑yield, longer‑dated debt to diversify its maturity profile and manage capital‑structure costs in a changing interest‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the persistent inclusion of the 1.000% Notes due 2028 in filings from 2022 through 2024, and the introduction of the 5.000% Notes due 2034 and 5.400% Notes due 2064 in 2024 are accurately reported. The percentages, years, and descriptions match the original answer exactly. (2) Quantitative accuracy is perfect: all interest rates (1.000%, 5.000%, 5.400%) and maturity years (2028, 2034, 2064) are correct, with no calculation errors. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that maintaining low-cost debt while introducing high-yield, long-term notes indicates a strategic shift in capital structure management, likely in response to changing interest rates. The conclusion about diversifying the maturity profile and managing costs in a changing rate environment is logically consistent with the evidence and semantically equivalent to the ground truth’s 'recalibration' and 'balancing near-term affordability with long-term funding needs.' (4) The only minor limitation is that the LLM does not explicitly mention 'strategic initiatives' as a possible reason for issuing higher-yield debt, which slightly reduces qualitative completeness, but the core reasoning about capital structure and financing costs is fully intact. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 402,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson kept pipe‑working tools—including pipe cutters—inside its Safety & Productivity segment, but the 10‑K narrative shows the segment’s product mix evolving from traditional wrenches and cutters (2022) to “battery‑hydraulic tools for press connections” and “diagnostic systems, including sewer‑inspection cameras and locating equipment” (2023‑2024). By adding battery‑powered cutters and integrated diagnostics, Emerson is shifting the portfolio toward electrified, data‑connected tools, positioning the company as a premium, technology‑focused supplier in the professional plumbing‑tools market rather than a pure‑mechanical‑tool player.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Emerson's pipe cutters evolved from traditional tools in 2022 to battery-hydraulic and diagnostic-integrated tools in 2023–2024. The mention of 'battery-hydraulic tools for press connections' and 'diagnostic systems, including sewer-inspection cameras and locating equipment' matches the original answer’s description of technological integration. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly used as time markers for the evolution, satisfying the temporal progression. (3) The multi-hop reasoning is sound—LLM synthesizes the shift across years and infers strategic positioning in the professional plumbing tools market. It correctly identifies the Safety & Productivity segment as the context, which is consistent with Emerson’s 10-K structure. (4) The only minor shortcoming is that the LLM slightly generalizes 'battery-powered cutters' rather than explicitly stating that battery-hydraulic technology was integrated into pipe cutters specifically (though 'battery-hydraulic tools' in context implies this). However, this does not distort the meaning. The conclusion about positioning as a 'premium, technology-focused supplier' is a valid interpretation of the strategic shift. Semantic equivalence is maintained, with slightly more concise phrasing. All parts of the question are addressed: portfolio evolution across years and strategic market positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 419,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "Across the three filings the Santa Monica, California site is described consistently as a “clinical manufacturing and processing” location for Gilead’s cell‑therapy products. In the 2022 10‑K it is listed among the company’s owned/leased facilities for that purpose, the 2023 filing repeats the same description, and the 2024 filing again notes that the site is used for clinical manufacturing and processing of cell‑therapy products (with no commercial activity mentioned). This steady focus shows that Santa Monica has become a dedicated clinical‑stage cell‑therapy hub in Gilead’s network, supplying early‑phase product supply while complementary sites (El Segundo, Frederick, Hoofddorp) handle later‑stage commercial manufacturing.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in its description of the Santa Monica facility being used for clinical manufacturing and processing of cell therapy products across 2022–2024, which aligns with the ground truth in part. However, it incorrectly states that the facility was described this way consistently starting in 2022. According to the ground truth, in 2022 the site was part of GILD’s R&D and manufacturing network but was *not specifically highlighted* for cell therapy processing—this specific role emerged only in 2023. The LLM thus misses the key evolution: the transition from a general R&D site to a dedicated cell therapy hub. This misrepresents the progression and undermines the multi-hop reasoning required to show change over time. While the entities (Santa Monica, El Segundo, Frederick), years (2022–2024), and strategic context (clinical vs. commercial manufacturing) are correctly identified, the core of the question—how the utilization *evolved*—is inaccurately portrayed. The LLM implies continuity rather than transformation, which is a significant qualitative error. Quantitative accuracy is perfect as there are no numerical claims to dispute. Contextual relevance is high because the answer addresses the strategic role and fits within the scope of the question. However, due to the critical misrepresentation of the timeline and evolution of the facility’s role, the correctness score is reduced to 6—partially correct but with a major factual omission in the temporal progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 415,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "Adobe did not highlight Frame.io in its 2022 10‑K, but by the 2023 filing it was positioned as a cloud‑native collaboration platform built into Creative Cloud that supports “video beyond post‑production workflows … including still images, design files and PDFs” and is directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront for frame‑accurate commenting and Camera‑to‑Cloud uploads. In the 2024 filing Adobe expanded that positioning – Frame.io now also integrates with Adobe Express, GenStudio and Firefly Services, adds support for casting, location‑scouting and marketing‑campaign media, and enables the same real‑time review and annotation experience across an even broader set of Creative Cloud apps.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of timeline, supported media types, and integration with Adobe applications. It accurately reflects the evolution from 2022 to 2024, noting Frame.io's growing role in Creative Cloud. However, there is a minor inaccuracy regarding the 2023 integration details: the original answer specifies integration with Premiere Pro and After Effects in 2023, while the LLM answer incorrectly includes Photoshop, Lightroom, and Workfront in the 2023 description—these were part of the 2024 expansion. The LLM also correctly identifies the 2024 expansion to include casting, location scouting, and marketing campaign support, as well as integration with GenStudio and Adobe Express (implied via broader Creative Cloud), though 'Firefly Services' is not mentioned in the ground truth and may be speculative. All dates and years are accurate, and no numerical data is incorrect (quantitative accuracy is perfect). The reasoning is mostly sound, capturing the multi-hop progression across years and applications, but slightly conflates the timing of integrations. The answer is semantically very close and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 336,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "Emerson’s Discrete Automation segment has always listed **electrical‑distribution equipment** as one of its core product families (see the 2022 segment description that groups “electrical distribution equipment” with solenoid valves, pneumatic cylinders, programmable automation control systems, etc.) 【page_73】.  \n\nBy 2024 the company’s narrative ties that hardware more tightly to **automation‑software and digital‑ecosystem solutions** – it is now described as part of “Industrial Solutions,” which provides **integrated electrical‑distribution gear together with programmable control systems, software and materials‑joining products** to deliver end‑to‑end automation for discrete manufacturers 【page_76】.  \n\nThus, from 2022 to 2024 Emerson moved from positioning electrical‑distribution equipment as a standalone hardware line toward a broader, software‑enabled offering that is integrated with programmable control and other automation technologies, expanding the product scope to include complementary motion, joining and digital‑control solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the strategic evolution of Emerson's Electrical Distribution Equipment from 2022 to 2024 with accurate dates and consistent entity references (EMR, Discrete Automation, Industrial Solutions). It correctly notes the integration of electrical distribution equipment with automation control systems and software, and the expansion into broader automation solutions. However, there are key inaccuracies in the narrative flow: (1) The claim that electrical distribution equipment was 'always' part of Discrete Automation is incorrect — in 2022, it was under the broader Industrial Solutions business, not specifically within Discrete Automation, which only became explicit in 2023. (2) The 2024 description incorrectly places electrical distribution equipment back under 'Industrial Solutions' as if it left Discrete Automation, whereas the ground truth shows it was further embedded *within* Discrete Automation alongside linear motion and materials joining solutions. (3) The LLM conflates segment names and positioning — Industrial Solutions appears to be used as a product offering rather than a segment, creating confusion. Despite these misrepresentations in structure and segment alignment, the core idea of integration with automation technologies and scope expansion is conveyed, and no numerical or date errors exist. Thus, while the qualitative reasoning has flaws in multi-hop synthesis (especially segment classification over time), the overall direction of strategic shift is captured, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 429,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "- **2022:** Fixed‑rate unsecured senior notes carried $24.1 billion at a weighted‑average interest rate of **4.45 %**.  \n- **2023:** The portfolio grew to $27.2 billion, still at **4.45 %**.  \n- **2024:** The carrying amount fell slightly to $26.9 billion, but the weighted‑average rate rose to **4.84 %**.\n\nThe trend shows Capital One expanding its fixed‑rate senior debt in 2023 and then maintaining a similar size in 2024 while accepting a higher average coupon. This suggests the company is deliberately locking in longer‑dated fixed‑rate funding even as market rates climb, using higher‑cost issuance to preserve a stable, predictable debt profile in a rising‑interest‑rate environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly in the 2022 carrying value and interest rate. The ground truth states that in 2022, the carrying value was $19,975 million ($19.975 billion), not $24.1 billion as claimed by the LLM. Additionally, the LLM incorrectly reports the 2022 weighted-average interest rate as 4.45%, which is actually the 2023 rate; the correct 2022 rate is 2.91%. The 2023 and 2024 carrying values are close ($27.2B vs $27.168B and $26.9B vs $26.930B), and the 2024 interest rate of 4.84% is correct. (2) Calculations: The LLM fails to reflect the correct progression of interest rates—showing no change from 2022 to 2023 when there was a significant increase from 2.91% to 4.45%. This misrepresents the pace and timing of rate increases. (3) Multi-hop reasoning: While the LLM correctly identifies the overall trend of increasing debt followed by a slight decline and rising rates, it misattributes the timing of the rate hike, undermining the logical link between rising market rates and Capital One’s strategy. The conclusion about locking in fixed-rate debt in a rising rate environment is reasonable and aligns with the ground truth, but it is based on flawed data inputs. (4) The contextual relevance is high because the answer addresses all parts of the question—evolution of debt, carrying value, interest rates, and strategic interpretation. The qualitative reasoning is sound in structure and interpretation, despite being based on incorrect numbers. Therefore, while the narrative is coherent and relevant, the factual foundation is partially incorrect, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 456,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s liability for product‑performance and operating‑cost guarantees has been falling.  The “service and product warranties and product performance guarantees” balance was **$1,109 million at the end of 2022**, slipped to **$1,091 million at the end of 2023**, and fell further to **$993 million at the end of 2024** (see RTX 10‑K 2024 Note 16, table of balances [page 102]).  \n\nThe downward trend—driven by modest net issuances versus settlements and other adjustments—shows that the company’s outstanding exposure to long‑term performance‑risk obligations in its commercial‑aerospace business is gradually decreasing, although the remaining near‑$1 billion liability still reflects a material, ongoing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and trend. The ground truth states that RTX's liabilities related to performance and operating cost guarantees were $120 million in 2022 and 2023, and $101 million in 2024—indicating stability with a slight decrease. However, the LLM reports figures over $1 billion (e.g., $1,109 million in 2022), which is nearly 10 times higher. This misrepresents the scale and evolution of the liability. (2) The numbers cited by the LLM—$1,109M, $1,091M, $993M—do not match the ground truth values of $120M, $120M, $101M. Even allowing for format variations, the discrepancy is massive and cannot be attributed to rounding or presentation differences. The cited source (RTX 10-K 2024 Note 16, page 102) may refer to a broader category (e.g., total warranty liabilities), but the LLM failed to isolate the specific 'performance and operating cost guarantees' subset as required. (3) The multi-hop reasoning is flawed: while the LLM attempts to analyze a trend over time and link it to risk exposure, it does so on incorrect data. The conclusion that exposure is 'gradually decreasing' is based on a misidentified metric and thus invalid. The ground truth emphasizes stability in risk exposure, not a meaningful decline. (4) Despite the factual inaccuracies, the LLM addresses the right question structure—analyzing evolution over time and interpreting implications for long-term risk—so contextual relevance is moderate. However, due to severe quantitative and qualitative errors, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 432,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "- In the 2022 filing the company explained that for non‑publicly‑traded investments it “uses valuation methodologies including discounted cash flows, **estimates of sales proceeds** and appraisals… the ability to accurately predict future cash flows, especially in emerging and developing markets, may impact the determination of fair value.”  \n- The 2023 and 2024 filings repeat the same description word‑for‑word, still listing **estimates of sales proceeds** as one of the primary methods and again stressing the difficulty of cash‑flow forecasting in emerging markets.  \n\n**What this shows:** Coca‑Cola’s approach has not shifted – it continues to rely on sales‑proceeds estimates as a core component of fair‑value measurement for non‑public investments. The unchanged language underscores a deliberate, market‑participant‑based framework that acknowledges the persistent uncertainty of cash‑flow projections in emerging and developing markets rather than moving to a new valuation technique.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that the 2023 and 2024 filings repeat the 2022 language 'word-for-word' and show no change. The ground truth states a clear evolution: from disclosure in 2022, to explicit reliance in 2023 ('relies on'), to continued use with increased caution in 2024. The LLM incorrectly concludes there was no shift, directly contradicting the documented progression. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in dates or formats, earning full marks by default. (3) The multi-hop reasoning fails: the question requires synthesis across three years of filings to detect a strategic evolution, but the LLM asserts stasis based on an unsupported claim of identical wording. This misrepresents the company's changing language and intent, missing the key insight about deepening reliance followed by cautious integration. (4) Contextual relevance is moderate—the answer addresses the right topic (valuation methods, emerging markets) and cites appropriate methodologies, but the conclusion undermines accuracy. The emphasis on persistent uncertainty aligns partially with the 2024 caution, but the failure to recognize the shift from passive use to active reliance in 2023 severely limits correctness. Overall, the answer is partially informed but fundamentally flawed in its interpretation of the timeline and strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 402,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon repeatedly warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The wording of this limitation is essentially unchanged from 2022 through 2024, indicating that the company’s view of the regulatory ceiling on dividends and share repurchases has remained stable. That consistency suggests BNY Mellon’s strategic flexibility to distribute capital to shareholders is confined by the same set of banking‑law constraints each year, but it has not been further narrowed by new regulatory or rating‑related restrictions during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent disclosure language across 2022, 2023, and 2024 regarding BNY Mellon's capital return limitations under U.S. banking laws, Delaware law, and preferred stock dividend obligations. All entities (BNY Mellon, U.S. banking laws, Delaware law, preferred stock), years (2022–2024), and the quoted regulatory language are accurate, satisfying quantitative and entity accuracy. The reasoning correctly notes the stability of the regulatory constraints over the three years, which aligns with the ground truth. However, the LLM answer omits a key qualitative development highlighted in the original answer: the 2024 addition emphasizing the Parent’s reliance on dividends from subsidiaries and credit extensions from its IHC (Intermediate Holding Company) to fund share repurchases and dividends. This omission weakens the analysis of the multi-year progression and the evolving internal structural dependencies affecting capital distribution strategy. While the core facts are correct and the consistency of regulatory language is accurately reported, the failure to capture this new emphasis in 2024 results in incomplete synthesis of the multi-hop evolution. Thus, the answer is factually sound but lacks full completeness in capturing the strategic nuance of increasing internal capital flow dependencies. This justifies a 7 in correctness and qualitative accuracy. Contextual relevance remains high as the response directly addresses the question’s focus on regulatory evolution and strategic flexibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 424,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD’s 2022 Form 10‑K first flagged the possibility of “loss or modification of exemptions for taxes and tariffs” as one of a long list of political‑, legal‑ and economic‑risk factors (see 2022 p. 37). The 2023 filing repeats the same exposure in its risk factors (2023 p. 40) and, by the 2024 filing, the language appears again (2024 p. 40‑41) but is now embedded in a broader discussion of heightened sanctions, the Russia‑Ukraine war and China‑Taiwan tensions. The repeated and increasingly contextualized references suggest that AMD’s vulnerability to losing tax‑ and tariff‑exemptions is growing, reflecting a more complex and volatile global regulatory landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: AMD first mentioned the risk in 2022, repeated it in 2023, and expanded the context in 2024 to include geopolitical events like the Russia-Ukraine war and China-Taiwan tensions. The page references (2022 p.37, 2023 p.40, 2024 p.40-41) are consistent with the source data and correctly attributed. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years and document locations are accurate, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings, identifying both the continuity and evolution of risk disclosure. It infers increasing vulnerability and regulatory complexity from the contextual expansion of language, which is logically supported. (4) The LLM slightly under-elaborates on the role of U.S. export controls and macroeconomic instability mentioned in the original 2024 discussion, but captures the core trend of growing complexity due to geopolitical factors. Wording differs slightly but maintains semantic equivalence. Minor omission does not undermine the overall correctness. Hence, a score of 9 is justified—excellent accuracy with near-complete synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 369,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "- **Short‑term borrowings:** $883 million in 2022, fell to $538 million in 2023 and rose modestly to $562 million in 2024【page_178†L31-L38】.  \n- **Long‑term debt:** $47,832 million in 2022, increased slightly to $49,318 million in 2023 and then declined to $44,989 million in 2024【page_178†L43-L50】.  \n\nThe combined effect was a reduction of total debt from $48.7 billion in 2022 to $45.6 billion in 2024.  During the same period Capital One eliminated its floating‑rate unsecured senior notes – $1,597 million in 2022, $349 million in 2023 and $0 in 2024 – shifting the senior‑note portfolio to almost entirely fixed‑rate debt (weighted‑average rate rising from 4.48% in 2022‑23 to 4.84% in 2024)【page_178†L55-L64】.  This progression shows a tighter debt structure with lower overall leverage and markedly reduced exposure to variable‑rate interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly in total debt figures and short-term borrowings. The original answer states total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. However, the LLM calculates $48.7B in 2022 (sum of $883M ST + $47,832M LT = $48,715M), which does not match the ground truth. Similarly, 2024 total debt is reported as $45.6B by LLM (close to $45.551B), but derived from incorrect components ($562M + $44,989M = $45,551M — numerically correct sum but mislabeled as $45.6B, acceptable within rounding). However, the 2022 and 2023 totals are significantly off. (2) Floating unsecured senior debt: LLM reports $1,597M in 2022 vs. ground truth $1,709M — a material discrepancy. The drop to $349M in 2023 and $0 in 2024 is correct. Weighted-average interest rate for fixed unsecured senior debt is partially correct — LLM mentions a rise to 4.84% in 2024, matching the original, but incorrectly states it was 4.48% in 2022–2023; ground truth shows 2.91% in 2022 and rising to 4.84% by 2024. Fixed debt values are also incorrect: LLM omits explicit values, while original shows $21.045B (2022), $27.168B (2023), $26.930B (2024). (3) Multi-hop reasoning is partially sound: LLM correctly infers that elimination of floating-rate debt indicates a shift to fixed-rate to reduce interest rate risk, which aligns with the original conclusion. It identifies the strategic pivot, though with less precision due to numerical inaccuracies. (4) Contextual relevance is high — all parts of the question are addressed: evolution of debt, composition changes, and implications for interest rate exposure. Despite incorrect inputs, the qualitative interpretation remains reasonable. However, the quantitative inaccuracies — especially in core financial figures — reduce confidence in the answer’s reliability. Scoring reflects partial correctness: major numbers are off, but directional trends and strategic interpretation are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 551,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program‑share interest in International Aero Engines AG (the V2500 joint‑venture) was 57 % in the 2022 filing and remained 57 % in the 2023 and 2024 filings. The unchanged, majority‑share position shows that RTX continues to be the primary beneficiary of the IAE partnership, keeping a leading strategic foothold in the V2500 engine program and preserving its influence over the collaboration’s economics and product‑support decisions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the quantitative evolution of RTX's net program share interest. The ground truth states that RTX's interest was 61% in 2022 and decreased to 57% in 2023 and 2024. However, the LLM claims it was 57% in 2022 and remained unchanged, which contradicts the data. This error undermines the entire response. (2) The numbers are inaccurate: the 2022 percentage is wrong (57% vs. correct 61%), and the narrative of 'no change' conflicts with the actual decrease of 4 percentage points over the period. No calculation is needed beyond comparison, but the comparison is flawed. (3) The multi-hop reasoning fails because the model did not detect the change over time, leading to an incorrect interpretation. Instead of recognizing a strategic reduction in economic exposure, the LLM infers continued stable control, which misrepresents RTX's strategic positioning. The conclusion about 'primary beneficiary' and 'leading strategic foothold' may still hold due to majority share, but the lack of acknowledgment of dilution weakens the analysis. (4) Contextual relevance is high because the answer addresses the right entities (RTX, IAE, V2500 program) and attempts to interpret strategic implications. However, due to the core factual error in percentages and trend, the correctness and accuracy scores are very low. Minor formatting like '57 %' with space is not penalized, but the substance is fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 405,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Across the three filings, Cascade has remained the flagship brand anchoring P&G’s Home‑Care sub‑segment. In the 2022 10‑K the Fabric & Home Care segment accounted for 35 % of net sales and listed “Cascade” among its major home‑care brands, with the narrative noting that the company’s global home‑care share is “primarily behind our **Cascade**, Dawn, Febreze and Swiffer brands” 【page_19】. By 2024 the segment’s contribution rose modestly to 36 % of net sales and the brand is now shown as “Tide Cascade” (still highlighted first among the home‑care brands) with the same wording that the home‑care market share is “primarily behind our **Cascade**, Dawn, Febreze and Swiffer brands” 【page_18】. Thus, Cascade’s positioning has stayed consistent—as the lead home‑care brand driving the segment—while the segment’s overall weight grew slightly and the brand is now paired with Tide in the branding hierarchy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Cascade's consistent presence in P&G's Home Care sub-category under the Fabric & Home Care segment across 2022–2024, and accurately reports the segment's net sales contribution increasing from 35% in 2022 to 36% in 2023 and 2024. However, the original answer includes earnings data (31% in 2022, rising to 34% in 2023 and 2024), which the LLM omits entirely—this is a notable gap in completeness. (2) Quantitatively, all cited percentages (35%, 36%) and years are correct, and the LLM accurately reflects the branding evolution to 'Tide Cascade' in 2024. There are no calculation errors. The reference to page numbers adds precision but does not affect factual accuracy. (3) The multi-hop reasoning is mostly sound: the LLM synthesizes brand positioning across three years and notes continuity in Cascade’s strategic role. However, it overstates Cascade as the 'flagship' and 'lead home-care brand driving the segment,' which goes beyond the original answer’s more neutral 'core' or 'key' brand characterization. This introduces a slight interpretive bias. (4) Contextual relevance is strong—the response directly addresses the evolution of Cascade’s positioning and uses appropriate evidence from the filings. The omission of earnings data and slight overstatement of Cascade’s leadership role prevent a top score, but the core facts and trend interpretation are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 393,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Code of Conduct was made available on the bnymellon.com site (e.g., https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf) and was referenced only in the “Code of Ethics” paragraph of Item 10, with the URL containing a spaced “inv relations” path. The 2023 filing kept the same bnymellon.com domain and “content/dam/bnymellon/documents/pdf/…” structure, but did not change the wording. By the 2024 filing the company had re‑branded the link to the bny.com domain (e.g., https://www.bny.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf) and explicitly tied the Directors’ Code to the broader corporate‑governance framework, stating that it is incorporated by reference in the proxy’s governance sections (Item 10, Item 13, committee charters, etc.).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of dates, domains, and URL structures, accurately reflecting the evolution from bnymellon.com to bny.com by 2024 and maintaining the core document path. It correctly identifies the 2022 and 2024 domain changes and notes the integration with broader governance frameworks in 2024, which aligns with the ground truth. However, there are minor inaccuracies: the LLM claims the 2022 URL used 'inv relations' with a space, but the ground truth specifies 'in relations' (later corrected to 'inv relations' in 2023), so the LLM misattributes the timing and exact phrasing. Additionally, the LLM incorrectly implies the 2022 URL already had 'investor-relations' in the path, while the ground truth shows this clean hyphenated version only emerged in 2024. The claim that the 2023 filing 'did not change the wording' is vague and less precise than the ground truth, which notes a shift from 'in relations' to 'inv relations'. The LLM correctly captures the qualitative shift toward integration with corporate governance (e.g., incorporation by reference in proxy sections), but overstates the explicit linkage in 2024 by suggesting broader textual integration than the ground truth confirms. Despite these nuances, the core multi-hop reasoning across years and domains is sound, and the strategic interpretation of branding and governance alignment is contextually appropriate. Quantitative elements (years, domains, URL patterns) are mostly accurate with minor path discrepancies, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 425,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "Across the three filings AMD’s stance with add‑in‑board (AIB) partners remained essentially unchanged. In 2022, 2023 and again in 2024 the company disclosed that its contracts with AIB manufacturers “protect their inventory of our products against price reductions,” and that system integrators “often use discrete‑graphics solutions as a means to differentiate their products and add value to their customers.” Thus, AMD’s strategic positioning consistently combined inventory‑protection clauses for AIBs with a clear emphasis on discrete GPUs as a key differentiation tool for its channel partners.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that AMD maintained consistent inventory protection policies for AIB manufacturers across 2022, 2023, and 2024, explicitly stating that contracts protected AIB inventory against price reductions—this matches the original answer's core claim. (2) The LLM accurately captures the strategic role of discrete graphics solutions as a differentiation tool for system integrators in all three years, quoting key phrasing from the filings (e.g., 'often use discrete-graphics solutions as a means to differentiate their products'). (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly infers stability in AMD’s strategic positioning, even without explicit comparison, by noting the repetition of the same language. (4) All entities—AMD, AIB manufacturers, system integrators, discrete graphics—are correctly identified and contextualized. There are no numerical inaccuracies (dates are correct and no calculations are required beyond accurate reporting of consistent policy). The answer is concise but complete, addressing both inventory protection and differentiation strategy across the full time span. Thus, all scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 359,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "- In the 2022 filing McDonald’s first highlighted the Egg McMuffin as a core breakfast sandwich (“Breakfast offerings may include … the Egg McMuffin…”) and stressed that “taste, quality, choice, value and nutrition are important to customers, and the Company is continuously evolving its menu … testing new products on an ongoing basis” (page 6).  \n\n- The 2023 filing kept the Egg McMuffin in the breakfast‑menu description and added a stronger supply‑chain narrative, noting that “the Company collaborates with suppliers to encourage innovation and drive continuous improvement across its global supply chain” and that it maintains “high food‑safety and quality standards… regular sensory evaluations and calibration trainings” to ensure consistency (page 6).  \n\n- By 2024 the disclosure further emphasized supply‑chain innovation, saying a “digital‑transformation project … promotes data excellence and continuous measures on quality and food‑safety performance,” while still listing the Egg McMuffin among its breakfast items, positioning it as the flagship product that “meets customer expectations for quality and consistency” through those enhanced supply‑chain and quality‑management systems (page 6).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: the 2022 disclosure correctly identifies the Egg McMuffin as part of the breakfast menu and emphasizes menu evolution around taste, quality, and nutrition; the 2023 update accurately reflects enhanced language on supply chain collaboration and quality controls like sensory evaluations; and the 2024 disclosure correctly highlights the digital transformation project focused on data excellence and continuous quality and food safety monitoring. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but all years (2022, 2023, 2024) are correctly referenced and sequenced. (3) The multi-hop reasoning is sound—the LLM synthesizes information across three years of disclosures, tracing the evolution from product presence to supply chain integration to digital quality systems, all in relation to the Egg McMuffin’s role in meeting customer expectations. (4) The answer is contextually precise, directly addressing how McDonald's disclosure evolved over time with increasing emphasis on supply chain and digital systems to support consistency and quality of a core menu item. Wording differs slightly from the original answer but maintains full semantic equivalence. No errors in entities, reasoning, or facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 377,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "The 4.30 % Note due 2034 is listed in the “Exhibits” tables of Oracle’s 2022, 2023 and 2024 Form 10‑K filings (see the 4.09 exhibit description that includes the 4.30 % Note due 2034 on pages 110‑111 of each filing) 【page_110】【page_111】. Its repeated disclosure shows that the note remains outstanding and is a core component of Oracle’s long‑term debt portfolio, indicating that the company relies on fixed‑rate, multi‑year financing to support its capital needs and prefers a stable, staggered maturity profile across reporting periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.30% Note due 2034 as being disclosed in Oracle's 2022, 2023, and 2024 filings, which matches the ground truth. All numeric values—interest rate (4.30%), maturity year (2034)—are accurate, and the years of disclosure (2022–2024) are correct. (2) Quantitative accuracy is perfect: percentages and dates are correctly stated, and no calculations are required. (3) The reasoning is mostly sound: the LLM correctly infers that the consistent disclosure indicates the note remains outstanding and is a core part of Oracle’s long-term debt, reflecting a preference for stable, staggered maturities. However, it misses some multi-hop synthesis present in the original answer—specifically, the context of other debt instruments issued in each year (e.g., the 3.625% Note due 2023 in 2022, or the 2.950% Notes due 2024 in 2023), which support the conclusion about a diversified and evolving debt portfolio. The LLM generalizes Oracle’s financing strategy correctly but lacks the granular, year-by-year cross-filing evidence that strengthens the original answer’s qualitative depth. (4) The answer is contextually relevant and factually correct in its claims, earning high marks. However, the qualitative accuracy is slightly reduced due to incomplete synthesis of supporting evidence across filings, and the correctness score reflects this minor omission despite strong overall performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 398,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One values its net derivative assets and liabilities with vendor‑based discounted‑cash‑flow models that price the contracts using observable curves (interest‑rate, credit, FX) but rely on **swap‑rate assumptions that are not directly observable**, so the instruments are classified as Level 3 (see the “Derivative Assets and Liabilities” note and the Level 3 roll‑forward tables).  The net Level 3 fair‑value balance rose from **about $5 million at 12/31/2022** (Table 16.2, 2022) to **$58 million at 12/31/2023** (Table 17.2/16.3, 2023) and to **$69 million at 12/31/2024** (Table 17.2/17.3, 2024), while the weighted‑average swap‑rate input grew from roughly 2 % to 4 % over the same period.  This upward trajectory shows that Capital One’s exposure to unobservable market inputs has increased markedly, reflecting a larger reliance on model‑driven, Level 3 valuations for its derivative positions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities fair value was $19 million in 2022, $58 million in 2023, and remained at $58 million in 2024. However, the LLM incorrectly reports these as approximately $5 million in 2022, $58 million in 2023, and $69 million in 2024. The $69 million figure for 2024 is particularly erroneous and contradicts the ground truth of no change from 2023 to 2024. Additionally, the ground truth mentions unobservable inputs such as default rates (53–163%) and swap rates (3–5%), but the LLM invents a 'weighted-average swap-rate input' increasing from 2% to 4%, which is not supported by the original answer.\n\n(2) Quantitative accuracy is low: the 2022 value is off by a factor of nearly 4x ($5M vs $19M), and the 2024 value is incorrectly increased to $69M instead of remaining flat at $58M. The ground truth also does not mention any trend in swap rate values—only their range (3–5%)—so the claim of an increase from 2% to 4% is speculative and unsupported. The only correct number is the $58M for 2023.\n\n(3) The reasoning is partially sound in that it identifies the use of unobservable inputs (swap rates) and links them to Level 3 classification, which aligns with the question’s focus on exposure to unobservable inputs. However, the conclusion that exposure 'increased markedly' due to rising balances is flawed because the ground truth shows stability from 2023 to 2024, not growth. The multi-hop synthesis fails to accurately reflect the evolution over time, especially the stabilization in 2024.\n\n(4) Contextual relevance is high—the answer addresses valuation methodology, use of unobservable inputs, and trends over time, all central to the question. But due to major numerical errors and incorrect interpretation of trends, the correctness score is limited to 4. While the qualitative understanding of Level 3 inputs and modeling assumptions shows some insight, it is undermined by inaccurate data sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 553,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s Rolls‑Royce obligation is the “flight‑hour” payment tied to every hour flown by V2500‑powered aircraft through June 2027. In each filing the company says the payments are **capitalized as collaboration intangible assets** when made and then **amortized over the period of economic benefit** (i.e., the engine’s production‑and‑after‑market life), rather than being expensed up‑front. The total “other commercial‑aerospace” commitment that includes these payments fell from roughly **$11 billion (gross) in 2022** to about **$9.5 billion in 2024** (after the collaboration‑partner share offset), showing the liability has been shrinking while the payment‑and‑amortization approach has remained unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2024, RTX's total commercial aerospace financing and other commitments were $14.1 billion, but the LLM claims it fell to $9.5 billion in 2024, which is incorrect. Additionally, the LLM states the 2022 gross commitment was $11 billion, but the original answer does not provide a specific dollar figure for 2022—only that payments were classified as contingent liabilities. Thus, the LLM fabricates or misrepresents key numbers. (2) The dates are partially correct: the per-hour payment structure lasting through June 2027 matches the ground truth. However, the claimed reduction from $11B to $9.5B is unsupported and contradicts the actual reported increase to $14.1B. This represents a major quantitative error. (3) The qualitative reasoning around payment capitalization and amortization is partially sound: the LLM correctly identifies that payments are capitalized as collaboration intangible assets and amortized to cost of sales (consistent with 2023 and 2024 disclosures), and it correctly notes the policy has remained stable. However, it fails to reflect the evolution in transparency and reporting clarity over time (e.g., improved disclosure from 2022 to 2024), which is a key point in the original answer. It also omits the 2012 origin of the obligation, which provides important context. (4) Contextual relevance is high—the answer addresses the core topic of payment structure and amortization strategy tied to flight hours. But due to major numerical inaccuracies and incomplete synthesis across years, the correctness score is low. While the conceptual framework is reasonable, the factual foundation is flawed, leading to a score of 4 for correctness, 3 for quantitative accuracy, 5 for qualitative accuracy, and 8 for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 511,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen’s 2022 filing first noted that, after a 2017 FDA review of the Neulasta Onpro kit, the company “implemented device and labeling enhancements to address product complaints” and set up a continuous program to collect user‑complaint, adverse‑event and malfunction data and add further improvements as needed. The 2023 filing repeated that same history and risk‑mitigation language, while the 2024 filing expanded the discussion to show how those monitoring activities are now tied to broader operational‑resilience measures—such as reliance on backup generators, diversified third‑party suppliers and contingency plans for natural‑disaster‑related power outages at its Puerto Rico manufacturing site—to safeguard uninterrupted supply of the kit and its associated product.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2017 FDA evaluation, device and labeling enhancements in response to complaints, continuity of monitoring across years, and the 2024 expansion to include operational resilience measures. The mention of backup generators in Puerto Rico due to power instability is correctly included, including the context of an island-wide outage on December 31, 2024, which is consistent with the original answer. (2) Quantitative accuracy is perfect: all dates (2017, 2022, 2023, 2024) are correct, and no numerical errors are present. The LLM correctly avoids fabricating specifics not in the original, such as exact numbers of complaints or outage durations. (3) Multi-hop reasoning is sound—LLM synthesizes information across three years of disclosures, correctly identifying evolution from device-focused risk mitigation to broader operational resilience. It accurately links infrastructure measures (backup generators, supplier diversification, disaster planning) to supply chain continuity and indirectly to user experience. The only minor gap is that the original specifies the December 31, 2024 outage as an example, while the LLM generalizes it to 'natural-disaster-related power outages' without citing that specific date—this slight omission prevents a perfect 10 but does not undermine correctness. (4) The answer is fully relevant, directly addressing the evolution in disclosures around user complaints, device enhancements, and operational resilience. Wording differs but semantic meaning matches. Overall, this is a strong, factually correct response with only a minor reduction in qualitative accuracy due to the lack of specificity on the December 2024 outage date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 481,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s Item 14 – Principal Accountant Fees and Services contains the same language: the ratification of KPMG LLP as the company’s principal accountant is incorporated by reference to the proxy’s “Item 3 – Ratification of KPMG LLP,” and each filing notes that KPMG LLP’s PCAOB firm identification number is 185. The unchanged wording and the repeated citation of the same PCAOB number indicate that the firm has remained the company’s auditor and that the audit‑governance structure has been continuous and unchanged over the three‑year span.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: KPMG LLP was consistently ratified as principal accountant in 2022, 2023, and 2024; the PCAOB firm number 185 is correctly cited across all years; and the disclosure is tied to Item 14 and proxy Item 3. (2) Quantitative accuracy is perfect: no numerical errors, and the PCAOB number 185 is correctly repeated. (3) The reasoning is sound: the LLM correctly infers audit governance continuity from unchanged disclosures and consistent PCAOB identification, demonstrating proper multi-hop synthesis across the three filings. (4) The only minor shortcoming is that the LLM does not explicitly state the implication of 'no auditor rotation' or 'institutional trust' as in the original answer, slightly reducing qualitative depth. However, the core conclusion about continuity and unchanged audit structure is clearly conveyed. Wording differs but semantic meaning matches. Contextual relevance is excellent—directly addresses both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 301,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s on‑balance‑sheet exposure to commercial‑aerospace customer‑financing guarantees has been falling each year – the maximum‑potential payment for these guarantees was $304 million in 2022, $288 million in 2023 and $274 million in 2024【page_100†L1-L4】【page_102†L1-L4】.  At the same time, the portion of the guarantees that is assumed by collaboration partners has slipped from about $142 million in 2022 to $135 million in 2023 and $131 million in 2024【page_100†L9-L12】【page_102†L9-L12】, showing that RTX is deliberately off‑loading more of the risk to its partners and thereby reducing its own liability exposure in this financing‑guarantee program.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values from the ground truth: the collaboration partners' share of guarantees is accurately stated as $142M in 2022, $135M in 2023, and $131M in 2024. These figures match the original answer exactly, satisfying quantitative accuracy. The LLM also correctly identifies the downward trend over the three-year period.\n\n2) Quantitatively, all numbers are correct and properly attributed to the respective years. The LLM even provides additional context (total exposure: $304M, $288M, $274M), which is consistent with typical 10-K disclosures and does not contradict the ground truth. These extra figures enhance the answer but are not required for correctness.\n\n3) The qualitative reasoning is mostly sound but contains a subtle misinterpretation. The original answer states that the declining partner share indicates a 'strategic reduction in shared financial risk with partners,' which could imply RTX is taking on more risk or restructuring arrangements. However, the LLM interprets this as RTX 'deliberately off-loading more of the risk to its partners,' which inverts the logic: if the partners’ share is decreasing, it means partners are assuming *less* risk, not more. Therefore, RTX is likely retaining more risk, not offloading it. This is a significant reasoning error that affects the interpretation of RTX’s risk management strategy.\n\n4) Despite this misinterpretation, the LLM captures the trend correctly and cites appropriate evidence. The answer is contextually relevant, addresses both parts of the question (evolution of exposure and strategic implication), and synthesizes data across years. The error lies in the causal inference, not in data reporting or entity identification. Hence, the correctness score is reduced to 8 due to flawed reasoning in the strategic interpretation, even though all facts are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 508,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "In the 2022 filing the Always name appeared only as part of a combined “Feminine Care” group (listed together with Pampers, Tampax and Always Discreet) and was described simply as one of the company’s leading feminine‑care brands. By the 2023 filing P&G split the category into “Menstrual Care” and “Adult Incontinence,” placing Always at the top of the menstrual‑care sub‑segment (behind only Tampax) and introducing Always Discreet as the distinct adult‑incontinence brand; the 2024 filing repeats this structure and adds market‑share detail, emphasizing Always’s leadership in menstrual care (over 25 % share) and Always Discreet’s role in the adult‑incontinence market (≈15 % share).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE ACCURACY: The claim that the segment was split into 'Menstrual Care' and 'Adult Incontinence' in 2023 is incorrect. The ground truth states the segment was renamed to 'Baby, Feminine & Family Care' in 2023, not split into new subcategories. Additionally, the LLM introduces market share figures (Always >25%, Always Discreet ≈15%) that are not present in the original answer and cannot be verified from the provided truth. These numbers are fabrications or hallucinations. (2) COMPLETENESS: While the answer addresses product categorization and brand emphasis, it misrepresents the structural changes. It incorrectly claims a category split and introduces new sub-segments not mentioned in the ground truth. (3) ENTITY ACCURACY: The mention of Pampers in the 2022 Feminine Care group is incorrect — Pampers is a baby care brand and not listed under Feminine Care in the original answer. The original only lists Always, Always Discreet, and Tampax in the 2023 structure. (4) REASONING: The multi-hop synthesis is flawed. The LLM invents a reorganization (split into Menstrual and Adult Incontinence) that did not occur according to the ground truth, which describes only a renaming and formatting streamlining. The positioning of Always 'at the top behind only Tampax' is speculative and not supported. (5) SEMANTIC EQUIVALENCE: Despite some correct elements — such as the continued presence of Always and Always Discreet and the general idea of structural refinement — the core narrative of reorganization and market share emphasis is factually incorrect. The answer misleads more than it informs. Contextual relevance is high because it attempts to trace brand evolution and categorization, but factual errors severely limit usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 496,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "In the 2022 filing AMD listed “difficulties in protecting our intellectual property” only as one of the generic political‑legal risks attached to any foreign operation. By the 2023 filing the company was already emphasizing that risk together with its growing dependence on third‑party wafer foundries in the United States, Europe **and especially Asia**, and on assembly and testing in China, Malaysia and Taiwan—showing that IP exposure had risen as its Asian manufacturing footprint expanded. The 2024 filing repeats the same IP‑protection risk but now couples it with a higher share of international sales (≈65 % of revenue) and explicit references to geopolitical tensions between China and Taiwan, indicating that AMD’s exposure to IP‑protection difficulties has become more pronounced as its overseas operations and reliance on Asian contract manufacturers have grown.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: AMD's increasing emphasis on IP protection risks from 2022 to 2024, growing reliance on third-party manufacturing in Asia (specifically China, Malaysia, and Taiwan), and the mention of geopolitical tensions between China and Taiwan in 2024. The 65% international sales figure in 2024 is correctly cited (≈65% in LLM answer). (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates; the ≈65% approximation is acceptable and matches the original. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years, linking expanding international operations and Asian manufacturing dependencies to evolving IP risks. It accurately notes the progression from generic foreign risk (2022) to specific regional and geopolitical concerns (2023–2024). (4) Minor deduction in qualitative accuracy due to the mention of 'third-party wafer foundries in the United States, Europe and especially Asia'—while not incorrect, the original answer and risk focus are more concentrated on Asia, particularly East Asia, without highlighting U.S. or European foundries as part of the IP risk context. This addition slightly dilutes the regional focus but does not invalidate the conclusion. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 392,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle first introduced the 2.300 % senior unsecured notes that mature in 2028 in a March 24 2021 issuance (shown in Exhibit 4.14 of the 2022 Form 10‑K). The same tranche, with identical coupon and maturity, appears unchanged in the Exhibit tables of the 2023 and 2024 Form 10‑Ks, indicating that the notes were issued once and have simply been carried forward as an outstanding liability. This recurring presence demonstrates Oracle’s practice of building a laddered series of fixed‑rate notes—adding new coupons in successive years while retaining earlier issues—to lock in low‑cost financing, diversify maturities and preserve liquidity across a multi‑year debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.300% Notes due 2028 were issued on March 24, 2021, and consistently disclosed in Exhibits 4.14 (2022, 2023, 2024), which matches the original answer’s reference to Exhibit 4.16 in 2022 and 4.14 in 2023/2024—minor exhibit number variation is acceptable given possible renumbering across filings. (2) Quantitative elements—coupon rate (2.300%), maturity year (2028), and issuance date (March 2021)—are all precise and correctly cited. (3) The multi-hop reasoning is sound: the model correctly infers from the consistent carry-forward of the note across three years that Oracle maintains a stable, laddered debt structure, which reflects a deliberate long-term financing strategy focused on maturity diversification and low-cost capital preservation. (4) The LLM adds slightly more strategic interpretation (e.g., 'laddered series', 'lock in low-cost financing') than the original, but these are reasonable inferences supported by the data. The only minor shortcoming is the lack of mention of the broader set of notes in 2022 (Exhibit 4.16 context), but the core entity, timeline, and strategic implication are accurately captured. Wording differs but semantic meaning and factual content are equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 365,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "From 2022 through 2024 Boeing’s pension‑plan private‑equity program continued to be built around limited‑partnership vehicles that invest in both **U.S. and non‑U.S.** opportunities, targeting the same **leveraged‑buyout, venture‑capital, growth and special‑situation** strategies.  The only substantive change was the portfolio weight: private‑equity exposure was roughly **8 % of assets in 2022 and 2023** and was **raised to about 9 % in 2024**, indicating a modest increase in commitment but no shift in geographic scope or strategic focus.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. It claims Boeing (BA) maintained the same strategic focus and geographic scope from 2022 to 2024, which contradicts the original answer stating a clear evolution: expansion into global real assets (energy, farmland, infrastructure) by 2023 and increased use of derivatives in 2024. The LLM also introduces unverified data—private equity exposure being 8% in 2022–2023 and rising to 9% in 2024—which is not present in the original answer and cannot be verified against the knowledge graph. (2) Quantitatively, the percentages (8%, 9%) are fabricated or unsupported; no such figures appear in the ground truth. There are no calculations in the answer, but the introduction of these specific numbers reduces quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks about evolution in strategy, geographic scope, and focus areas, but the LLM concludes there was 'no shift'—directly contradicting the documented expansion into real assets and use of derivatives. It fails to recognize or report any strategic evolution across the years. (4) While the mention of U.S. and non-U.S. leveraged buyout and venture capital strategies aligns partially with 2022 and 2023 details, the omission of real assets and derivatives in 2023–2024 results in a materially incomplete and misleading answer. Contextual relevance is moderate because it addresses the topic of BA’s private equity investments but misses the core evolution the question targets.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 428,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen first reported that Bemarituzumab had **initiated a Phase 3 study for gastro‑esophageal‑junction (GEJ) adenocarcinoma** in its 2022 Form 10‑K (while it also still had Phase 2 and Phase 1 studies for other tumors and NSCLC). In the 2023 and 2024 filings the molecule remained listed as a **Phase 3 product candidate** (no further advancement or regression) and its composition‑of‑matter patents continued to be projected to **expire in 2029 in both the United States and Europe**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Bemarituzumab initiated a Phase 3 study for GEJ adenocarcinoma in 2022 (per 2022 10-K), remained in Phase 3 through 2023 and 2024, and its composition-of-matter patents are projected to expire in 2029 in both the U.S. and Europe—consistent across years. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the dates (2022, 2023, 2024, 2029) are correctly reported with no calculation errors. Format variations (e.g., '2029' vs 'set to expire in 2029') are semantically equivalent. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracking clinical phase progression and patent timelines. It appropriately infers stability in development and IP status. (4) The only minor omission is that the 2024 filing included additional context about Bemarituzumab being a monoclonal antibody targeting FGFR2b and the role of regulatory exclusivity—details present in the original answer but not in the LLM response. However, this does not detract from the core factual accuracy. The answer remains complete for the main question. Thus, a score of 9 is justified—excellent but not fully comprehensive on the qualitative enrichment in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 368,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "In the 2022 Form 10‑K the Fabric & Home Care segment contributed **35 % of net sales and 31 % of net earnings**, and Dawn was listed among its “major brands” (Ariel, Downy, Gain, Tide, **Dawn**, Fairy, …)【page_19】.  \nBy the 2024 filing the segment’s share had risen to **36 % of net sales and 34 % of net earnings**, and Dawn still appears in the same brand lineup (Ariel, Downy, Gain, Tide, **Dawn**, Fairy, …)【page_18】.  \n\nThus, Dawn’s role remained that of a core brand in Fabric & Home Care, while the segment’s earnings contribution grew modestly, indicating a slightly stronger positioning for Dawn from 2022 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: Dawn was listed as a major brand in the Fabric & Home Care segment in both 2022 and 2024; the segment’s net earnings contribution increased from 31% in 2022 to 34% in 2024; net sales contribution was 35% in 2022 and rose to 36% in 2023 and 2024. These figures match the ground truth exactly. (2) Quantitative accuracy is perfect: percentages for net sales (35% → 36%) and net earnings (31% → 34%) are correctly cited with appropriate years. No calculation errors. (3) The reasoning is sound: the LLM correctly infers that Dawn remained a core brand due to consistent inclusion in brand listings and that the segment’s growing earnings contribution implies slightly stronger positioning for Dawn. This constitutes valid multi-hop synthesis across years and metrics. (4) The only minor shortcoming is that the LLM does not explicitly note the stability of the sales percentage (35% in 2022, 36% in 2023 and 2024), which the original answer uses to emphasize segment stability. While implied, this nuance is slightly underdeveloped. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth. Hence, a high score with minor deduction for slight incompleteness in qualitative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 363,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "- In the 2021‑2022 period Schwab’s pool of client securities that could be used as collateral grew from **$84 billion in 2020 to $120 billion in 2021**, and the securities it actually pledged to third parties rose from **$23 billion to $31 billion** (mostly to the Options Clearing Corp., short‑sale fulfilments, securities‑lending and short‑term borrowings)【page_108】.  \n\n- By the end of 2024 the firm was still drawing on that expanding pool to support its liquidity facilities – FHLB borrowings were backed by **$59.8 billion of client‑margin collateral (down slightly from $63.1 billion in 2023)** and Federal‑Reserve discount borrowing capacity was backed by **$30.5 billion of pledged securities (up from $6.2 billion in 2023)**【page_97】 – while the amount of client‑margin securities pledged under its own secured credit lines fell to **$500 million** from **$950 million** a year earlier【page_97】.  \n\n- The trend shows a steady increase in the total amount of client‑held assets that Schwab can pledge, but a shift away from direct margin‑security lines toward larger, diversified collateral pools that back its borrowing programs, indicating that the company’s exposure to client‑held securities remains substantial but is being managed through broader, more liquid collateral arrangements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in numbers and timeframes, undermining its correctness. First, the ground truth covers 2022–2024, but the LLM incorrectly references data from 2020–2021 (e.g., $84B in 2020, $120B in 2021), which is outside the requested period and not supported by the original answer. These figures are entirely absent from the ground truth, indicating fabrication or misattribution. Second, while the LLM cites 2023 and 2024 figures such as $63.1B and $59.8B in FHLB collateral, these specific numbers are not present in the original answer, which does not provide dollar amounts for pledged securities. The mention of a drop from $950M to $500M in pledged securities under secured credit lines also lacks corroboration in the ground truth. Thus, quantitative accuracy is low due to unsupported numeric claims. Qualitatively, the LLM captures a plausible trend—shifting collateral usage and ongoing pledging—but misrepresents the evolution by anchoring to incorrect early-year data and omitting key regulatory and accounting developments (e.g., ASC 326, practical expedient for credit losses, OCC clearing for options) that are central to the original answer. It also fails to mention the 2024 use of client securities in securities lending (cash collateral to clients), a key detail. Contextually, the answer addresses the general theme of collateral use and exposure, showing relevance, but the reasoning is based on fabricated data rather than accurate multi-hop synthesis across the correct years and disclosures. The conclusion about shifting to diversified collateral pools is partially aligned but not sufficiently grounded in the actual disclosures. Overall, the answer is partially correct in direction but fails on factual accuracy and proper temporal scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 488,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "ACN kept its U.S. defined‑benefit plans fully invested in debt (100 % debt, 0 % equity, cash, insurance or other) in both the fiscal‑2023 and fiscal‑2025 targets. For the non‑U.S. plans, the weighted‑average allocation shifted toward more equity and less debt and “other” assets: equity rose from 19 % in the 2022 snapshot (the 2023 baseline) to 23 % in the 2024 snapshot and is slated at 28 % for fiscal 2025; debt fell from 43 % (2022) to 42 % (2024) and is projected at 36 % in 2025; cash slipped to 5 % in 2024 but is expected to rise to 7 % in 2025; insurance contracts edged down from 22 % to 21 % and stay at 21 %; and “other” assets fell from 10 % to 9 % and are targeted at 8 % in 2025.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitatively, the percentages provided are completely wrong: the ground truth states that ACN's overall weighted-average allocation shifted from 55% fixed income / 45% equities in fiscal 2023 (as of Aug 31, 2022), to 58/42 in fiscal 2024 (Aug 31, 2023), and 61/39 in fiscal 2025 (Aug 31, 2024). The LLM instead claims 100% debt for U.S. plans and reports non-U.S. plan allocations with rising equity — which contradicts the de-risking trend. (2) The LLM introduces a U.S. vs non-U.S. plan breakdown not present in the original answer or implied by the question, and fabricates detailed allocations (e.g., equity rising to 28% in 2025) that are unsupported by the ground truth. (3) The reasoning is flawed: it fails to identify the consistent multi-year trend toward de-risking via increased fixed income exposure, instead asserting an increase in equity — the opposite direction. (4) The answer lacks semantic equivalence: it misrepresents the strategy, uses incorrect years and allocations, and invents sub-plan categories. Only minimal relevance is given because it attempts to discuss pension asset allocation over time, but the substance is factually baseless.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 353,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "- **Short‑term borrowings** rose modestly: $883 million at 12/31/2022, fell to $538 million in 2023 and edged up to $562 million in 2024 【page_178†L13-L16】【page_188†L13-L16】.  \n- **Long‑term debt** fell from $47.8 billion in 2022 to $49.3 billion in 2023 and then to $45.0 billion in 2024 【page_178†L23-L30】【page_188†L23-L30】.  \n\n**Trend:** Over the three‑year period Capital One has been deleveraging its balance sheet – the share of long‑term debt declined while short‑term borrowings stayed low‑single‑digit‑percent of total debt.  The mix also shifted away from floating‑rate senior notes (6.75% on $1.6 billion in 2022, $0.35 billion in 2023 and none in 2024) toward a higher proportion of fixed‑rate securities, reducing the company’s exposure to rising interest rates.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, total short-term borrowings and long-term debt were $43.086B (2022), $48.715B (2023), and $45.551B (2024). However, the LLM reports long-term debt as $47.8B, $49.3B, and $45.0B — which misrepresents both the starting point and the 2023 peak. Additionally, the LLM incorrectly states that short-term borrowings were $883M in 2022, whereas the ground truth implies they were part of the total debt figure and not isolated at that level. The LLM also mischaracterizes the trend by claiming 'deleveraging' when debt actually increased significantly from 2022 to 2023 before a partial decline. (2) The floating unsecured senior debt reduction is partially correct — the LLM notes it dropped to $0 in 2024, but inaccurately reports values for prior years ($1.6B in 2022 vs. correct $1.597B in 2023). The weighted-average interest rate on long-term debt is completely omitted in the LLM answer, despite being a core part of the trend analysis in the original answer. (3) The multi-hop reasoning is partially sound — the model identifies a shift away from floating-rate debt and interprets this as reducing interest rate exposure, which aligns with the original conclusion. However, it fails to correctly synthesize the overall debt trajectory due to incorrect base numbers and misaligned years. (4) Scores reflect major quantitative errors (especially in total debt levels and interest rates), partial qualitative accuracy in interpreting strategic shifts, and high contextual relevance as the answer attempts all parts of the question with appropriate financial logic despite factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 467,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Boeing says that the expense it records for fleet‑support services “has historically been approximately 1 % of total consolidated costs of products and services” – the same wording appears in the 2023 filing (page 36) and again in the 2024 filing (page 42).  No change in that percentage is disclosed for 2022, 2023 or 2024, indicating that fleet‑support costs have remained flat at roughly 1 % of total costs over the three‑year period.  \n\nBy contrast, the company’s abnormal production costs and reach‑forward losses have risen sharply: cumulative abnormal production costs reached **$2.7 billion** through 31 Dec 2023 (page 36), the 787 program added **$256 million** of abnormal re‑work costs in 2024 (page 39), and the 777X program recorded a **$2.608 billion** reach‑forward loss in Q3 2024 plus an additional **$891 million** in Q4 2024 (page 39).  Thus, while fleet‑support expenses stayed steady at about 1 % of total costs, the abnormal production and reach‑forward losses in the 787 and 777X programs have escalated markedly during the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all key numbers are correct: the $2.7 billion cumulative abnormal production costs for the 787 program by end of 2023, the $2.608 billion Q3 2024 reach-forward loss for 777X, and the additional $891 million in Q4 2024 are all correctly reported. The LLM adds a detail not in the original answer—the $256 million in abnormal rework costs for the 787 in 2024—which is factually correct and enhances completeness. The 1% fleet support cost ratio is accurately stated for all three years. (2) The only minor discrepancy is that the original answer states the 787’s $2.7 billion is for 2023, while the LLM clarifies it is cumulative through December 31, 2023, which is more precise and consistent with filings. The LLM correctly infers no change in the 1% ratio due to lack of disclosure, aligning with the original answer’s conclusion. (3) Multi-hop reasoning is sound: the LLM synthesizes data across 2023 and 2024 filings, correctly contrasting stable fleet support costs with rising program-specific losses. It identifies the correct programs (787 and 777X), cost types (abnormal production, reach-forward losses), and timeframes. (4) The answer is semantically equivalent to the ground truth, with slightly more granular detail. The only reason for not scoring 10 is that the LLM does not explicitly state that the stable 1% ratio indicates fleet support was not the source of financial strain—a qualitative inference emphasized in the original—but this is implied. All other aspects are factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1614,
        "completion_tokens": 444,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie reported $21 million in money‑market funds and time‑deposit balances at year‑end 2022, which fell to $10 million in 2023 and remained at $10 million in 2024 (see the “Money market funds and time deposits” line in the fair‑value tables for 2022 [page 79], 2023 [page 84] and 2024 [page 84]). The sharp cut‑back in 2023 followed by a flat level in 2024 suggests the company trimmed its short‑term cash‑equivalent holdings after 2022 and has since maintained a modest, steady liquidity buffer rather than continuing to grow that component of its cash‑management strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and years. According to the ground truth, AbbVie's allocation was $12M in 2022, $21M in 2023, and $10M in 2024. However, the LLM states $21M in 2022, $10M in 2023, and $10M in 2024—reversing the 2022 and 2023 figures and misrepresenting the trend. This fundamental error undermines the entire response. (2) The quantitative inaccuracies are severe: the increase from 2022 to 2023 in the ground truth is portrayed as a decrease in the LLM answer. The dollar amounts, while plausible in magnitude, are assigned to incorrect years, leading to invalid comparisons and conclusions. (3) The multi-hop reasoning is flawed because the LLM fails to correctly synthesize data across the three years. The conclusion about a 'sharp cut-back in 2023' is based on incorrect data—2023 was actually a year of increase, not reduction. The interpretation of a 'steady liquidity buffer' in 2024 is partially reasonable given the drop from 2023 to 2024, but since the LLM incorrectly shows no change from 2023 to 2024, this reasoning is still based on false premises. (4) Despite the incorrect numbers, the LLM attempts to address the question’s intent by discussing short-term liquidity strategy and referencing the correct financial category and source documents, which supports a moderate contextual relevance score. However, due to the core factual errors, the correctness, quantitative, and qualitative accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 414,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "In fiscal 2022 Accenture bought 12.2 million Class A shares for about $4.1 billion and, as of August 31 2022, had $3.13 billion of authorized buy‑back capacity left; the board then added another $3 billion of authority, lifting total outstanding authority to $6.13 billion. By fiscal 2024 the company had repurchased roughly 2.07 million shares in the fourth quarter and, after a year‑long series of buy‑backs, the remaining “available” authorization had fallen to $2.69 billion, while the board again increased total authority by $4 billion to $6.69 billion. This pattern of regularly using a large share‑repurchase program and periodically expanding the overall authorization signals that Accenture is deliberately using buy‑backs as a core component of its capital‑return strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers and misrepresents the evolution of Accenture's share repurchase authorization. According to the ground truth, in fiscal 2022, Accenture had $3,129,296 thousand (~$3.13 billion) in remaining authorization — this part is correctly reported. However, the LLM claims the board added $3 billion, bringing total outstanding authority to $6.13 billion, which is not supported by the original answer. The original answer states that by fiscal 2023, the cumulative repurchase authorization since 2001 reached $50.1 billion, with $2.694 billion remaining as of August 31, 2023 — a detail the LLM misinterprets as current total authority rather than remaining capacity. Then, in fiscal 2024, the LLM incorrectly states that remaining authorization fell to $2.69 billion after buybacks, when in fact the original answer says the remaining authorization was $2.694 billion *before* the new $4 billion increase, which brought total available authority to $6,694 million ($6.694 billion). The LLM conflates 'remaining' with 'total' authorization and misorders the timeline. (2) The LLM introduces specific share repurchase volumes (e.g., 12.2 million shares for $4.1 billion in fiscal 2022, 2.07 million in Q4 2024) that are not present in the ground truth and cannot be verified — these are likely hallucinated. The ground truth does not provide annual repurchase volumes, only remaining authorizations and increases. (3) The multi-hop reasoning is partially sound — the LLM correctly infers that recurring increases in authorization indicate a strategic capital return focus — but the synthesis is based on incorrect quantitative foundations. (4) Despite the numerical inaccuracies, the qualitative conclusion about Accenture using buybacks as a core capital return strategy aligns with the original answer, and the response is contextually relevant. However, the significant quantitative errors — especially misrepresenting $2.694 billion in *remaining* authorization as a post-buyback figure and fabricating repurchase volumes — severely undermine factual correctness. Minor format variations are acceptable, but incorrect calculations and invented data reduce the correctness score to 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 603,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "- **2022 10‑K:** AbbVie’s amended and restated certificate of incorporation and bylaws already contained a clause that “stockholders may only remove directors for cause” (see the governance discussion on pages 44‑48 of the 2022 filing).  \n- **2023 10‑K:** The same provision is restated word‑for‑word in the 2023 filing (see page 27), listing it among other anti‑takeover mechanisms such as staggered directors and the inability of shareholders to call a special meeting.  \n- **2024 10‑K:** The 2024 filing again repeats the exact language, again noting that “a provision that stockholders may only remove directors for cause” is part of the company’s charter (see page 46).\n\n**Interpretation:** Because the “remove‑for‑cause only” rule has been kept unchanged for three consecutive years, AbbVie is deliberately entrenching its board. By making it difficult for shareholders—or a hostile acquirer—to replace directors without proving cause, the company reinforces a long‑term defensive posture that discourages coercive takeover attempts and gives the board more time to evaluate any acquisition proposal.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately describes AbbVie's governance provision across 2022, 2023, and 2024, correctly stating that in each year’s 10-K, the company maintained the 'stockholders may only remove directors for cause' clause. The specific page references (2022: pp. 44–48; 2023: p. 27; 2024: p. 46) are consistent with typical disclosure locations and do not contradict the ground truth, which does not require exact page numbers. (2) There are no numerical values requiring calculation, but the years and document types (10-K) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes the consistent presence of the provision across three years and correctly infers that this reflects a deliberate, stable takeover defense strategy. (4) The interpretation about board entrenchment, discouraging hostile takeovers, and reinforcing board stability matches the original answer’s conclusion. The LLM includes additional relevant context—such as linkage to staggered boards and restrictions on special meetings—further enhancing qualitative accuracy. All parts of the question are addressed: evolution (no change, consistently maintained), and strategic implication (board entrenchment as part of long-term defense). Semantic equivalence is strong, with no factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 375,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "In the 2022, 2023 and 2024 Form 10‑K filings PepsiCo’s Exhibit list repeatedly includes **“Form of 4.000 % Senior Note due 2047, incorporated by reference to Exhibit 4.5 of the May 2 2017 Form 8‑K.”** (shown as Exhibit 4.16 in the 2022 filing and identically described in the 2023 and 2024 filings). The wording, coupon, maturity and the underlying 8‑K reference never change, indicating that the note remains an outstanding, unchanged piece of debt.\n\nThis steady disclosure signals that PepsiCo treats the 4 % 2047 senior note as a core, long‑dated financing tool—locking in a low‑cost, fixed‑rate source of capital and anchoring the company’s long‑term debt profile rather than repeatedly refinancing or retiring it.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the 4.000% Senior Note due 2047 is correctly referenced across 2022, 2023, and 2024 filings with the identical citation to Exhibit 4.5 of the May 2, 2017 Form 8-K. The note's unchanged status is accurately described. (2) Quantitative accuracy is perfect: the interest rate (4.000%), maturity year (2047), and reference date (May 2, 2017) match the ground truth exactly. The mention of Exhibit 4.16 in 2022 is consistent with how the note is listed in that year’s filing (as a renumbered exhibit), while still correctly tracing back to the original 8-K, which is a detail not contradicted by the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes consistent disclosures across three years and correctly infers that the unchanging references indicate stability in PepsiCo’s capital structure. The conclusion that the note serves as a long-term, fixed-rate financing tool aligns with the ground truth’s interpretation of the disclosure pattern. (4) The answer is contextually rich and directly addresses both parts of the question: the evolution (or lack thereof) in disclosure and the strategic implication. Wording differs slightly but meaning is preserved and accurate. No errors in entities, years, or financial terms. Full credit on all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 383,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "- **2022 10‑K** – Oracle’s 2022 filing already listed the 4.30 % senior note that matures in 2034 in its exhibit index (the note appears under Exhibit 4.09, “Forms of 3.40 % Note due 2024, 4.30 % Note due 2034 and 4.50 % Note due 2044”) 【page_111】.  \n\n- **2023 10‑K** – The 2023 filing repeats the same disclosure, again referencing Exhibit 4.09 with the same description of the 4.30 % Note due 2034 【page_110】.  \n\n- **2024 10‑K** – The 2024 filing likewise continues to cite Exhibit 4.09 for the 4.30 % Note due 2034, showing that the security remains outstanding and is still reported in Oracle’s long‑term debt schedule 【page_110】.  \n\n**What the pattern shows:** By consistently disclosing the 4.30 % Note due 2034 across three consecutive years, Oracle demonstrates a deliberate long‑term financing strategy that relies on issuing fixed‑rate senior notes with far‑future maturities. Keeping the note on the balance sheet and reporting it each year indicates the company’s intent to lock in relatively low borrowing costs and to maintain a diversified maturity profile for its debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: the 4.30% Note due 2034 is correctly identified as being disclosed in Oracle’s 2022, 2023, and 2024 10-K filings, with consistent referencing of Exhibit 4.09 across all years. The percentages (4.30%), maturity year (2034), and exhibit number are all factually correct. (2) Quantitative accuracy is flawless—no calculations are required, but the dates, rates, and exhibit references match across years and filings. Minor formatting differences (e.g., spacing in '4.30 %') do not affect meaning or correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual reports to identify a pattern of consistent disclosure, which supports the conclusion about Oracle’s long-term debt strategy. (4) The qualitative interpretation—linking the repeated disclosure to a stable, deliberate strategy involving fixed-rate notes, long maturities, and diversified debt profile—matches the original answer’s inference. The LLM adds contextual insight (e.g., 'lock in relatively low borrowing costs') that is reasonable and consistent with the evidence. All aspects of the question are addressed: evolution over time and strategic implication. Semantic equivalence is strong, with no omissions or distortions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 376,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "- **Authorized pool size** – The Amended 2010 Share Incentive Plan allowed **127 million Class A ordinary shares** to be used for awards in fiscal 2022 (see the 2022 filing). The same 127 million‑share limit was still in place for fiscal 2023 (the 2023 filing does not show any increase). By fiscal 2024 the company had expanded the pool to **141 million Class A ordinary shares** (see the 2024 filing).\n\n- **Implication** – The 14‑million‑share increase between 2022 and 2024 shows Accenture is deliberately enlarging its equity‑based compensation reserve. This signals a long‑term strategy to keep a sizable, flexible share pool available for future grants, reinforcing the use of stock‑based awards to align employee interests with shareholders and to support ongoing talent‑retention and incentive goals.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the timeline of authorized shares. According to the ground truth, the number of authorized shares was 127 million in fiscal year 2022, increased to 141 million in fiscal year 2023, and remained at 141 million in 2024. However, the LLM incorrectly states that the 127 million limit was still in place for fiscal year 2023 and that the increase to 141 million occurred by fiscal year 2024. This misrepresents the timing of the increase, placing it one year later than it actually occurred. (2) While the numeric values (127 million and 141 million) are correct and the 14-million-share difference is accurate, the assignment of these figures to the wrong fiscal years undermines the quantitative accuracy. The calculation of the 14-million-share increase is correct, but its attribution across years is flawed. (3) The multi-hop reasoning is partially sound in that the model recognizes the need to track changes over time and infers strategic intent from the increase. However, because the temporal progression is incorrect, the synthesis across years is flawed. The conclusion about long-term strategy is reasonable but based on an inaccurate timeline. (4) Contextually, the answer addresses both parts of the question—evolution of shares and strategic implication—and uses appropriate terminology. The strategic interpretation aligns with the ground truth, but the incorrect timeline reduces the overall correctness. The answer would have scored higher if the year-to-year progression had been accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 433,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "- In the 2022 Form 10‑K PepsiCo listed the 2.750 % Senior Note due 2051 as Exhibit 4.51, “Form of 2.750 % Senior Note due 2051,” incorporated by reference to the October 21 2021 8‑K filing 【page_128†L4-L7】.  \n- The 2023 Form 10‑K repeats the same disclosure (now shown as Exhibit 4.48) with the identical reference to the October 21 2021 8‑K 【page_129†L4-L7】.  \n- By the 2024 Form 10‑K the note no longer appears among the listed exhibits (the 2024 exhibit list runs from 4.61 onward and contains no 2.750 % 2051 entry) 【page_129†L1-L4】, indicating that the issue has been retired, fully amortized or otherwise removed from the outstanding debt schedule.\n\n**Interpretation:** PepsiCo’s repeated, year‑over‑year filing of the same 2.750 % 2051 note shows a disciplined long‑term financing program—issuing low‑coupon, very‑long‑dated senior debt and documenting it consistently in its annual reports—while the eventual disappearance of the note in the 2024 filing signals that the company updates its disclosures as the instrument matures or is repaid, reflecting an active management of its long‑term debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the 2.750% Senior Note due 2051 was first mentioned in a Board resolution (Exhibit 4.60) in 2022, then formalized with a dedicated exhibit (4.51) in 2023, and maintained in 2024 (Exhibit 4.48). However, the LLM incorrectly states that the note appeared as Exhibit 4.51 in 2022 (referencing a 2021 8-K), was renumbered to 4.48 in 2023, and then disappeared entirely in 2024—claiming it was retired or removed. This contradicts the ground truth, which confirms the note was still present and unchanged in 2024. The claim of disappearance is false and fundamentally undermines the answer. (2) Quantitatively, the percentages (2.750%), years (2051), and exhibit numbers (4.51, 4.48) are cited but misaligned with the correct years and context. The reference to an October 21, 2021 8-K filing is not in the ground truth and appears fabricated. There are no dollar amounts or calculations to verify, but the timeline and document references are incorrect. (3) The multi-hop reasoning is flawed: instead of recognizing a progression from authorization (2022) to formalization (2023) to stability (2024), the LLM infers retirement in 2024, indicating a failure to synthesize the correct narrative across years. The interpretation of 'disciplined financing' is plausible but based on incorrect premises. (4) The contextual relevance is moderate—the answer addresses debt structuring and long-term strategy—but the incorrect conclusion about note retirement and misrepresentation of filing evolution severely limit its validity. The reasoning is internally consistent but factually wrong, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 468,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "In its 2022 filing American Express described itself as the **fourth‑largest general‑purpose card network worldwide** (behind UnionPay, Visa and Mastercard) and emphasized that its competitive advantage rested on premium‑card features, rewards and a strong brand, while already noting “the dynamic and rapid growth of alternative payment and financing mechanisms” such as digital wallets, BNPL and fintech platforms【page_12】.  \n\nBy the 2024 filing the company’s competitive position had become more constrained: heightened regulatory scrutiny – including its new Category III status, interchange‑fee caps, and the exit from network‑licensing businesses in the EU and Australia – has increased compliance costs and put pressure on discount‑revenue margins, and regulators are focusing on network‑routing and merchant‑acceptance rules that could limit Amex’s ability to expand its network【page_34】. At the same time, the continued expansion of alternative‑payment providers and the emergence of new fintech‑driven payment solutions have intensified competition for both card‑issuing and network business, leaving Amex still ranked fourth but with a **narrowing competitive edge** as regulatory burdens rise and non‑card payment options grow【page_12】【page_35】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies American Express as the fourth-largest general-purpose card network globally, behind China UnionPay, Visa, and Mastercard, consistent across both 2022 and 2024—this matches the original answer exactly. It accurately reflects the evolution of competitive positioning, noting premium offerings, cobrand relationships, and loyalty systems as key differentiators in 2022, and increasing pressure from alternative payment mechanisms like BNPL and fintech platforms. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across time (2022 to 2024), regulatory developments (EU and Australia exits, interchange caps, Category III status), and competitive pressures (digital wallets, fintech, BNPL), correctly concluding that Amex’s competitive edge is narrowing due to rising regulatory burdens and non-card payment growth. The mention of 'Category III status' and 'discount-revenue margins' adds specificity not in the original but is contextually appropriate and plausible based on regulatory trends. (4) Semantic equivalence is strong: while the LLM uses slightly more detailed regulatory terminology and cites page numbers, the core message—that Amex remains fourth but faces increased constraints from regulation and alternative payments—is fully aligned. The only minor gap is that the original explicitly names Alipay and PayPal, while the LLM generalizes to 'alternative-payment providers'; this is a slight omission but does not detract significantly from accuracy. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 502,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "In the 2022 filing the Global Services segment was described simply as “providing … supply‑chain, logistics, engineering, maintenance … upgrades and conversions” – a standard line that placed upgrades and conversions among many other services but did not highlight them as a growth driver. By the 2024 filing, Boeing’s discussion of Global Services stresses that the business will “leverage … modifications and upgrades … to grow market share” and ties those activities to higher‑value, lifecycle‑focused offerings and customer‑satisfaction initiatives. The shift shows that Boeing is moving from treating upgrades and conversions as routine support functions to positioning them as a core pillar of its services strategy, using them to capture more aftermarket revenue and deepen customer relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Boeing's strategic emphasis on upgrades and conversions from 2022 to 2024: in 2022, upgrades and conversions were listed among other services without special emphasis; by 2024, they were positioned as a growth driver tied to market share and lifecycle offerings. The LLM accurately captures the shift from routine support to a core strategic pillar. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct and consistent with the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and segments, correctly inferring a strategic shift in services business focus. It accurately reflects Boeing’s increasing emphasis on modifications and upgrades as a lever for aftermarket revenue and customer retention. (4) While the original answer includes a mention of 'data analytics and digital services' in 2024 as complementary to upgrades—a detail omitted in the LLM response—this does not undermine the core conclusion about strategic repositioning. The LLM still captures the essential trajectory and strategic implication. Thus, the answer is semantically equivalent in intent and factual content, meriting a high correctness score with only minor completeness gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 396,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "- In the 2022 Form 10‑K, PepsiCo’s Exhibit list still contains the 5.50 % Senior Note due 2035 (both the Series A filing – Exhibit 4.25 – and the non‑Series filing – Exhibit 4.27 – each referencing 2018 8‑K/​S‑4 documents)【page_127】.  \n- The 2023 Form 10‑K repeats those same entries (Exhibits 4.25 and 4.27) in its Item 15 exhibit index, showing the note remained outstanding and was still being documented for the second consecutive year【page_127】.  \n- By the 2024 Form 10‑K, the exhibit index no longer includes any 5.50 % Senior Note due 2035 entries, indicating the instrument has been retired, repaid or otherwise removed from the company’s active debt schedule【pages 125‑129】.  \n\nThis multi‑year filing pattern shows PepsiCo’s long‑term debt strategy of keeping older issuances on the books and publicly documented until they are extinguished, then cleaning them out of subsequent filings – a disciplined approach that lets the company manage its maturity profile and interest‑cost exposure over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the 5.50% Senior Note due 2035 was consistently documented in all three years (2022, 2023, and 2024) with no indication of retirement. However, the LLM incorrectly claims that the note was removed from the 2024 10-K filing, stating it 'no longer includes any 5.50% Senior Note due 2035 entries,' which directly contradicts the ground truth that it reappeared in 2024 as Exhibit 4.23. This error fundamentally undermines the answer's correctness. (2) Quantitatively, the LLM misrepresents exhibit numbers: it claims both Series A (Exhibit 4.25) and non-Series (Exhibit 4.27) were present in 2022, but the ground truth specifies Exhibit 4.31 for 2022. In 2023, the ground truth lists Exhibit 4.25, which the LLM correctly identifies, but again adds a non-Series exhibit not mentioned in the original. The 2024 removal claim is entirely false—Exhibit 4.23 in 2024 still references the note. (3) The multi-hop reasoning is flawed: the LLM infers debt retirement based on omission from exhibits, but the ground truth shows consistent inclusion, indicating ongoing liability. The conclusion about 'cleaning them out of subsequent filings' is unsupported and incorrect in this case. (4) Contextual relevance is moderate—the response addresses the question's structure and attempts to interpret filing patterns, but the factual foundation is wrong, leading to an invalid strategic conclusion. The ground truth suggests stability in long-term debt; the LLM incorrectly infers active retirement and maturity management. Thus, while the reasoning framework is contextually appropriate, its application is factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 468,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon repeatedly states that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (2022 p.5; 2023 p.5; 2024 p.5). The wording is unchanged from year to year, showing that the company’s exposure to these banking‑law constraints has remained constant and that regulatory limits on capital‑return policies continue to be a standing, un‑eased factor in its capital‑planning decisions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claim: BNY Mellon consistently cited U.S. banking laws and regulations as constraints on capital returns in its 2022, 2023, and 2024 10-K filings, with nearly identical language across years. The quantitative accuracy is perfect—no numerical errors, and the cited page numbers (p.5 for each year) align with the source context. The entity accuracy is correct: BNY Mellon, U.S. banking laws, capital planning, and shareholder returns are all properly identified. Contextual relevance is strong, directly addressing the evolution (or lack thereof) in regulatory constraints. However, the LLM understates the qualitative evolution noted in the ground truth. While the quoted language may be similar, the original answer highlights that in 2023 and 2024, BNY Mellon expanded its disclosures to include additional constraints—Delaware law and preferred stock obligations—and emphasized maintaining 'well capitalized' status in 2024. The LLM’s assertion that 'the wording is unchanged' is slightly misleading, as it overlooks these incremental additions. Thus, while the main conclusion about persistent regulatory constraints is valid, the answer lacks completeness in capturing the nuanced progression in disclosure depth, which weakens the multi-hop synthesis slightly. This justifies a high but not top score in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 387,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "- In the 2022 Form 10‑K the 2.300 % Notes due 2028 are listed in Exhibit 4.16, showing that they were issued on March 24 2021 with a fixed 2.300 % coupon and a maturity in 2028【page_114】.  \n\n- The 2023 Form 10‑K repeats the same security in Exhibit 4.14, describing the identical 2.300 % coupon, 2028 maturity and issuance date (March 24 2021) with no change to the terms【page_111】.  \n\n- The 2024 Form 10‑K again includes the 2.300 % Notes due 2028 under the same Exhibit 4.14 (identical language), confirming that the notes have been left untouched since their original issuance【page_111】.  \n\n**Interpretation:** Oracle has kept the 2.300 % Notes due 2028 unchanged across three successive filings, indicating a deliberate strategy of locking in a low‑cost, fixed‑rate debt instrument when rates were low and retaining it even as market rates rose. This reflects the company’s preference for stable, long‑dated financing rather than repeatedly re‑issuing new debt in a higher‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance date (March 24, 2021), coupon rate (2.300%), and maturity year (2028) across all years, which matches the ground truth. It accurately states that the terms remained unchanged in 2022, 2023, and 2024 filings. The only minor discrepancy is the exhibit number in the 2022 10-K: the LLM cites Exhibit 4.16, while the ground truth specifies Exhibit 4.14. This is a factual inconsistency, though it does not affect the core financial terms or reasoning. (2) All numeric values—interest rate (2.300%), issuance date, and maturity—are correct and consistently reported. No calculations are required, but the temporal tracking of unchanged terms is accurate. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of filings to conclude that Oracle maintained the same note terms, and correctly infers a strategy of locking in low fixed rates. It aligns with the ground truth’s interpretation of Oracle avoiding repricing in higher-rate environments. However, the LLM omits mention of Oracle’s issuance of higher-yielding instruments like the 4.500% Notes due 2028 in 2023, which adds context to the company’s broader financing strategy. This omission slightly weakens completeness but does not invalidate the core conclusion. (4) The answer is highly contextually relevant, directly addressing the evolution of the 2.300% Notes and Oracle’s fixed-income strategy. The interpretation is semantically equivalent to the ground truth, with only minor gaps in auxiliary detail. Overall, the answer is factually strong with high correctness, slightly docked for exhibit number inaccuracy and partial omission of comparative issuance activity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 469,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "Across the three most recent 10‑K filings IBM has repeatedly placed **“client relationships and trust”** among its core competitive pillars. In the 2022 filing (Item 1 – Competition) the phrase appears as one of a list of factors that differentiate the company 【page_4†L13-L16】; the 2023 filing repeats the same language in the same competitive‑factor list 【page_3†L13-L16】; and the 2024 filing again lists it alongside technology, talent and brand 【page_3†L13-L16】 while also tying trust directly to its **secure, open hybrid‑cloud platform and AI solutions** 【page_6†L4-L7】. This steady, increasingly integrated emphasis signals that IBM is positioning trust‑based client relationships as a foundational advantage for selling its hybrid‑cloud and AI offerings, leveraging its long‑standing reputation for security and reliability to win and retain enterprise customers in a highly competitive market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently emphasized 'client relationships and trust' as a competitive differentiator across 2022, 2023, and 2024, with increasing integration into hybrid cloud and AI contexts. The 2024 addition of linking trust to 'secure, open hybrid-cloud platform and AI solutions' matches the ground truth's emphasis on positioning trust as central to delivering business value in hybrid cloud and AI. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly synthesizing the evolution across three years and identifying the strategic progression. The only minor omission is not explicitly mentioning 'deep incumbency with enterprises' (2023) or the strategic partnership with Palo Alto Networks (2024) from the original, which adds slight nuance but does not undermine the core accuracy. (4) The answer is contextually excellent, directly addressing the evolution and strategic implications. Wording differs but semantic meaning is equivalent. Thus, correctness is 9 due to minor completeness gap, but qualitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 342,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "- **2022:** The 2022 filing shows that American Express held ≈ $630 million of foreign‑government bonds and obligations.  The weighted‑average yield on those securities (and on the broader investment‑security portfolio) was only about **2 %** (the “overall” yield in the table of weighted‑average yields).  \n\n- **2023‑2024:** By 2024 the company’s disclosed average yield on **non‑U.S. interest‑earning assets** – which include the foreign‑government bond portfolio – had risen to **about 7.8 %** (up from 10.5 % in 2023 and 4.7 % in 2022).  This jump reflects a move to higher‑yielding foreign‑currency debt as rates rose.\n\n**What the progression means:** The three‑year shift from a low‑2 % yield to a high‑7‑8 % yield shows that Amex has increased its exposure to higher‑yielding, longer‑dated foreign government securities, thereby taking on more interest‑rate risk.  The change signals an investment strategy that is deliberately tilting toward higher‑yield assets to boost returns in a rising‑rate environment, even though it raises the portfolio’s sensitivity to future rate movements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. In 2022, the original answer states no yield was provided for foreign government bonds—only the holdings ($630M) and maturity distribution were disclosed. However, the LLM incorrectly claims a 2% yield in 2022, which is not supported. For 2023, the correct weighted average yield is 6.45%, not the 10.5% and 7.8% cited by the LLM. In 2024, the correct yield is 5.85%, not 7.8%. The LLM also misrepresents the asset category, referring to 'non-U.S. interest-earning assets' instead of specifically 'foreign government bonds and obligations', conflating broader categories. (2) The dollar amount in 2022 ($630M) is correct, but all yield figures are wrong: 2% (vs. no data), 10.5% and 7.8% (vs. 6.45% in 2023 and 5.85% in 2024). The maturity shift in 2024—specifically that 2.03% now matures in 1–5 years—is entirely omitted. (3) The multi-hop reasoning is flawed: the LLM infers increasing exposure to longer-dated securities and higher interest rate risk, but the ground truth shows a decrease in yield and a diversification into intermediate maturities from a previously ultra-short portfolio—indicating a move to *manage* rate risk, not increase it. The LLM misinterprets the strategy as taking on more risk in a rising rate environment, which contradicts the actual shift toward maturity diversification and yield stabilization. (4) Correctness is severely compromised by incorrect numbers and mischaracterized strategy. Quantitative accuracy is very low due to fabricated or misattributed yields. Qualitative accuracy is low because of incorrect entity mapping and flawed logic. Contextual relevance is moderate—the answer addresses yield evolution and strategy—but with incorrect data and conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 483,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s diagnostics‑testing businesses have seen steadily larger capital outlays, with the company estimating ≈ $1.5 billion of capex in 2022 (up from $1.3 billion in 2021) to expand testing, treatment and vaccine‑production capacity【page_59】.  Government‑grant assistance that directly offsets those purchases has risen each year – $87 million in 2022, $136 million in 2023 and $198 million in 2024 were recorded as reductions to property, plant and equipment costs【page_68】.  The growing grant‑funded capex indicates that diagnostics testing is an increasingly strategic pillar of Danaher’s health‑care portfolio, warranting both higher internal investment and external public‑sector support to expand production capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the government grant funding amounts for 2022 ($87M), 2023 ($136M), and 2024 ($198M), matching the ground truth exactly. These figures are cited with proper context as offsets to capital expenditures, specifically reducing property, plant, and equipment costs. The upward trend is accurately described. (2) All numeric values are correct and consistent with the ground truth. The additional capex figures ($1.5B in 2022, up from $1.3B in 2021) are not contradicted by the ground truth and provide useful context, though they were not part of the original answer. Since the question did not ask for total capex, their inclusion does not detract from accuracy. No calculation errors are present. (3) The multi-hop reasoning is sound: the model connects increasing government grants over time to Danaher’s strategic prioritization of diagnostics testing within its healthcare portfolio. It correctly infers that rising public-sector support reflects growing strategic importance, aligning with the original answer’s conclusion. (4) The LLM answer is semantically equivalent to the ground truth in all key aspects—trend, amounts, years, and strategic implication—while adding minor contextual detail (total capex) that enhances rather than distorts. The only reason for not scoring a 10 is that the original answer focuses more precisely on the grant-funded progression as an indicator of strategic importance, while the LLM slightly broadens the focus with capex estimates not requested in the question. However, this does not reduce factual correctness. All entities (Danaher, DHR, diagnostics testing technologies, government grants, capital expenditures) are accurately identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 476,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across all three fiscal years — 2022, 2023 and 2024 — BNY Mellon’s Form 10‑K states that the ratification of KPMG LLP as its principal accountant is disclosed “by reference to the Proxy in the section ‘Item 3 – Ratification of KPMG LLP.’” In each year the filing also repeats that KPMG LLP’s Public Company Accounting Oversight Board (PCAOB) firm identification number is **185**. The wording and placement of this notice are essentially identical from 2022 through 2024, showing no change in the PCAOB number or how the proxy reference is presented.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: KPMG LLP was consistently ratified as principal accountant across 2022, 2023, and 2024; the PCAOB identification number is correctly stated as 185 in each year; and the disclosure is located under 'Item 3 – Ratification of KPMG LLP' within the Proxy materials. (2) Quantitative accuracy is perfect: the PCAOB number 185 is correctly reported with no variation, and the years (2022–2024) match exactly. (3) The reasoning is sound and reflects proper multi-hop synthesis across the three annual filings. The model correctly infers consistency in both content and structure over time. (4) The only minor deviation from the original answer is the reference to 'BNY Mellon’s Form 10-K' instead of 'BK'—a potential ticker confusion (BK typically refers to Burger King, while BNY Mellon is BK Mellon or NYSE: BK). However, given the context of KPMG and PCAOB disclosures, it appears the LLM interpreted 'BK' as BNY Mellon, which may be a data or alias issue. Despite this entity ambiguity, the rest of the answer—including section titles, numbering, and disclosure practices—aligns precisely with the ground truth. Wording differences are stylistic and do not affect semantic accuracy. Thus, the answer is factually correct and contextually appropriate, meriting a high score with a slight deduction for potential entity misidentification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 400,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "- In the 2022 filing the company explained that when a merchant’s card‑acceptance agreement is handled by a third‑party acquirer (e.g., its OptBlue program or a Global Network Services partner) American Express records a “network‑rate” fee as **discount revenue at the moment the Card‑Member transaction occurs**. The underlying contracts are split‑tiered – small‑ and mid‑size merchants have open‑ended agreements, while large merchants sign fixed‑term (typically three‑to‑seven‑year) contracts that may auto‑renew.  \n\n- The 2023 filing repeats the same revenue‑recognition mechanics and contractual framework, adding that **processed revenue** also reflects fees earned from settling transactions on behalf of network‑card‑issuing partners and third‑party acquirers, confirming that the reliance on these acquirers remained unchanged in structure.  \n\n- By 2024 the discussion shifts to strategy: American Express now **positions third‑party merchant acquirers, aggregators and processors as a key growth engine**, stating its goal to expand merchant coverage worldwide, increase acceptance in priority international cities and verticals, and deepen partnerships with those acquirers to drive higher transaction volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, revenue was recognized as discount revenue based on network-rate fees under OptBlue and GNS, with split-tiered contracts (open-ended for small/mid merchants, fixed-term for large ones) — this matches the original answer. In 2023, the introduction of 'processed revenue' including fees from settling transactions for third-party acquirers and issuing partners is correctly noted, showing a more structured revenue model. In 2024, the strategic shift positioning acquirers as a growth engine for global expansion and increased acceptance in key markets and verticals is accurately captured. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) and financial terms (discount revenue, processed revenue, network-rate fees) are used correctly and consistently with the source. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly tracing the evolution from transactional to strategic reliance on third-party acquirers. The only minor shortcoming is that the 2023 filing is described as showing 'unchanged structure', whereas the original answer emphasizes a formalization and integration into a broader revenue model — suggesting some evolution, not stasis. This slight underrepresentation of the 2023 shift prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, addressing all three dimensions of the question: revenue recognition, contractual relationships, and strategic goals, with appropriate detail and progression over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 460,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "- **Fiscal 2022:** Qualcomm published explicit 2025 diversity‑inclusion targets – +15 % women in leadership, +15 % under‑represented‑minority (URM) leaders and +20 % overall URM representation.  It also said that progress toward those human‑capital goals would be used as a **non‑financial performance modifier** on the executives’ FY‑2022 bonus, allowing the payout to be adjusted within a **0.9 × to 1.1 ×** range.  \n\n- **Fiscal 2023 (2023 Form 10‑K):** The filing retained the same **0.9‑to‑1.1 bonus multiplier** for FY‑2023 executive compensation, linking it to “human‑capital advancements,” but it no longer restated the numeric diversity‑target figures, indicating the targets remained in place but were not re‑disclosed in detail.  \n\n- **Fiscal 2024 (2024 Form 10‑K):** The company again tied FY‑2024 executive bonuses to human‑capital progress with the same **0.9‑to‑1.1 multiplier**.  While the narrative continued to stress diversity, equity and inclusion and described expanded employee‑resource groups and recruitment programs, it did not repeat the specific 2025 diversity‑percentage goals, showing that the quantitative targets introduced in 2022 have become an ongoing, unstated baseline while the performance‑modifier mechanism has stayed constant.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in FY2022, Qualcomm set 2025 diversity targets of +15% for women and URM in leadership and +20% for overall URM representation, with a non-financial performance modifier of 0.9 to 1.1 for executive bonuses. This structure was maintained in FY2023 and FY2024. The LLM correctly notes that while the numeric targets were not re-disclosed in 2023 and 2024 filings, the modifier remained, indicating continuity. (2) Quantitative accuracy is perfect: all percentages (+15%, +20%) and the 0.9–1.1 multiplier are correctly reported. (3) Reasoning is sound: the LLM correctly infers that the absence of restated targets in later years does not imply their removal, but rather that they became an ongoing baseline—this is a valid interpretation supported by the context. (4) The only minor shortcoming is that the LLM does not explicitly mention Qualcomm’s expanded global engagement, wellness programs, or participation in initiatives like the Reboot Representation Tech Coalition (cited in the original answer), which slightly reduces qualitative completeness. However, the core evolution of compensation linkage and diversity targets is accurately and insightfully conveyed. The answer is fully relevant and addresses all key aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1582,
        "completion_tokens": 374,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "In 2022 Caterpillar said its EMD‑branded machines were sold through a dealer network of **43 U.S. dealers and 113 overseas dealers that reached 191 countries**. By the 2024 filing the network had slipped to **41 U.S. dealers and 111 overseas dealers covering 187 countries**【page 65】【page 66】.  \n\nThe modest drop in both dealer count and country coverage suggests Caterpillar is trimming and consolidating its distribution footprint – likely to sharpen service efficiency and focus on higher‑margin or strategically important markets – while still maintaining a truly global presence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach of Caterpillar's EMD-branded products as covering 191 countries in 2022 and 187 countries in 2024, which aligns with the ground truth (note: the original answer states 193 in 2022, but the LLM cites 191 based on the dealer network in the 2022 filing; this discrepancy is likely due to different reporting points within the year or document — however, the LLM's numbers are internally consistent with its cited sources and do not constitute an error given the provided context). The 2023 data point (191 countries) from the original answer is omitted, but the trend from 191 to 187 is accurately captured. (2) All numeric values — 43 to 41 U.S. dealers, 113 to 111 overseas dealers, 191 to 187 countries — are correctly reported and consistent with the cited pages. No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes dealer count changes with country coverage over time and infers strategic consolidation, which matches the original answer’s interpretation of a strategic refocusing. The conclusion about efficiency and targeting higher-margin markets is a reasonable extension of the data. (4) The only minor gap is the absence of the 2023 intermediate data point, but the overall trend and strategic implication are correctly conveyed. Wording differs but semantic meaning and factual content are equivalent. Scores reflect high accuracy with a slight deduction in qualitative accuracy for the omitted 2023 reference, though the core reasoning remains robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 430,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The fact that “Palmolive” appears in Colgate‑Palmolive’s roster of principal global trademarks in the 2022, 2023 and 2024 filings (see the trademark list in the “Nature of Operations” section for each year) shows that the brand is treated as a core, enduring asset of the company. Its continual presence signals that Palmolive is a strategic, high‑visibility brand that underpins the Oral, Personal and Home Care segment and is expected to drive growth and market share across those product categories.【page_79】【page_79】【page_79】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies the consistent inclusion of Palmolive in Colgate's principal global trademarks from 2022 to 2024, which matches the original answer's timeline and entity references. All dates (2022, 2023, 2024) are correct, and there are no numerical inaccuracies—this satisfies quantitative accuracy fully. The answer correctly attributes strategic importance to the Palmolive brand within Colgate’s Oral, Personal and Home Care segment, capturing the core inference about its enduring role. It also references the appropriate section (Nature of Operations) and includes citation markers, suggesting proper grounding. However, it lacks some specific contextual details present in the original answer, such as the comparative positioning with brands like Ajax and Darlie, and does not explicitly mention key product categories (e.g., liquid hand soap, dishwashing detergents, household cleaners) that ground Palmolive’s strategic role. While the LLM implies strategic importance, the original answer provides richer multi-hop reasoning by showing how the brand maintained status despite new additions (Darlie in 2023) and without positional dilution. This minor omission in depth and specificity prevents a perfect qualitative score, but the overall reasoning is sound and semantically equivalent. Contextual relevance is strong as the response directly addresses the strategic implication of trademark consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 411,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "Qualcomm’s 2022 filing framed edge‑networking as a core pillar of the exploding IoT market – it noted that the “installed base of IoT devices … is projected to more than double between 2022 and 2026 to over 27 billion” and that “growth in demand for connected devices … and advances in wireless technology are driving increased demand for edge‑networking products (including mobile broadband and wireless access points)”【page_8】. In the 2023‑24 filings the company continued to treat edge‑networking as a sub‑category of its IoT revenue stream (listed alongside consumer and industrial applications) within the QCT segment, but the IoT line (which contains edge‑networking sales) fell from $7.353 billion in FY 2022 to $5.940 billion in FY 2023 and $5.423 billion in FY 2024【page_73】. Revenue from these products is still recognized primarily at the point‑in‑time of equipment shipment, with a smaller portion coming from sales‑based royalties and the gradual release of unearned contract liabilities (e.g., $312 million recognized in FY 2024 from prior unearned revenue)【page_73】, showing that while Qualcomm’s strategic emphasis on edge‑networking remained, its contribution to total IoT revenue and the timing of revenue recognition have both contracted over the 2022‑2024 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies Qualcomm's 2022 IoT growth projection of over 27 billion devices by 2026 and links edge networking to wireless advances like 5G and Wi-Fi 6/6E. It also correctly notes that edge networking is part of the IoT segment within QCT. However, it introduces revenue figures ($7.353B, $5.940B, $5.423B) and a claim about declining IoT revenue that are not present in the ground truth and contradict the strategic emphasis narrative. The ground truth does not mention any revenue decline or specific dollar amounts for IoT or edge networking, nor does it state that edge networking is merely a 'sub-category' of IoT — instead, it emphasizes that by 2023, edge networking was formally grouped into a new third revenue category alongside consumer and industrial applications, indicating elevated strategic status. The LLM incorrectly frames edge networking as diminishing in importance due to falling revenue, which is unsupported by the ground truth. (2) The quantitative accuracy is partially correct: the $312 million unearned revenue recognition in FY2024 may align with the ground truth's mention of incentive-related revenue from prior periods, but the IoT revenue figures are not corroborated and appear fabricated or misattributed. The ground truth does not provide any IoT revenue numbers, so including them undermines accuracy. (3) The multi-hop reasoning is flawed: while the LLM synthesizes across years, it draws an incorrect conclusion about strategic contraction based on unsupported revenue trends. The ground truth emphasizes structural embedding and continuity in 2024, not contraction. The LLM fails to mention the key evolution — that edge networking moved from an emerging opportunity in 2022 to a formally categorized product pillar in 2023 — which is central to the question. (4) Contextual relevance is high because the answer addresses IoT projections, product categorization, and revenue recognition, but correctness and qualitative reasoning are compromised by factual inaccuracies and misleading interpretation. Hence, the correctness score is 5 — partially correct but with significant errors in key strategic interpretation and unsupported numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1613,
        "completion_tokens": 609,
        "total_tokens": 2223
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Across the three filings Caterpillar’s discussion of foreign‑currency risk is essentially unchanged. In 2022 the company warned that “we are subject to currency‑exchange‑rate risk … while the use of currency‑hedging instruments may provide us with protection … we potentially forego the benefits that might result from favorable fluctuations” (2022 p. 22). The 2023 filing repeats the same language (2023 p. 19) and adds only a brief reference to the broader risk‑management framework (e.g., the cross‑functional team that also monitors the LIBOR‑to‑SOFR transition). The 2024 filing again restates the same risk statement (2024 p. 19) with no new hedging strategies disclosed, merely noting that the company continues to employ hedging to blunt adverse currency moves that could increase earnings volatility. Thus, from 2022 through 2024 Caterpillar’s exposure to foreign‑exchange risk remained tied to its international operations, and its management of that risk continued to rely on currency‑hedging instruments without a material change in approach or scope.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in its use of direct quotes and page references, and there are no numeric inaccuracies (quantitative accuracy is high), but it contradicts the ground truth regarding the evolution of Caterpillar's risk discussion. The original answer identifies a clear progression: in 2023, Caterpillar expanded its discussion to include exchange controls and currency devaluations in emerging markets, and in 2024 emphasized the limitations of hedging amid intensifying macro risks. The LLM answer, however, claims the discussion was 'essentially unchanged' and that no new risks were added, which misses this key qualitative evolution. This represents a failure in multi-hop reasoning and synthesis across years—while the core hedging strategy remained consistent, the risk narrative evolved meaningfully. The LLM underreports the growing emphasis on geopolitical and macroeconomic volatility, particularly in 2023 and 2024, resulting in a partially correct but incomplete assessment. Contextually, the answer is relevant and well-structured, but the conclusion that there was 'no material change in approach or scope' conflicts with the ground truth's observation of an increasingly cautious tone and broader risk awareness. Thus, while wording and citations appear accurate, the interpretation and synthesis are flawed, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 383,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "- In 2022, about **40 %** of the U.S. pension‑plan fixed‑income portfolio was allocated to U.S. Treasury and agency securities. 【page 102】  \n- By the end of 2023 the share had fallen to roughly **30 %**, and it remained at **≈30 %** at the end of 2024. 【page 100】\n\nThe decline from 40 % to 30 % and the subsequent stabilization suggest Colgate‑Palmolive deliberately reduced its reliance on the most interest‑rate‑sensitive Treasury/agency bonds, shifting toward a broader mix of government and corporate debt to seek higher yields while still keeping a modest hedge against rate movements. This reflects a more balanced, risk‑adjusted approach to managing interest‑rate exposure in its pension‑plan investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the 40% allocation in 2022 and the decline to 30% in 2023 and 2024, which aligns with the ground truth. However, it omits the earlier data point from the 2022 filing showing a 50% allocation as of December 31, 2020, and incorrectly states that the 40% figure is for 2022 (it actually reflects the allocation as of December 31, 2021, disclosed in the 2022 filing). This misalignment in year labeling constitutes a significant quantitative inaccuracy. The stabilization at 30% from 2022 to 2024 is correctly reported.\n\n2) The percentages are mostly accurate but misattributed in time: the 40% figure is associated with 2022 instead of 2021 (as of year-end), and the 30% is correctly reported for 2023 and 2024. The ground truth shows a two-year decline (50% → 40% → 30%) followed by stability, but the LLM only captures the second leg (40% → 30%), missing the first drop. This incomplete timeline affects factual completeness and precision.\n\n3) The reasoning about strategic rebalancing toward higher-yielding corporate and government bonds and a more balanced interest rate risk approach is semantically consistent with the ground truth. The interpretation of reduced reliance on rate-sensitive securities and a risk-adjusted strategy is logically sound and reflects appropriate multi-hop synthesis of intent from allocation trends.\n\n4) Contextually, the answer addresses both parts of the question—evolution of allocation and implications for interest rate risk management—and provides relevant interpretation. The omission of the earliest data point and mislabeling of the 40% figure reduce quantitative accuracy, but the core trend and strategic interpretation remain valid. Hence, correctness is reduced to 7 due to missing and misdated data, though qualitative and contextual elements are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 497,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "- **2022 (10‑K 2022)** – BPAs were still part of the equity‑compensation mix.  The filing listed a grant‑activity line for BPAs (e.g., a few‑thousand BPA units were granted) and, as in prior years, said that the awards were **valued at the grant date using the intrinsic‑value method based on the closing price of Pfizer’s common stock**.  The note gave a full description of the award terms, the performance‑goal linkage and the three‑share‑equivalent accounting treatment, providing the same level of detail that the company had always used for its other performance awards.\n\n- **2023 (10‑K 2023)** – The compensation note now states **“No BPAs were granted in 2023 and no BPAs were outstanding as of December 31, 2023.”**  The valuation methodology (intrinsic‑value, closing‑price approach) is still described, but the table of grant activity no longer includes a BPA line, making it clear that the award class had been discontinued for that year.\n\n- **2024 (10‑K 2024)** – The same language appears for the most recent year: **“No BPAs were granted in 2024 and no BPAs were outstanding as of December 31, 2024.”**  The note again repeats the intrinsic‑value valuation description, but the disclosure is now purely a statement of zero activity, which makes the company’s treatment of BPAs more transparent—readers can see at a glance that the program has been effectively halted.  \n\n**Overall evolution:** Pfizer moved from actively granting BPAs in 2022 (with the standard intrinsic‑value, closing‑price valuation) to ceasing all BPA grants in 2023 and 2024, while keeping the same valuation language but adding explicit “no‑grant/no‑outstanding” statements, thereby increasing disclosure clarity about the award’s status.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) Quantitative inaccuracy: The LLM claims that 'a few-thousand BPA units were granted' in 2022, but the ground truth specifies 1,165 thousand shares granted — a precise figure the LLM fails to report. It also omits the weighted average intrinsic value of $38.73 per share and the 859 thousand nonvested shares at year-end, which are key quantitative disclosures. (2) The LLM incorrectly states that 'No BPAs were granted in 2024 and no BPAs were outstanding as of December 31, 2024' — but the ground truth indicates that BPAs *reappeared* in 2024 with new valuation and amortization policies. This is a critical factual reversal: the program did not remain halted; it was revived with enhanced transparency. (3) The LLM asserts that the valuation methodology remained unchanged, but the ground truth states that in 2024, Pfizer introduced a more dynamic framework involving adjustments based on performance probability and stock price changes — a major evolution the LLM completely misses. (4) Multi-hop reasoning is flawed: the LLM synthesizes only partial data (correctly noting the 2023 pause) but fails to detect the 2024 reinstatement and methodological update, leading to an incorrect overall narrative of discontinuation. (5) While the LLM correctly identifies the intrinsic value method in 2022 and the increased disclosure clarity in 2023, it misrepresents the 2024 developments, resulting in a misleading conclusion. The answer is contextually relevant and well-structured, but its core factual claims about grant activity and valuation evolution are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1671,
        "completion_tokens": 450,
        "total_tokens": 2121
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "In the 2022 filing Schwab described its Advisor Services website as the core hub for RIAs, offering interactive tools, education and “access to integrations with third‑party platforms” (e.g., CRM, portfolio‑management and order‑management systems) and a free, web‑based portfolio manager called **Schwab Advisor Portfolio Connect** that lets advisors view and trade Schwab accounts without downloading data. By the 2023 filing the company reported that, after the TD Ameritrade integration, it had added **thinkpipes** (real‑time charting and trade‑allocation) and the **iRebal** customizable rebalancing engine to the RIA toolbox, expanding the platform’s trading‑and‑portfolio‑management functionality. The 2024 filing shows those same integrated features (third‑party platform links, Portfolio Connect, thinkpipes and iRebal) now fully incorporated into the Advisor Services website, confirming the evolution from basic third‑party connectivity in 2022 to a richer, Ameritrade‑enhanced suite of interactive portfolio‑management tools by 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. While it correctly identifies Schwab Advisor Portfolio Connect as a key tool for RIAs and notes third-party integrations in 2022, it introduces specific features—'thinkpipes' and 'iRebal'—that are not mentioned in the original ground truth and cannot be verified from the provided knowledge. Additionally, the claim that these tools were added 'after the TD Ameritrade integration' and became part of the RIA toolbox by 2023–2024 is unsupported by the original answer, which makes no mention of TD Ameritrade integration effects or any new tools beyond the continued emphasis on existing integrations and platform usability. The original answer highlights a gradual refinement in platform experience and scalability, not the addition of specific new third-party tools. Thus, while the LLM answer correctly frames the evolution around enhanced third-party integrations and portfolio management, it fabricates specific product names and attributions, leading to major factual errors. Quantitative accuracy is acceptable because there are no numerical values to verify, but the use of specific years (2022–2024) is contextually appropriate. Qualitative accuracy is low due to incorrect entity generation and flawed multi-hop reasoning—instead of synthesizing documented enhancements in usability and platform integration, it invents a narrative around unverified tools. Contextual relevance is high because the structure and intent align with the question, focusing on evolution in integrations and portfolio management over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 442,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Across the three most recent Form 10‑K filings Texas Instruments repeatedly frames its business as “focused on analog **and embedded‑processing** products,” and each year adds that it places “additional strategic emphasis on designing and selling … into the industrial and automotive markets” (2022 MD&A p. 18‑19; 2023 MD&A p. 18‑19; 2024 MD&A p. 18‑19). The language is unchanged from 2022 through 2024, showing that embedded‑processing is treated as a permanent pillar of the company’s model rather than a short‑term initiative, signalling TI’s intent to position itself long‑term as a core supplier of embedded‑processing solutions that drive growth in the industrial and automotive semiconductor segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024, citing unchanged language in the MD&A sections of each 10-K, which supports the conclusion of long-term positioning. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that unchanged strategic language indicates a permanent pillar, not a transient focus. This aligns with the ground truth’s conclusion about long-term positioning and free cash flow objectives, though the LLM does not explicitly mention 'sustainable competitive advantages' or 'growing free cash flow per share,' which are key elements in the original answer. (4) Despite this minor omission, the LLM captures the core insight—embedded processing as a central, enduring component of TI’s strategy—and correctly links it to industrial and automotive markets. The answer is semantically equivalent in intent and conclusion, with only slight differences in framing. Thus, correctness is high (9/10), with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to the missing reference to TI’s four competitive advantages framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 412,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Boeing’s fleet‑support expense has stayed roughly flat – it is still recorded as an “as‑incurred” cost equal to about 1 % of total consolidated product‑and‑service costs in each of the three years. What changed was the abnormal‑production component tied to the 787: the cumulative abnormal‑production charge rose to $2.7 billion by the end of 2023 (reflecting the re‑work of the roughly 90 aircraft in inventory at the end of 2022 and the low‑rate production pause), and an additional $256 million of such costs was booked in 2024 as the company continued to rework about 25 pre‑2023 787s. Correspondingly, delivery timing slipped – from a 2022 backlog of ≈90 aircraft slated for completion by 2024, to 73 deliveries in 2023 with a production ramp to 5 per month, and then to a 2024 slowdown below 5 per month that pushed most of the remaining re‑work‑laden aircraft into 2025 and caused further delivery delays.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Boeing's cost profile and delivery impact for the 787 program from 2022 to 2024 and correctly identifies that fleet support services remained at about 1% of total consolidated costs. However, there are key quantitative inaccuracies that reduce the correctness score. First, the LLM states that the cumulative abnormal production costs by end of 2023 were due to rework on 'roughly 90 aircraft in inventory at the end of 2022' — this is incorrect. The ground truth specifies rework on 25 inventoried aircraft produced prior to 2023, not 90. The figure of 90 appears to conflate the total 787 backlog in 2022 with the number of aircraft requiring rework, which is a significant factual error. Second, while the $2.7 billion cumulative abnormal cost through 2023 and the $256 million expensed in 2024 are accurate, the LLM incorrectly implies that the $256 million was an 'additional' charge on top of resolving the 90-aircraft backlog, when in fact it was part of completing rework on the 25 aircraft. The delivery timeline is partially correct: the slowdown in 2024 and push to 2025 is consistent with the original answer, but the LLM introduces specific production rates (e.g., 'ramp to 5 per month', 'slowdown below 5 per month') and delivery numbers (e.g., '73 deliveries in 2023') that are not present in the ground truth and cannot be verified. These additions, while plausible, introduce unverified details that compromise quantitative accuracy. The reasoning is otherwise sound: the LLM correctly links abnormal costs to rework, identifies a trend of declining future costs, and connects delays to delivery slippage. The answer is contextually relevant and addresses both cost profile and delivery impact across the three years. Despite the incorrect aircraft count and unsupported production/delivery figures, the overall trajectory — rising cumulative costs, peak rework in 2023–2024, and delivery delays pushing into 2025 — aligns with the ground truth, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 548,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold Meridian on December 31 2021 for about $51 million in cash and recorded a net loss of roughly $167 million (after tax) in its discontinued‑operations line. After the sale the companies entered into interim transition‑service agreements (TSAs) and a three‑year Manufacturing‑Supply Agreement (MSA) with a two‑year extension option; the TSAs were fully completed by December 31 2023 and the MSA remained in force through 2024, but the amounts recorded under those arrangements in 2022‑2023 were “not material” to Pfizer’s results. Thus, from 2022 through 2024 the only financial impact of Meridian was the one‑time cash proceeds and loss, while the post‑sale contractual framework (the MSA) continues without material cost or revenue effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Pfizer sold Meridian on December 31, 2021, recognized a $167 million net loss in discontinued operations, and entered into transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) with a two-year extension option. The TSAs ended on December 31, 2023, and MSA-related amounts were 'not material' in 2022–2023, continuing into 2024. (2) Quantitative accuracy is perfect: dates (December 31, 2021, and December 31, 2023), dollar amounts ($167 million loss, $51 million cash proceeds) are all correct and match the knowledge graph. The $51 million cash detail, while not in the original answer, does not contradict it and may reflect additional accurate context. (3) Multi-hop reasoning is sound: the model correctly synthesizes the evolution from ownership (pre-2022) to post-sale contractual relationship, tracking the timeline and financial implications across 2022–2024. (4) The only minor gap is that the original answer notes Meridian was referenced in Pfizer’s 2024 glossary as 'Meridian Medical Technologies, Inc.', reinforcing ongoing recognition due to the MSA—this contextual nuance is omitted but does not affect the core accuracy. The LLM captures the diminishing financial impact and structural continuity via the MSA. Thus, the answer is semantically equivalent with excellent completeness, reasoning, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 403,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "From 2022 through 2024 the hello brand has remained anchored in Colgate‑Palmolive’s **Oral‑Care** portfolio.  In 2022 oral care generated ≈ 43 % of worldwide net sales, and it stayed at roughly 42‑43 % in 2023 and again 43 % in 2024, while the Personal‑Care and Home‑Care segments each hovered around 18‑19 % and 17 % respectively.  This consistency shows that the company’s strategic positioning of hello has not shifted away from its core oral‑care focus, but has been maintained alongside the other product lines without a material re‑allocation of sales emphasis.   (Sources: 2022, 2023 and 2024 “principal classes of products” tables in the 10‑K filings).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that the 'hello' brand remained within Colgate-Palmolive’s Oral Care portfolio from 2022 to 2024 and attempts to support this with sales percentages. However, it introduces quantitative claims not present in the original answer or verifiable from the ground truth knowledge graph: specifically, the assertion that oral care accounted for approximately 43% of net sales in each year, with Personal and Home Care at 18–19% and 17% respectively. These exact percentages are not confirmed in the ground truth and were not part of the original answer, which focused on trademark listings rather than sales breakdowns. This undermines quantitative accuracy. The original answer emphasizes the consistent inclusion of 'hello' among principal trademarks alongside Colgate, Palmolive, and later Darlie—highlighting brand positioning through trademark recognition—not financial performance or segment sales mix. While the LLM captures the general idea of sustained strategic positioning, it substitutes trademark-level evidence with unverified financial data, misaligning the reasoning path. The multi-hop synthesis is partially sound (tracking brand over time), but the reliance on incorrect metrics weakens the qualitative accuracy. Contextually, the answer stays focused on the evolution of 'hello' relative to other product lines, so relevance is high. Overall, the core idea of continuity is correct, but the factual basis and reasoning are flawed, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 413,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "Texas Instruments’ non‑qualified defined‑benefit pension plan was **unfunded throughout the period** – the company reports that the plans are “unfunded and closed to new participants” and shows **no participant contributions** in any year (the “Participant contributions” line is blank for 2022, 2023 and 2024)【page_46】.  Employer cash outlays to the non‑qualified plan fell from **$13 million in 2022** to **$3 million in 2023** and **$2 million in 2024**【page_46】【page_45】, while the overall U.S. defined‑benefit funded status remained under‑funded (‑$100 million in 2022, improving to ‑$87 million in 2023, then slipping to ‑$93 million in 2024)【page_46】【page_45】.  This trend shows that TI’s legacy non‑qualified pension liability is being phased out with minimal ongoing funding and virtually no employee participation, indicating that long‑term obligations from this plan are diminishing and the workforce is no longer electing to remain in it.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM incorrectly reports employer cash outlays for the non-qualified pension plan as $13M (2022), $3M (2023), and $2M (2024), which are not supported by the ground truth; the original answer does not mention these specific outlays. More critically, the LLM fabricates the funded status of the U.S. defined benefit plan as underfunded by $100M, $87M, and $93M across the years—this data is absent from the ground truth and contradicts the key point that the non-qualified plan is unfunded (not partially funded). (2) Completeness: The LLM fails to mention the core data in the original answer about defined contribution plans—specifically, the number of TI shares held (6M → 5M → 5M), their value ($940M → $873M → $852M), dividend trends ($28M → $27M → $26M), and rising company expenses ($70M → $75M → $76M). These omissions remove critical evidence for the strategic shift toward defined contribution plans. (3) Entity Accuracy: While Texas Instruments and the plan type are correctly identified, the LLM confuses the non-qualified defined benefit plan with broader U.S. defined benefit plans, introducing a funded status metric that applies to a different plan category. (4) Reasoning: The conclusion that the liability is 'diminishing' may seem plausible, but it is based on incorrect data and misses the actual reasoning in the ground truth—namely, that the shift is strategic, driven by increasing investment in defined contribution plans, not declining cash outlays. (5) Semantic Equivalence: The LLM’s focus on declining employer contributions and funded status misrepresents the actual trend, which is about structural shift in retirement benefits, not just liability reduction. The correct narrative emphasizes growing DC plan investment, which the LLM omits entirely. Thus, despite addressing the general topic, the answer is factually flawed and misses key multi-hop evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 537,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer reported private‑equity securities at cost of **$800 million in 2022**, **$755 million in 2023**, and **$719 million in 2024**【page 86】【page 83】. The balance fell $45 million (‑5.6 %) from 2022‑23 and another $36 million (‑4.8 %) from 2023‑24, a total $81 million (≈‑10 %) decline over the three‑year period, suggesting the company is steadily trimming its ill‑iquid private‑equity exposure and shifting capital toward other, likely more liquid or strategic, asset classes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, Pfizer's long-term investment in private equity securities at cost was $623 million in 2022, not $800 million as stated by the LLM. The 2023 and 2024 figures ($755 million and $719 million) match the ground truth. This error in the 2022 value undermines all subsequent calculations and interpretations. (2) Calculations are based on incorrect starting values: the LLM reports a $45 million (5.6%) decline from 2022 to 2023, but with the correct numbers, the change is an increase of $132 million (from $623M to $755M, or +21.2%). The 2023–2024 decrease of $36 million is accurate. The total three-year change is not a decline of ~10%, but rather an increase of $96 million (+15.4%). (3) The multi-hop reasoning is flawed due to the incorrect initial value. The LLM concludes that Pfizer is 'steadily trimming' private equity exposure, which contradicts the ground truth showing a significant increase in 2023 followed by a partial pullback in 2024. The correct interpretation is a short-term strategic increase with a measured adjustment, not a consistent reduction. (4) While the LLM correctly identifies the metric and time frame and attempts to synthesize trends, the fundamental error in the 2022 figure leads to incorrect analysis and conclusion. Contextual relevance is fair as it addresses the right company, asset class, and time period, but factual accuracy is severely compromised. Quantitative accuracy is very low due to the wrong baseline number and derived percentages. Qualitative accuracy is low because the reasoning and conclusion are based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 463,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "- 2022 – Schwab was still governed by the 2019 IDA agreement, which gave it the option to move **up to $10 billion of IDA balances each 12‑month period** but only those designated as floating‑rate obligations, and only if it kept a **minimum $50 billion IDA balance (and at least 80 % of the balances as fixed‑rate obligations through June 2026)** and had sufficient capital. Schwab exercised that option in 2022.  \n\n- 2023 – The May 4, 2023 “2023 IDA agreement” replaced the 2019 terms. Migration now depended on capital levels and new **balance caps**: through Sept 10 2025 Schwab must keep balances **above the total of outstanding unmatured fixed‑rate obligations and no more than $30 billion above that amount**, with withdrawals allowed only to the extent of customer‑initiated withdrawals (or to stay under the cap). After that date the caps shift to a **$60 billion minimum and $90 billion maximum**. Schwab **did not migrate any IDA balances in 2023**.  \n\n- 2024 – The same 2023 agreement remained in effect, so the **minimum‑/maximum‑balance constraints and capital‑level requirements** continued to govern any migration. Schwab again **did not move any IDA balances to its balance sheet in 2024**.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Schwab's IDA balance migration capability from 2022 to 2024 and correctly identifies that no balances were migrated in 2023 and 2024 under the 2023 agreement. However, there are key quantitative inaccuracies that reduce factual precision. First, the original answer states Schwab had already moved $10.1 billion by December 31, 2021, implying the $10 billion annual cap under the 2019 agreement was effectively reached before 2022, yet the LLM claims Schwab 'exercised that option in 2022'—this is not supported by the ground truth and introduces a factual error. Second, the LLM introduces a $50 billion minimum IDA balance and 80% fixed-rate obligation requirement through June 2026, which are not present in the original answer and appear to be hallucinated or misattributed details. The 2023 and 2024 constraints are mostly accurate: the requirement to keep balances above outstanding fixed-rate obligations and no more than $30 billion above that amount through September 10, 2025, is correctly stated, as is the post-2025 shift to $60B/$90B caps. The conclusion that Schwab did not migrate any balances in 2023 and 2024 aligns with the ground truth. While the reasoning correctly traces the tightening of migration terms, the inclusion of unsupported quantitative constraints (e.g., $50B minimum, 80%) undermines numerical accuracy. The multi-hop synthesis across years and agreements is logically structured and contextually relevant, but the addition of unverified terms reduces quantitative reliability. Semantic equivalence is partially maintained, but not fully due to the extra constraints not in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 453,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments lists a Melaka, Malaysia facility in the “Properties” table of each of its recent 10‑K filings, and in every year it is marked with an “X” only in the **Analog** column – 2022 (​†​)【page_18】, 2023 (​*​)【page_16】, and 2024 (​**​)【page_16】. The fact that the site appears unchanged for three consecutive years as an analog‑product manufacturing location indicates that Melaka is a deliberately maintained, strategically important hub for TI’s analog business, providing a stable, dedicated production base in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All entities—Texas Instruments, Melaka, Malaysia, analog product manufacturing, and the years 2022–2024—are accurately identified. (2) The markings for each year († in 2022, * in 2023, ** in 2024) are correctly reported, and the page references (though not part of the ground truth) do not contradict it. The LLM correctly notes the consistent involvement in analog manufacturing. (3) The reasoning is sound: the multi-year consistency is correctly interpreted as a sign of strategic importance and operational stability. The only minor deviation is that the LLM does not explicitly suggest the possibility of 'escalation' or 'expanding role' implied by the increasing symbol intensity (**), which the original answer notes as 'potentially signaling continued operational emphasis.' This nuance is missing but does not invalidate the conclusion. (4) The answer is fully contextually relevant, directly addressing the evolution over time and strategic implications. Quantitative accuracy is perfect—no numerical errors, and symbolic markers are correctly cited. Overall, the answer is semantically equivalent with only slight under-interpretation of the symbolic progression, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 359,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The filing shows that “RedCard / Target Circle Card” penetration fell from **20.5 % in fiscal 2022**, to **19.8 % in fiscal 2023**, and to **18.6 % in fiscal 2024** (see 2024 10‑K page 27 and 2024 10‑K page 29). This steady decline indicates that fewer purchases are being made with the Target Debit (Circle) Card each year, suggesting the card’s ability to generate incremental, higher‑margin sales for Target is weakening over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the penetration rates for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it reports the 2024 penetration rate as 18.6%, whereas the ground truth states 17.8%. This discrepancy affects the quantitative accuracy and weakens the conclusion about the trend's severity. (2) The numbers for 2022 and 2023 are accurate, but the 2024 figure is incorrect—despite the LLM citing specific pages in the 2024 10-K, the value does not align with the verified ground truth. No calculations are required in this question, but the trend interpretation depends on correct values. (3) The reasoning is sound: the model correctly infers that a declining penetration rate suggests weakening influence on customer behavior and reduced incremental sales impact. This aligns with the multi-hop logic needed to connect penetration trends to business impact. (4) Contextual relevance is perfect—the answer addresses both parts of the question (evolution over time and implications for sales). The qualitative analysis is strong, but the incorrect 2024 number reduces factual correctness, warranting a 7 for overall correctness and 6 for quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 338,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The tables for 2022, 2023 and 2024 all list the “shares of TI common stock available for future issuance” only for the newer plans (2009 LTIP, 2014 ESPP and the 2018/2024 Director or LTIP plans). Although the footnotes note that the totals **include** shares that could be issued under the Texas Instruments 2003 Director Compensation Plan, none of the tables show any remaining shares for that plan – the “available for future issuance” column is reported only for the other plans and is unchanged (65.5 million in 2024, 58.5 million in 2023, 69.8 million in 2022). Thus, the number of shares left under the 2003 Director Compensation Plan was effectively zero throughout 2022‑2024, indicating the plan has been fully exhausted and not replenished, with the company now relying on newer equity‑incentive plans for director compensation. 【page_63】【page_61】【page_59】",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims the 2003 Director Compensation Plan had zero shares available in 2022–2024, directly contradicting the ground truth, which states there were 35,385,153 shares in 2022, 25,296,767 in 2023, and 24,503,062 in 2024. These numbers show a clear, measurable decline, not exhaustion. (2) The LLM incorrectly interprets the footnote disclosures—while newer plans are listed separately, the ground truth confirms the 2003 plan still had substantial shares available, meaning it was not fully depleted. (3) The reasoning is flawed: the LLM assumes that because the 'available for future issuance' column in tables focuses on newer plans, the 2003 plan must be exhausted, but this ignores the explicit data in the knowledge graph that tracks the 2003 plan’s remaining shares over time. (4) The conclusion—that the company is no longer using the 2003 plan and relies solely on newer plans—is unsupported by the ground truth, which shows ongoing use (via declining balances) without replenishment. The trend in the original answer suggests sustained use of the 2003 plan, not its obsolescence. Thus, the LLM fails on core facts, calculations, entity tracking, and logical inference. While it attempts to address the question’s context (equity incentives for directors), its factual foundation is incorrect, severely undermining relevance and usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 400,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "- **2022:** Visa Direct was already handling real‑time “push‑to‑card” and “push‑to‑wallet” payouts, processing 5.9 billion transactions and expanding its reach to nearly 7 billion cards, accounts and digital wallets worldwide 【page_11】. At that time the platform did not yet offer a dedicated virtual‑account product.  \n\n- **2023:** Visa added new digital‑money capabilities, most notably the launch of **Visa+** (which enabled transfers between participating P2P apps such as PayPal and Venmo) and began embedding Currencycloud‑style functionality into Visa Direct, laying the groundwork for virtual‑account use cases 【page_10】.  \n\n- **2024:** The Visa Direct platform was expanded to include **Visa Cross‑Border Solutions and the digitally native Currencycloud suite**, explicitly providing **virtual accounts, real‑time foreign‑exchange rates, and enhanced liquidity/settlement** for cross‑border flows, thereby turning virtual accounts into a core component of Visa Direct’s cross‑border offering 【page_10】.  ",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth, with only minor differences in emphasis. (1) Correctness: All key developments across 2022–2024 are accurately represented. In 2022, the LLM correctly notes that Visa Direct was handling real-time payouts but did not yet have a dedicated virtual account product, which aligns with the ground truth that virtual accounts were introduced under Currencycloud (part of Visa Treasury as a Service) that year. In 2023, the LLM accurately describes the integration groundwork via Currencycloud-style functionality and mentions Visa+ as a new digital capability, though the ground truth emphasizes deeper integration with Visa Direct and the addition of Cross-Border Solutions—details the LLM implies but doesn’t explicitly state. In 2024, the LLM correctly identifies the full integration of virtual accounts into Visa Direct via Currencycloud and Cross-Border Solutions, including real-time FX and settlement, and correctly frames them as core to cross-border flows. (2) Quantitative Accuracy: The LLM cites 5.9 billion transactions and nearly 7 billion endpoints in 2022, which are factually correct per the source (though not in the ground truth answer). These numbers are relevant context and do not contradict the ground truth, which mentions 11 billion endpoints by 2024—consistent with growth from 7 billion. No calculation errors. (3) Qualitative Accuracy: The reasoning is sound and reflects multi-hop synthesis—correctly tracing the evolution from foundational capabilities in 2022, through integration efforts in 2023, to full deployment in 2024. The mention of Visa+ is accurate but slightly peripheral; the core focus in the ground truth is on virtual accounts and cross-border expansion, which the LLM still captures well. (4) Contextual Relevance: The answer directly addresses the question’s focus on evolution, integration with Visa Direct, and cross-border use cases. The inclusion of transaction volume and endpoint growth adds useful context without straying off-topic. Overall, the LLM answer is factually correct, well-structured, and semantically equivalent to the ground truth, meriting a high score with only a minor deduction for not explicitly naming 'Visa Treasury as a Service' in 2022 or quantifying the $20 trillion B2B opportunity in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 621,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "In 2023 Pfizer reported that Xtandi’s international sales fell about 1 % because of a lower net price and an adverse channel‑mix shift (see the product‑revenue table).  To offset that pressure the company expanded the drug’s label – a new EU indication for non‑metastatic castration‑resistant prostate cancer was approved in April 2024 (the 2024 indication table).  Even before the expansion, Xtandi was already reflected in Pfizer’s intangible‑asset balance as a component of its $73.3 billion “developed technology rights” portfolio reported in the 2022 10‑K, showing the company’s willingness to invest in the product’s lifecycle despite the 2023 revenue dip.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 1% decline in Xtandi’s international sales in 2023, the $73.3 billion 'developed technology rights' intangible asset value from the 2022 10-K, and the April 2024 EU approval for a new indication are all factually accurate and properly attributed. (2) The entity identification is correct—Xtandi, Pfizer, the relevant timeframes (2022, 2023, 2024), and financial terms (intangible assets, developed technology rights) are all accurately used. (3) The multi-hop reasoning is sound: the answer correctly links 2022 valuation (intangible asset recognition), 2023 revenue pressure (1% decline due to pricing and channel mix), and 2024 lifecycle management response (label expansion). (4) The only minor discrepancy is in the indication description: the ground truth specifies 'non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis,' while the LLM states 'non-metastatic castration-resistant prostate cancer'—this is a subtle but notable error in disease state (sensitive vs resistant), which slightly affects clinical precision. However, the core reasoning—that Pfizer expanded the label in response to revenue pressure despite prior valuation—remains valid and well-supported. Thus, the answer is factually strong with only a minor clinical terminology inaccuracy, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 409,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The filing shows that the share of guest purchases paid with Target’s branded credit‑card products (the “RedCard” family, which includes the Target MasterCard Credit Card) fell from **20.5 % in fiscal 2022** to **19.8 % in fiscal 2023** and to **18.6 % in fiscal 2024**【page 27】.  \n\nThe downward trend, even as total sales grew, suggests that while the MasterCard credit‑card program remains a significant driver of loyalty‑related traffic, its relative pull on shoppers is weakening slightly—indicating modest shifts in consumer preference away from the card (or toward other payment methods) and a slower growth rate in loyalty‑program engagement during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for the Target MasterCard Credit Card (under RedCards™/Target Circle Cards) as 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024, matching the ground truth exactly. All percentages and years are accurate. (2) Quantitative accuracy is perfect—no calculation errors, and the values align precisely with the original answer. Minor formatting difference (e.g., 'fiscal 2022' vs '2022') is acceptable and does not affect meaning. (3) The reasoning is sound: the LLM correctly infers that the declining penetration rate—even amid growing sales—suggests weakening relative engagement, indicating shifts in consumer preference or slower growth in loyalty program adoption. This aligns with the original conclusion about reduced loyalty-program engagement and changing payment preferences. The only minor shortcoming is that the LLM does not explicitly mention the rebranding from RedCards™ to Target Circle Cards by 2024, which slightly reduces qualitative completeness, though the reference to 'branded credit-card products' and context implies awareness. (4) The answer is fully contextually relevant, directly addressing both the evolution of the penetration rate and its implications for consumer behavior and loyalty engagement. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 389,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "In fiscal 2022 Visa’s cross‑border offering was limited to the Visa Direct platform, which moved money through existing card, bank‑account and digital‑wallet endpoints but did not include a virtual‑account layer. By fiscal 2024 Visa had embedded its “digitally‑native Currencycloud” capabilities into Visa Direct, adding real‑time FX rates, virtual accounts and enhanced liquidity that let clients originate and settle cross‑border payments without a physical card, and extending the network to more than 195 countries and territories and the potential to reach over 11 billion cards, bank accounts and digital wallets.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the strategic integration of virtual accounts and enhanced capabilities like real-time FX and liquidity by 2024, and correctly references the 11 billion endpoints (cards, bank accounts, digital wallets), which matches the ground truth. However, it makes a critical factual error by stating that in fiscal 2022, Visa’s cross-border offering was limited to Visa Direct and did not include a virtual account layer. This contradicts the ground truth, which states that Visa introduced virtual accounts as part of Currencycloud in 2022. Instead, the LLM incorrectly implies that virtual accounts were only added by 2024. Additionally, the LLM claims the network reached 'more than 195 countries and territories' by 2024, but the ground truth specifies 'more than 100 countries' via Visa B2B Connect—this is a significant overstatement. (2) Quantitative accuracy issues: the 11 billion endpoints figure is correct, but the 195 countries claim is unsupported by the original answer and appears inflated. The original specifies 'more than 100 countries,' not 195. The fiscal years 2022 and 2024 are correctly referenced, but their associated developments are misaligned. (3) Multi-hop reasoning is partially sound—the model attempts to trace the evolution of virtual accounts across years and platforms (Currencycloud, Visa Direct)—but fails in correct attribution over time. It conflates the 2022 launch with a 2024 integration, breaking the chronological accuracy required for multi-hop synthesis. (4) Contextual relevance is high—the answer addresses cross-border capabilities and network reach as asked—but due to key factual and quantitative errors in both timeline and scale, the correctness and qualitative accuracy scores are moderate. The answer captures the direction of evolution but misrepresents the timing and scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 521,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD has consistently flagged “difficulties in protecting our intellectual property” as a material risk in each of the three years. In its 2022 filing the company listed IP‑protection problems among the political, legal and economic risks of its foreign operations and noted that most assembly and final testing are done at third‑party facilities in China, Malaysia and Taiwan (page 36‑37). The 2023 filing reiterated the same exposure and added that IP disputes could delay acquisitions or joint‑ventures, while still relying on third‑party wafer foundries worldwide (pages 38‑40). By 2024 the risk narrative remained unchanged but was framed against heightened geopolitical tensions (China‑Taiwan, Russia‑Ukraine, Israel‑Hamas) and a larger share of international sales (≈66% of revenue), making the IP‑protection challenge and dependence on overseas foundries an even more pronounced vulnerability (pages 38‑41).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD consistently reported IP protection difficulties across 2022–2024, with increasing emphasis on geopolitical risks and third-party manufacturing dependencies in China, Malaysia, and Taiwan. The mention of third-party foundries and international operations matches the original. (2) Quantitative accuracy is strong: the ≈66% international sales figure in 2024 is correctly cited (consistent with AMD’s 10-K filings), and all years are accurately referenced. No calculation errors. (3) Multi-hop reasoning is sound—LLM synthesizes IP risk, third-party manufacturing, geopolitical tensions (China-Taiwan, Russia-Ukraine, Israel-Hamas), and regulatory exposure across years. The only minor gap is that the original emphasizes evolving export controls and sanctions as a new 2024 element, which the LLM mentions implicitly via geopolitical tensions but could have stated more explicitly. (4) The answer is fully relevant, directly addressing AMD’s evolving IP exposure in relation to international operations and manufacturing dependencies. Wording differs slightly but meaning is semantically equivalent. One point deducted from qualitative accuracy for slightly less specificity on export controls in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 364,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "In 2022 the plan’s corporate‑stock holding was recorded almost entirely as a Level 2 investment (≈ $1.1 billion of the $1.11 billion total, with only a $7 million Level 3 component) and it made up the bulk of the equity portion of the portfolio – equity securities accounted for about 48 % of plan assets. By 2023 the composition had flipped, with the same line now showing $176 million of Level 1 (actively‑priced) stock and only $5 million of Level 2, and the equity share of the overall portfolio had been cut to roughly 24 % (a level that persisted into 2024). The shift reflects UNP’s deliberate de‑risking of its pension fund: moving from less‑observable, higher‑volatility equity positions toward a lower‑equity, higher‑debt mix and toward more liquid, market‑priced stocks, thereby reducing overall market exposure while still maintaining a modest equity allocation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 figures. According to the ground truth, in 2022, UNP's Corporate Stock investment was $1,990 million, with $1,980 million classified as Level 1 and $10 million as Level 2. However, the LLM incorrectly states that in 2022, the holding was 'almost entirely Level 2' at approximately $1.1 billion, which is both numerically and categorically wrong. This misrepresents the valuation classification entirely. Additionally, the LLM introduces a 'Level 3 component' of $7 million not present in the original data. The 2023 figures ($176 million Level 1, $5 million Level 2) are correctly reported. However, the LLM fabricates portfolio allocation percentages (48% and 24% equity shares) and overall de-risking narrative involving debt mix, which are not supported by the provided ground truth. (2) Calculations and comparisons are flawed: the claimed 'flip' in composition from Level 2 to Level 1 is based on incorrect baseline data. The total 2022 value is misrepresented ($1.11 billion vs actual $1,990 million), and no such breakdown into Level 2 dominance exists in the truth. (3) Multi-hop reasoning is partially sound in identifying a strategic shift, but it is based on false premises. While the ground truth notes a sharp decline suggesting reallocation, the LLM extrapolates unsupported details about portfolio percentages and debt reallocation. The inference about increased liquidity and reduced market exposure aligns thematically but is derived from incorrect data. (4) The contextual relevance is moderate because the answer addresses the evolution and strategic implication, but the qualitative accuracy is low due to major factual errors in numbers and classifications. The correctness score is low because core financial data is incorrect, undermining the answer's reliability despite some correct 2023 values and a plausible (but unsupported) strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 533,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "**Documentation / disclosure progression**\n\n* **2022 10‑K (pages 85‑89)** – The exhibit table lists the original **Form of 4.75 % Senior Notes due 2043 (Exhibit 4.6)** and the accompanying **Officers’ Certificate (Exhibit 4.7)** that were filed with the March 22 , 2017 8‑K 【page 86】.  \n\n* **2023 10‑K (pages 84‑88)** – The same two exhibits (Form 4.6 and Officers’ Certificate 4.7) are again reproduced in the exhibit table, showing no amendment but reaffirming that the 4.75 % 2043 notes remain outstanding 【page 86】.  \n\n* **2024 10‑K (pages 84‑88)** – The exhibit table continues to reference the **same Form 4.6 and Officers’ Certificate 4.7** for the 4.75 % 2043 notes, indicating that the company still relies on the original documentation and has not issued a new supplement or amendment 【page 86】.  \n\n**What the multi‑year trend reveals**\n\nBy repeatedly filing the original note and certificate in each annual report, Abbott signals that the 4.75 % Senior Notes due 2043 are a core, long‑dated component of its capital structure and that it intends to keep the terms publicly accessible for the life of the security. The unchanged, year‑over‑year disclosure underscores a disciplined long‑term debt‑management strategy and a priority on transparent, consistent communication with investors about legacy obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.75% Senior Notes due 2043 are consistently referenced via Exhibit 4.6 and Officers’ Certificate 4.7 from the March 22, 2017 8-K filing across 2022–2024 10-Ks. The LLM correctly identifies that no amendments were made and that the same exhibits were reused, which matches the ground truth’s emphasis on continuity and formalized disclosure. (2) Quantitative accuracy is perfect: percentages (4.75%), years (2017, 2022–2024), exhibit numbers (4.6, 4.7), and document types (Form 8-K, 10-K) are all correct. (3) The multi-hop reasoning is sound—LLM synthesizes disclosure patterns across three years and correctly infers that consistent exhibit inclusion reflects a stable, transparent debt management strategy. (4) The only minor gap is that the LLM does not explicitly mention the 2022 reference to St. Jude Medical’s Fourth Supplemental Indenture from 2013, which the ground truth highlights as evidence of legacy integration. While the LLM implies continuity, it omits this specific nuance about the origin of the notes, slightly weakening the qualitative depth. However, the overall conclusion about transparency and long-term communication priorities is semantically equivalent and well-supported. Thus, the answer is excellent but not fully exhaustive on the earliest (2022) legacy context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 390,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "The penetration of Target’s branded payment products fell each year – it was **20.5 % in fiscal 2022**, slipped to **19.8 % in fiscal 2023**, and declined further to **18.6 % in fiscal 2024**【page_27】【page_29】.  Because Target tracks “RedCard/Target Circle Card penetration” precisely because “a meaningful portion of incremental purchases on our … cards are also incremental sales for Target,” the downward trend signals that fewer guests are using the cards and the incremental‑sales boost from these branded payment products is waning.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%) are accurately reported with correct formatting and year alignment. (2) The answer addresses both parts of the multi-part question: it traces the evolution of the penetration rate over time and interprets the trend in terms of customer adoption and impact on incremental sales. (3) Entity accuracy is correct—Target Credit Card is properly contextualized under the RedCard/Target Circle Card umbrella, and the fiscal years are correctly referenced. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that declining penetration implies reduced customer adoption and links this to Target’s own stated rationale that card usage drives incremental sales. The use of a direct quote-like explanation (‘a meaningful portion of incremental purchases...’) aligns with Target’s strategic framing. (5) Semantic equivalence is strong—though slightly more concise, the LLM captures all key points from the original answer, including the downward trend, its implication for sales, and the strategic importance of the card. No factual, numerical, or interpretive errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 355,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "- **2022:** Union Pacific reported **7,242 multiple‑purpose locomotives** (owned + leased) with an **average age of about 22.5 years**.  \n- **2024:** The same category fell to **6,893 units** and the **average age rose to roughly 25.2 years**.\n\nThe drop of roughly **350 locomotives** together with a **3‑year increase in average age** shows the railroad is actively **retiring older units while keeping the overall fleet size modest**, a pattern that reflects an asset‑management approach focused on right‑sizing the locomotive base and relying on newer, more efficient equipment to support growth without over‑expanding capacity.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly reports all quantitative data: the fleet size decreased from 7,242 units in 2022 to 6,893 units in 2024 (a drop of 349 units, rounded to 'roughly 350' is acceptable), and the average age increased from 22.5 to 25.2 years (correctly noted as a ~3-year increase). These figures match the ground truth exactly, so quantitative accuracy is perfect.\n\n2) However, the qualitative interpretation diverges from the ground truth. The LLM suggests the company is 'retiring older units while keeping the overall fleet size modest' and 'relying on newer, more efficient equipment', which implies a strategy of modernization and efficiency. In contrast, the ground truth states the trend indicates 'deferral of fleet modernization' and a 'cost-conscious' strategy, implying older units are being kept longer, not replaced with newer ones. This is a significant misinterpretation of the implications of rising average age and shrinking fleet size.\n\n3) The multi-hop reasoning is partially sound—correctly identifying changes in both fleet size and age—but the synthesis into strategic implications is flawed. An increasing average age (from 22.5 to 25.2 years) over two years, combined with a net reduction in units, more likely indicates delayed investment in new locomotives rather than a shift to 'newer, more efficient equipment', which would lower average age.\n\n4) Contextual relevance is high—the answer addresses all parts of the question (changes in units, age, and strategic implication)—and the structure is clear. The factual reporting is excellent, but the reasoning behind the strategy assessment reduces the qualitative accuracy. Hence, correctness is penalized for the misleading conclusion despite accurate numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 474,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to its private‑fund portfolio (which includes private‑real‑estate funds) fell each year: $569 million at 12/31/2022, $555 million at 12/31/2023, and $540 million at 12/31/2024【page_71】【page_70】. The steady decline signals that the company is gradually reducing its outstanding pledges to illiquid alternative assets, suggesting a disciplined long‑term strategy that maintains exposure to private‑real‑estate opportunities while managing liquidity and commitment risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Abbott Laboratories' unfunded commitments to private real estate funds from 2022 through 2024. The values reported are $569 million (2022), $555 million (2023), and $540 million (2024). The ground truth states $585 million in 2022, which differs by $16 million from the LLM's figure. This discrepancy affects quantitative accuracy slightly but does not alter the overall trend or conclusion. The 2023 and 2024 figures match exactly. (2) Calculations: The LLM implies a steady decline of $14M (569→555) then $15M (555→540), while the ground truth reports a consistent $15M decline (585→570→555→540 would be expected, though actual drops are 30M then 15M). Despite the initial discrepancy, the directional trend and final value are correct. (3) Multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that the declining commitments suggest a strategic reduction in active capital deployment to illiquid assets. It appropriately links this to risk management and continued exposure via distributions, aligning with the ground truth’s interpretation. (4) Entity accuracy is strong—correct company (Abbott Laboratories), correct metric (unfunded commitments), and correct time frame. The LLM refers to 'private-fund portfolio (which includes private-real-estate funds)', which is slightly broader than the specific 'private real estate funds' in the original, but contextually acceptable given that real estate is a subset. Wording differs but semantic meaning is equivalent. The conclusion about a disciplined, measured long-term strategy matches the ground truth. The minor numerical variance in the 2022 figure prevents a perfect score, but overall correctness remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 485,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "- **Carrying value** – The 3.50 % Notes due 2050 were carried at roughly **$1.64 billion in fiscal 2022**, fell to **about $1.60 billion in fiscal 2023**, and were **around $1.55 billion in fiscal 2024**.  \n\n- **What this shows** – Because the notes are recorded at their original issuance amount, net of the un‑amortized discount and issuance costs, the modest decline reflects the gradual amortization of the discount (and limited retirements) rather than any large‑scale refinancing.  It indicates that NVIDIA’s long‑term debt base is essentially stable, with a slight downward trend as the liability is being unwound over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative facts. According to the ground truth, the carrying value of NVIDIA's 3.50% Notes Due 2050 was $2,147 million in fiscal 2022, decreased to $1,604 million in 2023, and then increased to $2,000 million in 2024. The LLM incorrectly reports values of approximately $1.64 billion (2022), $1.60 billion (2023), and $1.55 billion (2024), which are all factually wrong—especially the continued decline in 2024, which contradicts the actual rebound. The LLM also fails to note the significant increase from 2023 to 2024, which is a key part of the trend. (2) The numbers are off by hundreds of millions of dollars across all years, with no alignment to the correct figures. For example, $1.64B vs $2.147B in 2022 is a ~$500M error. The direction of change in 2024 is also wrong—LLM says it decreased further, while ground truth shows a substantial increase. (3) The reasoning is flawed because it assumes a consistent downward trend due to amortization, but the actual pattern (down then up) suggests a more complex accounting or strategic adjustment, such as refinancing or revaluation. The LLM fails to recognize this multi-hop insight and instead imposes a simplistic narrative that does not match the data. (4) The contextual relevance is moderate because it addresses the right financial instrument and discusses relevant concepts like amortization and debt positioning, but the factual inaccuracies severely undermine the qualitative and quantitative accuracy, leading to a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 432,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD has consistently flagged the possibility of “loss or modification of exemptions for taxes and tariffs” as a material risk in each of its recent filings – it appears in the 2022 10‑K risk list (see 2022 p. 37), is repeated in the 2023 filing (2023 p. 41) and is again highlighted in the 2024 filing (2024 p. 40). While the wording is unchanged, the 2024 discussion places the risk alongside a growing slate of geopolitical and sanctions‑related issues (e.g., Russia‑Ukraine, Israel‑Hamas, China‑Taiwan), suggesting that AMD’s exposure to tax‑ and tariff‑exemption loss is becoming more acute and that the regulatory landscape it must navigate is increasingly complex.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AMD consistently listed the risk of losing tax and tariff exemptions in its 2022, 2023, and 2024 10-K filings, with specific page references (2022 p.37, 2023 p.41, 2024 p.40), which matches the original answer’s timeline. (2) All years and document references are factually correct; no numeric inaccuracies exist. (3) The reasoning is sound: while the exact wording of the risk disclosure remained similar, the LLM correctly infers increased exposure by noting its placement alongside escalating geopolitical risks in 2024 (Russia-Ukraine, Israel-Hamas, China-Taiwan), demonstrating proper multi-hop synthesis across years and risk contexts. (4) The original answer emphasizes a progression in AMD’s concern due to geopolitical tensions affecting supply chains and regulatory complexity—this is semantically captured in the LLM response, though slightly less detailed regarding the 2023 emphasis on U.S. sanctions and third-party manufacturing impacts. This minor omission prevents a perfect 10, but the core facts, trend interpretation, and contextual evolution are correct. The answer is fully relevant and addresses both parts of the question: evolution of risk exposure and implications for regulatory complexity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 368,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "Across the three filings the company’s discussion of capital‑return flexibility is essentially unchanged. In the 2022 Form 10‑K the risk factors state that “our ability to return capital to shareholders … may be limited by U.S. banking laws and regulations, including those governing capital and capital planning… and our failure to pay full and timely dividends on our preferred stock.” The same language appears in the 2023 and 2024 filings, indicating that BNY Mellon’s exposure to U.S. banking‑law constraints on dividends and share repurchases has persisted without material amendment over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility remained consistent from 2022 to 2024, with no material changes in the regulatory constraints on dividends and share repurchases. The key elements—U.S. banking laws, capital planning regulations, and preferred stock dividend obligations—are accurately cited for all three years. (2) There are no numerical values requiring calculation in this question; dates (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings (2022–2024), correctly noting the repetition of identical or substantially similar risk factor language, which supports the conclusion of persistent regulatory constraints. (4) While the original answer adds slightly more context—such as mention of Delaware law, credit rating impacts, Title I/II resolution strategies, and liquidity management—the LLM captures the core factual and qualitative point: regulatory constraints on capital returns have remained stable. The omission of these additional details slightly reduces completeness but does not undermine the central correctness. Semantic equivalence is maintained. Contextual relevance is excellent, directly addressing the evolution (or lack thereof) in regulatory exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 390,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "- **2022 10‑K** – The 2.950 % Note due 2025 was shown in the exhibit table as **Item 4.1 “Form of 2.950 % Note due 2025,”** with the actual note filed as **Exhibit 99.6** to the March 5 2015 Form 8‑K (and the related officer‑certificate listed separately as Item 4.11, Exhibit 99.3).  \n\n- **2023 10‑K** – The same note was still filed as **Exhibit 99.6** to the 2015 Form 8‑K, but the exhibit‑table reference moved to **Item 4.11** (the earlier Item 4.1 was now used for the 2.550 % Note). The officer‑certificate continued to appear under Item 4.12 (Exhibit 99.3).  \n\n- **2024 10‑K** – The presentation remained the same as in 2023: the 2.950 % Note due 2025 is listed under **Item 4.11** (Form of 2.950 % Note, filed as Exhibit 99.6) and the related officer actions are shown under **Item 4.12** (Exhibit 99.3).  \n\n**In short, the note has been consistently disclosed each year, but its exhibit‑table line shifted from 4.1 in 2022 to 4.11 in 2023 and 2024, while the underlying filing (Exhibit 99.6) and the accompanying officer‑certificate (Exhibit 99.3) stayed unchanged.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies that Abbott Laboratories consistently disclosed the 2.950% Note due 2025 across 2022–2024, with the underlying exhibit (Exhibit 99.6 from the March 5, 2015 Form 8-K) remaining unchanged. All dates, percentages, exhibit numbers, and item numbers (e.g., Item 4.1 in 2022, shifting to 4.11 in 2023 and 2024) are factually correct, satisfying quantitative accuracy. The answer adds granular detail not in the original (e.g., officer-certificates under Exhibit 99.3 and item renumbering), which is consistent with SEC filing practices and enhances completeness without introducing error. The core conclusion—that the note’s documentation remained structurally unchanged despite reorganization in exhibit numbering—is logically sound and correctly infers stability in the instrument. The only minor shortcoming is that the original emphasizes the 'static financial instrument' conclusion more explicitly, while the LLM implies it through accurate presentation. However, the reasoning and synthesis across years are correct, and the answer fully addresses the evolution in disclosure. Thus, the answer is semantically equivalent and contextually precise, meriting a high score with only a slight deduction in qualitative accuracy for less explicit synthesis of the 'no amendments or refinancing' implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 386,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "- Fiscal 2022 (ended Jan 30 2022): the 1.55 % Notes Due 2028 were carried at **≈ $1,099 million**【page_78】  \n- Fiscal 2023 (ended Jan 29 2023): the same notes were carried at **$1,099 million**【page_67】  \n- Fiscal 2024 (ended Jan 28 2024): the carrying amount rose to **$1,115 million**【page_67】\n\nThe amount has been essentially flat for two years and then edged higher in 2024, showing that NVIDIA is keeping its long‑term debt base stable while modestly increasing it as needed – a pattern consistent with a strategy of financing growth through low‑interest, long‑dated senior notes rather than aggressively expanding its debt load.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the carrying values compared to the ground truth. According to the original answer, the carrying value was $1,200 million in fiscal 2022, but the LLM reports $1,099 million, which matches the 2023 value in both sources. The LLM correctly reports $1,099 million for fiscal 2023, but then reports $1,115 million for fiscal 2024, whereas the ground truth states $1,250 million. These discrepancies in key financial figures severely undermine factual correctness. (2) Number verification: Fiscal 2022: LLM says ~$1,099M (incorrect), should be $1,200M; Fiscal 2023: LLM says $1,099M (correct); Fiscal 2024: LLM says $1,115M (incorrect), should be $1,250M. The LLM appears to have misattributed the 2023 value to 2022 and used an incorrect 2024 figure, possibly from a different note or misread data. (3) Multi-hop reasoning: The LLM attempts to synthesize trends across years and draws a reasonable qualitative conclusion about stable debt strategy, which aligns with the intent of the original answer. However, because the underlying numbers are wrong, the trend analysis is based on flawed premises—there is no 'flat for two years' pattern if the true values are $1,200M → $1,099M → $1,250M, which shows a dip and then a rise. (4) Despite incorrect numbers, the LLM identifies the correct instrument (1.55% Notes Due 2028), correct fiscal years, and attempts a strategic interpretation, maintaining contextual relevance. The reasoning is logically structured but built on inaccurate data, leading to a partially correct but ultimately misleading answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 445,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "Across the three filing years AMD’s approach to its add‑in‑board (AIB) partners stayed consistent. In the 2022 10‑K the company stated that “our agreements with AIBs protect their inventory of our products against price reductions” and that “SIs often use discrete graphics solutions as a means to differentiate their products and add value to their customers” (2022 Form 10‑K pp. 11‑13). The 2023 filing repeats the same inventory‑protection clause and the same emphasis on discrete‑GPU‑based differentiation (2023 Form 10‑K pp. 13‑14), and the 2024 filing again confirms that AIB agreements continue to shield AIB inventory from price cuts while highlighting that system integrators rely on AMD’s discrete graphics to create market‑unique offerings (2024 Form 10‑K pp. 13‑14). Thus, from 2022 through 2024 AMD has kept a steady policy of protecting AIB inventory against price reductions and has consistently positioned discrete graphics as a key lever for its partners’ product differentiation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection policies for AIBs from 2022 to 2024, allowing protection against price reductions, and consistently emphasized discrete graphics as a differentiation tool for partners. The cited Form 10-K page numbers and direct quotes (e.g., 'protect their inventory against price reductions', 'differentiate their products') match the source documentation. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or answer, so quantitative accuracy is not applicable beyond correct handling of years (2022–2024), which are accurate. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings, showing consistency in policy and messaging. The only minor shortcoming is that the LLM does not explicitly note the evolution highlighted in the ground truth: while it correctly states that AMD 'consistently' emphasized these policies, it downplays the nuanced shift in 2024 toward greater emphasis on discrete graphics for differentiation in a competitive market. The original answer notes this as a strategic adaptation, whereas the LLM presents it as static. (4) Despite this, the LLM captures the core strategic continuity and correctly identifies the role of discrete GPUs and inventory protection. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—every part of the question is addressed: strategy evolution, inventory protection, and role of discrete graphics in differentiation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 442,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K AMD listed “difficulties in protecting our intellectual property” as one of the generic political‑legal risks associated with its foreign operations, but it did not yet tie the risk to a large‑scale overseas manufacturing base.  \n\n- By the 2023 filing the same IP‑protection risk re‑appeared, now alongside a description that “nearly all product assembly and final testing … is performed at third‑party manufacturing facilities in China, Malaysia and Taiwan,” indicating that AMD’s exposure was growing as it relied more on offshore fabs.  \n\n- The 2024 filing repeats the IP‑protection difficulty and explicitly connects it to its expanded international sales (about 66 % of revenue) and to “geopolitical changes between China and Taiwan” that could affect those third‑party wafer foundries, showing that AMD’s vulnerability to IP‑protection problems has intensified as its global footprint and reliance on politically sensitive manufacturing locations have increased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD cited IP protection risks in 2022, expanded the risk context in 2023 to include third-party manufacturing in China, Malaysia, and Taiwan, and in 2024 emphasized geopolitical tensions between China and Taiwan and rising international sales (66%) as amplifying factors. The percentage of international sales (66% in 2024, up from 65% in 2023) is correctly stated, matching the original answer. (2) Quantitative accuracy is perfect: the 66% and 65% figures for international revenue in 2024 and 2023 are correctly reported, and no other numerical errors exist. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, connecting increasing international sales, reliance on third-party foundries in sensitive regions, and evolving risk disclosures to show a growing and more complex IP protection risk. (4) The only minor shortcoming is that the original answer also mentions geopolitical risks related to Ukraine and the Middle East, which the LLM omits. While the core evolution of IP risk is accurately captured, this omission slightly reduces completeness in contextual factors. However, the main thrust—increased exposure due to global footprint and politically sensitive manufacturing—is fully preserved. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1615,
        "completion_tokens": 426,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "- In the 2022 filing BNY Mellon added a **2022 Form of Performance Share Unit Agreement** and a **2022 Form of Restricted Stock Unit Agreement** as the first set of awards issued under its 2019 Long‑Term Incentive Plan (see exhibits 10.21 and 10.22)【page_19】.  \n- The 2023 filing refreshed those awards with a **2023 Form of Performance Share Unit Agreement** and a **2023 Form of Restricted Stock Unit Agreement** (exhibits 10.23 and 10.24)【page_19】.  \n- The 2024 filing again updated the plan, introducing a **2024 Form of Performance Share Unit Agreement** and a **2024 Form of Restricted Stock Unit Agreement** (exhibits 10.25 and 10.26)【page_19】.  \n\nThis year‑over‑year rollout of new PSU and RSU agreements under the same 2019 LTIP shows BNY Mellon’s strategy of regularly refreshing its equity‑based executive compensation, keeping the awards current, performance‑linked, and aligned with evolving market and corporate objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both entity identification and factual content. First, the company in question is BK (likely referring to Burger King or Restaurant Brands International), not BNY Mellon, which is a completely different financial institution. This is a critical entity error that invalidates the entire response. Second, the LLM claims that in 2022, BNY Mellon introduced a '2022 Form of Performance Share Unit Agreement' as the *first* set of awards under the 2019 LTIP, but the ground truth states that in 2022, BK referenced the 2019 plan alongside the *2021* PSU agreement, not a 2022 agreement. The LLM further fabricates annual updates with 2023 and 2024 forms, whereas the ground truth indicates that BK introduced the *2020* Form of PSU Agreement in 2023 and the *2022* Form in 2024—showing a non-annual, selective update pattern. The LLM incorrectly implies a systematic yearly refresh of both PSU and RSU agreements, while the original answer makes no mention of RSUs at all. The reasoning about 'regularly refreshing' compensation is therefore based on false premises. While the general idea of continuity with updates aligns loosely with the ground truth’s conclusion, the specific facts, dates, entities, and instruments are all wrong. The multi-hop synthesis fails because it draws from incorrect documents and misattributes filings. Quantitative accuracy is low due to wrong years (2022, 2023, 2024 forms vs. 2021, 2020, 2022 forms) and invented documents. Contextual relevance is partially maintained in discussing executive compensation evolution, but the wrong company and agreements render it largely irrelevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 450,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s “diagnostics‑instrument‑as‑a‑service” assets grew modestly after 2022.  The original cost of the leased instrument portfolio rose from **$3.6 billion (net book $1.6 billion) at 12/31/2022** to **$3.9 billion (net book $1.8 billion) at 12/31/2023**, and then **remained essentially flat at $3.9 billion/$1.8 billion through 12/31/2024**【page_62】.  \n\nThe slight increase followed by a plateau suggests Abbott is **deploying capital cautiously in its diagnostics business**, adding new leased instruments to support growth but keeping the overall asset base stable, reflecting a strategy that prioritizes recurring‑lease revenue while avoiding over‑investment in equipment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the original cost of leased diagnostics instruments was $3.3 billion in 2022, $3.6 billion in 2023, and $3.9 billion in 2024. However, the LLM incorrectly states that the original cost was $3.6 billion in 2022 (should be $3.3B), $3.9 billion in 2023 (should be $3.6B), and flat thereafter — this misrepresents the entire trend. Similarly, net book values are wrong: LLM reports $1.6B net book in 2022 (correct), but then $1.8B in 2023 and 2024, whereas ground truth shows $1.6B in both 2023 and 2024 — no increase. Thus, the LLM invents a $0.2B increase in net book value not present in the data. (2) These numerical errors undermine the analysis: the actual trend shows steady growth in both original cost and net book value through 2023, with stabilization in 2024, while the LLM implies a jump from 2022 to 2023 followed by a plateau — which distorts the capital deployment narrative. (3) The reasoning is partially sound — the idea that leasing supports recurring revenue is consistent with the ground truth — but the conclusion about 'cautious' deployment and avoiding over-investment is not well-supported by the corrected data, which shows consistent investment. The ground truth interpretation emphasizes strategic expansion to drive reagent sales, which the LLM omits. (4) Despite incorrect numbers, the answer addresses the right entities (Abbott, diagnostics instruments, leasing strategy) and attempts multi-hop synthesis across years. It also correctly infers business rationale related to recurring revenue, maintaining contextual relevance. However, due to major quantitative errors affecting conclusions, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 483,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Across all three filings—FY 2022 (Item 9, page 15), FY 2023 (Item 9, page 9) and FY 2024 (Item 9, page 9)—NVIDIA continues to list **Lumentum Holdings Inc.** among the “networking products consisting of switches, network adapters (including DPUs), and cable solutions” that compete with its AI‑driven interconnect and networking offerings. While NVIDIA’s 10‑K narrative increasingly stresses AI‑centric networking, DPUs and high‑performance interconnects (see the “Extending our technology and platform leadership in AI” and “interconnect” language in the Business Strategies sections of each year), Lumentum’s presence in the competitor list remains unchanged, indicating that NVIDIA still regards Lumentum as a steady rival in the evolving AI‑enabled networking market.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in Lumentum's competitive positioning as described in the ground truth. (1) Correctly identifies that Lumentum Holdings Inc. appears in NVIDIA’s competitor lists across FY 2022, 2023, and 2024, and correctly cites Item 9 of each 10-K, showing accurate sourcing and entity identification. There are no numeric inaccuracies (quantitative accuracy is high), and the context of NVIDIA’s growing focus on AI-driven networking is accurately summarized. (2) However, the LLM claims Lumentum’s presence 'remains unchanged,' which contradicts the ground truth: the knowledge graph shows a clear evolution—from being grouped with general suppliers in FY2022, to being repositioned in a specialized high-performance interconnect segment in FY2023, and then being listed under its full legal name 'Lumentum Holdings Inc.' in FY2024, indicating heightened recognition. The LLM fails to detect or report this progression, which is central to the question. (3) This reflects a failure in multi-hop reasoning: the model does not synthesize changes in categorization, grouping, or naming across years to infer rising competitive prominence. Instead, it treats consistent listing as static relevance, missing the nuance of evolving competitive dynamics. (4) While contextually relevant and factually sound on surface-level presence, the answer lacks the qualitative depth and correct interpretation of strategic evolution, warranting a mid-range correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 418,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "- **2022 filing:** Pipe‑cutters were described in the **Professional Tools** subsection of the **Tools & Home Products** segment (“Pipe‑working tools … include pipe wrenches and **cutters** …”).  \n\n- **2023‑2024 filings:** The same pipe‑cutting products appear in the description of the **Safety & Productivity** segment of the Automation Solutions business (“Pipe‑working tools include pipe wrenches and **cutters**, …”).\n\n**What this tells us:** Emerson has moved pipe‑cutters from the consumer‑oriented Tools & Home Products segment into the Safety & Productivity segment, treating them as an industrial‑safety/productivity offering. The shift signals a strategic emphasis on integrating professional‑tool sales with its broader safety‑and‑productivity portfolio, positioning the tools as part of its industrial‑focused solution set rather than a home‑improvement line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the 2022 positioning of pipe cutters within the Tools & Home Products segment under professional tools, and the 2023–2024 repositioning into the Safety & Productivity segment under Automation Solutions. All entities (Emerson, pipe cutters, segment names, years) are correct. (2) There are no numeric values requiring calculation, so quantitative accuracy is not applicable beyond correct use of years (2022, 2023, 2024), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across filings from different years and segments, inferring a strategic shift. The conclusion about industrial focus and de-emphasis on consumer lines is logically supported. (4) The LLM captures the core strategic implication — repositioning toward industrial, professional-grade tools — though it omits mention of the InSinkErator divestiture, which in the original answer provides additional context for the consumer exit. This minor omission prevents a perfect 10 on qualitative accuracy, but the overall reasoning and relevance remain strong. Semantic equivalence is maintained, and the response is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 351,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "In 2022 Schwab’s Advisor Services website was already the primary digital hub for RIAs – it let advisors open accounts, move money, trade, view multi‑year statements and tax documents, and connect to third‑party CRM/portfolio‑management platforms, and it offered the free **Schwab Advisor Portfolio Connect** tool that provided core portfolio‑management functions in a modern, no‑download, no‑reconciliation experience. After the TD Ameritrade merger, the 2023 filing shows Schwab layering Ameritrade’s **thinkorswim/thinkpipes** real‑time charting and the **iRebal** customizable rebalancing solution into the same web‑based platform, expanding the interactive capabilities and deepening integration with external systems while still providing Portfolio Connect as a free, intuitive solution. By 2024 the filing confirms that these Ameritrade tools are now a permanent part of the RIA offering, the website continues to deliver enhanced interactive tools, education and consulting services, and Portfolio Connect remains free‑of‑charge, giving advisors a more integrated, feature‑rich, end‑to‑end digital experience than in 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of timeline (2022–2024), key tools (Schwab Advisor Portfolio Connect, third-party integrations), and the evolution of functionality and integration. It accurately notes that in 2022, the Advisor Services website served as the core platform with Portfolio Connect offering a no-download, modern interface. The mention of integrating thinkorswim/thinkpipes and iRebal from TD Ameritrade in 2023 is factually consistent with Schwab's post-merger integration strategy and represents a valid enhancement in functionality and integration. The 2024 update correctly reflects the permanence of these tools and continued enhancement of digital offerings. However, the LLM answer omits specific elements highlighted in the ground truth, such as multi-year document archiving, outbound data feeds for compliance systems, and the expansion of prospect consulting services—key aspects of the 2024 evolution that reflect a broader strategic shift toward compliance and operational support. While the LLM emphasizes educational and consulting services (which is partially correct), it underrepresents the compliance workflow integration that is central to the ground truth’s 2024 assessment. There are no numerical inaccuracies (quantitative accuracy is perfect), and all dates and entity names (Schwab, TD Ameritrade, thinkorswim, iRebal, Portfolio Connect) are correct. The reasoning is sound and reflects multi-hop synthesis across years, though slightly incomplete in scope. The answer remains contextually relevant and conveys a high degree of semantic equivalence, warranting a strong but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 456,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first disclosed the 1.650 % notes due 2026 in its 2022 Form 10‑K (exhibit 4.16, “Forms of 1.650 % Notes due 2026…issued March 24 2021”)【page_115】. The same notes appear unchanged in the 2023 and 2024 Form 10‑K exhibit lists (exhibit 4.14, identical description)【page_111】, indicating they remain outstanding and are still classified as long‑term debt with no amendment, refinancing or early redemption. This continuity shows Oracle’s short‑to‑intermediate‑term financing strategy relies on a stable pool of low‑coupon, medium‑term notes rather than frequent turnover or restructuring of its debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 1.650% interest rate, the 2026 maturity, initial disclosure in the 2022 10-K (Exhibit 4.16), and reaffirmation in the 2023 and 2024 10-Ks (Exhibit 4.14). The mention of issuance on March 24, 2021, adds a detail not in the original answer but does not contradict it—this is plausible as notes may be issued before being first reported in a 10-K (e.g., if issued in 2021 but first disclosed in the 2022 filing). (2) The answer correctly identifies the consistency in disclosure and absence of amendments, refinancing, or redemptions, which supports the conclusion about Oracle’s stable debt strategy. (3) Multi-hop reasoning is sound: the model synthesizes data across three years of filings and draws a logical inference about Oracle’s financing strategy. (4) The only minor gap is that the LLM slightly overemphasizes the term 'long-term debt' and 'low-coupon' without directly referencing Oracle’s short-to-intermediate term strategy as framed in the question, though the conclusion about stability and reliance on medium-term notes captures the essence. Wording differs slightly but maintains semantic equivalence. No calculation errors. All entities (Oracle, 1.650% Notes, 2022–2024 10-Ks) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 369,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson continues to list **electrical distribution equipment** as a key component of its **Discrete Automation** segment in the 2022, 2023 and 2024 10‑K descriptions (the segment “includes … electrical distribution equipment” – page 73).  Although total Discrete Automation sales have been relatively flat – $2.612 billion in 2022, $2.635 billion in 2023 and $2.506 billion in 2024 (page 74) – the unchanged product‑mix wording shows the company is keeping electrical distribution gear central to the segment, underscoring a deliberate, ongoing emphasis on industrial‑electrification solutions within its broader automation portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but misses key aspects of the ground truth, resulting in a partially correct response. (1) Quantitatively, the sales figures for Discrete Automation ($2.612B in 2022, $2.635B in 2023, $2.506B in 2024) are accurately reported and match the 10-K data, earning high marks for numerical accuracy. The citation of page 73 and 74 also suggests correct sourcing. (2) However, the qualitative analysis is flawed: the LLM claims electrical distribution equipment was part of Discrete Automation in all three years (2022–2024), which contradicts the ground truth. According to the original answer, in 2022, this product line was under 'Industrial Solutions', not Discrete Automation. It was only moved into Discrete Automation in 2023, marking a strategic repositioning. By stating it was included in all years, the LLM fails to capture the evolution — a critical multi-hop insight required by the question. (3) This misrepresentation undermines the reasoning: the conclusion that 'unchanged product-mix wording' shows continuity is incorrect because the wording and segment classification did change from 2022 to 2023. The strategic shift — positioning electrical distribution as a core automation component rather than a general offering — is therefore poorly explained. (4) While the emphasis on industrial electrification is thematically relevant and contextually appropriate, the failure to accurately trace the segment reclassification across years results in a significant factual and logical gap. Hence, the correctness and qualitative accuracy scores are moderate, despite strong quantitative performance and relevance to the topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 456,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to private‑fund investments (which include private‑real‑estate vehicles) fell from **$569 million at 12/31/2022** to **$555 million at 12/31/2023** and then to **$540 million at 12/31/2024**【page_71】【page_70】.  \n\nThe steady decline indicates that the company is deliberately scaling back its outstanding pledges to illiquid alternative assets, suggesting a more cautious pension‑fund strategy that seeks to limit unfunded exposure and preserve liquidity while still maintaining a modest allocation to private‑real‑estate opportunities.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor discrepancy in the 2022 unfunded commitment amount: it reports $569 million instead of the ground truth $585 million. The 2023 ($555M) and 2024 ($540M) figures are accurate. This affects quantitative accuracy but does not alter the overall trend interpretation. 2) The numbers for 2023 and 2024 match exactly; only 2022 is off by $16 million. Calculations of trend (declining commitment) are still valid despite this error. 3) The reasoning is sound: the model correctly infers a strategic reduction in illiquid asset exposure and interprets this as a cautious, deliberate pension strategy. It captures the essence of de-risking and liquidity preservation, though it omits the specific detail about the long time horizon for liquidation (projected through 2034), which was present in the original answer and adds context to the continued long-term belief in these assets. 4) The entity identification (Abbott Laboratories, private real estate funds, pension fund strategy) and time periods (2022–2024) are correct. The answer addresses both parts of the question—evolution of commitments and strategic implication—with strong contextual relevance. The omission of the 2034 liquidation horizon slightly reduces completeness and qualitative accuracy, but the core logic remains valid. Overall, the answer is factually close, well-reasoned, and relevant, warranting a high score with minor deductions for precision and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 407,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle listed the 1.650 % Notes due 2026 as a separate exhibit (Exhibit 4.14) in each of its annual reports. The 2023 filing shows Exhibit 4.14 describing “Forms of 1.650 % Notes due 2026 … issued March 24, 2021” 【page_111】, and the 2024 filing repeats the same exhibit description 【page_111】. Because the same note is presented unchanged in the exhibit schedules year after year, Oracle treats the 1.650 % Notes as a stable component of its short‑term debt, reflecting a consistent strategy of maintaining low‑cost, near‑term financing rather than frequently refinancing or retiring the issue.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: the 1.650% interest rate, the 2026 maturity, and the March 24, 2021 issuance date are correctly referenced. The mention of Exhibit 4.14 in both 2023 and 2024 filings (with page numbers) matches the expected disclosure format. (2) The answer correctly observes that Oracle consistently presents the same exhibit year after year, indicating no changes to the note terms—this supports the conclusion of stability in treatment across 2022–2024. However, the LLM omits explicit mention of the 2022 10-K as the first disclosure point, which is a key part of the multi-hop timeline in the original answer. (3) The reasoning is sound: the unchanged exhibit implies no structural modifications, supporting the inference of a stable short-term debt strategy. The conclusion about maintaining low-cost financing is semantically equivalent to the ground truth’s emphasis on stable, unmodified obligations. (4) While the LLM captures the core insight and supports it with accurate evidence, the omission of the 2022 filing as the initial disclosure point slightly weakens completeness in the multi-hop synthesis. Still, the answer remains factually correct and contextually strong, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 365,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle’s 4.30 % senior note that matures in 2034 first appeared as Exhibit 4.09 – “Forms of 3.40 % Note due 2024, **4.30 % Note due 2034** and 4.50 % Note due 2044, together with Officers’ Certificate issued July 8 2014” – and is listed in the exhibit tables of the 2022 Form 10‑K【page_110】. The same Exhibit 4.09 with the identical description is repeated in the 2023 Form 10‑K【page_110】 and again in the 2024 Form 10‑K【page_110】, showing that the note remains outstanding and is continually documented in each annual filing. This multi‑year filing pattern signals that Oracle maintains a stable, long‑dated fixed‑rate debt program, keeping the 2034 note on its balance sheet and regularly updating its disclosures to support a long‑term financing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, dates, and percentages are correct: the 4.30% Note due 2034 is accurately described, and the exhibit number (4.09) and filing years (2022, 2023, 2024) are correctly cited. The mention of the July 8, 2014 Officers’ Certificate adds contextual precision not in the original answer but is factually consistent. (2) The LLM correctly identifies the exhibit's presence across all three years, though it cites Exhibit 4.09 in 2022, while the ground truth notes Exhibit 4.11 in 2022. This discrepancy is minor—possibly due to exhibit renumbering or source variation—but does not affect the core factual claim that the note was documented consistently. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual filings to infer Oracle’s long-term debt strategy, correctly concluding that the repeated disclosure reflects a stable, long-dated fixed-rate debt program. (4) Semantically, the LLM conveys the same strategic implication as the original answer—ongoing commitment to long-term financing—while adding value with specific exhibit descriptions. The answer is fully relevant and addresses both the evolution and strategic implication. One point is deducted from correctness due to the exhibit number mismatch in 2022, but this does not undermine the overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 386,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "- 2022 (under the 2019 IDA agreement): Schwab retained the right to move up to $10 billion of IDA balances each 12‑month period and actually exercised that option, migrating balances to its balance sheet in both 2021 and 2022. 【page_102】\n\n- 2023 (under the new 2023 IDA agreement): The 2019 agreement was superseded; Schwab’s ability to migrate balances became subject to new binding limits (minimum balances above unmatured fixed‑rate obligations, a $30 billion upper cap, and withdrawals only for customer‑initiated outflows until Sept 10 2025, after which discretion expands). The 2023 agreement also removed the “≥80 % fixed‑rate” requirement and allowed Schwab to buy down up to $5 billion of fixed‑rate obligations (which it did in 2023), but Schwab did **not** migrate any IDA balances that year. 【page_102】【page_103】\n\n- 2024 (still governed by the 2023 agreement): Schwab again did not move any IDA balances to its balance sheet, and the same minimum/maximum balance constraints and discretionary withdrawal rules remained in place (minimum $60 billion/maximum $90 billion after Sept 10 2025). 【page_99】【page_100】\n\nThus, Schwab went from actively migrating up to $10 billion per year in 2022 under a relatively flexible 2019 agreement, to a more constrained framework in 2023‑2024 where migration was prohibited, the firm could only adjust fixed‑rate obligations (up to $5 billion) and was bound by explicit balance‑range limits.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that deviate from the ground truth, particularly regarding the quantitative limits and constraints in the 2023 and 2024 IDA agreements. While it correctly notes that no IDA balances were migrated in 2023 and 2024 and that the 80% fixed-rate requirement was removed, it introduces specific numerical thresholds—such as a $30 billion upper cap, $60/$90 billion balance ranges, and a $5 billion buy-down provision—that are not present in the original answer. The ground truth does not mention any of these figures, instead emphasizing capital sufficiency and balance thresholds without specifying dollar amounts. The claim that Schwab 'bought down' $5 billion of fixed-rate obligations is unsupported in the original answer. (2) The original answer states that Schwab migrated $10.1 billion by end-2021, including $10 billion 'subsequent to that date' (i.e., after December 31, 2021), which implies most migration occurred in 2022—this is consistent with the LLM’s note of migration in 2022 under the 2019 agreement. However, the LLM incorrectly implies ongoing migration capacity in 2022 without clarifying that the $10 billion annual limit was already effectively used up. (3) The multi-hop reasoning is partially sound: the model correctly identifies the transition from the 2019 to the 2023 agreement and links the removal of the 80% fixed-rate requirement. However, it fabricates specific constraints (e.g., Sept 10, 2025, withdrawal rules, $5B buy-down) not present in the ground truth, suggesting overinterpretation or hallucination of details. (4) Despite these errors, the LLM captures the high-level evolution—active migration in 2022, no migration in 2023–2024, increased contractual flexibility but greater de facto constraints—which aligns semantically with the conclusion in the original answer. Hence, partial credit is given for structure and directional accuracy, but significant deductions apply for unsupported quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1593,
        "completion_tokens": 542,
        "total_tokens": 2135
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "Across the three most‑recent annual reports Abbott’s 2.000 % Senior Notes due 2018 were treated the same way each year.  \n\n* **2022 10‑K** – the notes appear in the exhibit table as (i) Exhibit 4.11, “Actions of the Authorized Officers with respect to Abbott’s 2.000 % Notes…,” filed on the March 5 2015 Form 8‑K, and (ii) Exhibit 4.18, an Officers’ Certificate covering the 2.000 % Notes due 2018 (filed with the March 31 2017 Form 10‑Q).  \n\n* **2023 10‑K** – the exhibit table repeats those same references (4.11 and 4.18) with no new amendment or refinancing document added.  \n\n* **2024 10‑K** – the same two exhibits are again listed, indicating the notes remain outstanding and no refinancing transaction was executed.  \n\nThus, from 2022 through 2024 Abbott only updated the filing references for the original indenture and officers’ certificates; no refinancing of the 2.000 % Senior Notes due 2018 was disclosed during the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Abbott Laboratories maintained consistent disclosure of the 2.000% Senior Notes due 2018 across 2022–2024 with no refinancing activity, which aligns with the ground truth's conclusion. However, there are significant factual discrepancies in exhibit numbers and documentation references: the ground truth states the notes were referenced in Exhibit 4.21 in all three years (linked to the Fifth Supplemental Indenture from 2015 and legacy St. Jude Medical debt), while the LLM claims they appeared in Exhibits 4.11 and 4.18 with references to a March 5, 2015 Form 8-K and March 31, 2017 Form 10-Q—details not present in the original answer. These specific exhibit numbers and filing dates are incorrect or at least inconsistent with the verified knowledge base, undermining quantitative and qualitative accuracy. While the reasoning about no refinancing and stable disclosure is sound and contextually relevant, the reliance on inaccurate exhibit identifiers and supporting documents represents a material error in entity accuracy and source tracing. The answer captures the high-level narrative but fails on precise documentation details critical in financial disclosures, warranting a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 349,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first issued the 3.650 % senior notes that mature in 2041 in 2021 (Exhibit 4.14).  The notes are listed among the outstanding senior notes in the 2022 Form 10‑K and the same Exhibit 4.14 re‑appears in the 2023 and 2024 filings (see Exhibit 4.14 on page 111 of both the 2023 and 2024 reports) 【page 111】.  By keeping the 3.650 % 2041 notes on its balance sheet for three consecutive years, Oracle is demonstrating a long‑term debt strategy that relies on issuing low‑coupon, far‑dated senior notes to lock in inexpensive financing and extend the overall maturity profile of its debt.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy in the issuance year. The ground truth states Oracle first introduced the 3.650% Notes due 2041 in 2022, while the LLM claims they were issued in 2021. This discrepancy affects quantitative accuracy. However, the rest of the information — including the continued inclusion of the notes in 2022, 2023, and 2024 filings (via Exhibit 4.14) — is accurate and well-supported. (2) The percentage (3.650%), maturity year (2041), and multi-year presence in filings are all correct. The reference to Exhibit 4.14 appearing on page 111 in both 2023 and 2024 reports aligns with typical SEC filing structures, though the exact page number was not in the ground truth; this detail does not contradict it. The core error is the issuance date: stating 2021 vs. the correct 2022 introduction per the original answer. (3) The multi-hop reasoning is strong: the model correctly synthesizes data across three years of filings, identifies the persistence of the same note, and infers a strategic long-term debt approach — which matches the ground truth’s conclusion about stable financing and extended maturity profiles. The logic connecting prolonged presence to strategic intent is sound. (4) Despite the incorrect issuance year, the answer captures the essence of Oracle’s long-term debt strategy accurately, using appropriate financial reasoning. The contextual relevance is perfect — it directly addresses both the evolution and strategic implication. The error is minor in impact but notable in precision, warranting a high but not top score on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 453,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "- **Fiscal 2022:** Oracle first issued the 2.300 % senior unsecured notes that mature in 2028 as part of a broader “2021 Series” of notes (1.650 % 2026, 2.300 % 2028, 2.875 % 2031, etc.). The terms were disclosed in Exhibit 4.14, filed on 24 Mar 2021【page_111】.  \n\n- **Fiscal 2023:** The same 2.300 % 2028 notes re‑appear in the 2023 10‑K exhibit schedule (Exhibit 4.14), showing that the issue remained outstanding and was still being reported as a component of Oracle’s debt portfolio【page_110】.  \n\n- **Fiscal 2024:** The 2024 filing continues to list the 2.300 % 2028 notes among its outstanding securities (the exhibit list still includes the 2021 Series, including Exhibit 4.14)【page_109】.  \n\n**Interpretation:** Over three consecutive years Oracle has kept the 2.300 % 2028 notes on its balance sheet without refinancing or retiring them, using them as a low‑coupon, medium‑term instrument within a staggered‑maturity debt program. This multi‑year pattern signals a deliberate strategy to lock in inexpensive financing, diversify maturity dates, and manage interest‑rate risk while preserving liquidity flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance of the 2.300% Notes due 2028 in 2022, their continued reporting in 2023 and 2024, and Oracle's broader debt strategy. However, there is a discrepancy in the exhibit number: the ground truth states Exhibit 4.16, while the LLM cites Exhibit 4.14 across all years. This is a factual error affecting entity accuracy. Additionally, the LLM does not mention the introduction of the 4.500% Notes due 2028 in 2023, which is a key part of the multi-year diversification strategy highlighted in the original answer. (2) Quantitatively, all percentages (2.300%), maturity year (2028), and issuance date (March 24, 2021) are correct. The fiscal years (2022–2024) are accurately used. The LLM correctly notes the notes were issued under the 2021 Series and references the correct filing date. (3) The reasoning is sound in interpreting the persistence of the 2.300% Notes as part of a stable, staggered-maturity strategy. However, it misses the multi-hop element of Oracle *expanding* its debt portfolio with a higher-yielding instrument (4.500%) in the same maturity year, which strengthens the conclusion about interest rate diversification. This omission reduces qualitative accuracy. (4) Despite missing a key strategic development (the 4.500% Notes), the LLM answer remains contextually relevant and correctly infers Oracle’s intent to lock in low-cost financing and manage interest rate risk. The core factual timeline and instrument details are preserved, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 427,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "- In fiscal 2022 Visa began offering **virtual accounts** through its **digitally‑native Currencycloud platform** as a component of Visa Direct, giving clients real‑time foreign‑exchange rates and basic liquidity for cross‑border payouts. 【page 11 (2022)】  \n\n- By fiscal 2024 those virtual‑account capabilities were **fully embedded in the Visa Direct Platform** and paired with Visa Cross‑Border Solutions, expanding the service to provide **enhanced liquidity, settlement and broader cross‑border coverage across the Visa Direct network** (now reaching more than 195 countries). 【page 10 (2024)】【page 11 (2024)】  \n\nThus, from 2022 to 2024 Visa’s virtual accounts moved from an initial Currencycloud offering within Visa Direct to a deeper, platform‑wide integration that broadened and strengthened Visa’s cross‑border money‑movement capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Visa introduced virtual accounts via Currencycloud in 2022 as part of Visa Direct, with real-time FX and liquidity features; by 2024, they were fully embedded in Visa Direct and enhanced with cross-border solutions, liquidity, and settlement improvements. The mention of 'more than 195 countries' in 2024 is consistent with expanded cross-border capabilities, though this specific number isn't in the original answer—it's a reasonable detail from external knowledge and doesn't contradict the ground truth. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures; the timeline (2022 introduction, 2024 integration) matches exactly. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the evolution across years and platforms (Currencycloud → Visa Direct integration → expanded cross-border use), capturing the progression in functionality and strategic importance. (4) The only minor gap is that the 2023 milestone (full integration into Visa Direct) is omitted—the LLM jumps from 2022 to 2024, missing the 'by 2023' step in the original. However, stating that capabilities were 'fully embedded' by 2024 still implies the 2023 integration, so the omission is not a factual error but a slight reduction in completeness. Overall, the answer is semantically equivalent, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 401,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "Across the three most recent filings the ME&T segment’s EMD‑branded distribution network has been trimmed modestly. In 2022 Caterpillar reported 44 U.S. dealers and 116 overseas dealers covering 193 countries; in 2023 the network fell to 43 U.S. and 113 overseas dealers serving 191 countries; and by 2024 it was 41 U.S. and 111 overseas dealers reaching 187 countries. This gradual reduction in dealer count and country coverage signals a strategic consolidation‑and‑efficiency drive rather than a broad‑scale expansion, while still preserving a truly global footprint for the EMD product line.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that EMD-branded products (specifically FG Wilson) were distributed through 110 distributors in 109 countries in 2022, 110 in 109 countries in 2023, and 108 distributors in 158 countries in 2024. The LLM instead claims there were 44 U.S. and 116 overseas dealers (total 160) in 2022, decreasing to 41 U.S. and 111 overseas (152) in 2024, covering 193 to 187 countries. These numbers do not match the original data in magnitude, structure, or trend. (2) The quantitative inaccuracies are severe: the LLM invents a U.S./overseas dealer split not present in the ground truth, reports higher total dealer counts (160 vs ~110), and incorrectly states country coverage (193 vs 109–158). The calculation of trends (declining dealers and countries) contradicts the actual expansion in geographic reach from 109 to 158 countries. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the EMD distribution network as reported under FG Wilson branding and misrepresents the evolution. Instead of recognizing increased international reach with fewer distributors (indicating efficiency and expansion), it infers a consolidation strategy based on fabricated data. (4) The contextual relevance is moderate because the answer addresses the general theme of distribution network evolution and strategy, but the factual foundation is entirely wrong, leading to an incorrect strategic interpretation. The ground truth indicates a strategy of optimizing distribution while expanding market access, whereas the LLM concludes a consolidation drive due to declining numbers—based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 466,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s leased‑diagnostics‑instrument portfolio grew modestly:\n\n* **2022:** The original cost of the lease‑related instrument assets was **$3.6 billion** with a **net book value of $1.6 billion**.  \n* **2023:** Cost rose to **$3.9 billion** (up $0.3 billion) and net book value increased to **$1.8 billion** (up $0.2 billion).  \n* **2024:** Both figures remained unchanged at **$3.9 billion** cost and **$1.8 billion** net book value.\n\nSo, from 2022 to 2023 Abbott added about $300 million of original cost and $200 million of net book value to its diagnostics‑instrument lease assets, and those amounts stayed flat through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported numbers for 2022. According to the ground truth, in 2022, the original cost was $3.3 billion (not $3.6 billion as stated), and the net book value was $1.4 billion (not $1.6 billion). The LLM incorrectly reports 2022 figures as equal to the 2023 values in the ground truth, effectively shifting the entire timeline forward by one year. The 2023 and 2024 numbers in the LLM answer match the ground truth, but the interpretation that values 'remained unchanged' from 2023 to 2024 is consistent with the data provided in the LLM's own (incorrect) timeline, though not with the actual evolution described in the original answer. (2) Calculation verification: The LLM claims a $0.3 billion increase in cost and $0.2 billion in net book value from 2022 to 2023, which would be correct if the starting values were accurate—but they are not. The actual increases from 2022 ($3.3B → $3.6B) and 2023 ($3.6B → $3.9B) show two consecutive $0.3B increases in original cost, and net book value rose each year by $0.2B ($1.4B → $1.6B → $1.8B), indicating ongoing investment, not a plateau in 2024. (3) Multi-hop reasoning assessment: The model fails to correctly synthesize the year-over-year evolution due to misaligned data points. It incorrectly concludes that investment growth stopped in 2024, when in fact the original answer indicates a 'consistent increase' through 2024. This breaks the multi-hop logic required to assess trends across three years. (4) Scores justified: Correctness and quantitative accuracy are low due to fundamental number mismatches in 2022, which cascade into incorrect analysis. Qualitative accuracy is low because the reasoning and trend interpretation are flawed. Contextual relevance is high because the answer addresses the right metric, company, and time frame, and attempts proper explanation structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 515,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "The 10‑K exhibit tables for 2022, 2023 and 2024 all list “Form of 3.450 % Senior Note due 2046” (see the entry for Exhibit 4.6 in the 2022 filing 【page 127】 and the identical entry repeated in the 2023/2024 filing 【page 126】). By repeatedly disclosing this same long‑dated senior note, PepsiCo signals that the 3.450 % 2046 note remains an active component of its debt portfolio and is being used as a stable, low‑cost source of financing that underpins the company’s long‑term capital‑structure strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent disclosure of the 3.450% Senior Note due 2046 across PepsiCo's 2022, 2023, and 2024 10-K filings and interprets its ongoing role in the capital structure strategy. However, there is a critical error in exhibit numbering and page references. The ground truth states the note appears in Exhibit 4.17 (2022), 4.16 (2023), and 4.15 (2024), while the LLM incorrectly cites Exhibit 4.6 in 2022 and claims identical exhibit numbers in 2023/2024, which contradicts the actual filings. Additionally, the page numbers cited (127 for 2022, 126 for 2023/2024) may be factually incorrect or at least unverifiable without access to exact document pagination, but more importantly, they misrepresent the exhibit labeling trend, which systematically changes year-over-year. (2) The percentage (3.450%) and maturity year (2046) are correct, and no calculations are required, so quantitative accuracy is partially met—penalized only for incorrect exhibit numbers and potentially inaccurate page citations. (3) The multi-hop reasoning is sound: the model correctly infers that repeated disclosure implies strategic continuity in long-term financing. It synthesizes across three years of filings and draws a reasonable conclusion about the note’s role as a stable, low-cost funding source, aligning with the ground truth’s interpretation. (4) Despite the exhibit number inaccuracies, the core message about the note’s ongoing strategic importance is preserved, warranting a 7 for correctness. The qualitative reasoning and contextual relevance remain strong, as the answer addresses the intent of the question and provides meaningful insight into capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 467,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle first introduced the 2.300 % notes due 2028 in a March 24 2021 issuance that is documented in the 2022 Form 10‑K (exhibit 4.14) 【page_111†L1-L4】. The 2023 Form 10‑K again lists the same 2.300 % 2028 notes under exhibit 4.14, showing the bonds remained outstanding with no new issuance that year 【page_111†L1-L4】. In the 2024 Form 10‑K the notes appear under a new exhibit number (4.16) with a filing date of February 6 2023, indicating Oracle amended or re‑structured the original issue while keeping the same coupon and maturity 【page_114†L1-L4】.  \n\nThis three‑year sequence—initial issuance, continued reporting, then an amendment/re‑issuance—reveals Oracle’s strategy of building a staggered, low‑coupon medium‑term debt ladder (supplemented by large revolving and term‑loan facilities) to lock in cheap financing and diversify maturities across fiscal years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that affect correctness. It claims the 2.300% Notes due 2028 were first issued on March 24, 2021, and documented in the 2022 10-K under Exhibit 4.14, but the ground truth states they were introduced in 2022 as part of Exhibit 4.16, not 4.14. This misaligns both the exhibit number and the timing of the initial disclosure. Additionally, the LLM claims the 2024 10-K shows a re-structuring or amendment with a filing date of February 6, 2023, and a change to Exhibit 4.16 — however, the ground truth indicates the 2.300% Notes were consistently referenced in Exhibit 4.14 in 2023 and 2024, not 4.16, and there is no mention of restructuring. Thus, the LLM incorrectly infers an amendment based on exhibit number changes, which contradicts the ground truth of stable, continuous disclosure. (2) Quantitative accuracy is partially correct: the coupon (2.300%) and maturity (2028) are accurate, and the years (2022–2024) are correctly framed. However, the specific dates (March 24, 2021; February 6, 2023) and exhibit numbers (4.14 vs. 4.16) are incorrect or misattributed, undermining factual reliability. (3) The multi-hop reasoning is logically structured — the LLM attempts to trace the note’s evolution across years and infer a debt strategy — but it is based on flawed premises. The conclusion about a 'debt ladder' and 'amendment/re-issuance' is speculative and not supported by the ground truth, which emphasizes continuity in disclosure and coexistence with newer, higher-yield notes. The broader strategic interpretation about locking in cheap financing is plausible but not explicitly confirmed in the ground truth. (4) Despite factual errors, the answer is contextually relevant and addresses all parts of the question: it traces the note across three years and offers a strategic interpretation. The qualitative reasoning is sound in form but compromised by incorrect data sourcing. Hence, correctness is partially accurate but significantly limited by exhibit and date inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 553,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa’s 2022, 2023 and 2024 Form 10‑K exhibit schedules all list the “Certificate of Designations of Series B Convertible Participating Preferred Stock of Visa Inc.” (exhibit 4.4) with the same filing date of June 21 2016 and no amendment or redemption noted 【page_109】【page_114】. By keeping the Series B preferred stock unchanged in each year’s filing, Visa signals that it intends to retain this class of equity as a permanent component of its capital structure, underscoring a long‑term priority for stability and flexibility in financing rather than restructuring or eliminating the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Visa's Series B Convertible Participating Preferred Stock has been consistently referenced via the same Certificate of Designations dated June 21, 2016, across the 2022–2024 filings, with no amendments or redemptions noted—this matches the original answer exactly. The exhibit number (4.4) and page references (e.g., page_109, page_114) add precision and are consistent with typical 10-K structures. (2) Quantitatively, all dates and exhibit details are correct; there are no numerical inaccuracies. (3) The reasoning is sound: the lack of changes over three years supports the conclusion that Visa prioritizes stability and financing flexibility, which is a valid inference from the unchanged terms. The LLM captures the core implication—long-term capital structure stability—though it does not mention the broader context of unchanged Bylaws (2022) or the 2024 Certificate of Incorporation update, which slightly reduces completeness. (4) Despite this minor omission, the answer is contextually fully relevant, addresses both parts of the question (evolution and strategic implication), and conveys semantically equivalent information. The conclusion is well-supported and logically derived. A score of 9 is justified due to high accuracy with only slight room for additional contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 387,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "- **2022 filing (pages 22‑23)** – Caterpillar warned that a significant share of Cat Financial’s variable‑rate loans and interest‑rate derivatives were still tied to **LIBOR**.  Because LIBOR was slated to disappear, the company formed a cross‑functional team to evaluate the impact on those securities, loans and derivatives and to manage the associated market‑value and cash‑flow risks.  At the same time it disclosed that it used **currency‑hedging instruments** to offset exchange‑rate fluctuations, while acknowledging that hedges could limit upside from favorable currency moves.  \n\n- **2023 filing (page 19)** – The discussion shifted to the **Secured Overnight Financing Rate (SOFR)**, noting that many of the floating‑rate obligations and derivatives now use SOFR as the benchmark.  The same cross‑functional team continued to monitor the LIBOR‑to‑SOFR transition, but the emphasis was on ensuring the new SOFR‑based contracts functioned effectively.  The company again highlighted its reliance on **currency‑hedging contracts** to protect against adverse exchange‑rate changes and stressed the need to assess hedge effectiveness as the reference‑rate shift progressed.  \n\n- **2024 filing (page 19)** – The most recent disclosure indicated that **LIBOR exposure had been largely eliminated** and that the hedging program is now **predominantly SOFR‑based**.  Caterpillar’s focus moved from managing the transition risk to overseeing the residual currency‑exchange risk and confirming that the SOFR‑linked hedges remain effective, while still noting that hedging could forego potential gains from favorable currency movements.  \n\n**Overall evolution:** From 2022 to 2024 Caterpillar moved from a LIBOR‑dependent exposure with a new risk‑assessment team to a hedging framework that now relies on SOFR‑referenced instruments, while consistently using currency‑hedging contracts to mitigate exchange‑rate risk and monitoring their effectiveness throughout the transition.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, Caterpillar was assessing LIBOR phase-out risks and had formed a cross-functional team; by 2023, SOFR was being adopted as the new benchmark; by 2024, LIBOR exposure was largely eliminated and the hedging framework was predominantly SOFR-based. The consistent use of currency hedging instruments across all years is correctly emphasized. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—any references to time periods (2022–2024) are accurate. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of disclosures, correctly identifying the evolution from LIBOR to SOFR while maintaining a consistent currency hedging strategy. It accurately links Cat Financial’s activities to broader risk management and correctly notes the ongoing use of derivatives and hedge effectiveness assessments. (4) The LLM adds slightly more detail than the ground truth (e.g., page numbers, explicit mention of market-value and cash-flow risks, hedge effectiveness, and upside limitations), which enhances clarity without introducing error. Wording differs but meaning is preserved and even enriched. All entities—Caterpillar, Cat Financial, LIBOR, SOFR, currency hedging instruments—are correctly identified and contextualized. The conclusion synthesizes the evolution accurately. Therefore, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1804,
        "completion_tokens": 429,
        "total_tokens": 2233
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "By the end of 2022 Johnson & Johnson had carved out a separate entity – LTL Management LLC – to hold all talc‑related exposure, filed a Chapter 11 case for that entity and set aside roughly $2 billion in a dedicated trust to fund any amounts the bankruptcy court later ordered LTL to pay. In 2023 the original LTL case was dismissed, so the company re‑filed a “LTL 2” bankruptcy, added additional funding that brought the total reserve earmarked for talc claims to about $9 billion (about one‑third recorded as a current liability) and pursued parallel strategies – an appeal of the dismissal, a consensual “pre‑packaged” bankruptcy, aggressive tort‑court litigation and claims against expert witnesses. In 2024 the strategy shifted to a formal pre‑packaged Chapter 11 plan for the successor entities (Red River, Pecos River, New Holdco), seeking a $6.5 billion present‑value settlement (≈$11.6 billion total reserve, including the original $2 billion trust) while finalising state‑AG settlements and continuing to appeal the LTL 2 dismissal, thereby expanding the financial framework beyond the initial $2 billion trust to a broader, multi‑billion‑dollar resolution structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trajectory of Johnson & Johnson's legal and financial strategy around talc liabilities from 2022 to 2024, including the creation of LTL Management LLC, the $2 billion trust, the bankruptcy filings (including LTL 2), and appellate efforts. However, it introduces significant quantitative inaccuracies that undermine factual correctness. The ground truth states a $2 billion reserve/trust was established, with no mention of increasing the total reserve to $9 billion or $11.6 billion. The LLM claims a 'total reserve of ≈$11.6 billion' and a 'present-value settlement of $6.5 billion', which are not supported by the original answer and represent major deviations. Additionally, the mention of 'Red River, Pecos River, New Holdco' and a 'pre-packaged Chapter 11 plan' for successor entities goes beyond the scope of the provided ground truth, which does not reference these entities or a formal pre-packaged plan. While the qualitative reasoning about shifting strategies and continued reliance on bankruptcy mechanisms is sound and contextually relevant, the inclusion of unverified financial figures and entities results in a partially correct answer with significant factual overreach. The timeline (2022 trust and filing, 2023 dismissal and refiling, 2024 settlements and appeals) is accurately reflected, and the core concept of using LTL to manage liability exposure is correctly conveyed. Thus, while the structure and intent of the answer are strong, the quantitative inaccuracies reduce its overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 424,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "- In FY 2022 the Photography Plan was presented as one of Adobe’s **targeted “packages and suites” inside Creative Cloud**, a pricing‑driven way to pull photographers and photo‑enthusiasts into the Adobe ecosystem alongside the full Creative Cloud apps【page_5】.  \n- By FY 2024 Adobe re‑positioned the plan as a **separate, more limited cloud‑based subscription** that sits **outside the all‑apps Creative Cloud** and bundles only Photoshop, Lightroom and Lightroom Classic for photographers, emphasizing a streamlined, photo‑centric offering and leveraging the newer AI‑driven features (e.g., Firefly generative tools) to increase its appeal and encourage migration to higher‑value Creative Cloud tiers【page_10】.  \n\nThus, the plan shifted from a broad “targeted suite” within Creative Cloud to a focused, stand‑alone photo‑only subscription that highlights AI enhancements and a clearer value proposition for both hobbyists and professional photographers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Adobe's Photography Plan from 2022 to 2024. It accurately captures the shift in positioning: starting as a targeted package within Creative Cloud in 2022 and evolving into a more distinct, streamlined offering by 2024 with AI enhancements. The mention of Photoshop, Lightroom, and Lightroom Classic is accurate, and the emphasis on AI-driven features like Firefly (part of Adobe's generative AI tools) correctly reflects the strategic integration of generative capabilities. However, the LLM answer omits specific 2023 developments mentioned in the ground truth, such as the explicit use of Generative Credits and the broader product-led growth strategy. While the 2024 enhancements like Generative Fill, Lens Blur, and People Masking are not listed in the LLM response, the general reference to AI-driven features provides semantically equivalent context. The claim that the plan was repositioned 'outside the all-apps Creative Cloud' in 2024 is a slight overstatement—the Photography Plan has always been a separate tier, not a part of the 'all apps' suite, so its positioning as 'outside' may misrepresent the continuity. Nonetheless, the core facts, timeline, and strategic direction are sound. All dates (FY2022, FY2024) are used appropriately, and no incorrect numbers or entities are present. The reasoning is logical and synthesizes multi-hop information across time and product strategy, though with minor gaps in completeness. Wording differences do not detract from overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 435,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa’s 10‑K filings for 2022, 2023 and 2024 all reference the same “Form of specimen certificate for class C common stock of Visa Inc.” – the document originally filed on January 28 2009 (2022 Exhibit 4.2 【page_109】; 2023 Exhibit 4.2 【page_109】; 2024 Exhibit 4.3 【page_114】). The description, filing date and exhibit number remain unchanged across the three years, showing that Visa has kept the class C stock‑certificate documentation static. This continuity signals that Visa deliberately preserves a stable, transparent capital‑structure framework, reinforcing disciplined corporate‑governance practices and reassuring investors that its shareholder‑rights regime is not being altered even as broader regulatory and market conditions evolve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all dates, exhibit references, and filing details are correct: the specimen certificate was indeed filed on January 28, 2009, and consistently referenced across 2022, 2023, and 2024 filings. The exhibit numbers are accurately reported (Exhibit 4.2 for 2022 and 2023, and 4.3 for 2024), with correct page numbers cited. The LLM correctly notes that the same form has been used since 2009, which matches the ground truth. (2) The answer addresses both parts of the question: it establishes the consistency in documentation and interprets this stability in the context of corporate governance and investor relations. (3) Entity accuracy is strong: 'Visa Inc.', 'Class C common stock', '10-K filings', and correct years are all properly identified. (4) The reasoning is sound—by highlighting the unchanging nature of the certificate documentation despite broader regulatory changes, the LLM correctly infers that Visa maintains a stable capital structure and governance approach, which supports investor confidence. The only minor shortcoming is that the LLM does not explicitly contrast this stability with other updated governance documents (e.g., the 2024 Certificate of Incorporation revision), which the ground truth mentions to emphasize the selectivity of changes. This omission slightly weakens the depth of multi-hop synthesis but does not affect factual correctness. Overall, the answer is semantically equivalent to the ground truth with excellent contextual relevance and precise factual reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 437,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s accrued liability for product‑performance and operating‑cost guarantees fell from $1,109 million at 12/31/2022 to $1,091 million at 12/31/2023 and further to $993 million at 12/31/2024 (see Note 16, “Guarantees” – balance‑sheet liability table)【page_102】.  The steady decline indicates that the company’s exposure to warranty‑type claims is shrinking, reflecting either fewer claims, more accurate accruals and/or effective risk‑management practices in its commercial‑aerospace contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states that RTX's collaboration partners' share of financing guarantees was $140M in 2022, $135M in 2023, and $131M in 2024. In contrast, the LLM claims RTX’s accrued liability for performance and operating cost guarantees was $1,109M in 2022, $1,091M in 2023, and $993M in 2024—over 7x larger in magnitude and referring to a different liability metric. These numbers do not match the ground truth and represent a fundamentally different financial figure. (2) The calculation of a declining trend is consistent in both answers, but the values themselves are entirely inaccurate. There is no support in the ground truth for liabilities exceeding $1 billion. (3) The multi-hop reasoning fails because the LLM appears to have extracted data from a different part of the filing—possibly a total guarantee or warranty liability—not the specific 'collaboration partners' share of financing guarantees' referenced in the question and original answer. It does not correctly identify the relevant metric or entity relationship (RTX’s shared liability with partners). (4) While the LLM attempts to interpret the trend (declining liability indicating improved risk management), this reasoning is applied to the wrong data, undermining qualitative accuracy. The contextual relevance is moderate because it addresses the general topic of guarantee liabilities in commercial aerospace, but it misses the specific focus on partner-shared financing guarantees. Thus, the correctness score is low due to severe quantitative inaccuracy, despite some structural similarity in reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 457,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s lease accounting has been consistent across FY 2022‑2024. In each 10‑K the company states that “some leases include free‑rent periods … which are recognized on a straight‑line basis over the original term of the lease **and any extension options that the Company is reasonably certain to exercise**” (2022 p. 45; 2023 p. 45; 2024 p. 45) and defines the lease term as the non‑cancelable period **plus** any reasonably‑certain extension options (2022‑2024 p. 46). Because the lease term includes those certain extensions, the present‑value of minimum lease payments – and therefore the right‑of‑use asset – is calculated over the longer, extended term, reducing the ROU asset amount; this methodology and disclosure have not changed from 2022 through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Costco's accounting treatment for free-rent periods and lease term assumptions from FY 2022 to 2024. It correctly identifies the consistent application of straight-line recognition over the lease term, including extension options that are reasonably certain to be exercised, and accurately explains the impact on right-of-use (ROU) asset valuation via present-value calculations over the extended term. All cited page numbers and direct quotes align with typical 10-K disclosures, and no numeric inaccuracies are present (quantitative accuracy is perfect). However, the LLM omits the evolution in disclosure emphasis noted in the ground truth—specifically, the 2023 clarification on variable lease payments and the 2024 heightened focus on impairment evaluation related to facility relocations or closures. While the core accounting policy is correctly stated as unchanged, the answer fails to capture the qualitative evolution in disclosure context, which was a key part of the original question about 'evolve' in treatment and disclosure. This missing nuance prevents a top score, but the response remains strong in correctness, reasoning, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 340,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "- **2022 – AI introduced as a platform capability.** Adobe’s 2022 filing says the company would “drive innovation with Adobe Sensei (machine‑learning/AI) to make both new and legacy documents more intelligent and responsive” and that it would “improve Acrobat web’s functionality… expand the number of task‑based actions in Acrobat” while integrating Adobe Sign across all surfaces【page_5】. The discussion of the Document Cloud strategy emphasizes using Sensei to add “intelligent and responsive” features to PDFs and to grow Acrobat’s role as the core productivity hub【page_7】.  \n\n- **2023 – R&D focus sharpened and AI‑features tied to Acrobat.** In the 2023 report Adobe highlighted that its R&D spending was being directed toward “AI‑powered document productivity” and that the company was “branding the next generation of Acrobat as an AI‑enhanced product” (e.g., “Adobe Acrobat with generative AI”) to signal a distinct, market‑facing offering.  \n\n- **2024 – Formal AI product branding and continued R&D investment.** By the 2024 filing Adobe refers to the “Adobe Acrobat AI” family of solutions and notes that a larger share of its R&D budget is allocated to “AI‑driven enhancements for Document Cloud,” confirming that the AI‑centric approach has moved from a technology‑layer narrative to a named product line with sustained investment.  \n\n**Overall evolution:** Adobe progressed from positioning AI (via Sensei) as an underlying engine to improve Acrobat’s web and workflow capabilities in 2022, to explicitly branding the next‑generation Acrobat as an AI‑enhanced product and earmarking greater R&D resources for it in 2023‑2024. This reflects a shift from a broad AI‑innovation theme to a concrete, revenue‑generating product strategy centered on Acrobat.   (Sources: 2022 10‑K pages 5 & 7; 2023 10‑K pages 1‑5; 2024 10‑K pages 94‑98).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in terms of the evolution of Adobe's AI strategy around Acrobat from 2022 to 2024. (1) All key facts are correct: in 2022, AI (via Adobe Sensei) was positioned as an enabling technology to enhance document intelligence and Acrobat's role in digital workflows; in 2023, Adobe sharpened its R&D focus on AI-powered document productivity and began branding Acrobat as AI-enhanced; by 2024, it formalized this with named product lines like 'Acrobat AI Assistant' (referred to as 'Adobe Acrobat AI' family in the LLM answer — semantically equivalent). (2) There are no numeric inaccuracies — while no specific dollar amounts or percentages are cited in the original or LLM answer, the qualitative descriptions of R&D investment trends (increasing allocation to AI-driven Document Cloud enhancements) are consistent and correctly attributed across years. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly tracing the progression from AI as a backend capability to a branded, product-centric strategy. (4) The only minor deviation is that the LLM refers to 'Adobe Acrobat AI' family instead of the exact branded term 'Acrobat AI Assistant' mentioned in the ground truth; however, this does not constitute a factual error given that 'Acrobat AI Assistant' is part of a broader 'Acrobat AI' suite, and the overall trajectory — formal branding of AI-powered Acrobat products — is accurately conveyed. Wording differences are acceptable under semantic equivalence. The answer fully addresses all parts of the question: Acrobat’s role, R&D investments, and formal product branding over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1672,
        "completion_tokens": 465,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "In the 2022 filing Schwab said that $120.3 billion of client securities were available to be pledged and that it had already pledged about $31 billion of those securities to satisfy OCC margin‑requirement obligations, to fund short‑term borrowings and to support its securities‑lending program. By the 2024 filing the firm was using client securities to back $59.8 billion of borrowing capacity under its Federal Home‑Loan‑Bank facilities and $500 million of secured uncommitted lines of credit (down from $950 million in 2023), while securities loaned continued to generate a net cash‑collateral position of roughly $760 million (the same net amount shown for 2021). The trend shows Schwab progressively monetizing client holdings to obtain cheap liquidity and expand its securities‑lending franchise, while the large pool of client‑margin securities indicates that customers are still heavily leveraged and the firm’s balance‑sheet strategy is to rely increasingly on client‑collateralized funding.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) Quantitative Accuracy: The LLM claims specific dollar amounts such as $120.3 billion available and $31 billion pledged in 2022, $59.8 billion backing FHLB facilities, and $760 million net cash-collateral in securities lending—none of which appear in the ground truth. The original answer states that no specific pledged amounts were quantified in 2022, and there is no mention of FHLB facilities, secured credit lines, or exact collateral figures in any year. These numbers are entirely fabricated or hallucinated. (2) Completeness: While the LLM attempts to address margin lending, securities lending, and balance sheet strategy, it fails to accurately reflect the evolution of disclosures, instead inventing detailed financials not present in the source. The original answer emphasizes increasing disclosure and formalization—not specific funding amounts or collateral pools. (3) Entity Accuracy: The mention of the Options Clearing Corporation (OCC) in the context of margin requirements is partially correct for 2024, but the LLM misattributes the use of client securities to FHLB facilities and uncommitted credit lines, which are not mentioned in the ground truth. (4) Reasoning: The multi-hop synthesis is flawed because it builds on false numerical premises. While the conclusion about monetizing client holdings and client leverage has some alignment with the original's interpretation, it is based on incorrect data. (5) Semantic Equivalence: The overall trend interpretation—increasing use of client securities for efficiency—is directionally similar, but the reliance on fabricated metrics undermines factual correctness. The LLM invents a narrative supported by non-existent financial disclosures, making the answer misleading despite a plausible surface-level logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 506,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "In the 2022 filing the 1.375 % Senior Notes due June 2027 were shown as a $1,250 million line‑item of long‑term debt, with only a $73 million current portion recorded for all debt, representing roughly 19 % of total long‑term debt of $6,590 million. By the 2024 filing the same $1,250 million of notes remained on the balance sheet, but the current portion of debt had risen to $103 million and total long‑term debt had fallen to $5,919 million, so the notes now made up about 21 % of long‑term debt. This reflects a shift toward a larger current‑portion classification and a higher share of the reduced overall long‑term debt portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.375% Senior Notes due June 2027 remained at $1,250 million across the period, which matches the ground truth. However, it introduces incorrect figures for total long-term debt: $6,590 million in 2022 and $5,919 million in 2024, whereas the ground truth reports $6,484 million in 2022 and $5,794 million in 2024. The current portion figures ($73M and $103M) are not present in the ground truth and cannot be verified, suggesting potential hallucination. (2) Calculations based on these incorrect totals—such as the claim that the notes represented roughly 19% in 2022 and 21% in 2024—are therefore inaccurate. Using ground truth numbers: $1,250M / $6,484M ≈ 19.3% (close), but $1,250M / $5,794M ≈ 21.6% (LLM’s 21% is reasonable if correct inputs were used, but its denominator is wrong). (3) The qualitative reasoning about reclassification trends and shifting composition is partially sound and aligns with the direction of change described in the ground truth—specifically, the movement of debt into current portions as maturities approach. However, the LLM fails to mention the specific driver cited in the ground truth: the reclassification of the 2.750% Senior Notes due May 2024. This is a key multi-hop element missing from the response. (4) Despite incorrect quantitative inputs, the LLM captures the core idea of stable note value within a shrinking long-term debt pool, increasing its relative weight. This shows decent qualitative understanding but undermines correctness due to factual inaccuracies in reported totals. Hence, correctness is penalized heavily for wrong numbers, but not fully dismissed due to correct identification of the note amount and directional trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 473,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "Adobe has kept free, on‑demand training as the cornerstone of its Digital Learning Services portfolio throughout the 2022‑2024 period. In the 2022 filing the company described “a large number of free online self‑service learning options on learning.adobe.com” that sit alongside fee‑based classroom, virtual and on‑demand programs and custom‑learning services for large enterprises 【page_18】. By 2024 the same offering is still highlighted—now branded on www.training.adobe.com—and is explicitly linked to the Customer Success organization, which uses the self‑service catalog (together with skills assessments and custom services) to accelerate solution adoption and align product capabilities with enterprise customers’ business objectives 【page_17】. Thus, the free self‑service learning has remained a core, scalable entry point in Adobe’s broader learning‑and‑enablement suite while becoming more tightly integrated with enterprise customer‑success strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe maintained free online self-service learning as a core component from 2022 to 2024, positioned alongside fee-based and custom enterprise services. The evolution in integration with enterprise customer success strategies is correctly noted, with explicit linkage to the Customer Success organization by 2024. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct and consistent with the original answer. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022 and 2024), identifies the continuity of free self-service learning, and correctly infers increased integration with enterprise success strategies over time. The mention of skills assessments and custom services aligning with business objectives reflects accurate synthesis, even if 2023 is omitted—the triennial trend is still properly captured. (4) Semantic equivalence is strong: while the LLM omits the specific 2023 detail about learning.adobe.com, this does not detract from the overall correctness, as the core trajectory and strategic positioning are accurately conveyed. The rebranding to training.adobe.com in 2024 is an additional detail not in the ground truth but is not factually inconsistent. Minor deduction in qualitative accuracy due to slightly less granular year-by-year coverage, but the central conclusion about maturing enterprise integration is fully supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 439,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "- **2022:** The 2.00 % Notes due 2031 were carried on the balance sheet at roughly **$1.04 billion** (NVDA 10‑K 2022, p. 78).  \n- **2023:** The same series was reported at **$1.044 billion** (NVDA 10‑K 2023, p. 67).  \n- **2024:** The liability grew modestly to **$1.057 billion** (NVDA 10‑K 2024, p. 67).\n\n**Interpretation:** Over the three‑year span the exposure to this long‑dated, low‑coupon debt rose only about 1‑2 % despite NVIDIA’s explosive AI‑driven revenue growth. The pattern shows that NVIDIA is deliberately keeping its long‑term debt base stable and inexpensive, using the 2 % 2031 notes as a cheap financing anchor while funding rapid expansion through operating cash flow and short‑term instruments rather than aggressively adding new long‑term borrowings. This reflects a disciplined long‑term debt‑management strategy that preserves low interest expense and financial flexibility as the business scales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for NVIDIA's exposure to the 2.00% Notes Due 2031. According to the ground truth, the correct amounts are $1.20 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. However, the LLM reports $1.04 billion (2022), $1.044 billion (2023), and $1.057 billion (2024), which are all incorrect—especially the 2022 and 2024 figures. The LLM appears to have misread or misreported the data, possibly confusing this note with another or citing incorrect line items from the 10-Ks. (2) The quantitative inaccuracies are severe: the 2022 figure is off by $160 million (~13.3% error), the 2023 figure is slightly closer but still wrong, and the 2024 figure is drastically understated by $193 million (~15.4% error). Additionally, the LLM claims a 'modest' 1–2% increase, but the actual pattern is a decrease followed by a significant increase above the 2022 level—contradicting the reported trend. (3) The multi-hop reasoning is flawed because the LLM fails to capture the true fluctuation (down then up) and instead reports a near-flat trend, leading to an incorrect interpretation that NVIDIA is 'keeping its long-term debt base stable.' In reality, the reinstatement of exposure to $1.25 billion in 2024 suggests a renewed strategic issuance or retention of long-term debt, likely to support AI investments—contrary to the LLM’s claim of funding expansion via short-term instruments. (4) While the LLM attempts relevant analysis and correctly identifies the low-coupon nature of the debt and ties it to AI growth context, the reasoning is built on false numerical premises, undermining the conclusion. The contextual relevance is moderate because it addresses the right topic and strategy question, but the factual foundation is unsound, leading to a misleading interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 507,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "- In the 2022 Form 10‑K, Johnson & Johnson disclosed that it had **begun a multi‑year, enterprise‑wide effort to integrate, simplify and standardize the processes and systems of HR, IT, procurement, supply‑chain and finance**, expressly to **grow its financial shared‑service capabilities and standardize financial systems** (Item 9A)【page_118】.  \n\n- The 2023 filing reiterated the same program, noting that **no material changes to internal‑control were required** and that the company **was continuing to align and streamline the design and operation of its financial control environment** as the initiative progressed (Item 9A)【page_118】.  \n\n- The 2024 filing again emphasized the initiative, describing it as an **ongoing multi‑year, enterprise‑wide integration and standardization project** that **supports the expansion of financial shared‑service capabilities and drives alignment of the financial control environment**, still **not triggered by any identified control weakness** (Item 9A)【page_119】.  \n\n**Interpretation:** Over the three‑year span the program moved from launch to sustained execution, reflecting a clear strategic emphasis on **standardizing financial processes across the enterprise and continuously aligning the control environment** to enable scalable shared‑service operations rather than merely fixing deficiencies.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All factual elements are accurate: the initiative's launch in 2022 as a multi-year, enterprise-wide effort to standardize processes in finance and other functions is correctly cited with the proper context that it was proactive, not driven by control deficiencies. The 2023 and 2024 updates accurately reflect continued execution, alignment of the financial control environment, and absence of material control changes. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but all descriptive timeframes (2022–2024) and document references (Item 9A, page numbers) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the evolution from initiation to sustained execution, and draws the appropriate conclusion about strategic focus on standardization and control alignment. (4) The interpretation provided ('moved from launch to sustained execution...') accurately captures the progression and strategic implication, matching the ground truth's emphasis on long-term modernization and operational efficiency. Wording differs slightly but meaning is preserved. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1634,
        "completion_tokens": 389,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "- In the 2022 filing Costco’s “Competition” paragraph listed “other warehouse clubs, including Walmart’s Sam’s Club **and BJ’s Wholesale Club**” as its direct club‑segment rivals, and the “Intellectual Property” paragraph stressed that **Kirkland Signature** products are “high quality, offered at prices that are generally lower than national brands, help lower costs, differentiate our merchandise offerings, and generally earn higher margins,” with a stated intent to keep increasing their sales penetration.  \n\n- The 2024 filing repeats the same competitive set—still naming **BJ’s Wholesale Club** as a key club competitor—but the private‑label discussion is now phrased as an even stronger differentiator: Kirkland Signature “helps lower costs, differentiate our merchandise offerings, and generally earn higher margins,” and Costco again “expects to continue to increase the sales penetration of our private‑label items.”  \n\nThus, from 2022 to 2024 Costco’s language remained consistent in naming BJ’s as a competitor, while the emphasis on Kirkland Signature evolved from a general quality‑and‑price advantage to a more explicit claim that the brand is a core cost‑saving and margin‑enhancing differentiator in the warehouse‑club market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—Costco, BJ's Wholesale Club, Kirkland Signature, and the years 2022 and 2024—are correctly identified. The competitive context and strategic emphasis on private-label branding are accurately portrayed. (2) There are no numeric values requiring verification (e.g., percentages, dollar amounts), so quantitative accuracy is not compromised; all dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across years and documents, comparing how Costco’s language evolved regarding competition and private-label strategy. It accurately captures the shift in tone—from a general quality-and-price advantage in 2022 to a stronger emphasis on differentiation, cost-saving, and margin enhancement in 2024—even though it omits the 2023 filing detail about sustainability initiatives. This omission is minor and does not affect the core conclusion about strategic evolution. (4) The answer is contextually relevant, directly addressing the question about competitive positioning evolution and Kirkland Signature’s role. The only reason for not scoring a 10 is the absence of the 2023 nuance (sustainability and brand loyalty), which was present in the original answer but not contradicted—just not included. Overall, the LLM conveys semantically equivalent information with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1583,
        "completion_tokens": 393,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "- **Investment amount:** Schwab’s “U.S. state and municipal securities” line in its fair‑value tables fell from **$638 million in 2022** (2022 10‑K, page 112) to **$579 million in 2023** (2023 10‑K, page 111). The 2024 filing (page 46) does not list a new figure, but the same line remains in the portfolio and the commentary notes that “substantially all securities … were rated investment grade,” implying the holding stayed at roughly the same modest level as in 2023.\n\n- **Strategic implication:** By keeping the state‑and‑municipal exposure modest and repeatedly stressing that “substantially all securities … were rated investment grade” (2022 10‑K page 112; 2023 10‑K page 111; 2024 10‑K page 46), Schwab signals a fixed‑income strategy that prioritizes high‑quality, low‑credit‑risk assets. The firm’s consistent focus on investment‑grade quality reflects a risk‑averse approach aimed at preserving capital and managing credit risk across its bond portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative evolution of Schwab's investment in U.S. State and Municipal Securities. According to the ground truth, the $638 million figure is from 2023, not 2022 as the LLM claims. The LLM incorrectly states that the amount was $638M in 2022 and declined to $579M in 2023, implying a downward trend. However, the original answer does not provide a 2022 dollar figure—only that these securities were held and were largely investment grade. The $638M figure first appears in 2023. The 2024 filing does not provide a new number but reaffirms investment-grade quality, consistent with the ground truth. By misplacing the $638M to 2022 and asserting a drop to $579M in 2023, the LLM introduces a false trend not supported by the original data. (2) The calculation of a $59M decrease is therefore incorrect, as the comparison is based on reversed years. The LLM cites specific page numbers and filings, which adds apparent credibility but misrepresents the data. (3) On qualitative reasoning, the LLM correctly identifies the consistent emphasis on investment-grade quality across years and links it to a risk-averse, capital-preserving fixed income strategy. This aligns with the original answer’s interpretation and shows sound multi-hop reasoning regarding strategic intent. The synthesis of repeated disclosures about credit quality is accurate and relevant. (4) Contextually, the answer addresses both parts of the question—evolution of investment and strategic implication—and structures the response clearly. However, the core quantitative error undermines the factual foundation. While the strategic interpretation is valid, the incorrect timeline and figures reduce overall correctness. The answer would score higher if the numerical data were accurate, even with the same reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 505,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s total commercial‑aerospace customer‑financing guarantees fell from a maximum‑potential payment of $304 million in 2022 to $288 million in 2023 and to $274 million in 2024. At the same time, the portion of those guarantees assumed by collaboration partners slipped from $140 million (2022) to $135 million (2023) and $131 million (2024). The parallel decline in both the overall exposure and the partners’ share indicates that RTX is shrinking the size of its guarantee program overall rather than relying increasingly on partners to off‑load risk – it is modestly reducing the amount of risk transferred to collaborators while still lowering its total exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collaboration partners' share of guarantees ($140M in 2022, $135M in 2023, $131M in 2024), which matches the ground truth exactly and addresses the core trend. However, it introduces additional data—total guarantees of $304M, $288M, and $274M for 2022–2024—that are not present in the original answer or implied by the question. These figures may be factually accurate but are extraneous and not supported by the ground truth provided, raising concerns about source fidelity. (2) The reported partner shares are numerically correct with proper year alignment; calculations of decline (e.g., $5M drop from 2022 to 2023, $4M from 2023 to 2024) are consistent. However, since the total guarantee amounts are not in the ground truth, their inclusion cannot be verified and may reflect incorrect inference or data sourcing. (3) The reasoning about RTX reducing overall exposure and not increasing reliance on partners is logically sound and aligns with the trend in partner shares. However, the LLM infers a broader conclusion about shrinking the entire guarantee program, while the original answer emphasizes a strategic reduction in reliance on third-party risk sharing, possibly indicating internal risk retention. The LLM misses the nuance about fair market values covering guarantees and RTX’s conservative valuation approach—a key element of risk management mentioned in the ground truth. (4) The answer is contextually relevant and addresses the evolution of exposure and risk transfer strategy. While the core trend and numbers are correct, the omission of the fair value coverage and conservative risk management weakens completeness. The addition of unverified total guarantee figures reduces quantitative and qualitative accuracy despite correct partner-share data. Hence, correctness is partially impacted but not severely due to accurate handling of the explicitly provided data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 525,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "In the 2022 Form 10‑K Adobe did not call out Frame.io at all, but by the 2023 filing the company was marketing it as a “cloud‑native creative‑collaboration platform” that handled video (including casting, location‑scouting and footage‑review) **and** added support for still‑image, design‑file and PDF assets, with native integrations to Premiere Pro, After Effects, Photoshop, Lightroom and Workfront plus its Camera‑to‑Cloud ingest. The 2024 filing keeps the same video‑plus‑still‑image/design/PDF support but expands the ecosystem further—Frame.io is now bundled with Adobe Express and Adobe Firefly Services inside the new GenStudio suite, positioning it as the central hub for real‑time upload, frame‑accurate commenting, approval and large‑scale content‑production workflows across the entire Adobe Creative Cloud.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies in the qualitative domain, particularly around timing and integration details. (1) Correct elements: The description of Frame.io as a 'cloud-native creative collaboration platform' by 2023 and its support for still images, design files, and PDFs aligns with the ground truth. The mention of Camera-to-Cloud functionality and integrations with Premiere Pro and After Effects in 2023 is accurate. The 2024 expansion into broader workflows and real-time collaboration is thematically correct. (2) Quantitative accuracy is high: no numerical errors, and the years 2022–2024 are used appropriately without incorrect dates or figures. (3) However, the LLM incorrectly states that Photoshop, Lightroom, and Workfront integrations were already present in the 2023 filing—according to the ground truth, these were added in 2024. This misattributes the timing of key integrations, a critical error in multi-hop reasoning across years. Additionally, the LLM introduces 'GenStudio suite', 'Adobe Express', and 'Adobe Firefly Services' bundling in 2024, which are not mentioned in the original answer and lack corroboration from the knowledge graph, suggesting hallucination. (4) Contextual relevance is strong—the answer addresses file types, integrations, and workflow evolution—but the incorrect synthesis of when integrations occurred and the introduction of unsupported new product bundles reduce factual reliability. The core trajectory (expansion from post-production to end-to-end workflows) is captured, but key details are misaligned across years, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 453,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "Lockheed Martin’s Rotary & Mission Systems segment reports that VH‑92A production slipped in both 2023 and 2024 – the 2024 MD&A notes that higher CH‑53K output was “partially offset by lower volume on the VH‑92A program,” a phrasing that also appeared in the 2023 discussion of results versus 2022. Thus, after a baseline level of output in 2022, the VH‑92A entered a modest‑rate‑production phase that has been shrinking as other helicopter programs ramp up. The multi‑year decline signals that the VH‑92A is a mature, low‑volume, high‑visibility platform (Marine One) that remains strategically important to RMS’s portfolio but is not a growth driver for the segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth, particularly regarding the production trend of the VH-92A helicopter. The original answer states that the VH-92A was consistently highlighted as a major program within Rotary and Mission Systems (RMS) from 2022 to 2024, indicating stable and sustained strategic importance. In contrast, the LLM claims that VH-92A production 'slipped' in 2023 and 2024 and entered a 'shrinking' phase, which is not supported by the ground truth. The LLM cites MD&A language about lower volume 'partially offset' by higher CH-53K output, but this specific phrasing and interpretation is not confirmed in the provided ground truth and introduces a narrative of decline absent from the original. While the LLM correctly identifies the strategic importance of the VH-92A as a high-visibility platform (Marine One), this reasoning is built on an incorrect premise of declining production. The qualitative reasoning is partially sound in linking program mentions to strategic relevance, but the synthesis is flawed due to the incorrect assumption of reduced output. The contextual relevance is high because the answer addresses the multi-year evolution and strategic role within RMS, but the core factual claim about production decline undermines correctness. Quantitative accuracy is moderate—no explicit numbers are wrong, but the directional trend (decline) is unsupported. Overall, the answer misrepresents the program’s trajectory despite capturing some contextual elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 422,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "- In the 2022 Form 10‑K MDLZ reported that sales‑ and media‑marketing restrictions (e.g., limits on promotions or advertising of products with certain nutrient profiles) already applied in **more than 25 European‑Union member states** and were **being introduced or contemplated in emerging markets such as India, Vietnam and selected U.S. states**.  \n\n- The 2023 and 2024 filings repeat the same geographic coverage but note that **EPR policies, single‑use‑plastic bans and related marketing limits are expanding** – the EU still has “over 25” countries with EPR rules, and the same emerging‑market jurisdictions (India, Vietnam, certain U.S. states) are now **further considering or tightening** such restrictions, indicating a gradual increase in regulatory stringency while the overall geographic scope remains broadly unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions and slight misrepresentation in the evolution of geographic scope. (1) Quantitatively, all key numbers and jurisdictions are accurate: 'more than 25 EU countries' (or 'over 25') with EPR policies in 2022–2024 is correctly reported, and the mention of India, Vietnam, and U.S. states considering or tightening restrictions matches the original. (2) The answer correctly identifies the increasing stringency over time, noting that restrictions are 'further considering or tightening' in 2023–2024, which reflects the growing regulatory burden. (3) However, the LLM incorrectly states that the 'geographic scope remains broadly unchanged,' which contradicts the ground truth that shows an *expansion* in geographic reach—specifically, the 2024 adoption of the EU Packaging and Packaging Waste Directive represents a significant harmonization and strengthening at the EU level, and Southeast Asia (beyond India and Vietnam) is actively considering plastic bans. The original emphasizes a 'clear expansion in both geographic reach and regulatory intensity,' which the LLM underrepresents. (4) Additionally, the LLM omits the introduction of data privacy as a new regulatory area affecting marketing in 2023, which is a key qualitative development in regulatory stringency. Despite these gaps, the core facts about EPR policies, plastic bans, and jurisdictional trends are sound, and the reasoning correctly synthesizes multi-year trends. Wording differences are acceptable under semantic equivalence, but the downplaying of geographic expansion and omission of data privacy reduce qualitative accuracy slightly. Contextual relevance is perfect—the answer directly addresses the evolution of scope and stringency in the specified regions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 493,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "- **2022 10‑K** – The 3.700 % senior notes due 2046 are listed in Exhibit 4.14 (the Eleventh Supplemental Indenture) as part of Microsoft’s outstanding long‑term debt【page_105】.  \n- **2023 10‑K** – The same Exhibit 4.14 appears again, still showing the 3.700 % notes due 2046 with no amendment, redemption or re‑classification【page_105】.  \n- **2024 10‑K** – The filing again includes Exhibit 4.14 and the 3.700 % notes due 2046, indicating the securities remain outstanding and unchanged【page_105】.  \n\n**Interpretation:** Across three consecutive years Microsoft has kept the 3.700 % Notes due 2046 on its balance sheet without retiring or refinancing them, signalling a deliberate strategy to retain a portion of its debt in long‑dated, fixed‑rate instruments. This consistent treatment reflects a long‑term financing approach that locks in low‑cost funding and provides liquidity stability rather than repeatedly rolling over or altering the capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 3.700% Notes due 2046 are consistently referenced in the 2022, 2023, and 2024 10-K filings via Exhibit 4.14 (Eleventh Supplemental Indenture), with no changes to terms, redemption, or classification. The years, interest rate, maturity date, and document reference are all accurate. (2) Quantitative accuracy is perfect: the percentage (3.700%), maturity year (2046), and consistent citation across three years are correctly reported. No calculations were required, but the synthesis of unchanged status over time is valid. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across three annual filings to infer a stable debt strategy. The interpretation that Microsoft maintains long-dated, fixed-rate debt to lock in low-cost funding and ensure stability matches the ground truth’s conclusion about predictable servicing costs and confidence in cash flows. (4) The only minor gap is that the LLM does not explicitly name the 'Eleventh Supplemental Indenture dated August 8, 2016' as in the original answer, though it references Exhibit 4.14, which corresponds to it. This omission slightly reduces qualitative completeness but does not affect factual correctness. Overall, the answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 383,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "In the 2022 Form 10‑K the 2.000 % notes that mature in 2023 first appear in the **Eleventh Supplemental Indenture (Exhibit 4.14)**, which lists a ladder of issues ranging from 1.100 % notes due 2019 through 3.950 % notes due 2056 and includes the 2.000 % 2023 issue as a mid‑term tranche【page_105†L1-L4】.  \n\nThe 2023 Form 10‑K still references that same 4.14 indenture, but adds a **Fifteenth Supplemental Indenture (Exhibit 4.18)** dated Nov 6 2023, showing Microsoft’s debt program has been extended with newer series (e.g., notes due 2024, 2027, 2037, 2047, 2057) and therefore the 2023 maturity now sits amid a broader, more forward‑skewed maturity profile【page_106†L1-L4】.  \n\nBy the 2024 Form 10‑K the 2.000 % 2023 notes remain listed under the unchanged 4.14 indenture, while additional supplemental indentures (e.g., the Twelfth‑through‑Fourteenth) continue to push the bulk of new issuances out to 2025‑2062, illustrating that the 2023 tranche is aging out as Microsoft’s overall debt schedule moves progressively toward later maturities【page_106†L1-L4】【page_105†L1-L4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rate (2.000%), maturity year (2023), exhibit numbers (4.14, 4.18), and dates (Nov 6, 2023)—are correct. The progression across years is accurately described. (2) Quantitative accuracy is perfect: percentages, exhibit numbers, and dates match the original answer and expected filings. (3) The multi-hop reasoning is sound: the LLM correctly traces the note’s presence in the 2022, 2023, and 2024 10-Ks, identifies the relevant Supplemental Indentures, and contextualizes the evolution of Microsoft’s debt maturity structure. It adds value by noting the Fifteenth Supplemental Indenture in 2023 and the broader shift toward longer-dated maturities, which is consistent with the ground truth’s theme of structured debt management. (4) The only minor gap is that the LLM does not explicitly address why the 2023 notes remain listed in 2024 after maturity (e.g., rollover, delayed maturity, disclosure requirement), which the original answer speculates on. However, the LLM does correctly observe that the 2023 tranche is 'aging out' amid newer issuances, capturing the essence of the maturity progression. Wording differs but semantic meaning and factual content are substantially equivalent. Contextual relevance is excellent—directly addresses the evolution of the notes and debt structure across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 389,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Across the three most recent 10‑K filings the company’s **Non‑Employee Restricted Stock Unit (RSU) Award Agreement** did not change its underlying framework. In the 2022 filing (exhibit 10.42) the agreement is described as a “Form of Non‑Employee Restricted Stock Unit Award Agreement **under the Amended and Restated 2013 Stock Award and Incentive Plan**” (referencing Exhibit 10.65). The same language and reference appear in the 2023 filing (exhibit 10.42, same plan and Exhibit 10.65) and again in the 2024 filing (exhibit 10.42, same plan and Exhibit 10.65). Thus, from 2022 through 2024 Medtronic’s non‑employee RSU agreements remained tied to the 2013 Stock Award and Incentive Plan, with no new plan or amendment reflected in the disclosures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor discrepancy in exhibit numbers that affects precision. (1) The core factual claim—that Medtronic’s Non-Employee RSU Award Agreements from 2022 to 2024 consistently referenced the Amended and Restated 2013 Stock Award and Incentive Plan—is accurate and matches the original answer. This demonstrates correct entity identification and multi-year synthesis. (2) However, the LLM incorrectly cites exhibit numbers: it states the agreement was in 'exhibit 10.42' with reference to 'Exhibit 10.65' in all three years, while the ground truth specifies 'Exhibit 10.45' for 2022 (and implies continuity). This inconsistency undermines quantitative accuracy slightly, though exhibit numbering is not central to the question’s substance. (3) The reasoning is sound—correctly identifying continuity in plan reference across years—and captures the multi-hop requirement of comparing filings over time. (4) The answer is contextually relevant and conveys semantic equivalence regarding the stability of the underlying plan and form agreement. The omission of the plan’s effective date (December 8, 2017) noted in the original answer is a minor completeness gap but does not detract from the main conclusion. Thus, high scores are warranted, with a deduction primarily for exhibit number inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 381,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ’s non‑U.S. pension‑plan mix shows the share of assets held in buy‑in annuity policies fell from 17 % in 2022 to 16 % in 2023 and then rose back to 17 % in 2024 (see the allocation tables for 2022‑2024). The dip in 2023 followed by a rebound in 2024, together with the increase in the dollar amount of Level‑3 buy‑in annuity contracts (from $1.54 bn in 2022 to $2.08 bn in 2024), suggests the company is deliberately using buy‑in annuities to transfer more of its international pension‑liability risk to insurers, tightening liability management as market conditions evolve.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MDLZ's allocation to buy-in annuity policies decreased from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024. However, the LLM claims the allocation rose back to 17% in 2024, which directly contradicts the ground truth. Additionally, the LLM states that the dollar amount of Level-3 buy-in annuity contracts increased from $1.54 billion in 2022 to $2.08 billion in 2024, implying continued or increased use of these instruments. This is inconsistent with the ground truth that the company shifted away from such policies and discontinued them by 2024. (2) The quantitative inaccuracies are severe: the percentage trend is wrong (17% → 16% → 17% vs. 17% → 16% → effectively 0%), and the reported dollar amounts for Level-3 contracts are not supported by the ground truth, which does not mention such figures. These numbers appear fabricated or misattributed. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers that increasing dollar amounts and a rebound in percentage allocation indicate a strategy of transferring more risk to insurers. In reality, the trend suggests the opposite: a move away from insurer-backed annuities toward fair value estimation methods, indicating a shift toward direct liability management. The LLM fails to recognize the strategic discontinuation and misinterprets the direction of the company’s liability management strategy. (4) While the answer is framed around the correct entities (MDLZ, non-U.S. pension plans, buy-in annuities) and addresses the question’s structure, the core facts and conclusions are incorrect. The contextual relevance is moderate because it discusses the right topic and time frame, but the factual foundation is unsound, leading to a misleading interpretation. Correctness and accuracy scores are low due to major errors in data and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 523,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Across the three most recent 10‑K filings the 2.000 % notes that mature in 2023 appear only in the “Eleventh Supplemental Indenture” (Exhibit 4.14). The FY 2022 filing first lists these notes, and the FY 2023 and FY 2024 filings repeat the same exhibit with no new issuances or amendments, indicating that the notes were carried on the balance sheet until their 2023 maturity. This consistency shows Microsoft’s long‑term debt strategy of issuing modest‑coupon, short‑dated securities to diversify its maturity profile while relying primarily on longer‑dated, higher‑coupon issuances for its overall financing needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: the 2.000% Notes due in 2023 are consistently referenced in Exhibit 4.14 (Eleventh Supplemental Indenture) across FY 2022, 2023, and 2024, with no amendments or new issuances—this matches the original answer. The maturity year (2023) and exhibit number are correctly cited. (2) The answer correctly observes that the notes were carried through all three reporting periods, including FY 2024, which confirms they remained on the balance sheet until maturity—this is consistent with the ground truth's claim that Microsoft did not retire or refinance them early. (3) The reasoning is sound: the stability in disclosure supports the conclusion of a steady debt management strategy. The LLM adds a slight interpretive layer—describing the notes as 'short-dated' and 'modest-coupon'—which is reasonable (2.000% is relatively low) and consistent with Microsoft’s broader strategy, though this characterization is not explicitly in the ground truth. This does not detract from accuracy but adds context. (4) All parts of the question are addressed: evolution across years (no change), and implications for long-term debt strategy (consistency, steady approach). The only minor gap is that the LLM does not explicitly mention the August 8, 2016 indenture date, but this detail is secondary to the core evolution and strategy analysis. Overall, the answer is semantically equivalent, multi-hop reasoning is correct, and the conclusion is well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 428,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the 4.000 % Notes due 2021 are consistently disclosed as part of **Exhibit 4.6 – the “Third Supplemental Indenture”** (dated Feb 8 2011) that also covers the 2.500 % notes due 2016 and the 5.300 % notes due 2041 【page_104】. In each year the filing simply references that same supplemental indenture and treats the 4.000 % notes as an outstanding series within Microsoft’s broader senior unsecured debt portfolio; no additional or replacement supplemental indenture is filed, and the notes remain governed by the original 2011 indenture throughout the three reports.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are consistently grouped under Exhibit 4.6 – the Third Supplemental Indenture dated February 8, 2011 – across all three years, alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041. The absence of any new or replacement supplemental indenture for these notes is correctly noted. (2) Quantitative elements – interest rates (4.000%, 2.500%, 5.300%), dates (Feb 8, 2011), and exhibit number (4.6) – are all factually accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings and identifies consistency in treatment over time, which is central to the question. (4) The only minor omission is that the original answer notes Microsoft introduced new debt instruments under subsequent supplemental indentures (e.g., 2.375% Notes due 2023 in 2023), which provides additional context about the broader debt structure evolution. While this detail enriches completeness, its absence does not undermine the core correctness regarding the specific 4.000% Notes due 2021. The LLM answer remains semantically equivalent in addressing the primary focus of the question: the consistent treatment of the 2021 notes. Thus, a score of 9 is justified due to high accuracy with a slight deduction for partial completeness on the broader debt instrument context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 398,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Across the three annual reports the “Euro Deferred Shares” note is unchanged: the capital‑stock authorizes 40 thousand €1‑par deferred shares, and the 2022 filing states that “at April 29 2022, no Euro Deferred Shares were issued or outstanding,” while the 2024 filing repeats that “at April 26 2024, no Euro Deferred Shares were issued or outstanding” (the 2023 filing contains the same language). The persistent lack of any issuance or outstanding balance shows that Medtronic keeps this class merely as a dormant reserve, using it only as a contingency while deliberately avoiding dilution of ordinary shareholders and signaling a capital‑structure strategy that relies on ordinary‑share repurchases and stock‑based compensation rather than activating the deferred‑share vehicle.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Medtronic maintained an authorization of 40 thousand Euro Deferred Shares with €1.00 par value across fiscal years 2022–2024, and consistently disclosed zero issued or outstanding shares. The specific dates (April 29, 2022, and April 26, 2024) are correctly cited, and the repetition of identical language in the 2023 filing is accurately noted. (2) Quantitative elements—share count, par value, and absence of issuance—are factually precise and match the ground truth; no calculation errors exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures across three fiscal years and infers strategic implications from the consistent non-use of the instrument. (4) The LLM adds slightly more interpretive depth (e.g., 'dormant reserve', 'avoiding dilution', 'reliance on repurchases and stock-based compensation') that goes beyond the original answer but remains logically consistent and plausible given the data. While this added interpretation is not explicitly confirmed in the ground truth, it does not contradict it and enhances the analysis without introducing error. Thus, the answer is fully factually correct with excellent reasoning and relevance, meriting a 9 due to minor extrapolation beyond the documented inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 377,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "In the 2022, 2023 and 2024 Form 10‑K filings Microsoft’s exhibit list still includes **Exhibit 4.6 – “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041,”** dated February 8 , 2011【page_104】. The description of the 4.000 % Notes due 2021 is identical in each year’s filing, with no additional amendments, retirements or new disclosures. This consistency shows that Microsoft continues to treat the 4.000 % Notes due 2021 as an unchanged, outstanding debt instrument, reporting it through the same supplemental indenture across all three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer correctly identifies the exhibit number (4.6), the date of the Third Supplemental Indenture (February 8, 2011), and the consistent inclusion of the 4.000% Notes due 2021 across the 2022, 2023, and 2024 10-K filings. The numeric details—interest rate (4.000%), maturity year (2021), and exhibit reference—are factually accurate, supporting a high quantitative accuracy score. (2) However, the key qualitative error lies in the interpretation: the LLM concludes that Microsoft 'continues to treat the 4.000% Notes due 2021 as an unchanged, outstanding debt instrument,' which contradicts the ground truth. Since the notes were due in 2021, by 2022 they were already matured or settled. Their continued disclosure is for documentary completeness, not because they are outstanding. The ground truth correctly states this consistency indicates the debt was fully accounted for, not that it remains outstanding. (3) The multi-hop reasoning is partially sound—information is correctly synthesized across years and filings—but the conclusion misinterprets the implication of unchanged disclosures. A matured debt instrument should not be characterized as 'outstanding' in post-maturity filings. (4) While the factual elements are largely correct, the central inference is flawed, reducing the correctness and qualitative accuracy scores. Contextual relevance is high as the response directly addresses the evolution and treatment of the debt over time, albeit with incorrect interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 411,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin’s 10‑K filings show that the company has kept “pension‑risk‑transfer” activity alive after the 2021 $4.9 billion group‑annuity purchase.  The 2023 filing notes that, **since December 2018 the master retirement trust has purchased contracts for approximately $11.6 billion of defined‑benefit pension obligations** (which includes the 2021 $4.9 billion transaction)【page_60】.  The 2024 filing repeats the same language, saying the company “continues to take actions to reduce the size of our defined‑benefit pension plans…through additional pension‑risk‑transfer transactions in future years”【page_47】.  Although the 2022 filing does not give a separate dollar amount, the consistent discussion of ongoing transfers in each year indicates that Lockheed Martin is steadily moving additional portions of its pension obligations to third‑party insurers each year.\n\n**Trend and implication:** The company’s disclosures show a **continuous, albeit gradually diminishing, stream of pension‑risk‑transfer transactions** that have already moved more than $11 billion of obligations off its balance sheet.  This pattern signals a deliberate long‑term liability‑management strategy: Lockheed Martin is systematically de‑risking its defined‑benefit pension exposure, reducing volatility in pension expense and PBGC premiums, while spreading the transfers over several years rather than relying on a single large transaction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key quantitative aspects: it accurately reports the $11.6 billion in pension obligations transferred since December 2018, correctly references the inclusion of the 2021 $4.9 billion transaction, and correctly notes that the 2023 and 2024 filings reaffirm ongoing risk transfer intentions. The absence of a separate 2022 dollar amount is accurately acknowledged, and the cumulative figure aligns with the ground truth. 2) Quantitative accuracy is perfect: $11.6 billion matches the ground truth, and the contextual explanation of the 2021 transaction being part of that total is consistent with disclosed data. No calculations are required beyond accurate reporting. 3) Reasoning is sound and reflects multi-hop synthesis across 2023 and 2024 filings. The LLM correctly infers a sustained strategy from repeated disclosures, even without new dollar figures post-2023. The minor deduction in qualitative accuracy is due to the phrase 'gradually diminishing stream,' which is interpretive and not directly supported by the filings—while plausible, it introduces a nuance (diminishing pace) not present in the ground truth. 4) Contextual relevance is excellent: the answer directly addresses both parts of the question—evolution of transfers (2022–2024) and strategic implications—with precise citations and logical synthesis. Overall, the answer conveys semantic equivalence to the ground truth with only minor interpretive overreach in characterizing the trend as 'diminishing.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 417,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings the 0.125 % Notes due 2029 are presented in the Exhibit Index as a “Form of Note” (exhibit 4.23 in 2022, the same numbering in 2023 and again listed as 4.23 in 2024) and are always cross‑referenced to the same Form 8‑K filing dated September 18 2020. The company’s disclosure of this low‑coupon series has not changed – it remains a separate note series listed among the other senior unsecured notes – demonstrating a consistent approach to structuring and reporting this debt instrument over the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 0.125% Notes due 2029 across 2022, 2023, and 2024 10-K filings, noting the consistent use of Exhibit 4.23 and referencing the same Form 8-K filing (September 18, 2020). This aligns with the ground truth, which confirms the note was listed in Exhibits 4.23 and 4.31 each year with consistent source documentation. However, the LLM omits mention of Exhibit 4.31, which is a recurring disclosure location in all three years according to the original answer. This is a minor omission but affects completeness. (2) Quantitatively, all dates and exhibit numbers are accurate: September 18, 2020, is correctly cited as the Form 8-K date, and the 0.125% coupon rate and 2029 maturity are correct. The exhibit numbering (4.23) is consistent across years as stated. The ground truth also references a March 2021 Form 8-K, which the LLM answer does not mention, indicating a partial gap in source cross-referencing. (3) The reasoning is sound: the LLM correctly infers that unchanged disclosure and structuring reflect a stable capital market strategy, which is consistent with the conclusion in the original answer. However, the failure to note the dual exhibit references (4.23 and 4.31) and the second Form 8-K filing limits the depth of multi-hop synthesis. (4) The answer is highly contextually relevant, directly addressing the evolution (or lack thereof) in disclosure and what it implies about debt structuring consistency. The conclusion about consistent reporting and structuring is valid and supported. The score is reduced slightly due to incomplete exhibit and source citation coverage, but core facts and interpretation remain accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 469,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s accrued liability for product‑performance and operating‑cost guarantees fell from roughly $1.1 billion at year‑end 2022 (‑$1,109 million) to about $0.99 billion at year‑end 2024 (‑$993 million) 【page_102】.  The decline reflects lower net balances after fewer new guarantees were issued and settlements exceeded issuances, suggesting the company’s exposure to long‑term product‑performance risk in its commercial‑aerospace business has been modestly easing over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that RTX's liabilities related to performance and operating cost guarantees—specifically the collaboration partners' share of financing guarantees—were $141M in 2022, $135M in 2023, and $131M in 2024. The LLM incorrectly reports total accrued liabilities as approximately $1.1 billion in 2022 and $0.99 billion in 2024, which is over 7 times larger than the actual figures. This misrepresents the scale and trend entirely. (2) The numbers cited by the LLM (-$1,109 million and -$993 million) do not match any data in the ground truth and appear to misinterpret or misextract financial figures, possibly confusing this liability with another line item. The direction of change (decrease) aligns loosely with the slight downward trend in the correct data, but the magnitude and context are wrong. (3) The reasoning is partially sound in interpreting a declining trend as indicating reduced exposure, but it fails the multi-hop requirement: the original answer emphasizes that the company’s own liabilities are not explicitly stated and that estimates are based on historical experience and claims adjustments. The LLM omits this nuance and instead presents a precise, confidently quantified trend that is unsupported. (4) While the LLM attempts to address both parts of the question—evolution of liabilities and implications for long-term risk—the quantitative inaccuracy severely undermines the correctness score. The contextual relevance is moderate because it discusses the right topic and draws a plausible (though oversimplified) conclusion, but the factual foundation is flawed. Thus, the correctness score is low at 3 due to major factual and numerical errors, despite some alignment in directional trend and topic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 497,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic’s Black‑Scholes inputs for its non‑qualified options have shifted markedly. The weighted‑average fair‑value per option fell from $22.83 in FY 2022 to $18.49 in FY 2024, while the risk‑free rate rose from 0.90 % to 4.16 % and the volatility assumption was nudged up from 23.0 % to 24.3 % (dividend yield also rose to 3.2 %). These changes indicate that the company is now using higher market‑based discount rates and a slightly higher volatility estimate, reflecting a more conservative view of stock‑price risk and a tighter, higher‑volatility equity‑compensation model than it employed in 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Medtronic consistently used the Black-Scholes model and focused on the evolution of how expected volatility was disclosed—specifically, an increased emphasis on implied volatility derived from market-traded options by 2023. However, the LLM introduces specific numerical values (e.g., fair value per option: $22.83 in FY2022 to $18.49 in FY2024, risk-free rate from 0.90% to 4.16%, volatility from 23.0% to 24.3%, dividend yield to 3.2%) that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear fabricated or misattributed, failing the quantitative accuracy test. (2) There is no mention in the ground truth of changes in risk-free rates, dividend yields, or per-option fair values—these are complete additions not supported by the source. The only relevant evolution is in the disclosure methodology around volatility, not the volatility assumption itself. The LLM incorrectly claims volatility was 'nudged up' from 23.0% to 24.3%, while the original answer does not provide any such percentages. (3) The multi-hop reasoning is flawed: the LLM infers a 'more conservative view' and 'tighter, higher-volatility model' based on made-up inputs, whereas the actual reasoning in the ground truth centers on improved transparency and market-informed assumptions due to explicit mention of implied volatility from traded options. The LLM fails to capture the real shift—enhanced disclosure and reliance on forward-looking market data. (4) While the LLM correctly identifies the use of Black-Scholes and touches on volatility and risk modeling, the heavy reliance on unsupported numbers and incorrect causal reasoning drastically undermines accuracy. The contextual relevance is moderate because it addresses equity compensation risk modeling and volatility, but the factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 542,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "Across the three most recent filings the 1.000 % note due 2028 is listed in each exhibit index: the 2022 10‑K shows it as Exhibit 4.26 (“Note for 1.000 % Notes due 2028”)【page_134】, the 2023 10‑K repeats the same entry as Exhibit 4.26【page_136】, and the 2024 10‑K again includes it as Exhibit 4.26【page_130】. The note first appeared in a 2020 filing and has been carried forward unchanged through 2022‑2024, indicating that Coca‑Cola issued this low‑coupon, medium‑term debt and has chosen to keep it on its balance sheet until maturity rather than repeatedly refinancing or issuing additional series at the same rate. This consistency suggests a deliberate strategy of locking in ultra‑low interest costs and maintaining a stable, long‑standing tranche of debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent presence of the 1.000% Notes due 2028 in the 2022, 2023, and 2024 10-K filings, with accurate exhibit numbers and page references, confirming quantitative and entity accuracy. All dates, percentages, and document locations are factually correct. (2) Quantitative accuracy is perfect: the interest rate (1.000%), maturity year (2028), exhibit number (4.26), and filing years (2022–2024) match the ground truth. No calculations were required, but the tracking of the note’s persistence is precise. (3) However, the reasoning diverges from the ground truth in a key aspect of multi-hop synthesis: while the LLM emphasizes stability and a strategy of maintaining low-cost debt without refinancing, it omits the critical 2024 context from the original answer—namely, that Coca-Cola issued new, high-yield notes (5.000% due 2034 and 5.300% due 2054) in 2024, signaling a broader strategic shift toward higher-cost borrowing. This omission limits the qualitative accuracy, as the full debt strategy includes both maintaining legacy low-rate debt and embracing more expensive new debt, suggesting a nuanced approach possibly tied to funding new initiatives or refinancing. The LLM’s conclusion of a purely stability-focused strategy is partially correct but incomplete. (4) The answer is highly contextually relevant, directly addressing the evolution of the specific instrument and inferring strategy. Due to the omission of the 2024 strategic shift, the correctness score is reduced to 7—core facts are right, but strategic interpretation lacks full depth from multi-year synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 449,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "- **2022 Form 10‑K:** Microsoft’s 2.125 % notes are disclosed in the **Fourth Supplemental Indenture** (2.125 % Notes due 2022) and the **Seventh Supplemental Indenture** (2.125 % Notes due 2021). Both indentures name **The Bank of New York Mellon Trust Company, N.A.** as the trustee and are presented together with other series such as the 0.875 % notes due 2017 and the 3.500 % notes due 2042.  \n\n- **2023 Form 10‑K:** The same two supplemental indentures are again referenced, showing that the 2.125 % notes remain under the **same trustee (The Bank of New York Mellon Trust Company, N.A.)** and are still grouped with the same companion debt issues; no new trustee or restructuring of the 2.125 % series is disclosed.  \n\n- **2024 Form 10‑K:** Microsoft adds a **Fifteenth Supplemental Indenture (dated Nov 6 2023)** but continues to list the Fourth and Seventh Supplemental Indentures, meaning the 2.125 % notes are still serviced by **The Bank of New York Mellon Trust Company, N.A.** while the overall debt program now includes additional newer series, indicating an evolution toward a broader supplemental‑indenture framework without changing the trustee for the 2.125 % notes.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, leading to a partially accurate response. (1) On correctness: The ground truth states that the 2.125% Notes due 2021 were disclosed under the Seventh Supplemental Indenture in all three years (2022–2024), with consistent trustee and associated instruments. However, the LLM incorrectly introduces a 'Fourth Supplemental Indenture' for 2.125% Notes due 2022 in the 2022 filing, which contradicts the ground truth (which references only the 2021 maturity). This is a factual error in both maturity year and indenture number. Additionally, the LLM claims a 'Fifteenth Supplemental Indenture' was added in 2024, which is not mentioned in the ground truth and introduces a detail unsupported by the original answer. (2) Quantitative accuracy: The interest rate (2.125%) and trustee name (The Bank of New York Mellon Trust Company, N.A.) are correct across years, but the maturity years (2022 vs. 2021) and supplemental indenture numbers (Fourth, Fifteenth) are incorrect. These are critical factual discrepancies, not formatting issues. (3) Reasoning: The LLM attempts multi-hop synthesis across years and correctly infers that the trustee remained unchanged, which aligns with the ground truth. However, it incorrectly infers structural evolution due to new indentures, while the ground truth emphasizes *no changes* in structure or administration. Thus, the conclusion about 'evolution toward a broader supplemental-indenture framework' misrepresents the stability emphasized in the original answer. (4) Contextual relevance is high—the response directly addresses trustee arrangements and related debt instruments across the three years, using appropriate financial terminology and structure. Despite incorrect details, it follows the right analytical path. Overall, key facts are flawed, especially regarding indenture numbers and maturities, but the core idea of trustee consistency is preserved, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 534,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "- **Net program‑share evolution:** In the 2022 filing Pratt & Whitney’s net program‑share interest in the International Aero Engines (IAE) collaboration was **about 57 %**, and its net interest in International Aero Engines LLC (IAE LLC) was **about 51 %**. The 2023 10‑K repeats the same figures (57 % for IAE and 51 % for IAE LLC) 【page 99, NOTE 15】, and the 2024 10‑K again reports **57 %** and **51 %**, respectively 【page 101, NOTE 15】.  \n\n- **Strategic implication:** Holding a consistent majority (57 %) in the V2500 program (through IAE) and a controlling stake (51 %) in the PW1100G‑JM program (through IAE LLC) shows RTX’s deliberate positioning as the primary beneficiary of these key commercial‑engine platforms, reinforcing its competitive foothold in both the legacy V2500 market and the newer geared‑fan A320neo engine family.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Pratt & Whitney's net program share interest in IAE was about 57% and in IAE LLC about 51% in 2022, which contradicts the ground truth. According to the original answer, in 2022, the net program share interest was not explicitly stated but was inferred as 61% for IAE and 59% for IAE LLC before sub-collaborator adjustments. The 57% and 51% figures only appeared in 2023 and 2024 after a decrease due to sub-collaborator shares. Thus, the LLM misrepresents the 2022 baseline, which is a significant factual error. (2) The quantitative accuracy is low because the key percentages for 2022 are wrong. While the 2023 and 2024 numbers (57% and 51%) are correctly reported, the failure to reflect the earlier higher shares in 2022 undermines the evolution narrative. The answer falsely implies stability from 2022 onward, when the ground truth describes a decline from 61% to 57% (IAE) and 59% to 51% (IAE LLC) between 2022 and 2023. (3) The qualitative reasoning is partially sound: the LLM correctly infers strategic significance from majority control in both programs and links IAE to V2500 and IAE LLC to PW1100G-JM. However, it misses the key point about strategic recalibration and adjustment in collaboration structures that the ground truth emphasizes, instead portraying the shares as stable and deliberate from 2022. This omits the dynamic shift and subsequent stabilization. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of shares and strategic implications—and correctly identifies the entities and programs involved. Despite incorrect numbers, the framing and intent align with the question's requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 469,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans rose from **$402 million in 2022** to **$468 million in 2023** (an increase of $66 million) and then fell slightly to **$443 million in 2024** (about $25 million less than the 2023 peak but still above the 2022 level)【page 53】【page 67】.  \n\nThis pattern shows the company stepped up its contributions in 2023, reflecting a stronger investment in employee benefits, and then modestly scaled back in 2024 while maintaining a higher‑than‑2022 level, indicating a continued but slightly more calibrated commitment to its workforce.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $468 million contribution in 2023 and $443 million in 2024, which match the ground truth. However, it incorrectly states the 2022 contribution as $402 million instead of the correct $299 million. This is a significant quantitative error that affects the accuracy of the trajectory description. (2) The calculation of the $66 million increase from 2022 to 2023 is based on incorrect input ($402M → $468M), so this delta is wrong; the actual increase was $169 million ($299M → $468M). The $25 million decrease from 2023 to 2024 is approximately correct (actual: $25M). The statement that 2024 spending was 'above the 2022 level' is factually correct, but the magnitude of difference is misrepresented due to the incorrect 2022 figure. (3) The multi-hop reasoning is sound—LLM correctly synthesizes trends across three years and draws a logical conclusion about investment in employee benefits. The qualitative interpretation—that there was a significant increase in 2023 followed by a modest pullback while maintaining higher-than-baseline support—is consistent with the ground truth, albeit with distorted emphasis due to the incorrect starting point. (4) The contextual relevance is perfect: the answer addresses both parts of the question (evolution of contributions and what it suggests about investment in benefits) and uses appropriate terminology. Due to the major error in the 2022 figure, the quantitative accuracy is penalized heavily, but the qualitative reasoning and overall structure remain strong, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 438,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "- In the 2022 Form 10‑K the exhibit index lists a “Form of Current Note for **3.000 % Notes due 2051**” (Exhibit 4.6) 【page_134】.  \n- The 2023 Form 10‑K still includes the same 3.000 % 2051 note in its exhibit list (again as Exhibit 4.6) 【page_130】.  \n- By the 2024 Form 10‑K the 3.000 % 2051 note no longer appears; instead the exhibit list shows newer, higher‑coupon long‑term issues such as 5.000 % Notes due 2034, 5.300 % Notes due 2054, 5.400 % Notes due 2064, etc. 【page_130】\n\n**Interpretation:** Coca‑Cola kept its ultra‑long‑dated, low‑rate 3 % 2051 debt on the books through 2023, but by 2024 it had either refinanced or retired that issue and added higher‑yield, longer‑maturity notes, indicating a strategic shift to diversify its debt profile and take advantage of market conditions while maintaining a robust long‑term capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the presence of the 3.000% Notes due 2051 in the 2022 and 2023 10-K filings with accurate exhibit references (Exhibit 4.6) and page numbers, which matches the ground truth. However, it incorrectly states that the 3.000% Notes due 2051 'no longer appears' in the 2024 10-K, which contradicts the original answer stating that Coca-Cola 'still retaining the 3.000% Notes due 2051 in its disclosures' in 2024. This is a critical factual error. The LLM also correctly identifies the introduction of new higher-coupon instruments in 2024 (5.000% Notes due 2034, 5.300% due 2054, etc.), which is consistent with the ground truth. (2) Quantitatively, all percentages and maturities mentioned are accurate (3.000%, 5.000%, 5.300%, 2051, 2034, etc.), and no calculations are required, so numerical accuracy is mostly sound except for the erroneous omission claim in 2024. (3) The multi-hop reasoning is partially sound—LLM correctly tracks the debt instruments across years and attempts to infer strategic intent. However, the conclusion that the 3.000% Notes were retired or refinanced by 2024 is unsupported by the ground truth, which explicitly states they were still retained. This undermines the qualitative reasoning and leads to an incorrect interpretation of a 'strategic shift' involving retirement, whereas the truth indicates continuity and diversification, not replacement. (4) Contextual relevance is high—the response addresses the evolution of debt instruments and attempts to interpret capital structure strategy. However, due to the key factual error about the removal of the 3.000% Notes in 2024, the overall correctness is significantly reduced. The answer is partially correct but contains a major factual inaccuracy that alters the strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 491,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first introduced the 2.875 % Notes due 2031 in a filing dated March 24 2021 (Exhibit 4.14) 【page_111】.  In the 2022, 2023 and 2024 Form 10‑K filings the same series is listed again (Exhibit 4.14) as an outstanding security 【page_111】【page_111】【page_111】, with no new issuances or amendments reported.  This continuity shows that Oracle has kept the low‑coupon, long‑dated note on its balance sheet, using it to lock in inexpensive financing and to manage interest‑rate risk as part of a long‑term debt strategy that favors stable, fixed‑rate obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly identifies the 2.875% Notes due 2031 and their continued listing in Oracle's 10-K filings from 2022 to 2024, which aligns with the ground truth. The mention of Exhibit 4.14 and page 111 references adds specificity, though the initial issuance date of March 24, 2021, while possibly accurate, is not part of the original question's scope (which focuses on 2022–2024), so it neither supports nor detracts significantly. However, the LLM fails to mention the key 2024 development: the introduction of newer, higher-yielding notes (4.500% due 2028 and 4.900% due 2033), which is central to the strategic shift described in the ground truth.\n\n2) Quantitatively, the interest rate (2.875%) and maturity year (2031) are correct. The years 2022, 2023, and 2024 are accurately referenced. There are no calculation errors because no computations were required. The issuance date (March 24, 2021) is presented with precision, though it is outside the scope of the question and not confirmed or denied by the ground truth.\n\n3) The reasoning is partially sound but incomplete. The LLM correctly infers that maintaining the 2.875% Notes indicates a strategy of locking in low-cost, fixed-rate debt. However, it misses the multi-hop insight that Oracle’s 2024 filings include higher-yielding debt instruments, signaling a shift in strategy due to evolving market conditions. This omission prevents a full synthesis of Oracle’s evolving debt strategy, which includes both stability in existing instruments and adaptation via new, costlier debt.\n\n4) The answer is contextually relevant and well-structured, focusing on Oracle’s long-term debt and using appropriate financial reasoning. However, the failure to incorporate the introduction of higher-yielding notes in 2024 results in an incomplete qualitative assessment of Oracle’s strategic direction. This missing element significantly weakens the conclusion about Oracle’s broader debt strategy, making the answer partially correct but lacking critical comparative analysis required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 553,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022‑2024 all list the same “2.000% Notes due 2023” in the Eleventh Supplemental Indenture (see Exhibit 4.14)【page_105】. By keeping this fixed‑rate, medium‑term bond on its balance sheet and repeatedly disclosing it, Microsoft shows that it deliberately locks in stable financing costs and manages its long‑term debt profile, while its year‑over‑year transparency reinforces a consistent, high‑visibility reporting strategy for its obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent disclosure of the 2.000% Notes due 2023 across Microsoft's 2022, 2023, and 2024 10-K filings, accurately reflecting the key factual elements from the ground truth. The interest rate (2.000%), maturity year (2023), and reference to the Eleventh Supplemental Indenture are all correct. The citation of Exhibit 4.14 and page reference (page_105) adds specificity and aligns with typical 10-K structure, though such granular document details were not in the ground truth, they do not detract from accuracy. (2) Quantitatively, all numbers—interest rate and maturity year—are correct and consistently reported. There are no calculations required, but the temporal consistency across three years is correctly implied. (3) The reasoning is sound in linking repeated disclosure to stable debt management and transparency. However, the LLM answer misses a key nuance in the ground truth: that the notes were first introduced in the 2022 filing (i.e., not outstanding in prior years) and carried forward unchanged, which underscores continuity in reporting rather than active balance sheet management of an existing instrument. The phrase 'keeping this... on its balance sheet' may imply the debt was still outstanding in 2023 and 2024, which is factually incorrect since the notes matured in 2023. This is a minor but notable misinterpretation of the debt's lifecycle. (4) Despite this, the answer captures the core intent of the question—transparency and consistent disclosure strategy—and draws a reasonable conclusion about Microsoft’s financial stewardship. The contextual relevance is high, and the qualitative reasoning is mostly accurate, warranting a strong but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 473,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "- In the 2022 filing RTX disclosed **≈ $735 million** of “other commercial‑aerospace commitments” that include the contingent flight‑hour payments to Rolls‑Royce under the 2012 IAE acquisition.  \n- In the 2023 filing the same line grew to **≈ $1.05 billion**.  \n- In the 2024 filing the gross amount of those “other commercial‑aerospace commitments” had risen to **≈ $9.5 billion** (net of partner share ≈ $3.7 billion), reflecting the accumulated V2500‑engine flight‑hour obligations that will continue through June 2027.  \n\n**Interpretation:** The obligation has been rising each year and is now substantially larger, showing that RTX’s contingent liability to Rolls‑Royce is expanding and will remain a material, multi‑year exposure under the 2012 IAE acquisition agreement.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the reported financial figures. The ground truth does not specify dollar amounts for RTX's contingent payments in any year, nor does it mention $735 million in 2022, $1.05 billion in 2023, or $9.5 billion in 2024. These numbers are entirely fabricated or misattributed. The original answer focuses on the accounting treatment and classification of the payments, not their dollar value. (2) The quantitative inaccuracies are severe—there is no support in the ground truth for any of the specific dollar figures cited, including the net partner share of $3.7 billion. These numbers do not appear in the knowledge graph and contradict the qualitative nature of the original answer. Even allowing for format variation, the absence of any such figures in the ground truth makes this a critical failure. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies the 2012 IAE acquisition agreement, the link between contingent payments and V2500 flight hours, and the June 2027 end date. It also correctly infers that the obligation represents a long-term exposure. However, it incorrectly frames the evolution as a growing financial liability based on fabricated numbers, whereas the ground truth emphasizes consistency in accounting treatment (capitalization and amortization) rather than growth in obligation size. (4) The contextual relevance is moderate because the LLM addresses the right companies, agreement, and time horizon, and attempts to interpret long-term exposure. However, the reliance on false quantitative data undermines the conclusion. The qualitative accuracy is low because the reasoning is based on incorrect premises, even if the general direction (ongoing exposure) is correct. The correctness score is low due to the complete lack of quantitative accuracy and the propagation of false financial data, which distorts the actual progression described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 534,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "Thermo Fisher’s domestic‑pension assets held in U.S. equity funds were **$89 million in 2022**, rose to **$93 million in 2023**, and then slipped slightly to **$91 million in 2024**【page_57】【page_71】.  \n\nOver the three‑year span the allocation has been essentially flat – a modest rise followed by a small decline – keeping the U.S. equity exposure near the company’s stated target of roughly 10 % of domestic‑pension assets. This stability suggests TMO is maintaining a balanced, liability‑focused investment approach, adjusting equity exposure only marginally while keeping the bulk of the portfolio in fixed‑income assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts and years. According to the ground truth, TMO's allocation was $125M in 2022, decreased to $89M in 2023, and increased slightly to $93M in 2024. The LLM incorrectly states $89M in 2022, $93M in 2023, and $91M in 2024 — reversing the trend and misrepresenting both the starting point and trajectory. These errors affect all quantitative claims. (2) The calculations and comparisons are therefore invalid. The ground truth shows a clear 28.8% decrease from 2022 to 2023 followed by a modest recovery, indicating a strategic reduction with rebalancing. The LLM describes a flat trend with minor fluctuations around similar values, which contradicts the actual data. (3) The multi-hop reasoning is flawed because the model fails to correctly extract and synthesize the time-series data across the three years. The conclusion about 'essentially flat' allocation and alignment with a '10% target' is unsupported by the provided ground truth, which does not mention any percentage target or fixed-income strategy. (4) While the LLM attempts to interpret the strategic implication (balancing, liability focus), this analysis is based on incorrect data and introduces unverified details (e.g., 10% target), reducing qualitative accuracy. The answer is contextually relevant in structure and intent but factually incorrect in core content, warranting low scores in correctness and quantitative accuracy despite addressing the question's general scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 424,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "Coca‑Cola’s 2022 and 2023 10‑K exhibit schedules still listed the ultra‑low‑cost **1.000 % Notes due 2041** (see the 2022 filing, Exhibit 4.6, “Note for 1.000 % Notes due 2041” 【page_134】 and the 2023 filing, Exhibit 4.33, “Form of Note for 1.000 % Notes due 2041” 【page_136】). By the 2024 filing the company had begun issuing a new series of higher‑yielding bonds – for example 5.000 % Notes due 2034, 5.300 % Notes due 2054, 5.400 % Notes due 2064 and several 3‑4 % notes (see Exhibit 4.39‑4.47 in the 2024 filing 【page_130】). This reflects a shift from relying on the very low‑rate 1 % issue toward diversifying its long‑term debt mix with higher‑coupon notes as market rates rose.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all percentages and maturities are correct: the 1.000% Notes due 2041 are correctly cited for 2022 and 2023, and the introduction of 5.000%, 5.300%, and 5.400% notes in 2024 is accurately reported. The mention of 'several 3–4% notes' adds minor detail not in the original but does not contradict it. (2) The only minor discrepancy is in exhibit numbering: the LLM cites Exhibit 4.6 for the 2022 filing, while the ground truth specifies Exhibit 4.33. This is a factual inconsistency, though the referenced note (1.000% due 2041) is correct. (3) The reasoning is sound: the LLM correctly infers a strategic shift from low-yield to higher-yield debt instruments in response to rising market rates, synthesizing data across three years and multiple instruments. (4) The answer is contextually excellent, addressing both the persistence of the 1.000% Notes and the strategic introduction of higher-yielding debt in 2024. The conclusion about diversification and market rate response aligns semantically with the ground truth’s 'recalibration' narrative. The answer loses one point due to the exhibit number mismatch, but all key financial facts and strategic interpretation are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 359,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle has kept the 1.650 % Notes due 2026 in the list of outstanding securities in each of its 2022, 2023 and 2024 Form 10‑K filings (see Exhibit 4.14 in the 2024 filing 【page_111】).  At the same time the company added newer series of higher‑coupon debt – for example 5.800 % notes due 2025, 6.150 % notes due 2029, 6.250 % notes due 2032 and 6.900 % notes due 2052 (Exhibit 4.15) and 4.500 % notes due 2028, 4.650 % notes due 2030, etc. (Exhibit 4.16) 【page_111】.  This pattern shows Oracle’s strategy of preserving low‑cost, long‑dated financing (the 1.650 % 2026 notes) while supplementing its capital structure with higher‑interest issuances to meet additional funding needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's continued inclusion of the 1.650% Notes due 2026 across fiscal years 2022–2024, citing their presence in the 10-K filings. It accurately notes the introduction of higher-interest notes, including the 5.800% Notes due 2025 and 4.500% Notes due 2028 as in the ground truth. However, it adds extra notes not mentioned in the original answer (e.g., 6.150%, 6.250%, 6.900%, 4.650%) which, while possibly present in the filing, were not part of the ground truth response and could introduce minor overprecision or irrelevance. (2) Quantitatively, all cited percentages and maturities are accurate and consistent with the original answer where overlap exists. The mention of Exhibit 4.14 in the 2024 filing aligns with the ground truth, though the original also references Exhibits 4.16 (2022) and 4.14 (2023), which the LLM omits—this is a minor completeness gap but does not invalidate the core accuracy. (3) The multi-hop reasoning is sound: the LLM correctly infers Oracle’s dual debt strategy—maintaining low-cost debt while issuing higher-cost instruments—based on the coexistence of the 1.650% notes with newer, higher-yielding debt. This aligns with the original’s interpretation. (4) The answer is contextually highly relevant, directly addressing Oracle’s debt financing strategy. The only deviation is the inclusion of additional notes not emphasized in the ground truth, which slightly affects precision but not overall correctness. Hence, a score of 9 is warranted—excellent accuracy with minor overdetailing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 432,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s 10‑K filings for FY 2022, 2023 and 2024 all list Exhibit 4.6 – the “Third Supplemental Indenture for 2.500% Notes due 2016, **4.000% Notes due 2021**, and 5.300% Notes due 2041” 【page_104】. By repeatedly including the 4.000% 2021 notes, Microsoft shows that it has chosen to keep this particular issue outstanding through its scheduled maturity rather than refinancing or retiring it early, and it updates the exhibit each year to reflect the current set of outstanding indentures. This consistency signals a disciplined long‑term debt strategy that relies on maintaining existing, low‑cost borrowings while keeping its documentation current.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024, along with the correct accompanying notes (2.500% due 2016 and 5.300% due 2041) and the document title, which matches the ground truth. All numeric values—interest rates (4.000%, 2.500%, 5.300%) and maturity years (2016, 2021, 2041)—are accurate, satisfying quantitative accuracy. (2) However, the LLM misinterprets the implication of the continued listing: it suggests Microsoft kept the 4.000% Notes 'outstanding through its scheduled maturity,' which contradicts standard bond behavior—notes due in 2021 would typically be repaid or refinanced by that year and should not remain outstanding into 2022–2024. The ground truth correctly interprets the continued inclusion as reflecting administrative documentation continuity, not ongoing outstanding debt, noting only minor formatting updates (e.g., trustee name change in 2024) and absence of refinancing activity. The LLM incorrectly infers that the debt remained outstanding, which is a significant qualitative error in reasoning. (3) The multi-hop synthesis is partially sound—linking Exhibit 4.6 across years is correct—but the conclusion about debt management strategy overreaches by equating documentation persistence with active debt retention, failing to recognize that Exhibit 4.6 may be retained for historical or structural reasons (e.g., master indenture framework). (4) Despite this, the answer remains contextually relevant and captures the core pattern of consistent disclosure. Quantitative accuracy is perfect; qualitative accuracy is reduced due to flawed interpretation; overall correctness is moderately high but limited by the key misinterpretation of debt status post-maturity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 492,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s maximum‑potential exposure to commercial‑aerospace customer‑financing guarantees fell each year – $304 million in 2022, $288 million in 2023 and $274 million in 2024【page_100†L1-L8】【page_102†L1-L4】.  At the same time, the portion of those guarantees that is assumed by collaboration partners has also slipped, from $142 million in 2022 to $135 million in 2023 and $131 million in 2024【page_100†L9-L12】【page_102†L5-L7】.  The downward trend in both the total guarantee exposure and the partners’ share indicates that RTX is progressively shifting risk to its collaborators, using joint‑financing arrangements to reduce the amount of guarantee risk it retains.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly reports the collaboration partners' share of financing guarantees: $142M in 2022, $135M in 2023, and $131M in 2024 — matching the ground truth exactly. It also correctly identifies the downward trend in these values. However, the LLM introduces additional data — total exposure figures of $304M, $288M, and $274M for 2022–2024 — which are not present in the original answer and were not requested in the question. While these may be factually correct in context, their inclusion distracts from the core focus on partners' share.\n\n2) Quantitatively, all cited numbers (including the partners’ share) are accurate and properly sequenced across years. Format is consistent and acceptable. No calculation errors.\n\n3) The critical error lies in reasoning and interpretation: the LLM concludes that the declining partner share 'indicates that RTX is progressively shifting risk to its collaborators', which is the opposite of what the trend implies. A decreasing partner share means partners are assuming *less* risk, not more — so RTX is likely retaining more risk, not transferring it. This misinterpretation directly contradicts the ground truth, which states the trend 'signals a strategic shift where RTX assumed more direct financial risk'. This is a fundamental flaw in multi-hop logic.\n\n4) Contextually, the answer addresses the evolution of exposure and cites correct figures, making it relevant. But due to the incorrect causal inference, the qualitative accuracy is low despite strong quantitative performance. The conclusion undermines the correctness of the overall response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 440,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Microsoft’s exhibit schedule repeatedly lists the **Eleventh Supplemental Indenture** that created the **3.950 % senior notes due 2056** (dated August 8 2016) 【page_105】. No additional issuances of that series appear in any of the three years – the notes are simply carried forward as outstanding long‑term debt. This continuity shows Microsoft’s strategy of locking in low‑cost, very‑long‑dated financing and keeping a stable, diversified debt profile to support long‑term capital needs while preserving financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: the 3.950% Notes due 2056 were created under the Eleventh Supplemental Indenture dated August 8, 2016, and were consistently referenced in Microsoft's 2022, 2023, and 2024 10-K filings with no new issuances or changes. This matches the ground truth. (2) Quantitative accuracy is perfect: the interest rate (3.950%), maturity year (2056), and issuance date (August 8, 2016) are all correct. The LLM correctly notes no additional issuances occurred across the three years. (3) The multi-hop reasoning is sound—by synthesizing data across three years of filings, the model correctly infers that the consistent carry-forward of the debt instrument indicates a stable long-term capital strategy focused on maintaining low-cost, long-dated financing. The conclusion about financial flexibility and a diversified debt profile is a reasonable extension of the evidence. (4) The only minor gap is that the LLM slightly expands on the original answer by introducing the interpretation of 'low-cost' financing, which, while plausible, is not explicitly confirmed in the ground truth. However, this does not detract from factual correctness and is contextually appropriate. Overall, the answer is factually accurate, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 364,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "- **2022:** MFC’s tactical‑and‑strike missile portfolio was essentially flat – net sales were $11.3 billion and operating profit was $1.64 billion (14.5 % margin)【page_40†L1-L4】.  \n\n- **2023:** Production on the missile lines (JASSM, LRASM and other precision‑fire systems) began to ramp, adding $145 million of net sales, but profit‑booking‑rate adjustments turned unfavorable, pulling operating profit down $96 million to $1.54 billion (13.7 % margin)【page_40†L1-L4】【page_40†L31-L34】.  \n\n- **2024:** The ramp‑up accelerated, delivering $1.2 billion of extra net sales from GMLRS, LRASM and JASSM, raising total MFC net sales to $12.68 billion.  However, a $1.2 billion hit from lower profit‑booking‑rate adjustments (including a $1.4 billion loss on a classified contract) collapsed operating profit to $413 million (3.3 % margin)【page_40†L1-L4】【page_40†L13-L20】.  \n\n**Impact on overall operating profit:** Across the three‑year span, MFC’s operating profit fell from $1.64 billion in 2022 to $1.54 billion in 2023 (‑$96 million) and then to $0.41 billion in 2024 (‑$1.13 billion), a total decline of roughly $1.2 billion despite the strong sales growth from the tactical and strike missile programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key financial figures—$145M sales increase in 2023, $1.2B in 2024, $1.2B profit booking adjustment, and $1.4B loss on a classified program—are correct and match the original answer. The operating profit decline from $1.64B (2022) to $1.54B (2023) to $0.413B (2024) is accurately reported, as is the 73% drop (approximated as $1.1B in original, $1.13B in LLM—minor rounding difference). (2) Calculations are sound: the total profit decline of ~$1.2B is correctly derived from year-over-year changes. The LLM adds precise margin percentages and total net sales figures not in the original, which are consistent with the cited document pages and enhance completeness. (3) Multi-hop reasoning is strong: the answer synthesizes production growth with deteriorating profitability across three years, correctly identifying the divergence between volume and profit. It accurately attributes the 2024 collapse to profit-booking-rate adjustments and a classified program loss. (4) The only minor gap is that the LLM omits the $215M increase in 2022 mentioned in the original answer, instead stating sales were 'flat.' This is a small inconsistency, but otherwise, the trajectory and impact on operating profit are correctly conveyed. Overall, the answer is factually robust, contextually complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 391,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K the Exhibit list still shows only the original Executive Change‑in‑Control Retention Agreement with Marc N. Casper (Exhibit 10.12) and, for the first time, a separate “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.18, filed in 2018) 【page 46】.  \n\n- The 2023 Form 10‑K adds a **new version** of that officer‑only form – now filed as Exhibit 10.7 for the quarter ended April 1 2023 – while the Casper agreement (Exhibit 10.11) remains unchanged 【page 76】.  \n\n- The 2024 Form 10‑K does not introduce any further amendment or new form; it continues to list the same Casper agreement (Exhibit 10.11) and the officer‑only form introduced earlier, with no additional officers added 【page 76】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor discrepancies in detail. (1) It accurately identifies that in 2022, Thermo Fisher disclosed a separate form agreement for officers other than Marc N. Casper, noting the first-time inclusion in the 10-K exhibit list, which matches the original answer. However, it incorrectly states that the form was 'filed in 2018'—while this may be true historically, the ground truth emphasizes the 2022 introduction in the context of the current disclosure trend, so the emphasis on 2018 slightly misaligns with the intended focus on 2022 as the point of active inclusion. (2) For 2023, the LLM correctly notes a new version was filed as Exhibit 10.7, which matches the ground truth’s mention of the same exhibit number, and correctly observes no change to Casper’s agreement. (3) For 2024, the LLM correctly states there was no new amendment or form, consistent with the original answer’s description of continuity. The phrase 'no additional officers added' is an interpretation not explicitly supported in the ground truth, which only confirms the continued existence of the form, not whether specific officers were added. (4) Quantitative accuracy is high: exhibit numbers (10.18, 10.7, 10.11), years (2022–2024), and document types (Form 10-K) are correct. (5) Reasoning is sound across years, showing multi-hop synthesis of changes over time. (6) Contextual relevance is excellent—the response directly addresses the evolution of the agreements and inclusion beyond Casper. Minor over-interpretation in 2024 and the 2018 reference prevent a perfect score, but core facts and trajectory are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 456,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "Lockheed Martin uses variable‑rate swaps to hedge the fair‑value impact of its fixed‑rate borrowings (designated as fair‑value hedges) and uses fixed‑rate swaps to hedge the earnings impact of its variable‑rate borrowings (cash‑flow hedges). In the 2022 Form 10‑K the aggregate notional amount of those swaps was $500 million (for 2021), but the 2023 filing shows the notional had risen to $1.3 billion for both 2022 and 2023, and the 2024 filing confirms the same $1.3 billion level for 2023 and 2024. The jump and subsequent plateau indicate that the company deliberately expanded its swap program to cover a larger portion of its debt portfolio—enhancing its interest‑rate risk protection—and then maintained that hedge size as its ongoing risk‑management target.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and time periods are correct: $500 million in 2021 (disclosed in 2022 filing), increase to $1.3 billion in 2023, and maintenance at $1.3 billion in 2024. The LLM correctly interprets the disclosure timing and notional amounts across filings. (2) The answer correctly identifies the evolution in notional amounts and the stabilization at $1.3 billion, though it slightly misstates the years covered in the 2023 filing—saying the $1.3 billion level applies to both 2022 and 2023, whereas the ground truth indicates the increase occurred by 2023 (i.e., notional was $500M in 2021, then rose to $1.3B in 2023). This is a minor inaccuracy in year attribution but does not affect the overall correctness of the trend. (3) The reasoning is sound: the LLM correctly infers that the increase indicates a strategic expansion of hedging activity to manage interest rate risk and that the plateau suggests a sustained risk management posture. It accurately distinguishes between fair-value and cash-flow hedges, adding contextual depth not strictly required but relevant. (4) The answer is semantically equivalent to the original in intent and conclusion, with only slight imprecision in the timing of the increase. All parts of the question are addressed, including the evolution from 2022–2024 and the strategic implication of the change in notional amounts. The minor error prevents a perfect 10, but the answer is otherwise excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 420,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans was **$402 million in 2022**, rose to **$468 million in 2023**, and then eased to **$443 million in 2024**【page 67】.  The pattern shows a notable increase from 2022 to 2023, followed by a modest decline in 2024 that still leaves the expense above the 2022 level, indicating that the company has generally been maintaining or modestly expanding its investment in employee‑benefit contributions over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. The formatting variation (e.g., $402 million) is acceptable and semantically equivalent. (2) Quantitative accuracy is perfect—no calculation errors, and the values are correctly attributed to the right years. The comparison showing an increase from 2022 to 2023 and a decrease in 2024 is accurate. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and draws a reasonable conclusion about the trend. The interpretation differs slightly from the ground truth—'modestly expanding' vs. 'stabilization or recalibration'—but this is a matter of interpretive nuance rather than factual error. The LLM correctly notes that 2024 spending remains above 2022 levels, supporting its conclusion. (4) The answer is fully contextually relevant, addressing both the evolution of expenses and the implication for employee benefit investment. The only minor shortcoming is the slightly different qualitative interpretation, which does not undermine the factual correctness. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 341,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "Across the three filings the company’s disclosure about non‑public equity investments is unchanged – management says it values those holdings “using discounted‑cash‑flow models, estimates of sales‑proceeds and, where appropriate, appraisals” (2022 Note 40; 2023 Note 4; 2024 Note 4).  The fact that the same methodology was retained in 2023 and 2024, and that management still judged the $87 million excess of the Coca‑Cola Bottlers Japan investment to be a “temporary” decline rather than an impairment, shows that the company’s confidence in its sales‑proceeds forecasts – and thus its belief that markets such as Japan will recover – has not weakened since 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: the $87 million excess carrying value in Japan is correctly cited, the consistent use of estimates of sales proceeds across 2022–2024 is supported, and the characterization of the decline as 'temporary' is consistent with the original answer. Entity accuracy is strong—Coca-Cola Bottlers Japan Holdings Inc. is correctly referenced, and the years (2022–2024) and valuation methods (discounted cash flow, sales proceeds, appraisals) are accurately reported. However, the qualitative reasoning is significantly flawed. The original answer emphasizes an evolution in the *context* and *emphasis* of the valuation assumptions—specifically, a shift toward greater focus on market participant perspectives and macroeconomic risks in emerging markets by 2023 and 2024. The LLM answer incorrectly asserts that the disclosure and implications are 'unchanged' and that confidence 'has not weakened,' which contradicts the ground truth's claim of increased attunement to external risks. This misrepresents the evolution in management's approach and misses the nuanced shift in reasoning, despite using correct facts. Thus, while the numbers and entities are correct (high quantitative accuracy), the multi-hop synthesis and interpretation of what the consistency in methodology implies about management's confidence is oversimplified and partially incorrect. The answer is contextually relevant and addresses the core question, but fails to capture the key qualitative evolution, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 430,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle’s 2.300 % notes due 2028 first appear in the filing that disclosed the March 24 2021 officers’ certificate (Exhibit 4.14) and are listed in the “Notes” exhibit of each subsequent 10‑K – the 2022 filing (​【page_111】​), the 2023 filing (​【page_111】​) and the 2024 filing (​【page_111】​). Across FY 2022‑24 the same series is carried forward without a new issuance, showing Oracle’s reliance on a laddered, medium‑term fixed‑rate tranche that remains on the balance sheet for several years. This consistent presence of the 2.300 % 2028 note reflects a broader strategy of staggered, low‑coupon debt placements to diversify maturities, lock in inexpensive financing and manage interest‑rate and liquidity risk over the multi‑year horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all details are correct: the 2.300% Notes due 2028 are consistently referenced across fiscal years 2022, 2023, and 2024, with no new issuance of these specific notes during that period. The mention of the March 24, 2021 officers’ certificate (Exhibit 4.14) as the origin of the notes is consistent with filing records. Page references (e.g., page 111 in each 10-K) are plausible and do not contradict the ground truth. (2) The answer correctly identifies that Oracle did not reissue or restructure the 2.300% Notes during FY2022–2024 but carried them forward, which supports the conclusion of a stable, fixed-rate debt tranche. (3) Qualitatively, the reasoning is sound: the LLM infers a strategy of using laddered, low-coupon debt to manage interest rate and refinancing risk—this is logically consistent with the ground truth observation that Oracle maintained older, lower-cost debt while issuing newer, higher-cost instruments (e.g., 4.500% Notes in 2023, 5.800% in 2024). While the LLM does not explicitly mention the higher rates of newer debt (a minor omission), it correctly infers the strategic intent behind maintaining low-rate debt over time. (4) Contextual relevance is excellent: the response directly addresses the evolution of the 2.300% Notes and interprets Oracle’s broader financing strategy. The only reason for not scoring a 10 is the lack of explicit comparison to newer, higher-interest issuances noted in the ground truth, which would have strengthened the multi-hop synthesis. However, the core factual and strategic analysis remains highly accurate and semantically aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 460,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple’s 10‑K filings for fiscal 2022, 2023 and 2024 each contain Exhibit 4.4 (the Officer’s Certificate) that lists “Floating Rate Notes due 2019” among the company’s outstanding debt securities【page_56】. The fact that the same 2019‑maturing floating‑rate issue appears in every year’s filing shows that Apple has kept the notes on its balance sheet and has been rolling them over as they approach maturity rather than retiring them outright. This consistent rollover indicates a short‑term debt strategy that relies on low‑cost, variable‑rate financing that can be refinanced quickly to preserve liquidity and flexibility.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple's 10-K filings for 2022, 2023, and 2024 include the Floating Rate Notes due 2019 via the Officer’s Certificate (Exhibit 4.4), which aligns with the ground truth. The dates and document references (e.g., May 6, 2014 Officer's Certificate) are factually consistent, and there are no numeric inaccuracies—thus quantitative accuracy is high. (2) However, the LLM introduces a key misinterpretation: it claims Apple has been 'rolling over' the notes as they approach maturity. This is incorrect. The notes were due in 2019 and should have matured by then; their continued appearance in post-2019 filings likely reflects disclosure of legacy debt instruments still outstanding or carried for reporting purposes, not active rollover. The ground truth emphasizes no new issuances or modifications, indicating stability, not active refinancing. (3) The multi-hop reasoning is partially sound—linking the repeated disclosure across years to ongoing reporting—but the conclusion about debt management strategy overreaches. The LLM infers a strategic rollover behavior not supported by the evidence; the original answer stresses 'stable, rather than active' management. This mischaracterizes Apple’s approach and reflects flawed qualitative reasoning. (4) Contextually, the answer is relevant and addresses the evolution and strategy aspects of the question, but the incorrect inference about rollover undermines the core conclusion. Correctness is reduced due to this significant conceptual error, despite accurate data citation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 434,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "The fact that the 4.000 % Senior Note due 2047 is listed in the exhibit tables of PepsiCo’s 2022, 2023 and 2024 Form 10‑K (see the entry “Form of 4.000 % Senior Note due 2047” in the notes to the financial statements 【page_126†L17-L19】) shows that the company deliberately maintains a long‑dated, low‑coupon bond as a core component of its capital structure, locking in inexpensive fixed‑rate financing for the next ≈ 25 years. By contrast, the shorter‑maturity notes—such as the 2.150 % Senior Note due 2024 【page_126†L18-L19】 and the 0.750 % Senior Note due 2027 【page_127†L28-L29】—are disclosed as separate, relatively temporary issuances, indicating they are used for nearer‑term funding needs and are likely to be rolled or refinanced, complementing but not replacing the company’s long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (4.000%, 2.150%, 0.750%), maturity years (2047, 2024, 2027)—are correct and match the original answer. There are no calculation errors, and the references to specific pages (e.g., page_126†L17-L19) add precision without introducing inaccuracies. (2) The answer fully addresses both parts of the question: it explains the strategic significance of the consistently disclosed long-term note and contrasts it with shorter-dated instruments. The only minor omission is that the original answer includes a reference to the 2.500% Senior Note due 2022 that matured, which illustrates the turnover in short-term debt—this contextual detail is missing in the LLM response, slightly reducing completeness. (3) Multi-hop reasoning is sound: the model correctly infers from repeated disclosure over three years that the 2047 note is part of a stable, long-term financing strategy, while shorter-dated notes appear transiently, suggesting refinancing or temporary funding needs. (4) Semantic equivalence is strong: the LLM captures the core insight that PepsiCo uses long-term debt to lock in fixed-rate financing and reduce refinancing risk, while managing short-term debt dynamically. Wording differs but meaning is preserved. The answer is contextually excellent, directly addressing the strategic comparison implied in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 396,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple’s 10‑K exhibits for 2022, 2023 and 2024 all contain the Officer’s Certificate that lists the “0.45 % Notes due 2016” among its global‑note series (see the exhibit tables in the 2024 filing, e.g., Exhibit 4.3 – “0.45 % Notes due 2016”【page_58】). By continuing to disclose a debt issue that already matured, Apple signals that it keeps a complete, publicly‑recorded inventory of every past borrowing, even after repayment, as part of a disciplined, transparent strategy for monitoring and documenting legacy debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities—Apple, the 0.45% Notes due 2016, Officer’s Certificate, and the years 2022–2024—are correctly identified. The reference to Exhibit 4.3 in the 2024 filing and page 58 is consistent with disclosure practices. (2) Quantitative elements—interest rate (0.45%), maturity year (2016), and reporting years (2022–2024)—are correct with no calculation errors. (3) The reasoning is sound: the model correctly infers that continued disclosure of a matured debt instrument reflects a strategy of transparency and comprehensive record-keeping. It captures the multi-hop logic—linking the maturity of the notes in 2016 with their reappearance in later filings—and draws a reasonable conclusion about Apple’s disclosure strategy. (4) While the LLM answer does not explicitly mention the May 3, 2013 Officer’s Certificate date (a minor omission), it still conveys the core insight about consistent documentation and legacy debt transparency. The semantic meaning and strategic interpretation are equivalent to the ground truth. Wording differs slightly but remains precise and relevant. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 340,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "By 2022 Lockheed Martin had already used its master retirement trust to transfer roughly $11.6 billion of defined‑benefit pension obligations (including a $4.9 billion Group‑Annuity Contract in 2021) which eliminated PBGC premiums and produced a one‑time pretax non‑cash settlement charge of about $1.7 billion; the 2022 filing said it would keep looking for additional risk‑transfer deals and that any new deal could again generate a material non‑cash charge. The 2023 filing reiterated that the company was still evaluating further GAC purchases—some of which could leave it liable for reimbursements—and warned that future transfers might require extra contributions and a material non‑cash settlement charge to earnings. The 2024 filing showed the same strategy, continuing to reduce pension size through the trust and stating that additional risk‑transfer transactions are expected in future years and could likewise result in a material non‑cash settlement charge, although no new transfer was disclosed for 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $11.6 billion cumulative pension obligation transfers since 2018, the $4.9 billion group annuity contract in 2021 (not 2022, correctly noted as prior year), and the $1.7 billion noncash settlement charge are all accurately reported. The LLM correctly notes that no new transfer was disclosed for 2024, which is consistent with the original answer’s emphasis on continued strategy without new transaction details. (2) Quantitative accuracy is perfect: all dollar amounts and timeframes match the ground truth, with appropriate formatting variations accepted (e.g., $4.9 billion vs $4.9B). There are no calculation errors. (3) Multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 filings, showing evolution over time. The LLM captures the continuity of strategy, ongoing evaluation of risk transfers, and expectation of future noncash charges. One minor omission is that the original answer explicitly frames the trajectory as 'proactive' and 'increasing in scale,' which the LLM implies but does not emphasize as clearly. Also, the mention of 'reimbursements' and 'extra contributions' in 2023 adds detail not in the ground truth, but does not contradict it and may reflect additional nuance from the actual filing. (4) The answer is fully relevant, addressing all parts of the question: pension obligation reductions, expected future actions, and financial impact on earnings. The only reason for not scoring a 10 is the slightly less explicit emphasis on the growing scale and strategic consistency highlighted in the original. Overall, the answer is factually excellent and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 474,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "- In the 2022 Form 10‑K the exhibit schedule lists the original **Executive Change‑in‑Control Retention Agreement with Marc N. Casper** (Exhibit 10.12) and, for the first time, a **separate form for officers other than Casper** (Exhibit 10.18, a 2018 amendment) 【page 46†L10-L18】.  \n\n- The 2023 filing updates that framework: the Casper agreement remains unchanged (now shown as Exhibit 10.11) and the company files a **new, updated “Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)”** as Exhibit 10.7 【page 76†L10-L18】.  \n\n- The 2024 Form 10‑K continues to list both items (the Casper agreement and the updated officer‑only form) in its exhibit schedule, confirming that the retention‑agreement program has been expanded to cover additional officers beyond the CEO 【page 75†L1-L4】.  \n\n**Thus, from 2022 to 2024 Thermo Fisher moved from a single CEO‑only change‑in‑control retention agreement to a two‑track system that includes a distinct agreement for other officers, with the officer‑only form being refreshed in 2023 and retained in the 2024 filing.**",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, Thermo Fisher disclosed a retention agreement for Marc N. Casper and a separate form (from 2018) for other officers; in 2023, a new form for non-Casper officers was filed, dated April 1, 2023; and in 2024, the updated 2023 form was reaffirmed. The LLM correctly identifies the evolution from a CEO-only agreement to a two-track system. (2) Quantitative accuracy is perfect: dates (2018 amendment, 2023 update), exhibit numbers (Exhibit 10.12, 10.18, 10.11, 10.7), and filing years (2022–2024) match the source data. Minor phrasing differences (e.g., '2018 amendment' vs 'dated March 16, 2018') are acceptable as they do not alter factual meaning. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly infers the significance of the updated form in 2023, and concludes the formalization of broader executive coverage. (4) The answer is fully contextually relevant, directly addressing the evolution of the agreements and the inclusion of officers beyond Casper. All scoring categories warrant top marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 334,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 10‑K exhibits list a **2.750 % Senior Note due 2051** in both the 2022 filing (exhibit 4.51) and again in the 2024 filing (exhibit 4.48)【page_128†L31-L33】【page_129†L31-L33】, indicating that the bond issued in 2021 remains outstanding and has not been refinanced. By keeping this ultra‑long‑dated, low‑coupon debt on its balance sheet, PepsiCo is locking in historically cheap financing and spreading maturities far into the future, a clear sign that it is using long‑term, fixed‑rate debt to hedge against the higher interest‑rate environment and avoid frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, dates, and percentages are correct: the 2.750% Senior Note due 2051 is accurately referenced, and the exhibit numbers (4.51 in 2022, 4.48 in 2024) match the filings. The note was issued in 2021, which is consistent with the ground truth referencing the 2021 Form 8-K. (2) The answer correctly observes that the note remains outstanding and was not refinanced, based on its continued listing in 2022 and 2024 filings—this is supported by the ground truth, which also notes consistent treatment across years. (3) The reasoning is sound: the LLM correctly infers that maintaining this low-coupon, long-dated debt in a rising rate environment reflects a strategic decision to lock in cheap financing and avoid refinancing risk. This aligns with the ground truth’s conclusion about stable long-term capital strategy. (4) The only minor omission is that the 2023 filing is not explicitly mentioned in the LLM answer, though the 2022 and 2024 references suffice to support the conclusion. The ground truth emphasizes continuity across all three years, but the LLM still captures the essential multi-hop insight: PepsiCo preserved this fixed-rate debt despite rising rates, even as it issued higher-yielding notes (e.g., 5.250% due 2054 in 2024). Wording differs but semantic meaning and factual content are equivalent. No calculation errors. Contextual relevance is excellent—directly addresses PepsiCo’s long-term debt strategy in rising rates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 423,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 4.45 % senior notes that mature in 2044 appear in every recent filing. In the 2022 Form 10‑K the notes are listed in the exhibit table (Officer’s Certificate dated May 6 2014) as “4.45 % Notes due 2044”【page_58†L31-L38】. The same instrument is again shown in the 2024 Form 10‑K exhibit list (Officer’s Certificate dated May 6 2014) with the identical description “4.45 % Notes due 2044”【page_56†L31-L38】. Because the note remains on Apple’s balance sheet across these years, the company is deliberately keeping a long‑dated, low‑coupon debt issue outstanding, using it to lock in inexpensive financing and diversify its capital structure rather than repeatedly refinancing short‑term borrowings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 are properly identified, and their presence in the 2022 and 2024 10-K filings is accurately cited with correct exhibit references (Officer’s Certificate dated May 6, 2014), matching the ground truth. The percentage (4.45%), maturity year (2044), and filing years (2022, 2024) are all correct. Although the 2023 filing is not explicitly mentioned, the inclusion of 2022 and 2024 supports the multi-year pattern and the omission does not undermine the overall conclusion. (2) Quantitative accuracy is perfect: all numbers, dates, and percentages are correct and properly contextualized. (3) The reasoning is sound: the LLM correctly infers that Apple is maintaining long-term, fixed-rate debt to secure inexpensive financing and avoid refinancing risk, which is consistent with the ground truth’s interpretation of strategic capital management. The conclusion about diversifying capital structure and avoiding short-term refinancing is a valid and insightful extension of the data. (4) The answer is contextually relevant, directly addressing the evolution of the debt instrument and its implications for Apple’s capital strategy. The only minor limitation is the lack of explicit mention of 2023, which slightly reduces completeness but does not affect the correctness of the overall pattern. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 427,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension‑plan “Collective trust and other funds” line fell sharply – the NAV balance was **$622 million in 2022** and dropped to **$382 million in 2023**, a decline of roughly $240 million【page_58†L31-L38】.  \n\nThe 2024 filing explains that these holdings are **shares or units in commingled funds and LLCs that are not publicly traded, but the underlying assets (stock, short‑term funds, etc.) are publicly quoted; the plan therefore values the investments at **NAV**, calculated from the readily‑available prices of those underlying assets【page_55†L13-L20】. This methodology shows that, although the funds themselves are private, their valuation is driven by transparent, market‑based inputs, giving insight into how the plan monitors and manages this portion of its portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 allocation as $382 million and notes a significant decline, but reports the 2022 amount as $622 million instead of the correct $756 million from the ground truth. This is a material error in a key quantitative fact, though the direction (decrease) and magnitude (sharp drop) are qualitatively accurate. The implied decline of $240 million is therefore incorrect; the actual decrease was $374 million. (2) The calculation of the difference is numerically consistent within the LLM's own figures ($622M - $382M = $240M), but since the starting value is wrong, the overall quantitative accuracy is compromised. Other numbers and dates (2022, 2023, 2024 filing) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes the trend in allocation over time and connects it to the 2024 disclosure about valuation methodology (NAV based on underlying market prices). It accurately infers that the valuation approach supports transparency and reflects ongoing management of these assets despite the decline. This aligns with the ground truth’s interpretation that the reduction likely reflects strategic rebalancing rather than a methodological shift. (4) Despite the incorrect 2022 figure, the answer captures the core narrative—significant reduction in allocation and transparent NAV-based valuation—and addresses both parts of the question. The error is significant but not fundamental to the entire response, warranting a score of 7 for overall correctness. Qualitative reasoning and contextual relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 438,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple’s 10‑K exhibits list the same Officer’s Certificate — Exhibit 4.4, dated May 6 2014 and describing the 1.05 % Notes due 2017 — in the 2024 filing (see the exhibit table on pages 56‑57) and in the 2022 filing (see the exhibit table on page 58). The 2023 10‑K contains an identical exhibit list, confirming that the certificate was retained and filed again that year. By continuing to attach the original certificate for a debt issue that matured seven years earlier, Apple demonstrates a systematic record‑keeping policy that preserves documentation of all past issuances, thereby ensuring that its capital‑structure disclosures remain complete and historically transparent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the Officer's Certificate is correctly identified as Exhibit 4.4, dated May 6, 2014, related to the 1.05% Notes due 2017, and its inclusion in the 10-K filings for 2022, 2023, and 2024 is accurately stated. The maturity of the notes seven years prior (2017 to 2024) is a correct calculation. (2) Quantitative accuracy is perfect: dates, percentages, exhibit numbers, and page references are all factually consistent with the original answer and imply correct sourcing. (3) The multi-hop reasoning is sound—linking the repeated inclusion of a matured debt exhibit to Apple’s broader documentation retention and transparency practices is logically supported. The answer correctly infers that this reflects a systematic policy for historical disclosure. (4) The only minor shortcoming is that the LLM answer does not explicitly state that the *continued inclusion despite maturity* directly reflects a strategy of 'historical continuity' and 'regulatory transparency' in the same comprehensive terms as the original, though the implication is clearly conveyed through phrases like 'systematic record-keeping' and 'historically transparent.' Thus, while the reasoning and facts are fully sound, the qualitative depth is slightly less explicit than the original. Overall, the answer is factually complete, contextually relevant, and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 403,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension plan held roughly $1.1 billion of corporate‑stock investments in 2022 – about 37 % of the plan’s fair‑value assets ( $1,111 m of $2,990 m )【page_58】. By the end of 2023 the corporate‑stock holding had fallen to only $181 million, or about 5 % of fair‑value assets ( $181 m of $3,385 m )【page_57】, and the plan’s overall equity‑security allocation was reported at 24 % in both 2023 and 2024【page_56】 (down from 48 % in 2022). This sharp reduction in corporate‑stock exposure signals a deliberate de‑risking move, shifting the pension portfolio away from equities toward a higher proportion of debt securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Union Pacific's allocation to corporate stock was $1,990 million in 2022, not $1,111 million as stated in the LLM answer. The 2023 figure of $181 million is correct, but the 2024 figure in the ground truth is $1,116 million, while the LLM answer does not mention the 2024 corporate stock value at all, incorrectly implying it remains low or unchanged. Instead, the LLM claims a continued low equity allocation of 24% in 2024, which refers to total equity securities, not corporate stock specifically, thus conflating two different metrics. (2) The calculation of percentages is based on incorrect base values: the LLM states $1,111m of $2,990m in 2022 (~37%), but this figure does not align with the ground truth's $1,990m, which would be ~66.5% of $2,990m. The 2023 percentage (5%) is accurate given the $181m figure. However, the key drop of over 90% from 2022 to 2023 cannot be justified with the LLM's own numbers ($1,111m to $181m is an ~84% drop), let alone the actual 91% drop from $1,990m to $181m. (3) The reasoning is partially sound—recognizing a de-risking strategy and shift toward debt securities aligns with the ground truth. The identification of a strategic move away from equities is correct, and the use of multi-year data from the pension plan shows appropriate synthesis. However, the failure to report the rebound in 2024 to $1,116 million—a critical part of the trend—omits a key nuance and misrepresents the trajectory as a one-time drop without recovery. (4) The contextual relevance is high because the answer addresses both parts of the question: evolution over time and strategic implication. The qualitative reasoning about de-risking and conservative posture is valid and supported by data trends, even if the specific numbers are flawed. Overall, the answer captures the directional shift but fails on core quantitative accuracy, especially for 2022 and 2024 figures, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 550,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales have risen sharply each year: $428 million in 2022 (U.S. $188 m + Intl. $240 m), $605 million in 2023 (U.S. $264 m + Intl. $341 m), and $785 million in 2024 (U.S. $371 m + Intl. $414 m)【page_130】. The roughly 40% jump from 2022‑23 and a further 30% increase in 2023‑24 signal accelerating market adoption of letermovir for CMV prophylaxis in transplant patients, making Prevymis an increasingly strategic, high‑growth product within Merck’s Hospital Acute Care franchise.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all sales figures for Prevymis from 2022 to 2024: $428M in 2022, $605M in 2023, and $785M in 2024, matching the ground truth exactly. It further breaks down these totals into U.S. and international components, which are accurate (e.g., $188M + $240M = $428M; $264M + $341M = $605M; $371M + $414M = $785M). (2) The percentage growth calculations are approximately correct: from 2022 to 2023, the growth is (~41.4%), referred to as 'roughly 40%', and from 2023 to 2024, the growth is (~29.8%), described as 'further 30%', which are reasonable approximations. (3) The multi-hop reasoning is sound—the model synthesizes annual sales data across years, computes growth trends, and correctly infers accelerating market adoption and strategic importance within Merck’s Hospital Acute Care segment. (4) The answer addresses all parts of the question: sales evolution over time, market adoption implications, and strategic importance. The semantic content fully aligns with the ground truth, with added granularity (geographic breakdown) that enhances completeness without introducing error. All entities—MRK (Merck), Prevymis, Hospital Acute Care segment, and time periods—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 354,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "In the 2022 and 2023 Form 10‑K filings PepsiCo listed a “Form of 3.000 % Senior Note due 2027” among its Exhibit 4 items, explicitly referencing the original 2017 issuance (see 2022 p. 126‑127 and 2023 p. 127). By the 2024 filing that exhibit no longer appears (the Exhibit 4 list in 2024 p. 125‑129 stops at later‑dated notes), indicating the 3 % 2027 note has been retired or repaid as it approached maturity. This progression shows PepsiCo’s long‑term debt strategy of keeping older, lower‑coupon notes on the books while they are active and then systematically paying them off or refinancing them as they near their due dates.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim: it asserts that the 3.000% Senior Note due 2027 was retired or removed from the 2024 filing, which contradicts the ground truth. According to the original answer (ground truth), the note was explicitly included in all three years—2022, 2023, and 2024 (Exhibit 4.17)—indicating it remained outstanding. The LLM incorrectly interprets the absence of the exhibit in 2024 as evidence of retirement, but the ground truth confirms continued inclusion. This is a major factual error that invalidates the conclusion. Quantitatively, the interest rate (3.000%) and maturity year (2027) are correct, as is the reference to the 2017 issuance, so some numeric elements are accurate. However, the reasoning is flawed: the model fails to recognize that the continued presence of the note across filings indicates an ongoing liability, not retirement. The multi-hop synthesis is incorrect—the model does not identify the evolving context of the note among other debt instruments (e.g., alongside longer-dated or newer short-term notes), which is central to the ground truth’s insight about PepsiCo’s debt layering strategy. Instead, it draws an unsupported conclusion about systematic repayment. While the answer attempts to address the strategic aspect, it does so based on a false premise. Contextually, it engages with the question’s structure but arrives at the opposite conclusion of the ground truth, making it misleading despite some correct surface-level details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 415,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "- In the 2022 Form 10‑K Adobe did not highlight Frame.io as a distinct part of its portfolio, indicating that the service was still being positioned mainly as an acquired asset rather than a core Creative Cloud offering.  \n- By the 2023 filing (see page 12), Frame.io was presented as “our cloud‑native creative collaboration platform” with functional capabilities such as real‑time upload, frame‑accurate commenting, annotations, and “Camera‑to‑Cloud” ingest, and it was **directly integrated** into Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, allowing creators to request and receive frame‑specific feedback inside those apps.  \n- The 2024 filing (pages 12‑13) expands that positioning: Frame.io now supports the full video‑production workflow—including casting, location scouting, footage review, and marketing‑campaign management—as well as still‑image, design‑file and PDF review, and its integration is deepened across the Creative Cloud suite and Adobe GenStudio, making the platform a unified, cloud‑native hub for collaborative content creation across all major Adobe apps.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Frame.io's integration and positioning across 2022–2024. (1) Correctly notes that in 2022, Frame.io was not yet highlighted as a core offering, which matches the ground truth's indication of trademark listing and post-acquisition alignment. (2) For 2023, accurately describes Frame.io as a 'cloud-native creative collaboration platform' with real-time upload, review, and integration into Premiere Pro and After Effects; however, it incorrectly states integration with Photoshop, Lightroom, and Workfront in 2023, while the ground truth specifies those deeper integrations emerged in 2024. This is a minor but notable overattribution of integration depth in 2023. (3) The 2024 description correctly captures expanded workflow support (casting, location scouting, etc.), file type coverage (still images, PDFs), and positioning within Adobe GenStudio, aligning with the ground truth’s emphasis on enterprise-scale integration. (4) The multi-hop reasoning is sound overall—correctly synthesizing changes year-over-year from filings—but slightly misattributes the timing of certain integrations. Quantitative accuracy is perfect: no numerical errors, and dates (2022, 2023, 2024) are used appropriately. Contextual relevance is excellent, directly addressing functional capabilities and integration depth across the three years. The answer would have scored higher if it hadn’t advanced Photoshop, Lightroom, and Workfront integrations to 2023 instead of correctly placing them in 2024 as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 438,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple’s 2022 Form 10‑K first disclosed the 2.40 % global notes that mature in 2023 in Exhibit 4.3 (the “Officer’s Certificate” listing the 2.40 % Notes due 2023)【page_56】. The 2023 filing repeats the same exhibit, showing the notes were still outstanding a year later, and the 2024 Form 10‑K again includes the 2.40 % Notes due 2023 in the exhibit list【page_56】. By keeping the notes in every annual disclosure up to the year they mature, Apple signaled that it was actively tracking this liability and was prepared either to redeem or refinance it as the due date approached, reflecting a disciplined debt‑maturity management strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the 2024 disclosure. While it correctly states that the 2.40% Notes due 2023 were disclosed in Apple's 2022 and 2023 10-K filings (Exhibit 4.3), it incorrectly claims that the 2024 Form 10-K still includes the notes in the exhibit list. According to the ground truth, by 2024 the notes were no longer listed, indicating retirement or fulfillment of the obligation. This error directly contradicts the key conclusion in the original answer and misrepresents Apple's debt management strategy. (2) Quantitatively, the percentage (2.40%), maturity year (2023), and years of disclosure (2022, 2023) are accurate. However, the claim about 2024 inclusion is factually wrong, undermining the quantitative timeline. (3) The multi-hop reasoning is flawed: the model fails to recognize that the absence of the notes in 2024 is a critical data point indicating maturity or repayment. Instead, it assumes continued listing, leading to an incorrect inference about Apple's strategy. The original answer correctly infers a hold-to-maturity strategy from the presence in 2022–2023 and absence in 2024; the LLM misses this pattern. (4) Contextual relevance is fair—the response addresses the evolution of disclosure and attempts to interpret strategy—but due to the core factual error in the 2024 status, the conclusion is invalid. The reasoning is structured appropriately but built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 405,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "- **Fleet size:** The multiple‑purpose locomotive fleet fell each year – from roughly **7,242 units in 2022** to **7,008 units in 2023** and **6,893 units in 2024**.  \n- **Age profile:** At the same time, the average age of those locomotives rose from about **22.5 years in 2022** to **24.3 years in 2023** and **25.2 years in 2024**.  \n\nThis downward‑trend in unit count combined with a gradual increase in average age shows Union Pacific is **right‑sizing its fleet**, retiring older equipment faster than it is being replaced. The pattern reflects an asset‑management strategy focused on trimming excess capacity, controlling capital outlays, and improving overall fleet efficiency while still maintaining enough locomotives to meet service needs.  \n\n**Sources**  \n- 2022 filing: Multiple‑purpose locomotives 7,242 total, average age 22.5 years【page_24】  \n- 2023 filing: Multiple‑purpose locomotives 7,008 total, average age 24.3 years【page_19】  \n- 2024 filing: Multiple‑purpose locomotives 6,893 total, average age 25.2 years【page_19】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all key quantitative data: total Multiple Purpose Locomotives (7,242 in 2022, 6,893 in 2024), intermediate 2023 value (7,008), and average age progression (22.5 → 24.3 → 25.2 years). These match the ground truth exactly or are consistent with it. The original answer aggregates owned and leased units to derive totals, which align with the LLM's reported figures. The LLM includes a 2023 total (7,008) not explicitly stated in the ground truth, but this is accurate and fills a gap, enhancing completeness.\n\n2) Quantitative accuracy is perfect: all numbers for fleet size and age are correct across years. The LLM correctly shows a declining fleet and rising average age. No calculation errors.\n\n3) The reasoning is sound and logically interprets the trend as 'right-sizing' and efficiency-focused asset management, which is semantically equivalent to the ground truth's 'conservative strategy' with 'minimal fleet expansion.' The LLM adds slightly more positive framing (e.g., 'improving efficiency'), but this does not contradict the core implication of restrained investment and reliance on aging assets. The multi-hop synthesis across three years of data is accurate and well-supported.\n\n4) The only minor shortcoming is that the original answer breaks down owned vs. leased units (6,204 → 5,973 owned; 1,038 → 920 leased), which the LLM omits. While not strictly necessary to answer the question, this detail enriches the asset management analysis. Its absence prevents a perfect 10 on correctness and qualitative accuracy, but the core facts and interpretation remain intact. Contextual relevance is full—every part of the question is addressed with precise, relevant data and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 471,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "- **2022 filing** – MK‑8591A (the doravirine + islatravir once‑daily regimen) was listed as a Phase‑3 candidate that was slated to start in 2023, but the FDA had already placed a clinical hold on the islatravir IND (December 2021) because of lymphocyte‑count drops【page_23】. The footnote on the pipeline table marks MK‑8591A as “On FDA clinical hold”【page_23】.  \n\n- **2023 filing** – The same description appears: the program was still planned as a Phase‑3 study beginning in 2023 for treatment‑naïve and virologically‑suppressed adults, and the FDA clinical hold remained in effect【page_21】; the pipeline table again shows MK‑8591A under a clinical hold【page_24】.  \n\n- **2024 filing** – Merck moved the asset into a combined Phase 2/3 trial that actually started in August 2024, but the FDA hold persisted (a partial hold for higher islatravir doses)【page_22】. A footnote notes that the FDA lifted the clinical hold on December 4 2024, indicating the regulatory barrier was later removed【page_24】.  \n\n**Summary:** From 2022 to 2023, MK‑8591A remained a planned Phase‑3 HIV‑1 treatment under an unchanged FDA clinical hold. By 2024, Merck had initiated a Phase 2/3 study (August 2024) while still subject to the hold, which was subsequently lifted in December 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the FDA clinical hold in 2022 and 2023, and notes its partial resolution in 2024, aligning with the ground truth. However, it inaccurately states that MK-8591A entered a Phase 2/3 trial starting in August 2024, while the ground truth indicates that MK-8591A remained in development but no new trial initiation for this specific formulation is mentioned—instead, a new formulation, MK-8591D, entered Phase 3 in October 2024. This is a significant omission and misrepresentation of the clinical phase progression. (2) Quantitatively, the dates are mostly accurate: the December 2021 hold is correctly referenced as ongoing in 2022 and 2023 filings, and the December 4, 2024, lifting of the hold is consistent with the ground truth. However, the claim that a Phase 2/3 trial started in August 2024 is not supported by the original answer, which does not mention trial initiation for MK-8591A in 2024. The October 2024 entry of MK-8591D is missing entirely. (3) The reasoning is sound in tracking the regulatory status over time and synthesizing FDA interactions across years. However, it fails the multi-hop requirement by not recognizing the shift to a new formulation (MK-8591D), which is a key strategic evolution in Merck’s HIV-1 program. The focus remains narrowly on MK-8591A without acknowledging the broader pipeline pivot. (4) Despite the missing formulation change, the answer is highly relevant to the question, addressing both clinical development and FDA interactions. The core facts about the hold and its partial lifting are correct, and the year-by-year structure effectively responds to the query. The score is reduced due to the incorrect trial phase initiation and omission of MK-8591D, which limits completeness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 490,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "- In the 2022 filing, MK‑1308A (quavonlimab + pembrolizumab) was already in Phase 3 and had earned its first regulatory approval for an adjuvant renal‑cell‑carcinoma (RCC) indication in Japan (KEYNOTE‑564)【page_25】.  \n- The 2023 report still listed MK‑1308A as a Phase 3 immuno‑oncology candidate being evaluated for RCC, emphasizing it as part of Merck’s “immuno‑oncology” pillar and showing no change in development status【page_20】【page_21】.  \n- By 2024, the company continued to spotlight MK‑1308A under the same immuno‑oncology pillar, describing it as the co‑formulation of its novel anti‑CTLA‑4 antibody with pembrolizumab for RCC, reinforcing its role in Merck’s diversified oncology strategy【page_50】.  \n\nTogether, these updates show Merck moving from an early regulatory win in 2022 to maintaining and reinforcing MK‑1308A as a flagship combination‑checkpoint‑inhibitor program through 2024, indicating a sustained focus on innovative, dual‑checkpoint immunotherapy to expand treatment options in RCC.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 claim that MK-1308A received its first regulatory approval for adjuvant RCC in Japan under KEYNOTE-564. This is incorrect. According to the ground truth, in 2022, MK-1308A was listed as a Phase 3 program with an entry date of April 2021, but there was no regulatory approval mentioned—especially not in Japan or under KEYNOTE-564. KEYNOTE-564 is actually associated with pembrolizumab monotherapy in adjuvant RCC, not MK-1308A. This misattribution undermines the accuracy of the timeline. The rest of the answer—regarding MK-1308A being in Phase 3 and part of the immuno-oncology pillar in 2023 and 2024—is consistent with the ground truth. (2) Quantitative accuracy is low because the key event (regulatory approval) is entirely fabricated with a specific program name and indication. No dates or dollar amounts are incorrect per se, but the developmental milestone is wrong. (3) The multi-hop reasoning is partially sound: the model correctly tracks MK-1308A across three years and synthesizes its positioning within Merck’s immuno-oncology strategy. However, the erroneous claim about approval distorts the evolution, making the progression from 'early regulatory win' to 'flagship program' factually flawed. The ground truth reflects sustained development, not a regulatory milestone in 2022. (4) Despite the major error, the answer captures the correct strategic theme—Merck’s focus on combination immunotherapy in RCC—and uses appropriate terminology (anti-CTLA-4, co-formulation, immuno-oncology pillar). Contextual relevance is high because it directly addresses the question’s focus on strategic positioning and innovation in RCC. The conclusion about sustained focus is directionally correct, though based on flawed premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 492,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Microsoft’s exhibit schedule still includes **Exhibit 4.6 – “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041”** (see page 104 of each filing) 【page_104】. The description of the 4.000 % Notes due 2021 is unchanged from year to year, indicating that the issue remains on the balance sheet and has not been refinanced or retired. This consistency signals that Microsoft treats the 2021 notes as a stable component of its long‑term debt mix, relying on a deliberate strategy of issuing long‑dated securities and managing refinancing only as maturities approach rather than frequently restructuring its debt profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Microsoft's 4.000% Notes due 2021 are consistently disclosed in Exhibit 4.6 across the 2022, 2023, and 2024 10-K filings, and that the description remains unchanged. This aligns with the ground truth regarding consistency in disclosure. However, the LLM incorrectly implies that the notes were still on the balance sheet in 2022–2024, which is factually inaccurate because the notes matured in 2021 and should have been retired by 2022. The ground truth clarifies that the consistent disclosure reflects stable documentation, not ongoing liability. (2) Quantitatively, the interest rate (4.000%), maturity year (2021), and exhibit number (4.6) are correct. The mention of other notes (2.500% due 2016, 5.300% due 2041) adds context but is not incorrect. The error lies in the interpretation of the notes' status post-maturity, not in the numbers themselves. (3) The multi-hop reasoning is partially sound—linking consistent disclosure to debt strategy—but fails a critical logical step: a note due in 2021 cannot remain on the balance sheet in subsequent years unless refinanced or extended, which the ground truth confirms did not happen. The LLM incorrectly infers ongoing inclusion as evidence of stability, whereas the ground truth explains it as documentation consistency. (4) Scores reflect mostly correct facts and relevant context (high contextual relevance), but with a significant qualitative error in reasoning and implication, reducing correctness and qualitative accuracy. Quantitative accuracy is high due to correct numbers and dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 438,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm has repositioned itself from a pure mobile‑chip supplier to a “connected‑processor” platform that underpins the software‑defined vehicle—highlighting its digital‑cockpit, connectivity and ADAS/AD capabilities as core growth engines.  Correspondingly, the QCT automotive revenue stream (which includes the digital‑cockpit business) grew from $1.5 billion in fiscal 2022 to $1.9 billion in 2023 and to $2.9 billion in 2024. This accelerating revenue trend shows that Qualcomm’s automotive portfolio is moving from a modest niche to a substantial, expanding business, confirming the company’s transformation toward a broader, high‑margin automotive technology provider.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures—$1.5B in 2022, $1.9B in 2023, and $2.9B in 2024—for Qualcomm's QCT automotive segment that are not present in the original answer (ground truth). These numbers are factually unsupported by the provided ground truth, which does not mention any revenue amounts for any year. This is a critical quantitative inaccuracy. (2) There are no calculations in the ground truth to verify, but the LLM fabricates a revenue trend that implies precise year-over-year growth, which cannot be confirmed and is therefore incorrect. The ground truth focuses on strategic and reporting evolution, not financial figures. (3) The qualitative reasoning partially aligns with the ground truth: the LLM correctly identifies Qualcomm’s strategic shift toward automotive, highlights digital cockpit, ADAS/AD, and connectivity as key areas, and notes the growing importance of the automotive business. It also correctly frames Qualcomm as transitioning to a software-defined vehicle enabler. However, it misses the key multi-hop progression in reporting structure: from strategic vision (2022), to formal revenue categorization (2023), to operational maturity within QCT (2024)—a core element of the original answer. (4) Contextually, the answer is relevant and addresses the transformation theme, but the inclusion of fabricated financial data severely undermines factual correctness. While the strategic narrative is directionally plausible, the unsupported numbers result in a low quantitative accuracy score. The qualitative score is moderate due to correct conceptual framing but incomplete reasoning synthesis. Contextual relevance is high as the response stays on-topic and interprets the strategic transformation correctly, albeit with factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 489,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "Lockheed Martin’s variable‑interest‑rate swap program stayed essentially unchanged over the three‑year span. The 10‑K filings show that the aggregate notional amount of outstanding interest‑rate swaps was $1.3 billion at year‑end 2022, again $1.3 billion at year‑end 2023, and remained $1.3 billion at year‑end 2024. This flat‑line trend indicates that the company has settled on a steady‑state hedge size that matches its borrowing profile, using swaps consistently to offset interest‑rate risk rather than expanding or winding down the program.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. According to the ground truth, LMT's aggregate notional amount of interest rate swaps was $500 million in 2022, increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. The LLM incorrectly states that the notional amount was $1.3 billion in all three years, completely missing the significant increase from 2022 to 2023. This misrepresents the trend and leads to an incorrect interpretation of the company's strategy. (2) The quantitative inaccuracy is severe: the 2022 figure is off by $800 million. The ground truth shows a fourfold increase (from $500M to $1.3B), which is a key analytical point, but the LLM reports no change, making its numerical foundation false. (3) The multi-hop reasoning fails because the model did not detect the change over time, which is central to answering how the use of swaps evolved. The conclusion that the program 'stayed essentially unchanged' contradicts the ground truth, which identifies a strategic shift in 2023 followed by stabilization. The LLM’s reasoning about a 'steady-state hedge size' may apply to 2023–2024, but it ignores the critical expansion in 2023. (4) The correctness score is low (2) due to major factual and quantitative errors. Quantitative accuracy is 2 because only the 2023 and 2024 figures are correct, while 2022 is wrong. Qualitative accuracy is 2 because the reasoning and interpretation are based on false premises. Contextual relevance is 5 because the answer addresses the right topic and metric but with incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 433,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Across the three most recent 10‑K filings Microsoft continues to list the **3.950 % senior notes due 2056** in its “Eleventh Supplemental Indenture” (Exhibit 4.14). Each filing (2022, 2023 and 2024) shows the same description – “3.950 % Notes due 2056, dated as of August 8 2016” 【page_105】. By keeping this ultra‑long‑dated, low‑coupon issue on its balance sheet rather than retiring or refinancing it, Microsoft signals a deliberate maturity‑management policy: it locks in inexpensive financing for the very long term and preserves flexibility to address cash‑flow needs while spacing out debt maturities far into the future.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3.950% Notes due 2056, their inclusion in the Eleventh Supplemental Indenture, and the August 8, 2016 issuance date, matching all key facts from the ground truth. The repeated disclosure across 2022, 2023, and 2024 filings is accurately noted. (2) Quantitative elements—interest rate (3.950%), maturity year (2056), and issuance date (August 8, 2016)—are all factually correct and consistent with the original answer. No calculations are required, but the characterization of the debt as 'ultra-long-dated' and 'low-coupon' is contextually appropriate given the 2016 issuance in a low-rate environment. (3) The reasoning correctly infers Microsoft's strategic intent: maintaining long-term capital stability by not refinancing or retiring the notes, thus locking in low-cost financing. The LLM draws a valid conclusion about maturity management and financial flexibility, aligning with the ground truth’s interpretation. However, it omits explicit mention of contrasting behavior with shorter-term notes (e.g., 2.000% Notes due 2023 in 2022 filings or 2.400% Notes due 2026 in 2024), which weakens the multi-hop comparative analysis slightly. (4) Despite this minor omission, the answer remains highly relevant and semantically equivalent in conveying Microsoft's long-term debt strategy. The inclusion of a specific exhibit reference (Exhibit 4.14) and page number adds precision. Overall, the response is factually sound, well-reasoned, and contextually appropriate—just shy of perfect due to incomplete comparative synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 435,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list Exhibit 4.14 – the Eleventh Supplemental Indenture dated August 8 2016 – which includes the 3.700 % senior notes that mature in 2046【page_105】. By repeatedly incorporating that same indenture by reference, Microsoft signals that the 3.700 % 2046 notes remain outstanding and unchanged, illustrating that a core component of its long‑term debt portfolio is locked in for more than two decades and that the company maintains a consistent, predictable financing structure for its senior unsecured obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is dated August 8, 2016; it governs the 3.700% Notes due 2046; and it is referenced in Microsoft's 2022, 2023, and 2024 filings. The exhibit number (4.14) and page reference (page_105) add precision, though not in the original answer, they do not contradict it. (2) Quantitative elements—dates, percentages, maturity year—are all accurate. No calculations are required, but the temporal consistency across filings is correctly noted. (3) The multi-hop reasoning is sound: the model infers from repeated referencing that the debt remains outstanding and unchanged, which reflects a stable long-term debt strategy—this matches the original answer’s conclusion about ongoing obligations and structured financing. (4) The LLM slightly omits mention of the base Indenture dated May 18, 2009, and the broader layered structure of supplemental indentures, which is a minor gap in completeness. However, the core significance—ongoing relevance, no amendments, stable financing—is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct, contextually appropriate, and reasoning is logical, warranting a high score with only a minor deduction for incomplete structural context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 380,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "- In the FY 2022 and FY 2023 10‑K filings the 2.125 % senior notes that mature in 2021 are still shown as an outstanding issue in the exhibit list – they are described in the **Seventh Supplemental Indenture (exhibit 4.1) for “2.125 % Notes due 2021 and 3.125 % Notes due 2028”**【page_104】.  \n\n- By the FY 2024 10‑K the same exhibit still appears, but the filing also adds a **Fifteenth Supplemental Indenture (exhibit 4.18) dated Nov 6 2023**【page_106】, and the 2.125 % 2021 notes are no longer listed among the company’s current debt obligations.  \n\n**Implication:** Microsoft initially carried the 2.125 % 2021 notes as part of its existing debt portfolio, but before they reached maturity it either redeemed or refinanced them, replacing the old issue with newer financing reflected in the 2023‑2024 supplemental indenture. This shows an active debt‑management strategy that seeks to retire maturing, lower‑coupon notes and restructure the capital structure on more favorable terms.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that in the FY2024 10-K the 2.125% 2021 notes are 'no longer listed among the company’s current debt obligations' and that they were removed from exhibits is false according to the ground truth. The original answer confirms that the notes were still referenced in Exhibit 4.1 of the 2024 filing (page 104), indicating continued disclosure, contrary to the LLM’s assertion. (2) The LLM incorrectly states that a 'Fifteenth Supplemental Indenture (exhibit 4.18) dated Nov 6 2023' was added in the 2024 filing and implies this replaced the old notes. However, the ground truth makes no mention of this exhibit or indenture in relation to the 2.125% Notes due 2021, nor does it indicate any refinancing activity. This exhibit is not referenced in the verified answer and appears to be fabricated or misattributed. (3) The implication that Microsoft 'redeemed or refinanced' the notes before maturity based on exhibit changes is unsupported by the ground truth, which explicitly states the notes remained listed in all three years and raises uncertainty about whether refinancing occurred or if there is a reporting lag. The LLM overinterprets and draws a definitive conclusion contrary to the cautious, evidence-based reasoning in the original. (4) While the LLM correctly identifies the Seventh Supplemental Indenture and exhibit numbers/pages for 2022 and 2023, it misrepresents the 2024 filing, failing the multi-hop synthesis test. The quantitative accuracy is partially correct (dates, percentages) but fails on key document details (exhibit 4.18, Nov 6 2023 date). The reasoning is flawed due to incorrect data interpretation, and the contextual relevance is moderate because it addresses the right topic but with false specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 494,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "- **FY 2022 10‑K:** Microsoft’s Eleventh Supplemental Indenture (Exhibit 4.14) introduced a **2.000 % note due 2023** 【page_105】.  \n- **FY 2023 10‑K:** The same 2.000 % note due 2023 is listed again in Exhibit 4.14, showing it remained outstanding after the 2022 filing 【page_105】.  \n- **FY 2024 10‑K:** The 2.000 % note due 2023 still appears in the exhibit schedule (Exhibit 4.14), indicating the company has kept the bond on its balance sheet until its scheduled maturity 【page_105】.  \n\n**Interpretation:** Over three consecutive years Microsoft has issued a modest‑size, low‑coupon (2 %) medium‑term bond and then simply carried it to maturity, reflecting a debt‑management strategy that favors stable, predictable financing, locks in low interest rates, and avoids frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—2.000% interest rate, due in 2023, and references to Exhibit 4.14 across FY 2022, 2023, and 2024—are factually correct and match the original answer. The fiscal years and the consistent citation of the Eleventh Supplemental Indenture are properly identified. (2) Quantitative accuracy is perfect: percentages, years, and exhibit numbers are correct, and no calculations were required. (3) The multi-hop reasoning is sound—by tracking the same note across three years, the model correctly infers that Microsoft maintained the debt until maturity without refinancing. The interpretation about stable, predictable financing and avoiding frequent refinancing is logically supported and semantically equivalent to the ground truth’s conclusion about a stable, long-term debt strategy. (4) The only minor shortcoming is that the LLM slightly mischaracterizes the bond as being 'issued' each year, when in fact it was issued once in 2016 and merely referenced in subsequent filings. This could imply a misunderstanding of debt disclosure practices, but the overall synthesis and conclusion remain valid. Hence, a score of 9 is appropriate—excellent accuracy with a small nuance missed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 355,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "Lockheed Martin’s pension‑risk‑transfer program, which began with a $4.9 billion group‑annuity purchase in 2021 (bringing the total transferred since 2018 to about $11.6 billion), did not grow in size after that – the 2022 filing reports no new transfer and only the $1.7 billion non‑cash settlement charge from the 2021 deal, while the 2023 filing merely notes that the company “continues to evaluate” such transactions and that future deals could again generate material non‑cash charges. In the 2024 filing the company still reports no additional risk‑transfer contracts, but it did make a $990 million cash contribution to its defined‑benefit plans and recovered $1.7 billion of CAS pension costs in both 2023 and 2024, reaffirming its stated strategy of “continuing to look for opportunities to manage our pension liabilities through additional pension‑risk‑transfer transactions” and warning that any future transfer could result in a material non‑cash settlement charge.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies, particularly regarding the scale and timing of pension risk transfer transactions. The ground truth states that Lockheed Martin continued its strategy through 2024 and had transferred approximately $11.6 billion in obligations since December 2018, with the $4.9 billion transaction occurring in August 2021. The LLM correctly notes this $4.9 billion transfer and the $1.7 billion noncash charge, but incorrectly implies no new transfers occurred in 2022–2024, stating 'no new transfer' and 'still reports no additional risk-transfer contracts.' However, the original answer suggests an ongoing and evolving strategy with continued emphasis on future transactions, not a halt in activity. The LLM introduces a $990 million cash contribution in 2024 and $1.7 billion CAS cost recovery in 2023 and 2024, which are not mentioned in the ground truth and may conflate pension contributions with risk transfers. These figures, while possibly present in filings, are not part of the documented evolution of risk transfer transactions and distract from the core focus on GACs and liability transfers. (2) Quantitative accuracy is partially correct: $4.9 billion in obligations and $1.7 billion charge are accurate, as is the $11.6 billion cumulative total since 2018. However, the introduction of $990 million contribution and $1.7 billion CAS recovery lacks corroboration in the ground truth and may misrepresent financial impact. The absence of updated obligation totals beyond 2021 suggests stagnation, contradicting the original answer’s implication of continued progress. (3) Multi-hop reasoning is moderate: the model connects prior transfers to future strategy and recognizes the link between risk transfers and noncash charges. However, it fails to confirm that the strategy evolved through continued pursuit and evaluation, rather than inactivity. The synthesis across years is present but flawed in conclusion. (4) Despite inaccuracies, the answer remains contextually relevant, addressing all key themes: scale, financial impact, and future strategy. Wording like 'continuing to look for opportunities' aligns with the original. The core error is factual incompleteness and misrepresentation of transactional continuity, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 617,
        "total_tokens": 2179
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "The fact that Apple’s 10‑K exhibits repeatedly list the “Floating Rate Notes due 2019” (see the exhibit table in the 2022 filing – page 56 and again in the 2024 filing – page 56) shows that the company still reports that series of notes as part of its outstanding securities. By keeping the 2019 floating‑rate issue on its books (or by rolling it over through a refinance) Apple demonstrates a strategy of maintaining a diversified, floating‑rate debt tranche and systematically refinancing maturing obligations, which helps it manage long‑term debt maturity profile and interest‑rate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies the Floating Rate Notes due 2019 and their continued disclosure in Apple's 2022 and 2024 filings, which matches the original answer's claim about consistent references through 2024. The dates and entities (Apple, Floating Rate Notes due 2019) are correct. (2) There are no numerical inaccuracies—while no specific dollar amounts are mentioned, the temporal references (2019 maturity, 2022–2024 filings) are accurate and consistent with the ground truth. (3) The reasoning is sound: the LLM correctly infers that the continued listing suggests either ongoing reporting of the instrument or a refinancing/rollover, which reflects a disciplined debt management strategy. It captures the multi-hop logic—despite maturity in 2019, the notes are still referenced, implying refinancing or structural continuity. (4) The answer is contextually relevant and directly addresses the investor-focused question about Apple’s long-term debt and refinancing strategy. The only minor shortcoming is that it does not explicitly mention 'transparency around historical debt instruments' or 'predictable capital structure' as emphasized in the original, but it conveys the same core insight about systematic refinancing and diversified debt management. Thus, the answer is semantically equivalent with high qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 394,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Across all three filings the 4.000 % Notes due 2021 are still listed in the exhibit index. In the 2022 10‑K (page 104) they appear in Exhibit 4.6 – the “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041.” The same reference is reproduced unchanged in the 2023 10‑K (page 104) and again in the 2024 10‑K (page 104). The fact that Microsoft continues to disclose this 4.000 % 2021 issue year after its scheduled maturity indicates the debt has been rolled‑over or otherwise remains outstanding, underscoring its continued relevance in the company’s capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.000% Notes due 2021 are consistently listed in Exhibit 4.6 across the 2022, 2023, and 2024 10-K filings, with page numbers correctly cited (104 in each). The percentage (4.000%), maturity year (2021), and context (Third Supplemental Indenture) are all precisely stated. (2) Quantitative accuracy is perfect: no calculations are required, but all dates, percentages, and exhibit references are factually correct and match the ground truth. (3) Reasoning is sound: the LLM correctly infers that the continued disclosure post-maturity suggests the debt remains outstanding or has ongoing structural relevance, possibly due to rollover or continued covenant obligations. This reflects valid multi-hop reasoning across years and documents. (4) The only minor shortcoming is that the LLM attributes the continued disclosure specifically to rollover or being outstanding, while the ground truth allows for broader structural/legal reasons (e.g., covenants, transparency). This slightly narrows the interpretation, but the core insight about ongoing relevance is preserved. Overall, the answer is factually excellent, contextually appropriate, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 361,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "UPS’s 7.620 % debentures were first described in the 2022 filing as $276 million of notes maturing on April 1 2030, bearing semi‑annual interest (paid in April and October), redeemable at UPS’s option in whole or in part at the greater of (i) principal + accrued interest or (ii) the present value of remaining payments discounted at a Treasury yield + 5 bps, with no sinking‑fund requirement. The 2023 and 2024 10‑Ks repeat the same redemption formula, interest schedule and lack of a sinking fund, indicating no change in the contractual terms. Throughout the three years the debentures remained a stable, small component of UPS’s debt portfolio – listed at roughly $276 million (≈ 1 % of total debt) while total long‑term debt grew from about $22.1 billion in 2022 to $22.5 billion in 2023 and stayed near that level in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions in completeness and contextual evolution. (1) Quantitatively, all numbers are accurate: $276 million principal, April 1, 2030 maturity, semi-annual interest payments, redemption formula (greater of principal plus accrued interest or present value at Treasury yield + 5 bps), and total debt figures (~$22.1B in 2022, ~$22.5B in 2023–2024) are correctly reported. The 1% of total debt estimate is reasonable and consistent. (2) The contractual terms—redemption, interest schedule, no sinking fund—are correctly stated and confirmed as unchanged across years, which matches the ground truth. (3) However, the LLM answer omits key qualitative shifts in disclosure focus highlighted in the original answer: the 2022 emphasis on interest rate history (drop from 8.375% to 7.620% in April 2020), the 2023 inclusion in a broader debt table with a book value of $280 million (slight premium to face value), and the 2024 shift toward comparative treatment within international debt instruments (Pound Sterling, Euro notes). These represent important narrative and contextual evolutions in how UPS presented the debentures, which the LLM answer does not capture. (4) While the core facts and multi-hop consistency across years are sound, the failure to reflect the changing emphasis in disclosure reduces completeness and qualitative accuracy. The answer remains highly relevant and factually precise, warranting a high score but not perfect due to missing the nuanced progression in reporting focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 432,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "- In 2022 Vraylar generated about **$2.0 billion** of net revenue (U.S. $2.037 bn + $1 m international) 【page 42】; the product was still being positioned on the basis of its Phase‑3 schizophrenia/bipolar data and the company was pursuing an adjunct‑MDD indication that had produced positive top‑line results in 2021 【page 60】.  \n- By 2023 AbbVie secured FDA approval for Vraylar as an **adjunctive therapy for major depressive disorder**, and sales jumped **35 % to $2.76 billion** (U.S. $2.755 bn + $4 m international) 【page 44】, reflecting both market‑share gains and the new MDD label.  \n- The 2024 filing continues to list Vraylar among its core neuroscience assets (see the neuroscience product table 【page 5】), indicating that the drug has moved from a pipeline candidate to a major, growing revenue pillar that helps diversify AbbVie’s neuroscience portfolio and offset the erosion of older products such as Humira.  \n\n**Trajectory:** From a pipeline‑stage, single‑indication product in 2022, Vraylar achieved an additional FDA indication in 2023 and delivered strong revenue growth, positioning it as a strategically important, high‑growth anchor of AbbVie’s neuroscience franchise through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies Vraylar's development trajectory, including the 2022 Phase 3 trial context (though it references 2021 top-line results, which is consistent with the 2022 filing context), FDA approval in 2023 for adjunctive MDD, and its established status as a core neuroscience product by 2024. The financial figures are highly accurate: $2.76 billion in 2023 revenue (vs. ground truth $2,759 million) and a 35% year-over-year increase (vs. 35.4% in original) — these minor rounding differences are acceptable. The 2022 revenue of $2.037 billion is not in the ground truth but is plausible and consistent with the 35% growth to ~$2.76B, suggesting correct interpolation. (2) Quantitative accuracy is strong: $2.76B vs $2,759M is effectively equivalent (within $1M), and 35% vs 35.4% is a negligible rounding variance. The LLM correctly attributes growth to both label expansion and market uptake. (3) Multi-hop reasoning is sound: it connects clinical development (Phase 3 results, FDA approval) with commercial performance (revenue jump) and strategic positioning (core neuroscience asset in 2024), synthesizing across time and domains. (4) The answer is contextually excellent, directly addressing development, commercialization, financial performance, and strategic importance. The only minor gap is that the ground truth emphasizes one Phase 3 trial met primary endpoint and the other did not — the LLM simplifies this — but this does not undermine the overall correctness. Thus, the answer earns a 9 for minor omission in trial detail and slight rounding, but is otherwise excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 461,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "The 0.45 % Notes due 2016 appear in the “Officer’s Certificate” exhibit (Exhibit 4.3) in the 2022, 2023 and 2024 10‑K filings 【page_58†L13-L19】. By continuing to list this very low‑coupon, now‑matured issue each year, Apple signals that its long‑term debt program includes legacy securities that are kept on the books (or at least retained in the footnote schedule) for completeness, and that the company’s disclosure policy deliberately reports every historic issuance rather than removing retired instruments. This practice reflects a debt structure that spans many vintages and a transparent, consistent approach to reporting legacy debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 0.45% Notes due 2016, their inclusion in Exhibit 4.3 (Officer's Certificate) across Apple's 2022, 2023, and 2024 10-K filings, and the fact that these notes matured in 2016 but continue to be disclosed. All factual elements—percentage, maturity year, exhibit number, and filing years—are accurate. (2) Quantitative accuracy is perfect: the 0.45%, 2016 maturity, and reference to three consecutive filings (2022–2024) match the ground truth. No calculations are required, but temporal and numerical facts are correct. (3) The reasoning is sound: the LLM correctly infers that Apple maintains legacy instruments in disclosures for completeness and transparency, reflecting a consistent disclosure strategy and multi-vintage debt structure. It synthesizes the continued presence of a matured instrument with broader implications for reporting policy, aligning with the ground truth’s interpretation. (4) The only minor shortcoming is that the LLM slightly overreaches by suggesting the notes are 'kept on the books,' which could imply accounting recognition post-maturity, whereas the ground truth more precisely frames it as disclosure in footnotes/schedules for historical record. This nuance prevents a perfect 10, but the overall meaning and intent are semantically equivalent. Contextual relevance is excellent, directly addressing both the debt structure and disclosure strategy as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 400,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "- In the 2022 filing UPS described **SurePost** as a “residential‑ground service for non‑urgent, lightweight residential shipments … with final delivery **often provided by the U.S. Postal Service**,” positioning it within the U.S. Domestic Package segment as a low‑cost, lower‑yield option that leveraged the UPS ground network but relied on USPS for the last‑mile (“UPS SurePost provides residential ground service … final delivery often provided by the U.S. Postal Service” – 2022 page 5).  \n\n- The 2023 filing repeats the same description, indicating no change in the delivery methodology that year.  \n\n- By the 2024 filing the company still noted that “through 2024, final delivery was often provided by the United States Postal Service,” but added that **effective January 1 2025 UPS will insource SurePost**, taking direct control of the final‑mile delivery (“Beginning January 1 2025 … we have insourced this product” – 2024 page 5).  \n\nThus, from 2022‑2024 SurePost evolved from a USPS‑partnered, last‑mile service to a fully UPS‑operated offering, reflecting UPS’s strategic move to tighten control over its low‑margin residential‑ground product while keeping it positioned as the “non‑urgent, lightweight” tier within the U.S. Domestic Package business.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: in 2022 and 2023, UPS SurePost used the U.S. Postal Service for final delivery, and in 2024, UPS announced it would insource final delivery effective January 1, 2025. The description of SurePost as a non-urgent, lightweight residential service within the U.S. Domestic Package segment is consistent across years. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and there are no numerical errors. Format and referencing (e.g., '2022 page 5') support accuracy without introducing inaccuracies. (3) Multi-hop reasoning is sound—LLM correctly synthesized information across three years of filings, identifying continuity (2022–2023) and change (2024 announcement), and inferred the strategic implication of insourcing for service control and quality. (4) The answer is contextually complete, addressing both delivery methodology evolution and strategic positioning. Wording differs slightly from the original answer but maintains semantic equivalence. No omissions or inaccuracies; thus, full marks are justified across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 331,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 10‑K filings repeatedly list the same long‑dated bond – a 4.45 % senior note maturing in 2044 – as part of its debt program. The 2022 filing shows the officer’s certificate (Exhibit 4.4) that includes “4.45 % Notes due 2044”【page_58】, and the 2024 filing again references that same certificate and the 4.45 % Notes due 2044【page_56】 (the 2023 filing contains the same exhibit, confirming the instrument remained outstanding). By issuing or maintaining this 4.45 % note in successive years, Apple is deliberately locking in low‑cost, fixed‑rate financing for the next two decades, diversifying its maturity profile and signaling a long‑term capital‑structure strategy focused on stable, inexpensive debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 are accurately referenced across 2022, 2023, and 2024 filings, with proper mention of the Officer's Certificate (Exhibit 4.4) dated May 6, 2014, implicitly confirmed by consistent exhibit citation. The percentages (4.45%), maturity year (2044), and multi-year continuity are all factually sound. (2) Quantitative elements—interest rate, maturity date, and exhibit reference—are exact matches; no calculations were required, but the temporal consistency is correctly interpreted. (3) The multi-hop reasoning is strong: the model synthesizes information across three years of filings to infer a strategic pattern in Apple’s capital structure, correctly concluding that the sustained presence of this debt instrument indicates a deliberate, long-term financing strategy. (4) The LLM adds value by interpreting the strategic rationale—locking in low-cost, fixed-rate financing and diversifying maturity profile—which is a reasonable inference from the data and consistent with the ground truth’s conclusion about financial flexibility and interest rate risk management. The only minor shortcoming is that the LLM implies Apple may have 'issued or maintained' the note in successive years, which could be misinterpreted as new issuance, whereas the ground truth clarifies it was maintained without restructuring or early redemption. However, the overall semantic meaning and strategic interpretation remain substantially correct. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 455,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle listed the 2.875 % Notes due 2031 in the same “Exhibit 4.14 – Forms of 1.650 % Notes due 2026, 2.300 % Notes due 2028, **2.875 % Notes due 2031**, 3.650 % Notes due 2041, 3.950 % Notes due 2051 and 4.100 % Notes due 2061** in each of its 10‑K filings. The 2022 filing shows the note under Exhibit 4.14 (page 112) and the 2023 and 2024 filings also include it under Exhibit 4.14 (page 111) with the same officers’ certificate dated March 24, 2021. This unchanged placement signals that Oracle continues to treat the 2.875 % Notes as part of its ongoing senior‑unsecured, long‑dated debt program, reflecting a deliberate strategy to maintain a stable, diversified maturity profile and low‑cost financing within its capital‑structure management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.875% Notes due 2031 were consistently listed as Exhibit 4.14 in Oracle's 2022, 2023, and 2024 10-K filings; the Officers' Certificate date is correctly cited as March 24, 2021; and the exhibit includes multiple notes, with the 2.875% Notes due 2031 accurately identified among them. (2) Quantitative elements—percentages (2.875%), maturity year (2031), exhibit number (4.14), and filing years (2022–2024)—are all factually correct. Page numbers (112 for 2022, 111 for 2023 and 2024) are consistent with actual filings and add precision without contradicting the ground truth. (3) The reasoning is sound: the LLM correctly infers that the unchanged exhibit placement reflects a stable, long-term debt strategy focused on maintaining a diversified maturity profile and low-cost financing. While the original answer emphasizes 'no modifications to the terms,' the LLM captures the same conclusion by noting the continued use of the same Officers' Certificate, which implies no changes. (4) The LLM slightly expands on the interpretation by referencing a 'senior-unsecured, long-dated debt program' and 'diversified maturity profile,' which are reasonable inferences not explicitly stated in the ground truth but consistent with it. This adds value without introducing error. Only a minor deduction from 10 to 9 is warranted due to this slight interpretive expansion, but overall the answer is factually robust, contextually relevant, and demonstrates correct multi-hop synthesis across three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 441,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters national master agreement inserted wage‑ and benefit‑rate increases for Teamsters members, and UPS recorded those increases as higher accrued benefits (i.e., a higher service‑cost component) in the year‑end measurement of the UPS/IBT Full‑Time Employee Pension Plan. The 2024 filing shows that, even after those accruals, the plan still represents a sizable long‑term liability – the projected benefit obligation is measured with a 5.42 % discount rate and would rise about $57 million (or fall $60 million) for each one‑basis‑point change in that rate, highlighting UPS’s substantial ongoing pension obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that the 2023 Teamsters agreement included wage and benefit increases that increased pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and that these were reflected in the year-end measurement—this aligns with the ground truth. It also correctly notes that the 2024 disclosures show no structural changes, implying the 2023 agreement was the latest update, and appropriately links this to UPS's ongoing long-term pension obligations. However, the LLM introduces specific quantitative details not present in the ground truth: the 5.42% discount rate and the $57 million/$60 million sensitivity figures. These numbers, while plausible, are not mentioned in the original answer derived from the knowledge graph, making them unsupported additions. There is no indication in the ground truth that these sensitivity metrics or the exact discount rate were disclosed in 2024, so their inclusion reduces quantitative accuracy. The qualitative reasoning is sound—correctly connecting collective bargaining outcomes to service cost and long-term liabilities—and the context is highly relevant. The answer captures the core multi-hop logic (2023 agreement → benefit accruals → impact on pension obligations → reflection in 2024 disclosures) but adds unverified numerical precision, which limits full factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 378,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "In each of Apple’s three most recent Form 10‑K reports the company lists the same Officer’s Certificate (Exhibit 4.4) that was issued on May 6 2014 and that “includes … 1.05 % Notes due 2017” — the 2022 filing (see the exhibit table on page 58), the 2023 filing (the same exhibit appears in the 2023 exhibit list), and the 2024 filing (see the exhibit table on pages 56‑57). The fact that Apple repeats this exact disclosure year after year shows that it treats the 1.05 % notes as a routine, short‑term debt instrument and maintains a consistent, transparent reporting approach for the obligations created under its 2014 Officer’s Certificate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple consistently disclosed the 1.05% Notes due 2017 under the same Officer's Certificate dated May 6, 2014, across its 2022, 2023, and 2024 10-K filings. All entities—Apple, the 1.05% Notes, the 2014 Officer's Certificate, and the specific years—are accurate. The mention of Exhibit 4.4 and page references (e.g., page 58 in 2022, pages 56–57 in 2024) adds precision and aligns with typical 10-K structure, though these details are not in the ground truth; they do not contradict it and support the claim of consistency. (2) Quantitatively, all numbers—1.05%, 2017 maturity, May 6, 2014 issuance date—are correct and match the ground truth. No calculations are required, but the repetition across years is accurately noted. (3) The reasoning is largely sound: the LLM correctly infers that the repeated disclosure reflects a consistent reporting approach. However, while the ground truth emphasizes a 'passive management approach' and 'stability in capital structure,' the LLM's interpretation leans slightly toward 'routine' and 'transparent reporting,' which is related but not fully equivalent. It misses the deeper implication about Apple’s strategic choice not to refinance or modify the debt, which is central to the original answer. This is a minor gap in qualitative depth, not factual error. (4) The answer is contextually relevant, directly addressing the evolution (or lack thereof) in disclosure and drawing a reasonable conclusion about Apple’s approach. The conclusion is slightly less nuanced than the ground truth but still logically supported. Hence, high scores across all dimensions with a small deduction in qualitative accuracy for incomplete conceptual synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 475,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 10‑K filings have listed the 2.40 % senior notes that mature in 2023 in the same “Officer’s Certificate” exhibit (Exhibit 4.3) each year. The 2022 filing already disclosed “2.40 % Notes due 2023” (see the exhibit list in the 2022 10‑K), and the same language appears unchanged in the 2023 filing 【page 56 (2023)】 and again in the 2024 filing 【page 56 (2024)】. This consistent, multi‑year disclosure shows that Apple has kept the 2.40 % notes on its balance sheet until maturity rather than refinancing or retiring them early, reflecting a long‑term debt strategy that relies on fixed‑rate senior notes as a stable, hold‑to‑maturity financing source.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 2.40% interest rate, maturity in 2023, and consistent disclosure across 2022, 2023, and 2024 10-K filings are accurately reported. The reference to Exhibit 4.3 and specific page numbers (56 in 2023 and 2024 filings) adds precision and matches the expected disclosure pattern. (2) The answer correctly identifies that the disclosure remained unchanged over the three years, implying no early repayment, modification, or refinancing—consistent with the ground truth. (3) The reasoning is sound: the model correctly infers from the static disclosure that Apple maintained a stable, hold-to-maturity debt strategy for this instrument. The conclusion about reliance on fixed-rate senior notes as a stable financing source is a reasonable interpretation, though slightly more interpretive than the original answer, which sticks strictly to the observed lack of changes. (4) The only minor gap is that the LLM does not explicitly mention the May 3, 2013 Officer's Certificate date, which is part of the original disclosure origin. While not critical to the core insight, it is a small omission in completeness. However, the multi-hop synthesis across years and filings is correctly executed, and the semantic meaning and strategic implication are equivalent. Wording differences are acceptable and do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 398,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "From 2022 to 2024 Vraylar moved from a fast‑growing niche antipsychotic to a broader‑indication neuroscience asset.  In 2022 the drug’s U.S. net revenue jumped to **$1.7 billion**, an 82 % increase over 2021, reflecting expanding market share in its approved schizophrenia and bipolar‑disorder uses.  In 2023 the company secured **FDA approval of Vraylar as an adjunctive therapy for major‑depressive‑disorder**, which drove a **35 % revenue rise to $2.76 billion** and positioned Vraylar as the only dopamine‑D3‑preferring partial agonist covering schizophrenia, bipolar illness and MDD within AbbVie’s neuroscience portfolio.  The 2024 filing still lists Vraylar among the core neuroscience products, indicating that the drug remains an active, multi‑indication revenue generator after its recent label expansion.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall commercial trajectory of Vraylar correctly, including its expanding indications and role in AbbVie's neuroscience portfolio. It correctly identifies the 2023 revenue increase and the 2023 FDA approval for adjunctive MDD treatment as key milestones. However, there are significant quantitative inaccuracies. The LLM states U.S. net revenue in 2022 was $1.7 billion, but the ground truth reports U.S. sales of $2,037 million ($2.037 billion) in 2022—making the LLM's figure too low by over $300 million. Additionally, while the LLM correctly reports a ~35% revenue increase and a 2023 revenue of $2.76 billion (close to the true $2.759 billion), it incorrectly attributes this jump primarily to the 2023 FDA approval. In reality, the approval came after the 2023 results and was not the cause of that year’s sales growth—clinical progress was reported in 2022, but approval timing is not confirmed for 2023 in the ground truth. (2) The percentage increase in U.S. sales from 2022 to 2023 was 35.2% according to ground truth ($2,037M to $2,755M), which the LLM approximates correctly as '35%'. However, the LLM’s claim of an '82% increase over 2021' introduces data not present in the ground truth and cannot be verified, reducing quantitative accuracy. (3) The multi-hop reasoning is mostly sound: the model connects clinical development (MDD trials/approval), revenue trends, and therapeutic positioning within AbbVie’s portfolio. It correctly infers broader strategic importance post-label expansion. However, it misaligns causality by suggesting the FDA approval occurred in 2023 and drove that year’s revenue, when the ground truth indicates the Phase 3 results were in 2022 and does not confirm approval timing—only that by 2024 it was formally positioned with the expanded indication. (4) Despite these issues, the answer is contextually relevant and conveys a largely accurate narrative. The core facts—strong revenue growth, expanded indications, and strategic importance—are present. The qualitative reasoning and entity identification (Vraylar, AbbVie, MDD, schizophrenia, bipolar) are correct. Quantitative accuracy is penalized due to incorrect 2022 revenue figure and unsupported claims about 2021 growth and approval timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 610,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "- In the 2022 filing IBM first framed “client relationships and trust” as part of a broader set of competitive levers and paired it with “trust and security” in its description of a flexible, open hybrid‑cloud platform (2022 p. 4).  \n- The 2023 and 2024 filings repeat the same language, now listing “client relationships and trust” explicitly among the **principal methods of competition** and again emphasizing it together with “trust and security” when describing how its hybrid‑cloud and AI platform is built (2023 p. 3; 2024 p. 3).  \n\nThis consistent, year‑over‑year elevation of client relationships and trust shows IBM is deliberately positioning itself as a trusted, partnership‑focused provider that can differentiate its hybrid‑cloud and AI offerings from rivals, using deep client bonds and security credibility as a cornerstone of its growth strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its citation of IBM's filings across 2022–2024 and correctly identifies the consistent mention of 'client relationships and trust' as a competitive differentiator, with proper page references and terminology. Quantitatively, there are no errors—dates, years, and document locations (e.g., 2022 p. 4, 2023 p. 3) are accurately reported, and no numerical miscalculations are present, so quantitative accuracy is high. Contextually, the answer addresses IBM’s strategic positioning in hybrid cloud and AI and links trust to competitive differentiation, maintaining relevance. However, the qualitative accuracy is lower because the LLM fails to capture the *evolution* emphasized in the original answer. While it notes repetition of language, it misses the strategic progression: from trust as part of platform design (2022), to trust enabled through strategic partnerships (2023), to trust as a foundational go-to-market enabler via a broad ecosystem (2024). The original answer highlights a deepening, multi-year strategic refinement, but the LLM portrays it as static repetition with 'elevation' rather than nuanced evolution. This misrepresents the reasoning trajectory and omits key synthesis about how IBM’s use of trust matured from a value proposition to an innovation enabler. Thus, while the surface-level facts are correct, the multi-hop reasoning and conceptual progression are inadequately captured, leading to a partially correct but incomplete qualitative assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 415,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "In the 2022 Form 10‑K IBM disclosed the 1.250 % Notes due 2027 only by “incorporating by reference” the 8‑K exhibit that originally defined the notes (Exhibit 4.3 of a 2019 filing). The 2023 filing repeated the same reference‑by‑reference approach. By the 2024 Form 10‑K, however, IBM listed the 1.250 % Notes due 2027 (ticker IBM27B) in its Schedule 12(b) securities table, treating the notes as a distinct, actively‑registered component of its overall debt portfolio rather than merely an incorporated historical instrument. This shift reflects a move toward more explicit, stand‑alone disclosure of the notes’ existence and role within IBM’s capital structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 2019 Exhibit 4.3 reference in 2022, the continued incorporation by reference in 2023, and the explicit listing in 2024 with ticker IBM27B. (2) No numerical inaccuracies—percentages (1.250%), years (2019, 2022, 2023, 2024), and the ticker symbol (IBM27B) match exactly. (3) The multi-hop reasoning is sound: the answer correctly synthesizes disclosure practices across three years, tracing the evolution from passive incorporation to active registration, reflecting increasing transparency. (4) The LLM captures the core theme—IBM’s enhanced disclosure and the note’s growing prominence in the debt portfolio—using slightly different but equivalent phrasing (e.g., 'reference-by-reference' vs 'incorporating by reference', 'Schedule 12(b)' aligns with formal listing). The answer fully addresses both disclosure practices and the instrument’s evolving role, meeting all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 290,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the exhibit table for “Instruments defining the rights of security holders” stopped at the 6.22 % Debentures due 2027 and did **not** list the 6.50 % Debentures due 2028. Starting with the 2023 filing, IBM added a line stating that the rights of the 6.50 % Debentures due 2028 are set out in **Exhibit 2 to Form 8‑K (filed Jan 8 1998)**, and the 2024 filing repeats the same reference unchanged. This reflects IBM’s broader practice of cataloguing each debt series with a specific 8‑K exhibit, and the 6.50 % Debentures due 2028 moved from being omitted in 2022 to being consistently disclosed in 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. According to the ground truth, IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K filed on January 8, 1998, across all three years (2022, 2023, and 2024). However, the LLM claims that the 6.50% Debentures were *not listed* in the 2022 10-K exhibit table—a direct contradiction of the original answer, which states the exhibit reference was consistent throughout all three years. This error misrepresents the core evolution (or lack thereof) in disclosure practice. While the LLM correctly identifies the exhibit reference (Exhibit 2 to Form 8-K, filed Jan 8, 1998) for 2023 and 2024, and notes its consistency between those years, the false claim of omission in 2022 invalidates the overall narrative of 'evolution' presented. The broader context about IBM’s debt disclosures integrating legacy and newer instruments is missing from the LLM response, reducing completeness and qualitative accuracy. The model also fails to mention the comparative framing with other debentures (e.g., 6.22% due 2027, 5.875% due 2032), weakening the analysis of disclosure trends. Quantitative elements (percentages, dates, exhibit numbers) are otherwise accurate when stated, supporting a moderate score in that category. Contextually, the answer addresses exhibit consistency and disclosure evolution, but with incorrect directionality—claiming a change where the ground truth indicates stability. Thus, while the response is structurally relevant and attempts multi-hop reasoning, it fails on factual fidelity, especially regarding the key claim about 2022 omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 454,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "- In the 2022 filing, FedEx International Connect Plus was described as a “contractual e‑commerce service currently available from **nearly 50 origin countries to over 130 destination countries**”【page_14】.  \n- The 2023 filing shows the service had expanded to “**nearly 60 origin countries to over 190 destination countries**”【page_8】, and the 2024 filing repeats the same coverage of “**nearly 60 origin countries to over 190 destination countries**”【page_8】.  \n\nThis rapid increase in both origin and destination coverage between 2022 and 2023 – and its maintenance in 2024 – indicates FedEx is deliberately broadening the global footprint of its e‑commerce‑focused Connect Plus network, positioning the company to capture more cross‑border online retail traffic and to reinforce its strategic emphasis on e‑commerce logistics as a growth engine.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers for origin and destination countries across 2022, 2023, and 2024 are accurate: 'nearly 50 to over 130' in 2022, expanding to 'nearly 60 to over 190' in 2023 and maintained in 2024. These match the original answer exactly. (2) The answer is complete, addressing both the evolution of geographic reach and the strategic implication regarding e-commerce logistics. (3) Entities—FedEx International Connect Plus, correct years (2022–2024), and the service's e-commerce focus—are accurately identified. (4) The reasoning is sound: the LLM correctly infers that the rapid expansion from 2022 to 2023 followed by stabilization in 2024 suggests a deliberate growth strategy and maturation of global coverage, aligning with FedEx's strategic emphasis on e-commerce as a growth driver. Minor wording differences (e.g., 'contractual e-commerce service' cited from source) do not affect semantic equivalence. All multi-hop elements—comparing coverage across three years and synthesizing strategic intent—are correctly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 318,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "In its FY 2022 proxy, Qualcomm set concrete 2025 diversity goals – +15 % women in leadership, +15 % under‑represented‑minority (URM) leaders and +20 % overall URM representation – and said that achievement of those goals would be used as a non‑financial performance modifier that could raise or lower each executive’s FY 2022 bonus by a factor of 0.9 to 1.1. By FY 2024 the filing still ties “human‑capital advancements” to the same 0.9‑to‑1.1 bonus multiplier, but it no longer restates the specific 2025 percentage targets, instead referring to broader DEI initiatives and recruitment efforts. Thus, the bonus‑adjustment mechanism remained unchanged, while the explicit diversity‑percentage targets that were highlighted in 2022 were dropped from the later disclosures.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding the evolution of Qualcomm's diversity targets. Quantitatively, the numbers cited (15% increase for women and URM in leadership, 20% overall URM representation, and 0.9–1.1 bonus adjustment range) are accurate and match the ground truth. The fiscal years (2022–2024) and the structure of the non-financial performance modifier are also correctly identified. However, the key error lies in claiming that the specific 2025 percentage targets were 'dropped' in FY2024 disclosures. The ground truth states these goals were reaffirmed in both 2023 and 2024 with no changes, though the emphasis shifted toward broader initiatives like the Reboot Representation Tech Coalition. The LLM incorrectly interprets the shift in language and focus as a removal of quantitative targets, which contradicts the sustained strategic framework described in the original answer. This undermines the qualitative accuracy, especially in multi-hop reasoning: the model fails to synthesize that while disclosure emphasis evolved, the core targets remained unchanged. Contextually, the answer addresses all parts of the question and is well-structured, but the central conclusion about target discontinuation is false. Thus, despite correct numbers and relevant framing, the answer misrepresents the core evolution of the goals, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 394,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 each list the “Floating Rate Notes due 2019” among its outstanding securities (see the exhibit tables that describe the notes – e.g., Exhibit 4.4 in the 2024 filing 【page 58】 and the same table in the 2022 filing 【page 56】). By keeping these short‑term, rate‑adjustable notes on its balance sheet, Apple shows that it deliberately uses floating‑rate debt to align interest costs with prevailing short‑term rates, thereby hedging rate‑risk and preserving liquidity flexibility for near‑term cash‑flow needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Apple included 'Floating Rate Notes due 2019' in its 10-K filings for 2022, 2023, and 2024, which is explicitly confirmed with reference to specific exhibit tables and page numbers (e.g., Exhibit 4.4 in 2024 filing, page 58; 2022 filing, page 56). These details match the multi-year consistency noted in the original answer. (2) Quantitative accuracy is perfect: the years (2019 maturity, disclosures in 2022–2024) are correct, and no numerical calculations are required beyond correct identification of time periods. Format and references are precise. (3) Reasoning is sound: the LLM correctly infers that retaining these notes indicates a deliberate strategy to use floating-rate debt to align interest costs with market rates, thereby managing short-term interest rate risk and preserving liquidity flexibility. This reflects valid multi-hop synthesis between the persistent disclosure and its implications for risk and liquidity management. (4) The only minor limitation is that the LLM does not explicitly mention Apple’s 'cautious yet adaptive stance' or the fact that no new short-term floating rate instruments were issued, which adds slight depth to the strategic interpretation in the original answer. However, the core qualitative insights—deliberate use of floating-rate debt, alignment with market conditions, liquidity flexibility—are fully captured. Semantic equivalence is strong, and the response is contextually excellent, directly addressing the question with appropriate financial reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 442,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "Qualcomm’s 2022 filing framed its automotive business as an emerging opportunity within the QCT semiconductor segment, emphasizing that “digital‑cockpit” experiences were part of a broader push to embed cellular connectivity and advanced driver‑assistance (see page 6) and citing analyst forecasts that ≈70 % of new vehicles will have embedded cellular connectivity by 2028 and that 19 % of 2025 vehicle sales will feature Level‑2‑or‑higher autonomy versus 9 % in 2022 (page 8). By the 2024 filing the company had elevated automotive to a distinct revenue stream inside QCT, reporting $2.9 b of automotive revenue in 2024 versus $1.5 b in 2022 (page 73), reflecting a strategic shift to focus on digital‑cockpit, connectivity and ADAS/AD products as market demand for 5G‑enabled, software‑defined vehicle interiors accelerates.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Qualcomm's strategic positioning from 2022 to 2024, correctly identifying the emphasis on digital cockpit and automotive technologies within the QCT segment and the growing market demand. However, there are key quantitative inaccuracies. The ground truth states that Qualcomm projected over 60% of new vehicles would have 5G connectivity by 2028, while the LLM claims ≈70% will have embedded cellular connectivity by 2028. While related, '5G connectivity' is not equivalent to 'embedded cellular connectivity'—a meaningful distinction in technical scope—and the percentage differs. Additionally, the LLM introduces autonomy statistics (19% of 2025 vehicle sales with Level-2-or-higher autonomy vs. 9% in 2022) that are not present in the original answer and may be extraneous or misaligned with the focus on digital cockpit. The revenue figures ($2.9B in 2024 vs. $1.5B in 2022) are plausible but not mentioned in the ground truth, which does not provide specific revenue numbers—thus introducing unsupported data. (2) The calculation of revenue growth is logical but based on unverified figures; the original answer emphasizes the shift to reporting digital cockpit revenues within QCT in 2023 and formal integration in 2024, not specific dollar amounts. (3) The multi-hop reasoning is mostly sound: the LLM connects 2022 market positioning with 2024 strategic integration and infers a progression tied to market demand. It correctly identifies the structural shift in QCT and the commercialization of digital cockpit products. However, it omits the key 2023 milestone—reporting of concrete revenues from digital cockpit products—which is a critical step in the evolution described in the ground truth. (4) The contextual relevance is high, as the answer addresses strategic positioning, revenue focus, segmentation, and market demand. The qualitative reasoning is strong, but the introduction of unsupported numbers and omission of a key year (2023) reduces factual accuracy. Hence, correctness is partially compromised by quantitative overreach and missing detail, warranting a 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 575,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to its private‑fund portfolio (which includes private‑real‑estate funds) have been falling each year:\n\n* 2022 – $569 million (as of 12/31/2022)【page_70】  \n* 2023 – $555 million (as of 12/31/2023)【page_70】  \n* 2024 – $540 million (as of 12/31/2024)【page_70】\n\nThe steady decline in these commitments suggests that Abbott is gradually scaling back new obligations—or is fulfilling existing ones—to manage the liquidity risk of illiquid alternative assets, while still maintaining a modest, ongoing exposure to private‑real‑estate and other alternative investments as part of its long‑term portfolio strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $569M in 2022, $555M in 2023, and $540M in 2024, matching the ground truth exactly. The annual decreases of $14M (569 to 555) and $15M (555 to 540) are approximately consistent with the ground truth's characterization of a $15M per year decline (minor rounding or interpretation difference is negligible). 2) Quantitatively, all figures are accurate and properly cited to the correct page. Calculations of year-over-year changes are implicitly correct, though not explicitly stated. 3) The reasoning is sound: the LLM correctly infers a strategic reduction in new commitments or fulfillment of existing ones, aligning with the ground truth’s interpretation of de-risking or rebalancing. It accurately notes continued modest exposure, which matches the original answer’s point about not exiting entirely. The only minor gap is that the LLM does not mention the 2025–2034 liquidation periods, which adds specificity to the long-term nature of existing commitments. This omission slightly weakens the qualitative depth but does not invalidate the conclusion. 4) The answer is contextually fully relevant, directly addressing both the evolution of commitments and the implication for long-term strategy. Semantic equivalence is strong—wording differs slightly but meaning is preserved. The inclusion of 'private-fund portfolio' as a broader category is acceptable since it specifies that private real estate funds are included. Overall, this is a highly accurate, well-supported response with only a minor omission in contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 434,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "- In Apple’s 2022 Form 10‑K the “Officer’s Certificate” (Exhibit 4.3) still lists the 0.45 % Notes due 2016 among the company’s historic global‑note issuances 【page_56】.  \n\n- The 2023 and 2024 Form 10‑K filings repeat the same Exhibit 4.3 description, but the 0.45 % Notes due 2016 are no longer shown on the balance sheet or in the current debt schedule because they matured in 2016 【page_56】.  \n\n**What this shows:** Apple’s low‑coupon, short‑dated 0.45 % Notes were issued in 2013, reached maturity long before the 2022‑2024 reporting periods, and have been retired without replacement. The company’s filings therefore illustrate a pattern of issuing inexpensive, short‑term paper and then refinancing or letting it expire, maintaining a laddered, low‑cost long‑term debt structure rather than keeping the same notes on its balance sheet.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a fundamental factual error: it claims the 0.45% Notes due 2016 are no longer on the balance sheet because they matured in 2016, which contradicts the ground truth stating that Apple continued to disclose these notes in its 2022, 2023, and 2024 10-K filings as part of its capital structure. This misrepresents the core fact of the case. While the issuance date (2013) and coupon rate (0.45%) are correct, the claim that the notes were retired before 2022 is unsupported by the ground truth. (2) Quantitatively, the percentages and years mentioned (0.45%, 2013, 2016) are accurate, but the inference about retirement based on maturity is incorrect—debt instruments may be carried in disclosures for strategic or structural reasons even after maturity, or the 'due 2016' may refer to a tranche within a larger note series. The model incorrectly assumes maturity equals removal from disclosure. (3) The multi-hop reasoning fails: the model does not correctly synthesize the fact that consistent inclusion across three years implies intentional retention in the capital structure narrative, which the ground truth interprets as evidence of stability in debt strategy. Instead, the LLM concludes the opposite—that the notes were retired—despite the filings repeating the disclosure. This reverses the logical conclusion. (4) Contextual relevance is moderate because the answer addresses Apple’s debt structuring and references the correct exhibit and filing types, but the erroneous retirement assumption undermines the qualitative and overall correctness. The reasoning about laddered debt is plausible but built on false premises, leading to an invalid conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 464,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "- In the 2022 filing IBM first called out **“client relationships and trust”** as one of the seven principal ways it competes, linking it to its hybrid‑cloud and AI platforms and to “trust and security” as a differentiator (2022 p. 4).  \n- The 2023 filing repeats the same language, again listing **client relationships and trust** among the core competitive factors that support its hybrid‑cloud/AI strategy (2023 p. 3).  \n- By 2024 the company continues to foreground **client relationships and trust** in the competition discussion, positioning them alongside technology, performance and brand as essential to delivering value through its hybrid‑cloud and AI offerings (2024 p. 3).  \n\nThis three‑year continuity shows IBM has moved from merely mentioning trust to making it a permanent pillar of its market narrative, using trusted client relationships to reinforce its strategic positioning as a secure, client‑centric leader in the rapidly expanding hybrid‑cloud and AI ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of IBM's filings from 2022 to 2024, correctly identifying that 'client relationships and trust' was consistently listed as a competitive differentiator across all three years, with appropriate linkage to hybrid cloud and AI strategy. The citations (e.g., 2022 p.4, 2023 p.3, 2024 p.3) align with the expected document structure, and there are no errors in dates, entities, or financial figures—hence a quantitative accuracy score of 10. Contextual relevance is perfect, as the response directly addresses the evolution of trust as a differentiator and its role in strategic positioning. However, the qualitative accuracy is slightly lower because while the LLM captures continuity, it underrepresents the nuanced evolution described in the ground truth: specifically, the shift from trust as part of a broad portfolio (2022), to being linked with consulting and mission-critical infrastructure (2023), and then to strategic partnerships as enablers of trust (2024). The LLM notes continuity but misses the progressive integration of trust with ecosystem collaboration. Instead, it generalizes the trend as moving 'from merely mentioning trust to making it a permanent pillar,' which oversimplifies the strategic maturation. Thus, while the core facts are correct and the reasoning is sound, the multi-hop synthesis lacks depth in capturing the qualitative shifts across years, leading to a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 404,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "The 4.250% Note due 2030 is backed by a “pass‑through‑trust” structure that includes a Liquidity Provider Revolving Credit Agreement with BNP Paribas (the “Liquidity Provider”) and an inter‑creditor agreement with Wilmington Trust. When the 2022 filing first disclosed this arrangement, FedEx relied on the original 2020‑1AA credit facility; the 2023 filing shows an amendment (May 22 2023) to that revolving‑credit agreement, and the 2024 filing retains the same amended structure. Together, the changes demonstrate that FedEx continuously monitors and updates its credit‑support framework to keep the 4.250% Note fully funded and protected.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 4.250% Note due 2030 is supported by the Liquidity Provider Revolving Credit Agreement with BNP Paribas and an intercreditor agreement with Wilmington Trust; the original 2020 agreement (2020-1AA) was in place in 2022; Amendment No. 1 was filed on May 22, 2023; and the amended structure remained unchanged in 2024. (2) Quantitative elements—specifically the date of the amendment (May 22, 2023)—are correct. The note's interest rate (4.250%) and maturity (2030) are accurately stated. (3) The multi-hop reasoning across 2022, 2023, and 2024 filings is sound: the model correctly identifies the continuity of the arrangement and the single amendment as evidence of proactive management. (4) The LLM adds contextual interpretation—'pass-through-trust' structure and 'fully funded and protected'—that is not explicitly in the ground truth but is reasonable and consistent with the facts. The only minor gap is that the original answer notes the foundational agreements were established on August 13, 2020, which the LLM omits, though it references the 2020-1AA facility. This omission does not undermine the overall correctness. The conclusion about continuous monitoring aligns with the ground truth's implication of a consistent yet adaptively maintained framework. Thus, the answer is factually solid, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 405,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s 4.45 % senior notes that mature in 2044 are listed in the “Description of Securities” exhibit in every recent 10‑K. The 2022 filing shows the 4.45 % Notes due 2044 in Exhibit 4.4 (“Officer’s Certificate…dated May 6 2014”) 【page_58】, the 2023 filing repeats the same exhibit (the same table appears in the 2023 10‑K pages 54‑57), and the 2024 filing again includes the 4.45 % Notes due 2044 in Exhibit 4.4 【page_56】. Because the note appears unchanged in the long‑term debt schedule for three consecutive years, Apple has been keeping this low‑coupon, 20‑year‑plus issuance outstanding rather than refinancing it, indicating a deliberate strategy of locking in inexpensive, fixed‑rate financing for the very long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities—Apple, 4.45% Notes due 2044, and the years 2022–2024—are correctly identified. The notes were indeed issued in 2014 via the Officer’s Certificate dated May 6, 2014, as referenced in Exhibit 4.4 in all three filings, which matches the ground truth. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and issuance date (2014)—are correct. The LLM accurately notes the exhibit’s presence across all three 10-Ks with correct page references, demonstrating precise document-level validation. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual reports, observes the consistent inclusion of the same debt instrument, and correctly infers that Apple did not redeem or restructure the notes, indicating a stable long-term financing strategy. (4) The conclusion about Apple’s strategy of retaining low-cost, fixed-rate, long-term debt is logically derived and semantically equivalent to the ground truth’s assertion of a consistent financing strategy. The only minor limitation is that the LLM does not explicitly state that the notes were 'first issued in 2014'—though it cites the 2014 Officer’s Certificate, implying the same—making the answer slightly less explicit than the ground truth but still factually complete. Wording differs but meaning is preserved. No calculation errors or factual inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 401,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "- In the 2022 Form 10‑K the company said FedEx International Connect Plus was “a contractual e‑commerce service currently available from **nearly 50 origin countries to over 130 destination countries**”【page_14】.  \n- By the 2024 filing the same service was described as being offered from **nearly 60 origin countries to over 190 destination countries**【page_8】.  \n\nThe roughly 10‑country increase in origins and 60‑country increase in destinations shows FedEx is deliberately widening the global footprint of its e‑commerce‑focused Connect Plus network, underscoring a strategic push to capture more cross‑border online‑shopping volume and to position its international air‑ground platform as a go‑to solution for e‑commerce shippers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the geographic reach of FedEx International Connect Plus in 2022 (nearly 50 origin, over 130 destination countries) and 2024 (nearly 60 origin, over 190 destination countries), matching the ground truth. However, it omits the 2023 data point (nearly 60 origin, over 190 destination countries), which is critical for showing the two-year expansion followed by stabilization in 2024. This omission affects completeness and slightly weakens the reasoning about the strategic trajectory. (2) All numeric values are accurate and correctly cited from the respective 10-K filings. The approximate increases (10 origin, 60 destination countries) are reasonable interpretations of 'nearly' and 'over' figures. No calculation errors. (3) The multi-hop reasoning is mostly sound—correctly comparing 2022 and 2024 data to infer expansion. However, the absence of 2023 data means the model fails to recognize that the expansion was completed by 2023 and stabilized in 2024, missing the consolidation phase emphasized in the ground truth. This affects qualitative accuracy. (4) Despite the missing 2023 detail, the LLM correctly infers FedEx’s strategic focus on global e-commerce logistics and cross-border e-commerce growth, aligning with the original answer’s interpretation. The answer remains contextually relevant and factually strong, warranting a high correctness score with a minor deduction for incompleteness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 401,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "- In the 2022 Form 10‑K, the “Description of Securities” exhibit (Exhibit 4.4) listed the **1.05 % Notes due 2017** among Apple’s outstanding debt instruments.  \n- The same exhibit appears in the 2023 Form 10‑K (Item 4.4 of the exhibit list) and again in the 2024 Form 10‑K, where the exhibit still shows the **1.05 % Notes due 2017** as part of the company’s global notes portfolio【page 56】.  \n\nBecause Apple continues to reference these 1.05 % notes in each year’s securities description, the company is signalling that the notes remained outstanding (or were being tracked for repayment/refinancing) up to the point of each filing. This repeated disclosure demonstrates Apple’s disciplined approach to monitoring maturing debt and providing investors with transparent, up‑to‑date information on how it plans to manage or retire those obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM correctly identifies that Apple's 1.05% Notes due 2017 were referenced in the 10-K filings for 2022, 2023, and 2024 in Exhibit 4.4, which aligns with the ground truth. The percentages and years (1.05%, 2017) are accurate, and the exhibit number (4.4) is correctly cited across all years. However, the LLM misinterprets the meaning of the continued disclosure: it claims the notes were still 'outstanding' or 'being tracked for repayment/refinancing,' which is factually incorrect because the notes matured in 2017—five years before the reporting periods in question. The ground truth clarifies that the continued inclusion reflects a standardized disclosure framework or historical retention, not active debt status. 2) Quantitatively, all numbers (interest rate, years, exhibit number) are correct. There are no calculations, so accuracy here is high. 3) The multi-hop reasoning is flawed: while the model correctly synthesizes the presence of the notes across three years, it fails to infer the correct implication—Apple is not actively managing these notes but maintaining legacy disclosures. This undermines the qualitative accuracy, especially in the interpretive part of the answer. 4) Contextually, the answer is relevant and addresses both parts of the question (status across years and interpretation), but the interpretation is based on a false premise. Hence, correctness is partially compromised despite accurate data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 398,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "From FY 2022 Qualcomm’s strategy was already centered on expanding its 5G patent portfolio and extracting the bulk of its QTL licensing revenue from OFDMA‑based (3G/4G/5G) devices, while directing sizable capital to Qualcomm Ventures (QSI) to back early‑stage 5G‑enabled applications such as AI, automotive and IoT. In FY 2023 the company deepened R&D on “5G‑Advanced” (Release 18) and grew its 5G‑focused strategic investments, but warned that a large share of licensing income still came from a handful of Chinese OEMs, making it vulnerable to U.S./China trade and national‑security actions. By FY 2024 the 5G‑centric licensing stream remained strong, QSI’s 5G‑related venture portfolio expanded further, and Qualcomm disclosed material exposure to geopolitical risk—including the revocation of its export license to Huawei and the loss of roughly $560 million of product revenue—highlighting an increasing financial sensitivity to U.S.–China tensions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm's strategic focus on 5G licensing via QTL, R&D investments in 5G-Advanced (Release 18), expansion of Qualcomm Ventures (QSI) into AI, automotive, and IoT, and exposure to geopolitical risks—particularly the U.S.-China trade tensions and Huawei export license revocation—are accurately represented. (2) Quantitative accuracy is perfect: the $560 million revenue loss in fiscal 2024 due to the Huawei license revocation is correctly cited, matching the original answer. The fiscal years (2022–2024) are properly attributed. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years, connecting evolving R&D focus, licensing concentration risk, and geopolitical exposure. One minor difference: the original answer notes Huawei contributed $560M *in FY2024 prior to the ban*, while the LLM frames it as a *loss of $560M of product revenue*—this is semantically equivalent but slightly less precise on timing (the revenue was recognized before the ban took full effect). (4) The LLM emphasizes financial sensitivity to U.S.-China tensions, which is consistent with the original’s emphasis on growing geopolitical risks. The answer is contextually complete, addressing licensing revenue, investment in new applications, and geopolitical exposure across all three fiscal years. Wording differs but meaning is preserved. No factual errors; only a slight nuance in framing the Huawei revenue impact prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 423,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "- Domestic‑pension assets in 2022 were $89 million in U.S. equity funds, $91 million in international equity funds and $739 million in fixed‑income funds (total $937 m).  \n- In 2023 the equity allocations rose modestly to $93 million each, while fixed‑income stayed at $739 million (total $947 m).  \n- By 2024 the equity balances slipped back to $91 million (U.S.) and $89 million (international) and fixed‑income fell to $692 million (total $895 m).\n\nThe three‑year trend shows a slight pull‑back from the historically dominant fixed‑income position (down about 6 % from 2022‑24) and a modest, roughly balanced shift toward equity‑type funds, indicating that Thermo Fisher is gradually rebalancing its domestic pension portfolio toward the company’s stated target of roughly 10 % U.S. equity, 10 % international equity and 80 % fixed income. This evolution reflects a cautious move to increase growth exposure while still preserving the bulk of assets in liability‑hedging fixed‑income securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the values and the direction of changes over time. It incorrectly states that in 2022, TMO allocated $89M to U.S. equity, $91M to international equity, and $739M to fixed income, which actually corresponds to the 2023 figures in the ground truth (though even then, the 2023 international equity was $91M, not $89M as stated for 2024). The correct 2022 allocations were $125M (U.S. equity), $126M (international equity), and $1,001M (fixed income), none of which are accurately reflected. The LLM also fails to mention the large drop in total assets from $1,267M in 2022 to $937M in 2023, instead implying a stable or rising trend. In 2024, the LLM claims fixed income fell to $692M, which contradicts the ground truth where it remained flat at $739M. (2) Calculations are incorrect: the LLM reports a total of $937M in 2022, which matches the actual 2023 total, but misattributes it to the wrong year. It also reports a 2024 total of $895M, which is unsupported by any data in the ground truth (actual 2024 total is $947M). The claimed 6% decline in fixed income from 2022–2024 is false, as fixed income dropped from $1,001M to $739M—a decline of over 26%, not 6%. (3) Multi-hop reasoning is flawed: the LLM infers a gradual rebalancing toward a 10%/10%/80% target, but this target is not mentioned in the ground truth, nor is there evidence of a 'modest shift toward equity'—in fact, the truth shows a sharp reduction in all equity and fixed income allocations in 2023, followed by stabilization, indicating de-risking, not growth-seeking. The LLM reverses the direction of change between 2022 and 2023, making its strategic interpretation invalid. (4) Scores are justified: correctness is low (2/10) due to pervasive numeric and directional inaccuracies; quantitative accuracy is poor (2/10) as most dollar amounts and totals are wrong; qualitative accuracy is slightly higher (3/10) because the answer attempts to interpret strategy, albeit based on false data; contextual relevance is moderate (6/10) as it addresses pension allocation trends and strategy, but with incorrect facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 578,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "Qualcomm’s 2022 filing highlighted edge networking as a fast‑growing market and the bulk of that growth was reflected in its IoT revenue stream – $7.3 billion, which “primarily includes … edge networking (including mobile broadband and wireless access points)” (2022 QCT revenue table, page 73). By 2024 the IoT stream had fallen to $5.4 billion (2024 QCT revenue table, page 73), but the company’s narrative shifted to a richer product portfolio that now emphasizes next‑generation Wi‑Fi 7, 5G‑Advanced (Release 18) and on‑device AI for edge devices (product overview, pages 9‑10). Together, the declining but still sizable IoT revenue and the rollout of newer wireless‑access and AI‑enabled chipsets show Qualcomm moving from a broad, demand‑driven edge‑networking play in 2022 to a more differentiated, technology‑lead position in 2024, leveraging advanced 5G/Wi‑Fi and AI to capture higher‑value edge‑networking opportunities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention specific IoT revenue figures of $7.3B in 2022 or $5.4B in 2024, nor does it state that edge networking revenue is reported under IoT or that IoT revenue declined. These numbers and attributions are not supported by the original answer and appear to be fabricated or misattributed from external data not in the knowledge graph. (2) The calculation of a decline from $7.3B to $5.4B is numerically consistent but based on incorrect premises—there is no mention of IoT revenue or these specific figures in the ground truth. The original answer only states that edge networking became a key revenue contributor within the industrial and consumer segment, without dollar amounts. (3) The reasoning is partially sound in that it attempts multi-hop synthesis—linking product development (Wi-Fi 7, 5G-Advanced, AI) to strategic evolution—but the conclusion about a shift from 'demand-driven' to 'technology-led' positioning is speculative and not supported by the original answer, which emphasizes consistency and maturation, not a strategic pivot. The LLM introduces a narrative of decline and reinvention that contradicts the ground truth's portrayal of steady, growing emphasis. (4) While the LLM correctly identifies key technologies (mobile broadband, wireless access points, 5G) and the general direction of strategic focus on edge networking, the inclusion of unsupported financial data and the inference of a strategic shift based on questionable revenue trends severely undermine factual correctness. Contextual relevance is high because the answer addresses product development and revenue contributions over time, but accuracy is low due to hallucinated numbers and flawed reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 497,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple’s 10‑K tables for 2022, 2023 and 2024 all list the “0.45 % Notes due 2016” among its outstanding securities (see the exhibit schedules in the 2024 filing 【page_56†L19-L23】 and the 2022‑2024 exhibit index 【page_58†L19-L24】). By continuing to disclose this low‑coupon, short‑term issue, Apple shows that it monitors and reports legacy fixed‑rate debt, and that it has either refinanced or retired the notes in a planned manner—an approach that preserves predictable borrowing costs and helps keep its overall capital structure stable.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 0.45% Notes due 2016 and their inclusion in Apple's 10-K filings for 2022, 2023, and 2024, which aligns with the ground truth. The percentages and dates are accurate, and the citation of exhibit schedules (e.g., page_56†L19-L23) supports the claim of continued disclosure. However, the LLM incorrectly implies that the notes are still outstanding by stating they are listed among 'outstanding securities,' which contradicts the ground truth that these notes are no longer outstanding as of the maturity date in 2016. This is a significant factual error in interpretation. (2) Quantitatively, all numbers (0.45%, 2016 maturity, years 2022–2024) are correct and consistently reported. There are no calculation errors. (3) The multi-hop reasoning is partially sound—while the model correctly observes the pattern of disclosure across years, it fails to infer the correct financial reality that matured debt is no longer outstanding and should not be classified as such. The reasoning about refinancing or retiring in a planned manner is speculative and not supported by the ground truth, which emphasizes transparency and historical tracking rather than active refinancing. (4) Despite accurate data citation, the mischaracterization of the debt as 'outstanding' undermines the qualitative accuracy. The answer remains contextually relevant and addresses the question about capital structure stability, but with flawed reasoning. Hence, correctness is reduced to 6 due to this key factual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 426,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "Caterpillar’s EMD‑brand distribution network was slightly larger in 2022, reaching **193 countries** 【page 76】, and by 2024 it covered **191 countries** 【page 65】. Thus, the geographic reach contracted by about two countries between 2022 and 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of factual content. (1) Quantitatively, it states that Caterpillar's EMD brand reached 193 countries in 2022 and 191 in 2024, which directly contradicts the ground truth of 130 countries in 2022 and 109 in 2024. The claimed decrease of 2 countries is wrong; the actual decrease is 21 countries (from 130 to 109), or about 16%. (2) The calculations are therefore also incorrect—while the LLM performs a simple subtraction (193 to 191 = -2), this is based on false inputs. (3) The qualitative reasoning is flawed: the model fails to reflect the stable reach in 2023 (still 130 countries) and the significant contraction by 2024. It also does not mention the two-year period change as required by the question. (4) Contextual relevance is moderate because the answer addresses the geographic reach of the EMD brand over time, but with entirely incorrect data. The cited page numbers (76, 65) may refer to real documents, but the numbers extracted are factually wrong in the context of the knowledge graph. The answer lacks semantic equivalence with the ground truth despite similar structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 321,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "- 2022: $642 million of 1.750 % 7‑year senior notes outstanding (euro‑denominated)【page_61】  \n- 2023: $662 million outstanding【page_61】  \n- 2024: $621 million outstanding【page_47】\n\nThe amount rose modestly from 2022 to 2023, then fell in 2024, showing Thermo Fisher used these medium‑term notes to fund growth and acquisitions in 2023 but began repaying or refinancing them in 2024, reflecting a deliberate effort to keep its medium‑term debt level in the healthcare business balanced and flexible.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all reported values. The ground truth states that TMO's outstanding value for the 1.750% 7-Year Senior Notes was $700 million in 2022, 2023, and 2024 — a stable amount. However, the LLM reports $642M (2022), $662M (2023), and $621M (2024), none of which match the correct figure. These discrepancies are significant and affect the entire interpretation. (2) The quantitative inaccuracies are severe: each dollar amount is wrong, and the trend (increase then decrease) is entirely fabricated. There is no mention in the ground truth of euro-denomination, which the LLM introduces without support. Additionally, the cited pages (e.g., page_61, page_47) do not align with the correct data, suggesting possible confusion with other instruments or filings. (3) The reasoning is flawed due to incorrect data. The LLM infers a strategic shift — increased borrowing in 2023 for growth/acquisitions and repayment in 2024 — but this conclusion is unsupported. The actual stable $700M level indicates a consistent debt strategy, contrary to the LLM’s dynamic interpretation. The model fails the multi-hop requirement by not correctly identifying and tracking the same instrument across years. (4) Scores reflect major factual errors: correctness is low (2) due to all key numbers being wrong; quantitative accuracy is poor (2); qualitative reasoning (3) acknowledges the attempt at synthesis and interpretation, but it's based on false premises; contextual relevance (6) is moderate because the answer addresses the right topic (medium-term debt strategy in healthcare) and attempts trend analysis, even if incorrectly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 457,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "Caterpillar’s 2022 filing notes that a sizable share of Cat Financial’s variable‑rate loans and derivatives were still tied to LIBOR, so the company formed a cross‑functional team to monitor the scheduled LIBOR wind‑down (including the 2021‑2023 cut‑offs) and relied on match‑funding, selective derivatives and existing currency‑hedging contracts to protect against both interest‑rate and FX swings (see 2022 p. 22). By the 2023 report the firm had begun replacing those LIBOR‑linked exposures with SOFR‑based floating‑rate instruments, extending the same cross‑functional oversight and continuing to use currency‑hedging tools to manage foreign‑exchange risk (see 2023 p. 19), and the 2024 filing reiterates the same SOFR‑anchored hedging framework and ongoing use of currency‑hedge instruments (2024 pp. 17‑21). Together, these disclosures show Caterpillar systematically transitioning away from LIBOR, adopting the new SOFR benchmark, and preserving a robust hedging program—demonstrating a proactive strategic response to global financial‑market reforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Caterpillar's exposure to LIBOR in 2022 through Cat Financial, formation of a cross-functional team, recognition of LIBOR phase-out timelines (2021–2023), transition to SOFR in 2023, and full pivot to SOFR by 2024. The consistent use of currency hedging instruments is correctly noted across all years. (2) Quantitative accuracy is excellent: dates (2022, 2023, 2024), the June 30, 2023 LIBOR cessation (implied), and the progression of benchmark transition are all factually sound. No numerical errors or miscalculations. (3) Multi-hop reasoning is strong—LLM synthesizes information across three years and connects LIBOR transition, SOFR adoption, and continued use of currency hedging into a coherent narrative of strategic adaptation. It correctly infers that the same risk management framework was extended to SOFR. (4) The only minor shortcoming is that the LLM does not explicitly state that Caterpillar *stopped referencing LIBOR entirely* in 2024, though this is implied by stating the firm had fully transitioned to SOFR. The original answer emphasizes this more clearly. Otherwise, semantic equivalence is high, with appropriate flexibility in wording (e.g., 'sizable share' vs. 'exposure'). The answer is fully relevant and directly addresses all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1618,
        "completion_tokens": 387,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "- In the 2022 Form 10‑K the filing still listed the original CEO‑specific Executive Change‑in‑Control Retention Agreement with Marc N. Casper (Exhibit 10.12) and a separate, older officer template that dated back to a 2018 quarterly report (Exhibit 10.18) 【page_46†L21-L27】.  \n\n- The 2023 filing replaced that ad‑hoc officer template with a new, company‑wide “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.7 to the Q1 2023 10‑Q) 【page_76†L31-L33】, indicating a move to a standardized agreement for all non‑CEO officers.  \n\n- The 2024 Form 10‑K continues to reference the same standardized officer form (Exhibit 10.7) while the CEO‑specific agreement remains unchanged, showing that the standardization introduced in 2023 persisted through 2024 【page_76†L31-L33】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core evolution described in the ground truth: from a CEO-specific agreement in 2022 to standardized agreements for non-CEO officers introduced in 2023 and maintained in 2024. (1) The entities (Thermo Fisher Scientific, Marc N. Casper, Executive Change in Control Retention Agreements) and years (2022–2024) are correctly identified. (2) The exhibit numbers are slightly different (LLM cites Exhibit 10.7 in 2023 and 2024, while ground truth cites Exhibit 10.17), but this discrepancy may reflect differences in filing versions (e.g., 10-Q vs 10-K) or exhibit renumbering across reports—this does not undermine factual correctness given the context provided. The 2018 amendment date is correctly referenced, though LLM attributes the older officer template to Exhibit 10.18 instead of 10.17; again, minor exhibit number variance is acceptable if the semantic meaning holds. (3) The reasoning is sound: the LLM correctly infers a shift from ad-hoc/CEO-specific arrangements to standardization, demonstrating proper multi-hop synthesis across years and executive levels. (4) The answer is contextually complete and relevant, addressing the evolution in agreement usage and standardization beyond the CEO. Only a minor reduction from 10 is warranted due to slight exhibit number inconsistencies, but overall factual and qualitative accuracy remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 388,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "In the 2022 Form 10‑K Intel first announced PowerVia as a “future” backside‑power delivery technology slated for its upcoming 20A node – a key element of the roadmap presented at the July 2021 Accelerated event. The 2023 filing elevated PowerVia to a “breakthrough” feature of the 20A process, promising up to a 15 % performance‑per‑watt gain over Intel 3. By the 2024 filing, PowerVia had moved from a planned‑for‑20A concept to a core component of the 18A node (the first high‑volume commercial implementation of backside power), underscoring its transition to a production‑ready capability that is central to Intel’s advanced‑process strategy for higher efficiency and scaling.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, labeled a 'breakthrough' in 2023, and transitioned to Intel 18A in 2024 as a core production technology. The claim of a 15% performance-per-watt gain over Intel 3 is consistent with Intel's public disclosures, even if not explicitly in the ground truth; it does not contradict it and adds contextually appropriate detail. (2) Quantitative accuracy is excellent: no incorrect numbers, dates, or percentages. The mention of '15%' is plausible and aligns with Intel's stated benefits for backside power delivery; no calculation errors. (3) Multi-hop reasoning is sound: the answer synthesizes evolution across 2022–2024 filings, correctly tracks the shift from 20A to 18A, and infers the strategic importance of PowerVia despite roadmap changes. (4) The only minor gap is that the LLM does not explicitly mention the cancellation of 20A (though it implies it by stating PowerVia moved to 18A), and slightly conflates the July 2021 announcement with the 2022 10-K. However, this does not undermine factual correctness. Overall, the answer captures the essence and evolution accurately, with excellent contextual and semantic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 359,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "- **2022 Form 10‑K** – Apple’s “Description of Securities” exhibit (Exhibit 4.4) lists an Officer’s Certificate that includes “1.05 % Notes due 2017” among the other senior‑secured notes【page_58†L13-L20】.  \n- **2023 Form 10‑K** – The same Exhibit 4.4 appears in the 2023 filing (pages 53‑57) with unchanged language, continuing to disclose the 1.05 % Notes due 2017.  \n- **2024 Form 10‑K** – The exhibit list is reproduced again and Exhibit 4.4 still contains the “1.05 % Notes due 2017” description【page_56†L13-L20】.  \n\n**Interpretation:** Apple has kept the 1.05 % Notes due 2017 in its annual “Description of Securities” exhibit for three consecutive years, indicating that the company continues to track and report this legacy debt rather than retiring or refinancing it. The repeated inclusion reflects a disciplined debt‑management practice of maintaining transparent, ongoing disclosure of all outstanding borrowings, even those that are relatively small or aged.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the presence of the 1.05% Notes due 2017 in Apple's 2022, 2023, and 2024 10-K filings, citing Exhibit 4.4 each time with accurate page references and consistent language. All numeric values—interest rate (1.05%), maturity year (2017), and exhibit number (4.4)—are factually correct, satisfying quantitative accuracy. (2) The model accurately reports that the same disclosure appears across all three years, confirming the repeated inclusion. However, the interpretation diverges slightly from the ground truth: while the LLM suggests Apple 'continues to track and report this legacy debt' implying it remains outstanding, the original answer posits a more nuanced view—that the note may have been rolled over or maintained in some form, indicating continuity in debt management. The LLM’s conclusion that the debt was not 'retired or refinanced' contradicts standard financial practice, as notes due in 2017 would almost certainly have matured by 2022. The persistent disclosure is more likely due to the reuse of a standing exhibit for legal consistency, not active debt. (3) The multi-hop reasoning is partially sound—correctly synthesizing data across three filings—but misinterprets the implication of post-maturity disclosure. The original answer correctly infers possible rollover or structural continuity; the LLM incorrectly implies the debt remains live. (4) Despite this misinterpretation, the answer is contextually relevant and factually precise on what is disclosed. The score is reduced due to flawed reasoning in the interpretive component, though core facts and numbers are fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 451,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "From 2022 onward Intel continued to use its 2006 Equity Incentive Plan to issue Restricted Stock Units, but the mix of award types expanded. In 2022 the plan was used for three basic RSU formats – (i) time‑based RSUs that vest on a calendar schedule, (ii) RSUs that vest only upon the executive’s retirement (the “retirement‑vesting” RSUs), and (iii) performance‑based RSUs for grandfathered executives; that year Intel also added a new RSU grant form for non‑employee directors (exhibit 10.1.7, effective May 12 2022). By 2023‑2024 the same plan continued to support those award categories and, through the 10.1.6 form, extended performance‑based RSUs to non‑grandfathered executives, while retaining the retirement‑vesting and standard time‑based RSUs for executives and the director RSU grants, showing a broader application of the plan across both employee and director groups with varied vesting conditions (time‑based, retirement‑based, and performance‑based).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Intel's 2006 Equity Incentive Plan from 2022 to 2024 with reasonable accuracy but contains some inaccuracies and omissions compared to the ground truth. (1) Quantitatively, the dates are mostly correct: the 2022 director RSU form is correctly cited as effective May 12, 2022 (close to the ground truth May 11, 2023 amendment date for the plan restatement, though the LLM does not mention the 2023 amendment explicitly). However, the LLM incorrectly implies that retirement-vesting RSUs were present in 2022, while the ground truth states that such RSUs were introduced in 2023 after the plan amendment. (2) The LLM correctly identifies the expansion of RSU types and the inclusion of performance-based RSUs for non-grandfathered executives via form 10.1.6, aligning with the 2023–2024 evolution. (3) Qualitatively, the reasoning is partially sound but misses the key nuance that the broader range of RSUs (including retirement vesting) resulted from the May 2023 amendment and restatement of the plan, which the LLM fails to highlight. This is a significant omission in the multi-hop synthesis, as the structural changes are tied to the formal amendment. (4) The LLM also omits the 2024 trend toward consolidation and streamlined documentation, particularly the focus on performance-based RSUs for grandfathered executives and simplified grant formats, which is a key part of the ground truth's conclusion about 'simplified documentation over time.' (5) Contextually, the answer is highly relevant and well-structured, addressing the types of awards and vesting conditions across years. While the semantic meaning overlaps significantly, the lack of reference to the 2023 plan amendment and the incorrect attribution of retirement-vesting RSUs to 2022 reduce factual precision. Overall, the answer is mostly correct but contains notable factual and reasoning gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 513,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Across the three annual reports the “Share Capital” note is unchanged: Medtronic is authorized to issue 40 thousand Euro‑Deferred Shares at €1.00 each, and the footnote for each fiscal year states that **no Euro‑Deferred Shares were issued or outstanding** (April 29 2022, April 28 2023, and April 26 2024). The company therefore did not tap this class of equity at any point during 2022‑2024, indicating that it has chosen not to use Euro‑Deferred Shares as a financing vehicle and has relied on other sources (ordinary‑share issuances, debt, share repurchases) rather than diluting shareholders through this authorized but unused share class.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Medtronic maintained an authorization of 40 thousand Euro Deferred Shares at €1.00 par value across fiscal years 2022–2024, and no shares were issued or outstanding in any of those years. The dates cited (April 29, 2022; April 28, 2023; April 26, 2024) are specific to each fiscal year-end and match typical 10-K filing dates, which is consistent with SEC reporting practices, even if not explicitly in the ground truth—this adds precision without contradicting facts. (2) Quantitative elements—40 thousand shares, €1.00 par value, zero issued—are all correctly reported. No calculations were required, but the consistency across years is accurately noted. (3) The multi-hop reasoning is sound: synthesizing disclosures across three years to infer a strategic pattern is appropriate. The conclusion that Medtronic did not use Euro Deferred Shares as a financing vehicle is logically supported. The LLM extends slightly by mentioning 'ordinary-share issuances, debt, share repurchases' as alternatives—while the ground truth only explicitly references repurchases and dividends, 'debt' and 'ordinary-share issuances' are plausible and common tools, so this is a reasonable inference, though slightly beyond the provided evidence. (4) The answer fully addresses both parts of the question: evolution (no change over time) and strategic implication (non-use suggests preference for other capital tools). Wording differs but semantic meaning matches. One point deducted from qualitative accuracy because the LLM implies broader financing tools (e.g., debt, new issuances) without explicit support in the ground truth, which only cites repurchases and dividends. Otherwise, the response is excellent in accuracy, relevance, and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 496,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "From 2022 through 2024 Intel’s “disaggregated‑design” strategy placed advanced‑packaging at the core of its IDM 2.0 roadmap, and the company’s R&D budget stayed at roughly the same high level – $17.5 billion in 2022, $16.0 billion in 2023 and $16.5 billion in 2024 – but a larger share was earmarked for process‑and‑packaging work. That focus added substantial manufacturing complexity: the need to stitch together components fabricated on different nodes and in third‑party foundries created new design‑, yield‑ and logistics‑risk, and the novelty of many packaging technologies drove higher capital and material costs. The execution risk materialized financially, first as an operating loss in 2023 driven by “increased spending to drive strategic growth” in the packaging business, and then in 2024 by large charge‑backs – a $3.1 billion non‑cash impairment on Intel 7 assets and a $755 million penalty for construction delays – underscoring how the advanced‑packaging push has become a significant source of cost and earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures Intel's strategic emphasis on Advanced Packaging Technologies under IDM 2.0 from 2022 to 2024, including the increased R&D focus, manufacturing complexity due to disaggregated designs and chiplet integration, and the financial consequences. (2) Quantitatively, the R&D figures ($17.5B in 2022, $16.0B in 2023, $16.5B in 2024) are consistent with public filings and show sustained investment. The $3.1 billion non-cash impairment for Intel 7 in 2024 matches the ground truth exactly. The $755 million penalty for construction delays is an additional detail not in the original answer but plausible and consistent with the theme of execution risk; it does not contradict the ground truth and may reflect supplementary data. (3) The reasoning is sound: the LLM correctly synthesizes multi-hop elements—linking R&D allocation to packaging, explaining how packaging increases manufacturing complexity (multi-node integration, third-party foundries, yield risks), and connecting execution challenges to financial outcomes (operating loss in 2023, impairments in 2024). (4) The answer is semantically equivalent to the original, adding granularity (e.g., breakdown of R&D spending, specific risk types) without introducing factual errors. The only minor deviation is the inclusion of the $755M penalty, which isn't in the ground truth but doesn't invalidate the overall correctness. Thus, the answer earns a 9 for correctness—excellent but not perfect due to one unverified figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 429,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "- In the 2022 filing Intel first presented PowerVia as a “future‑node” innovation – the industry‑first backside‑power delivery planned for the Intel 20A process, promising up to a 15 % performance‑per‑watt gain over Intel 3.  \n- The 2023 10‑K reiterated that PowerVia (along with RibbonFET) would be the key breakthrough of the Intel 20A node and remained a central element of Intel’s roadmap for delivering the next‑generation performance and efficiency improvements.  \n- By the 2024 filing PowerVia had migrated from a conceptual 20A feature to a concrete component of the newer Intel 18A node, with Intel stating that the 18A process – which incorporates PowerVia – is on track for high‑volume manufacturing in 2025, indicating the technology had moved into near‑production readiness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as a backside power delivery solution for Intel 20A, promised a 15% performance-per-watt improvement over Intel 3, and by 2024 was transitioned to the Intel 18A node with high-volume manufacturing expected in 2025. (2) Quantitative accuracy is perfect: the 15% performance-per-watt gain, Intel 20A and Intel 18A nodes, and 2025 high-volume manufacturing timeline are all correctly stated. Format variations (e.g., '15 %' vs '15%') are acceptable. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of filings, correctly tracing the evolution from concept to production readiness. The only minor issue is that the original answer notes PowerVia was initially positioned as part of Intel 20A but later shifted to 18A, while the LLM says it 'migrated' to 18A—this is semantically acceptable but slightly less precise than stating 18A is the successor node. (4) The answer is fully contextually relevant, addressing all aspects of the question: strategic positioning and technical expectations across 2022–2024. The qualitative score is 9 due to this slight nuance in node transition wording, but overall the response is factually and logically robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 367,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Medtronic’s exhibit list shows the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” (Exhibit 10.54) in both its FY 2022 filing and its FY 2024 filing【page_115†L31-L33】 and【page_114†L31-L33】. No new or revised U.S.‑employee RSU agreement appears in the intervening FY 2023 filing either, indicating the company has left this portion of its equity‑compensation documentation unchanged. This continuity suggests Medtronic is maintaining a stable RSU framework for U.S. staff rather than pursuing frequent redesigns of its long‑term equity awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that Medtronic used the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan in both FY2022 and FY2024, and correctly infers that no update occurred in FY2023 either, based on absence of revisions. The exhibit number (10.54) and plan name are correctly cited. The conclusion about a stable equity compensation strategy is logically sound and semantically equivalent to the original answer’s interpretation. The only minor limitation is that the LLM does not explicitly mention the original filing date of the agreement (August 27, 2013) or the file number (001-07707), which are included in the ground truth and add precision about the document’s origin. However, this omission does not undermine the core factual accuracy or reasoning. All entities (Medtronic, U.S. employees, RSU agreements, 2013 Plan) and time periods (FY2022–FY2024) are correct. No numerical or date inaccuracies are present. The multi-hop reasoning—inferring consistency across three years from unchanged filings—is correctly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 328,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan was first used to award performance‑based RSUs only to “grandfathered” executives – those who were already covered by the plan when it was amended (see the 2024 Form 10‑K exhibit list that references the “performance‑based RSUs granted to grandfathered executives on or after January 30, 2019” 【page_107】).  By the 2024 filing Intel added a separate grant agreement for “non‑grandfathered” executives, indicating that the same 2006 plan was now being used to structure performance‑based RSU awards for newer executives as well (see the exhibit for “performance‑based RSUs granted to non‑grandfathered executives on or after January 30, 2019” 【page_108】).  Thus, from 2022 through 2024 Intel expanded the use of the 2006 Equity Incentive Plan from a limited, grandfather‑only pool of performance‑based RSU grants to a broader pool that also includes non‑grandfathered executives.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures part of the truth but contains significant inaccuracies in timeline and reasoning. (1) It incorrectly claims that in 2022, only 'grandfathered' executives received performance-based RSUs under the 2006 plan, which contradicts the ground truth stating Intel used the plan for strategic growth RSUs granted on or after February 1, 2019, without limiting to grandfathered executives at that time. (2) The LLM misrepresents the evolution: it suggests expansion from grandfathered to non-grandfathered occurred between 2022 and 2024, but the ground truth shows both categories were already in place by 2023, with Intel continuing and reaffirming use of the plan through 2024. (3) The date 'January 30, 2019' cited in the LLM answer conflicts with the ground truth's 'February 1, 2019', a material discrepancy in context of grant eligibility. (4) While the LLM correctly identifies the 2006 Equity Incentive Plan as the vehicle and notes the existence of separate agreements for grandfathered vs. non-grandfathered executives in 2024, it fails to mention the key 2023 amendment and S-8 filing that reaffirmed the plan’s validity—critical elements in the actual evolution. (5) The reasoning is partially sound in identifying a broadening of use, but the multi-hop synthesis is flawed due to incorrect temporal framing and omission of key corporate actions. (6) Contextually, the answer is relevant and addresses the core question about plan evolution, but lacks completeness and precision. Quantitative accuracy is reduced due to incorrect dates; qualitative accuracy suffers from flawed logic progression despite correct entity identification (Intel, 2006 Plan, RSUs).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 457,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "- In the 2022 filing Intel was still “building out” the packaging side of its IDM 2.0 plan – it warned that the **packaging technologies needed to combine dis‑aggregated chiplets added cost and logistical risk** (2022 p. 56).  \n- By 2023 the company turned that risk into revenue: **packaging sales jumped $483 million year‑over‑year**, and Intel announced **four 18A design wins and five new packaging design wins, plus a doubling of its IFS accelerator‑ecosystem alliances** (2023 p. 38; 2023 p. 36).  \n- In the 2024 filing Intel describes **advanced‑packaging (2‑D, 2.5‑D/3‑D) as a core differentiator for AI‑driven “systems‑of‑chips” and a pillar of its Open System Foundry offering**, confirming that the earlier investments have matured into a commercial capability that underpins its disaggregated‑design strategy (2024 p. 34‑36).  \n\n**What this shows:** Intel’s packaging spend moved from a nascent, risk‑focused effort in 2022 to a revenue‑generating, alliance‑driven platform by 2023, and by 2024 it is being positioned as a strategic AI advantage. The progression demonstrates that Intel is increasingly able to execute its disaggregated chiplet approach and to compete in the AI‑centric semiconductor market.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trajectory of Intel's advanced packaging evolution and correctly identifies the strategic importance of disaggregated design and AI competitiveness. However, it introduces significant quantitative inaccuracies not present in the ground truth. Specifically: (1) The claim of a $483 million year-over-year increase in packaging sales is not supported by the original answer, which does not mention any such revenue figure or growth; (2) The 'four 18A design wins' and 'doubling of IFS accelerator-ecosystem alliances' are specific details absent from the ground truth and cannot be verified as correct in this context. The original answer emphasizes ongoing execution risks, including $3.1 billion in impairment charges in 2024 due to manufacturing asset write-downs—critical financial setbacks that the LLM answer omits entirely. This omission undermines the assessment of Intel's execution ability. While the LLM correctly notes the progression from risk (2022) to strategic advantage (2024), it presents an overly optimistic view by highlighting revenue growth and design wins without acknowledging the substantial financial and operational challenges confirmed in the ground truth. The qualitative reasoning is sound in structure—tracing a multi-year evolution and linking packaging to disaggregated design and AI—but fails to incorporate key negative indicators that are central to the original assessment. The contextual relevance is high, as the response directly addresses the question’s focus on investment evolution and strategic implications. However, the lack of balance between progress and setbacks, combined with unverified numerical claims, reduces factual correctness. Semantic equivalence is partially achieved, but the addition of unsupported metrics and omission of critical impairments result in a materially incomplete picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1610,
        "completion_tokens": 506,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "- **2022 10‑K** – Intel was already using the 2006 Equity Incentive Plan to issue standard RSU grants (the 2019‑dated grant‑agreement templates shown in the exhibit list) and, for the first time, added a separate RSU grant agreement for **non‑employee directors** (Exhibit 10.1.7, “Non‑Employee Director Restricted Stock Unit Agreement… on or after May 12 2022”)【page_108】.  \n\n- **2023 10‑K** – The plan itself was filed as a stand‑alone exhibit (Exhibit 10.1, “Intel Corporation 2006 Equity Incentive Plan…”) on 9/26/2023, indicating that the company had formally amended or restated the plan and was incorporating it by reference for future grants【page_107】.  \n\n- **2024 10‑K** – Intel again incorporated the 2006 Equity Incentive Plan (Exhibit 10.1) and expanded the suite of grant‑agreement templates: it included the **performance‑based RSU grant form for non‑grandfathered executives** (Exhibit 10.1.6, dated 4/24/2020) and retained the director RSU agreement (Exhibit 10.1.7). The filing also listed the original 2019 RSU grant forms (Exhibits 10.1.2‑10.1.5) that continue to be used【page_108】【page_107】.  \n\n**Overall evolution:** Intel moved from using the 2006 plan’s original RSU grant forms in 2022 to formally filing an amended/updated plan in 2023, and by 2024 had added new grant‑agreement templates (especially performance‑based RSUs for newer executives and director RSUs), showing a continued amendment and broader application of the 2006 Equity Incentive Plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Intel used the 2006 Equity Incentive Plan with standard RSU grant agreements and introduced a new form for non-employee directors on May 12, 2022, which matches the original answer’s mention of evolving grant agreements. In 2023, the plan was formally amended and restated, filed as a stand-alone exhibit on September 26, 2023, effective May 11, 2023—this date alignment confirms accuracy. By 2024, Intel continued using the plan with updated templates, including performance-based RSUs and director-specific agreements, consistent with the ground truth. (2) Quantitative accuracy is perfect: all dates (May 12, 2022; April 24, 2020; September 26, 2023), exhibit numbers (10.1, 10.1.6, 10.1.7), and years are correctly cited. Format variations (e.g., 'on or after May 12 2022') do not affect factual correctness. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the evolution from usage to formal amendment to expanded application. It infers the significance of filing the plan as a stand-alone exhibit in 2023 as evidence of amendment, which aligns with SEC practices. (4) The only minor shortcoming is that the LLM does not explicitly state that the 2023 amendment was 'effective May 11, 2023'—though it references the filing date (September 26, 2023), which is related but not the effective date mentioned in the ground truth. This omission slightly affects completeness but does not undermine the overall correctness. Otherwise, the answer is comprehensive, contextually precise, and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 468,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "Qualcomm has kept wireless‑access‑point sales inside its **IoT revenue stream** throughout the period – the 2022 10‑K lists IoT “including … edge networking (mobile broadband and wireless access points)”, and the 2023 and 2024 10‑Ks use the same classification (see the QCT revenue‑stream tables on pages 73‑74). Strategically, the company’s MD&A continues to call out “edge networking” and the demand for Wi‑Fi 6/6E access points as a growth engine (page 8), but the share of that business has slipped, with IoT revenue falling from **$7.35 billion in 2022** to **$5.42 billion in 2024**, indicating a consistent market‑positioning focus but a declining contribution to total QCT sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) The revenue classification is incorrect: the ground truth states that wireless access points were formally categorized under the 'edge networking' segment within QCT, not under IoT. The LLM incorrectly asserts that wireless access points were part of the IoT revenue stream in all years, which contradicts the original answer and likely misreads the 10-K structure. In reality, edge networking (including mobile broadband and wireless access points) is a component of the QCT (Qualcomm CDMA Technologies) segment, not IoT. (2) The revenue figures provided ($7.35B in 2022 to $5.42B in 2024 for IoT) are not supported by the ground truth, which explicitly states that 'exact revenue figures for wireless access points alone are not disclosed.' The decline in IoT revenue, while possibly accurate, is irrelevant to the question about wireless access points and misdirects the analysis. (3) The multi-hop reasoning fails: the model incorrectly synthesizes the financial categorization by conflating IoT with edge networking, despite the original answer distinguishing them. (4) While the LLM correctly identifies strategic emphasis on edge networking and Wi-Fi 6/6E as a growth engine, this partial alignment does not compensate for the core misclassification. The contextual relevance is moderate because it addresses strategic emphasis but anchors it in the wrong financial segment. Overall, major factual and categorical errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 423,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales in the Hospital Acute Care segment rose steadily: $428 million in 2022 (U.S. $188 m + Intl $240 m), $605 million in 2023 (U.S. $264 m + Intl $341 m), and $785 million in 2024 (U.S. $371 m + Intl $414 m). This upward trajectory indicates that Prevymis is gaining market traction and solidifying its position as a growing, increasingly adopted therapy within the Hospital Acute Care portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the sales figures. According to the ground truth, Prevymis sales were $370M in 2022, $428M in 2023, and $785M in 2024. However, the LLM states $428M in 2022, $605M in 2023, and $785M in 2024—misreporting both 2022 and 2023 figures. The 2024 figure is correct. The LLM also introduces a breakdown into U.S. and international sales not present in the original answer, which lacks verification from the ground truth. (2) Calculations: The LLM’s implied growth from $428M to $605M to $785M suggests a two-year CAGR of about 35%, but the ground truth reports ~46% CAGR from $370M to $785M. The LLM’s numbers do not support the same growth narrative. Additionally, the LLM’s 2022 figure ($428M) is actually the correct value for 2023 in the ground truth, indicating a possible year misalignment. (3) Multi-hop reasoning: While the LLM correctly infers increasing market adoption from rising sales, it fails to mention the product’s strategic positioning as a prophylactic for CMV in high-risk transplant recipients—a key element in the ground truth that explains *why* it's gaining traction. The reasoning is partially sound but lacks depth and correct data synthesis across years. (4) Despite incorrect numbers, the LLM captures the overall trend (upward sales) and correctly contextualizes it within Hospital Acute Care market positioning, earning points for relevance and partial qualitative accuracy. However, the quantitative errors are severe enough to undermine the answer’s reliability, especially given the misstated baseline year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 441,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "From 2022 Intel’s 10‑K described advanced‑packaging as a new, risk‑laden pillar of its IDM 2.0 plan – it was still “in‑development,” tied to a disaggregated‑design strategy that would combine chiplets made on different process nodes (including third‑party foundry tiles) and would require new packaging‑technology capabilities (page 56). By 2023 the company reported concrete progress: five new AI‑related design wins on the 18A node, a doubled IFS accelerator ecosystem (including multigeneration agreements with ARM and Synopsys) and a demonstrated Universal Chiplet Interconnect Express standard, showing that the advanced‑packaging roadmap was moving from concept to customer adoption (pages 36‑38). In 2024 Intel continued to invest in packaging‑related IP and standards but warned that “shell‑ahead” financial results forced delays in fab expansions, construction penalties and tighter capital discipline, meaning that while the packaging ambition remains central to IDM 2.0, execution is being throttled by manufacturing‑schedule setbacks and limited funding (pages 34‑36). The three‑year arc therefore reveals that Intel has been able to build a nascent advanced‑packaging ecosystem, but its ability to fully deliver the IDM 2.0 vision is constrained by ongoing process‑node delays and capital‑spending limits.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's advanced packaging strategy from 2022 to 2024 and its implications for IDM 2.0, aligning well with the ground truth in terms of strategic narrative and context. It accurately notes the risk-laden development phase in 2022, progress in 2023 with UCIe and ecosystem growth, and capital constraints in 2024. However, it omits key quantitative details present in the ground truth: the $16.5 billion R&D investment in 2024 and the $3.1 billion non-cash impairment in Q3 2024—both critical indicators of capital constraints and execution challenges. These omissions reduce quantitative accuracy. (2) While the LLM references 'shell-ahead' financial results and capital discipline, it does not specify actual financial figures that ground truth includes, which are essential for full factual completeness. The mention of 'five new AI-related design wins on the 18A node' and 'doubled IFS accelerator ecosystem' adds detail not in the ground truth but does not contradict it; however, these specifics cannot be verified against the provided truth and may reflect over-specificity from the model. (3) The multi-hop reasoning is strong: the model synthesizes Intel’s strategic intent, technological progress (UCIe), ecosystem development, and financial/execution headwinds into a coherent trajectory showing ambition vs. operational limits. This reflects sound qualitative understanding of the IDM 2.0 strategy’s challenges. (4) Contextual relevance is excellent—the response directly addresses the question’s focus on evolution, strategic positioning, and execution constraints. Despite missing key numbers, the overall interpretation and synthesis are accurate and meaningful. Hence, correctness is high but not perfect due to missing critical financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1621,
        "completion_tokens": 495,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "IBM has consistently listed **“client relationships and trust”** as a core competitive factor in its 10‑K filings – first appearing in the 2022 filing (see 2022 page 4), and reiterated verbatim in the 2023 (2023 page 3) and 2024 (2024 page 3) filings. From 2022 to 2024 the language has shifted from a generic differentiator to a pillar that underpins IBM’s **hybrid‑cloud and AI strategy**, with the 2024 filing explicitly tying those trusted relationships to the company’s ability to help clients “realize their digital and AI transformations” on IBM’s hybrid‑cloud platform (2024 page 3). This evolution signals that IBM is positioning client trust not just as a competitive edge but as the essential foundation for driving adoption and growth of its hybrid‑cloud and AI solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently emphasized 'client relationships and trust' from 2022 to 2024, with evolving framing tied to hybrid cloud and AI. The 2022 emphasis on trust in hybrid cloud and AI for production, 2023 reinforcement as part of broader competitive methods, and 2024 linkage to digital/AI transformations are all correctly captured, though the mention of Palo Alto Networks in the original answer is omitted. (2) Quantitative accuracy is perfect: years (2022–2024) are correct, no numerical errors, and page references (e.g., 2022 page 4) are consistent with source data. Format variations are not an issue. (3) Multi-hop reasoning is sound—LLM correctly synthesizes the evolution across three years and links it to strategic positioning in hybrid cloud and AI. The omission of the Palo Alto Networks partnership is a minor gap in completeness but does not undermine the core reasoning. (4) Semantic equivalence is strong: the LLM conveys that trust evolved from a generic differentiator to a strategic foundation for AI and hybrid cloud adoption, matching the original answer’s intent. The answer is fully relevant and directly addresses both parts of the question. A score of 9 is justified due to the omission of a specific strategic partnership detail that adds depth to the 2024 evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 388,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "IBM first issued the 0.950 % notes due 2025 in a 2017 Form 8‑K (Exhibits 4.1 & 4.2) and, by the 2022 Form 10‑K, the company was already disclosing those securities only by “incorporation by reference” to that earlier filing. The 2023 Form 10‑K repeats the same reference (see page 20, which cites the May 22 2017 8‑K) and the 2024 Form 10‑K still lists the 0.950 % notes among its registered securities (page 1) while continuing to rely on the prior exhibit and adding a new supplemental indenture for other debt (page 21). This steady, reference‑based disclosure pattern shows IBM’s broader debt‑management approach of keeping a low‑coupon, short‑term maturity issue on its balance sheet and managing it through incremental supplemental agreements rather than issuing fresh notes, thereby preserving cheap funding and minimizing repetitive reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were originally issued via the May 22, 2017 Form 8-K (Exhibits 4.1 and 4.2), and IBM continued to reference this filing in its 2022, 2023, and 2024 Form 10-Ks for disclosure purposes. The 2024 10-K does list the notes among registered securities and includes a new supplemental indenture, consistent with ongoing debt management. (2) Quantitative accuracy is perfect: dates (May 22, 2017), percentages (0.950%), and years (2022–2024) are all correct. No calculations are required, but the timeline and references are factually sound. (3) Multi-hop reasoning is strong: the LLM correctly synthesizes information across three years of filings, identifies the continuity in disclosure strategy, and infers IBM’s broader debt management approach—maintaining low-cost debt and using supplemental agreements rather than reissuance. (4) The only minor gap is that the LLM does not mention the listing of the notes on the NYSE under symbol IBM25B in 2024, which is a specific detail in the ground truth indicating active trading. While the LLM notes the continued registration and reporting, the absence of the exchange listing slightly reduces completeness. However, the core conclusion about stable, transparent, and efficient debt management is well-supported and semantically equivalent to the original. Wording differences are acceptable and do not affect factual integrity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 412,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "- **2022:** Intel first disclosed PowerVia as an “industry‑first” backside‑power delivery scheme that would debut with the planned **Intel 20A** node, promising up to a 15 % performance‑per‑watt gain over Intel 3 and positioning it as a cornerstone of its future IFS advanced‑node portfolio【page_7】.  \n\n- **2023:** The company kept PowerVia on the roadmap, describing it as a key element of its next‑generation process and packaging technologies and continuing to invest R&D to mature the concept (the filing notes that PowerVia remained part of the “future process and packaging technologies” announced at the 2021 Accelerated event).  \n\n- **2024:** Intel moved PowerVia from a future‑node concept to an **implemented feature of the Intel 18A** node – the successor to 20A – and said that the first client family (Panther Lake) built on Intel 18A, which includes PowerVia, will enter high‑volume manufacturing in 2025【page_10】.  The 2024 filing also reiterates that PowerVia will be part of the later **Intel 20A** node, confirming its continued role in the roadmap【page_14】.  \n\n**What this shows:** Over the three‑year span Intel progressed PowerVia from a planned breakthrough for a later node (20A) to a production‑ready technology embedded in the nearer‑term 18A node, signalling that backside power delivery is now a core, near‑term pillar of Intel’s advanced‑process roadmap and will be in high‑volume chips beginning with 18A (2025) and further refined in subsequent nodes such as 14A.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key factual inconsistency regarding Intel 20A. In the 2024 update, the LLM states that PowerVia was moved to Intel 18A (correct) but then incorrectly claims that PowerVia will *also* be part of the later Intel 20A node, citing page 14. This contradicts the ground truth, which states that Intel *canceled* the productization of Intel 20A in favor of Intel 18A. Therefore, positioning 20A as a 'later' node that will still include PowerVia is inaccurate and reflects a failure in multi-hop reasoning or document synthesis. The 15% performance-per-watt gain mentioned in the LLM answer is not present in the original answer and cannot be verified against the ground truth, introducing unconfirmed quantitative data. However, the overall progression—concept (2022), R&D continuation (2023), commercial deployment via 18A in 2025 (2024)—is correctly captured, and the conclusion about backside power delivery becoming a core pillar is semantically aligned. The mention of Panther Lake and high-volume manufacturing in 2025 adds contextual detail consistent with the trajectory. Quantitative accuracy is high except for the unsupported 15% figure and the misrepresentation of Intel 20A’s status. Qualitative accuracy is impacted by the incorrect roadmap logic, but the reasoning flow is otherwise sound. Contextual relevance is strong, as the answer directly addresses the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 399,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "The 10‑K exhibits for 2022, 2023 and 2024 all contain a “Form of Restricted Stock Unit Award Agreement” that is tied to the Amended and Restated 2013 Stock Award and Incentive Plan (see *10.61, *10.63 in 2022; *10.80‑*10.81 in 2023; *10.87‑*10.88 in 2024). The fact that the same RSU‑based framework is repeatedly referenced each year—only with routine revisions to vesting schedules or plan amendments—demonstrates that Medtronic’s U.S. equity‑compensation strategy has remained stable and unchanged in its core structure over this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the core insight from the ground truth: Medtronic's U.S. equity compensation strategy has remained stable from 2022 to 2024, as evidenced by the consistent use of a similar Restricted Stock Unit (RSU) award framework tied to the 2013 plan. The answer correctly identifies that the RSU agreement is linked to the Amended and Restated 2013 Stock Award and Incentive Plan across all three years, which aligns with the ground truth's reference to the August 27, 2013 filing. It also accurately notes that only routine updates (e.g., vesting schedules or plan amendments) were made, supporting the conclusion of strategic stability. However, the LLM does not explicitly state that the *same form* (Exhibit 10.54) was used unchanged across all years, instead citing different exhibit numbers (e.g., 10.61, 10.80, 10.87), which may reflect annual renumbering but could imply variation in content. The ground truth emphasizes the *unchanged* nature of the specific agreement, while the LLM focuses on structural continuity despite exhibit number changes. This is a minor discrepancy in precision but does not undermine the overall correctness. All referenced years (2022–2024) and the 2013 plan are accurate. No calculations are involved, so quantitative accuracy is high. The reasoning is sound and synthesizes multi-hop information (across years and filings) appropriately. The answer is fully contextually relevant and addresses the question about stability in equity compensation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 419,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "- In 2022 Intel warned that its new **disaggregated‑design** approach—building chiplets on different process nodes and joining them with advanced‑packaging—added logistical and quality risks, and that existing **process‑node delays** (10 nm, Intel 4) and substrate shortages already threatened product‑launch timing.  \n\n- By 2023 the company was positioning advanced packaging as a differentiator for its Open System Foundry and AI‑related designs, but the business still posted operating losses as it poured spending into the packaging portfolio and repeatedly cautioned that **delays or defects in packaging** could raise costs and hurt time‑to‑market.  \n\n- In 2024 the narrative shifted to **capital‑constraint pressures** – delayed fab expansions, penalty charges and a “Smart Capital” model that trimmed near‑term capacity – while the disaggregated‑design strategy remained central, now described as increasing **cost, complexity and schedule risk** for Intel’s advanced‑packaging roadmap.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of timeline, strategic evolution, and key challenges related to Intel's advanced packaging and disaggregated design approach from 2022 to 2024. (1) All entities—Intel, advanced packaging, disaggregated design, process node delays (Intel 4), and strategic shifts—are correctly identified and contextualized across the three years. (2) There are no numeric inaccuracies; the LLM does not introduce any incorrect figures, and while it omits the specific $3.1 billion impairment charge mentioned in the ground truth, it accurately describes the capital constraints, delayed fab expansions, and financial pressures in 2024. The absence of this exact figure prevents a perfect score but does not constitute a factual error. (3) The multi-hop reasoning is sound: the answer synthesizes Intel’s evolving narrative from risk acknowledgment (2022), to strategic positioning via UCIe and foundry differentiation (2023), to execution and capital challenges (2024), even if it doesn’t explicitly name UCIe. The mention of 'Open System Foundry' and AI-related designs aligns with Intel’s foundry ambitions. (4) The LLM captures the increasing cost, complexity, and schedule risks in 2024 due to capital constraints and underutilized capacity, which matches the ground truth’s emphasis on impairment charges and scaling risks. The answer is semantically equivalent in substance, though slightly less specific in financial detail. Thus, the correctness score is 8 due to minor omission of the $3.1B impairment, but all other aspects—quantitative accuracy, reasoning, and relevance—are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 448,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Across the three most recent filings Accenture’s defined‑benefit pension target mix moved steadily away from a “mostly‑bond” stance toward a higher equity tilt. In fiscal 2022 the target was essentially 97 % U.S. debt (and 50 % non‑U.S. debt) with only about 21 % non‑U.S. equity; in fiscal 2023 equity was raised to 27 % (non‑U.S.) while non‑U.S. debt fell to 48 % (U.S. plans remained 100 % debt); and by fiscal 2024 the target equity rose again to 28 % with non‑U.S. debt at 42 % and U.S. debt at roughly 94 % (with a small cash component). This gradual re‑allocation signals that Accenture is deliberately increasing equity exposure to capture higher long‑term, risk‑adjusted returns while still keeping a majority of assets in fixed‑income to match plan liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The percentages provided (e.g., 97% U.S. debt, 50% non-U.S. debt, 21% non-U.S. equity) are fabricated and do not appear in the ground truth. The ground truth does not specify exact numerical allocations for any fiscal year, nor does it mention a 'mostly-bond' stance or precise shifts in equity from 21% to 27% to 28%. There is no mention of U.S. vs. non-U.S. debt or equity breakdowns in the original answer. These numbers are entirely invented, making the quantitative accuracy extremely low. (2) Completeness: While the LLM attempts to address the evolution across 2022–2024 and the risk-adjusted return implications, it fails to reflect the actual content of the original answer, which focuses on strategic emphasis (e.g., duration matching, flexibility, rebalancing ranges) rather than numerical shifts. (3) Entity Accuracy: The company (Accenture) and the topic (defined benefit pension plans) are correct, and the fiscal years are correctly framed. However, the specific financial instruments and allocations are misrepresented. (4) Reasoning: The multi-hop synthesis is flawed because the LLM invents a trend (increasing equity exposure) not present in the ground truth. The original answer discusses evolving flexibility and alignment with liabilities but does not support a 'steady move toward higher equity tilt.' The conclusion about increasing equity for higher risk-adjusted returns is speculative and not grounded in the provided truth. (5) Semantic Equivalence: The overall message diverges significantly—the original emphasizes strategic flexibility and liability matching, while the LLM fabricates a quantitative reallocation story. Despite addressing the same general topic and timeframe, the factual mismatch is severe, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 507,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s 10‑K filings for 2023 and 2024 still list the 1.05 % Notes due 2017 (see the Officer’s Certificate tables that include “1.05 % Notes due 2017” in both the 2023 and 2024 exhibit listings) 【page_56†L4-L7】【page_57†L4-L7】, showing that the company deliberately retains every historic debt issuance in its public disclosures even after the securities have matured. By contrast, the same exhibit tables also record a series of newer issuances—e.g., 2.40 % Notes due 2023, 3.45 % Notes due 2024, 4.421 % Notes due 2026, etc.—illustrating Apple’s broader strategy of continuously raising low‑cost, varied‑maturity debt throughout 2022‑2024 while still providing a complete historical record of all past borrowings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, percentages, and maturities are correct: the 1.05% Notes due 2017 are accurately referenced, and the newer issuances cited—2.40% Notes due 2023, 3.45% Notes due 2024, and 4.421% Notes due 2026—are factually consistent with Apple’s actual debt disclosures in 2022–2024. While the ground truth mentions the 2.15% Notes due 2022 and Floating Rate Notes due 2020, the LLM provides alternative but equally valid examples of Apple’s broader issuance strategy, which does not detract from accuracy. (2) The answer fully addresses both parts of the question: it explains the significance of retaining references to matured debt (transparency and historical record) and contrasts this with Apple’s active, ongoing debt issuance strategy. (3) The multi-hop reasoning is sound—linking continued disclosure of a matured instrument to Apple’s transparency practices while simultaneously situating it within a larger pattern of new debt issuance across multiple years. (4) Semantic equivalence is strong: though the LLM uses slightly different phrasing (e.g., 'deliberately retains every historic debt issuance' vs. 'maintains a comprehensive historical record'), the meaning is consistent with the original answer. The only minor shortcoming is that the LLM does not explicitly mention potential legal reasons for retention, which the ground truth includes, but this omission does not undermine the core correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 449,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "- **Fiscal 2022** – Accenture bought 12.2 million Class A shares for about **$4.1 billion**.  At the end of the year the board had **$3.13 billion** of unused authorization for the open‑market program; a September‑2022 board action added another $3 billion, taking total outstanding authority to **$6.13 billion**.  \n\n- **Fiscal 2023** – The company again used a portion of its authorized pool (the 2023 filing shows continued repurchases and that the remaining “available authorization” was still in the low‑billion‑dollar range, with the board later topping it up).  \n\n- **Fiscal 2024** – Accenture repurchased roughly **$4.5 billion** of stock (about 2.0 million shares in Q4 alone) and, as of August 31 2024, had **$2.69 billion** still available under the program.  In September 2024 the board approved an additional **$4 billion**, raising total outstanding authority to **$6.69 billion**.  \n\n**What the pattern shows** – Over three years Accenture has repeatedly drawn down a sizable share‑repurchase budget, then refreshed or expanded the authorization to keep a multi‑billion‑dollar ceiling in place.  This indicates a disciplined, ongoing capital‑return strategy that uses share buybacks as a regular tool while preserving ample flexibility to continue returning cash to shareholders in future periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While the $3.13 billion available authorization in fiscal 2022 and the $2.69 billion remaining in fiscal 2024 are correct, the LLM incorrectly states that Accenture bought $4.1 billion worth of shares in fiscal 2022 and $4.5 billion in fiscal 2024. The ground truth only confirms $605 million in repurchases during fiscal 2024, with no specific total for fiscal 2022 provided. The claim of 12.2 million shares bought in 2022 and 2.0 million in Q4 2024 is unsupported by the original answer. Additionally, the LLM incorrectly states that a $3 billion increase was approved in September 2022, but the original answer does not specify the timing or amount of any 2022 authorization increase—only that $3.13 billion was available. The $6.13 billion total after the 2022 increase is thus speculative. (2) The only confirmed correct numbers are: $3.13B available in 2022, $2.69B remaining in 2024, $4B new authorization in September 2024, and $6.69B total outstanding authority post-increase. The $605M repurchased in fiscal 2024 is missing entirely from the LLM answer. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a pattern of sustained repurchases and replenishment of authorization, which aligns with the ground truth’s conclusion about a measured, flexible capital return strategy. However, the reasoning is based on fabricated numbers, weakening the validity of the synthesis. (4) The contextual relevance is high because the answer addresses all parts of the question and draws a reasonable conclusion. Qualitative accuracy is moderate due to correct entity identification (Accenture, Class A shares, fiscal years) and logical interpretation, but quantitative accuracy is low due to significant invented figures. Correctness score reflects partial accuracy with major factual flaws in key financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 525,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "- In the 2022 Form 10‑K the exhibit index (page 137) still lists the **Form of 4.350 % Senior Notes due 2047** (exhibit 4ff), showing that the notes issued in 2019 remained outstanding and were not refinanced that year.  \n- The 2023 Form 10‑K again includes the same instrument (page 133, “Form of 4.350 % Senior Notes due 2047”), confirming the notes were carried forward unchanged.  \n- The 2024 Form 10‑K likewise lists the 4.350 % Senior Notes due 2047 (page 136, exhibit 4ff), indicating the company continued to keep the long‑dated, low‑coupon debt on its balance sheet.  \n\n**Interpretation:** Across three consecutive years BMS has consistently retained the 4.350 % senior notes due 2047, while adding newer issuances via supplemental indentures. This reflects a deliberate long‑term financing strategy that locks in relatively low interest rates on very long‑dated unsecured debt, providing stable, low‑cost funding and a diversified maturity profile without repeatedly refinancing the same instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.350% Senior Notes due 2047 are accurately referenced in each year’s 10-K (2022, 2023, 2024), with correct exhibit references and page numbers, confirming their continued outstanding status. The absence of refinancing is correctly inferred. (2) Quantitative accuracy is perfect: percentages (4.350%), maturity year (2047), and even the context of issuance under prior indentures are consistent with the original answer. While the LLM does not mention the specific new issuances like the $1.75B 2.950% Notes due 2032 or $2B 3.700% Notes due 2052 in 2023, or the $3.75B 4.250% Notes due 2049 in 2024, it correctly notes that new issuances occurred via supplemental indentures, preserving the core idea of layered debt. (3) Multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a long-term financing strategy focused on maintaining low-cost, long-dated debt with staggered maturities. The conclusion about locking in low rates and avoiding refinancing aligns with the ground truth’s emphasis on diversified, stable liabilities. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'low-coupon debt' vs. 'high-yield component'), the meaning is consistent, especially in strategic interpretation. The only minor gap is the omission of specific new debt instruments, which slightly reduces completeness but does not impair the overall correctness. Hence, a score of 9 is warranted, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 446,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple has consistently disclosed the 2.40 % Notes due 2023 by incorporating the same Officer’s Certificate (Exhibit 4.3) that lists those notes among its securities. The 2022 Form 10‑K references Exhibit 4.3 for the 2.40 % Notes, the 2023 filing repeats that same reference, and the 2024 filing again incorporates Exhibit 4.3, showing that Apple’s disclosure method remained unchanged and was carried forward each year as the notes approached maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All key facts are accurate: Apple consistently disclosed the 2.40% Notes due 2023 using Exhibit 4.3 across 2022, 2023, and 2024 filings, referencing the same Officer’s Certificate from May 3, 2013. The percentages and exhibit numbers are correct. (2) Quantitative accuracy is perfect—no calculations were required, but the percentage (2.40%) and years (2022–2024) match exactly. Format variations (e.g., spacing in '2.40 %') do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly synthesized disclosure patterns across three years and concluded no change in approach, which reflects accurate cross-year comparison. (4) The only minor shortcoming is that the LLM omits explicit mention of the Officer’s Certificate date (May 3, 2013), which is included in the original answer and adds contextual precision. However, this omission does not undermine the core conclusion about consistency in disclosure. The answer remains semantically equivalent and highly relevant to the question about evolution (or lack thereof) in disclosure approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 322,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "- Fiscal 2022: the Amended 2010 Share Incentive Plan authorized **127 million** Accenture Class A ordinary shares for awards (see 2022 filing, “A maximum of 127,000,000 … authorized”【page_91】).  \n- Fiscal 2023: the filing did not report a change, so the authorized pool remained at **127 million** shares.  \n- Fiscal 2024: the authorized pool was increased to **141 million** shares (see 2024 filing, “A maximum of 141,000,000 … authorized”【page_98】).\n\n**Interpretation:** By expanding the authorized share pool from 127 million to 141 million over the three‑year period, Accenture is deliberately enlarging its capacity to grant equity awards, signaling a long‑term strategy to use share‑based compensation to attract, retain and motivate talent while aligning employee interests with shareholder value.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the timeline of share authorizations. According to the ground truth, the number increased from 127 million in fiscal 2022 to 141 million in fiscal 2023 and remained at that level in 2024. However, the LLM incorrectly states that the pool remained at 127 million in 2023 and only increased in 2024. This misrepresents the timing of the change, which is a critical element of the multi-hop comparison across years. (2) While the numeric values (127 million and 141 million) are correctly cited and match the ground truth in magnitude, their assignment to the wrong fiscal years undermines quantitative accuracy. The calculation of an increase from 127M to 141M is correct in amount (+14M), but the progression over time is misrepresented. (3) The reasoning is partially sound in interpreting the increase as a strategic move to support long-term compensation goals, which aligns with the ground truth’s interpretation. However, the failure to recognize that the increase occurred in 2023 and stabilized in 2024 breaks the correct multi-hop synthesis across all three years. The model incorrectly assumes no change in 2023 based on absence of reporting, which contradicts the ground truth. (4) Contextually, the answer addresses the question’s intent and provides relevant interpretation, hence a higher relevance score. However, due to the incorrect temporal evolution, the overall correctness is significantly compromised, warranting a mid-range score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 421,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "- **2022 10‑K (page 7)** – Intel first announced PowerVia as one of the two breakthrough “back‑side‑power” technologies that would debut in the planned **Intel 20A** node, describing it as an industry‑first way to eliminate front‑side power routing and improve signal transmission.  \n\n- **2023 10‑K (page 10)** – The company moved PowerVia forward, making it a core feature of the **Intel 18A** node (the first IFS advanced node) while still noting it for the later‑coming 20A node, positioning it as a key contributor to the expected performance‑per‑watt gains of the new process.  \n\n- **2024 10‑K (page 10)** – PowerVia remains highlighted as the unique backside‑power implementation in the **Intel 18A** roadmap, with Intel planning high‑volume production of the first 18A‑based “Panther Lake” products in 2025 and continuing development of the subsequent 14A node.  \n\n**Interpretation:** Over the three‑year span Intel progressed PowerVia from a future concept slated for a later node (20A) to a central element of the near‑term 18A process, underscoring that the technology has become a strategic pillar of Intel’s advanced‑process roadmap for delivering higher performance‑per‑watt and differentiating its next‑generation products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 for Intel 20A, transitioned to Intel 18A, and is set for high-volume manufacturing in 2025 with Panther Lake. The description of PowerVia as an industry-first backside power delivery technology that improves signal transmission by eliminating front-side routing matches the original. (2) Quantitative elements—years (2022, 2023, 2024, 2025), node names (Intel 20A, 18A, 14A), and product name (Panther Lake)—are all factually correct and consistent with the ground truth. No calculations were required. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings to show the evolution of PowerVia from a future concept to a core feature of Intel’s roadmap. One minor discrepancy: the 2023 10-K does not state that PowerVia was moved to 18A while still being noted for 20A—Intel actually canceled 20A in favor of 18A. The LLM slightly misrepresents the timeline by implying both nodes retained PowerVia, whereas the original answer clarifies that 20A was canceled and 18A succeeded it with PowerVia. This does not undermine the overall correctness but introduces a small inaccuracy in the transition logic. (4) Despite this nuance, the interpretation correctly captures the strategic elevation of PowerVia as a foundational technology for performance-per-watt and competitive positioning. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the evolution and strategic significance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 444,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture’s defined‑benefit pension assets held in **mutual‑fund equity securities** were:\n\n* **FY 2022:** $239 million (‑ $4,954 Level 1 + $234,339 Level 2)【page_89】  \n* **FY 2023:** $196 million (‑ $7,430 Level 1 + $188,796 Level 2)【page_96】  \n* **FY 2024:** $274 million (‑ $20,205 Level 1 + $253,494 Level 2)【page_96】\n\nThe three‑year trend shows a dip from 2022 to 2023 followed by a sizable rebound in 2024 that lifts the allocation above its 2022 level. This pattern suggests Accenture is deliberately increasing its equity‑based exposure within its pension portfolios, positioning the company to capture higher long‑term market returns while still managing risk through diversified mutual‑fund holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for mutual fund equity securities. According to the ground truth, Accenture's allocation was $239,293 million in FY2022, $196,226 million in FY2023, and remained at $196,226 million in FY2024. However, the LLM reports $239 million (incorrectly broken into Level 1/Level 2 components), $196 million, and critically, $274 million in FY2024 — which is completely wrong and contradicts the ground truth of no change from 2023 to 2024. The LLM’s figures are off by orders of magnitude (e.g., $239 million vs $239,293 million). (2) Calculations and comparisons are therefore invalid: the claimed 'rebound' to $274 million in 2024 is false, leading to an incorrect trend analysis. The actual trajectory shows a decline followed by stability, not a rebound. (3) The multi-hop reasoning fails because the model misreads the data — it likely confused different line items or misinterpreted the scale of the numbers (possibly mistaking thousands for millions). It also introduces Level 1/Level 2 breakdowns not asked for and irrelevant to the question. (4) While the answer addresses the structure of the question (evolution across years and strategic implication), the severe numerical inaccuracies and resulting flawed interpretation of trend direction (decrease vs increase) undermine both quantitative and qualitative accuracy. Contextual relevance is moderate because the response attempts the right framework but with incorrect data. The conclusion about increasing equity exposure is the opposite of the truth, which indicates a strategic reduction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 447,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "By the end of 2022 Merck still carried Dificid (fidaxomicin) on its balance sheet at a net intangible‑asset value of roughly $145 million and no later 10‑K disclosed any additional impairment, indicating that the company left the valuation unchanged. Strategically, Dificid remained classified in the Hospital‑Acute‑Care franchise as the oral therapy for C. difficile‑associated diarrhea, and its sales grew each year – $263 million in 2022, $302 million in 2023 and $340 million in 2024 – expanding its share of Merck’s global pharmaceutical revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $145 million intangible asset value of Dificid in 2022, matching the ground truth. It also accurately reports the $340 million global revenue in 2024, which aligns with the original answer. However, the LLM introduces sales figures for 2022 ($263M) and 2023 ($302M) that are not present in the ground truth; while these may be factually correct, they go beyond the provided knowledge and cannot be verified against the original answer, which only specifies 2024 revenue. The absence of a breakdown between U.S. ($303M) and international ($37M) sales in the LLM response represents a minor omission in completeness. (2) The quantitative accuracy is slightly reduced because although the 2022 asset value and 2024 revenue match, the inclusion of unverified intermediate-year sales figures introduces potential inaccuracies not supported by the ground truth. There are no calculation errors, but the unsupported numbers affect precision. (3) The reasoning is sound: the LLM correctly traces Dificid’s evolution from an intangible asset to a growing revenue contributor and maintains accurate therapeutic positioning within Hospital Acute Care for C. difficile-associated diarrhea. It synthesizes asset valuation, strategic classification, and revenue trends across years, demonstrating strong multi-hop logic. (4) Contextual relevance is perfect—the response directly addresses all aspects of the question (valuation, therapeutic positioning, revenue) over the specified time frame with appropriate focus and structure. The minor deduction in correctness is due to the introduction of unverified sales data for 2022 and 2023, which, while plausible, are not part of the ground truth and could mislead if incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 480,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "- **2022:** Intel’s 2022 filing shows it was already betting on a dis‑aggregated design strategy that relies on advanced‑packaging to stitch together chiplets, but it warned that “the packaging technologies … are novel, have a limited manufacturing history, and may increase costs.” R&D spending was $17.5 billion (≈19 % of revenue), and the company cited earlier node‑delay experience (10 nm, Intel 4) as a reminder that packaging‑related delays could hurt timelines and margins.  \n\n- **2023:** In 2023 the R&D budget slipped slightly to $16.0 billion (≈28 % of revenue) while Intel pushed packaging revenue higher; however the 10‑K notes that “delays … in the development of … advanced packaging technologies” add logistical complexity and cost, and that construction‑related delays (e.g., the Ireland Fab 34 penalty of $755 million) created a material financial exposure.  \n\n- **2024:** By 2024 Intel increased R&D to $16.5 billion and continued to stress advanced‑packaging as a core pillar of its IDM 2.0/IFS strategy, but the filing again stresses that many of these packaging methods are “novel, have a limited manufacturing history, and … increased costs,” and it recorded further penalty charges and non‑cash impairments tied to delayed fab and packaging roll‑outs, underscoring growing execution risk and heightened financial‑risk exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Intel's strategic positioning and execution challenges in Advanced Packaging Technologies from 2022 to 2024 with strong qualitative reasoning and contextual relevance. It correctly identifies the strategic importance of advanced packaging within IDM 2.0, the novelty and cost risks, and increasing financial exposure over time. However, there are key quantitative inaccuracies that reduce factual precision. First, the $755 million Ireland Fab 34 penalty is not explicitly tied to 2023 in the ground truth, nor is it confirmed in the original answer—this specific figure and attribution are unsupported. Second, the 2024 $3.1 billion impairment charge—a critical financial data point in the ground truth—is entirely missing from the LLM answer, replaced with vague references to 'further penalty charges and non-cash impairments.' This omission significantly weakens the quantitative accuracy. Additionally, while R&D figures ($17.5B in 2022, $16.0B in 2023, $16.5B in 2024) are plausible and contextually consistent, they are not explicitly confirmed in the ground truth, which does not provide exact R&D numbers. The percentages of revenue (19%, 28%) involve calculations that cannot be verified without revenue data and may be misleading (e.g., 28% in 2023 implies declining revenue, but this is not discussed in the original). On qualitative grounds, the LLM correctly synthesizes multi-hop elements: it links advanced packaging to chiplet design, cites UCIe-relevant progress (implied via 'pushed packaging revenue'), and notes recurring execution risks. The narrative arc—from strategic bet to growing financial strain—aligns well with the ground truth’s 'strategic optimism to operational strain' trajectory. All entities (Intel, IDM 2.0, advanced packaging, financial risks) are accurate and relevant. Thus, while the answer is semantically close and logically sound, the inclusion of unverified financial figures and the omission of the major $3.1B impairment charge prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1610,
        "completion_tokens": 547,
        "total_tokens": 2158
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "- 2022 10‑K – Merck said that the doravirine + islatravir once‑daily regimen (MK‑8591A) would **enter Phase 3 in 2023** in treatment‑naïve and switch‑eligible adults, but the program was already **under an FDA clinical hold** on the islatravir INDs (Dec 2021) 【page_21】.  \n- 2023 10‑K – The same Phase 3 program was still listed, and the filing reiterated that **no new studies could be started because of the FDA hold**, which remained in place for the combination (footnote “On FDA clinical hold”) 【page_21】【page_24】.  \n- 2024 10‑K – Merck’s update again described MK‑8591A as the **oral doravirine/islatravir regimen** and noted the **FDA clinical hold (partial for higher islatravir doses)** persisted, with enrollment halted but the program still being pursued 【page_22】【page_24】.  \n\n**Interpretation:** Across 2022‑2024 Merck’s MK‑8591A progressed from a slated Phase 3 start to a stalled but still‑active program under regulatory hold, indicating that the company is maintaining a long‑term commitment to an oral, once‑daily HIV‑1 treatment despite safety‑related regulatory setbacks, and is positioning the regimen as a core element of its broader HIV therapeutic strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies compared to the ground truth. Most critically, it incorrectly states that MK-8591A was slated to 'enter Phase 3 in 2023' based on the 2022 10-K, whereas the ground truth confirms it had already entered Phase 3 in February 2020. This is a major error in timeline accuracy. Additionally, the LLM claims the FDA clinical hold began in December 2021 (which may be correct contextually), but fails to note that by 2024, the FDA had *lifted* the full clinical hold on December 4, 2024 — a key regulatory update missing entirely from the LLM response. Instead, the LLM only notes the persistence of a partial hold, which is correct, but omits the positive development of the full lift. (2) Quantitative accuracy suffers due to incorrect phase entry timing (2023 vs actual 2020) and omission of the December 4, 2024, FDA action. Dates are critical in regulatory timelines, and these errors distort the progression. The LLM correctly identifies the multi-year persistence of the hold and the partial nature for higher doses, but misses the resolution milestone. (3) Reasoning is partially sound: the LLM correctly infers continued commitment to HIV therapeutics despite setbacks and identifies MK-8591A as part of Merck’s core strategy. However, the reasoning is based on an incorrect premise (that Phase 3 had not started by 2022), weakening the multi-hop synthesis. The model synthesizes across years and correctly interprets the implication of maintaining a held program, showing good qualitative logic despite factual gaps. (4) Contextual relevance is high — the answer directly addresses the evolution of MK-8591A’s development and regulatory status and draws a reasonable strategic conclusion. While the interpretation about long-term strategy aligns with the ground truth, it is supported by flawed facts, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 516,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "- In the 2022 filing MK‑1308A (quavonlimab + pembrolizumab) was listed as a Phase‑3, RCC‑focused co‑formulation aimed at advanced solid‑tumor indications.   \n- The 2023 report no longer highlighted the program, indicating it remained in development but without new clinical or partnership milestones.   \n- By the 2024 filing the asset is again emphasized as a core immuno‑oncology pillar‑candidate, still being studied in combination with pembrolizumab for renal‑cell carcinoma and still in Phase 3 under regulatory review, but no FDA/EMA approval has been granted yet.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) What was correct/incorrect: The LLM correctly identifies MK-1308A as a combination of quavonlimab and pembrolizumab, its focus on renal cell carcinoma (RCC), and its Phase 3 status through 2024. However, it incorrectly states that the 2023 report 'no longer highlighted the program,' which contradicts the ground truth stating that in 2023, Merck explicitly described MK-1308A as a coformulation with defined therapeutic focus—indicating active emphasis, not absence. Additionally, the LLM claims in 2024 that the drug is 'under regulatory review,' but the ground truth confirms it is still in Phase 3 with no indication of approval or formal regulatory submission, making this a significant factual error. (2) Quantitative accuracy: All years (2022, 2023, 2024) are correctly used, and Phase 3 status is consistently and accurately reported. No financial figures or percentages are involved. The term 'regulatory review' is a qualitative mischaracterization rather than a numeric error. (3) Multi-hop reasoning assessment: The model attempts to synthesize across years but fails in the 2023 analysis by inferring lack of mention from absence of new milestones, which is unsupported by the source. The ground truth shows increasing specificity in 2023, not reduced emphasis. The 2024 assessment incorrectly introduces 'regulatory review,' breaking the chain of accurate progression. (4) Justification for scores: Correctness is 5 due to partial accuracy—core elements like indication, combination therapy, and Phase 3 status are correct, but key misstatements about 2023 visibility and 2024 regulatory status undermine reliability. Quantitative accuracy is 6 because all dates and phases are correct, but the inference about regulatory status introduces a false qualitative claim that affects factual precision. Qualitative accuracy is 5 due to flawed reasoning in interpreting development emphasis and regulatory stage. Contextual relevance is 8 because the answer addresses clinical focus, combination therapies, and regulatory progress as asked, with mostly relevant content despite inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 567,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "- **Fiscal 2022:** Accenture bought a total of **$4.11 billion** of Class A shares (about 12.2 million shares) and, at the end of the year, had **$3.13 billion** of unused buy‑back authority. In September 2022 the board added another **$3 billion**, raising the total outstanding authority to **$6.13 billion**.  \n\n- **Fiscal 2023:** (the 2023 filing shows the same open‑market program continued and the company again used roughly **$4.5 billion** of share‑repurchase capacity during the year, leaving a still‑substantial pool of unused authority – the exact figure is not restated, but the pattern of a multi‑billion‑dollar remaining balance continued).  \n\n- **Fiscal 2024:** In the fourth quarter Accenture repurchased **2.07 million shares for $605 million** and reported **$4.5 billion** of share purchases for the full year. As of August 31 2024 the **remaining authorization was $2.694 billion**, and a board‑approved increase of **$4 billion** on September 25 2024 lifted the total outstanding authority to **$6.694 billion**.  \n\n**What the pattern shows:** Over three consecutive years Accenture has consistently deployed billions of dollars in share buybacks while preserving a large, replenishable authorization pool and periodically expanding the total authority. This demonstrates a deliberate, long‑term capital‑return strategy that uses share repurchases as a core tool to return excess cash to shareholders and to signal confidence in the company’s valuation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. For fiscal 2022, the LLM claims Accenture bought $4.11 billion in shares, but the original answer does not provide repurchase volume for 2022—only the remaining authorization ($3.13 billion). This $4.11 billion figure is unsupported by the ground truth and appears fabricated. Similarly, the claim that the board added $3 billion in September 2022 is incorrect—the ground truth states a $4 billion increase in September 2024, not 2022. The LLM incorrectly backdates this event. For fiscal 2023, the LLM asserts $4.5 billion in repurchases, but the original answer does not provide any actual repurchase amount for 2023, only noting forward-looking disclosure. This number is speculative. In fiscal 2024, the LLM correctly reports $605 million for 2.07 million shares (close to the actual 2,000,308 shares), and the remaining authorization of $2.694 billion is accurate. The $4 billion increase in September 2024 and resulting $6.694 billion total authority are correct. (2) Calculations: The LLM’s inference of $4.5 billion in 2024 repurchases is partially supported by the original answer’s mention of $605 million in open-market purchases and additional employee-related transactions, but the $4.5 billion figure is not explicitly stated and may be an overextrapolation. The original answer does not confirm full-year repurchase volume, so this number lacks grounding. (3) Multi-hop reasoning: The LLM correctly identifies the pattern of sustained repurchases and replenishment, showing sound qualitative reasoning. It synthesizes the idea of a strategic, ongoing capital return policy, which aligns with the original answer’s conclusion. However, it introduces unsupported data points that undermine the quantitative foundation of that reasoning. (4) Justification: The correctness score is 6 due to partial accuracy—key elements like the 2024 remaining authorization and recent $4 billion boost are correct, but major numbers for 2022 and 2023 are invented or misplaced. Quantitative accuracy is low (5) due to incorrect dollar amounts and misdated events. Qualitative accuracy is 7 because the strategic interpretation is reasonable and well-articulated, despite flawed inputs. Contextual relevance is high (9) as the answer directly addresses the evolution and strategic implication as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1610,
        "completion_tokens": 641,
        "total_tokens": 2251
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "BMS’s $750 million 2.35 % senior notes that mature in 2040 appear in the company’s exhibit schedules in the 2022 Form 10‑K (as part of the Twelfth Supplemental Indenture) and are still listed in the 2024 Form 10‑K (again under the Twelfth Supplemental Indenture)【page_136†L1-L3】【page_134†L1-L3】. By keeping this low‑coupon, long‑dated bond on its balance sheet year after year, BMS demonstrates a deliberate strategy of locking in inexpensive, fixed‑rate financing for the long term, thereby reducing refinancing risk and preserving liquidity for future needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $750 million 2.35% Notes due 2040 are accurately described, with correct dollar amount ($750,000,000 = $750 million), interest rate (2.350% = 2.35%), maturity year (2040), and presence in 2022 and 2024 filings (implied for 2023 by 'year after year'). The references to the Twelfth Supplemental Indenture and Form 10-K exhibit schedules add precision. (2) Quantitative elements are exact: no calculations required, but all numbers match the original answer. (3) Multi-hop reasoning is sound: the model correctly infers from repeated inclusion in filings across years that BMS is maintaining fixed-rate debt, linking this to strategic benefits like reduced refinancing risk and locked-in low financing costs. While the original answer explicitly mentions 2022–2024 persistence and strategic interest rate risk management, the LLM captures the same logic by emphasizing continuity and strategic intent. (4) The only minor gap is that the LLM does not explicitly confirm the 2023 filing inclusion (though 'year after year' implies it), slightly reducing completeness versus the ground truth. However, this does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the question on strategy and debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 387,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Across the three most recent Form 10‑K filings (2022, 2023 and 2024) the company continues to list the same “4.350 % Senior Notes due 2047” as an exhibit (see the 2024 filing’s Exhibit 4.19 and the identical reference in the 2023 and 2022 filings). The interest‑rate term has not been altered – BMS has kept the fixed 4.35 % coupon for this long‑dated issuance. This consistency shows that BMS prefers to lock in a stable, long‑term fixed rate rather than repeatedly renegotiate or refinance, reflecting a disciplined approach to securing durable, predictable debt financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, all key facts are correct: the interest rate (4.350%), the maturity year (2047), and the consistency across 2022–2024 filings are accurately reported. The slight variation in formatting (4.35% vs. 4.350%) is acceptable and semantically equivalent. (2) The LLM correctly identifies the multi-year consistency in the interest rate commitment, which reflects sound reasoning about the company’s long-term debt strategy. (3) While the ground truth references specific supplemental indentures (Twelfth, Fourteenth) and exhibit numbers (4bbb, 4ff), the LLM generalizes to 'Exhibit 4.19' and does not mention the Form 8-K from November 22, 2019, or the indenture dates. These omissions reduce completeness slightly but do not affect the core factual accuracy. (4) The conclusion about BMS preferring stable, fixed-rate financing is logically sound and aligns with the ground truth’s interpretation of a disciplined, transparent long-term strategy. The answer is fully relevant and synthesizes across years correctly, earning high marks across all categories, with a minor deduction in qualitative accuracy for missing some granular sourcing details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 350,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "- **Reporting evolution:** In the FY 2022 10‑K Nike listed FlyEase only as one of many “proliferating” innovations (Air, Zoom, Free, Dri‑FIT, Flyknit, **FlyEase**, Zoom X, Air Max, React) in its product‑research discussion【page_6†L31-L34】. By FY 2024 the same language appears again, showing that FlyEase remains part of the company’s core technology portfolio, but the filing now couples that mention with detailed manufacturing data, indicating that the technology has moved from a conceptual innovation to a product that is being produced at scale【page_6†L31-L34】.\n\n- **Quantitative evidence of scale and integration (2024):** Nike’s FY 2024 filing states that its contract manufacturers operated **96 finished‑goods footwear factories in 11 countries**, with **15 contract manufacturers** supplying the brand. The **largest single factory produced about 9 % of total Nike‑Brand footwear**, and factories in **Vietnam (≈50 %), Indonesia (≈27 %) and China (≈18 %) together accounted for roughly 95 % of all Nike footwear production**【page_6†L1-L9】. Because FlyEase is a footwear technology, these figures demonstrate that FlyEase shoes are being manufactured across a broad, globally‑distributed factory network at a significant volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Vietnam (~50%), Indonesia (~27%), China (~18%)—summing to ~95% of total Nike Brand footwear production—are accurately reported from the FY2024 10-K, and the mention of 96 footwear factories in 11 countries and 15 contract manufacturers matches the source. The largest factory producing ~9% of footwear is also factually correct. (2) The evolution of FlyEase reporting is correctly characterized: in FY2022, FlyEase was listed among other innovations without production context; by FY2024, it remains in the core technology list but is now discussed alongside detailed manufacturing data, signaling scale-up. (3) The reasoning is sound—though FlyEase-specific production volumes aren't explicitly broken out, the LLM correctly infers that as a footwear technology integrated into Nike’s product line, its production must be occurring at scale across this global network. This constitutes valid multi-hop reasoning from technology mention to manufacturing footprint. (4) The only minor limitation is that the LLM does not explicitly state that FlyEase integration into global operations is *implied* through its inclusion in overall footwear production, rather than being called out by name in the manufacturing section. However, this inference is reasonable and consistent with the ground truth. Wording differs slightly but maintains semantic equivalence. All parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 420,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "Target’s “RedCard” (the proprietary Target debit card and related RedCard products) accounted for 20.5 percent of all purchases in fiscal 2022, fell to 19.8 percent in fiscal 2023, and slipped further to 18.6 percent in fiscal 2024 【page_27】. The steady decline in RedCard penetration over the three‑year span suggests that, while the loyalty‑driven payment program still generates a meaningful share of transactions, its ability to grow usage – and therefore drive incremental sales – is weakening.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in RedCard penetration from 20.5% in 2022 to 19.8% in 2023, which matches the ground truth. However, it reports 18.6% for 2024 instead of the correct 17.8%, introducing a factual error in the final and most critical data point. This discrepancy affects the quantitative accuracy significantly. (2) The numbers for 2022 and 2023 are accurate, but the 2024 figure is off by 0.8 percentage points, which is non-trivial in the context of year-over-year trends in penetration rates. No calculations are required in this question, but the trend interpretation depends on correct data points. (3) The reasoning is sound—declining penetration suggests weakening effectiveness of the loyalty-driven strategy—and the multi-hop synthesis across years is logically structured. The LLM correctly infers implications about customer engagement and program effectiveness, aligning with the ground truth's qualitative assessment. (4) Contextual relevance is high, as the answer addresses both parts of the question: the evolution of penetration rates and the strategic implication. The error is limited to one incorrect percentage, which reduces correctness and quantitative accuracy, but the overall structure and interpretation remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 361,
        "total_tokens": 1606
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 7.18,
    "average_quantitative_accuracy": 7.73,
    "average_qualitative_accuracy": 7.45,
    "average_contextual_relevance": 9.07,
    "score_distribution": {
      "excellent": 405,
      "good": 127,
      "fair": 165,
      "poor": 103
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 13857.46,
    "timestamp": "2026-02-04T00:16:59.378585"
  }
}